data_1v06_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1v06 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.0 t -96.9 93.39 6.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 110.222 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 23.7 p -87.72 144.2 26.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.808 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.501 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 13.8 mm -85.21 -37.95 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.32 0.581 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -151.91 131.38 12.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 18.4 t-80 58.62 -138.43 0.81 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.492 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 51.5 t -98.61 37.18 1.52 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 110.155 176.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -113.44 137.59 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.44 172.02 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.044 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.7 141.12 51.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.976 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.13 5.56 54.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.212 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 50.1 m -99.08 147.98 24.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.46 137.0 49.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.195 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 39.9 mt -113.12 144.06 43.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.257 -174.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 40.8 t -153.17 92.03 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.558 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -86.43 123.1 31.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.1 m170 . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.849 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 75.2 m95 . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.9 pt20 -111.71 165.37 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -85.34 160.37 19.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.501 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 3.6 t -61.33 -45.21 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.6 0.714 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -58.12 -23.16 53.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.9 -52.01 11.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.009 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -68.11 -40.37 82.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.43 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.74 76.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.615 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.734 178.059 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.3 t80 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.76 19.31 44.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.388 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.4 t -66.92 -25.21 66.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.535 0.207 . . . . 0.0 111.312 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -99.17 -27.98 13.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.13 161.84 10.85 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.899 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -117.65 106.19 12.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.75 -0.725 . . . . 0.0 110.404 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.7 ttpp -90.56 119.32 30.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 -175.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 tt -60.08 113.13 2.17 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.09 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.421 HD22 ' HB2' ' A' ' 283' ' ' ASP . 95.4 mt -86.25 -52.14 5.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.452 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.2 t -148.57 158.98 44.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.783 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 4.1 t60 -135.71 136.24 40.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -127.3 139.52 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.571 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.481 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 28.5 mt-10 -108.95 106.4 16.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 110.063 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.637 -172.463 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.238 0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.82 152.95 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.992 0.901 . . . . 0.0 113.068 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.33 114.08 26.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.985 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.8 ttmt -107.09 116.12 31.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.445 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 34.1 mt -119.88 131.23 55.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.205 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.6 m -95.45 114.95 26.77 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.553 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.4 m-85 -100.99 164.93 11.58 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.337 0.589 . . . . 0.0 112.471 -171.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.421 ' HB2' HD22 ' A' ' 265' ' ' LEU . 6.6 t70 -133.19 129.12 20.75 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.019 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.531 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 83.6 Cg_endo -81.44 9.12 4.01 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 122.155 1.903 . . . . 0.0 112.348 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 -47.97 0.99 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' HG21 ' A' ' 286' ' ' THR . 5.0 t -124.53 98.19 5.63 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 291' ' ' LEU . 5.2 p -67.52 -6.98 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.464 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.28 -12.6 61.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.538 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -66.2 -37.18 84.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.38 126.98 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.467 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.542 HD22 HG23 ' A' ' 287' ' ' VAL . 1.8 mt -59.97 135.32 57.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.179 0.489 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -109.45 119.24 38.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 6.5 m -109.35 139.96 43.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 73.5 t -136.75 131.47 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -105.67 117.62 34.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.319 169.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 9.6 p -134.53 178.17 7.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.877 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -81.06 165.54 21.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.658 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -68.75 -22.91 64.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.839 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.76 19.62 15.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.241 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.23 120.04 79.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.351 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.5 136.46 13.93 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.482 2.122 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.434 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 79.9 m-85 -124.2 124.96 43.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 8.0 t80 -77.53 93.07 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 332' ' ' ASP . 65.8 t -80.47 130.34 36.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.57 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 56.6 tttp -56.39 133.9 53.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.824 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.8 m-20 78.95 -17.13 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.02 0.825 . . . . 0.0 112.283 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.56 ' HE2' ' O ' ' A' ' 327' ' ' GLU . 11.6 tttp -111.36 -41.86 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.073 0.463 . . . . 0.0 111.571 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 104.71 -155.13 17.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -61.66 113.61 2.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.96 0.41 . . . . 0.0 110.587 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.428 ' CB ' HG21 ' A' ' 328' ' ' ILE . 19.7 m -131.08 164.94 24.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.043 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 t -160.99 179.76 8.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.636 0.255 . . . . 0.0 110.771 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.445 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 67.3 m-85 -91.53 -34.32 14.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.07 70.31 40.77 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 42.4 Cg_exo -59.13 -30.49 93.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.792 2.328 . . . . 0.0 113.425 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 16.0 m -70.35 -25.31 63.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.9 tp -87.54 -42.36 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.296 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 325' ' ' CYS . 9.2 m -53.87 -46.08 71.22 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.877 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.9 -27.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.14 -30.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 0.0 110.417 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -92.85 -38.58 11.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.613 -173.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -114.67 -4.02 12.81 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 122.118 -0.364 . . . . 0.0 111.859 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.01 78.87 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 48.1 mt -118.67 111.26 37.87 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 122.834 -0.216 . . . . 0.0 110.697 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.95 118.18 5.5 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.426 2.084 . . . . 0.0 110.82 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 85.0 m -117.76 153.94 32.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.3 0.571 . . . . 0.0 112.056 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 69.0 m -89.6 166.26 13.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.848 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . 0.56 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 25.2 tt0 -77.02 125.16 28.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.315 0.246 . . . . 0.0 111.194 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -80.64 168.0 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.791 175.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -133.06 151.1 52.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.1 mm -59.41 111.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.269 0.557 . . . . 0.0 109.717 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.56 1.15 21.64 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.413 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 304' ' ' VAL . 16.8 m-20 -79.0 128.75 33.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.457 0.646 . . . . 0.0 111.047 176.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.8 137.91 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.796 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 55.6 m -103.44 133.76 47.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.302 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.0 144.9 29.52 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.258 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.498 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.2 Cg_endo -87.98 166.09 7.12 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.143 2.562 . . . . 0.0 112.624 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 119.07 6.02 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.623 2.215 . . . . 0.0 111.157 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 118.34 -19.35 10.79 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.611 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.521 ' HD1' ' HB3' ' A' ' 341' ' ' ASP . 21.7 t-80 -69.32 127.44 92.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.98 -13.98 40.66 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.178 2.585 . . . . 0.0 113.115 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.57 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 32.9 t70 -90.31 -23.25 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.83 87.36 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.054 0.454 . . . . 0.0 109.786 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.84 -44.16 92.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.603 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.18 80.15 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.914 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.507 -178.29 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.614 -0.571 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.5 t -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.1 p -85.94 149.6 25.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.83 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.488 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.2 mm -79.23 -43.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -151.99 137.56 17.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.549 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.537 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 25.7 t-80 54.54 -136.53 1.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.537 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 47.8 t -100.25 37.6 1.64 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.145 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -111.12 137.14 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.347 0.594 . . . . 0.0 111.443 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.12 175.9 5.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.42 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -69.23 135.17 50.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.03 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.36 48.39 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.471 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.7 m -96.13 143.93 26.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.3 -0.45 . . . . 0.0 109.923 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -109.48 141.73 41.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.824 0.345 . . . . 0.0 110.548 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 46.5 mt -118.12 143.13 46.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.24 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.3 t -151.0 99.45 2.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.42 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.559 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 35.4 m-85 -91.97 132.41 36.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.7 m170 . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.76 -171.309 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 65.3 m95 . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 121.66 0.743 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 18.4 pt20 -128.66 161.21 30.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.685 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -82.06 158.1 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.423 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.6 t -58.25 -46.46 88.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.613 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.416 ' HA ' HG22 ' A' ' 211' ' ' ILE . 25.6 mt-10 -57.55 -23.09 48.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.625 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.29 -45.94 14.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.0 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.75 -35.91 65.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.983 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.08 67.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.709 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.748 . . . . 0.0 109.691 173.549 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.538 ' HH ' ' HD3' ' A' ' 284' ' ' PRO . 4.4 t80 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 121.018 0.437 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.15 27.52 12.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.022 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.0 p -68.84 -22.61 64.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -99.52 -27.15 13.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.26 0.552 . . . . 0.0 109.811 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 150.19 154.39 6.43 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.946 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 5.5 mp -113.25 98.66 7.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.952 -0.624 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 8.4 tptp -77.99 115.62 17.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.489 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.5 tt -59.84 111.74 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 283' ' ' ASP . 82.8 mt -83.13 -51.87 7.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.061 0.458 . . . . 0.0 111.061 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.8 t -148.54 161.81 40.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.161 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.597 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -141.59 150.38 41.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.027 -168.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.79 135.58 12.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.884 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -87.18 106.06 17.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.196 -168.147 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 m -134.6 157.07 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.695 0.76 . . . . 0.0 112.099 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 90.0 mt -94.18 109.66 21.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.467 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -96.35 112.36 24.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.665 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 279' ' ' LYS . 29.6 mt -121.42 142.75 49.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.527 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 32.3 m -108.26 117.04 33.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.418 ' HZ ' HD13 ' A' ' 280' ' ' LEU . 96.2 m-85 -105.6 157.45 17.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.554 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.42 ' HB2' HD23 ' A' ' 265' ' ' LEU . 7.2 t70 -126.82 132.79 24.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.714 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.538 ' HD3' ' HH ' ' A' ' 257' ' ' TYR . 65.2 Cg_endo -79.4 5.55 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.017 1.811 . . . . 0.0 112.174 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.7 -13.29 42.33 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.2 t -153.89 133.13 12.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.057 0.456 . . . . 0.0 110.156 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.0 -8.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.856 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.4 -23.2 63.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.314 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.87 -2.93 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.075 0.464 . . . . 0.0 110.248 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.07 169.95 29.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.949 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.71 152.16 19.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.559 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -126.4 120.47 29.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.448 ' N ' HD23 ' A' ' 292' ' ' LEU . 8.9 m -111.25 138.58 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 75.6 t -137.38 137.59 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.42 121.1 40.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.809 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -138.38 173.29 11.76 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -68.64 160.87 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.122 0.486 . . . . 0.0 111.23 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.658 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -64.62 -27.42 68.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.31 24.99 4.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.433 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -75.31 121.34 84.99 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.206 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.28 131.27 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.279 1.986 . . . . 0.0 111.805 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -121.82 116.62 24.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.532 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 29.1 t80 -73.25 108.69 6.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.896 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 74.1 t -99.12 137.96 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.427 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.654 ' HB3' HG11 ' A' ' 333' ' ' VAL . 60.0 tttp -56.78 124.46 18.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.792 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 77.95 -1.45 2.58 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.878 0.736 . . . . 0.0 112.177 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -117.16 -33.16 4.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 90.25 -157.13 25.64 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -60.87 113.02 2.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.294 0.547 . . . . 0.0 110.019 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.43 ' CB ' HG21 ' A' ' 328' ' ' ILE . 15.4 m -125.23 166.75 15.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.6 t -161.58 -178.58 6.68 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.461 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 33.3 m-85 -90.32 -41.48 11.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 110.292 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.35 77.31 68.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.948 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.03 -38.7 93.27 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.042 2.495 . . . . 0.0 113.448 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 2.3 p -62.34 -24.96 67.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.253 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.74 -45.24 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.768 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.2 m -59.03 -39.78 83.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.094 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.504 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.5 p -70.31 -19.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.531 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.25 -40.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.295 0.569 . . . . 0.0 110.33 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.76 -58.28 3.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.771 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -95.51 -14.93 23.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.727 0.299 . . . . 0.0 111.284 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 84.33 10.31 80.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.876 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.8 mt -109.09 115.69 56.49 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.71 111.29 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.351 2.034 . . . . 0.0 110.184 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 67.8 m -108.48 157.18 18.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.987 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 164.68 23.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.992 171.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.43 123.57 35.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.236 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.43 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.4 161.83 4.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.98 152.56 51.9 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 38.9 mm -54.87 114.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 0.0 110.742 -174.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.64 -3.59 19.69 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.714 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.422 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 4.2 m-20 -75.42 128.15 34.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.531 0.665 . . . . 0.0 111.161 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 305' ' ' LYS . 0.9 OUTLIER -87.48 131.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.586 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 42.3 t -95.14 134.7 37.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.975 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.62 145.34 30.84 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.154 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.5 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.9 Cg_endo -87.95 166.44 7.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.833 2.355 . . . . 0.0 112.188 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.88 126.3 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.588 2.192 . . . . 0.0 111.35 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.69 -12.99 35.49 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.773 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.11 131.44 81.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 -33.25 87.96 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.43 2.754 . . . . 0.0 113.504 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.26 -22.3 44.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.57 0.224 . . . . 0.0 111.051 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.8 84.36 4.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 98.8 mt -73.49 -46.2 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.245 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.54 52.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 110.284 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.83 -177.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 N-CA-C 110.688 -0.543 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.1 t -100.38 85.85 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.052 0.454 . . . . 0.0 110.18 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.2 p -85.78 142.02 29.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.436 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.7 mm -88.6 -45.34 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.203 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.479 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 78.8 t90 -151.64 130.12 12.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.659 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 30.4 t-80 55.68 -144.99 0.64 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.659 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 30.6 t -94.79 44.74 1.1 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.357 0.599 . . . . 0.0 109.898 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -115.38 136.66 52.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.298 0.57 . . . . 0.0 111.155 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.89 174.45 6.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.297 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -63.63 133.76 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.036 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.11 19.17 34.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.802 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.57 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.8 m -104.51 149.13 25.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.454 ' O ' HG11 ' A' ' 294' ' ' VAL . 8.9 mtt180 -113.6 138.67 49.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.93 0.395 . . . . 0.0 111.471 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 67.7 mt -117.6 145.93 43.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.973 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 9.1 t -156.46 95.57 1.58 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.871 0.367 . . . . 0.0 110.643 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -86.21 118.1 25.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 0.0 110.656 -178.01 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 52.8 m95 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.066 0.46 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.5 pt20 -97.91 157.21 16.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.462 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.72 162.96 21.61 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -61.38 -51.34 74.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.145 0.497 . . . . 0.0 109.811 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 36.9 mt-10 -56.34 -22.88 33.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.585 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.33 -45.34 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.565 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 70.1 t80 -75.96 -41.04 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 0.0 110.474 176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.73 68.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 8.7 ttm180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.065 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.554 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.3 t80 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.49 67.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.978 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 53.0 m -70.15 -7.13 39.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.785 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -103.51 -31.58 9.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.275 0.56 . . . . 0.0 109.672 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.04 153.69 6.76 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.027 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.2 mp -119.17 103.33 9.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.604 0.361 . . . . 0.0 110.652 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 33.8 ttpt -86.7 123.73 32.18 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.004 0.431 . . . . 0.0 111.06 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.426 ' HG ' HD11 ' A' ' 280' ' ' LEU . 2.7 tt -65.36 97.75 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.654 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 283' ' ' ASP . 88.1 mt -71.63 -49.49 39.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.901 0.381 . . . . 0.0 110.461 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.1 t -151.46 165.95 32.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.274 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.756 ' HD2' ' HE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -131.44 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.618 -169.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -140.82 121.66 14.46 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.59 99.66 9.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.204 0.526 . . . . 0.0 109.841 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.6 t . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.92 -172.234 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.15 154.75 41.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.759 0.79 . . . . 0.0 112.421 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.432 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 84.6 mt -92.5 107.42 19.2 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.729 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.0 ttmt -106.69 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.452 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . 43.6 mt -118.19 135.45 54.24 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.3 m -91.47 110.28 21.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.55 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 90.3 m-85 -99.7 162.15 13.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.095 0.474 . . . . 0.0 111.48 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.1 t70 -130.65 135.25 27.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.316 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.554 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -81.28 11.12 3.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.162 1.908 . . . . 0.0 112.43 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.26 -8.87 62.87 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 t -153.33 106.02 2.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.481 -0.86 . . . . 0.0 109.537 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.94 -8.88 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.497 0.665 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.99 -26.31 68.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.104 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.34 -44.31 25.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.17 153.32 5.93 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.474 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -74.34 143.33 44.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.854 0.359 . . . . 0.0 110.592 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.06 118.75 28.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 140.84 41.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.9 t -134.14 131.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -104.19 118.6 37.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 12.3 p -136.13 165.33 25.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.668 0.271 . . . . 0.0 111.493 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -61.72 162.13 9.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.208 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.8 mm? -70.79 -21.31 62.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 -175.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.0 22.5 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.16 119.14 74.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.339 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.24 134.47 9.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.203 1.935 . . . . 0.0 111.713 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.505 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -120.71 119.4 32.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.415 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 35.8 t80 -75.13 93.55 2.8 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.23 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 71.5 t -79.87 138.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.728 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.553 ' HB3' HG11 ' A' ' 333' ' ' VAL . 57.4 tttp -61.26 134.88 57.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.226 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 7.1 m-20 76.27 -33.36 0.21 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.562 0.745 . . . . 0.0 112.087 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -86.68 -43.86 12.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.787 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 98.18 -155.96 20.36 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.99 112.89 1.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.037 0.419 . . . . 0.0 110.459 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.418 ' CB ' HG23 ' A' ' 328' ' ' ILE . 17.7 m -129.84 165.66 21.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.697 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.3 t -161.57 -176.88 5.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.586 0.231 . . . . 0.0 110.389 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.756 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 36.6 m-85 -92.91 -40.93 10.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.88 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -120.99 76.38 30.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.298 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.1 Cg_exo -57.27 -35.51 98.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.908 2.405 . . . . 0.0 113.148 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 3.7 p -65.19 -26.06 67.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.8 -47.08 8.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.278 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.2 m -57.87 -38.6 76.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.103 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.574 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.6 p -68.79 -20.23 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 111.464 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.99 -49.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.269 0.557 . . . . 0.0 109.816 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -67.41 -55.59 13.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.158 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -100.68 -9.68 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 78.23 15.91 80.36 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.592 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.0 mt -110.87 114.49 54.22 Favored Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 122.846 -0.208 . . . . 0.0 110.798 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.49 104.64 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.57 2.18 . . . . 0.0 110.33 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.5 m -104.39 154.07 20.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.046 -169.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.7 165.1 23.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.946 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.36 123.91 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.219 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.418 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.2 160.92 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -134.16 154.68 51.07 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 49.3 mm -52.29 115.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.324 0.583 . . . . 0.0 111.426 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.28 -2.9 22.27 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.073 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.437 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 6.5 m-20 -75.29 124.58 27.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.305 0.553 . . . . 0.0 110.78 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -86.76 143.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 55.8 m -112.16 132.52 54.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.985 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.404 HD12 ' OD2' ' A' ' 341' ' ' ASP . 82.1 mt -100.64 147.65 33.92 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.705 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.515 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 55.1 Cg_endo -91.89 170.33 2.87 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.495 2.797 . . . . 0.0 112.828 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.74 133.17 23.19 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.534 2.156 . . . . 0.0 111.38 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.74 55.85 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.629 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.402 ' HD1' ' HB3' ' A' ' 341' ' ' ASP . 18.2 t-80 -77.73 125.2 86.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.95 -21.73 73.37 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.047 2.498 . . . . 0.0 112.823 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 34.0 t70 -80.0 -27.38 39.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.683 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.36 88.85 3.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.816 169.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 83.7 mt -71.74 -43.49 69.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.368 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -114.41 73.93 0.85 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.598 -178.65 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 N--CA 1.479 0.662 0 N-CA-C 110.118 -0.762 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -100.4 87.79 3.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -82.97 143.9 30.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.945 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.11 -42.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.34 0.591 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -148.08 135.21 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.167 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.57 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 30.9 t-80 55.15 -135.01 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.57 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 12.0 p -97.64 24.4 6.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -104.6 139.83 38.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 112.064 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 174.94 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.391 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.57 140.53 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.607 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.82 11.1 54.35 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.976 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.555 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 80.9 m -103.34 146.92 27.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -113.99 139.88 48.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.938 0.399 . . . . 0.0 110.779 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.523 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.6 mt -116.17 146.47 42.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.375 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.1 96.45 1.95 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.18 119.18 29.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.6 m170 . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.969 -178.201 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.406 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 89.3 m95 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.561 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 7.9 pt20 -108.96 161.55 15.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.541 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.13 162.91 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.555 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.43 -47.15 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.18 -22.22 50.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.75 -55.22 5.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.531 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.561 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 76.3 t80 -65.04 -41.0 95.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.83 -33.5 71.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.445 175.532 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.421 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 24.5 t80 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.116 0.484 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 106.48 6.94 35.28 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.549 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.9 m -67.1 -14.15 62.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 111.409 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.99 -30.82 11.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 0.0 109.294 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 149.3 161.15 9.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.526 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -122.6 99.1 6.22 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 122.483 0.313 . . . . 0.0 110.711 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 68.2 tttt -82.37 123.63 29.28 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.134 0.493 . . . . 0.0 111.525 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.97 95.35 0.26 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.584 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.419 HD22 ' HB2' ' A' ' 283' ' ' ASP . 77.9 mt -71.47 -47.38 56.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 0.0 110.565 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.8 t -151.24 162.55 40.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.444 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.97 143.32 40.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.049 -168.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -149.57 137.49 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.366 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -98.99 97.17 8.35 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.445 -0.724 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.409 -171.287 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.8 m -132.17 156.85 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.661 0.744 . . . . 0.0 112.062 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.34 107.57 19.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.382 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.1 ttmm -98.94 106.25 18.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.4 HD13 ' CE1' ' A' ' 312' ' ' PHE . 21.1 mt -112.95 138.04 50.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.529 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 4.1 m -103.09 110.19 22.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.447 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 92.1 m-85 -100.33 162.66 12.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.032 0.444 . . . . 0.0 111.849 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.419 ' HB2' HD22 ' A' ' 265' ' ' LEU . 14.6 t70 -128.89 134.44 26.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.14 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 76.8 Cg_endo -80.0 12.55 2.43 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.259 1.973 . . . . 0.0 112.291 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 -14.45 49.61 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 t -153.15 127.42 9.16 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.822 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.28 -8.45 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.215 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -50.74 -41.06 56.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.996 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -77.05 -43.51 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.89 167.51 11.52 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.67 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 83.2 mt -90.24 140.56 29.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 0.0 111.192 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -113.05 122.85 48.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.435 ' N ' HD23 ' A' ' 292' ' ' LEU . 20.8 m -111.67 135.18 52.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.0 t -133.06 136.27 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.066 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.406 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 52.8 mt-10 -115.57 121.94 44.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 109.772 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.5 p -138.56 175.34 9.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.748 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -70.03 158.21 36.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.998 0.427 . . . . 0.0 110.832 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -64.77 -17.07 63.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.282 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -97.49 13.58 29.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.88 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -72.26 120.98 83.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.574 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.85 141.52 13.46 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.239 1.959 . . . . 0.0 111.662 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.496 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.1 m-85 -127.84 127.27 43.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.538 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 31.2 t80 -80.09 96.32 6.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.34 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 332' ' ' ASP . 53.6 t -82.31 130.88 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.907 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.473 ' HB3' HG11 ' A' ' 333' ' ' VAL . 56.1 tttp -55.86 134.21 51.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.35 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.2 m120 77.64 -23.08 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.872 0.733 . . . . 0.0 112.202 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -96.08 -43.49 7.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.0 111.446 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.56 -126.27 8.43 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.24 118.47 29.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.804 0.802 . . . . 0.0 109.958 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 20.1 m -131.45 166.57 21.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.527 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.0 t -161.52 -175.57 4.84 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.476 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 48.2 m-85 -92.77 -41.45 10.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 0.0 110.403 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.53 76.64 45.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 77.6 Cg_exo -55.25 -31.48 76.58 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.246 2.631 . . . . 0.0 113.597 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 33.9 t -71.22 -23.21 61.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.257 0.551 . . . . 0.0 110.096 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 61.2 tp -87.89 -44.85 10.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.116 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.4 HG23 ' SG ' ' A' ' 325' ' ' CYS . 8.3 m -54.5 -41.03 69.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.028 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.547 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.5 p -73.41 -18.28 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 96.1 t -88.24 -35.64 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.317 0.58 . . . . 0.0 110.013 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.26 -53.23 5.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.128 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -103.84 -4.04 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 70.02 26.33 74.45 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.564 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.5 mt -116.63 110.97 41.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 122.753 -0.263 . . . . 0.0 110.59 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -71.79 115.83 4.46 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.493 2.129 . . . . 0.0 110.399 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 73.7 m -116.96 156.98 26.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.437 0.637 . . . . 0.0 111.977 -169.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 58.6 m -79.99 165.95 22.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.255 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.59 140.42 29.57 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.89 164.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.357 0.599 . . . . 0.0 110.62 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -118.78 142.35 47.78 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 30.8 mm -60.22 114.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 109.843 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.3 -4.24 20.07 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.956 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.509 ' HB3' HG11 ' A' ' 304' ' ' VAL . 70.7 m-20 -73.84 130.55 40.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.97 133.29 33.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.057 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 50.9 m -98.12 134.83 40.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.142 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 43.8 mt -108.94 142.06 24.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.041 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.51 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.2 Cg_endo -85.06 168.43 10.53 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.325 2.683 . . . . 0.0 112.362 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.426 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 56.6 Cg_endo -71.37 114.3 3.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.797 2.332 . . . . 0.0 111.687 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.01 -20.67 8.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.813 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.474 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 28.9 t-80 -67.11 126.66 92.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.64 -27.25 50.28 Favored 'Trans proline' 0 N--CA 1.476 0.453 0 C-N-CA 123.721 2.947 . . . . 0.0 113.738 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.474 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 2.7 m-20 -79.96 -22.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.326 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.14 85.99 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.254 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.63 -43.88 70.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.572 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -107.04 42.52 1.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 1.1 t80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.941 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.6 t -86.19 92.06 8.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.079 0.466 . . . . 0.0 110.161 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.7 p -79.15 147.07 32.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.5 mm -79.5 -45.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.62 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -149.4 132.73 16.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.595 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 28.0 t-80 57.19 -139.46 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.595 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 44.5 t -97.5 36.74 1.45 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.384 0.612 . . . . 0.0 110.202 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.56 140.73 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 111.701 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.99 170.83 8.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -67.57 133.68 49.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.957 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.17 44.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.49 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.558 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 87.7 m -86.65 142.07 28.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -110.62 136.78 49.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.172 0.511 . . . . 0.0 110.941 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 57.1 mt -112.41 147.48 36.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.967 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.0 t -150.87 93.01 1.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.97 0.414 . . . . 0.0 110.234 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.453 ' CD2' ' HG ' ' A' ' 292' ' ' LEU . 78.3 m-85 -83.57 119.14 24.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.7 m170 . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.062 0.458 . . . . 0.0 110.559 -177.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 80.3 m95 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.176 0.512 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.696 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 10.0 pt20 -128.07 165.16 20.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.39 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.5 163.86 15.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.233 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.558 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.0 t -58.46 -51.5 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -58.01 -23.44 54.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.18 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.58 -45.29 54.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.696 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.4 t80 -75.1 -45.41 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.49 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -55.72 -43.83 76.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.499 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 -179.446 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.502 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 23.0 t80 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.105 0.479 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.82 8.65 59.15 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.011 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.7 m -67.79 -15.86 63.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -102.88 -31.69 10.14 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 164.08 156.77 9.0 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.217 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.7 mp -119.97 103.75 9.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.709 -0.746 . . . . 0.0 110.163 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 21.8 ttpp -88.29 119.35 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.269 0.557 . . . . 0.0 111.339 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.412 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.7 tt -62.12 103.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.347 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 283' ' ' ASP . 86.7 mt -76.2 -49.17 17.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.898 0.38 . . . . 0.0 110.528 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 34.4 t -153.11 164.02 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.539 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -141.44 135.75 30.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 41.2 tt0 -130.14 137.54 50.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.245 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.39 124.43 34.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.628 -167.777 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.83 156.57 31.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.017 0.913 . . . . 0.0 112.861 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 79.1 mt -95.51 116.25 28.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.639 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 40.4 ttmt -100.65 112.25 24.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.458 HD11 ' CZ ' ' A' ' 282' ' ' PHE . 19.3 mt -118.45 130.34 55.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 31.4 m -97.97 111.01 23.48 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.542 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.5 m-85 -96.94 162.48 13.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.332 0.587 . . . . 0.0 111.872 -172.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.438 ' HB2' HD22 ' A' ' 265' ' ' LEU . 4.1 t70 -127.85 127.45 23.94 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.502 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 80.0 Cg_endo -79.45 10.12 3.17 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.181 1.92 . . . . 0.0 112.067 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.7 -15.03 53.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.8 t -153.85 135.07 14.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.197 0.522 . . . . 0.0 110.667 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.32 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.131 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.87 -32.12 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.861 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -84.2 -47.13 11.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.524 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.43 159.49 7.96 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.794 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.1 151.17 25.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -119.68 123.4 43.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 26.0 m -110.27 130.92 55.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.51 131.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.384 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.52 118.38 34.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.6 p -134.58 164.0 28.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.732 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -66.17 157.85 30.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.364 0.602 . . . . 0.0 111.109 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.5 mm? -61.59 -23.83 66.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.212 -168.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.71 23.2 5.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.516 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.37 121.09 84.27 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.538 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.56 130.66 7.96 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.286 1.991 . . . . 0.0 111.609 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.433 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 90.8 m-85 -120.66 114.2 21.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 25.4 t80 -73.3 102.45 3.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.327 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 332' ' ' ASP . 55.2 t -88.7 136.04 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.255 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.646 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 54.4 tttp -57.93 124.46 19.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.905 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.9 m120 76.81 -5.21 2.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.366 0.666 . . . . 0.0 112.392 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -110.85 -32.25 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.14 0.495 . . . . 0.0 111.403 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.92 -152.68 21.9 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -64.74 112.38 3.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 117.18 0.49 . . . . 0.0 110.382 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.487 ' CB ' HG21 ' A' ' 328' ' ' ILE . 16.4 m -125.33 165.26 18.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.0 t -161.48 -177.84 6.22 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.432 ' CZ ' HD22 ' A' ' 280' ' ' LEU . 65.3 m-85 -93.0 -39.34 11.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.523 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -123.74 73.73 54.02 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.748 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.97 -37.05 93.75 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.176 2.584 . . . . 0.0 113.356 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.2 m -64.74 -25.75 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.232 0.539 . . . . 0.0 110.693 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.1 tp -87.25 -44.3 11.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.963 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.2 m -55.18 -41.86 72.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.993 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.468 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 14.8 p -70.77 -26.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.66 -35.16 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -84.32 -58.44 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.917 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.48 -10.98 24.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 78.04 25.65 61.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.615 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.6 mt -122.71 113.11 30.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 122.849 -0.206 . . . . 0.0 110.877 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.85 119.41 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.423 2.082 . . . . 0.0 110.365 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 68.2 m -117.37 156.11 28.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 112.141 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 57.5 m -79.71 164.45 23.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.104 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -93.76 115.79 28.23 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -66.46 165.23 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 111.229 -173.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -122.26 140.37 52.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.721 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.32 115.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.221 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 115.3 -2.27 22.27 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.908 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.483 ' HB3' HG12 ' A' ' 304' ' ' VAL . 44.0 m-20 -75.23 132.95 41.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.33 0.586 . . . . 0.0 111.34 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -93.68 135.16 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.964 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 51.1 m -100.81 132.69 46.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.463 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.433 HD12 ' OD2' ' A' ' 341' ' ' ASP . 76.0 mt -100.18 144.85 29.2 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.273 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.484 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 86.1 Cg_endo -87.63 165.04 7.78 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.099 2.532 . . . . 0.0 112.744 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.99 113.49 3.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.921 2.414 . . . . 0.0 111.572 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 124.83 -23.22 6.29 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.952 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.554 ' HD1' ' HB3' ' A' ' 341' ' ' ASP . 12.7 t-80 -65.79 128.0 93.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.9 -20.24 64.31 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.127 2.551 . . . . 0.0 112.495 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.646 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 23.2 t0 -79.32 -26.03 42.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.967 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.442 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -72.16 98.89 2.22 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.53 -39.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.899 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.99 103.64 4.2 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.459 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.005 -178.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -107.99 109.41 20.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.0 p -96.28 147.4 23.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.384 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.73 -40.54 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.382 0.61 . . . . 0.0 109.817 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.427 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 71.4 t90 -156.7 134.52 10.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.924 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.618 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 27.3 t-80 57.5 -142.42 0.72 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.618 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 49.1 t -96.98 37.29 1.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.465 0.65 . . . . 0.0 110.157 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.89 133.32 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.59 171.55 8.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.546 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -61.57 131.15 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.933 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.13 12.55 31.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.286 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.511 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 52.2 m -103.5 149.94 24.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.6 mpt_? -119.67 144.73 47.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.937 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.536 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.4 mt -118.99 147.81 43.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.24 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 42.4 t -158.11 98.16 1.57 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.811 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -81.86 126.26 31.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.8 m170 . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.835 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 70.2 m95 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.5 pt20 -97.32 155.42 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -82.53 161.8 22.21 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.511 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.0 t -63.59 -38.21 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -21.84 64.72 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.242 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -80.93 -50.33 9.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.443 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.474 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 63.8 t80 -65.84 -46.1 79.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.717 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.89 71.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 110.478 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.272 178.199 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 32.4 t80 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.14 55.88 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.494 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 50.7 m -65.56 -11.01 40.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -104.7 -34.16 8.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.285 0.564 . . . . 0.0 109.808 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 169.47 154.01 8.88 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.923 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.3 mp -122.63 99.82 6.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.778 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.5 ttpt -83.93 122.28 28.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.234 0.54 . . . . 0.0 110.942 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.444 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 2.3 tt -65.24 110.4 2.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.899 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 283' ' ' ASP . 80.1 mt -85.12 -44.66 12.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.714 0.292 . . . . 0.0 111.161 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.6 t -153.12 157.19 40.01 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.96 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.3 OUTLIER -133.46 142.84 48.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.022 -170.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -149.23 125.95 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.73 120.8 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 -171.516 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.403 ' HB2' HD22 ' A' ' 298' ' ' LEU . 67.4 m . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.46 157.82 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.847 0.832 . . . . 0.0 112.566 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 95.8 mt -95.57 112.89 24.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.741 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.5 ttmm -99.39 105.5 17.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.525 HD13 ' HE1' ' A' ' 312' ' ' PHE . 22.1 mt -113.12 139.69 48.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.524 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.8 m -101.16 110.6 22.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.544 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.9 m-85 -100.85 158.53 15.91 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 0.0 111.685 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 265' ' ' LEU . 9.7 t70 -124.94 135.96 27.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.362 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -83.44 9.81 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.948 1.765 . . . . 0.0 112.431 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.09 -6.15 53.59 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -153.26 125.19 7.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.343 0.592 . . . . 0.0 110.467 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -10.3 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.37 -35.45 80.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.919 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.17 -46.9 26.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.204 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.02 166.2 10.7 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.442 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.93 146.2 28.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.915 0.388 . . . . 0.0 110.686 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.433 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER -119.46 121.13 38.75 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.8 m -106.96 132.14 53.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 88.1 t -131.15 135.28 60.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.055 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -114.61 122.05 45.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.078 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.3 p -136.03 175.07 9.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 299' ' ' ASP . 10.5 mmmm -66.19 157.53 31.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.488 0.185 . . . . 0.0 111.056 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.1 mm? -60.8 -37.27 81.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.837 0.827 . . . . 0.0 109.677 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 297' ' ' LYS . 6.6 p-10 -80.79 24.52 0.48 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.08 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -82.92 119.65 74.73 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.347 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.06 132.8 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.078 1.852 . . . . 0.0 111.682 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.8 118.25 30.34 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.419 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 2.5 t80 -72.32 102.81 3.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.142 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.42 135.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.307 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.54 ' HB3' HG11 ' A' ' 333' ' ' VAL . 56.9 tttp -61.17 134.57 57.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 76.61 -6.45 2.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.531 0.732 . . . . 0.0 112.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.04 -47.75 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.64 -147.25 16.18 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . 0.432 ' HZ2' ' HA ' ' A' ' 345' ' ' PHE . 98.9 m95 -72.85 102.14 3.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.679 0.739 . . . . 0.0 110.974 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.509 ' CB ' HG21 ' A' ' 328' ' ' ILE . 5.6 m -106.47 172.51 6.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.737 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.1 t -163.04 179.2 7.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.532 0.206 . . . . 0.0 110.625 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.525 ' HE1' HD13 ' A' ' 280' ' ' LEU . 32.0 m-85 -92.84 -35.26 13.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 298' ' ' LEU . 93.0 m-85 -125.25 74.35 67.68 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 62.5 Cg_exo -55.09 -33.65 84.49 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.179 2.586 . . . . 0.0 113.534 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 35.9 t -74.85 -22.07 58.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.975 0.417 . . . . 0.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.6 tp -87.88 -45.75 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.502 . . . . 0.0 110.311 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.411 HG23 ' SG ' ' A' ' 325' ' ' CYS . 14.1 m -52.91 -37.17 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.974 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.69 -24.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.713 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.82 -33.81 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.0 110.456 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -101.99 -54.37 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.432 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -91.67 -8.05 48.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.161 -0.337 . . . . 0.0 110.736 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.58 16.94 76.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.378 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.521 HG21 ' HG ' ' A' ' 325' ' ' CYS . 42.8 mt -110.04 110.41 58.75 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.41 105.33 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.495 2.13 . . . . 0.0 110.445 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.521 ' HG ' HG21 ' A' ' 323' ' ' ILE . 84.4 m -101.47 159.18 15.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 112.369 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 1.4 p -85.83 159.68 19.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.416 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -79.93 125.61 29.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.509 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.82 168.36 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.386 -0.525 . . . . 0.0 109.816 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -133.37 146.67 51.48 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 41.3 mm -54.46 113.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.374 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.57 -4.37 19.52 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.419 -176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.52 121.42 17.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.155 0.502 . . . . 0.0 110.467 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -84.74 133.05 30.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.691 0.758 . . . . 0.0 112.115 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 47.3 t -95.39 134.79 37.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.376 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 69.1 mt -105.62 144.57 29.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.853 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -86.94 163.51 8.88 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.803 2.336 . . . . 0.0 112.142 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 121.42 8.73 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 112.047 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.01 31.98 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.491 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.44 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 25.3 t-80 -75.18 134.08 74.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 339' ' ' HIS . 11.7 Cg_endo -54.73 -28.8 58.86 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.975 3.117 . . . . 0.0 114.0 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.44 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 1.5 m-20 -78.27 -35.15 48.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.419 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -70.52 98.74 1.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.888 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.88 -45.66 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.256 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -131.18 94.51 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.432 ' HA ' ' HZ2' ' A' ' 309' ' ' TRP . 3.5 t80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.594 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.481 0.78 0 N-CA-C 110.769 -0.512 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 99.41 10.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.6 p -85.79 145.29 27.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.905 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.457 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.4 mm -80.41 -43.23 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.511 0.672 . . . . 0.0 109.5 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -151.51 136.04 16.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.244 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.529 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 25.4 t-80 55.53 -136.09 1.27 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.529 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 46.3 t -100.13 32.06 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.64 . . . . 0.0 110.011 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -103.0 139.81 38.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.256 0.55 . . . . 0.0 111.417 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 177.74 5.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.462 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -65.59 143.73 57.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.327 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.01 58.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.184 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 39.9 m -106.24 145.61 31.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.45 144.0 38.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.949 0.404 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 67.0 mt -119.45 149.05 42.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.057 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.2 t -158.07 103.96 1.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.042 0.448 . . . . 0.0 110.426 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.52 123.32 34.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.261 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -177.491 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.409 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 49.4 m95 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.372 0.606 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.556 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 8.7 pt20 -98.95 160.88 13.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.979 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 160.6 17.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -57.35 -48.83 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HA ' HG22 ' A' ' 211' ' ' ILE . 16.0 mt-10 -56.42 -24.82 47.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.35 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.53 -47.42 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.434 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.556 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.8 t80 -68.82 -42.15 77.61 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.605 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.34 70.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.332 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.835 176.428 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 21.8 t80 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.0 0.429 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.54 17.21 55.47 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.431 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -21.03 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.07 -27.56 13.19 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.459 0.647 . . . . 0.0 109.586 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.48 166.65 17.28 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.653 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.93 99.98 6.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.796 -0.702 . . . . 0.0 110.316 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 49.1 tttp -84.0 117.87 23.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.059 0.456 . . . . 0.0 110.589 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 280' ' ' LEU . 3.1 tt -58.69 107.57 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.13 -42.02 16.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.659 0.266 . . . . 0.0 110.924 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.3 t -153.49 168.02 27.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.409 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.674 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -140.35 137.09 33.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.921 -167.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -143.77 135.63 26.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.414 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -106.76 127.59 53.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.913 -175.795 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.61 154.72 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.753 0.787 . . . . 0.0 112.905 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.555 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 95.5 mt -94.77 109.65 21.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.668 171.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -104.24 110.82 23.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.044 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 312' ' ' PHE . 45.7 mt -120.89 138.82 53.91 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.836 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.2 m -92.84 114.77 27.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 83.5 m-85 -102.72 161.56 13.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.055 0.455 . . . . 0.0 111.614 -174.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.0 t70 -131.15 135.81 27.8 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.138 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 95.9 Cg_endo -79.71 13.03 2.22 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.23 1.954 . . . . 0.0 112.714 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.17 -16.23 42.45 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.9 t -153.86 129.33 9.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.021 -0.589 . . . . 0.0 109.866 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.98 -8.16 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -61.32 -26.12 67.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.747 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.46 -46.67 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.1 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.33 166.46 10.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.905 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.35 148.69 25.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.76 121.98 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 14.8 m -105.99 133.11 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 59.1 t -132.72 134.1 58.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.409 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 90.4 mt-10 -107.84 112.72 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.931 172.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 10.2 p -122.95 172.5 8.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -76.77 160.81 28.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 0.0 110.317 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.707 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.76 -23.28 67.2 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -174.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -97.88 16.98 19.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.421 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.98 117.55 55.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.662 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.98 122.38 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.081 1.854 . . . . 0.0 111.432 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.506 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -112.04 105.73 14.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 26.4 t80 -70.67 108.9 4.61 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.979 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.48 138.2 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.557 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.667 ' HB3' HG11 ' A' ' 333' ' ' VAL . 55.0 tttp -63.14 128.59 36.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.456 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.0 OUTLIER 72.13 17.33 5.08 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.635 0.584 . . . . 0.0 111.811 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.436 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 34.0 mttp -137.99 -43.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.431 . . . . 0.0 111.76 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.405 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 98.55 -160.09 20.42 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.14 115.66 3.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.537 0.668 . . . . 0.0 110.286 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 17.0 m -127.59 165.18 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.139 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.4 t -160.58 171.68 18.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.995 0.426 . . . . 0.0 110.397 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.674 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 73.6 m-85 -85.88 -35.68 20.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.526 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -127.01 76.45 76.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.253 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.49 -34.44 97.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.686 2.257 . . . . 0.0 112.537 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.9 p -65.45 -23.04 66.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.167 0.508 . . . . 0.0 110.814 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.46 -46.35 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.777 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.403 HG23 ' SG ' ' A' ' 325' ' ' CYS . 30.0 m -56.43 -41.77 76.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.932 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 13.2 p -70.27 -21.36 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.752 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.0 -38.33 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.371 0.605 . . . . 0.0 110.242 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -80.87 -56.8 3.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.032 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.43 -8.76 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.843 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 75.38 21.07 78.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.462 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -115.23 116.2 42.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 122.773 -0.251 . . . . 0.0 110.432 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.48 117.71 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.514 2.142 . . . . 0.0 110.79 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 317' ' ' THR . 63.3 m -117.76 160.98 20.46 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -168.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 78.5 m -85.43 164.25 18.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.599 173.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.46 125.88 34.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.05 165.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.003 0.906 . . . . 0.0 111.542 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -121.09 144.16 48.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.833 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.78 110.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.684 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.33 2.89 19.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.754 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.436 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 44.7 m-20 -69.83 124.78 24.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.076 0.465 . . . . 0.0 110.641 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.706 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -91.25 125.2 44.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.826 0.822 . . . . 0.0 111.993 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.7 133.82 34.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.161 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.27 141.54 22.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.793 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -84.65 163.34 12.38 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.52 115.29 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.785 2.324 . . . . 0.0 111.45 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.9 -20.16 8.19 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.357 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.443 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 17.0 t-80 -66.49 133.3 94.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.45 -24.09 67.29 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.665 2.91 . . . . 0.0 113.598 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 2.3 m-20 -78.53 -32.39 47.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.715 0.293 . . . . 0.0 110.594 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.651 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.74 87.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.084 0.469 . . . . 0.0 110.284 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.28 -47.68 88.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -130.86 99.65 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.92 -179.008 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.5 t -113.5 100.01 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.6 p -92.9 144.41 25.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 10.6 mm -83.48 -36.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.833 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -156.19 132.31 9.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.265 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.554 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 21.0 t-80 56.86 -139.15 0.92 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.554 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 49.4 t -98.96 40.05 1.23 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.634 . . . . 0.0 110.272 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -114.7 137.4 51.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.423 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.43 172.11 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.574 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -64.75 127.64 32.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.816 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.69 7.93 38.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.171 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.0 m -96.69 150.4 20.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.408 ' O ' HG11 ' A' ' 294' ' ' VAL . 0.6 OUTLIER -117.02 140.35 49.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 110.988 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 79.0 mt -117.29 145.7 43.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.173 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.46 99.36 1.89 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.428 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.91 128.98 35.69 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.9 m170 . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.573 -174.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 39.6 m95 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.463 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.1 pt20 -102.78 156.2 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.052 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.9 159.34 22.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 2.4 t -59.75 -43.85 92.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 211' ' ' ILE . 35.0 mt-10 -57.86 -22.81 49.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.544 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.76 -50.51 8.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.463 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 68.0 t80 -65.23 -43.61 90.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.79 71.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.784 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 176.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.7 t80 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.85 13.35 50.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.009 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.8 t -67.01 -17.43 64.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.788 0.328 . . . . 0.0 111.084 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -108.62 -25.59 10.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.067 0.46 . . . . 0.0 110.395 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.14 158.53 9.14 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.312 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.7 mp -120.75 99.8 6.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.304 0.641 . . . . 0.0 110.587 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 29.2 ttpt -85.3 118.83 25.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.09 103.83 0.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.282 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.79 -52.75 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.352 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.9 t -147.65 167.32 24.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.442 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.451 ' ND1' HD22 ' A' ' 280' ' ' LEU . 5.0 t60 -145.9 135.61 23.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.145 0.498 . . . . 0.0 111.128 -173.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 32.6 tt0 -127.05 142.23 51.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.203 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -109.17 116.2 31.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 -170.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.9 m -129.06 154.24 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 122.172 0.987 . . . . 0.0 112.992 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.07 114.27 25.96 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.921 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 23.0 ttmm -103.32 110.81 22.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.502 HD13 ' HE1' ' A' ' 312' ' ' PHE . 20.5 mt -112.76 135.4 53.54 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.387 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.9 m -99.65 109.86 22.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.598 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 76.5 m-85 -100.08 163.98 12.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.443 . . . . 0.0 112.182 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 29.4 t70 -133.39 138.56 31.64 Favored Pre-proline 0 C--O 1.221 -0.437 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.296 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.551 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.3 Cg_endo -83.89 11.22 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.879 1.72 . . . . 0.0 112.532 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.68 -16.39 40.43 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -146.77 110.52 4.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.769 -0.715 . . . . 0.0 109.739 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.59 -14.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.279 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -67.1 -15.99 64.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.326 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.55 -43.57 22.79 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.65 170.71 11.92 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.223 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.48 147.45 23.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -122.92 121.23 35.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 292' ' ' LEU . 42.0 m -111.55 133.77 53.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 91.1 t -131.05 135.57 59.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.049 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -112.55 115.69 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.2 p -132.87 161.8 33.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.996 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -57.83 158.76 6.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.092 0.473 . . . . 0.0 111.829 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -63.97 -34.83 78.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.61 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -87.37 31.34 0.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.425 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -86.21 118.87 71.12 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.028 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.19 137.45 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.116 1.877 . . . . 0.0 111.821 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -119.92 142.81 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 18.2 t80 -96.73 98.62 10.3 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.961 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.708 HG22 ' OG ' ' A' ' 310' ' ' SER . 51.0 t -87.04 131.95 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 0.0 111.403 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.524 ' HB3' HG11 ' A' ' 333' ' ' VAL . 56.7 tttp -57.93 122.92 14.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.573 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 15.2 m120 77.88 2.06 2.88 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.909 0.756 . . . . 0.0 111.833 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -116.68 -21.78 8.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.83 -121.33 5.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.41 140.51 29.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.398 0.599 . . . . 0.0 110.117 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.86 ' HB2' HG23 ' A' ' 328' ' ' ILE . 75.3 p -143.38 167.15 22.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.108 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.8 t -164.48 171.76 14.21 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.767 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.502 ' HE1' HD13 ' A' ' 280' ' ' LEU . 57.1 m-85 -89.22 -21.14 23.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.485 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.58 70.38 52.51 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.32 -39.14 63.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.909 2.406 . . . . 0.0 112.898 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 19.4 m -66.63 -26.07 66.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 66.9 tp -87.56 -47.65 8.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.194 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.3 m -59.05 -39.02 80.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.372 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.539 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 10.9 p -68.77 -19.58 24.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 111.264 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.23 -41.97 13.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 110.372 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -77.14 -53.09 8.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.871 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -98.82 -15.92 19.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.786 0.326 . . . . 0.0 111.083 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 81.75 18.41 68.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.609 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.2 mt -113.18 113.36 49.06 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.907 -0.172 . . . . 0.0 110.748 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.76 110.42 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 110.487 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.428 ' HB3' ' C ' ' A' ' 310' ' ' SER . 58.2 m -111.29 157.66 19.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 0.0 111.971 -170.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.3 m -84.03 159.73 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.123 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.22 122.98 28.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.86 HG23 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.12 164.89 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.473 0.654 . . . . 0.0 110.671 -177.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -119.93 141.44 49.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.792 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 mm -57.18 110.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.074 0.464 . . . . 0.0 109.845 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.89 3.74 19.62 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.352 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -79.56 131.07 35.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.217 0.532 . . . . 0.0 110.793 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.6 p -93.83 126.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.24 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.5 m -93.28 136.63 33.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.342 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 55.6 mt -105.93 146.13 32.27 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.357 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 58.3 Cg_endo -88.53 165.36 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.933 2.422 . . . . 0.0 112.425 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.47 115.81 3.9 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.868 2.378 . . . . 0.0 111.824 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 122.17 -22.56 7.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.061 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.512 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 16.2 t-80 -67.0 127.78 93.64 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.34 -22.85 60.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.411 2.741 . . . . 0.0 113.554 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.512 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 4.5 m-20 -79.06 -27.25 43.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.54 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.563 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -75.29 85.93 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.305 0.574 . . . . 0.0 110.169 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.7 mt -72.88 -45.44 55.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.734 -173.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.65 43.74 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.435 0.636 . . . . 0.0 110.812 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.593 -0.579 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.2 t -97.19 87.58 4.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.051 0.453 . . . . 0.0 109.936 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.9 p -79.3 143.93 34.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.835 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.473 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.7 mm -79.35 -43.86 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.435 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 76.9 t90 -152.98 136.06 15.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.408 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.575 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 32.6 t-80 55.23 -135.75 1.34 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.575 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 15.0 p -96.05 23.91 6.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.798 0.332 . . . . 0.0 111.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -108.61 140.21 42.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.975 -173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.53 178.57 4.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.772 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.77 132.02 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.039 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.05 17.85 26.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.092 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 25.0 m -107.82 147.44 30.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 220' ' ' ARG . 3.7 mpt_? -110.6 144.23 39.81 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.211 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.596 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.0 mt -117.24 144.49 44.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.889 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 16.6 t -153.39 95.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.126 0.489 . . . . 0.0 110.358 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -86.16 118.21 25.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.0 m170 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.109 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 72.7 m95 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -106.63 164.52 12.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.39 172.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.64 160.5 16.6 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.97 -0.456 . . . . 0.0 110.299 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.9 t -60.03 -47.33 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 24.8 mt-10 -59.03 -22.36 60.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.63 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -81.7 -47.58 12.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.135 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.565 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 54.8 t80 -70.08 -48.67 56.78 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.45 69.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.211 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 19.4 ttm180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.597 0.713 . . . . 0.0 109.55 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.607 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 11.2 t80 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 103.09 12.21 32.21 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.391 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.8 m -68.74 -13.68 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.826 0.346 . . . . 0.0 111.758 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -108.27 -30.19 8.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.851 0.357 . . . . 0.0 110.282 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.77 157.89 8.86 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.07 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -122.53 105.8 10.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 110.476 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 22.0 ttpt -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.14 0.495 . . . . 0.0 110.976 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.52 107.48 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.868 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 283' ' ' ASP . 61.1 mt -82.51 -41.1 20.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.466 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.7 t -158.39 162.35 37.62 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.791 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -140.94 140.25 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -133.43 139.69 46.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.246 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.61 106.14 18.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 109.776 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.0 t . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.69 -174.313 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.1 m -129.62 154.88 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.772 0.796 . . . . 0.0 111.838 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 295' ' ' GLU . 96.9 mt -95.57 110.61 22.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.558 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -98.24 110.66 23.2 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 17.2 mt -113.82 129.93 56.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.124 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 37.6 m -97.52 118.12 33.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.51 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 79.5 m-85 -106.55 164.65 11.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.288 0.566 . . . . 0.0 112.417 -171.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 265' ' ' LEU . 19.0 t70 -131.29 135.06 26.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.146 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.607 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 72.8 Cg_endo -84.17 5.59 6.24 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.202 1.935 . . . . 0.0 112.346 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 -18.87 27.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.452 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -142.29 126.65 17.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.052 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.97 -8.15 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.39 -39.69 92.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.03 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.04 -46.76 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.036 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.99 11.48 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.39 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.0 143.26 29.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.72 0.295 . . . . 0.0 110.578 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 294' ' ' VAL . 1.1 tm? -117.5 119.44 35.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.0 m -106.8 135.27 48.62 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.502 HG21 HD12 ' A' ' 292' ' ' LEU . 73.8 t -134.04 135.22 55.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.436 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 278' ' ' LEU . 41.8 mt-10 -126.95 127.73 45.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.716 173.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 300' ' ' HIS . 9.2 t -141.19 -174.61 4.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.773 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -76.0 172.84 12.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.9 mm? -74.67 -10.54 59.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.352 -168.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.96 17.45 24.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.721 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . 0.546 ' HD2' ' SG ' ' A' ' 296' ' ' CYS . 48.4 t-80 -75.89 117.93 67.36 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.527 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.5 135.16 17.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.158 1.905 . . . . 0.0 111.783 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.472 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -121.24 125.57 47.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 7.7 t80 -81.84 90.79 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.567 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 332' ' ' ASP . 65.6 t -72.95 123.86 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.035 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.738 ' HB3' HG11 ' A' ' 333' ' ' VAL . 60.4 tttp -56.33 139.69 47.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.38 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.9 m-20 77.1 -8.68 1.65 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.819 0.699 . . . . 0.0 112.114 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -119.21 -54.0 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.17 -149.67 18.05 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -67.73 120.64 14.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.172 0.486 . . . . 0.0 110.259 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.0 m -134.94 169.66 17.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.351 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 43.2 t -160.63 172.13 17.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.914 0.387 . . . . 0.0 110.777 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -87.14 -28.88 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.974 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.46 76.39 77.63 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.687 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.543 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 65.8 Cg_exo -54.74 -41.96 73.08 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.103 2.535 . . . . 0.0 113.141 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 6.9 m -64.02 -24.35 67.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.8 tp -87.32 -49.14 7.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.951 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -55.75 -44.65 77.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.377 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.19 -31.67 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.745 0.307 . . . . 0.0 111.752 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.11 -40.35 22.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.229 0.538 . . . . 0.0 110.243 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.19 -49.97 13.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.589 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -102.75 -9.06 20.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.767 0.318 . . . . 0.0 111.737 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 75.67 29.6 59.27 Favored Glycine 0 CA--C 1.516 0.127 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.7 mt -128.34 112.79 19.67 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 122.772 -0.252 . . . . 0.0 110.433 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.8 116.79 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.448 2.099 . . . . 0.0 110.877 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 72.8 m -117.62 147.59 42.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.287 0.565 . . . . 0.0 111.698 -169.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.55 164.97 22.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.653 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.13 128.18 34.25 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.98 178.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.422 0.629 . . . . 0.0 111.07 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -141.71 132.88 26.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.93 115.13 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 O-C-N 123.67 0.606 . . . . 0.0 110.162 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.71 6.72 16.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.516 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.55 ' HB2' HG11 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -70.4 128.91 37.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 176.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.2 p -97.56 112.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.73 0.776 . . . . 0.0 111.13 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.9 m -79.96 132.29 36.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.425 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.85 145.91 31.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.908 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.436 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.1 Cg_endo -86.68 168.7 8.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.008 2.472 . . . . 0.0 112.357 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 42.0 Cg_endo -68.12 126.16 14.03 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.885 2.39 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.51 -21.33 30.74 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.35 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.4 122.0 77.81 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.79 -23.53 72.41 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 123.182 2.588 . . . . 0.0 113.108 -171.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.534 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 37.4 t70 -79.06 -27.18 43.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.55 86.57 4.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.178 0.513 . . . . 0.0 109.993 169.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 60.0 mt -66.86 -50.65 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.633 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -99.57 31.57 3.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.0 111.08 -169.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.358 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.481 0.752 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.4 t -94.78 94.3 8.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.287 0.565 . . . . 0.0 109.998 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -84.87 143.54 28.98 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.216 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 235' ' ' GLU . 11.4 mm -86.26 -41.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.58 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.461 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 80.9 t90 -154.33 127.63 8.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.653 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 38.4 t-80 59.06 -146.56 0.51 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.653 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 49.4 t -94.64 39.82 1.09 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.292 0.567 . . . . 0.0 110.37 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.13 138.04 45.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.361 0.601 . . . . 0.0 111.594 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.97 169.16 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.022 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.413 ' HG3' ' OE2' ' A' ' 235' ' ' GLU . 56.9 tttp -62.42 128.15 34.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.734 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.35 -16.85 34.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.027 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 60.6 m -73.73 148.17 42.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.483 ' O ' HG12 ' A' ' 294' ' ' VAL . 0.4 OUTLIER -109.37 150.71 27.64 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.436 178.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.564 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.4 mt -123.54 143.88 49.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.9 t -151.96 92.03 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.449 . . . . 0.0 110.412 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.97 124.8 27.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.3 m170 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 110.91 -177.115 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.405 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 83.6 m95 . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 121.437 0.636 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.6 pt20 -99.99 158.44 15.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.513 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.43 161.44 16.28 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.913 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -58.5 -49.7 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.641 0.734 . . . . 0.0 109.355 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 35.3 mt-10 -58.08 -22.3 49.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.585 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.6 -45.77 24.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.331 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -74.96 -46.84 32.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.427 ' CB ' HG23 ' A' ' 211' ' ' ILE . . . -59.7 -25.07 64.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.568 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.662 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 35.9 ttm180 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.337 0.589 . . . . 0.0 109.835 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.631 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.7 t80 . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 97.25 18.55 28.44 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.376 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.6 m -75.8 -13.27 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.993 0.425 . . . . 0.0 110.459 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.07 -31.94 8.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 109.323 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.23 157.92 8.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.003 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.5 mp -123.12 98.7 6.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 123.234 0.614 . . . . 0.0 110.363 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 69.8 tttt -84.15 122.06 28.31 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.7 105.09 0.6 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.76 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 283' ' ' ASP . 87.0 mt -79.16 -48.13 14.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.7 t -150.28 163.37 38.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.849 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -134.08 148.49 51.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.888 -167.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.16 139.32 21.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.894 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -111.09 94.28 4.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.491 0.662 . . . . 0.0 109.468 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.459 ' HG ' HG22 ' A' ' 277' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.444 -0.74 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.308 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.459 HG22 ' HG ' ' A' ' 270' ' ' SER . 6.4 m -136.86 154.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.596 0.712 . . . . 0.0 112.03 -175.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 94.7 mt -92.54 109.4 20.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.259 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 4.9 ttpp -102.95 109.0 20.39 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 293' ' ' THR . 38.4 mt -118.71 140.9 49.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.247 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.0 m -99.05 122.56 42.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.54 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.2 m-85 -110.63 158.88 18.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.384 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.441 ' HB2' HD23 ' A' ' 265' ' ' LEU . 10.7 t70 -128.21 130.62 23.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.663 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.631 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 97.4 Cg_endo -86.82 12.55 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.607 2.204 . . . . 0.0 112.451 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.96 -16.61 46.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.883 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.5 t -154.4 139.92 17.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 111.031 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.99 -9.88 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.31 -38.76 77.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.183 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.82 -43.47 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.903 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 133.38 163.48 10.47 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.769 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.94 149.27 22.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.071 0.463 . . . . 0.0 110.143 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 294' ' ' VAL . 1.8 tm? -126.75 123.29 37.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.8 m -115.64 136.84 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 68.3 t -131.92 137.14 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.639 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.434 ' CG ' ' HD3' ' A' ' 279' ' ' LYS . 87.8 mt-10 -106.39 127.86 53.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.642 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.4 p -142.99 172.2 13.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -66.09 154.56 39.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.308 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.733 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.2 mm? -62.45 -21.13 65.21 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.47 0.652 . . . . 0.0 110.742 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.68 16.7 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.779 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -70.69 122.64 87.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -82.3 122.4 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.518 2.145 . . . . 0.0 111.906 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.66 120.62 42.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.7 t80 -72.84 104.4 4.01 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.23 137.15 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.267 0.556 . . . . 0.0 111.074 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.471 ' HB3' HG11 ' A' ' 333' ' ' VAL . 55.1 tttp -57.92 129.93 44.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.813 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.7 m120 72.94 2.3 4.33 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.627 0.579 . . . . 0.0 112.099 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.443 ' HE2' ' HD1' ' A' ' 329' ' ' HIS . 44.2 mttp -121.6 -41.37 2.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.657 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 95.6 -152.78 20.47 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.67 113.84 3.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.238 0.519 . . . . 0.0 110.699 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.9 m -126.21 165.55 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.5 t -161.54 -177.83 6.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.656 0.265 . . . . 0.0 110.939 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.41 ' CD1' HD11 ' A' ' 278' ' ' LEU . 30.1 m-85 -91.59 -43.6 9.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.244 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.67 74.22 17.67 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.705 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.7 Cg_exo -55.6 -36.26 94.28 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.748 2.298 . . . . 0.0 112.946 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.2 t -63.1 -28.48 70.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.115 0.484 . . . . 0.0 110.559 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.3 tp -87.35 -41.97 13.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.886 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.463 HG23 ' SG ' ' A' ' 325' ' ' CYS . 7.9 m -53.33 -44.06 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.778 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.442 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.9 p -72.14 -20.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.31 -34.93 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.384 0.612 . . . . 0.0 110.117 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -84.67 -53.03 5.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.188 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.73 -11.52 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.103 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 76.98 24.85 65.66 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.254 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.1 mt -120.97 113.17 33.02 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.874 -0.192 . . . . 0.0 110.572 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.05 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.47 2.113 . . . . 0.0 110.7 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.463 ' SG ' HG23 ' A' ' 317' ' ' THR . 79.5 m -117.57 155.88 29.04 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -169.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.55 165.77 18.8 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.618 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.57 126.71 33.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 162.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . 0.443 ' HD1' ' HE2' ' A' ' 307' ' ' LYS . 64.4 m80 -130.03 153.75 48.12 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.5 mm -63.15 109.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.68 -0.61 20.1 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.825 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 3.3 m-20 -76.88 129.43 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.532 0.666 . . . . 0.0 110.221 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.35 134.74 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.535 0.683 . . . . 0.0 112.654 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 50.5 t -95.85 138.95 32.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.971 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 76.0 mt -109.96 141.87 24.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.527 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.57 164.15 9.36 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.884 2.389 . . . . 0.0 112.033 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.49 122.78 9.8 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.292 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 114.45 -17.0 19.12 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.813 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.511 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 21.6 t-80 -70.34 132.18 87.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.24 -26.35 76.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.389 2.726 . . . . 0.0 113.479 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.511 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 1.9 m-20 -79.24 -26.67 42.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.668 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -80.02 85.83 5.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.68 -43.98 46.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.243 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -120.92 80.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.886 -178.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -105.64 92.01 4.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.3 p -82.23 141.52 32.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.033 0.444 . . . . 0.0 110.967 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -82.85 -37.76 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.709 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -156.88 135.65 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.537 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 23.1 t-80 55.83 -139.26 0.97 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.537 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 43.6 t -100.4 42.68 1.1 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.376 0.607 . . . . 0.0 109.92 176.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.09 139.48 50.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 111.89 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.1 174.83 5.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.825 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 235' ' ' GLU . 64.4 tttm -63.77 127.89 33.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.421 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.85 -1.55 38.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.473 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.515 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 68.1 m -86.21 140.1 30.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -111.11 137.88 48.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.449 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 47.1 mt -112.78 145.49 40.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.717 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 21.3 t -149.48 97.46 2.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.185 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -85.74 108.28 17.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.0 m170 . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.105 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.0 m95 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 122.011 0.91 . . . . 0.0 113.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 12.2 pt20 -130.92 168.37 17.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.246 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -88.59 160.2 17.54 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.975 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.59 -46.93 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 217' ' ' LYS . 27.3 mt-10 -57.73 -23.45 51.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.243 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.09 -44.75 21.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.341 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.575 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.9 t80 -74.26 -44.07 54.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.423 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.94 72.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.118 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 176.163 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 39.2 t80 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.024 0.44 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.19 26.61 23.27 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.591 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -81.41 -16.42 52.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.176 0.513 . . . . 0.0 110.417 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.88 -29.49 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 142.1 151.81 5.59 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.586 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.57 97.59 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.73 0.412 . . . . 0.0 110.863 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.9 ttpp -85.68 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.182 0.515 . . . . 0.0 111.139 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.491 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 4.6 tt -54.77 122.48 10.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.465 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 283' ' ' ASP . 59.2 mt -95.0 -47.71 6.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.561 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.7 t -151.0 164.98 35.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -142.12 133.04 25.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.207 0.527 . . . . 0.0 111.632 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -128.67 146.19 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.49 128.69 53.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.828 0.823 . . . . 0.0 110.359 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.864 -167.014 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.1 m -132.72 153.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.147 0.975 . . . . 0.0 113.228 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 89.9 mt -92.92 119.96 32.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.249 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.7 ttmt -108.33 111.82 23.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.503 HD13 ' HE1' ' A' ' 312' ' ' PHE . 36.9 mt -118.5 129.4 55.35 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.011 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.1 m -92.97 110.79 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -96.51 155.27 16.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD23 ' A' ' 265' ' ' LEU . 15.7 t0 -118.84 123.43 29.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.448 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 60.5 Cg_endo -73.36 2.76 5.32 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.065 1.843 . . . . 0.0 111.755 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.79 9.85 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.5 t -145.9 130.94 18.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.11 -12.25 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.085 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.18 -34.7 78.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.557 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.52 -45.26 69.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 135.94 176.16 14.21 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.366 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 79.1 mt -103.32 150.33 23.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.915 0.388 . . . . 0.0 110.618 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -127.02 119.43 26.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.4 m -109.76 139.39 44.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.9 t -132.93 132.73 59.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -109.47 115.26 29.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 6.2 p -134.3 165.64 24.67 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.53 155.9 28.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.138 0.494 . . . . 0.0 111.01 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.762 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.1 mm? -64.4 -19.53 65.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.078 -173.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.21 17.67 16.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.194 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.51 117.27 60.74 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.773 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.65 116.38 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.238 1.959 . . . . 0.0 111.445 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.8 m-85 -103.59 116.06 31.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.355 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 11.4 t80 -73.48 105.08 4.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.406 175.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 332' ' ' ASP . 54.5 t -92.75 130.79 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.349 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.76 ' HB3' HG11 ' A' ' 333' ' ' VAL . 58.9 tttp -59.97 126.44 27.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 13.2 m120 77.64 0.05 2.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.995 0.81 . . . . 0.0 111.993 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -117.08 -33.8 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 111.495 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 94.47 -151.14 20.04 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 345' ' ' PHE . 97.3 m95 -67.77 117.6 9.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.462 0.631 . . . . 0.0 109.457 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.421 ' CB ' HG21 ' A' ' 328' ' ' ILE . 15.6 m -128.28 166.66 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.772 0.32 . . . . 0.0 110.641 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 41.4 t -160.77 168.11 25.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.509 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.503 ' HE1' HD13 ' A' ' 280' ' ' LEU . 63.4 m-85 -84.92 -28.57 25.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.946 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.11 75.41 75.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.595 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.42 -45.02 43.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.883 2.388 . . . . 0.0 112.677 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 18.3 m -62.5 -21.08 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.447 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.05 -45.3 10.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.909 0.385 . . . . 0.0 110.166 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.509 HG23 ' SG ' ' A' ' 325' ' ' CYS . 36.4 m -55.51 -40.74 72.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.742 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.557 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.9 p -71.72 -19.71 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.788 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.3 t -87.61 -36.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.327 0.584 . . . . 0.0 110.185 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -81.86 -54.88 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -101.79 -11.37 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.837 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 81.59 14.78 77.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.638 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.5 mt -110.53 114.18 55.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.634 0.217 . . . . 0.0 111.08 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.96 118.49 5.65 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.633 2.222 . . . . 0.0 110.601 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.509 ' SG ' HG23 ' A' ' 317' ' ' THR . 62.6 m -117.77 157.78 25.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.248 0.547 . . . . 0.0 112.306 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.6 m -79.91 164.88 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.06 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -92.03 122.16 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.19 166.1 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.548 0.689 . . . . 0.0 111.412 -175.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -124.12 142.33 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.34 114.45 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 115.67 -0.65 21.72 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.525 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.477 ' HB3' HG12 ' A' ' 304' ' ' VAL . 51.3 m-20 -73.15 132.09 42.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.88 175.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.76 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -92.92 134.8 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.273 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 49.5 t -96.5 134.32 39.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.369 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 82.2 mt -105.84 143.68 27.37 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.59 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.416 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 69.1 Cg_endo -86.91 167.66 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.637 2.225 . . . . 0.0 112.074 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.74 129.8 24.49 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.008 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.26 -14.32 54.94 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -69.3 128.3 92.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.36 -22.59 75.0 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.325 2.683 . . . . 0.0 113.866 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.87 -31.04 45.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -69.0 91.73 0.49 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.281 0.562 . . . . 0.0 109.954 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.0 mt -66.33 -41.53 89.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.671 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -129.13 101.7 6.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 309' ' ' TRP . 3.8 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.519 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -91.3 99.58 12.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.048 0.452 . . . . 0.0 110.098 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -87.63 141.77 28.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.454 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.4 mm -79.44 -40.31 21.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.334 0.588 . . . . 0.0 109.752 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -156.89 134.38 10.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.107 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.624 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 34.0 t-80 55.94 -139.22 0.97 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.624 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 40.3 t -99.8 40.09 1.27 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.418 0.628 . . . . 0.0 109.864 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -110.23 134.6 52.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.061 0.458 . . . . 0.0 111.237 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.51 176.17 6.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -67.37 137.82 56.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.66 31.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.022 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 38.2 m -112.11 147.63 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.07 143.6 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.824 0.345 . . . . 0.0 111.058 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.8 mt -119.64 143.75 47.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.809 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 41.8 t -154.07 98.03 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -83.34 122.18 28.12 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 31.4 m170 . . . . . 0 C--N 1.328 -0.366 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -174.44 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.487 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 85.4 m95 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.208 0.527 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 9.1 pt20 -120.45 154.37 35.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.688 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.37 162.57 23.33 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -60.68 -50.82 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.03 -24.2 57.38 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.289 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.17 -50.67 21.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.55 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 62.1 t80 -70.59 -43.65 68.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.698 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.53 68.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.245 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 239' ' ' ARG . 36.6 ttt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.474 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 14.9 t80 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.64 21.48 23.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.225 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.1 t -70.05 -23.56 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.02 -31.75 17.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.58 0.705 . . . . 0.0 109.828 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 141.0 144.28 4.41 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.762 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.2 mp -97.92 99.18 10.47 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.419 0.287 . . . . 0.0 111.0 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 19.2 ttpp -84.96 117.75 24.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.467 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.1 tt -61.22 102.83 0.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.829 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 283' ' ' ASP . 67.1 mt -77.2 -47.65 19.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.445 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -152.58 163.15 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.097 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -133.68 146.2 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.668 -168.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.44 140.04 27.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.16 107.75 16.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 -170.6 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.67 154.87 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.997 0.904 . . . . 0.0 113.072 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 98.7 mt -94.15 110.31 22.04 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.807 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.8 ttmt -104.28 109.63 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.812 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.45 HD13 ' HE1' ' A' ' 312' ' ' PHE . 40.9 mt -116.14 136.82 52.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.751 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 27.8 m -93.58 109.66 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.55 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 84.3 m-85 -101.09 150.05 23.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.324 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 12.8 t70 -116.6 133.44 23.02 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.7 Cg_endo -79.21 9.81 3.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.861 1.707 . . . . 0.0 112.04 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.38 63.16 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -146.73 100.01 3.27 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.603 0.716 . . . . 0.0 109.508 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.29 -18.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.415 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.25 -32.43 64.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.538 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.37 -1.18 49.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 111.472 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.08 172.96 25.31 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.791 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.4 mt -97.84 141.13 31.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.723 0.297 . . . . 0.0 110.22 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 121.29 44.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 28.2 m -110.06 133.97 52.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 89.2 t -131.69 134.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.518 -174.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 88.3 mt-10 -106.44 120.97 43.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.681 171.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 11.0 p -133.23 167.2 20.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.467 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 297' ' ' LYS . 14.0 mmmm -75.44 163.24 27.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.06 0.457 . . . . 0.0 110.494 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.613 HD21 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -66.89 -16.09 64.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.757 -168.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.97 26.0 10.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.159 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -79.24 117.53 67.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.726 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.48 133.35 11.72 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.242 1.961 . . . . 0.0 111.903 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.444 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 98.8 m-85 -118.07 125.04 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.423 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -76.51 89.34 3.27 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.524 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 332' ' ' ASP . 73.2 t -76.79 134.12 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.464 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.578 ' HB3' HG11 ' A' ' 333' ' ' VAL . 69.2 tttt -59.35 125.53 24.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.901 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.3 m120 81.45 -26.39 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.093 0.871 . . . . 0.0 112.171 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.444 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 39.7 mttp -89.83 -35.12 15.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.093 0.473 . . . . 0.0 111.203 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.89 -153.06 21.73 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -63.99 115.06 4.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.983 0.392 . . . . 0.0 110.209 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.454 ' CB ' HG21 ' A' ' 328' ' ' ILE . 19.0 m -127.74 169.19 14.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.222 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 45.9 t -160.7 169.37 22.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.45 ' HE1' HD13 ' A' ' 280' ' ' LEU . 53.4 m-85 -84.28 -32.27 24.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.929 174.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -126.95 77.38 75.1 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.421 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.0 Cg_exo -56.35 -36.81 97.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.814 2.343 . . . . 0.0 112.564 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.7 m -70.29 -20.75 63.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.43 -47.81 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 m -57.17 -40.95 78.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.048 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.2 p -68.5 -20.42 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.894 0.378 . . . . 0.0 111.642 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.5 t -91.01 -38.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.326 0.584 . . . . 0.0 110.393 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -78.81 -53.77 6.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.788 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -95.24 -22.22 17.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.096 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 88.15 12.97 64.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.306 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.0 mt -109.2 115.82 56.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.0 109.48 2.7 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.532 2.155 . . . . 0.0 110.706 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 59.5 m -109.09 155.01 21.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.765 -170.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 79.2 m -84.8 166.38 16.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.015 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.29 123.51 31.63 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.291 -0.256 . . . . 0.0 110.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.454 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.34 164.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.229 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -134.33 150.82 50.97 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . 0.558 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.0 mm -55.27 113.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 110.527 -176.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.4 -2.09 20.46 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.865 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.444 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 9.5 m-20 -73.51 128.35 35.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.257 0.551 . . . . 0.0 111.159 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.4 p -88.95 136.39 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.844 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 58.3 m -103.02 134.22 46.82 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.097 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 59.9 mt -104.39 143.14 26.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.503 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.566 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 63.5 Cg_endo -88.72 166.86 6.04 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.214 2.609 . . . . 0.0 112.871 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.5 128.69 17.61 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.352 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.88 -19.37 35.62 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.905 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -70.96 129.23 89.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 -32.0 80.11 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.807 3.005 . . . . 0.0 113.868 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.33 -23.06 43.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.9 86.51 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.917 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.25 -45.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.528 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -110.38 47.5 0.96 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.286 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.346 179.739 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 110.871 -0.473 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.6 t -91.69 93.65 9.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.0 p -84.11 143.79 29.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.479 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.8 mm -79.33 -44.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.44 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -151.37 137.19 18.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.416 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.545 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 24.1 t-80 56.43 -137.4 1.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.545 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 45.1 t -100.23 34.09 2.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.307 0.575 . . . . 0.0 110.112 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -108.63 138.57 44.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.29 175.65 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.882 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -68.32 130.3 42.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.419 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.82 36.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.113 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.48 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 23.9 m -101.82 145.55 29.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.17 143.7 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.735 0.302 . . . . 0.0 110.903 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 44.1 mt -121.65 144.13 48.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.654 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 10.1 m -148.99 91.93 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.458 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 12.3 m-85 -88.2 120.06 29.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.0 m170 . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 110.805 -173.444 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.539 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 68.1 m95 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.563 0.697 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 23.4 pt20 -101.0 167.27 10.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.567 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.13 159.11 17.67 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.3 t -58.17 -48.72 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 109.716 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.65 -21.51 40.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.762 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.2 -52.48 8.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.451 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 66.1 t80 -65.43 -41.38 93.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.839 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.04 73.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.768 174.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 12.6 t80 . . . . . 0 C--O 1.231 0.107 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 100.23 12.09 40.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.188 -1.005 . . . . 0.0 113.554 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.6 t -74.55 -15.48 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.038 0.447 . . . . 0.0 110.139 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -88.8 -26.47 21.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.591 0.71 . . . . 0.0 109.339 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.4 144.22 5.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.0 mp -105.46 98.2 7.93 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.434 0.294 . . . . 0.0 111.372 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.6 tttm -84.48 118.0 24.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.015 0.435 . . . . 0.0 110.648 -176.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.46 107.21 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 283' ' ' ASP . 85.9 mt -80.75 -51.62 8.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.714 0.292 . . . . 0.0 110.351 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.0 t -150.71 163.16 39.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.521 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.3 t60 -137.03 139.68 41.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 0.0 111.509 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -133.23 138.69 46.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.836 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.521 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 9.2 mt-10 -108.15 121.88 45.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 0.0 110.069 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.135 -173.444 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.69 154.11 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.853 0.835 . . . . 0.0 112.591 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.457 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 88.4 mt -94.38 114.36 26.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.734 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 20.3 ttpp -109.04 114.84 28.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.49 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 38.0 mt -115.72 130.83 57.0 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.251 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.0 m -93.91 111.79 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.515 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 77.3 m-85 -100.99 159.7 14.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.84 -172.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 35.9 t70 -122.94 137.45 28.13 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.652 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 86.9 Cg_endo -85.54 11.32 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.213 1.942 . . . . 0.0 112.083 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.71 39.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -154.14 115.56 4.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.339 0.59 . . . . 0.0 110.161 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.58 -7.77 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.654 0.74 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.13 -20.15 61.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.134 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.6 -38.63 39.49 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 145.31 168.21 12.82 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.243 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.11 143.06 26.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.458 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.9 OUTLIER -117.42 117.5 29.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.44 ' N ' HD23 ' A' ' 292' ' ' LEU . 5.5 m -108.94 138.21 45.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.0 t -132.13 132.98 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.539 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 70.6 mt-10 -104.16 116.34 32.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.588 170.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.561 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 11.1 p -128.06 167.24 17.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.992 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -81.65 161.14 23.55 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.8 mm? -61.54 -13.36 20.74 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.26 -169.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -108.18 13.11 26.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.591 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -71.69 119.35 73.62 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 0.0 110.888 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.44 136.39 17.51 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.21 1.94 . . . . 0.0 112.105 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.561 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.6 m-85 -122.77 118.15 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.694 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 17.0 t80 -74.5 101.65 4.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.368 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 332' ' ' ASP . 53.4 t -90.6 135.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.205 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.604 ' HB3' HG11 ' A' ' 333' ' ' VAL . 59.1 tttm -62.0 128.4 35.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 16.3 m120 72.55 11.32 5.62 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.72 0.637 . . . . 0.0 111.721 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.451 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 38.0 mttp -128.3 -42.9 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.986 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 100.15 -153.3 19.39 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -63.97 116.84 6.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 117.24 0.52 . . . . 0.0 109.795 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.423 ' CB ' HG23 ' A' ' 328' ' ' ILE . 16.7 m -128.31 166.43 18.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.034 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -160.43 167.05 28.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.49 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 71.0 m-85 -85.98 -19.57 30.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.113 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -137.21 72.78 52.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.656 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.513 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.4 Cg_exo -52.62 -37.62 74.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.924 2.416 . . . . 0.0 113.19 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.4 t -68.76 -22.48 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.511 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.2 tp -87.92 -47.01 8.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 0.0 110.218 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.484 HG23 ' SG ' ' A' ' 325' ' ' CYS . 27.9 m -55.02 -41.66 71.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.999 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.484 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.3 p -71.99 -17.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 111.58 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.56 -39.86 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.311 0.576 . . . . 0.0 110.458 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.47 -46.12 18.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.368 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -107.88 -12.32 15.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.61 0.243 . . . . 0.0 111.106 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 81.4 14.97 77.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.1 mt -109.26 114.55 57.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 122.628 -0.337 . . . . 0.0 110.86 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -72.07 116.27 4.64 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.527 2.151 . . . . 0.0 110.561 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 68.1 m -117.93 156.37 28.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.183 0.516 . . . . 0.0 112.101 -170.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.2 m -83.49 160.05 21.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.49 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.21 127.18 32.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.423 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.61 172.79 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.697 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 143.87 50.88 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.703 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.4 mm -63.03 111.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.813 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.5 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 116.12 -0.14 20.93 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.401 -173.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.475 ' HB3' HG11 ' A' ' 304' ' ' VAL . 66.0 m-20 -73.53 125.33 27.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.275 0.559 . . . . 0.0 110.755 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.0 OUTLIER -88.01 127.78 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.829 0.823 . . . . 0.0 112.041 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 42.0 t -89.51 131.08 35.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.73 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.8 mt -102.92 141.87 23.39 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.699 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 52.7 Cg_endo -89.13 170.26 4.94 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.844 2.362 . . . . 0.0 111.889 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 135.02 40.43 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.384 2.056 . . . . 0.0 111.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 98.76 -15.7 60.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.483 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -72.44 128.4 88.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.16 -31.27 54.29 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.123 3.216 . . . . 0.0 114.078 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.37 -24.0 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.249 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.44 85.07 3.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.95 -44.15 51.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.014 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -114.56 62.51 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 110.441 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.653 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 111.161 -0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.1 t -90.03 103.97 16.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.4 p -87.48 146.68 25.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.006 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.475 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -90.44 -38.3 10.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 109.607 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.413 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 82.8 t90 -157.1 128.73 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.25 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.672 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 38.7 t-80 57.83 -151.51 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.672 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 37.3 t -88.37 46.36 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.779 -0.576 . . . . 0.0 110.411 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -117.44 139.12 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.166 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.84 171.98 7.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.314 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.28 135.71 56.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.735 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.08 10.39 45.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.797 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.542 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 62.1 m -103.56 145.7 29.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.494 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.0 mpt_? -115.7 142.6 46.53 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.766 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 71.9 mt -118.91 148.6 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.697 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 7.7 m -156.96 96.53 1.61 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.444 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.413 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 3.8 m-85 -88.87 126.21 35.27 Favored 'General case' 0 C--O 1.228 -0.066 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 110.467 -177.795 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.2 pt20 -100.55 157.85 16.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.58 162.8 15.47 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -58.17 -47.54 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 28.8 mt-10 -55.49 -23.8 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.72 -46.02 14.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.68 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -75.16 -39.38 60.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.421 ' CB ' HG21 ' A' ' 211' ' ' ILE . . . -66.24 -26.06 67.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.29 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 41.8 ttm105 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.838 0.827 . . . . 0.0 109.474 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.603 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 13.9 t80 . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 98.7 14.17 38.28 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.174 -1.013 . . . . 0.0 112.695 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 8.1 t -69.05 -14.76 63.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.106 0.479 . . . . 0.0 110.879 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -100.95 -28.89 12.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.392 0.615 . . . . 0.0 110.316 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.4 153.65 6.85 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.628 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -121.64 102.45 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -0.616 . . . . 0.0 110.462 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.4 ttpt -87.79 125.09 34.25 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.37 102.93 0.93 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.181 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.06 -52.94 8.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.743 0.306 . . . . 0.0 110.46 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.4 t -146.34 157.97 43.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.128 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.481 ' ND1' HD22 ' A' ' 280' ' ' LEU . 9.3 t60 -141.85 145.32 34.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.288 0.566 . . . . 0.0 111.289 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.598 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . 34.1 tt0 -137.79 141.41 40.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.693 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -102.33 99.06 9.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.607 -169.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.8 m -135.54 155.82 37.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.97 105.31 17.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.901 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' A' ' 268' ' ' GLU . 82.3 tttt -94.03 105.09 17.11 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.994 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.557 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 14.0 mt -115.64 132.22 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.966 0.413 . . . . 0.0 111.464 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 m -104.33 117.49 34.33 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.509 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 92.5 m-85 -105.41 168.65 8.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.096 0.475 . . . . 0.0 111.974 -171.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -137.43 136.77 20.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.511 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.603 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.4 Cg_endo -80.72 8.86 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.025 1.817 . . . . 0.0 112.451 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.65 -23.09 10.44 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 8.4 t -154.19 133.78 12.84 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.92 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.3 -7.21 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.296 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -56.95 -24.63 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.851 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.13 -46.96 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.561 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.72 148.84 4.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.99 152.54 45.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 110.617 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -133.11 117.04 17.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.431 ' N ' HD23 ' A' ' 292' ' ' LEU . 7.4 m -105.97 135.98 46.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.509 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 69.5 t -135.39 122.96 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.151 0.501 . . . . 0.0 111.135 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.508 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -107.49 110.06 21.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.327 -178.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.487 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.0 p -125.37 175.63 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.566 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -75.77 166.13 23.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.521 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.566 HD21 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -71.75 -18.01 62.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.61 -168.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -100.43 19.63 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.28 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.26 121.62 85.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.665 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.46 133.03 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.371 2.047 . . . . 0.0 111.626 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.487 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -119.4 121.7 40.11 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.943 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 28.0 t80 -76.23 102.15 5.7 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.752 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 332' ' ' ASP . 78.6 t -92.62 134.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.3 0.571 . . . . 0.0 111.097 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.535 ' HB3' HG11 ' A' ' 333' ' ' VAL . 63.9 tttp -62.08 127.23 30.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.241 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.0 m120 76.01 3.39 3.73 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.792 0.683 . . . . 0.0 111.947 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -123.95 -28.88 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 87.2 -153.74 25.69 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.06 115.04 4.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.03 0.443 . . . . 0.0 110.363 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.47 ' CB ' HG23 ' A' ' 328' ' ' ILE . 15.1 m -125.45 168.08 14.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.926 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -162.26 178.63 8.54 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.356 -0.215 . . . . 0.0 110.452 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.557 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 52.2 m-85 -95.94 -22.07 17.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.84 68.19 71.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 84.3 Cg_exo -48.92 -37.83 37.48 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 113.379 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 30.3 m -62.3 -31.28 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.084 0.469 . . . . 0.0 111.041 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.49 -44.15 11.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.437 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 m -56.42 -39.52 73.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.728 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.461 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.7 p -71.75 -23.51 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 -43.92 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 0.0 110.216 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.88 -54.29 7.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.245 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -99.34 -15.73 18.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.241 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 87.57 10.11 70.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.8 mt -109.72 117.73 51.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.583 0.191 . . . . 0.0 110.839 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 104.31 1.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.567 2.178 . . . . 0.0 110.405 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 64.3 m -102.45 156.5 17.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.196 -169.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 56.1 m -79.82 152.95 29.44 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.945 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -79.26 117.66 20.47 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.47 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -68.45 165.09 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 0.0 110.726 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -121.36 140.72 51.74 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.9 mm -55.48 112.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.147 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.48 3.58 20.58 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.139 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.471 ' HB3' HG11 ' A' ' 304' ' ' VAL . 50.8 m-20 -81.01 135.24 35.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.13 135.31 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.598 0.713 . . . . 0.0 112.129 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 60.2 m -100.82 135.53 42.12 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.742 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.74 142.0 23.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.353 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.78 165.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.214 2.609 . . . . 0.0 111.993 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.39 121.34 8.45 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.461 2.107 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 112.66 -11.2 25.6 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.446 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.3 127.22 86.74 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.7 -24.75 38.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.662 2.908 . . . . 0.0 113.935 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.23 -31.86 43.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.275 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.1 91.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 110.028 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 55.4 mt -74.58 -48.92 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.344 -176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.56 53.43 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.994 0.426 . . . . 0.0 110.673 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.023 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.1 t -95.45 94.82 8.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.325 0.583 . . . . 0.0 110.229 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.8 p -86.0 141.92 29.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.162 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.465 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.6 mm -88.36 -38.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.346 0.593 . . . . 0.0 109.72 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -156.15 135.93 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.386 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.544 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 18.8 t-80 53.53 -141.04 0.89 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.544 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 53.3 t -98.4 38.68 1.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.498 0.666 . . . . 0.0 109.931 176.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.55 139.35 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.241 0.544 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.4 173.17 7.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.383 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -62.57 137.57 58.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.113 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.76 60.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.096 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.1 m -82.54 145.64 29.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.41 139.3 49.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.382 0.61 . . . . 0.0 111.383 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 53.5 mt -113.45 148.01 36.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.193 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 11.7 t -153.9 98.09 2.14 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.2 0.524 . . . . 0.0 110.653 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.88 116.27 19.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.762 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.591 -178.407 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 73.1 m95 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.922 0.391 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 9.4 pt20 -124.98 162.15 25.12 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.39 162.99 17.88 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.067 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -59.76 -44.41 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.77 -23.57 30.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.975 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.19 -53.95 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.225 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.559 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 67.2 t80 -68.89 -42.81 76.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.29 -41.13 75.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.719 178.108 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 46.2 t80 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.72 24.14 50.75 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.0 t -78.01 -5.94 52.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.605 0.241 . . . . 0.0 111.59 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.04 -31.06 7.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.495 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 161.41 153.3 6.98 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.102 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.5 mp -121.2 103.69 9.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.904 0.482 . . . . 0.0 110.717 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 30.0 tttm -87.29 119.61 27.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.973 0.416 . . . . 0.0 110.558 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.78 113.31 2.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 283' ' ' ASP . 89.0 mt -87.43 -52.05 5.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.1 t -145.76 160.24 42.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.322 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -143.36 141.58 30.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 41.5 tt0 -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.478 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -100.97 124.08 46.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.917 -170.092 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.981 0.896 . . . . 0.0 113.307 -172.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 92.8 mt -96.9 114.34 25.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.987 172.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.641 ' HB2' ' HZ1' ' A' ' 279' ' ' LYS . 4.5 ttmp? -97.84 109.9 22.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.448 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 16.4 mt -116.55 127.01 54.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.467 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 90.3 m -98.02 120.02 37.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.481 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.0 m-85 -105.41 161.74 14.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.462 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.416 ' HB2' HD23 ' A' ' 265' ' ' LEU . 37.4 t70 -125.8 132.08 24.2 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.524 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.468 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -80.59 11.11 3.03 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.302 2.002 . . . . 0.0 111.706 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.4 11.08 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.334 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -153.67 138.01 16.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.045 0.45 . . . . 0.0 110.354 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.81 -9.27 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.895 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -34.68 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.93 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -78.71 -44.09 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.609 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.74 161.13 8.66 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.985 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.57 145.24 25.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.013 0.435 . . . . 0.0 110.645 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.66 122.52 27.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 99.6 m -115.79 136.39 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.6 t -129.76 136.42 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.192 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.47 120.99 39.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -136.89 169.88 17.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.046 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -64.82 161.86 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.403 0.62 . . . . 0.0 111.13 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -70.71 -18.09 62.81 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.503 -168.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.34 24.14 9.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.374 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.9 122.31 86.23 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.551 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.76 129.76 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.381 2.054 . . . . 0.0 111.999 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.469 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 93.7 m-85 -116.52 118.48 32.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 35.3 t80 -73.78 100.06 3.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.707 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 74.8 t -88.7 134.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.342 0.591 . . . . 0.0 110.743 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.512 ' HB3' HG11 ' A' ' 333' ' ' VAL . 62.8 tttp -57.96 127.44 32.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.682 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.3 m-20 76.85 -2.79 2.62 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.036 0.835 . . . . 0.0 111.945 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -119.46 -21.2 7.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.758 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 78.21 -152.01 37.52 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.846 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.38 115.68 4.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 164.51 21.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.019 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -161.53 176.88 10.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.844 0.354 . . . . 0.0 111.25 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 328' ' ' ILE . 63.0 m-85 -87.58 -34.38 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.01 71.82 53.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 80.9 Cg_exo -52.09 -36.94 67.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.839 2.359 . . . . 0.0 112.756 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 5.9 p -63.55 -29.35 70.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.2 0.524 . . . . 0.0 111.299 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.26 -47.42 8.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.8 m -56.5 -41.3 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.366 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.452 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 14.7 p -69.06 -21.33 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 111.68 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 73.1 t -91.28 -29.51 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.567 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.82 -52.15 5.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.966 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -99.92 -6.46 26.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 74.4 20.34 79.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.6 116.18 36.93 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.645 0.222 . . . . 0.0 110.798 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.98 106.31 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.729 2.286 . . . . 0.0 111.238 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.7 m -106.53 151.2 25.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.038 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 65.2 m -79.66 147.97 31.8 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.858 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.14 134.28 51.46 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.958 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.487 HD13 ' CD2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -88.44 171.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.143 0.496 . . . . 0.0 110.101 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -132.57 156.71 46.37 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.72 110.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 115.47 4.05 20.21 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.845 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.74 127.57 32.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.444 0.622 . . . . 0.0 110.341 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.9 p -90.92 136.97 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.862 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.9 m -102.32 134.91 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.387 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 66.1 mt -101.93 145.91 31.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.12 165.25 8.46 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.988 2.459 . . . . 0.0 112.49 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.404 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 49.6 Cg_endo -69.26 122.64 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.645 2.23 . . . . 0.0 111.755 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.68 -17.6 27.82 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.706 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -65.99 125.64 90.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.48 -21.67 72.52 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 123.01 2.473 . . . . 0.0 113.128 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.63 -23.16 29.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.586 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.19 99.12 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.46 -45.31 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.206 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -124.44 84.96 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.279 -0.263 . . . . 0.0 110.879 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 2.1 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.46 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.718 -0.532 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -94.3 93.06 7.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.342 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -85.31 140.23 30.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.992 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.473 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.8 mm -91.78 -43.18 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 109.886 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -149.8 126.86 11.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.594 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 26.2 t-80 59.74 -149.59 0.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.594 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 43.8 t -90.68 36.15 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.367 0.604 . . . . 0.0 110.414 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 294' ' ' VAL . 62.5 m-85 -106.39 141.48 37.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.213 0.53 . . . . 0.0 111.059 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.88 170.38 8.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.367 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -67.16 131.39 45.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.82 7.72 41.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.905 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.484 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.3 m -97.89 150.2 21.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -114.95 143.07 45.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.771 0.32 . . . . 0.0 110.6 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 73.8 mt -120.71 147.66 44.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.605 -171.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 38.2 t -155.29 102.7 2.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.526 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.417 ' CD2' HD22 ' A' ' 292' ' ' LEU . 7.4 m-85 -90.08 128.06 36.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.8 m170 . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.166 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 96.5 m95 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.3 pt20 -107.78 160.81 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.951 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -83.56 159.38 21.66 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.471 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.484 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.8 t -57.95 -51.45 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.2 -23.46 22.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.837 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.84 -52.33 11.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.382 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.33 -39.95 62.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.201 0.525 . . . . 0.0 110.486 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.415 ' CB ' HG21 ' A' ' 211' ' ' ILE . . . -64.1 -26.3 68.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.877 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 109.714 175.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.527 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 52.6 t80 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 121.173 0.511 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 78.56 25.17 61.34 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.2 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 52.7 p -76.64 -8.98 58.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.573 0.687 . . . . 0.0 111.878 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -110.18 -30.23 7.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.541 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 165.26 158.01 10.24 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.821 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -126.3 101.48 6.75 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.082 0.553 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.9 ttpp -87.7 119.59 28.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.291 0.567 . . . . 0.0 110.686 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.78 107.39 0.96 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.237 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.2 -48.26 12.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.35 . . . . 0.0 110.765 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.1 t -152.69 164.88 36.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.149 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.525 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 9.9 t60 -146.4 138.74 25.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.375 0.607 . . . . 0.0 111.992 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.626 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 10.2 tt0 -133.04 140.65 47.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.413 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.525 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 10.1 mt-10 -108.56 108.64 19.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.381 0.61 . . . . 0.0 110.323 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.731 -174.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.62 154.06 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.791 0.805 . . . . 0.0 112.486 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.88 108.18 19.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.394 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.626 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 2.3 ttmp? -92.29 108.34 19.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.432 HD22 ' ND1' ' A' ' 267' ' ' HIS . 14.7 mt -116.0 120.02 37.78 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.655 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 8.8 m -90.97 116.48 28.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.478 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 69.6 m-85 -105.25 167.82 9.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.359 0.599 . . . . 0.0 112.433 -171.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.44 134.62 21.28 Favored Pre-proline 0 C--O 1.217 -0.606 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.458 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.527 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -77.64 9.6 2.87 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 121.557 1.505 . . . . 0.0 112.169 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.95 -5.43 56.38 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -154.64 135.42 13.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.352 0.596 . . . . 0.0 110.766 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.44 -8.04 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.32 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.27 -39.92 80.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.583 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -82.45 -46.75 13.07 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.392 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 136.24 176.67 14.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.77 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.74 150.88 24.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.884 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.422 HD21 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -136.45 121.04 18.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.422 ' N ' HD21 ' A' ' 292' ' ' LEU . 14.1 m -108.36 134.27 51.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.478 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 97.3 t -129.47 128.58 66.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.101 0.476 . . . . 0.0 110.881 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -113.97 107.88 16.28 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.455 -177.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.5 p -123.6 173.14 8.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.093 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -75.88 163.29 27.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.674 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -65.6 -14.32 60.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.066 -170.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.02 11.13 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.784 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.21 118.97 73.92 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.151 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.81 133.29 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.405 2.07 . . . . 0.0 111.814 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.49 119.58 34.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 25.7 t80 -74.51 107.19 6.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.518 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 332' ' ' ASP . 57.0 t -94.89 133.39 35.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.309 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.715 ' HB3' HG11 ' A' ' 333' ' ' VAL . 55.4 tttp -63.95 128.92 37.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.575 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 6.4 m-20 75.39 12.73 3.18 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.98 0.8 . . . . 0.0 112.027 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -133.51 -48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.015 0.436 . . . . 0.0 111.268 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 105.97 -156.45 16.43 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -171.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -61.3 114.58 3.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.312 0.556 . . . . 0.0 110.678 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.422 ' CB ' HG23 ' A' ' 328' ' ' ILE . 19.5 m -128.92 166.46 19.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.257 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -161.36 175.07 12.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.252 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.44 ' CE2' HD13 ' A' ' 328' ' ' ILE . 76.6 m-85 -88.48 -37.42 15.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.743 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -122.53 77.17 46.05 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.895 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -58.18 -31.41 93.34 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.975 2.45 . . . . 0.0 113.114 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 40.4 t -75.8 -21.2 57.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.341 0.591 . . . . 0.0 110.073 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.88 -48.6 7.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.217 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -51.49 -40.3 59.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.054 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.2 p -74.79 -29.54 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.209 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.36 -37.45 79.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.63 0.729 . . . . 0.0 110.319 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -100.8 -38.94 8.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.047 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -107.18 -3.63 19.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.142 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 69.35 16.16 71.04 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.942 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.72 109.6 52.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.666 -0.314 . . . . 0.0 110.588 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.74 118.03 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.737 2.291 . . . . 0.0 110.211 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.0 m -116.76 160.52 20.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.302 0.572 . . . . 0.0 112.494 -168.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.2 m -81.09 166.66 20.52 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.976 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -93.26 129.35 39.36 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.44 HD13 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -73.6 168.3 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.258 0.551 . . . . 0.0 110.696 -177.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -125.23 142.18 51.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.56 114.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.079 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.27 -4.24 20.13 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.159 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.475 ' HB3' HG12 ' A' ' 304' ' ' VAL . 54.2 m-20 -73.63 132.87 43.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -95.3 134.36 33.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.171 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.9 t -96.14 133.06 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.401 -176.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 83.6 mt -102.04 140.58 21.3 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.39 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.59 163.68 9.37 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.933 2.422 . . . . 0.0 112.152 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.57 122.58 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.587 2.192 . . . . 0.0 112.023 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.97 -7.17 41.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.426 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -74.44 125.83 89.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.71 -22.13 51.13 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.451 2.767 . . . . 0.0 114.233 -171.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.76 -28.47 44.81 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.726 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.05 85.3 2.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 86.4 mt -70.71 -43.89 76.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.892 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -124.05 81.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.534 -178.795 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.2 t -110.44 99.02 8.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.035 0.445 . . . . 0.0 110.067 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.5 p -84.07 150.49 25.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.895 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.481 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.0 mm -90.35 -40.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.702 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.477 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 85.7 t90 -150.14 125.94 10.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.577 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 28.6 t-80 60.94 -138.54 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.577 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 43.8 t -95.4 32.38 1.78 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.252 0.548 . . . . 0.0 110.32 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -107.48 137.73 44.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.399 0.619 . . . . 0.0 111.645 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.71 178.75 4.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.284 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -63.06 144.62 56.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.262 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.54 11.71 63.76 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.399 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.539 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 44.9 m -101.88 145.74 28.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.404 ' O ' HG11 ' A' ' 294' ' ' VAL . 1.0 OUTLIER -111.81 136.29 51.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.727 0.299 . . . . 0.0 110.594 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.42 144.18 43.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.727 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 8.5 m -154.08 93.92 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.08 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.477 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 11.7 m-85 -80.67 126.6 31.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.7 m170 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 121.052 0.453 . . . . 0.0 110.066 178.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 51.7 m95 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -96.38 153.21 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.67 158.35 20.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -55.68 -49.73 72.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.424 0.631 . . . . 0.0 109.84 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.25 -23.24 55.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.762 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.37 -58.03 3.53 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.995 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -62.65 -48.27 80.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.123 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.08 80.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.632 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.945 -175.704 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 121.246 0.546 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 91.11 14.92 56.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.447 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.6 t -68.5 -12.99 62.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.093 0.447 . . . . 0.0 111.795 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -102.96 -32.54 9.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 0.0 109.977 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.56 160.73 10.51 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.427 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 4.4 mp -123.67 100.53 6.83 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.455 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.9 ttpt -82.18 122.36 27.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.009 0.433 . . . . 0.0 110.173 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.482 ' CD1' HD23 ' A' ' 280' ' ' LEU . 46.1 tp -64.28 103.19 0.6 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.897 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' ' 283' ' ' ASP . 59.1 mt -81.94 -44.16 17.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.761 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 t -151.91 152.13 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.329 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.5 t60 -135.52 137.71 42.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.471 0.653 . . . . 0.0 111.466 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 34.1 tt0 -129.48 140.46 51.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.969 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.555 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 21.7 mt-10 -115.33 103.52 10.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.272 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.78 -174.584 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.44 155.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.852 0.834 . . . . 0.0 112.785 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.551 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 82.8 mt -93.13 108.0 19.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.838 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 49.5 tttm -103.64 106.89 17.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 282' ' ' PHE . 9.6 mt -111.91 140.85 46.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.24 -173.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 21.9 m -112.92 116.07 29.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 280' ' ' LEU . 86.6 m-85 -108.96 161.76 14.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 17.6 t70 -121.54 132.34 24.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.118 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.74 10.18 3.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 113.047 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.99 -17.72 51.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.894 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -145.46 128.32 16.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.291 0.567 . . . . 0.0 110.24 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 -11.01 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.244 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.44 -31.31 72.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.096 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.96 -46.48 15.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.712 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 131.06 -163.42 23.5 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.988 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 mt -108.85 165.07 11.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.728 0.299 . . . . 0.0 110.858 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -136.18 119.58 16.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.3 m -108.88 135.82 49.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 53.2 t -136.71 136.1 48.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -100.64 124.25 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.21 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.0 p -136.86 170.79 15.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.652 0.263 . . . . 0.0 110.482 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -81.5 165.85 20.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.246 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.581 ' H ' HD23 ' A' ' 298' ' ' LEU . 2.0 mm? -67.85 -17.78 64.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.51 -172.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -105.3 22.05 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.299 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -78.76 119.04 75.82 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.45 137.23 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.0 111.94 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.441 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 88.4 m-85 -123.98 120.63 33.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.493 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 46.5 t80 -75.87 110.25 10.16 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.239 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.523 HG12 ' HB3' ' A' ' 332' ' ' ASP . 51.8 t -99.05 137.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.412 -175.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -57.53 126.43 27.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.236 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 28.5 m120 75.72 -6.84 1.91 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.377 0.671 . . . . 0.0 112.33 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -114.74 -20.76 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.813 0.34 . . . . 0.0 111.527 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.66 -152.63 41.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.765 0.317 . . . . 0.0 110.419 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 19.8 m -129.01 166.2 19.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.988 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 12.4 t -161.94 -178.58 6.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 280' ' ' LEU . 69.8 m-85 -95.65 -35.91 11.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.63 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.71 70.92 48.73 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.29 -35.62 96.61 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.263 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.6 p -68.03 -20.82 65.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.246 0.546 . . . . 0.0 110.511 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.0 tp -88.15 -44.04 11.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.114 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.2 m -55.05 -39.79 69.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.567 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.3 p -71.23 -23.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.73 -39.2 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 110.098 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -80.12 -58.35 3.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.027 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -92.95 -25.46 18.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.916 0.389 . . . . 0.0 111.312 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 90.36 22.09 35.85 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.064 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.4 mt -115.41 114.55 42.73 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.96 103.71 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.79 2.327 . . . . 0.0 110.768 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 48.1 m -103.85 156.99 17.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.376 -168.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.9 m -81.56 165.34 21.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.61 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -92.25 124.16 36.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.438 HD12 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -67.8 165.3 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 -175.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -122.79 138.9 54.5 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.82 112.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.057 0.456 . . . . 0.0 110.344 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.07 6.11 19.01 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.185 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.523 ' HB3' HG12 ' A' ' 304' ' ' VAL . 5.7 m-20 -81.05 134.53 35.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.0 111.594 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 2.4 t -79.63 125.58 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.419 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 72.5 m -94.49 119.58 33.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.4 mt -100.99 141.59 22.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.83 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.472 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 78.2 Cg_endo -86.67 166.1 8.92 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.253 2.635 . . . . 0.0 112.442 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.75 115.45 4.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.676 2.251 . . . . 0.0 111.805 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 119.49 -16.57 10.51 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.313 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -67.7 127.25 93.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.22 -24.63 51.55 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.569 2.846 . . . . 0.0 114.211 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.26 -35.16 48.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.618 0.247 . . . . 0.0 110.647 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.53 86.41 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 110.136 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.5 -53.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.17 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.97 74.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.367 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.048 178.314 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.652 -0.557 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -92.08 103.69 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 110.167 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 p -84.58 141.31 30.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 8.9 mm -85.85 -42.79 16.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.293 0.568 . . . . 0.0 109.657 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -154.65 128.69 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.908 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.667 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 44.7 t-80 57.63 -149.67 0.46 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.667 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 34.2 t -88.61 43.75 1.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.688 -0.632 . . . . 0.0 110.397 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.421 ' CZ ' HG22 ' A' ' 294' ' ' VAL . 65.3 m-85 -114.31 138.53 50.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.201 0.524 . . . . 0.0 111.274 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.4 176.09 5.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.328 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.498 ' HG3' ' CD ' ' A' ' 235' ' ' GLU . 88.1 tttt -62.54 141.99 58.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.292 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.26 4.7 64.27 Favored Glycine 0 CA--C 1.517 0.178 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.401 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.1 m -94.69 149.15 21.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -113.44 143.32 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.96 0.409 . . . . 0.0 110.973 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.432 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 63.5 mt -118.18 148.94 41.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.076 -174.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 35.0 t -154.13 101.33 2.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.996 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -86.38 98.06 10.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 291' ' ' LEU . 22.6 m170 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.496 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 62.8 m95 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.368 0.604 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 11.7 pt20 -132.15 156.41 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.989 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.79 154.27 38.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -58.29 -47.61 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 168.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.498 ' CD ' ' HG3' ' A' ' 217' ' ' LYS . 4.6 mt-10 -59.05 -21.59 59.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.501 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.0 -52.35 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.204 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.507 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.7 t80 -62.86 -48.45 78.99 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.011 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.05 -34.92 68.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.006 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 11.2 ttm180 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.518 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.66 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 41.6 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.28 15.97 59.74 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.418 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.9 p -69.11 -15.09 63.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.93 -26.59 10.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.49 156.74 8.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.638 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -123.88 100.11 6.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.392 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 76.0 tttt -84.42 124.4 31.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -65.36 104.59 0.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.52 -45.83 16.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.6 t -152.01 164.61 36.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.804 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.544 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.87 139.66 40.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.493 -168.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -146.31 140.98 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.283 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.76 109.81 21.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.047 0.451 . . . . 0.0 109.792 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.221 -171.59 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.01 155.63 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.826 0.822 . . . . 0.0 112.551 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.21 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.17 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -97.82 106.77 19.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 312' ' ' PHE . 20.5 mt -114.46 139.26 49.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.4 m -103.76 120.8 41.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.555 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.8 m-85 -109.39 163.75 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 31.9 t70 -132.75 137.56 30.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.846 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.66 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 93.5 Cg_endo -83.24 9.42 4.1 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.241 1.961 . . . . 0.0 112.674 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.42 -11.19 50.78 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -153.18 114.75 4.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.544 0.688 . . . . 0.0 109.718 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.21 -8.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.985 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.25 -23.18 66.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.905 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.76 -42.97 20.92 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.758 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.7 153.52 5.95 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.992 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 224' ' ' HIS . 1.9 mt -73.15 155.18 39.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.011 0.434 . . . . 0.0 110.931 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 294' ' ' VAL . 1.7 tm? -136.09 119.49 16.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 19.0 m -110.38 137.05 48.62 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.421 HG22 ' CZ ' ' A' ' 215' ' ' PHE . 90.9 t -130.73 134.93 61.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.159 -176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.496 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 32.8 mt-10 -117.83 120.66 38.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 172.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 3.9 p -137.44 172.32 13.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.636 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.21 162.04 23.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 110.777 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.4 mm? -69.72 -8.9 51.89 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.123 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -105.03 13.87 30.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.416 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -73.43 116.59 52.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.826 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.14 119.4 5.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.247 1.965 . . . . 0.0 111.584 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.65 119.38 38.85 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 12.1 t80 -74.27 106.35 5.87 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.507 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.0 t -94.45 134.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.349 0.595 . . . . 0.0 111.273 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.545 ' HB3' HG11 ' A' ' 333' ' ' VAL . 49.8 tttp -58.5 125.27 22.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.329 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.4 m120 78.08 -1.95 2.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.407 0.683 . . . . 0.0 112.196 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 38.9 mttp -117.75 -28.72 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 111.35 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . 0.4 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 86.15 -152.4 25.62 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.71 116.79 5.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.067 0.433 . . . . 0.0 110.091 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.409 ' CB ' HG23 ' A' ' 328' ' ' ILE . 16.5 m -128.66 166.23 19.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.368 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.5 t -160.85 171.74 18.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.805 0.336 . . . . 0.0 110.649 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.544 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 56.6 m-85 -86.23 -36.42 19.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.64 174.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -126.25 77.3 72.21 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.454 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 48.8 Cg_exo -57.08 -38.51 95.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.94 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 20.0 m -66.06 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.0 110.796 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.24 -47.25 9.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.995 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.424 HG23 ' SG ' ' A' ' 325' ' ' CYS . 33.9 m -56.62 -41.83 77.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.064 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.55 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 13.5 p -69.33 -20.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.707 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.01 -43.79 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -72.13 -51.56 20.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.076 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -101.49 -20.34 15.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.033 0.444 . . . . 0.0 111.026 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 86.28 24.09 41.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.409 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.2 mt -118.86 113.52 35.95 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.888 -0.183 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -71.2 117.02 4.94 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 110.305 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.424 ' SG ' HG23 ' A' ' 317' ' ' THR . 80.2 m -117.6 155.46 29.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.007 0.432 . . . . 0.0 112.1 -169.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.31 164.75 23.84 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.266 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -92.52 120.36 32.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.409 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.06 162.45 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.506 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -125.34 150.36 47.25 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.37 113.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.681 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.507 ' O ' ' HE3' ' A' ' 263' ' ' LYS . . . 115.87 1.36 21.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.018 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 23.9 m-20 -75.27 127.33 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.178 0.513 . . . . 0.0 110.433 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.63 133.98 30.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.407 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 53.6 t -94.82 131.25 40.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.235 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.3 mt -103.14 140.78 21.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.216 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.417 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.4 Cg_endo -86.81 167.34 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.88 2.387 . . . . 0.0 111.916 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.09 127.21 17.93 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 111.356 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 111.05 -18.22 26.32 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.431 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.517 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 12.3 t-80 -71.27 127.43 91.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.03 -22.28 73.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.255 2.636 . . . . 0.0 113.448 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.517 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 4.1 m-20 -78.17 -25.81 47.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.159 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.48 86.68 2.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.09 -45.66 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.766 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . 0.514 ' H ' ' HH ' ' A' ' 303' ' ' TYR . 3.8 t-20 -124.2 75.72 1.4 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.648 0.261 . . . . 0.0 110.459 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.574 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.656 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -103.86 89.45 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.233 0.539 . . . . 0.0 109.934 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -76.82 144.13 39.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.28 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.403 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.4 mm -81.33 -42.08 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.421 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 68.9 t90 -153.8 139.93 18.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.327 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.498 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 21.3 t-80 53.1 -137.54 1.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 52.1 t -100.35 35.03 2.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.488 0.661 . . . . 0.0 109.968 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.97 140.32 42.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.4 0.619 . . . . 0.0 111.656 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD21 ' N ' ' A' ' 216' ' ' LEU . 3.3 mm? -100.03 175.73 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.023 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -66.66 139.97 57.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.885 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.66 12.1 51.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.959 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 61.6 m -105.82 146.88 29.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -115.65 140.66 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.02 0.438 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 80.0 mt -114.53 145.08 42.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.107 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.35 109.1 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.463 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -99.58 115.5 29.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.0 m170 . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.878 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.51 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 57.7 m95 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.7 pt20 -117.49 162.84 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.34 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -89.18 160.0 17.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.066 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -57.95 -47.9 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -55.26 -22.74 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.63 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.93 -56.99 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.641 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.583 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 80.6 t80 -66.55 -40.4 89.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -53.47 -50.98 64.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.754 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.488 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 t80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.077 0.465 . . . . 0.0 111.874 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.38 42.68 3.91 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.827 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.8 m -79.1 -17.95 54.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -104.85 -29.49 10.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.478 0.656 . . . . 0.0 109.684 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 156.38 160.55 10.11 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.75 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -118.2 100.31 7.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.519 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.7 ttpt -83.9 117.05 23.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.214 0.53 . . . . 0.0 110.426 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.416 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.2 tt -61.22 103.7 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.136 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.4 -48.93 14.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.883 0.373 . . . . 0.0 110.444 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.9 t -151.94 167.18 29.2 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.408 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.535 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.6 t60 -141.1 139.81 34.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.294 0.569 . . . . 0.0 111.512 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 35.9 tt0 -133.66 144.37 49.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.808 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 25.6 mt-10 -115.85 133.19 56.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.814 0.34 . . . . 0.0 110.133 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.701 -170.506 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.56 155.6 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.972 0.891 . . . . 0.0 112.945 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.71 116.69 29.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.313 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 22.4 ttmm -107.29 114.08 27.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.487 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 26.9 mt -114.63 135.59 53.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.868 0.366 . . . . 0.0 110.344 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 12.4 m -97.64 115.57 28.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.541 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 61.7 m-85 -106.06 163.54 12.69 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -170.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -132.0 137.87 31.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.327 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.488 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 86.7 Cg_endo -87.03 11.13 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.341 2.027 . . . . 0.0 112.649 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.89 -12.73 56.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.27 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 t -153.49 134.87 14.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.974 0.416 . . . . 0.0 110.088 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.01 -8.52 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.525 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -55.07 -49.28 72.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.95 2.59 38.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 84.91 179.13 51.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.157 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mt -84.47 135.45 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.966 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 294' ' ' VAL . 1.3 tm? -111.37 120.12 41.13 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 25.4 m -112.73 135.92 52.91 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 96.2 t -132.27 135.42 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.743 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.51 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 83.2 mt-10 -107.52 120.4 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 169.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.578 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.1 p -131.88 173.37 11.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -74.68 164.9 26.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.644 0.259 . . . . 0.0 110.941 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.9 mm? -66.2 -28.84 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.336 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.73 26.11 5.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.293 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -77.63 116.77 60.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.485 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.44 125.15 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.256 1.971 . . . . 0.0 111.646 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.578 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -111.45 116.3 30.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.525 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 17.9 t80 -74.67 104.66 5.42 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.487 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.1 t -92.38 134.73 29.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.659 ' HB3' HG11 ' A' ' 333' ' ' VAL . 45.9 tttt -59.47 120.7 9.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.225 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.6 m120 74.45 6.9 4.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.004 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.462 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 34.2 mttp -117.02 -30.41 5.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.002 0.429 . . . . 0.0 110.582 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.91 -155.8 23.32 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.47 116.09 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.033 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.456 ' CB ' HG21 ' A' ' 328' ' ' ILE . 15.6 m -124.83 167.47 14.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.077 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 39.9 t -160.57 165.86 30.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.818 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.487 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 60.3 m-85 -86.83 -16.55 35.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.281 173.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -142.11 73.35 22.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.73 -41.03 77.52 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.812 2.341 . . . . 0.0 112.581 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 14.6 m -60.42 -29.04 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.27 -46.09 10.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.253 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.2 m -57.34 -41.24 79.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.158 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.5 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.5 p -68.82 -19.86 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 0.0 111.573 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.7 t -89.96 -45.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.075 0.464 . . . . 0.0 110.265 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -71.9 -58.7 3.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.314 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -95.75 -13.78 23.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 0.0 110.732 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 85.1 10.75 77.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.859 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.4 mt -108.82 117.56 53.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 122.741 -0.27 . . . . 0.0 111.008 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.89 116.76 4.83 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.513 2.142 . . . . 0.0 110.409 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.1 m -117.2 159.06 23.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.376 0.608 . . . . 0.0 112.462 -168.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 61.4 m -81.59 151.0 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.142 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 120.06 22.09 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.456 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.31 165.57 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.891 0.853 . . . . 0.0 111.413 -174.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -121.94 141.63 51.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.373 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.8 mm -58.09 113.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 109.673 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.41 -0.92 20.56 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.78 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.462 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 66.9 m-20 -71.33 124.77 25.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.208 0.527 . . . . 0.0 111.181 176.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.659 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -89.57 126.08 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.859 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.1 t -88.96 135.09 33.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.061 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 81.4 mt -106.37 144.07 28.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.631 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.3 160.61 13.11 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.474 2.116 . . . . 0.0 111.757 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.77 114.84 3.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.965 2.444 . . . . 0.0 112.25 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 115.29 -13.68 18.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.519 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.46 132.42 94.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.71 -31.1 49.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.105 3.204 . . . . 0.0 114.349 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -79.18 -23.12 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.99 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.07 95.76 3.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.066 0.46 . . . . 0.0 110.333 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.36 -42.27 81.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.855 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -139.62 98.14 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.091 -176.291 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 110.834 -0.487 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.6 t -103.52 110.63 22.75 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.5 p -94.9 150.76 19.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.287 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.5 mm -79.28 -45.96 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.376 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TRP . . . . . 0.42 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 78.5 t90 -151.36 136.71 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.445 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.632 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 44.2 t-80 56.04 -133.54 1.49 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' CYS . . . . . 0.632 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 14.9 p -99.17 26.61 5.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.012 0.434 . . . . 0.0 110.867 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -105.61 135.41 47.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.952 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.57 174.84 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.424 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -64.31 139.34 58.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.847 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.77 12.05 44.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.138 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 30.8 m -102.38 158.18 16.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.24 151.59 42.15 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.416 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 56.5 mt -122.31 145.72 47.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.13 92.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.658 175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -78.61 123.02 26.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 12.6 m170 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 0.0 111.632 -174.725 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' TRP . . . . . 0.443 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 88.3 m95 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -100.09 158.97 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.532 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.05 164.35 21.46 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.163 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.1 t -66.27 -39.06 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.23 -22.05 64.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.503 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.69 -53.32 12.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.33 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.488 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 88.1 t80 -74.68 -40.31 61.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.236 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.4 76.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.842 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.607 0.718 . . . . 0.0 109.909 178.492 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.672 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 38.3 t80 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.95 11.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.656 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.9 t -78.81 -24.82 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.704 0.288 . . . . 0.0 110.552 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -99.39 -25.37 14.49 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.39 168.0 17.83 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.646 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.04 102.79 7.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.771 -0.714 . . . . 0.0 110.138 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 75.5 tttt -87.49 119.12 27.45 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.0 110.796 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.51 107.87 0.74 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.163 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 283' ' ' ASP . 71.7 mt -83.13 -45.83 13.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.0 0.429 . . . . 0.0 110.48 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 32.8 t -151.88 156.33 39.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.211 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.415 ' ND1' HD22 ' A' ' 280' ' ' LEU . 5.8 t60 -139.12 138.22 36.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -131.57 141.46 49.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.397 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.28 129.61 53.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.649 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.5 m -130.04 152.59 37.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 122.029 0.918 . . . . 0.0 112.897 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.64 112.87 24.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.591 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.556 ' HZ3' ' HB2' ' A' ' 279' ' ' LYS . 4.4 ttmp? -102.87 110.0 21.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 23.0 mt -115.34 129.73 56.69 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 87.7 m -98.94 117.17 32.84 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.424 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.0 m-85 -104.51 167.02 10.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.137 -170.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD22 ' A' ' 265' ' ' LEU . 21.9 t70 -132.34 134.52 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.413 175.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . 0.672 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.2 Cg_endo -83.72 12.11 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.143 1.895 . . . . 0.0 112.332 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.64 62.06 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -153.71 102.94 2.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.911 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.52 -15.28 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.421 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.16 -28.24 69.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.671 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -72.27 -40.5 67.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 110.161 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.85 152.72 5.98 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.422 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.26 147.76 28.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.221 0.511 . . . . 0.0 110.638 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 294' ' ' VAL . 1.5 tm? -125.05 118.32 25.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 83.8 m -110.3 134.0 52.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 292' ' ' LEU . 75.3 t -130.33 136.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.561 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 62.5 mt-10 -112.54 127.94 56.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.105 170.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.0 p -139.82 176.28 8.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.93 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.94 164.17 26.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.913 0.387 . . . . 0.0 110.329 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.7 mm? -64.85 -17.84 64.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.245 -173.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.35 17.89 20.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.979 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.92 118.47 72.07 Favored Pre-proline 0 C--N 1.323 -0.563 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.339 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.58 139.82 16.36 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.104 1.869 . . . . 0.0 111.677 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . 0.464 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 80.9 m-85 -124.5 129.73 51.16 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.9 t80 -82.63 89.62 6.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.498 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.549 HG23 ' OD1' ' A' ' 332' ' ' ASP . 74.8 t -75.83 125.91 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.068 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.65 ' HB3' HG11 ' A' ' 333' ' ' VAL . 62.9 tttp -56.09 141.4 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.641 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.4 m-20 78.21 -20.04 0.41 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.47 0.708 . . . . 0.0 111.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -105.2 -60.53 1.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 111.345 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 125.76 -124.34 5.19 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.25 117.39 28.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.765 0.782 . . . . 0.0 110.606 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.8 m -131.8 167.88 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.23 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.3 t -161.34 -177.34 5.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.425 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 71.6 m-85 -91.81 -39.09 11.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.22 73.2 57.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.877 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -57.17 -34.21 97.34 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.121 2.547 . . . . 0.0 113.213 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.8 p -65.35 -30.02 70.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.8 tp -83.15 -44.11 15.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.157 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -55.36 -44.16 75.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.151 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.461 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 13.7 p -69.81 -27.04 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.541 -176.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.7 -38.52 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.285 0.565 . . . . 0.0 110.186 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.26 -58.19 3.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.051 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -98.97 -8.46 25.42 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 76.25 21.44 75.62 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.2 mt -116.58 111.22 41.78 Favored Pre-proline 0 C--N 1.327 -0.394 0 O-C-N 122.876 -0.191 . . . . 0.0 110.646 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.33 117.95 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.582 2.188 . . . . 0.0 110.534 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 58.0 m -117.38 157.65 25.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.711 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 72.6 m -87.38 165.2 15.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.232 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.76 127.04 33.06 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.085 -0.384 . . . . 0.0 109.97 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.425 HD13 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -72.27 177.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 0.0 110.598 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -139.19 141.07 37.97 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.6 mm -52.34 112.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 109.575 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.49 9.13 15.27 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.735 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 304' ' ' VAL . 0.2 OUTLIER -72.29 127.99 34.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.61 111.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.946 0.879 . . . . 0.0 111.051 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.7 m -79.24 127.84 32.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.112 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 69.5 mt -98.75 138.95 20.77 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.066 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' PRO . . . . . 0.48 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.6 Cg_endo -86.14 176.65 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.923 2.415 . . . . 0.0 111.734 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.96 155.1 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.255 1.97 . . . . 0.0 111.029 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.0 -23.14 5.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.564 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' HIS . . . . . 0.47 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 21.7 t-80 -65.32 126.26 91.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -24.49 79.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.096 2.531 . . . . 0.0 113.152 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.47 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 4.4 m-20 -79.94 -25.15 40.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.497 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.21 84.87 3.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.392 0.615 . . . . 0.0 109.507 173.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.26 -44.54 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.639 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.74 44.24 1.94 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.93 0.395 . . . . 0.0 110.616 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.093 -178.345 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.0 t -96.9 93.39 6.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 110.222 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 23.7 p -87.72 144.2 26.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.808 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.501 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 13.8 mm -85.21 -37.95 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.32 0.581 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -151.91 131.38 12.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.498 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 18.4 t-80 58.62 -138.43 0.81 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.492 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 51.5 t -98.61 37.18 1.52 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 110.155 176.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -113.44 137.59 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.44 172.02 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.044 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.7 141.12 51.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.976 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.13 5.56 54.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.212 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 50.1 m -99.08 147.98 24.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.46 137.0 49.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.195 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 39.9 mt -113.12 144.06 43.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.257 -174.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 40.8 t -153.17 92.03 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.558 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -86.43 123.1 31.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -75.1 -4.63 39.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.442 ' HZ2' ' CG ' ' A' ' 289' ' ' ASP . 65.2 tttp -63.87 -26.32 68.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.603 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -109.05 -172.13 1.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 5.5 p -85.34 3.48 39.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -77.26 66.79 3.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.4 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -75.19 -11.39 60.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.906 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.21 172.39 6.89 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.57 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -82.17 120.12 24.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -170.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.9 pt20 -111.71 165.37 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -85.34 160.37 19.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.501 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 3.6 t -61.33 -45.21 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.6 0.714 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -58.12 -23.16 53.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.9 -52.01 11.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.009 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -68.11 -40.37 82.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.43 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.74 76.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.615 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -70.71 -44.32 67.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.734 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.94 97.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.416 0.627 . . . . 0.0 110.623 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.402 ' O ' ' HE2' ' A' ' 255' ' ' LYS . . . -92.66 28.66 1.96 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.459 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.1 p -55.18 -36.11 65.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.046 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 35.2 t -90.8 134.19 34.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.96 8.27 33.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.377 0.608 . . . . 0.0 111.218 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -179.12 124.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.643 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 250' ' ' GLN . 45.2 mt-10 -114.86 49.56 1.03 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.53 -24.75 61.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.646 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.33 -23.25 32.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.043 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 76.5 mt -121.99 -62.51 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 246' ' ' GLU . 20.8 tt0 -141.23 92.83 2.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 44.5 ttm -69.04 149.11 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 123.15 -46.32 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.541 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.1 m -58.71 111.86 1.42 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 256' ' ' GLY . 1.6 t60 -173.23 147.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -172.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 241' ' ' ALA . 4.8 mptp? -78.31 38.33 0.29 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -89.84 -39.49 6.17 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.784 -170.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.3 t80 -64.17 115.39 4.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.418 0.609 . . . . 0.0 109.699 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.76 19.31 44.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.388 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.4 t -66.92 -25.21 66.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.535 0.207 . . . . 0.0 111.312 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -99.17 -27.98 13.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.13 161.84 10.85 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.899 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -117.65 106.19 12.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.75 -0.725 . . . . 0.0 110.404 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.7 ttpp -90.56 119.32 30.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 -175.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 tt -60.08 113.13 2.17 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.09 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.421 HD22 ' HB2' ' A' ' 283' ' ' ASP . 95.4 mt -86.25 -52.14 5.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.452 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.2 t -148.57 158.98 44.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.783 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 4.1 t60 -135.71 136.24 40.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -127.3 139.52 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.571 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.481 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 28.5 mt-10 -108.95 106.4 16.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 110.063 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.3 t -127.11 178.02 6.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.637 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.44 121.0 66.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.352 0.596 . . . . 0.0 109.921 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 8.5 t -111.89 115.36 28.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.571 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.1 p90 52.68 30.51 8.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.625 0.77 . . . . 0.0 112.177 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.24 61.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.256 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -106.45 125.57 51.16 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.682 -0.305 . . . . 0.0 111.021 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.4 m -65.21 134.33 53.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.82 152.95 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.992 0.901 . . . . 0.0 113.068 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.33 114.08 26.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.985 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.8 ttmt -107.09 116.12 31.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.445 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 34.1 mt -119.88 131.23 55.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.205 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.6 m -95.45 114.95 26.77 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.553 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.4 m-85 -100.99 164.93 11.58 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.337 0.589 . . . . 0.0 112.471 -171.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.421 ' HB2' HD22 ' A' ' 265' ' ' LEU . 6.6 t70 -133.19 129.12 20.75 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.019 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.531 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 83.6 Cg_endo -81.44 9.12 4.01 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 122.155 1.903 . . . . 0.0 112.348 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 -47.97 0.99 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' HG21 ' A' ' 286' ' ' THR . 5.0 t -124.53 98.19 5.63 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 291' ' ' LEU . 5.2 p -67.52 -6.98 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.464 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.28 -12.6 61.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.538 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . 0.442 ' CG ' ' HZ2' ' A' ' 225' ' ' LYS . 9.9 t70 -66.2 -37.18 84.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.38 126.98 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.467 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.542 HD22 HG23 ' A' ' 287' ' ' VAL . 1.8 mt -59.97 135.32 57.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.179 0.489 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -109.45 119.24 38.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 6.5 m -109.35 139.96 43.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 73.5 t -136.75 131.47 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -105.67 117.62 34.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.319 169.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 9.6 p -134.53 178.17 7.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.877 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -81.06 165.54 21.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.658 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -68.75 -22.91 64.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.839 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.76 19.62 15.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.241 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.23 120.04 79.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.351 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.5 136.46 13.93 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.482 2.122 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.434 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 79.9 m-85 -124.2 124.96 43.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 8.0 t80 -77.53 93.07 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 332' ' ' ASP . 65.8 t -80.47 130.34 36.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.57 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 56.6 tttp -56.39 133.9 53.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.824 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.8 m-20 78.95 -17.13 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.02 0.825 . . . . 0.0 112.283 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.56 ' HE2' ' O ' ' A' ' 327' ' ' GLU . 11.6 tttp -111.36 -41.86 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.073 0.463 . . . . 0.0 111.571 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 104.71 -155.13 17.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -61.66 113.61 2.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.96 0.41 . . . . 0.0 110.587 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.428 ' CB ' HG21 ' A' ' 328' ' ' ILE . 19.7 m -131.08 164.94 24.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.043 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 t -160.99 179.76 8.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.636 0.255 . . . . 0.0 110.771 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.445 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 67.3 m-85 -91.53 -34.32 14.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.07 70.31 40.77 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 42.4 Cg_exo -59.13 -30.49 93.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.792 2.328 . . . . 0.0 113.425 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 16.0 m -70.35 -25.31 63.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.9 tp -87.54 -42.36 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.296 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 325' ' ' CYS . 9.2 m -53.87 -46.08 71.22 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.877 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.9 -27.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.14 -30.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 0.0 110.417 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -92.85 -38.58 11.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.613 -173.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -114.67 -4.02 12.81 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 122.118 -0.364 . . . . 0.0 111.859 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.01 78.87 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 48.1 mt -118.67 111.26 37.87 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 122.834 -0.216 . . . . 0.0 110.697 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.95 118.18 5.5 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.426 2.084 . . . . 0.0 110.82 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 85.0 m -117.76 153.94 32.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.3 0.571 . . . . 0.0 112.056 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 69.0 m -89.6 166.26 13.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.848 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . 0.56 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 25.2 tt0 -77.02 125.16 28.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.315 0.246 . . . . 0.0 111.194 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.428 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -80.64 168.0 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.791 175.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -133.06 151.1 52.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.1 mm -59.41 111.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.269 0.557 . . . . 0.0 109.717 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.56 1.15 21.64 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.413 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 304' ' ' VAL . 16.8 m-20 -79.0 128.75 33.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.457 0.646 . . . . 0.0 111.047 176.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.8 137.91 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.796 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 55.6 m -103.44 133.76 47.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.302 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.0 144.9 29.52 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.258 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.498 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.2 Cg_endo -87.98 166.09 7.12 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.143 2.562 . . . . 0.0 112.624 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 119.07 6.02 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.623 2.215 . . . . 0.0 111.157 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 118.34 -19.35 10.79 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.611 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.521 ' HD1' ' HB3' ' A' ' 341' ' ' ASP . 21.7 t-80 -69.32 127.44 92.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.98 -13.98 40.66 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.178 2.585 . . . . 0.0 113.115 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.57 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 32.9 t70 -90.31 -23.25 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.83 87.36 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.054 0.454 . . . . 0.0 109.786 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.84 -44.16 92.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.603 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.18 80.15 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.914 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.507 -178.29 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.614 -0.571 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.5 t -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.1 p -85.94 149.6 25.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.83 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.488 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.2 mm -79.23 -43.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -151.99 137.56 17.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.549 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.537 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 25.7 t-80 54.54 -136.53 1.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.537 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 47.8 t -100.25 37.6 1.64 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.145 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -111.12 137.14 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.347 0.594 . . . . 0.0 111.443 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.12 175.9 5.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.42 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -69.23 135.17 50.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.03 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.36 48.39 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.471 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.7 m -96.13 143.93 26.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.3 -0.45 . . . . 0.0 109.923 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -109.48 141.73 41.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.824 0.345 . . . . 0.0 110.548 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 46.5 mt -118.12 143.13 46.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.24 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.3 t -151.0 99.45 2.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.42 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.559 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 35.4 m-85 -91.97 132.41 36.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -78.94 -16.56 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.76 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 16.8 pttp -79.5 -18.79 51.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.411 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.44 173.61 7.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.2 m -80.91 7.6 10.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.271 0.558 . . . . 0.0 110.316 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -82.05 66.57 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.598 0.713 . . . . 0.0 110.011 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.542 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 12.0 pttp -62.11 -19.86 63.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.402 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.542 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 36.5 mt-10 -122.42 175.47 6.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.94 135.0 46.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.66 0.743 . . . . 0.0 112.75 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 18.4 pt20 -128.66 161.21 30.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.685 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -82.06 158.1 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.423 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.6 t -58.25 -46.46 88.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.613 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.416 ' HA ' HG22 ' A' ' 211' ' ' ILE . 25.6 mt-10 -57.55 -23.09 48.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.625 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.29 -45.94 14.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.0 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.712 ' CZ ' ' HG3' ' A' ' 255' ' ' LYS . 85.3 t80 -73.75 -35.91 65.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.983 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.08 67.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.709 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -62.58 -29.31 70.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.748 . . . . 0.0 109.691 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.67 -8.7 58.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.938 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.861 ' HA ' ' HD3' ' A' ' 255' ' ' LYS . . . -76.56 -7.52 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.318 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.0 m -71.91 -12.32 61.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.212 0.53 . . . . 0.0 110.118 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.8 m -90.3 152.55 20.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.67 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 245' ' ' ASN . 16.4 t70 -106.85 -169.18 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.503 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 20.0 m120 -68.12 72.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.99 51.51 1.53 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.445 ' OE2' ' HA ' ' A' ' 245' ' ' ASN . 25.2 mm-40 -59.94 -24.9 64.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.044 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.49 -20.27 57.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.111 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.35 107.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.644 0.735 . . . . 0.0 109.708 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -66.54 81.41 0.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.661 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.88 46.79 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 107.27 100.92 2.68 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.962 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.1 p -104.73 -178.93 3.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -85.85 135.22 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.347 0.594 . . . . 0.0 110.113 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.861 ' HD3' ' HA ' ' A' ' 241' ' ' ALA . 10.1 mptt -87.81 42.42 1.05 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.101 -173.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -88.9 13.55 62.69 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.538 ' HH ' ' HD3' ' A' ' 284' ' ' PRO . 4.4 t80 -66.08 117.18 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.018 0.437 . . . . 0.0 109.872 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.15 27.52 12.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.022 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.0 p -68.84 -22.61 64.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -99.52 -27.15 13.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.26 0.552 . . . . 0.0 109.811 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 150.19 154.39 6.43 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.946 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 5.5 mp -113.25 98.66 7.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.952 -0.624 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 8.4 tptp -77.99 115.62 17.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.489 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.5 tt -59.84 111.74 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 283' ' ' ASP . 82.8 mt -83.13 -51.87 7.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.061 0.458 . . . . 0.0 111.061 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.8 t -148.54 161.81 40.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.161 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.597 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -141.59 150.38 41.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.027 -168.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.79 135.58 12.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.884 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -87.18 106.06 17.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 t -111.75 -178.45 3.44 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.196 -168.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.07 133.01 61.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.2 t -122.32 87.14 2.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.293 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 58.49 55.4 4.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.665 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.08 34.65 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.678 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.615 ' HG3' HG12 ' A' ' 277' ' ' VAL . 3.3 pt-20 -148.02 133.19 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.402 0.601 . . . . 0.0 111.07 177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -73.07 128.54 35.76 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.855 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.615 HG12 ' HG3' ' A' ' 275' ' ' GLU . 8.9 m -134.6 157.07 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.695 0.76 . . . . 0.0 112.099 -175.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 90.0 mt -94.18 109.66 21.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.467 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -96.35 112.36 24.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.665 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 279' ' ' LYS . 29.6 mt -121.42 142.75 49.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.527 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 32.3 m -108.26 117.04 33.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.418 ' HZ ' HD13 ' A' ' 280' ' ' LEU . 96.2 m-85 -105.6 157.45 17.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.554 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.42 ' HB2' HD23 ' A' ' 265' ' ' LEU . 7.2 t70 -126.82 132.79 24.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.714 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.538 ' HD3' ' HH ' ' A' ' 257' ' ' TYR . 65.2 Cg_endo -79.4 5.55 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.017 1.811 . . . . 0.0 112.174 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.7 -13.29 42.33 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.2 t -153.89 133.13 12.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.057 0.456 . . . . 0.0 110.156 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.0 -8.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.856 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.4 -23.2 63.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.314 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 4.1 m-20 -90.87 -2.93 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.075 0.464 . . . . 0.0 110.248 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.07 169.95 29.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.949 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.71 152.16 19.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.559 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -126.4 120.47 29.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.448 ' N ' HD23 ' A' ' 292' ' ' LEU . 8.9 m -111.25 138.58 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 75.6 t -137.38 137.59 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.42 121.1 40.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.809 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -138.38 173.29 11.76 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -68.64 160.87 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.122 0.486 . . . . 0.0 111.23 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.658 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -64.62 -27.42 68.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.31 24.99 4.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.433 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -75.31 121.34 84.99 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.206 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.28 131.27 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.279 1.986 . . . . 0.0 111.805 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -121.82 116.62 24.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.532 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 29.1 t80 -73.25 108.69 6.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.896 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 74.1 t -99.12 137.96 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.427 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.654 ' HB3' HG11 ' A' ' 333' ' ' VAL . 60.0 tttp -56.78 124.46 18.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.792 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 77.95 -1.45 2.58 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.878 0.736 . . . . 0.0 112.177 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -117.16 -33.16 4.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 90.25 -157.13 25.64 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -60.87 113.02 2.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.294 0.547 . . . . 0.0 110.019 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.43 ' CB ' HG21 ' A' ' 328' ' ' ILE . 15.4 m -125.23 166.75 15.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.6 t -161.58 -178.58 6.68 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.461 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 33.3 m-85 -90.32 -41.48 11.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 110.292 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.35 77.31 68.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.948 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.03 -38.7 93.27 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.042 2.495 . . . . 0.0 113.448 -175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 2.3 p -62.34 -24.96 67.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.253 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.74 -45.24 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.768 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.2 m -59.03 -39.78 83.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.094 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.504 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.5 p -70.31 -19.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.531 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.25 -40.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.295 0.569 . . . . 0.0 110.33 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.76 -58.28 3.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.771 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -95.51 -14.93 23.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.727 0.299 . . . . 0.0 111.284 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 84.33 10.31 80.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.876 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.8 mt -109.09 115.69 56.49 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.71 111.29 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.351 2.034 . . . . 0.0 110.184 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 67.8 m -108.48 157.18 18.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.987 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 164.68 23.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.992 171.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.43 123.57 35.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.236 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.43 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.4 161.83 4.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.98 152.56 51.9 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 38.9 mm -54.87 114.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 0.0 110.742 -174.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.64 -3.59 19.69 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.714 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.422 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 4.2 m-20 -75.42 128.15 34.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.531 0.665 . . . . 0.0 111.161 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 305' ' ' LYS . 0.9 OUTLIER -87.48 131.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.586 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 42.3 t -95.14 134.7 37.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.975 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.62 145.34 30.84 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.154 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.5 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.9 Cg_endo -87.95 166.44 7.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.833 2.355 . . . . 0.0 112.188 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.88 126.3 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.588 2.192 . . . . 0.0 111.35 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.69 -12.99 35.49 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.773 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.11 131.44 81.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 -33.25 87.96 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.43 2.754 . . . . 0.0 113.504 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.26 -22.3 44.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.57 0.224 . . . . 0.0 111.051 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.8 84.36 4.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 98.8 mt -73.49 -46.2 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.245 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.54 52.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 110.284 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.83 -177.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 N-CA-C 110.688 -0.543 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.1 t -100.38 85.85 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.052 0.454 . . . . 0.0 110.18 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.2 p -85.78 142.02 29.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.436 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.7 mm -88.6 -45.34 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.203 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.479 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 78.8 t90 -151.64 130.12 12.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.659 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 30.4 t-80 55.68 -144.99 0.64 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.659 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 30.6 t -94.79 44.74 1.1 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.357 0.599 . . . . 0.0 109.898 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -115.38 136.66 52.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.298 0.57 . . . . 0.0 111.155 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.89 174.45 6.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.297 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -63.63 133.76 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.036 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.11 19.17 34.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.802 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.57 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.8 m -104.51 149.13 25.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.454 ' O ' HG11 ' A' ' 294' ' ' VAL . 8.9 mtt180 -113.6 138.67 49.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.93 0.395 . . . . 0.0 111.471 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 67.7 mt -117.6 145.93 43.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.973 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' ' 228' ' ' ASN . 9.1 t -156.46 95.57 1.58 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.871 0.367 . . . . 0.0 110.643 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -86.21 118.1 25.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 228' ' ' ASN . 13.5 m170 -66.5 -16.99 64.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 0.0 110.656 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.38 -31.74 70.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.408 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 227' ' ' SER . 4.1 pt-20 -145.27 -95.05 0.1 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.581 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 22.9 t -77.22 61.17 2.06 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.665 ' HA ' ' SG ' ' A' ' 222' ' ' CYS . 7.2 p30 -102.57 26.13 8.29 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.626 -0.671 . . . . 0.0 112.318 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 19.9 pttp -92.01 -29.81 16.4 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.857 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 35.9 mt-10 -131.83 176.88 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.081 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -99.09 109.63 22.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.857 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.5 pt20 -97.91 157.21 16.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.462 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.72 162.96 21.61 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -61.38 -51.34 74.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.145 0.497 . . . . 0.0 109.811 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 36.9 mt-10 -56.34 -22.88 33.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.585 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.33 -45.34 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.565 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 70.1 t80 -75.96 -41.04 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 0.0 110.474 176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.73 68.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.612 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 8.7 ttm180 -69.06 -34.06 74.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.065 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.08 60.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.932 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -88.87 15.56 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.882 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 2.0 p -63.76 -59.06 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.73 78.83 6.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.95 57.85 4.08 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.323 0.582 . . . . 0.0 111.554 -168.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.14 42.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.699 0.761 . . . . 0.0 110.724 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.613 ' H ' ' HB ' ' A' ' 253' ' ' THR . 12.5 mm-40 -86.68 45.49 1.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.003 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.97 -54.04 6.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.478 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -69.1 -32.16 71.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.87 -57.76 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.779 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -93.35 -64.91 1.04 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.622 -172.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.53 ' HE1' ' HB3' ' A' ' 226' ' ' GLU . 11.5 tmm? -168.12 -70.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.053 0.454 . . . . 0.0 110.169 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.48 71.29 0.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.627 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.613 ' HB ' ' H ' ' A' ' 246' ' ' GLU . 22.0 m -93.02 110.29 21.76 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.944 -0.151 . . . . 0.0 110.639 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -159.85 139.52 11.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.515 0.674 . . . . 0.0 111.134 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 255' ' ' LYS . 33.6 ttmt -75.12 41.14 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.549 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -115.85 -9.05 12.8 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.963 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.554 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.3 t80 -73.25 117.65 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.721 0.76 . . . . 0.0 109.999 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.49 67.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.978 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 53.0 m -70.15 -7.13 39.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.785 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -103.51 -31.58 9.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.275 0.56 . . . . 0.0 109.672 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.04 153.69 6.76 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.027 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.2 mp -119.17 103.33 9.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.604 0.361 . . . . 0.0 110.652 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 33.8 ttpt -86.7 123.73 32.18 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.004 0.431 . . . . 0.0 111.06 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.426 ' HG ' HD11 ' A' ' 280' ' ' LEU . 2.7 tt -65.36 97.75 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.654 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 283' ' ' ASP . 88.1 mt -71.63 -49.49 39.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.901 0.381 . . . . 0.0 110.461 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.1 t -151.46 165.95 32.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.274 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.756 ' HD2' ' HE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -131.44 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.618 -169.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -140.82 121.66 14.46 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.59 99.66 9.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.204 0.526 . . . . 0.0 109.841 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.6 t -117.82 178.76 4.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.92 -172.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.4 t -118.13 116.78 27.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.777 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 52.29 19.34 1.09 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.824 1.25 . . . . 0.0 112.483 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.18 -21.23 12.17 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.809 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -97.56 129.12 44.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.644 0.259 . . . . 0.0 111.03 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.8 m -67.62 131.26 45.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.15 154.75 41.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.759 0.79 . . . . 0.0 112.421 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.432 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 84.6 mt -92.5 107.42 19.2 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.729 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.0 ttmt -106.69 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.452 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . 43.6 mt -118.19 135.45 54.24 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.3 m -91.47 110.28 21.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.55 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 90.3 m-85 -99.7 162.15 13.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.095 0.474 . . . . 0.0 111.48 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.1 t70 -130.65 135.25 27.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.316 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.554 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -81.28 11.12 3.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.162 1.908 . . . . 0.0 112.43 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.26 -8.87 62.87 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 t -153.33 106.02 2.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.481 -0.86 . . . . 0.0 109.537 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.94 -8.88 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.497 0.665 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.99 -26.31 68.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.104 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.34 -44.31 25.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.17 153.32 5.93 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.474 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -74.34 143.33 44.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.854 0.359 . . . . 0.0 110.592 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.06 118.75 28.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 140.84 41.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.9 t -134.14 131.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -104.19 118.6 37.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 12.3 p -136.13 165.33 25.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.668 0.271 . . . . 0.0 111.493 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -61.72 162.13 9.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.208 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.8 mm? -70.79 -21.31 62.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 -175.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.0 22.5 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.16 119.14 74.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.339 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.24 134.47 9.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.203 1.935 . . . . 0.0 111.713 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.505 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -120.71 119.4 32.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.415 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 35.8 t80 -75.13 93.55 2.8 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.23 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 71.5 t -79.87 138.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.728 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.553 ' HB3' HG11 ' A' ' 333' ' ' VAL . 57.4 tttp -61.26 134.88 57.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.226 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 7.1 m-20 76.27 -33.36 0.21 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.562 0.745 . . . . 0.0 112.087 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -86.68 -43.86 12.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.787 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 98.18 -155.96 20.36 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.99 112.89 1.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.037 0.419 . . . . 0.0 110.459 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.418 ' CB ' HG23 ' A' ' 328' ' ' ILE . 17.7 m -129.84 165.66 21.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.697 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.3 t -161.57 -176.88 5.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.586 0.231 . . . . 0.0 110.389 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.756 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 36.6 m-85 -92.91 -40.93 10.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.88 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -120.99 76.38 30.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.298 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.1 Cg_exo -57.27 -35.51 98.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.908 2.405 . . . . 0.0 113.148 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 3.7 p -65.19 -26.06 67.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.8 -47.08 8.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.278 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.2 m -57.87 -38.6 76.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.103 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.574 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.6 p -68.79 -20.23 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 111.464 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.99 -49.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.269 0.557 . . . . 0.0 109.816 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -67.41 -55.59 13.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.158 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -100.68 -9.68 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 78.23 15.91 80.36 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.592 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.0 mt -110.87 114.49 54.22 Favored Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 122.846 -0.208 . . . . 0.0 110.798 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.49 104.64 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.57 2.18 . . . . 0.0 110.33 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.5 m -104.39 154.07 20.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.046 -169.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.7 165.1 23.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.946 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.36 123.91 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.219 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.418 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.2 160.92 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -134.16 154.68 51.07 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 49.3 mm -52.29 115.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.324 0.583 . . . . 0.0 111.426 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.28 -2.9 22.27 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.073 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.437 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 6.5 m-20 -75.29 124.58 27.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.305 0.553 . . . . 0.0 110.78 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -86.76 143.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 55.8 m -112.16 132.52 54.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.985 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.404 HD12 ' OD2' ' A' ' 341' ' ' ASP . 82.1 mt -100.64 147.65 33.92 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.705 -177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.515 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 55.1 Cg_endo -91.89 170.33 2.87 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.495 2.797 . . . . 0.0 112.828 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.74 133.17 23.19 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.534 2.156 . . . . 0.0 111.38 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.74 55.85 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.629 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.402 ' HD1' ' HB3' ' A' ' 341' ' ' ASP . 18.2 t-80 -77.73 125.2 86.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.95 -21.73 73.37 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.047 2.498 . . . . 0.0 112.823 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 34.0 t70 -80.0 -27.38 39.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.683 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.36 88.85 3.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.816 169.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 83.7 mt -71.74 -43.49 69.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.368 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -114.41 73.93 0.85 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.598 -178.65 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 N--CA 1.479 0.662 0 N-CA-C 110.118 -0.762 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -100.4 87.79 3.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -82.97 143.9 30.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.945 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.11 -42.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.34 0.591 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -148.08 135.21 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.167 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.57 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 30.9 t-80 55.15 -135.01 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.57 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 12.0 p -97.64 24.4 6.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -104.6 139.83 38.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 112.064 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 174.94 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.391 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.57 140.53 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.607 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.82 11.1 54.35 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.976 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.555 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 80.9 m -103.34 146.92 27.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -113.99 139.88 48.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.938 0.399 . . . . 0.0 110.779 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.523 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.6 mt -116.17 146.47 42.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.375 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.1 96.45 1.95 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.18 119.18 29.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -69.72 -9.53 54.79 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.969 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.91 -30.71 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.892 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -113.75 -175.8 2.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.258 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.2 t -88.68 7.65 32.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.866 0.365 . . . . 0.0 110.82 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -83.08 75.94 9.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -76.41 -21.03 56.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.751 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.73 150.81 20.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.83 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.406 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 89.3 m95 -70.15 123.52 21.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.561 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 7.9 pt20 -108.96 161.55 15.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.541 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.13 162.91 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.555 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.43 -47.15 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.18 -22.22 50.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.75 -55.22 5.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.531 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.561 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 76.3 t80 -65.04 -41.0 95.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.83 -33.5 71.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -69.78 -44.37 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.445 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.392 0.615 . . . . 0.0 110.716 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.48 21.14 4.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.103 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.8 t -66.4 -38.51 87.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 27.0 m -78.99 120.89 24.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -101.94 5.14 40.68 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.824 -170.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -152.65 120.3 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.311 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -134.45 25.22 3.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.845 0.831 . . . . 0.0 108.796 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.97 -15.79 61.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.899 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.43 -33.09 48.8 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.6 mt -74.4 -63.4 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.43 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 177.76 -51.42 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.21 0.528 . . . . 0.0 110.465 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 51.7 tpp -69.5 133.82 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.867 -173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -79.5 53.66 4.27 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.674 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 10.7 m -66.94 120.56 13.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.494 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -174.12 151.77 1.75 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -85.67 37.67 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -70.52 -29.49 69.79 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.62 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.421 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 24.5 t80 -68.44 100.58 1.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.512 0.656 . . . . 0.0 110.239 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 106.48 6.94 35.28 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.549 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.9 m -67.1 -14.15 62.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 111.409 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.99 -30.82 11.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 0.0 109.294 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 149.3 161.15 9.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.526 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -122.6 99.1 6.22 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 122.483 0.313 . . . . 0.0 110.711 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 68.2 tttt -82.37 123.63 29.28 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.134 0.493 . . . . 0.0 111.525 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.97 95.35 0.26 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.584 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.419 HD22 ' HB2' ' A' ' 283' ' ' ASP . 77.9 mt -71.47 -47.38 56.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 0.0 110.565 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.8 t -151.24 162.55 40.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.444 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.97 143.32 40.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.049 -168.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -149.57 137.49 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.366 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -98.99 97.17 8.35 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 p -99.83 176.67 5.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.409 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.1 p -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.605 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 7.7 t -141.36 130.71 23.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 60.79 26.24 16.07 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.44 0.463 . . . . 0.0 111.718 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.06 86.56 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.782 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -121.27 153.75 37.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.3 m -77.7 134.75 38.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.683 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.8 m -132.17 156.85 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.661 0.744 . . . . 0.0 112.062 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.34 107.57 19.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.382 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.1 ttmm -98.94 106.25 18.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.4 HD13 ' CE1' ' A' ' 312' ' ' PHE . 21.1 mt -112.95 138.04 50.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.529 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 4.1 m -103.09 110.19 22.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.447 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 92.1 m-85 -100.33 162.66 12.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.032 0.444 . . . . 0.0 111.849 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.419 ' HB2' HD22 ' A' ' 265' ' ' LEU . 14.6 t70 -128.89 134.44 26.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.14 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 76.8 Cg_endo -80.0 12.55 2.43 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.259 1.973 . . . . 0.0 112.291 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 -14.45 49.61 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 t -153.15 127.42 9.16 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.822 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.28 -8.45 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.215 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -50.74 -41.06 56.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.996 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -77.05 -43.51 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.89 167.51 11.52 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.67 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 83.2 mt -90.24 140.56 29.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 0.0 111.192 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -113.05 122.85 48.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.435 ' N ' HD23 ' A' ' 292' ' ' LEU . 20.8 m -111.67 135.18 52.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.0 t -133.06 136.27 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.066 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.406 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 52.8 mt-10 -115.57 121.94 44.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 109.772 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.5 p -138.56 175.34 9.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.748 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -70.03 158.21 36.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.998 0.427 . . . . 0.0 110.832 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -64.77 -17.07 63.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.282 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -97.49 13.58 29.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.88 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -72.26 120.98 83.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.574 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.85 141.52 13.46 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.239 1.959 . . . . 0.0 111.662 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.496 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.1 m-85 -127.84 127.27 43.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.538 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 31.2 t80 -80.09 96.32 6.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.34 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 332' ' ' ASP . 53.6 t -82.31 130.88 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.907 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.473 ' HB3' HG11 ' A' ' 333' ' ' VAL . 56.1 tttp -55.86 134.21 51.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.35 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.2 m120 77.64 -23.08 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.872 0.733 . . . . 0.0 112.202 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -96.08 -43.49 7.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.0 111.446 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.56 -126.27 8.43 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.24 118.47 29.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.804 0.802 . . . . 0.0 109.958 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 20.1 m -131.45 166.57 21.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.527 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.0 t -161.52 -175.57 4.84 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.476 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 48.2 m-85 -92.77 -41.45 10.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 0.0 110.403 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.53 76.64 45.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 77.6 Cg_exo -55.25 -31.48 76.58 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.246 2.631 . . . . 0.0 113.597 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 33.9 t -71.22 -23.21 61.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.257 0.551 . . . . 0.0 110.096 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 61.2 tp -87.89 -44.85 10.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.116 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.4 HG23 ' SG ' ' A' ' 325' ' ' CYS . 8.3 m -54.5 -41.03 69.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.028 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.547 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.5 p -73.41 -18.28 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 96.1 t -88.24 -35.64 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.317 0.58 . . . . 0.0 110.013 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.26 -53.23 5.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.128 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -103.84 -4.04 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 70.02 26.33 74.45 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.564 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.5 mt -116.63 110.97 41.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 122.753 -0.263 . . . . 0.0 110.59 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -71.79 115.83 4.46 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.493 2.129 . . . . 0.0 110.399 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 73.7 m -116.96 156.98 26.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.437 0.637 . . . . 0.0 111.977 -169.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 58.6 m -79.99 165.95 22.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.255 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.59 140.42 29.57 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.89 164.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.357 0.599 . . . . 0.0 110.62 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -118.78 142.35 47.78 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 30.8 mm -60.22 114.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 109.843 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.3 -4.24 20.07 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.956 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.509 ' HB3' HG11 ' A' ' 304' ' ' VAL . 70.7 m-20 -73.84 130.55 40.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.97 133.29 33.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.057 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 50.9 m -98.12 134.83 40.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.142 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 43.8 mt -108.94 142.06 24.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.041 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.51 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.2 Cg_endo -85.06 168.43 10.53 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.325 2.683 . . . . 0.0 112.362 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.426 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 56.6 Cg_endo -71.37 114.3 3.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.797 2.332 . . . . 0.0 111.687 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.01 -20.67 8.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.813 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.474 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 28.9 t-80 -67.11 126.66 92.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.64 -27.25 50.28 Favored 'Trans proline' 0 N--CA 1.476 0.453 0 C-N-CA 123.721 2.947 . . . . 0.0 113.738 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.474 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 2.7 m-20 -79.96 -22.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.326 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.14 85.99 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.254 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.63 -43.88 70.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.572 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -107.04 42.52 1.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 1.1 t80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.941 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.6 t -86.19 92.06 8.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.079 0.466 . . . . 0.0 110.161 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.7 p -79.15 147.07 32.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.5 mm -79.5 -45.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.62 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -149.4 132.73 16.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.595 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 28.0 t-80 57.19 -139.46 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.595 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 44.5 t -97.5 36.74 1.45 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.384 0.612 . . . . 0.0 110.202 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.56 140.73 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 111.701 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.99 170.83 8.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -67.57 133.68 49.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.957 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.17 44.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.49 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.558 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 87.7 m -86.65 142.07 28.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -110.62 136.78 49.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.172 0.511 . . . . 0.0 110.941 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 57.1 mt -112.41 147.48 36.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.967 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.0 t -150.87 93.01 1.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.97 0.414 . . . . 0.0 110.234 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.453 ' CD2' ' HG ' ' A' ' 292' ' ' LEU . 78.3 m-85 -83.57 119.14 24.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -69.23 -16.22 63.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.062 0.458 . . . . 0.0 110.559 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -79.75 -7.55 58.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.239 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -104.92 174.92 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.126 0.488 . . . . 0.0 110.742 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.6 m -82.56 -3.98 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.554 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -94.74 90.44 6.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.488 . . . . 0.0 110.741 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -77.88 -36.53 49.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.18 0.99 . . . . 0.0 108.652 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 230' ' ' GLU . 5.1 mp0 -62.06 155.47 23.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.669 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -74.42 138.84 43.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 0.0 112.372 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.696 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 10.0 pt20 -128.07 165.16 20.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.39 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.5 163.86 15.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.233 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.558 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.0 t -58.46 -51.5 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -58.01 -23.44 54.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.18 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.58 -45.29 54.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.696 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.4 t80 -75.1 -45.41 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.49 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -55.72 -43.83 76.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.499 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.68 -34.54 74.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.28 -16.66 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.72 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 253' ' ' THR . . . -90.87 18.69 6.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.055 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 41.0 m -57.98 -36.59 72.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.276 0.56 . . . . 0.0 109.608 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.41 ' O ' HG23 ' A' ' 253' ' ' THR . 8.2 t -90.7 151.26 21.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -114.55 -8.06 12.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.064 0.935 . . . . 0.0 109.76 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -152.28 139.56 19.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.685 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.9 70.7 1.46 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.24 -22.52 38.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.321 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.08 -0.51 40.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 249' ' ' ILE . 4.8 mt -139.09 150.44 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -71.41 69.45 0.58 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.171 0.51 . . . . 0.0 109.821 171.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.8 161.22 42.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.06 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -152.61 94.26 0.15 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.776 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 254' ' ' HIS . 2.9 m -66.74 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.466 ' H ' ' HB ' ' A' ' 253' ' ' THR . 17.3 t60 64.1 93.05 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.952 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -69.53 -11.38 60.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.01 -13.86 50.26 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.779 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.502 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 23.0 t80 -65.28 105.84 1.21 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.376 0.588 . . . . 0.0 109.79 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.82 8.65 59.15 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.011 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.7 m -67.79 -15.86 63.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -102.88 -31.69 10.14 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 164.08 156.77 9.0 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.217 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.7 mp -119.97 103.75 9.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.709 -0.746 . . . . 0.0 110.163 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 21.8 ttpp -88.29 119.35 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.269 0.557 . . . . 0.0 111.339 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.412 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.7 tt -62.12 103.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.347 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 283' ' ' ASP . 86.7 mt -76.2 -49.17 17.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.898 0.38 . . . . 0.0 110.528 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 34.4 t -153.11 164.02 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.539 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -141.44 135.75 30.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 41.2 tt0 -130.14 137.54 50.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.245 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.39 124.43 34.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t -138.28 178.53 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.628 -167.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.44 69.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.1 t -134.34 122.61 22.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 59.47 35.45 22.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.375 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 77.02 3.69 81.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.938 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.591 ' HB3' ' HE2' ' A' ' 297' ' ' LYS . 46.2 mt-10 -112.12 136.37 51.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.5 m -71.04 134.61 47.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.071 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.83 156.57 31.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.017 0.913 . . . . 0.0 112.861 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 79.1 mt -95.51 116.25 28.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.639 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 40.4 ttmt -100.65 112.25 24.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.458 HD11 ' CZ ' ' A' ' 282' ' ' PHE . 19.3 mt -118.45 130.34 55.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 31.4 m -97.97 111.01 23.48 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.542 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.5 m-85 -96.94 162.48 13.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.332 0.587 . . . . 0.0 111.872 -172.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.438 ' HB2' HD22 ' A' ' 265' ' ' LEU . 4.1 t70 -127.85 127.45 23.94 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.502 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 80.0 Cg_endo -79.45 10.12 3.17 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.181 1.92 . . . . 0.0 112.067 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.7 -15.03 53.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.8 t -153.85 135.07 14.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.197 0.522 . . . . 0.0 110.667 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.32 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.131 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.87 -32.12 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.861 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -84.2 -47.13 11.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.524 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.43 159.49 7.96 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.794 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.1 151.17 25.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -119.68 123.4 43.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 26.0 m -110.27 130.92 55.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.51 131.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.384 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.52 118.38 34.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.6 p -134.58 164.0 28.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.732 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 275' ' ' GLU . 33.7 mmtp -66.17 157.85 30.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.364 0.602 . . . . 0.0 111.109 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.5 mm? -61.59 -23.83 66.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.212 -168.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.71 23.2 5.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.516 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.37 121.09 84.27 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.538 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.56 130.66 7.96 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.286 1.991 . . . . 0.0 111.609 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.433 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 90.8 m-85 -120.66 114.2 21.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 25.4 t80 -73.3 102.45 3.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.327 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 332' ' ' ASP . 55.2 t -88.7 136.04 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.255 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.646 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 54.4 tttp -57.93 124.46 19.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.905 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.9 m120 76.81 -5.21 2.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.366 0.666 . . . . 0.0 112.392 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -110.85 -32.25 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.14 0.495 . . . . 0.0 111.403 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.92 -152.68 21.9 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -64.74 112.38 3.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 117.18 0.49 . . . . 0.0 110.382 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.487 ' CB ' HG21 ' A' ' 328' ' ' ILE . 16.4 m -125.33 165.26 18.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.0 t -161.48 -177.84 6.22 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.432 ' CZ ' HD22 ' A' ' 280' ' ' LEU . 65.3 m-85 -93.0 -39.34 11.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.523 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -123.74 73.73 54.02 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.748 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.97 -37.05 93.75 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.176 2.584 . . . . 0.0 113.356 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.2 m -64.74 -25.75 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.232 0.539 . . . . 0.0 110.693 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.1 tp -87.25 -44.3 11.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.963 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.2 m -55.18 -41.86 72.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.993 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.468 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 14.8 p -70.77 -26.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.66 -35.16 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -84.32 -58.44 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.917 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.48 -10.98 24.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 78.04 25.65 61.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.615 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.6 mt -122.71 113.11 30.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 122.849 -0.206 . . . . 0.0 110.877 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.85 119.41 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.423 2.082 . . . . 0.0 110.365 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 68.2 m -117.37 156.11 28.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 112.141 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 57.5 m -79.71 164.45 23.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.104 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -93.76 115.79 28.23 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -66.46 165.23 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 111.229 -173.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -122.26 140.37 52.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.721 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.32 115.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.221 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 115.3 -2.27 22.27 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.908 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.483 ' HB3' HG12 ' A' ' 304' ' ' VAL . 44.0 m-20 -75.23 132.95 41.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.33 0.586 . . . . 0.0 111.34 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -93.68 135.16 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.964 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 51.1 m -100.81 132.69 46.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.463 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.433 HD12 ' OD2' ' A' ' 341' ' ' ASP . 76.0 mt -100.18 144.85 29.2 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.273 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.484 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 86.1 Cg_endo -87.63 165.04 7.78 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.099 2.532 . . . . 0.0 112.744 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.99 113.49 3.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.921 2.414 . . . . 0.0 111.572 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 124.83 -23.22 6.29 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.952 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.554 ' HD1' ' HB3' ' A' ' 341' ' ' ASP . 12.7 t-80 -65.79 128.0 93.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.9 -20.24 64.31 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.127 2.551 . . . . 0.0 112.495 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.646 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 23.2 t0 -79.32 -26.03 42.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.967 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.442 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -72.16 98.89 2.22 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.53 -39.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.899 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.99 103.64 4.2 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.459 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.005 -178.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -107.99 109.41 20.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.0 p -96.28 147.4 23.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.384 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.73 -40.54 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.382 0.61 . . . . 0.0 109.817 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.427 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 71.4 t90 -156.7 134.52 10.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.924 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.618 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 27.3 t-80 57.5 -142.42 0.72 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.618 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 49.1 t -96.98 37.29 1.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.465 0.65 . . . . 0.0 110.157 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.89 133.32 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.59 171.55 8.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.546 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -61.57 131.15 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.933 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.13 12.55 31.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.286 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.511 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 52.2 m -103.5 149.94 24.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.6 mpt_? -119.67 144.73 47.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.937 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.536 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.4 mt -118.99 147.81 43.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.24 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 42.4 t -158.11 98.16 1.57 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.811 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.519 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 27.5 m-85 -81.86 126.26 31.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -66.66 -28.91 68.84 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 16.2 pttm -81.62 -5.19 57.82 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.083 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 65.4 mm-40 -97.73 160.67 14.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.852 0.358 . . . . 0.0 110.175 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 4.6 m -84.65 32.09 0.52 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.414 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.03 103.02 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.185 0.517 . . . . 0.0 110.871 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -88.15 -46.5 9.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.706 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.21 148.59 44.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.363 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -71.22 117.2 12.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.712 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.5 pt20 -97.32 155.42 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -82.53 161.8 22.21 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.511 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.0 t -63.59 -38.21 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -21.84 64.72 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.242 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -80.93 -50.33 9.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.443 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.474 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 63.8 t80 -65.84 -46.1 79.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.717 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.89 71.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 110.478 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -67.25 -44.9 78.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.272 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.98 71.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.409 0.623 . . . . 0.0 110.565 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 244' ' ' ASP . . . -90.59 21.58 3.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 8.3 t -76.94 -33.33 57.71 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 30.8 m -83.21 60.71 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.529 ' OD1' ' HA ' ' A' ' 254' ' ' HIS . 37.4 t70 -84.56 52.48 2.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.5 -168.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 247' ' ' GLU . 3.3 p-10 -176.37 47.84 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.593 ' HB2' HG22 ' A' ' 253' ' ' THR . 43.1 mt-10 -81.15 38.72 0.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 245' ' ' ASN . 11.5 pt-20 -66.46 -23.4 66.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.102 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.42 -37.16 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.153 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.632 HG21 ' HG2' ' A' ' 250' ' ' GLN . 71.3 mt -93.38 -57.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.404 -175.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.632 ' HG2' HG21 ' A' ' 249' ' ' ILE . 18.4 mm-40 -120.68 141.46 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.915 0.388 . . . . 0.0 110.985 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 14.6 tpt -74.55 70.07 1.76 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.144 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 144.89 88.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.631 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 246' ' ' GLU . 11.3 m -146.15 81.18 1.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.529 ' HA ' ' OD1' ' A' ' 244' ' ' ASP . 42.4 t60 -161.23 135.9 7.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.761 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -67.34 39.52 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -91.87 4.65 78.81 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.164 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 32.4 t80 -69.41 108.09 3.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.14 55.88 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.494 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 50.7 m -65.56 -11.01 40.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -104.7 -34.16 8.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.285 0.564 . . . . 0.0 109.808 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 169.47 154.01 8.88 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.923 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.3 mp -122.63 99.82 6.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.778 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.5 ttpt -83.93 122.28 28.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.234 0.54 . . . . 0.0 110.942 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.444 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 2.3 tt -65.24 110.4 2.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.899 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 283' ' ' ASP . 80.1 mt -85.12 -44.66 12.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.714 0.292 . . . . 0.0 111.161 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.6 t -153.12 157.19 40.01 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.96 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.3 OUTLIER -133.46 142.84 48.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.022 -170.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -149.23 125.95 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.73 120.8 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.8 t -139.23 179.66 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.09 138.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.3 t -140.82 113.38 8.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.756 0.312 . . . . 0.0 110.25 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 57.87 42.5 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.507 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 95.87 -26.47 20.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.443 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -103.51 138.35 40.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.084 0.442 . . . . 0.0 111.031 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.403 ' HB2' HD22 ' A' ' 298' ' ' LEU . 67.4 m -74.09 131.26 41.15 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.46 157.82 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.847 0.832 . . . . 0.0 112.566 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 95.8 mt -95.57 112.89 24.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.741 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.5 ttmm -99.39 105.5 17.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.525 HD13 ' HE1' ' A' ' 312' ' ' PHE . 22.1 mt -113.12 139.69 48.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.524 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.8 m -101.16 110.6 22.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.544 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.9 m-85 -100.85 158.53 15.91 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 0.0 111.685 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 265' ' ' LEU . 9.7 t70 -124.94 135.96 27.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.362 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -83.44 9.81 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.948 1.765 . . . . 0.0 112.431 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.09 -6.15 53.59 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -153.26 125.19 7.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.343 0.592 . . . . 0.0 110.467 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -10.3 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.37 -35.45 80.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.919 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . 0.456 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 10.7 t70 -76.17 -46.9 26.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.204 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.02 166.2 10.7 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.442 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.93 146.2 28.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.915 0.388 . . . . 0.0 110.686 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.433 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER -119.46 121.13 38.75 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.8 m -106.96 132.14 53.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 88.1 t -131.15 135.28 60.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.055 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -114.61 122.05 45.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.078 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.3 p -136.03 175.07 9.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.444 ' HB3' ' OD1' ' A' ' 299' ' ' ASP . 10.5 mmmm -66.19 157.53 31.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.488 0.185 . . . . 0.0 111.056 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.1 mm? -60.8 -37.27 81.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.837 0.827 . . . . 0.0 109.677 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 297' ' ' LYS . 6.6 p-10 -80.79 24.52 0.48 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.08 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -82.92 119.65 74.73 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.347 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.06 132.8 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.078 1.852 . . . . 0.0 111.682 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.8 118.25 30.34 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.419 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 2.5 t80 -72.32 102.81 3.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.142 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.42 135.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.307 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.54 ' HB3' HG11 ' A' ' 333' ' ' VAL . 56.9 tttp -61.17 134.57 57.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 76.61 -6.45 2.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.531 0.732 . . . . 0.0 112.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.04 -47.75 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.64 -147.25 16.18 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . 0.432 ' HZ2' ' HA ' ' A' ' 345' ' ' PHE . 98.9 m95 -72.85 102.14 3.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.679 0.739 . . . . 0.0 110.974 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.509 ' CB ' HG21 ' A' ' 328' ' ' ILE . 5.6 m -106.47 172.51 6.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.737 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.1 t -163.04 179.2 7.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.532 0.206 . . . . 0.0 110.625 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.525 ' HE1' HD13 ' A' ' 280' ' ' LEU . 32.0 m-85 -92.84 -35.26 13.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 298' ' ' LEU . 93.0 m-85 -125.25 74.35 67.68 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 62.5 Cg_exo -55.09 -33.65 84.49 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.179 2.586 . . . . 0.0 113.534 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 35.9 t -74.85 -22.07 58.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.975 0.417 . . . . 0.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.6 tp -87.88 -45.75 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.502 . . . . 0.0 110.311 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.411 HG23 ' SG ' ' A' ' 325' ' ' CYS . 14.1 m -52.91 -37.17 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.974 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.69 -24.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.713 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.82 -33.81 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.0 110.456 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -101.99 -54.37 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.432 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -91.67 -8.05 48.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.161 -0.337 . . . . 0.0 110.736 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.58 16.94 76.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.378 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.521 HG21 ' HG ' ' A' ' 325' ' ' CYS . 42.8 mt -110.04 110.41 58.75 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.41 105.33 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.495 2.13 . . . . 0.0 110.445 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.521 ' HG ' HG21 ' A' ' 323' ' ' ILE . 84.4 m -101.47 159.18 15.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 112.369 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 1.4 p -85.83 159.68 19.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.416 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -79.93 125.61 29.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.509 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.82 168.36 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.386 -0.525 . . . . 0.0 109.816 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -133.37 146.67 51.48 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 41.3 mm -54.46 113.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.374 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.57 -4.37 19.52 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.419 -176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.52 121.42 17.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.155 0.502 . . . . 0.0 110.467 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -84.74 133.05 30.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.691 0.758 . . . . 0.0 112.115 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 47.3 t -95.39 134.79 37.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.376 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 69.1 mt -105.62 144.57 29.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.853 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -86.94 163.51 8.88 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.803 2.336 . . . . 0.0 112.142 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 121.42 8.73 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 112.047 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.01 31.98 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.491 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.44 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 25.3 t-80 -75.18 134.08 74.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 339' ' ' HIS . 11.7 Cg_endo -54.73 -28.8 58.86 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.975 3.117 . . . . 0.0 114.0 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.44 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 1.5 m-20 -78.27 -35.15 48.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.419 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -70.52 98.74 1.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.888 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.88 -45.66 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.256 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -131.18 94.51 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.432 ' HA ' ' HZ2' ' A' ' 309' ' ' TRP . 3.5 t80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.594 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.481 0.78 0 N-CA-C 110.769 -0.512 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 99.41 10.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.6 p -85.79 145.29 27.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.905 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.457 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.4 mm -80.41 -43.23 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.511 0.672 . . . . 0.0 109.5 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -151.51 136.04 16.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.244 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.529 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 25.4 t-80 55.53 -136.09 1.27 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.529 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 46.3 t -100.13 32.06 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.64 . . . . 0.0 110.011 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -103.0 139.81 38.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.256 0.55 . . . . 0.0 111.417 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 177.74 5.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.462 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -65.59 143.73 57.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.327 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.01 58.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.184 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 39.9 m -106.24 145.61 31.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.45 144.0 38.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.949 0.404 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 67.0 mt -119.45 149.05 42.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.057 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.2 t -158.07 103.96 1.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.042 0.448 . . . . 0.0 110.426 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.52 123.32 34.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.261 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -71.09 -20.78 62.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -85.15 3.49 38.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -128.84 175.63 8.48 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.8 t -93.21 6.18 48.92 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.239 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -77.87 86.69 4.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.87 0.843 . . . . 0.0 110.11 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -83.27 -41.37 18.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.366 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.25 156.52 31.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.409 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 49.4 m95 -71.91 112.26 7.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.372 0.606 . . . . 0.0 112.536 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.556 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 8.7 pt20 -98.95 160.88 13.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.979 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 160.6 17.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -57.35 -48.83 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HA ' HG22 ' A' ' 211' ' ' ILE . 16.0 mt-10 -56.42 -24.82 47.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.35 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.53 -47.42 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.434 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.556 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.8 t80 -68.82 -42.15 77.61 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.605 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.34 70.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.332 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -64.38 -44.34 91.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.835 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.98 83.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.17 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.447 ' HA ' HG23 ' A' ' 253' ' ' THR . . . -90.74 21.97 3.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.048 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.0 m -79.75 -9.71 59.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.207 0.527 . . . . 0.0 110.004 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.556 ' HB3' HG22 ' A' ' 253' ' ' THR . 21.7 t -91.3 159.3 16.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.56 ' O ' ' HG3' ' A' ' 246' ' ' GLU . 20.9 t0 -67.04 154.21 41.76 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.438 ' N ' HD21 ' A' ' 245' ' ' ASN . 0.1 OUTLIER -62.42 105.82 0.67 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.75 0.785 . . . . 0.0 111.708 -176.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 244' ' ' ASP . 34.6 mt-10 -115.22 37.42 3.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.978 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -20.88 59.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.676 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.69 -23.44 56.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.191 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.604 HG21 ' HG2' ' A' ' 250' ' ' GLN . 55.6 mt -101.21 -62.22 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.532 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.604 ' HG2' HG21 ' A' ' 249' ' ' ILE . 76.6 mm-40 -145.24 -68.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 24.7 ttt -92.26 154.35 18.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 111.467 -167.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.97 67.6 0.87 Allowed Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.556 HG22 ' HB3' ' A' ' 243' ' ' CYS . 1.9 p -99.02 30.18 3.52 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.152 0.501 . . . . 0.0 111.641 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -90.01 75.54 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.399 0.618 . . . . 0.0 109.349 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -67.19 -3.12 6.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.167 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -73.85 -4.61 67.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.381 -0.437 . . . . 0.0 113.446 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 21.8 t80 -60.37 124.2 19.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.213 0.507 . . . . 0.0 109.92 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.54 17.21 55.47 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.431 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -21.03 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.07 -27.56 13.19 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.459 0.647 . . . . 0.0 109.586 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.48 166.65 17.28 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.653 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.93 99.98 6.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.796 -0.702 . . . . 0.0 110.316 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 49.1 tttp -84.0 117.87 23.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.059 0.456 . . . . 0.0 110.589 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 280' ' ' LEU . 3.1 tt -58.69 107.57 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.13 -42.02 16.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.659 0.266 . . . . 0.0 110.924 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.3 t -153.49 168.02 27.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.409 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.674 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -140.35 137.09 33.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.921 -167.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -143.77 135.63 26.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.414 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -106.76 127.59 53.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t -149.35 178.04 9.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.913 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.7 p -117.44 116.46 51.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 23.7 t -122.49 125.13 45.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.253 -172.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 59.74 29.4 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.667 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 86.87 -1.29 86.83 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.84 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.28 130.27 55.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.803 0.335 . . . . 0.0 110.375 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 18.7 m -68.95 131.13 44.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.61 154.72 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.753 0.787 . . . . 0.0 112.905 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.555 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 95.5 mt -94.77 109.65 21.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.668 171.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -104.24 110.82 23.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.044 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.494 HD12 ' CE1' ' A' ' 312' ' ' PHE . 45.7 mt -120.89 138.82 53.91 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.836 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.2 m -92.84 114.77 27.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 83.5 m-85 -102.72 161.56 13.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.055 0.455 . . . . 0.0 111.614 -174.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.0 t70 -131.15 135.81 27.8 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.138 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 95.9 Cg_endo -79.71 13.03 2.22 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.23 1.954 . . . . 0.0 112.714 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.17 -16.23 42.45 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.9 t -153.86 129.33 9.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.021 -0.589 . . . . 0.0 109.866 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.98 -8.16 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -61.32 -26.12 67.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.747 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.46 -46.67 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.1 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.33 166.46 10.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.905 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.35 148.69 25.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.76 121.98 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 14.8 m -105.99 133.11 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 59.1 t -132.72 134.1 58.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.409 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 90.4 mt-10 -107.84 112.72 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.931 172.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 10.2 p -122.95 172.5 8.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -76.77 160.81 28.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 0.0 110.317 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.707 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.76 -23.28 67.2 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -174.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -97.88 16.98 19.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.421 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.98 117.55 55.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.662 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.98 122.38 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.081 1.854 . . . . 0.0 111.432 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.506 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -112.04 105.73 14.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.651 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 26.4 t80 -70.67 108.9 4.61 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.979 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.48 138.2 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.557 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.667 ' HB3' HG11 ' A' ' 333' ' ' VAL . 55.0 tttp -63.14 128.59 36.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.456 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.0 OUTLIER 72.13 17.33 5.08 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.635 0.584 . . . . 0.0 111.811 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.436 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 34.0 mttp -137.99 -43.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.431 . . . . 0.0 111.76 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.405 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 98.55 -160.09 20.42 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.14 115.66 3.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.537 0.668 . . . . 0.0 110.286 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 17.0 m -127.59 165.18 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.139 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.4 t -160.58 171.68 18.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.995 0.426 . . . . 0.0 110.397 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.674 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 73.6 m-85 -85.88 -35.68 20.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.526 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -127.01 76.45 76.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.253 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.49 -34.44 97.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.686 2.257 . . . . 0.0 112.537 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.9 p -65.45 -23.04 66.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.167 0.508 . . . . 0.0 110.814 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.46 -46.35 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.777 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.403 HG23 ' SG ' ' A' ' 325' ' ' CYS . 30.0 m -56.43 -41.77 76.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.932 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.523 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 13.2 p -70.27 -21.36 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.752 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.0 -38.33 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.371 0.605 . . . . 0.0 110.242 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -80.87 -56.8 3.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.032 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.43 -8.76 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.843 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 75.38 21.07 78.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.462 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -115.23 116.2 42.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 122.773 -0.251 . . . . 0.0 110.432 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.48 117.71 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.514 2.142 . . . . 0.0 110.79 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 317' ' ' THR . 63.3 m -117.76 160.98 20.46 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -168.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 78.5 m -85.43 164.25 18.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.599 173.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.46 125.88 34.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.05 165.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.003 0.906 . . . . 0.0 111.542 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -121.09 144.16 48.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.833 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.78 110.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.684 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.33 2.89 19.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.754 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.436 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 44.7 m-20 -69.83 124.78 24.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.076 0.465 . . . . 0.0 110.641 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.706 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -91.25 125.2 44.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.826 0.822 . . . . 0.0 111.993 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.7 133.82 34.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.161 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.27 141.54 22.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.793 -174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -84.65 163.34 12.38 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.52 115.29 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.785 2.324 . . . . 0.0 111.45 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.9 -20.16 8.19 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.357 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.443 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 17.0 t-80 -66.49 133.3 94.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.45 -24.09 67.29 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.665 2.91 . . . . 0.0 113.598 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 2.3 m-20 -78.53 -32.39 47.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.715 0.293 . . . . 0.0 110.594 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.651 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.74 87.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.084 0.469 . . . . 0.0 110.284 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.28 -47.68 88.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -130.86 99.65 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.92 -179.008 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.5 t -113.5 100.01 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.6 p -92.9 144.41 25.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 10.6 mm -83.48 -36.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.833 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.546 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 78.6 t90 -156.19 132.31 9.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.265 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.554 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 21.0 t-80 56.86 -139.15 0.92 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.554 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 49.4 t -98.96 40.05 1.23 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.634 . . . . 0.0 110.272 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -114.7 137.4 51.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.423 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.43 172.11 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.574 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -64.75 127.64 32.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.816 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.69 7.93 38.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.171 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.0 m -96.69 150.4 20.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.408 ' O ' HG11 ' A' ' 294' ' ' VAL . 0.6 OUTLIER -117.02 140.35 49.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 110.988 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 79.0 mt -117.29 145.7 43.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.173 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.46 99.36 1.89 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.428 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.91 128.98 35.69 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -76.99 -19.63 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.573 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -77.36 -21.38 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.264 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.47 173.8 7.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -88.75 30.07 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.283 0.563 . . . . 0.0 110.157 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.02 67.99 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.826 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -5.79 46.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.929 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.47 152.4 20.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -77.35 110.58 12.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.463 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.1 pt20 -102.78 156.2 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.052 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.9 159.34 22.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.523 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 2.4 t -59.75 -43.85 92.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.422 ' HA ' HG23 ' A' ' 211' ' ' ILE . 35.0 mt-10 -57.86 -22.81 49.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.544 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.76 -50.51 8.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.463 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 68.0 t80 -65.23 -43.61 90.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.79 71.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.784 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -65.66 -36.89 84.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.13 64.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.624 0.726 . . . . 0.0 110.391 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -93.89 21.52 6.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.741 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.414 ' HB2' ' HG3' ' A' ' 246' ' ' GLU . 58.1 m -38.54 -70.81 0.09 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.971 0.795 . . . . 0.0 112.159 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 244' ' ' ASP . 25.9 p -74.47 -62.53 1.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 171.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.455 ' N ' ' SG ' ' A' ' 243' ' ' CYS . 32.2 t70 178.57 -31.25 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.965 168.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.952 ' HB3' ' HB2' ' A' ' 248' ' ' GLU . 15.7 m120 -132.31 58.54 1.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.73 -173.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 242' ' ' SER . 6.4 mm-40 -75.56 -4.42 39.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.158 0.504 . . . . 0.0 110.872 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -116.36 13.78 15.59 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.527 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.952 ' HB2' ' HB3' ' A' ' 245' ' ' ASN . 41.8 tt0 -59.53 -15.89 21.16 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.935 0.874 . . . . 0.0 110.672 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 64.8 mt -69.1 -24.34 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.594 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -139.08 -47.95 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.768 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.42 172.45 6.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -101.03 42.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.235 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.5 m -64.83 113.71 4.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 122.457 0.303 . . . . 0.0 110.501 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.522 ' HB2' HD22 ' A' ' 245' ' ' ASN . 20.7 t60 -154.49 128.88 9.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.428 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.546 ' HB2' ' HE1' ' A' ' 212' ' ' TRP . 6.5 ptpp? -75.13 29.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.291 0.567 . . . . 0.0 112.202 -173.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -85.72 -19.86 57.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.532 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.7 t80 -67.27 110.66 3.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.85 13.35 50.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.009 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.8 t -67.01 -17.43 64.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.788 0.328 . . . . 0.0 111.084 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -108.62 -25.59 10.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.067 0.46 . . . . 0.0 110.395 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.14 158.53 9.14 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.312 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.7 mp -120.75 99.8 6.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.304 0.641 . . . . 0.0 110.587 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 29.2 ttpt -85.3 118.83 25.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.09 103.83 0.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.282 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.79 -52.75 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.352 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.9 t -147.65 167.32 24.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.442 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.451 ' ND1' HD22 ' A' ' 280' ' ' LEU . 5.0 t60 -145.9 135.61 23.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.145 0.498 . . . . 0.0 111.128 -173.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 32.6 tt0 -127.05 142.23 51.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.203 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -109.17 116.2 31.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.3 t -141.79 178.43 7.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.98 129.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 8.3 t -132.07 121.32 23.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 58.93 31.92 21.77 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.52 0.512 . . . . 0.0 111.658 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 90.58 -13.12 66.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.87 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -102.74 133.89 47.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.675 -0.309 . . . . 0.0 110.336 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 46.7 m -71.46 130.07 40.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.9 m -129.06 154.24 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 122.172 0.987 . . . . 0.0 112.992 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.07 114.27 25.96 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.921 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 23.0 ttmm -103.32 110.81 22.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.502 HD13 ' HE1' ' A' ' 312' ' ' PHE . 20.5 mt -112.76 135.4 53.54 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.387 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.9 m -99.65 109.86 22.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.598 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 76.5 m-85 -100.08 163.98 12.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.443 . . . . 0.0 112.182 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 29.4 t70 -133.39 138.56 31.64 Favored Pre-proline 0 C--O 1.221 -0.437 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.296 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.551 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.3 Cg_endo -83.89 11.22 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.879 1.72 . . . . 0.0 112.532 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.68 -16.39 40.43 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -146.77 110.52 4.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.769 -0.715 . . . . 0.0 109.739 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.59 -14.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.279 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -67.1 -15.99 64.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.326 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.55 -43.57 22.79 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.65 170.71 11.92 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.223 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.48 147.45 23.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -122.92 121.23 35.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 292' ' ' LEU . 42.0 m -111.55 133.77 53.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 91.1 t -131.05 135.57 59.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.049 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -112.55 115.69 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.2 p -132.87 161.8 33.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.996 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -57.83 158.76 6.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.092 0.473 . . . . 0.0 111.829 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -63.97 -34.83 78.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.61 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -87.37 31.34 0.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.425 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -86.21 118.87 71.12 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.028 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.19 137.45 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.116 1.877 . . . . 0.0 111.821 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -119.92 142.81 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 18.2 t80 -96.73 98.62 10.3 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.961 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.708 HG22 ' OG ' ' A' ' 310' ' ' SER . 51.0 t -87.04 131.95 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 0.0 111.403 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.524 ' HB3' HG11 ' A' ' 333' ' ' VAL . 56.7 tttp -57.93 122.92 14.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.573 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 15.2 m120 77.88 2.06 2.88 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.909 0.756 . . . . 0.0 111.833 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -116.68 -21.78 8.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.83 -121.33 5.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.41 140.51 29.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.398 0.599 . . . . 0.0 110.117 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.86 ' HB2' HG23 ' A' ' 328' ' ' ILE . 75.3 p -143.38 167.15 22.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.108 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.8 t -164.48 171.76 14.21 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.767 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.502 ' HE1' HD13 ' A' ' 280' ' ' LEU . 57.1 m-85 -89.22 -21.14 23.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.485 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.58 70.38 52.51 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.32 -39.14 63.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.909 2.406 . . . . 0.0 112.898 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 19.4 m -66.63 -26.07 66.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 66.9 tp -87.56 -47.65 8.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.194 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.3 m -59.05 -39.02 80.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.372 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.539 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 10.9 p -68.77 -19.58 24.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 111.264 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.23 -41.97 13.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 110.372 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -77.14 -53.09 8.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.871 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -98.82 -15.92 19.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.786 0.326 . . . . 0.0 111.083 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 81.75 18.41 68.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.609 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.2 mt -113.18 113.36 49.06 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.907 -0.172 . . . . 0.0 110.748 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.76 110.42 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 110.487 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.428 ' HB3' ' C ' ' A' ' 310' ' ' SER . 58.2 m -111.29 157.66 19.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 0.0 111.971 -170.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.3 m -84.03 159.73 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.123 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.22 122.98 28.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.86 HG23 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.12 164.89 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.473 0.654 . . . . 0.0 110.671 -177.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -119.93 141.44 49.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.792 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 mm -57.18 110.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.074 0.464 . . . . 0.0 109.845 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.89 3.74 19.62 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.352 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -79.56 131.07 35.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.217 0.532 . . . . 0.0 110.793 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.6 p -93.83 126.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.24 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.5 m -93.28 136.63 33.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.342 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 55.6 mt -105.93 146.13 32.27 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.357 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 58.3 Cg_endo -88.53 165.36 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.933 2.422 . . . . 0.0 112.425 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.47 115.81 3.9 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.868 2.378 . . . . 0.0 111.824 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 122.17 -22.56 7.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.061 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.512 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 16.2 t-80 -67.0 127.78 93.64 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.34 -22.85 60.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.411 2.741 . . . . 0.0 113.554 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.512 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 4.5 m-20 -79.06 -27.25 43.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.54 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.563 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -75.29 85.93 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.305 0.574 . . . . 0.0 110.169 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.7 mt -72.88 -45.44 55.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.734 -173.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -109.65 43.74 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.435 0.636 . . . . 0.0 110.812 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.593 -0.579 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.2 t -97.19 87.58 4.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.051 0.453 . . . . 0.0 109.936 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.9 p -79.3 143.93 34.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.835 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.473 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.7 mm -79.35 -43.86 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.759 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 76.9 t90 -152.98 136.06 15.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.408 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.575 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 32.6 t-80 55.23 -135.75 1.34 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.575 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 15.0 p -96.05 23.91 6.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.798 0.332 . . . . 0.0 111.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -108.61 140.21 42.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.975 -173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.53 178.57 4.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.772 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.77 132.02 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.039 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.05 17.85 26.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.092 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 25.0 m -107.82 147.44 30.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 220' ' ' ARG . 3.7 mpt_? -110.6 144.23 39.81 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.211 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.596 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.0 mt -117.24 144.49 44.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.889 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 16.6 t -153.39 95.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.126 0.489 . . . . 0.0 110.358 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -86.16 118.21 25.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -72.6 -9.29 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -66.81 -34.22 77.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.145 176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -104.22 -177.27 3.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.992 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 p -79.75 -0.16 33.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -80.71 105.84 12.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -90.46 -41.55 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.733 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -92.9 -178.99 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.563 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -82.68 117.62 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -106.63 164.52 12.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.39 172.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.64 160.5 16.6 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.97 -0.456 . . . . 0.0 110.299 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.9 t -60.03 -47.33 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 24.8 mt-10 -59.03 -22.36 60.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.63 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -81.7 -47.58 12.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.135 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.565 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 54.8 t80 -70.08 -48.67 56.78 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.45 69.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.211 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 19.4 ttm180 -68.91 -37.35 78.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.597 0.713 . . . . 0.0 109.55 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.56 -8.93 59.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.699 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.761 ' HB1' ' HE3' ' A' ' 255' ' ' LYS . . . -86.71 28.48 0.87 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.729 0.776 . . . . 0.0 110.36 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.6 m -96.55 -56.25 2.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.021 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.4 m -93.84 24.95 3.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.698 ' HB3' ' HA ' ' A' ' 241' ' ' ALA . 9.5 p-10 -82.87 36.21 0.49 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.052 0.453 . . . . 0.0 111.399 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -139.66 -36.26 0.51 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.978 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -68.49 -17.81 64.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.443 0.639 . . . . 0.0 109.799 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.45 -5.45 46.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.397 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 251' ' ' MET . 66.1 tt0 -67.98 -10.37 52.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.837 0.827 . . . . 0.0 110.536 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.3 -33.15 53.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.72 -42.72 4.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.469 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -118.95 -178.81 3.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -90.41 38.28 3.24 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.061 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 254' ' ' HIS . 1.0 OUTLIER -69.95 108.82 4.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.365 0.266 . . . . 0.0 110.661 -177.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.486 ' C ' ' H ' ' A' ' 256' ' ' GLY . 3.2 t60 176.27 130.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.761 ' HE3' ' HB1' ' A' ' 241' ' ' ALA . 0.0 OUTLIER -73.68 25.36 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.515 177.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -79.27 -13.63 82.58 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.994 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.607 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 11.2 t80 -66.85 107.1 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 103.09 12.21 32.21 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.391 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.8 m -68.74 -13.68 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.826 0.346 . . . . 0.0 111.758 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -108.27 -30.19 8.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.851 0.357 . . . . 0.0 110.282 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.77 157.89 8.86 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.07 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -122.53 105.8 10.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 110.476 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 22.0 ttpt -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.14 0.495 . . . . 0.0 110.976 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.52 107.48 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.868 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 283' ' ' ASP . 61.1 mt -82.51 -41.1 20.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.466 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.7 t -158.39 162.35 37.62 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.791 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -140.94 140.25 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -133.43 139.69 46.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.246 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.61 106.14 18.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 109.776 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.0 t -109.6 179.73 4.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.69 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.72 128.92 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.023 0.44 . . . . 0.0 110.119 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.6 t -131.63 124.44 29.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.333 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 56.06 32.6 20.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.629 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.1 -2.71 88.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -111.23 133.3 53.67 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.733 -0.275 . . . . 0.0 110.297 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.2 m -67.15 137.92 56.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.1 m -129.62 154.88 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.772 0.796 . . . . 0.0 111.838 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 295' ' ' GLU . 96.9 mt -95.57 110.61 22.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.558 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -98.24 110.66 23.2 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 17.2 mt -113.82 129.93 56.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.124 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 37.6 m -97.52 118.12 33.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.51 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 79.5 m-85 -106.55 164.65 11.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.288 0.566 . . . . 0.0 112.417 -171.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 265' ' ' LEU . 19.0 t70 -131.29 135.06 26.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.146 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.607 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 72.8 Cg_endo -84.17 5.59 6.24 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.202 1.935 . . . . 0.0 112.346 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 -18.87 27.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.452 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -142.29 126.65 17.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.052 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.97 -8.15 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.39 -39.69 92.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.03 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.04 -46.76 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.036 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.99 11.48 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.39 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.0 143.26 29.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.72 0.295 . . . . 0.0 110.578 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 294' ' ' VAL . 1.1 tm? -117.5 119.44 35.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.0 m -106.8 135.27 48.62 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.502 HG21 HD12 ' A' ' 292' ' ' LEU . 73.8 t -134.04 135.22 55.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.436 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 278' ' ' LEU . 41.8 mt-10 -126.95 127.73 45.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.716 173.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 300' ' ' HIS . 9.2 t -141.19 -174.61 4.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.773 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -76.0 172.84 12.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.9 mm? -74.67 -10.54 59.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.352 -168.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.96 17.45 24.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.721 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . 0.546 ' HD2' ' SG ' ' A' ' 296' ' ' CYS . 48.4 t-80 -75.89 117.93 67.36 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.527 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.5 135.16 17.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.158 1.905 . . . . 0.0 111.783 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.472 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -121.24 125.57 47.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 7.7 t80 -81.84 90.79 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.567 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 332' ' ' ASP . 65.6 t -72.95 123.86 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.035 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.738 ' HB3' HG11 ' A' ' 333' ' ' VAL . 60.4 tttp -56.33 139.69 47.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.38 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.9 m-20 77.1 -8.68 1.65 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.819 0.699 . . . . 0.0 112.114 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -119.21 -54.0 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.17 -149.67 18.05 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -67.73 120.64 14.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.172 0.486 . . . . 0.0 110.259 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.0 m -134.94 169.66 17.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.351 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 43.2 t -160.63 172.13 17.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.914 0.387 . . . . 0.0 110.777 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -87.14 -28.88 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.974 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.46 76.39 77.63 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.687 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.543 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 65.8 Cg_exo -54.74 -41.96 73.08 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.103 2.535 . . . . 0.0 113.141 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 6.9 m -64.02 -24.35 67.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.8 tp -87.32 -49.14 7.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.951 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -55.75 -44.65 77.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.377 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.19 -31.67 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.745 0.307 . . . . 0.0 111.752 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.11 -40.35 22.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.229 0.538 . . . . 0.0 110.243 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.19 -49.97 13.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.589 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -102.75 -9.06 20.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.767 0.318 . . . . 0.0 111.737 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 75.67 29.6 59.27 Favored Glycine 0 CA--C 1.516 0.127 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.7 mt -128.34 112.79 19.67 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 122.772 -0.252 . . . . 0.0 110.433 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.8 116.79 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.448 2.099 . . . . 0.0 110.877 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.543 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 72.8 m -117.62 147.59 42.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.287 0.565 . . . . 0.0 111.698 -169.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.55 164.97 22.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.653 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.13 128.18 34.25 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.98 178.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.422 0.629 . . . . 0.0 111.07 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -141.71 132.88 26.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.93 115.13 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 O-C-N 123.67 0.606 . . . . 0.0 110.162 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.71 6.72 16.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.516 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.55 ' HB2' HG11 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -70.4 128.91 37.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 176.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.2 p -97.56 112.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.73 0.776 . . . . 0.0 111.13 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.9 m -79.96 132.29 36.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.425 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.85 145.91 31.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.908 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.436 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.1 Cg_endo -86.68 168.7 8.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.008 2.472 . . . . 0.0 112.357 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 42.0 Cg_endo -68.12 126.16 14.03 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.885 2.39 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.51 -21.33 30.74 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.35 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.4 122.0 77.81 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.79 -23.53 72.41 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 123.182 2.588 . . . . 0.0 113.108 -171.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.534 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 37.4 t70 -79.06 -27.18 43.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.55 86.57 4.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.178 0.513 . . . . 0.0 109.993 169.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 60.0 mt -66.86 -50.65 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.633 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -99.57 31.57 3.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.0 111.08 -169.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.358 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.481 0.752 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.4 t -94.78 94.3 8.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.287 0.565 . . . . 0.0 109.998 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -84.87 143.54 28.98 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.216 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 235' ' ' GLU . 11.4 mm -86.26 -41.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.58 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.461 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 80.9 t90 -154.33 127.63 8.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.653 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 38.4 t-80 59.06 -146.56 0.51 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.653 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 49.4 t -94.64 39.82 1.09 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.292 0.567 . . . . 0.0 110.37 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.13 138.04 45.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.361 0.601 . . . . 0.0 111.594 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.97 169.16 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.022 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.413 ' HG3' ' OE2' ' A' ' 235' ' ' GLU . 56.9 tttp -62.42 128.15 34.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.734 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.35 -16.85 34.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.027 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 60.6 m -73.73 148.17 42.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.483 ' O ' HG12 ' A' ' 294' ' ' VAL . 0.4 OUTLIER -109.37 150.71 27.64 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.436 178.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.564 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.4 mt -123.54 143.88 49.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.9 t -151.96 92.03 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.449 . . . . 0.0 110.412 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.497 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 47.3 m-85 -75.97 124.8 27.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -65.4 -22.1 66.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 110.91 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -78.05 -6.89 56.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.497 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 60.8 mm-40 -100.43 172.3 7.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.016 0.436 . . . . 0.0 110.881 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.9 m -96.87 26.44 4.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.168 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -114.87 97.44 6.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 111.505 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -78.66 -35.73 44.84 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.04 139.07 56.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.098 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.405 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 83.6 m95 -73.47 122.73 22.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -172.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.6 pt20 -99.99 158.44 15.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.513 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.43 161.44 16.28 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.913 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -58.5 -49.7 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.641 0.734 . . . . 0.0 109.355 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.662 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 35.3 mt-10 -58.08 -22.3 49.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.585 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.6 -45.77 24.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.331 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -74.96 -46.84 32.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.427 ' CB ' HG23 ' A' ' 211' ' ' ILE . . . -59.7 -25.07 64.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.568 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.662 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 35.9 ttm180 -63.13 -36.81 84.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.337 0.589 . . . . 0.0 109.835 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.39 -23.22 62.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.594 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.657 ' HB1' ' HE3' ' A' ' 255' ' ' LYS . . . -91.38 13.85 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.705 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.0 m -81.42 -9.73 59.67 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 247' ' ' GLU . 1.7 p -75.59 -68.94 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 t70 178.52 -160.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -77.65 52.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.393 1.451 . . . . 0.0 110.501 171.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -140.5 30.06 1.93 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.766 ' OE1' ' HB ' ' A' ' 253' ' ' THR . 6.1 mp0 -57.46 -52.51 65.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.205 -172.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -101.64 -23.9 14.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.028 0.442 . . . . 0.0 111.368 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 253' ' ' THR . 0.2 OUTLIER -134.82 120.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.03 68.96 0.47 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.572 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 41.2 ttm -169.91 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.642 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 173.48 91.41 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.766 ' HB ' ' OE1' ' A' ' 247' ' ' GLU . 7.2 m -95.52 -79.83 0.43 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.907 -0.172 . . . . 0.0 111.145 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.534 ' HB3' ' O ' ' A' ' 253' ' ' THR . 22.0 t-80 74.22 141.64 0.07 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.796 0.685 . . . . 0.0 109.575 -173.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.657 ' HE3' ' HB1' ' A' ' 241' ' ' ALA . 9.3 mptt -49.86 -50.6 45.08 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.311 0.382 . . . . 0.0 110.667 -171.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 74.1 -65.92 1.89 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.358 165.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.631 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.7 t80 -66.45 105.75 1.56 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 110.868 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 97.25 18.55 28.44 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.376 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.6 m -75.8 -13.27 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.993 0.425 . . . . 0.0 110.459 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.07 -31.94 8.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 109.323 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.23 157.92 8.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.003 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.54 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.5 mp -123.12 98.7 6.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 123.234 0.614 . . . . 0.0 110.363 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 69.8 tttt -84.15 122.06 28.31 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.7 105.09 0.6 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.76 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 283' ' ' ASP . 87.0 mt -79.16 -48.13 14.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.7 t -150.28 163.37 38.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.849 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -134.08 148.49 51.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.888 -167.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.16 139.32 21.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.894 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -111.09 94.28 4.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.491 0.662 . . . . 0.0 109.468 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.459 ' HG ' HG22 ' A' ' 277' ' ' VAL . 0.9 OUTLIER -100.42 177.91 4.9 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.308 -171.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.6 p -127.3 116.82 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.394 0.616 . . . . 0.0 110.053 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 69.7 p -112.19 113.43 25.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.612 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 54.38 35.37 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.461 0.475 . . . . 0.0 111.814 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.29 -21.69 36.7 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.496 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -110.85 134.72 52.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.13 0.465 . . . . 0.0 111.227 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 19.4 m -71.84 137.92 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.025 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.459 HG22 ' HG ' ' A' ' 270' ' ' SER . 6.4 m -136.86 154.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.596 0.712 . . . . 0.0 112.03 -175.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 94.7 mt -92.54 109.4 20.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.259 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 4.9 ttpp -102.95 109.0 20.39 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 293' ' ' THR . 38.4 mt -118.71 140.9 49.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.247 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.0 m -99.05 122.56 42.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.54 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.2 m-85 -110.63 158.88 18.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.384 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.441 ' HB2' HD23 ' A' ' 265' ' ' LEU . 10.7 t70 -128.21 130.62 23.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.663 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.631 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 97.4 Cg_endo -86.82 12.55 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.607 2.204 . . . . 0.0 112.451 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.96 -16.61 46.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.883 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.5 t -154.4 139.92 17.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 111.031 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.99 -9.88 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.31 -38.76 77.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.183 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.82 -43.47 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.903 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 133.38 163.48 10.47 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.769 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.94 149.27 22.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.071 0.463 . . . . 0.0 110.143 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 294' ' ' VAL . 1.8 tm? -126.75 123.29 37.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.8 m -115.64 136.84 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 68.3 t -131.92 137.14 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.639 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.434 ' CG ' ' HD3' ' A' ' 279' ' ' LYS . 87.8 mt-10 -106.39 127.86 53.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.642 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.4 p -142.99 172.2 13.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -66.09 154.56 39.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.308 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.733 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.2 mm? -62.45 -21.13 65.21 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.47 0.652 . . . . 0.0 110.742 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.68 16.7 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.779 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -70.69 122.64 87.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -82.3 122.4 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.518 2.145 . . . . 0.0 111.906 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.66 120.62 42.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.7 t80 -72.84 104.4 4.01 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.23 137.15 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.267 0.556 . . . . 0.0 111.074 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.471 ' HB3' HG11 ' A' ' 333' ' ' VAL . 55.1 tttp -57.92 129.93 44.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.813 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.7 m120 72.94 2.3 4.33 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.627 0.579 . . . . 0.0 112.099 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.443 ' HE2' ' HD1' ' A' ' 329' ' ' HIS . 44.2 mttp -121.6 -41.37 2.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.657 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 95.6 -152.78 20.47 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.67 113.84 3.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.238 0.519 . . . . 0.0 110.699 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.9 m -126.21 165.55 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.5 t -161.54 -177.83 6.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.656 0.265 . . . . 0.0 110.939 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.41 ' CD1' HD11 ' A' ' 278' ' ' LEU . 30.1 m-85 -91.59 -43.6 9.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.244 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.67 74.22 17.67 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.705 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.7 Cg_exo -55.6 -36.26 94.28 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.748 2.298 . . . . 0.0 112.946 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 23.2 t -63.1 -28.48 70.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.115 0.484 . . . . 0.0 110.559 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.3 tp -87.35 -41.97 13.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.886 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.463 HG23 ' SG ' ' A' ' 325' ' ' CYS . 7.9 m -53.33 -44.06 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.778 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.442 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.9 p -72.14 -20.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.31 -34.93 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.384 0.612 . . . . 0.0 110.117 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -84.67 -53.03 5.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.188 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.73 -11.52 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.103 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 76.98 24.85 65.66 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.254 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.1 mt -120.97 113.17 33.02 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.874 -0.192 . . . . 0.0 110.572 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.05 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.47 2.113 . . . . 0.0 110.7 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.463 ' SG ' HG23 ' A' ' 317' ' ' THR . 79.5 m -117.57 155.88 29.04 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -169.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.55 165.77 18.8 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.618 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.57 126.71 33.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 162.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . 0.443 ' HD1' ' HE2' ' A' ' 307' ' ' LYS . 64.4 m80 -130.03 153.75 48.12 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.5 mm -63.15 109.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.68 -0.61 20.1 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.825 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 3.3 m-20 -76.88 129.43 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.532 0.666 . . . . 0.0 110.221 174.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.35 134.74 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.535 0.683 . . . . 0.0 112.654 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 50.5 t -95.85 138.95 32.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.971 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 76.0 mt -109.96 141.87 24.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.527 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.57 164.15 9.36 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.884 2.389 . . . . 0.0 112.033 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.49 122.78 9.8 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.292 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 114.45 -17.0 19.12 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.813 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.511 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 21.6 t-80 -70.34 132.18 87.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.24 -26.35 76.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.389 2.726 . . . . 0.0 113.479 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.511 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 1.9 m-20 -79.24 -26.67 42.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.668 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -80.02 85.83 5.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.68 -43.98 46.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.243 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -120.92 80.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.886 -178.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -105.64 92.01 4.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.3 p -82.23 141.52 32.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.033 0.444 . . . . 0.0 110.967 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -82.85 -37.76 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.709 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -156.88 135.65 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.537 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 23.1 t-80 55.83 -139.26 0.97 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.537 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 43.6 t -100.4 42.68 1.1 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.376 0.607 . . . . 0.0 109.92 176.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.09 139.48 50.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 111.89 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.1 174.83 5.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.825 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 235' ' ' GLU . 64.4 tttm -63.77 127.89 33.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.421 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.85 -1.55 38.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.473 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.515 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 68.1 m -86.21 140.1 30.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -111.11 137.88 48.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.449 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 47.1 mt -112.78 145.49 40.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.717 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . 0.703 ' HA ' HD22 ' A' ' 228' ' ' ASN . 21.3 t -149.48 97.46 2.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.185 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -85.74 108.28 17.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -71.04 -19.38 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -58.86 -36.46 74.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.498 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.78 -156.5 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.642 -173.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -85.27 -17.28 37.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.703 HD22 ' HA ' ' A' ' 222' ' ' CYS . 1.4 p-10 -93.02 108.06 19.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.591 -171.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.776 ' HD2' ' HG3' ' A' ' 230' ' ' GLU . 0.9 OUTLIER -102.38 7.42 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.456 174.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.776 ' HG3' ' HD2' ' A' ' 229' ' ' LYS . 27.2 mt-10 -114.35 172.22 7.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.329 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -87.52 132.85 33.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.011 0.91 . . . . 0.0 113.211 -168.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 12.2 pt20 -130.92 168.37 17.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.246 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -88.59 160.2 17.54 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.975 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.59 -46.93 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 217' ' ' LYS . 27.3 mt-10 -57.73 -23.45 51.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.243 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.09 -44.75 21.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.341 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.575 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.9 t80 -74.26 -44.07 54.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.423 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.94 72.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.118 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -58.77 -41.77 87.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.56 72.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.06 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.408 ' O ' ' HE3' ' A' ' 255' ' ' LYS . . . -90.31 20.08 4.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.728 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 29.7 t -63.02 -28.96 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.04 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 244' ' ' ASP . 22.8 p -76.43 -80.65 0.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' A' ' 254' ' ' HIS . 16.4 t70 177.05 -33.71 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.907 0.861 . . . . 0.0 109.127 173.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.416 ' CG ' ' HB2' ' A' ' 254' ' ' HIS . 55.2 t30 177.54 128.59 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.411 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 249' ' ' ILE . 40.2 mt-10 -95.12 50.09 1.25 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 110.228 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -41.97 81.1 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.326 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.51 -24.87 25.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.155 0.503 . . . . 0.0 110.216 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 246' ' ' GLU . 34.9 mt -79.58 -47.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.746 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -150.01 -62.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.34 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 58.2 ttp -152.06 -76.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.28 -0.263 . . . . 0.0 111.411 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.46 142.78 7.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.457 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.47 38.36 0.17 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.703 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 67.8 t60 -83.25 144.02 30.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.426 -171.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 241' ' ' ALA . 94.4 mttt -89.27 34.95 0.8 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.102 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -99.03 -15.4 33.45 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.951 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 39.2 t80 -74.59 120.64 20.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 110.034 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.19 26.61 23.27 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.591 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -81.41 -16.42 52.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.176 0.513 . . . . 0.0 110.417 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.88 -29.49 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 142.1 151.81 5.59 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.586 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.57 97.59 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.73 0.412 . . . . 0.0 110.863 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.9 ttpp -85.68 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.182 0.515 . . . . 0.0 111.139 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.491 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 4.6 tt -54.77 122.48 10.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.465 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 283' ' ' ASP . 59.2 mt -95.0 -47.71 6.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.561 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.7 t -151.0 164.98 35.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -142.12 133.04 25.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.207 0.527 . . . . 0.0 111.632 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -128.67 146.19 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.49 128.69 53.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.828 0.823 . . . . 0.0 110.359 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 30.8 t -133.07 179.98 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.864 -167.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.19 128.7 56.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.03 0.443 . . . . 0.0 109.874 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 32.2 t -126.47 111.31 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.119 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 54.91 42.25 31.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.16 -11.72 59.92 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.905 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -97.14 115.25 27.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 110.481 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.6 m -62.34 133.95 55.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.1 m -132.72 153.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.147 0.975 . . . . 0.0 113.228 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 89.9 mt -92.92 119.96 32.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.249 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.7 ttmt -108.33 111.82 23.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.503 HD13 ' HE1' ' A' ' 312' ' ' PHE . 36.9 mt -118.5 129.4 55.35 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.011 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.1 m -92.97 110.79 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -96.51 155.27 16.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD23 ' A' ' 265' ' ' LEU . 15.7 t0 -118.84 123.43 29.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.448 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 60.5 Cg_endo -73.36 2.76 5.32 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.065 1.843 . . . . 0.0 111.755 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.79 9.85 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.5 t -145.9 130.94 18.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.11 -12.25 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.085 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.18 -34.7 78.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.557 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.52 -45.26 69.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 135.94 176.16 14.21 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.366 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 79.1 mt -103.32 150.33 23.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.915 0.388 . . . . 0.0 110.618 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -127.02 119.43 26.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.4 m -109.76 139.39 44.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.9 t -132.93 132.73 59.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -109.47 115.26 29.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 6.2 p -134.3 165.64 24.67 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.53 155.9 28.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.138 0.494 . . . . 0.0 111.01 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.762 HD21 ' H ' ' A' ' 298' ' ' LEU . 1.1 mm? -64.4 -19.53 65.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.078 -173.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.21 17.67 16.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.194 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.51 117.27 60.74 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.773 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.65 116.38 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.238 1.959 . . . . 0.0 111.445 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.8 m-85 -103.59 116.06 31.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.355 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 11.4 t80 -73.48 105.08 4.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.406 175.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 332' ' ' ASP . 54.5 t -92.75 130.79 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.349 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.76 ' HB3' HG11 ' A' ' 333' ' ' VAL . 58.9 tttp -59.97 126.44 27.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 13.2 m120 77.64 0.05 2.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.995 0.81 . . . . 0.0 111.993 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -117.08 -33.8 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 111.495 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 94.47 -151.14 20.04 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 345' ' ' PHE . 97.3 m95 -67.77 117.6 9.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.462 0.631 . . . . 0.0 109.457 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.421 ' CB ' HG21 ' A' ' 328' ' ' ILE . 15.6 m -128.28 166.66 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.772 0.32 . . . . 0.0 110.641 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 41.4 t -160.77 168.11 25.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.509 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.503 ' HE1' HD13 ' A' ' 280' ' ' LEU . 63.4 m-85 -84.92 -28.57 25.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.946 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.11 75.41 75.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.595 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.42 -45.02 43.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.883 2.388 . . . . 0.0 112.677 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 18.3 m -62.5 -21.08 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.447 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.05 -45.3 10.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.909 0.385 . . . . 0.0 110.166 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.509 HG23 ' SG ' ' A' ' 325' ' ' CYS . 36.4 m -55.51 -40.74 72.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.742 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.557 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.9 p -71.72 -19.71 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.788 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.3 t -87.61 -36.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.327 0.584 . . . . 0.0 110.185 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -81.86 -54.88 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -101.79 -11.37 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.837 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 81.59 14.78 77.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.638 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.5 mt -110.53 114.18 55.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.634 0.217 . . . . 0.0 111.08 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.96 118.49 5.65 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.633 2.222 . . . . 0.0 110.601 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.509 ' SG ' HG23 ' A' ' 317' ' ' THR . 62.6 m -117.77 157.78 25.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.248 0.547 . . . . 0.0 112.306 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.6 m -79.91 164.88 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.06 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -92.03 122.16 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.19 166.1 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.548 0.689 . . . . 0.0 111.412 -175.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -124.12 142.33 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.34 114.45 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 115.67 -0.65 21.72 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.525 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.477 ' HB3' HG12 ' A' ' 304' ' ' VAL . 51.3 m-20 -73.15 132.09 42.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.88 175.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.76 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -92.92 134.8 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.273 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 49.5 t -96.5 134.32 39.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.369 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 82.2 mt -105.84 143.68 27.37 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.59 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.416 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 69.1 Cg_endo -86.91 167.66 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.637 2.225 . . . . 0.0 112.074 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.74 129.8 24.49 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.008 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.26 -14.32 54.94 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -69.3 128.3 92.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.36 -22.59 75.0 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.325 2.683 . . . . 0.0 113.866 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.87 -31.04 45.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.534 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -69.0 91.73 0.49 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.281 0.562 . . . . 0.0 109.954 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.0 mt -66.33 -41.53 89.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.671 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -129.13 101.7 6.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 309' ' ' TRP . 3.8 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.519 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -91.3 99.58 12.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.048 0.452 . . . . 0.0 110.098 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -87.63 141.77 28.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.454 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.4 mm -79.44 -40.31 21.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.334 0.588 . . . . 0.0 109.752 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -156.89 134.38 10.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.107 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.624 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 34.0 t-80 55.94 -139.22 0.97 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.624 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 40.3 t -99.8 40.09 1.27 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.418 0.628 . . . . 0.0 109.864 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -110.23 134.6 52.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.061 0.458 . . . . 0.0 111.237 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.51 176.17 6.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -67.37 137.82 56.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.66 31.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.022 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 38.2 m -112.11 147.63 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.559 HH12 ' HB3' ' A' ' 272' ' ' SER . 0.3 OUTLIER -111.07 143.6 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.824 0.345 . . . . 0.0 111.058 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.8 mt -119.64 143.75 47.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.809 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . 0.485 ' HA ' HD22 ' A' ' 228' ' ' ASN . 41.8 t -154.07 98.03 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 174.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.516 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 34.8 m-85 -83.34 122.18 28.12 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -66.98 -24.32 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.563 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 19.0 pttp -75.1 -12.67 60.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.996 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 9.0 mm-40 -94.38 172.39 8.23 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.187 0.518 . . . . 0.0 110.843 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 6.3 m -88.16 18.1 4.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.382 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.485 HD22 ' HA ' ' A' ' 222' ' ' CYS . 3.8 p-10 -115.48 102.6 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.184 0.993 . . . . 0.0 111.41 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -83.69 -31.8 25.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.646 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -70.57 154.93 41.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.026 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.487 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 85.4 m95 -79.96 138.67 37.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.235 -175.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 9.1 pt20 -120.45 154.37 35.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.688 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.37 162.57 23.33 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -60.68 -50.82 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.03 -24.2 57.38 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.289 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.17 -50.67 21.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.55 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 62.1 t80 -70.59 -43.65 68.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.698 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.53 68.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.245 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 239' ' ' ARG . 36.6 ttt180 -68.15 -34.81 77.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.38 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.09 -20.03 49.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.991 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -83.99 15.78 3.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.762 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.9 p -72.65 -27.74 62.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.992 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 21.2 m -80.06 149.18 30.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.71 -177.76 5.62 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.824 ' HB2' ' HG2' ' A' ' 247' ' ' GLU . 0.3 OUTLIER -73.89 103.13 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.757 0.789 . . . . 0.0 112.889 -170.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.489 ' HB3' HD13 ' A' ' 249' ' ' ILE . 4.1 mm-40 -89.13 44.9 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.514 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.824 ' HG2' ' HB2' ' A' ' 245' ' ' ASN . 18.0 mm-40 -62.07 -41.81 98.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.309 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.84 -24.62 62.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 246' ' ' GLU . 62.4 mt -75.49 -60.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.76 -56.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.298 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 14.0 tpt -81.29 149.29 29.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.596 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.54 82.81 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.287 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 m -97.72 18.36 15.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.511 0.672 . . . . 0.0 110.601 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 245' ' ' ASN . 84.8 t60 -71.21 94.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.45 4.26 0.1 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -95.83 30.49 8.38 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.236 -176.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.474 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 14.9 t80 -74.28 119.66 18.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.64 21.48 23.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.225 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.1 t -70.05 -23.56 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.02 -31.75 17.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.58 0.705 . . . . 0.0 109.828 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 141.0 144.28 4.41 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.762 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.55 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.2 mp -97.92 99.18 10.47 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.419 0.287 . . . . 0.0 111.0 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 19.2 ttpp -84.96 117.75 24.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.467 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.1 tt -61.22 102.83 0.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.829 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 283' ' ' ASP . 67.1 mt -77.2 -47.65 19.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.445 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -152.58 163.15 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.097 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -133.68 146.2 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.668 -168.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.44 140.04 27.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.16 107.75 16.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.3 t -127.43 178.46 6.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.8 p -128.5 127.15 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.559 ' HB3' HH12 ' A' ' 220' ' ' ARG . 13.7 t -116.1 106.55 13.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.777 -173.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.2 p90 54.94 17.08 1.69 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.82 1.248 . . . . 0.0 113.022 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 123.05 -16.29 8.2 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.464 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.95 115.03 29.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.876 0.369 . . . . 0.0 110.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 22.9 m -68.02 133.62 49.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.67 154.87 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.997 0.904 . . . . 0.0 113.072 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.462 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 98.7 mt -94.15 110.31 22.04 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.807 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.8 ttmt -104.28 109.63 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.812 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.45 HD13 ' HE1' ' A' ' 312' ' ' PHE . 40.9 mt -116.14 136.82 52.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.751 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 27.8 m -93.58 109.66 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.55 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 84.3 m-85 -101.09 150.05 23.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.324 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 12.8 t70 -116.6 133.44 23.02 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.474 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.7 Cg_endo -79.21 9.81 3.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.861 1.707 . . . . 0.0 112.04 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.38 63.16 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -146.73 100.01 3.27 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.603 0.716 . . . . 0.0 109.508 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.29 -18.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.415 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.25 -32.43 64.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.538 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 1.5 m-20 -82.37 -1.18 49.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 111.472 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.08 172.96 25.31 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.791 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.4 mt -97.84 141.13 31.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.723 0.297 . . . . 0.0 110.22 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 121.29 44.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 28.2 m -110.06 133.97 52.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 89.2 t -131.69 134.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.518 -174.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 88.3 mt-10 -106.44 120.97 43.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.681 171.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 11.0 p -133.23 167.2 20.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.467 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 297' ' ' LYS . 14.0 mmmm -75.44 163.24 27.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.06 0.457 . . . . 0.0 110.494 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.613 HD21 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -66.89 -16.09 64.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.757 -168.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.97 26.0 10.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.159 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -79.24 117.53 67.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.726 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.48 133.35 11.72 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.242 1.961 . . . . 0.0 111.903 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.444 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 98.8 m-85 -118.07 125.04 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.423 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -76.51 89.34 3.27 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.524 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 332' ' ' ASP . 73.2 t -76.79 134.12 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.464 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.578 ' HB3' HG11 ' A' ' 333' ' ' VAL . 69.2 tttt -59.35 125.53 24.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.901 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.3 m120 81.45 -26.39 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.093 0.871 . . . . 0.0 112.171 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.444 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 39.7 mttp -89.83 -35.12 15.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.093 0.473 . . . . 0.0 111.203 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.89 -153.06 21.73 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -63.99 115.06 4.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.983 0.392 . . . . 0.0 110.209 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.454 ' CB ' HG21 ' A' ' 328' ' ' ILE . 19.0 m -127.74 169.19 14.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.222 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 45.9 t -160.7 169.37 22.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.45 ' HE1' HD13 ' A' ' 280' ' ' LEU . 53.4 m-85 -84.28 -32.27 24.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.929 174.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -126.95 77.38 75.1 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.421 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.0 Cg_exo -56.35 -36.81 97.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.814 2.343 . . . . 0.0 112.564 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.7 m -70.29 -20.75 63.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.43 -47.81 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 m -57.17 -40.95 78.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.048 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.512 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.2 p -68.5 -20.42 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.894 0.378 . . . . 0.0 111.642 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.5 t -91.01 -38.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.326 0.584 . . . . 0.0 110.393 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -78.81 -53.77 6.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.788 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -95.24 -22.22 17.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.096 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 88.15 12.97 64.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.306 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.0 mt -109.2 115.82 56.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -72.0 109.48 2.7 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.532 2.155 . . . . 0.0 110.706 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 59.5 m -109.09 155.01 21.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.765 -170.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 79.2 m -84.8 166.38 16.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.015 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.29 123.51 31.63 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.291 -0.256 . . . . 0.0 110.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.454 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.34 164.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.229 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -134.33 150.82 50.97 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . 0.558 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.0 mm -55.27 113.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 110.527 -176.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.4 -2.09 20.46 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.865 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.444 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 9.5 m-20 -73.51 128.35 35.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.257 0.551 . . . . 0.0 111.159 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.4 p -88.95 136.39 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.844 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 58.3 m -103.02 134.22 46.82 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.097 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 59.9 mt -104.39 143.14 26.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.503 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.566 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 63.5 Cg_endo -88.72 166.86 6.04 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.214 2.609 . . . . 0.0 112.871 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.5 128.69 17.61 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.352 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.88 -19.37 35.62 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.905 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -70.96 129.23 89.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 -32.0 80.11 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.807 3.005 . . . . 0.0 113.868 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.33 -23.06 43.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.9 86.51 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.917 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.25 -45.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.528 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -110.38 47.5 0.96 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.286 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.346 179.739 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 110.871 -0.473 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.6 t -91.69 93.65 9.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.0 p -84.11 143.79 29.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.479 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.8 mm -79.33 -44.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.44 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -151.37 137.19 18.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.416 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.545 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 24.1 t-80 56.43 -137.4 1.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.545 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 45.1 t -100.23 34.09 2.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.307 0.575 . . . . 0.0 110.112 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -108.63 138.57 44.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.29 175.65 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.882 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -68.32 130.3 42.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.419 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.82 36.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.113 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.48 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 23.9 m -101.82 145.55 29.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.17 143.7 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.735 0.302 . . . . 0.0 110.903 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 44.1 mt -121.65 144.13 48.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.654 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 10.1 m -148.99 91.93 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.458 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 12.3 m-85 -88.2 120.06 29.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -70.78 -9.88 58.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 110.805 -173.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -73.77 -25.52 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.325 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.62 -165.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.215 0.531 . . . . 0.0 110.276 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.5 t -89.82 3.73 51.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -82.03 43.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -12.77 60.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.047 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.0 154.28 18.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.931 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.539 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 68.1 m95 -71.36 108.96 5.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.563 0.697 . . . . 0.0 112.516 -169.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 23.4 pt20 -101.0 167.27 10.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.567 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.13 159.11 17.67 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.3 t -58.17 -48.72 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 109.716 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.65 -21.51 40.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.762 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.2 -52.48 8.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.451 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 66.1 t80 -65.43 -41.38 93.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.839 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.04 73.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -60.96 -51.1 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.768 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.77 91.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.117 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -87.32 5.64 37.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.059 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.0 m -103.93 27.89 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.531 0.682 . . . . 0.0 110.617 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.703 ' HB3' HG22 ' A' ' 253' ' ' THR . 36.5 t -90.63 -179.21 5.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.52 ' O ' ' HB ' ' A' ' 253' ' ' THR . 32.9 t70 -59.85 156.98 13.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 253' ' ' THR . 0.2 OUTLIER -76.31 68.17 2.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.767 ' HB3' HD13 ' A' ' 249' ' ' ILE . 28.5 mt-10 -83.22 47.32 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.232 -175.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 1.051 ' HA ' ' HA3' ' A' ' 252' ' ' GLY . 11.2 pt-20 -71.75 -26.06 62.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.171 -173.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -94.89 -3.25 49.09 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.122 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 246' ' ' GLU . 44.5 mt -77.24 -59.3 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.08 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -166.42 -56.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.233 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 23.1 ttt -79.23 -54.58 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.978 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 1.051 ' HA3' ' HA ' ' A' ' 247' ' ' GLU . . . 98.35 84.99 1.8 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.915 -175.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.703 HG22 ' HB3' ' A' ' 243' ' ' CYS . 4.0 m -90.43 85.38 6.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.044 0.45 . . . . 0.0 110.39 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.44 ' C ' ' H ' ' A' ' 256' ' ' GLY . 31.9 t60 -143.3 105.55 4.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.459 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -69.5 32.17 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.598 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -91.3 -2.84 70.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.464 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 12.6 t80 -62.89 112.29 2.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 100.23 12.09 40.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.188 -1.005 . . . . 0.0 113.554 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.6 t -74.55 -15.48 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.038 0.447 . . . . 0.0 110.139 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -88.8 -26.47 21.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.591 0.71 . . . . 0.0 109.339 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.4 144.22 5.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.0 mp -105.46 98.2 7.93 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.434 0.294 . . . . 0.0 111.372 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.6 tttm -84.48 118.0 24.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.015 0.435 . . . . 0.0 110.648 -176.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.46 107.21 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 283' ' ' ASP . 85.9 mt -80.75 -51.62 8.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.714 0.292 . . . . 0.0 110.351 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.0 t -150.71 163.16 39.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.521 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.3 t60 -137.03 139.68 41.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 0.0 111.509 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -133.23 138.69 46.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.836 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.521 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 9.2 mt-10 -108.15 121.88 45.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 0.0 110.069 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -139.97 174.08 10.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.135 -173.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.65 113.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 17.8 t -120.38 121.64 39.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.416 -171.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 58.65 30.17 19.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.523 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.98 82.95 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.027 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -110.22 127.32 54.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 0.189 . . . . 0.0 110.503 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.6 m -65.25 132.12 48.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.69 154.11 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.853 0.835 . . . . 0.0 112.591 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.457 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 88.4 mt -94.38 114.36 26.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.734 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 20.3 ttpp -109.04 114.84 28.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.49 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 38.0 mt -115.72 130.83 57.0 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.251 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.0 m -93.91 111.79 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.515 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 77.3 m-85 -100.99 159.7 14.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.84 -172.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 35.9 t70 -122.94 137.45 28.13 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.652 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.583 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 86.9 Cg_endo -85.54 11.32 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.213 1.942 . . . . 0.0 112.083 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.71 39.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -154.14 115.56 4.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.339 0.59 . . . . 0.0 110.161 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.58 -7.77 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.654 0.74 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.13 -20.15 61.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.134 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.6 -38.63 39.49 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 145.31 168.21 12.82 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.243 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.11 143.06 26.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.458 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.9 OUTLIER -117.42 117.5 29.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.44 ' N ' HD23 ' A' ' 292' ' ' LEU . 5.5 m -108.94 138.21 45.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.0 t -132.13 132.98 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.539 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 70.6 mt-10 -104.16 116.34 32.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.588 170.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.561 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 11.1 p -128.06 167.24 17.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.992 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -81.65 161.14 23.55 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.8 mm? -61.54 -13.36 20.74 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.26 -169.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -108.18 13.11 26.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.591 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -71.69 119.35 73.62 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 0.0 110.888 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.44 136.39 17.51 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.21 1.94 . . . . 0.0 112.105 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.561 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.6 m-85 -122.77 118.15 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.694 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 17.0 t80 -74.5 101.65 4.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.368 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 332' ' ' ASP . 53.4 t -90.6 135.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.205 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.604 ' HB3' HG11 ' A' ' 333' ' ' VAL . 59.1 tttm -62.0 128.4 35.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 16.3 m120 72.55 11.32 5.62 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.72 0.637 . . . . 0.0 111.721 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.451 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 38.0 mttp -128.3 -42.9 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.986 175.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 100.15 -153.3 19.39 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -63.97 116.84 6.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 117.24 0.52 . . . . 0.0 109.795 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.423 ' CB ' HG23 ' A' ' 328' ' ' ILE . 16.7 m -128.31 166.43 18.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.034 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -160.43 167.05 28.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.49 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 71.0 m-85 -85.98 -19.57 30.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.113 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -137.21 72.78 52.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.656 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.513 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.4 Cg_exo -52.62 -37.62 74.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.924 2.416 . . . . 0.0 113.19 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.4 t -68.76 -22.48 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.511 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.2 tp -87.92 -47.01 8.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 0.0 110.218 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.484 HG23 ' SG ' ' A' ' 325' ' ' CYS . 27.9 m -55.02 -41.66 71.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.999 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.484 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.3 p -71.99 -17.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 111.58 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.56 -39.86 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.311 0.576 . . . . 0.0 110.458 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.47 -46.12 18.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.368 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -107.88 -12.32 15.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.61 0.243 . . . . 0.0 111.106 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 81.4 14.97 77.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.1 mt -109.26 114.55 57.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 122.628 -0.337 . . . . 0.0 110.86 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -72.07 116.27 4.64 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.527 2.151 . . . . 0.0 110.561 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 68.1 m -117.93 156.37 28.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.183 0.516 . . . . 0.0 112.101 -170.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.2 m -83.49 160.05 21.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.49 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.21 127.18 32.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.423 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.61 172.79 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.697 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 143.87 50.88 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.703 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.4 mm -63.03 111.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.813 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.5 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 116.12 -0.14 20.93 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.401 -173.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.475 ' HB3' HG11 ' A' ' 304' ' ' VAL . 66.0 m-20 -73.53 125.33 27.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.275 0.559 . . . . 0.0 110.755 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.0 OUTLIER -88.01 127.78 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.829 0.823 . . . . 0.0 112.041 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 42.0 t -89.51 131.08 35.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.73 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.8 mt -102.92 141.87 23.39 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.699 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 52.7 Cg_endo -89.13 170.26 4.94 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.844 2.362 . . . . 0.0 111.889 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 135.02 40.43 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.384 2.056 . . . . 0.0 111.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 98.76 -15.7 60.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.483 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -72.44 128.4 88.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.16 -31.27 54.29 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.123 3.216 . . . . 0.0 114.078 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.37 -24.0 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.249 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.44 85.07 3.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.95 -44.15 51.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.014 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -114.56 62.51 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 110.441 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.653 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 111.161 -0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.1 t -90.03 103.97 16.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.4 p -87.48 146.68 25.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.006 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.475 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -90.44 -38.3 10.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 109.607 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.413 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 82.8 t90 -157.1 128.73 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.25 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.672 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 38.7 t-80 57.83 -151.51 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.672 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 37.3 t -88.37 46.36 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.779 -0.576 . . . . 0.0 110.411 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -117.44 139.12 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.166 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.84 171.98 7.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.314 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.28 135.71 56.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.735 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.08 10.39 45.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.797 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.542 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 62.1 m -103.56 145.7 29.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.494 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.0 mpt_? -115.7 142.6 46.53 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.766 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 71.9 mt -118.91 148.6 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.697 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 7.7 m -156.96 96.53 1.61 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.444 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.413 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 3.8 m-85 -88.87 126.21 35.27 Favored 'General case' 0 C--O 1.228 -0.066 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -78.24 -9.7 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 110.467 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.542 ' HZ3' ' HB2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -62.03 -18.95 62.26 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.675 174.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.52 -166.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 6.6 t -93.74 49.51 1.36 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.931 -0.48 . . . . 0.0 111.098 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -77.14 75.57 3.7 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -86.04 -49.89 7.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.72 157.21 19.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.63 122.96 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -163.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.2 pt20 -100.55 157.85 16.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.58 162.8 15.47 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -58.17 -47.54 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 28.8 mt-10 -55.49 -23.8 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.72 -46.02 14.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.68 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.53 ' CZ ' ' HG3' ' A' ' 255' ' ' LYS . 88.0 t80 -75.16 -39.38 60.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.421 ' CB ' HG21 ' A' ' 211' ' ' ILE . . . -66.24 -26.06 67.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.29 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 41.8 ttm105 -67.57 -33.67 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.838 0.827 . . . . 0.0 109.474 174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.39 -8.72 59.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.029 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.513 ' HA ' ' HE2' ' A' ' 255' ' ' LYS . . . -70.15 -7.22 39.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.9 m -58.72 -45.83 88.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.72 82.98 5.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.893 ' HA ' ' HD3' ' A' ' 255' ' ' LYS . 6.5 p-10 -76.89 -8.95 58.3 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 111.58 -170.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -136.09 102.29 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.506 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.673 ' HG2' HD11 ' A' ' 249' ' ' ILE . 41.0 mt-10 -107.56 39.3 1.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 0.0 109.666 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.92 -33.69 74.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.699 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.43 -27.41 24.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.839 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.673 HD11 ' HG2' ' A' ' 246' ' ' GLU . 31.7 mt -69.92 -49.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.65 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -133.72 -61.73 0.79 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.587 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 50.3 tpp -160.79 -68.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.971 0.415 . . . . 0.0 110.81 -175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.32 101.32 0.16 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.892 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 246' ' ' GLU . 15.6 m -98.98 -66.56 0.89 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 80.6 t60 53.64 91.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.393 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.893 ' HD3' ' HA ' ' A' ' 244' ' ' ASP . 13.1 mptt -63.23 -7.91 7.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.014 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.61 9.75 61.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.978 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.603 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 13.9 t80 -60.56 115.75 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.37 0.585 . . . . 0.0 109.612 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 98.7 14.17 38.28 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.174 -1.013 . . . . 0.0 112.695 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 8.1 t -69.05 -14.76 63.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.106 0.479 . . . . 0.0 110.879 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -100.95 -28.89 12.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.392 0.615 . . . . 0.0 110.316 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.4 153.65 6.85 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.628 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -121.64 102.45 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -0.616 . . . . 0.0 110.462 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.4 ttpt -87.79 125.09 34.25 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.37 102.93 0.93 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.181 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.06 -52.94 8.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.743 0.306 . . . . 0.0 110.46 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.4 t -146.34 157.97 43.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.128 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.481 ' ND1' HD22 ' A' ' 280' ' ' LEU . 9.3 t60 -141.85 145.32 34.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.288 0.566 . . . . 0.0 111.289 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.598 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . 34.1 tt0 -137.79 141.41 40.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.693 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -102.33 99.06 9.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.8 t -113.66 178.14 4.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.607 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 6.5 p -133.8 119.69 33.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.323 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 t -117.45 115.86 26.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 55.76 33.95 22.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.29 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 98.6 -21.3 46.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.844 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.45 119.61 34.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.472 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 41.5 m -70.89 134.88 47.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.8 m -135.54 155.82 37.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.97 105.31 17.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.901 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' A' ' 268' ' ' GLU . 82.3 tttt -94.03 105.09 17.11 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.994 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.557 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 14.0 mt -115.64 132.22 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.966 0.413 . . . . 0.0 111.464 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 m -104.33 117.49 34.33 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.509 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 92.5 m-85 -105.41 168.65 8.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.096 0.475 . . . . 0.0 111.974 -171.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -137.43 136.77 20.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.511 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.603 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.4 Cg_endo -80.72 8.86 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.025 1.817 . . . . 0.0 112.451 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.65 -23.09 10.44 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 8.4 t -154.19 133.78 12.84 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.92 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.3 -7.21 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.296 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -56.95 -24.63 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.851 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.13 -46.96 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.561 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.72 148.84 4.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.99 152.54 45.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 110.617 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -133.11 117.04 17.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.431 ' N ' HD23 ' A' ' 292' ' ' LEU . 7.4 m -105.97 135.98 46.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.509 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 69.5 t -135.39 122.96 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.151 0.501 . . . . 0.0 111.135 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.508 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -107.49 110.06 21.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.327 -178.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.487 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.0 p -125.37 175.63 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.566 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -75.77 166.13 23.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.521 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.566 HD21 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -71.75 -18.01 62.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.61 -168.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -100.43 19.63 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.28 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.26 121.62 85.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.665 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.46 133.03 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.371 2.047 . . . . 0.0 111.626 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.487 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -119.4 121.7 40.11 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.943 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 28.0 t80 -76.23 102.15 5.7 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.752 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 332' ' ' ASP . 78.6 t -92.62 134.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.3 0.571 . . . . 0.0 111.097 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.535 ' HB3' HG11 ' A' ' 333' ' ' VAL . 63.9 tttp -62.08 127.23 30.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.241 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.0 m120 76.01 3.39 3.73 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.792 0.683 . . . . 0.0 111.947 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -123.95 -28.88 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 87.2 -153.74 25.69 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.06 115.04 4.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.03 0.443 . . . . 0.0 110.363 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.47 ' CB ' HG23 ' A' ' 328' ' ' ILE . 15.1 m -125.45 168.08 14.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.926 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -162.26 178.63 8.54 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.356 -0.215 . . . . 0.0 110.452 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.557 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 52.2 m-85 -95.94 -22.07 17.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.84 68.19 71.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 84.3 Cg_exo -48.92 -37.83 37.48 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 113.379 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 30.3 m -62.3 -31.28 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.084 0.469 . . . . 0.0 111.041 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.49 -44.15 11.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.437 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 m -56.42 -39.52 73.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.728 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.461 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.7 p -71.75 -23.51 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 -43.92 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 0.0 110.216 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.88 -54.29 7.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.245 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -99.34 -15.73 18.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.241 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 87.57 10.11 70.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.8 mt -109.72 117.73 51.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.583 0.191 . . . . 0.0 110.839 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 104.31 1.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.567 2.178 . . . . 0.0 110.405 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 64.3 m -102.45 156.5 17.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.196 -169.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 56.1 m -79.82 152.95 29.44 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.945 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -79.26 117.66 20.47 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.47 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -68.45 165.09 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 0.0 110.726 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -121.36 140.72 51.74 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.9 mm -55.48 112.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.147 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.48 3.58 20.58 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.139 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.471 ' HB3' HG11 ' A' ' 304' ' ' VAL . 50.8 m-20 -81.01 135.24 35.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.13 135.31 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.598 0.713 . . . . 0.0 112.129 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 60.2 m -100.82 135.53 42.12 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.742 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.74 142.0 23.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.353 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.78 165.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.214 2.609 . . . . 0.0 111.993 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.39 121.34 8.45 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.461 2.107 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 112.66 -11.2 25.6 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.446 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.3 127.22 86.74 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.7 -24.75 38.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.662 2.908 . . . . 0.0 113.935 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.23 -31.86 43.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.275 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.1 91.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 110.028 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 55.4 mt -74.58 -48.92 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.344 -176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.56 53.43 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.994 0.426 . . . . 0.0 110.673 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.023 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.1 t -95.45 94.82 8.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.325 0.583 . . . . 0.0 110.229 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.8 p -86.0 141.92 29.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.162 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.465 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.6 mm -88.36 -38.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.346 0.593 . . . . 0.0 109.72 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -156.15 135.93 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.386 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.544 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 18.8 t-80 53.53 -141.04 0.89 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.544 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 53.3 t -98.4 38.68 1.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.498 0.666 . . . . 0.0 109.931 176.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.55 139.35 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.241 0.544 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.4 173.17 7.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.383 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -62.57 137.57 58.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.113 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.76 60.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.096 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.1 m -82.54 145.64 29.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.41 139.3 49.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.382 0.61 . . . . 0.0 111.383 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 53.5 mt -113.45 148.01 36.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.193 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 228' ' ' ASN . 11.7 t -153.9 98.09 2.14 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.2 0.524 . . . . 0.0 110.653 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.88 116.27 19.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.762 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.851 ' HA ' ' HB2' ' A' ' 228' ' ' ASN . 11.2 m170 -64.17 -24.66 67.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.591 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 289' ' ' ASP . 39.2 tttp -70.46 -17.87 62.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.05 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.504 ' HB2' ' H ' ' A' ' 227' ' ' SER . 7.9 mt-10 -126.85 -101.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.115 0.483 . . . . 0.0 111.319 -176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.504 ' H ' ' HB2' ' A' ' 226' ' ' GLU . 15.5 t -93.27 65.4 3.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.665 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.851 ' HB2' ' HA ' ' A' ' 224' ' ' HIS . 3.2 t-20 -80.8 38.76 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.903 0.859 . . . . 0.0 109.733 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.575 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 18.7 pttp -112.82 -30.4 7.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.563 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.575 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 42.0 mt-10 -135.36 173.03 12.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.745 0.307 . . . . 0.0 110.283 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -107.67 137.3 45.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 9.4 pt20 -124.98 162.15 25.12 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.39 162.99 17.88 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.067 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -59.76 -44.41 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.77 -23.57 30.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.975 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.19 -53.95 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.225 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.559 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 67.2 t80 -68.89 -42.81 76.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.29 -41.13 75.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -65.0 -33.35 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.719 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -78.48 -39.15 39.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.379 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -90.72 17.2 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.738 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 33.0 p -76.1 -25.45 55.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.597 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 20.5 m -72.92 156.36 38.94 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.623 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.29 147.73 46.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 166.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 254' ' ' HIS . 2.2 p-10 -79.82 57.14 2.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -167.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -80.03 -17.51 52.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -79.72 -34.04 40.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.715 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 253' ' ' THR . 34.7 tt0 -141.89 67.5 1.33 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.265 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.75 -31.3 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 113.034 -1.893 . . . . 0.0 111.984 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -71.89 -54.19 10.84 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.219 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 47.2 ttp -91.74 -67.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.184 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 131.91 93.6 0.59 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.919 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 248' ' ' GLU . 14.5 m -76.15 77.47 2.97 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 245' ' ' ASN . 47.4 t60 -160.01 178.5 9.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -170.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -88.53 41.95 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.68 0.276 . . . . 0.0 111.013 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -91.36 -34.2 7.63 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.745 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 46.2 t80 -64.73 121.44 14.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.707 0.753 . . . . 0.0 110.491 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.72 24.14 50.75 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.0 t -78.01 -5.94 52.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.605 0.241 . . . . 0.0 111.59 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.04 -31.06 7.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.495 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 161.41 153.3 6.98 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.102 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.5 mp -121.2 103.69 9.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.904 0.482 . . . . 0.0 110.717 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 30.0 tttm -87.29 119.61 27.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.973 0.416 . . . . 0.0 110.558 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.78 113.31 2.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 283' ' ' ASP . 89.0 mt -87.43 -52.05 5.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.1 t -145.76 160.24 42.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.322 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -143.36 141.58 30.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 41.5 tt0 -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.478 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -100.97 124.08 46.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.4 m -146.22 167.71 22.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.917 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.31 129.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 12.3 t -131.99 119.82 21.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 56.48 39.35 30.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 111.298 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 81.12 -6.11 64.4 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.884 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -102.46 120.45 40.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.613 0.245 . . . . 0.0 111.147 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 34.1 m -66.74 127.66 33.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.981 0.896 . . . . 0.0 113.307 -172.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 92.8 mt -96.9 114.34 25.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.987 172.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.641 ' HB2' ' HZ1' ' A' ' 279' ' ' LYS . 4.5 ttmp? -97.84 109.9 22.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.448 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 16.4 mt -116.55 127.01 54.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.467 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 90.3 m -98.02 120.02 37.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.481 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.0 m-85 -105.41 161.74 14.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.462 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.416 ' HB2' HD23 ' A' ' 265' ' ' LEU . 37.4 t70 -125.8 132.08 24.2 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.524 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.468 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -80.59 11.11 3.03 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.302 2.002 . . . . 0.0 111.706 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.4 11.08 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.334 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -153.67 138.01 16.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.045 0.45 . . . . 0.0 110.354 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.81 -9.27 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.895 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -34.68 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.93 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 57.5 m-20 -78.71 -44.09 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.609 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.74 161.13 8.66 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.985 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.57 145.24 25.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.013 0.435 . . . . 0.0 110.645 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.66 122.52 27.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 99.6 m -115.79 136.39 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.6 t -129.76 136.42 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.192 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.47 120.99 39.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -136.89 169.88 17.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.046 -176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -64.82 161.86 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.403 0.62 . . . . 0.0 111.13 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -70.71 -18.09 62.81 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.503 -168.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.34 24.14 9.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.374 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.9 122.31 86.23 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.551 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.76 129.76 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.381 2.054 . . . . 0.0 111.999 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.469 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 93.7 m-85 -116.52 118.48 32.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 35.3 t80 -73.78 100.06 3.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.707 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 74.8 t -88.7 134.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.342 0.591 . . . . 0.0 110.743 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.512 ' HB3' HG11 ' A' ' 333' ' ' VAL . 62.8 tttp -57.96 127.44 32.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.682 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.3 m-20 76.85 -2.79 2.62 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.036 0.835 . . . . 0.0 111.945 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -119.46 -21.2 7.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.758 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 78.21 -152.01 37.52 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.846 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.38 115.68 4.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 164.51 21.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.019 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -161.53 176.88 10.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.844 0.354 . . . . 0.0 111.25 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 328' ' ' ILE . 63.0 m-85 -87.58 -34.38 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.01 71.82 53.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 80.9 Cg_exo -52.09 -36.94 67.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.839 2.359 . . . . 0.0 112.756 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 5.9 p -63.55 -29.35 70.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.2 0.524 . . . . 0.0 111.299 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.26 -47.42 8.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.8 m -56.5 -41.3 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.366 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.452 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 14.7 p -69.06 -21.33 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 111.68 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 73.1 t -91.28 -29.51 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.567 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.82 -52.15 5.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.966 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -99.92 -6.46 26.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 74.4 20.34 79.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.6 116.18 36.93 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.645 0.222 . . . . 0.0 110.798 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.98 106.31 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.729 2.286 . . . . 0.0 111.238 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.7 m -106.53 151.2 25.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.038 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 65.2 m -79.66 147.97 31.8 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.858 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.14 134.28 51.46 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.958 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.487 HD13 ' CD2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -88.44 171.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.143 0.496 . . . . 0.0 110.101 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -132.57 156.71 46.37 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.72 110.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 115.47 4.05 20.21 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.845 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.74 127.57 32.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.444 0.622 . . . . 0.0 110.341 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.9 p -90.92 136.97 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.862 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.9 m -102.32 134.91 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.387 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 66.1 mt -101.93 145.91 31.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.12 165.25 8.46 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.988 2.459 . . . . 0.0 112.49 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.404 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 49.6 Cg_endo -69.26 122.64 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.645 2.23 . . . . 0.0 111.755 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.68 -17.6 27.82 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.706 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -65.99 125.64 90.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.48 -21.67 72.52 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 123.01 2.473 . . . . 0.0 113.128 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.63 -23.16 29.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.586 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.19 99.12 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.46 -45.31 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.206 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -124.44 84.96 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.279 -0.263 . . . . 0.0 110.879 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 2.1 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.46 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.718 -0.532 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -94.3 93.06 7.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.342 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -85.31 140.23 30.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.992 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.473 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.8 mm -91.78 -43.18 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 109.886 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -149.8 126.86 11.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.594 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 26.2 t-80 59.74 -149.59 0.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.594 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 43.8 t -90.68 36.15 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.367 0.604 . . . . 0.0 110.414 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 294' ' ' VAL . 62.5 m-85 -106.39 141.48 37.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.213 0.53 . . . . 0.0 111.059 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.88 170.38 8.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.367 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -67.16 131.39 45.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.82 7.72 41.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.905 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.484 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.3 m -97.89 150.2 21.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -114.95 143.07 45.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.771 0.32 . . . . 0.0 110.6 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 73.8 mt -120.71 147.66 44.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.605 -171.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 38.2 t -155.29 102.7 2.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.526 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.417 ' CD2' HD22 ' A' ' 292' ' ' LEU . 7.4 m-85 -90.08 128.06 36.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -75.13 -15.79 60.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.5 -32.61 74.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.889 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -111.57 172.56 6.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.734 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.7 m -88.47 41.03 0.99 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.411 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.424 HD22 ' HB3' ' A' ' 232' ' ' GLN . 66.2 t30 -119.61 87.57 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 110.06 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.14 -42.8 30.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.126 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.15 146.61 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.604 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -75.18 126.96 32.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.898 -170.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.3 pt20 -107.78 160.81 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.951 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -83.56 159.38 21.66 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.471 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.484 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.8 t -57.95 -51.45 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.2 -23.46 22.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.837 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.84 -52.33 11.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.382 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.33 -39.95 62.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.201 0.525 . . . . 0.0 110.486 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.415 ' CB ' HG21 ' A' ' 211' ' ' ILE . . . -64.1 -26.3 68.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.877 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -73.07 -34.82 66.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 109.714 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -43.01 84.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.538 0.685 . . . . 0.0 109.929 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -93.41 29.55 1.93 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.096 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 26.5 t -49.96 -60.97 2.42 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.174 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.427 ' HB2' ' OG1' ' A' ' 253' ' ' THR . 7.5 m -62.5 151.89 36.17 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 254' ' ' HIS . 48.2 m-20 -77.11 -39.58 48.97 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.464 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.5 p30 176.03 133.72 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.086 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.8 43.41 1.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.549 0.69 . . . . 0.0 109.341 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.53 1.09 51.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.854 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.1 -29.69 60.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.7 mt -77.26 -51.85 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.089 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -174.8 -58.09 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.918 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 41.5 ttm -170.61 146.09 2.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -158.73 -104.06 0.2 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.857 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.427 ' OG1' ' HB2' ' A' ' 243' ' ' CYS . 0.8 OUTLIER -80.56 -92.25 0.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 16.1 t-80 69.12 109.17 0.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.031 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -52.88 -40.5 63.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.941 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 77.37 -79.78 1.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.791 -0.641 . . . . 0.0 114.157 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.527 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 52.6 t80 -80.46 131.42 35.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.391 0.596 . . . . 0.0 111.739 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 78.56 25.17 61.34 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.2 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 52.7 p -76.64 -8.98 58.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.573 0.687 . . . . 0.0 111.878 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -110.18 -30.23 7.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.541 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 165.26 158.01 10.24 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.821 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -126.3 101.48 6.75 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.082 0.553 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.9 ttpp -87.7 119.59 28.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.291 0.567 . . . . 0.0 110.686 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.78 107.39 0.96 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.237 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.2 -48.26 12.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.35 . . . . 0.0 110.765 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.1 t -152.69 164.88 36.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.149 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.525 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 9.9 t60 -146.4 138.74 25.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.375 0.607 . . . . 0.0 111.992 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.626 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 10.2 tt0 -133.04 140.65 47.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.413 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.525 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 10.1 mt-10 -108.56 108.64 19.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.381 0.61 . . . . 0.0 110.323 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.2 t -126.8 179.17 5.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.731 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.59 131.23 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.2 t -133.13 121.01 21.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 58.52 36.44 25.23 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.3 -15.01 47.54 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.068 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.8 122.02 41.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 111.2 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.8 m -67.62 133.72 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.597 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.62 154.06 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.791 0.805 . . . . 0.0 112.486 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.88 108.18 19.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.394 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.626 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 2.3 ttmp? -92.29 108.34 19.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.432 HD22 ' ND1' ' A' ' 267' ' ' HIS . 14.7 mt -116.0 120.02 37.78 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.655 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 8.8 m -90.97 116.48 28.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.478 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 69.6 m-85 -105.25 167.82 9.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.359 0.599 . . . . 0.0 112.433 -171.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.44 134.62 21.28 Favored Pre-proline 0 C--O 1.217 -0.606 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.458 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.527 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -77.64 9.6 2.87 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 121.557 1.505 . . . . 0.0 112.169 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.95 -5.43 56.38 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -154.64 135.42 13.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.352 0.596 . . . . 0.0 110.766 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.44 -8.04 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.32 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.27 -39.92 80.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.583 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -82.45 -46.75 13.07 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.392 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 136.24 176.67 14.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.77 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.74 150.88 24.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.884 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.422 HD21 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -136.45 121.04 18.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.422 ' N ' HD21 ' A' ' 292' ' ' LEU . 14.1 m -108.36 134.27 51.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.478 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 97.3 t -129.47 128.58 66.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.101 0.476 . . . . 0.0 110.881 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -113.97 107.88 16.28 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.455 -177.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.5 p -123.6 173.14 8.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.093 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -75.88 163.29 27.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.674 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.6 mm? -65.6 -14.32 60.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.066 -170.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.02 11.13 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.784 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.21 118.97 73.92 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.151 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.81 133.29 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.405 2.07 . . . . 0.0 111.814 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.49 119.58 34.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 25.7 t80 -74.51 107.19 6.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.518 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 332' ' ' ASP . 57.0 t -94.89 133.39 35.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.309 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.715 ' HB3' HG11 ' A' ' 333' ' ' VAL . 55.4 tttp -63.95 128.92 37.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.575 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 6.4 m-20 75.39 12.73 3.18 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.98 0.8 . . . . 0.0 112.027 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -133.51 -48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.015 0.436 . . . . 0.0 111.268 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 105.97 -156.45 16.43 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -171.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -61.3 114.58 3.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.312 0.556 . . . . 0.0 110.678 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.422 ' CB ' HG23 ' A' ' 328' ' ' ILE . 19.5 m -128.92 166.46 19.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.257 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -161.36 175.07 12.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.252 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.44 ' CE2' HD13 ' A' ' 328' ' ' ILE . 76.6 m-85 -88.48 -37.42 15.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.743 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -122.53 77.17 46.05 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.895 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -58.18 -31.41 93.34 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.975 2.45 . . . . 0.0 113.114 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 40.4 t -75.8 -21.2 57.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.341 0.591 . . . . 0.0 110.073 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.88 -48.6 7.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.217 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -51.49 -40.3 59.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.054 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.2 p -74.79 -29.54 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.209 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.36 -37.45 79.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.63 0.729 . . . . 0.0 110.319 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -100.8 -38.94 8.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.047 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -107.18 -3.63 19.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.142 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 69.35 16.16 71.04 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.942 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.72 109.6 52.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.666 -0.314 . . . . 0.0 110.588 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.74 118.03 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.737 2.291 . . . . 0.0 110.211 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.0 m -116.76 160.52 20.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.302 0.572 . . . . 0.0 112.494 -168.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.2 m -81.09 166.66 20.52 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.976 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -93.26 129.35 39.36 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.44 HD13 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -73.6 168.3 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.258 0.551 . . . . 0.0 110.696 -177.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -125.23 142.18 51.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.56 114.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.079 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.27 -4.24 20.13 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.159 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.475 ' HB3' HG12 ' A' ' 304' ' ' VAL . 54.2 m-20 -73.63 132.87 43.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -95.3 134.36 33.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.171 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.9 t -96.14 133.06 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.401 -176.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 83.6 mt -102.04 140.58 21.3 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.39 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.59 163.68 9.37 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.933 2.422 . . . . 0.0 112.152 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.57 122.58 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.587 2.192 . . . . 0.0 112.023 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.97 -7.17 41.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.426 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -74.44 125.83 89.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.71 -22.13 51.13 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.451 2.767 . . . . 0.0 114.233 -171.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.76 -28.47 44.81 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.726 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.05 85.3 2.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 86.4 mt -70.71 -43.89 76.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.892 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -124.05 81.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.534 -178.795 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.2 t -110.44 99.02 8.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.035 0.445 . . . . 0.0 110.067 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.5 p -84.07 150.49 25.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.895 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.481 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.0 mm -90.35 -40.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.702 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.477 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 85.7 t90 -150.14 125.94 10.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.577 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 28.6 t-80 60.94 -138.54 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.577 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 43.8 t -95.4 32.38 1.78 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.252 0.548 . . . . 0.0 110.32 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -107.48 137.73 44.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.399 0.619 . . . . 0.0 111.645 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.71 178.75 4.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.284 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -63.06 144.62 56.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.262 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.54 11.71 63.76 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.399 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.539 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 44.9 m -101.88 145.74 28.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.404 ' O ' HG11 ' A' ' 294' ' ' VAL . 1.0 OUTLIER -111.81 136.29 51.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.727 0.299 . . . . 0.0 110.594 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.42 144.18 43.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.727 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . 0.537 ' HB3' HD21 ' A' ' 228' ' ' ASN . 8.5 m -154.08 93.92 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.08 174.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.477 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 11.7 m-85 -80.67 126.6 31.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -75.42 -12.44 60.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.052 0.453 . . . . 0.0 110.066 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -60.06 -30.17 69.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.633 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -114.95 169.93 8.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.935 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.3 m -74.45 69.19 1.64 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.989 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 222' ' ' CYS . 20.3 p-10 -65.7 101.12 0.59 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 121.772 0.796 . . . . 0.0 111.458 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -91.67 -45.71 8.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.532 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -118.93 161.35 20.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.234 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -80.74 113.0 18.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.416 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -96.38 153.21 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.67 158.35 20.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -55.68 -49.73 72.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.424 0.631 . . . . 0.0 109.84 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.25 -23.24 55.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.762 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.37 -58.03 3.53 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.995 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -62.65 -48.27 80.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.123 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.08 80.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.632 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -83.68 -22.95 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.945 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.63 -29.85 20.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.56 90.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.774 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 253' ' ' THR . 34.6 p 178.77 -177.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.463 0.477 . . . . 0.0 110.395 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 41.8 m -90.12 -33.24 16.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.644 ' HA ' ' HZ3' ' A' ' 255' ' ' LYS . 25.9 t70 179.52 -28.9 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.522 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -165.98 91.48 0.48 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.66 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.655 ' HB2' HG23 ' A' ' 253' ' ' THR . 6.6 mm-40 -107.67 38.86 2.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.64 -26.93 67.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.905 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -70.44 -24.75 62.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.037 0.446 . . . . 0.0 110.365 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.611 HG23 ' HG2' ' A' ' 250' ' ' GLN . 61.9 mt -68.08 -45.17 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.726 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.611 ' HG2' HG23 ' A' ' 249' ' ' ILE . 22.5 mm-40 -131.99 -85.05 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -176.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -170.05 -69.09 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -101.92 102.84 2.4 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.915 HG21 ' HB3' ' A' ' 242' ' ' SER . 2.4 m -137.91 73.99 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.5 0.667 . . . . 0.0 109.426 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -152.1 158.9 43.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.989 -169.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.644 ' HZ3' ' HA ' ' A' ' 244' ' ' ASP . 12.2 mptt -69.78 44.14 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.591 0.357 . . . . 0.0 111.124 174.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.03 91.34 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.56 115.34 4.6 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 117.8 0.8 . . . . 0.0 110.544 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 91.11 14.92 56.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.447 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.6 t -68.5 -12.99 62.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.093 0.447 . . . . 0.0 111.795 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -102.96 -32.54 9.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 0.0 109.977 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.56 160.73 10.51 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.427 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 4.4 mp -123.67 100.53 6.83 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.455 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.9 ttpt -82.18 122.36 27.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.009 0.433 . . . . 0.0 110.173 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.482 ' CD1' HD23 ' A' ' 280' ' ' LEU . 46.1 tp -64.28 103.19 0.6 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.897 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.471 HD22 ' HB2' ' A' ' 283' ' ' ASP . 59.1 mt -81.94 -44.16 17.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.761 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 t -151.91 152.13 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.329 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.5 t60 -135.52 137.71 42.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.471 0.653 . . . . 0.0 111.466 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 34.1 tt0 -129.48 140.46 51.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.969 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.555 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 21.7 mt-10 -115.33 103.52 10.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.272 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -120.38 174.28 6.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.78 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 271' ' ' VAL . 6.2 p -115.3 104.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.809 0.814 . . . . 0.0 109.047 177.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.4 t -93.72 104.68 16.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 57.94 17.79 4.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.476 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 123.85 -15.34 7.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.929 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.98 122.73 47.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.198 0.499 . . . . 0.0 111.472 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.0 m -62.52 128.06 34.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.44 155.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.852 0.834 . . . . 0.0 112.785 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.551 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 82.8 mt -93.13 108.0 19.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.838 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 49.5 tttm -103.64 106.89 17.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 282' ' ' PHE . 9.6 mt -111.91 140.85 46.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.24 -173.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 21.9 m -112.92 116.07 29.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 280' ' ' LEU . 86.6 m-85 -108.96 161.76 14.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 17.6 t70 -121.54 132.34 24.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.118 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.74 10.18 3.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 113.047 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.99 -17.72 51.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.894 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -145.46 128.32 16.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.291 0.567 . . . . 0.0 110.24 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 -11.01 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.244 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.44 -31.31 72.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.096 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.96 -46.48 15.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.712 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 131.06 -163.42 23.5 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.988 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 mt -108.85 165.07 11.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.728 0.299 . . . . 0.0 110.858 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -136.18 119.58 16.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.3 m -108.88 135.82 49.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 53.2 t -136.71 136.1 48.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -100.64 124.25 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.21 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.0 p -136.86 170.79 15.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.652 0.263 . . . . 0.0 110.482 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -81.5 165.85 20.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.246 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.581 ' H ' HD23 ' A' ' 298' ' ' LEU . 2.0 mm? -67.85 -17.78 64.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.51 -172.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -105.3 22.05 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.299 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -78.76 119.04 75.82 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.45 137.23 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.0 111.94 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.441 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 88.4 m-85 -123.98 120.63 33.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.493 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 46.5 t80 -75.87 110.25 10.16 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.239 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.523 HG12 ' HB3' ' A' ' 332' ' ' ASP . 51.8 t -99.05 137.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.412 -175.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -57.53 126.43 27.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.236 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 28.5 m120 75.72 -6.84 1.91 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.377 0.671 . . . . 0.0 112.33 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -114.74 -20.76 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.813 0.34 . . . . 0.0 111.527 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.66 -152.63 41.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.765 0.317 . . . . 0.0 110.419 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 19.8 m -129.01 166.2 19.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.988 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 12.4 t -161.94 -178.58 6.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 280' ' ' LEU . 69.8 m-85 -95.65 -35.91 11.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.63 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.71 70.92 48.73 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.29 -35.62 96.61 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.263 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.6 p -68.03 -20.82 65.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.246 0.546 . . . . 0.0 110.511 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.0 tp -88.15 -44.04 11.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.114 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.2 m -55.05 -39.79 69.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.567 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 11.3 p -71.23 -23.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.73 -39.2 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 110.098 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -80.12 -58.35 3.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.027 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -92.95 -25.46 18.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.916 0.389 . . . . 0.0 111.312 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 90.36 22.09 35.85 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.064 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 61.4 mt -115.41 114.55 42.73 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.96 103.71 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.79 2.327 . . . . 0.0 110.768 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 48.1 m -103.85 156.99 17.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.376 -168.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.9 m -81.56 165.34 21.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.61 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -92.25 124.16 36.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.438 HD12 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -67.8 165.3 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 -175.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -122.79 138.9 54.5 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.82 112.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.057 0.456 . . . . 0.0 110.344 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.07 6.11 19.01 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.185 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.523 ' HB3' HG12 ' A' ' 304' ' ' VAL . 5.7 m-20 -81.05 134.53 35.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.0 111.594 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 2.4 t -79.63 125.58 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.419 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 72.5 m -94.49 119.58 33.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.4 mt -100.99 141.59 22.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.83 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.472 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 78.2 Cg_endo -86.67 166.1 8.92 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.253 2.635 . . . . 0.0 112.442 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.75 115.45 4.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.676 2.251 . . . . 0.0 111.805 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 119.49 -16.57 10.51 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.313 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -67.7 127.25 93.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.22 -24.63 51.55 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.569 2.846 . . . . 0.0 114.211 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.26 -35.16 48.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.618 0.247 . . . . 0.0 110.647 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.53 86.41 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 110.136 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.5 -53.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.17 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.97 74.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.367 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.048 178.314 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.652 -0.557 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -92.08 103.69 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 110.167 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 p -84.58 141.31 30.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 8.9 mm -85.85 -42.79 16.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.293 0.568 . . . . 0.0 109.657 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -154.65 128.69 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.908 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.667 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 44.7 t-80 57.63 -149.67 0.46 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.667 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 34.2 t -88.61 43.75 1.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.688 -0.632 . . . . 0.0 110.397 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.421 ' CZ ' HG22 ' A' ' 294' ' ' VAL . 65.3 m-85 -114.31 138.53 50.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.201 0.524 . . . . 0.0 111.274 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.4 176.09 5.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.328 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.498 ' HG3' ' CD ' ' A' ' 235' ' ' GLU . 88.1 tttt -62.54 141.99 58.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.292 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.26 4.7 64.27 Favored Glycine 0 CA--C 1.517 0.178 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.401 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.1 m -94.69 149.15 21.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -113.44 143.32 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.96 0.409 . . . . 0.0 110.973 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.432 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 63.5 mt -118.18 148.94 41.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.076 -174.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 229' ' ' LYS . 35.0 t -154.13 101.33 2.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.996 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -86.38 98.06 10.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 291' ' ' LEU . 22.6 m170 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.781 ' HA ' ' HA2' ' A' ' 290' ' ' GLY . 40.2 tttp -48.34 -40.66 26.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.986 173.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.69 -168.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.6 p -82.67 42.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.936 0.398 . . . . 0.0 110.684 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 222' ' ' CYS . 22.3 t-20 -122.38 96.79 5.18 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.602 0.715 . . . . 0.0 111.07 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.687 ' HA ' ' SG ' ' A' ' 222' ' ' CYS . 0.0 OUTLIER -115.41 19.58 15.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.841 0.829 . . . . 0.0 110.544 174.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -107.14 139.69 41.16 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.335 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.496 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 62.8 m95 -74.29 130.27 39.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.368 0.604 . . . . 0.0 111.912 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 11.7 pt20 -132.15 156.41 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.989 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.79 154.27 38.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -58.29 -47.61 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 168.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.498 ' CD ' ' HG3' ' A' ' 217' ' ' LYS . 4.6 mt-10 -59.05 -21.59 59.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.501 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.0 -52.35 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.204 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.507 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.7 t80 -62.86 -48.45 78.99 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.011 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.05 -34.92 68.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.006 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 11.2 ttm180 -71.53 -45.11 63.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.518 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.6 63.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.494 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 255' ' ' LYS . . . -90.75 28.0 1.64 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.135 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.9 m -56.58 -29.84 62.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 168.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 1.085 ' HA ' ' HG2' ' A' ' 247' ' ' GLU . 7.9 p -73.49 116.37 13.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.415 166.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.6 -18.58 63.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 122.139 0.971 . . . . 0.0 108.642 175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.738 ' O ' ' HB ' ' A' ' 253' ' ' THR . 1.5 m-20 -136.11 -68.67 0.5 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.222 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.657 ' HG3' ' C ' ' A' ' 245' ' ' ASN . 8.5 mt-10 -154.68 18.61 0.46 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -161.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 1.085 ' HG2' ' HA ' ' A' ' 243' ' ' CYS . 0.1 OUTLIER -59.23 -48.19 82.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.118 0.417 . . . . 0.0 111.238 -171.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -105.8 -40.9 5.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.41 -69.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -168.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 246' ' ' GLU . 0.0 OUTLIER 179.49 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.026 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 56.0 ttp -75.63 68.21 2.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.188 0.518 . . . . 0.0 109.911 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.54 89.03 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.202 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.738 ' HB ' ' O ' ' A' ' 245' ' ' ASN . 27.6 m -153.03 -77.51 0.12 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 64.1 t60 65.12 114.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.808 0.692 . . . . 0.0 112.056 175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.576 ' HD2' ' HB1' ' A' ' 241' ' ' ALA . 47.6 mtpt -80.55 40.3 0.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -118.7 3.76 14.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.915 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.66 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 41.6 t80 -72.72 121.18 19.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.282 0.541 . . . . 0.0 109.594 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.28 15.97 59.74 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.418 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.9 p -69.11 -15.09 63.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.93 -26.59 10.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.49 156.74 8.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.638 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -123.88 100.11 6.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.392 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 76.0 tttt -84.42 124.4 31.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -65.36 104.59 0.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.52 -45.83 16.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.6 t -152.01 164.61 36.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.804 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.544 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.87 139.66 40.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.493 -168.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -146.31 140.98 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.283 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.76 109.81 21.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.047 0.451 . . . . 0.0 109.792 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -124.3 179.89 4.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.221 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.15 119.76 62.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 109.784 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 13.1 t -130.24 140.98 50.66 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 47.33 28.7 1.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.803 0.841 . . . . 0.0 111.922 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 95.82 -16.55 60.96 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.325 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -108.04 148.22 30.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.05 0.452 . . . . 0.0 111.509 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.6 m -67.54 128.97 38.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 172.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.01 155.63 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.826 0.822 . . . . 0.0 112.551 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.21 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.17 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -97.82 106.77 19.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 312' ' ' PHE . 20.5 mt -114.46 139.26 49.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.4 m -103.76 120.8 41.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.555 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.8 m-85 -109.39 163.75 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 31.9 t70 -132.75 137.56 30.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.846 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.66 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 93.5 Cg_endo -83.24 9.42 4.1 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.241 1.961 . . . . 0.0 112.674 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.42 -11.19 50.78 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -153.18 114.75 4.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.544 0.688 . . . . 0.0 109.718 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.21 -8.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.985 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.25 -23.18 66.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.905 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.76 -42.97 20.92 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.758 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 225' ' ' LYS . . . 141.7 153.52 5.95 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.992 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 224' ' ' HIS . 1.9 mt -73.15 155.18 39.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.011 0.434 . . . . 0.0 110.931 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.408 HD12 HG21 ' A' ' 294' ' ' VAL . 1.7 tm? -136.09 119.49 16.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 19.0 m -110.38 137.05 48.62 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.421 HG22 ' CZ ' ' A' ' 215' ' ' PHE . 90.9 t -130.73 134.93 61.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.159 -176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.496 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 32.8 mt-10 -117.83 120.66 38.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 172.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 3.9 p -137.44 172.32 13.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.636 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.21 162.04 23.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 110.777 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.4 mm? -69.72 -8.9 51.89 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.123 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -105.03 13.87 30.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.416 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -73.43 116.59 52.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.826 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.14 119.4 5.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.247 1.965 . . . . 0.0 111.584 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.65 119.38 38.85 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 12.1 t80 -74.27 106.35 5.87 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.507 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.0 t -94.45 134.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.349 0.595 . . . . 0.0 111.273 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.545 ' HB3' HG11 ' A' ' 333' ' ' VAL . 49.8 tttp -58.5 125.27 22.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.329 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.4 m120 78.08 -1.95 2.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.407 0.683 . . . . 0.0 112.196 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 38.9 mttp -117.75 -28.72 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 111.35 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.4 ' HA3' ' CZ ' ' A' ' 303' ' ' TYR . . . 86.15 -152.4 25.62 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.71 116.79 5.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.067 0.433 . . . . 0.0 110.091 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.409 ' CB ' HG23 ' A' ' 328' ' ' ILE . 16.5 m -128.66 166.23 19.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.368 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.5 t -160.85 171.74 18.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.805 0.336 . . . . 0.0 110.649 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.544 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 56.6 m-85 -86.23 -36.42 19.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.64 174.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -126.25 77.3 72.21 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.454 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 48.8 Cg_exo -57.08 -38.51 95.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.94 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 20.0 m -66.06 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.0 110.796 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.24 -47.25 9.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.995 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.424 HG23 ' SG ' ' A' ' 325' ' ' CYS . 33.9 m -56.62 -41.83 77.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.064 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.55 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 13.5 p -69.33 -20.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.707 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.01 -43.79 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -72.13 -51.56 20.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.076 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -101.49 -20.34 15.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.033 0.444 . . . . 0.0 111.026 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 86.28 24.09 41.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.409 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.2 mt -118.86 113.52 35.95 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.888 -0.183 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -71.2 117.02 4.94 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 110.305 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.424 ' SG ' HG23 ' A' ' 317' ' ' THR . 80.2 m -117.6 155.46 29.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.007 0.432 . . . . 0.0 112.1 -169.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.31 164.75 23.84 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.266 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -92.52 120.36 32.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.409 HG23 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.06 162.45 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.506 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -125.34 150.36 47.25 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.37 113.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.681 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.507 ' O ' ' HE3' ' A' ' 263' ' ' LYS . . . 115.87 1.36 21.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.018 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 23.9 m-20 -75.27 127.33 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.178 0.513 . . . . 0.0 110.433 174.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.63 133.98 30.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.407 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 53.6 t -94.82 131.25 40.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.235 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.3 mt -103.14 140.78 21.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.216 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.417 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.4 Cg_endo -86.81 167.34 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.88 2.387 . . . . 0.0 111.916 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.09 127.21 17.93 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 111.356 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 111.05 -18.22 26.32 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.431 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.517 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 12.3 t-80 -71.27 127.43 91.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.03 -22.28 73.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.255 2.636 . . . . 0.0 113.448 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.517 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 4.1 m-20 -78.17 -25.81 47.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.159 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.48 86.68 2.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.09 -45.66 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.766 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . 0.514 ' H ' ' HH ' ' A' ' 303' ' ' TYR . 3.8 t-20 -124.2 75.72 1.4 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.648 0.261 . . . . 0.0 110.459 -174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.574 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.656 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -103.86 89.45 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.233 0.539 . . . . 0.0 109.934 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -76.82 144.13 39.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.28 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.403 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.4 mm -81.33 -42.08 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.421 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 68.9 t90 -153.8 139.93 18.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.327 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.498 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 21.3 t-80 53.1 -137.54 1.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.518 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 52.1 t -100.35 35.03 2.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.488 0.661 . . . . 0.0 109.968 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.97 140.32 42.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.4 0.619 . . . . 0.0 111.656 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD21 ' N ' ' A' ' 216' ' ' LEU . 3.3 mm? -100.03 175.73 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.023 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -66.66 139.97 57.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.885 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.66 12.1 51.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.959 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.514 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 61.6 m -105.82 146.88 29.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -115.65 140.66 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.02 0.438 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 80.0 mt -114.53 145.08 42.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.107 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.35 109.1 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.463 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -99.58 115.5 29.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -65.04 -37.56 87.98 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -65.03 -27.55 68.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.887 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 228' ' ' ASN . 42.2 mm-40 -89.64 167.93 12.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 27.1 t -82.18 31.08 0.39 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.978 0.418 . . . . 0.0 110.389 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 226' ' ' GLU . 3.1 m-20 -120.94 70.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 -176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -3.7 58.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.507 0.67 . . . . 0.0 110.528 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -93.46 161.96 14.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.497 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.51 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 57.7 m95 -80.2 124.86 29.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.435 0.636 . . . . 0.0 111.822 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.7 pt20 -117.49 162.84 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.34 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -89.18 160.0 17.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.066 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -57.95 -47.9 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -55.26 -22.74 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.63 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.93 -56.99 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.641 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.583 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 80.6 t80 -66.55 -40.4 89.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -53.47 -50.98 64.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.754 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -56.08 -29.78 61.05 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.35 18.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.098 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.29 -40.8 11.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -170.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.2 p -90.02 63.26 5.86 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.37 -40.36 51.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.008 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.483 ' O ' ' HB ' ' A' ' 253' ' ' THR . 5.9 t0 178.52 -177.73 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.44 70.46 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.405 ' HB3' HD13 ' A' ' 249' ' ' ILE . 31.4 mt-10 -79.03 52.07 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.396 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.2 -12.61 52.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.379 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.1 11.43 16.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.115 0.96 . . . . 0.0 109.274 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 246' ' ' GLU . 7.3 mt -138.77 135.57 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -64.22 74.58 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.295 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 25.6 ttt -156.4 -48.2 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.578 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 64.39 70.17 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.919 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 244' ' ' ASP . 0.2 OUTLIER -65.59 -68.89 0.33 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' A' ' 255' ' ' LYS . 73.2 t60 59.85 -164.25 0.22 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.742 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 254' ' ' HIS . 6.0 tptm -97.96 26.35 5.29 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.521 -0.737 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 77.93 -174.64 54.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 114.929 0.731 . . . . 0.0 114.929 168.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.488 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 t80 -48.3 131.87 16.48 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.233 1.013 . . . . 0.0 111.874 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.38 42.68 3.91 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.827 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 21.8 m -79.1 -17.95 54.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -104.85 -29.49 10.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.478 0.656 . . . . 0.0 109.684 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 156.38 160.55 10.11 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.75 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -118.2 100.31 7.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.519 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.7 ttpt -83.9 117.05 23.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.214 0.53 . . . . 0.0 110.426 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.416 ' O ' ' HA3' ' A' ' 331' ' ' GLY . 3.2 tt -61.22 103.7 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.136 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 71.6 mt -78.4 -48.93 14.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.883 0.373 . . . . 0.0 110.444 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.9 t -151.94 167.18 29.2 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.408 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.535 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.6 t60 -141.1 139.81 34.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.294 0.569 . . . . 0.0 111.512 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 35.9 tt0 -133.66 144.37 49.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.808 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.535 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 25.6 mt-10 -115.85 133.19 56.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.814 0.34 . . . . 0.0 110.133 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 t -155.56 -179.62 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.701 -170.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.44 131.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 0.0 110.316 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 14.2 t -126.79 107.52 10.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.151 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 57.2 48.74 14.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.166 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 83.94 -12.58 52.9 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.175 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.04 125.35 51.45 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.652 -0.322 . . . . 0.0 111.02 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 67.7 m -64.45 134.73 55.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.56 155.6 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.972 0.891 . . . . 0.0 112.945 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.71 116.69 29.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.313 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 22.4 ttmm -107.29 114.08 27.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.487 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 26.9 mt -114.63 135.59 53.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.868 0.366 . . . . 0.0 110.344 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 12.4 m -97.64 115.57 28.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.541 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 61.7 m-85 -106.06 163.54 12.69 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -170.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -132.0 137.87 31.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.327 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.488 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 86.7 Cg_endo -87.03 11.13 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.341 2.027 . . . . 0.0 112.649 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.89 -12.73 56.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.27 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 t -153.49 134.87 14.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.974 0.416 . . . . 0.0 110.088 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.01 -8.52 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.525 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -55.07 -49.28 72.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.95 2.59 38.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 84.91 179.13 51.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.157 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mt -84.47 135.45 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.966 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 294' ' ' VAL . 1.3 tm? -111.37 120.12 41.13 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 25.4 m -112.73 135.92 52.91 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 96.2 t -132.27 135.42 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.743 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.51 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 83.2 mt-10 -107.52 120.4 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 169.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.578 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.1 p -131.88 173.37 11.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -74.68 164.9 26.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.644 0.259 . . . . 0.0 110.941 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.9 mm? -66.2 -28.84 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.336 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.73 26.11 5.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.293 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -77.63 116.77 60.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.485 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.44 125.15 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.256 1.971 . . . . 0.0 111.646 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.578 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -111.45 116.3 30.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.525 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 17.9 t80 -74.67 104.66 5.42 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.487 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.1 t -92.38 134.73 29.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.659 ' HB3' HG11 ' A' ' 333' ' ' VAL . 45.9 tttt -59.47 120.7 9.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.225 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.6 m120 74.45 6.9 4.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.004 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.462 ' HZ2' ' CG ' ' A' ' 332' ' ' ASP . 34.2 mttp -117.02 -30.41 5.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.002 0.429 . . . . 0.0 110.582 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.91 -155.8 23.32 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.47 116.09 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.033 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.456 ' CB ' HG21 ' A' ' 328' ' ' ILE . 15.6 m -124.83 167.47 14.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.077 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 39.9 t -160.57 165.86 30.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.818 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.487 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 60.3 m-85 -86.83 -16.55 35.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.281 173.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -142.11 73.35 22.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.73 -41.03 77.52 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.812 2.341 . . . . 0.0 112.581 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 14.6 m -60.42 -29.04 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.27 -46.09 10.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.253 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.2 m -57.34 -41.24 79.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.158 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.5 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 12.5 p -68.82 -19.86 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 0.0 111.573 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.7 t -89.96 -45.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.075 0.464 . . . . 0.0 110.265 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -71.9 -58.7 3.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.314 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -95.75 -13.78 23.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 0.0 110.732 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 85.1 10.75 77.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.859 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.4 mt -108.82 117.56 53.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 122.741 -0.27 . . . . 0.0 111.008 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.89 116.76 4.83 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.513 2.142 . . . . 0.0 110.409 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.1 m -117.2 159.06 23.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.376 0.608 . . . . 0.0 112.462 -168.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 61.4 m -81.59 151.0 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.142 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 120.06 22.09 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.456 HG21 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.31 165.57 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.891 0.853 . . . . 0.0 111.413 -174.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -121.94 141.63 51.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.373 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.8 mm -58.09 113.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 109.673 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 264' ' ' LEU . . . 116.41 -0.92 20.56 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.78 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.462 ' CG ' ' HZ2' ' A' ' 307' ' ' LYS . 66.9 m-20 -71.33 124.77 25.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.208 0.527 . . . . 0.0 111.181 176.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.659 HG11 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -89.57 126.08 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.859 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.1 t -88.96 135.09 33.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.061 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 81.4 mt -106.37 144.07 28.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.631 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.3 160.61 13.11 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.474 2.116 . . . . 0.0 111.757 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.77 114.84 3.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.965 2.444 . . . . 0.0 112.25 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 115.29 -13.68 18.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.519 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.46 132.42 94.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.71 -31.1 49.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.105 3.204 . . . . 0.0 114.349 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -79.18 -23.12 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.99 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.07 95.76 3.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.066 0.46 . . . . 0.0 110.333 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.36 -42.27 81.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.855 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -139.62 98.14 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.091 -176.291 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 110.834 -0.487 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.6 t -103.52 110.63 22.75 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.5 p -94.9 150.76 19.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.287 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 253' ' ' THR . 32.5 mm -79.28 -45.96 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.376 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TRP . . . . . 0.629 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 78.5 t90 -151.36 136.71 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.445 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.632 ' ND1' ' H ' ' A' ' 214' ' ' CYS . 44.2 t-80 56.04 -133.54 1.49 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.632 ' H ' ' ND1' ' A' ' 213' ' ' HIS . 14.9 p -99.17 26.61 5.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.012 0.434 . . . . 0.0 110.867 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -105.61 135.41 47.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.952 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.57 174.84 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.424 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -64.31 139.34 58.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.847 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.77 12.05 44.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.138 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 30.8 m -102.38 158.18 16.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.24 151.59 42.15 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.416 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 56.5 mt -122.31 145.72 47.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.13 92.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.658 175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -78.61 123.02 26.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -67.95 -20.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 0.0 111.632 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -76.94 -7.56 55.78 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.834 0.349 . . . . 0.0 110.92 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -97.12 170.78 8.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.026 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.2 m -96.42 7.72 45.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.459 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -91.58 84.89 5.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -9.07 59.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.708 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -94.81 153.14 17.88 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' TRP . . . . . 0.443 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 88.3 m95 -74.08 120.04 19.12 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -100.09 158.97 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.532 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.05 164.35 21.46 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.163 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.1 t -66.27 -39.06 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.23 -22.05 64.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.503 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.69 -53.32 12.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.33 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.488 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 88.1 t80 -74.68 -40.31 61.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.236 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.4 76.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.842 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -67.76 -24.54 65.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.607 0.718 . . . . 0.0 109.909 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -80.6 -9.6 59.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.715 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.904 ' HA ' ' HZ2' ' A' ' 255' ' ' LYS . . . -80.69 -48.91 11.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.155 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 96.4 p 178.18 -145.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.58 -33.98 15.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.956 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -168.31 175.17 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -171.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 247' ' ' GLU . 17.8 p-10 -74.86 72.11 2.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.702 0.763 . . . . 0.0 109.622 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -76.05 40.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.628 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 245' ' ' ASN . 10.1 pt-20 -75.93 -16.32 60.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.059 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -82.85 -30.45 28.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.2 -56.41 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.529 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -168.17 -61.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.327 . . . . 0.0 110.413 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 53.7 ttm -161.29 148.16 14.76 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -165.45 -128.88 1.0 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.681 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 211' ' ' ILE . 9.2 m -61.8 -15.18 39.4 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.79 76.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 166.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.904 ' HZ2' ' HA ' ' A' ' 241' ' ' ALA . 22.0 tptt -62.66 -56.31 18.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.73 -162.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 150.98 -59.26 0.43 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.256 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.672 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 38.3 t80 -61.27 114.93 3.44 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.95 11.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.656 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.9 t -78.81 -24.82 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.704 0.288 . . . . 0.0 110.552 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -99.39 -25.37 14.49 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.39 168.0 17.83 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.646 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.424 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.04 102.79 7.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.771 -0.714 . . . . 0.0 110.138 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.651 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 75.5 tttt -87.49 119.12 27.45 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.0 110.796 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.51 107.87 0.74 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.163 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 283' ' ' ASP . 71.7 mt -83.13 -45.83 13.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.0 0.429 . . . . 0.0 110.48 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 32.8 t -151.88 156.33 39.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.211 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.415 ' ND1' HD22 ' A' ' 280' ' ' LEU . 5.8 t60 -139.12 138.22 36.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -131.57 141.46 49.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.397 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.28 129.61 53.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.1 t -148.47 178.52 8.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -118.3 122.94 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 109.763 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.8 m -115.29 94.27 4.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.31 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 57.9 65.73 1.25 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.347 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.85 22.14 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.589 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.94 122.93 49.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.992 0.396 . . . . 0.0 110.733 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.5 m -71.63 129.66 39.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.5 m -130.04 152.59 37.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 122.029 0.918 . . . . 0.0 112.897 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.64 112.87 24.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.591 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.556 ' HZ3' ' HB2' ' A' ' 279' ' ' LYS . 4.4 ttmp? -102.87 110.0 21.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' A' ' 312' ' ' PHE . 23.0 mt -115.34 129.73 56.69 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 87.7 m -98.94 117.17 32.84 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.424 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.0 m-85 -104.51 167.02 10.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.137 -170.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD22 ' A' ' 265' ' ' LEU . 21.9 t70 -132.34 134.52 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.413 175.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . 0.672 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.2 Cg_endo -83.72 12.11 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.143 1.895 . . . . 0.0 112.332 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.64 62.06 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -153.71 102.94 2.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.911 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.52 -15.28 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.421 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.16 -28.24 69.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.671 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -72.27 -40.5 67.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 110.161 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.85 152.72 5.98 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.422 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.26 147.76 28.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.221 0.511 . . . . 0.0 110.638 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 294' ' ' VAL . 1.5 tm? -125.05 118.32 25.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 83.8 m -110.3 134.0 52.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 292' ' ' LEU . 75.3 t -130.33 136.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.561 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 62.5 mt-10 -112.54 127.94 56.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.105 170.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.0 p -139.82 176.28 8.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.93 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.94 164.17 26.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.913 0.387 . . . . 0.0 110.329 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 298' ' ' LEU . 1.7 mm? -64.85 -17.84 64.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.245 -173.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.35 17.89 20.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.979 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.92 118.47 72.07 Favored Pre-proline 0 C--N 1.323 -0.563 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.339 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.58 139.82 16.36 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.104 1.869 . . . . 0.0 111.677 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . 0.464 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 80.9 m-85 -124.5 129.73 51.16 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.9 t80 -82.63 89.62 6.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.498 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.549 HG23 ' OD1' ' A' ' 332' ' ' ASP . 74.8 t -75.83 125.91 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.068 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.65 ' HB3' HG11 ' A' ' 333' ' ' VAL . 62.9 tttp -56.09 141.4 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.641 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.4 m-20 78.21 -20.04 0.41 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.47 0.708 . . . . 0.0 111.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -105.2 -60.53 1.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 111.345 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 125.76 -124.34 5.19 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.25 117.39 28.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.765 0.782 . . . . 0.0 110.606 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.8 m -131.8 167.88 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.23 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.3 t -161.34 -177.34 5.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.425 ' CZ ' HD23 ' A' ' 280' ' ' LEU . 71.6 m-85 -91.81 -39.09 11.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.22 73.2 57.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.877 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -57.17 -34.21 97.34 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.121 2.547 . . . . 0.0 113.213 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.8 p -65.35 -30.02 70.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.8 tp -83.15 -44.11 15.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.157 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -55.36 -44.16 75.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.151 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.461 ' O ' ' HA3' ' A' ' 322' ' ' GLY . 13.7 p -69.81 -27.04 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.541 -176.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.7 -38.52 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.285 0.565 . . . . 0.0 110.186 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.26 -58.19 3.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.051 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -98.97 -8.46 25.42 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 318' ' ' VAL . . . 76.25 21.44 75.62 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.2 mt -116.58 111.22 41.78 Favored Pre-proline 0 C--N 1.327 -0.394 0 O-C-N 122.876 -0.191 . . . . 0.0 110.646 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.33 117.95 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.582 2.188 . . . . 0.0 110.534 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 58.0 m -117.38 157.65 25.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.711 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 72.6 m -87.38 165.2 15.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.232 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.76 127.04 33.06 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.085 -0.384 . . . . 0.0 109.97 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.425 HD13 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -72.27 177.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 0.0 110.598 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -139.19 141.07 37.97 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.6 mm -52.34 112.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 109.575 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.49 9.13 15.27 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.735 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' A' ' 304' ' ' VAL . 0.2 OUTLIER -72.29 127.99 34.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.61 111.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.946 0.879 . . . . 0.0 111.051 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.7 m -79.24 127.84 32.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.112 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 69.5 mt -98.75 138.95 20.77 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.066 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' PRO . . . . . 0.48 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.6 Cg_endo -86.14 176.65 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.923 2.415 . . . . 0.0 111.734 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.96 155.1 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.255 1.97 . . . . 0.0 111.029 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.0 -23.14 5.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.564 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.47 ' HD1' ' HB2' ' A' ' 341' ' ' ASP . 21.7 t-80 -65.32 126.26 91.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -24.49 79.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.096 2.531 . . . . 0.0 113.152 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.47 ' HB2' ' HD1' ' A' ' 339' ' ' HIS . 4.4 m-20 -79.94 -25.15 40.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.497 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.21 84.87 3.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.392 0.615 . . . . 0.0 109.507 173.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.26 -44.54 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.639 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.74 44.24 1.94 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.93 0.395 . . . . 0.0 110.616 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.093 -178.345 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.0 t -96.9 93.39 6.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 110.222 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 23.7 p -87.72 144.2 26.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.808 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.504 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 13.8 mm -85.21 -37.95 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.32 0.581 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -151.91 131.38 12.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 18.4 t-80 58.62 -138.43 0.81 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 51.5 t -98.61 37.18 1.52 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 110.155 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -113.44 137.59 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.44 172.02 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.044 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.7 141.12 51.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.976 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.13 5.56 54.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.212 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 50.1 m -99.08 147.98 24.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.46 137.0 49.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.195 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 39.9 mt -113.12 144.06 43.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.257 -174.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 40.8 t -153.17 92.03 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.558 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.431 ' CD2' HD23 ' A' ' 292' ' ' LEU . 5.8 m-85 -86.43 123.1 31.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.1 m170 . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.849 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 75.2 m95 . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.9 pt20 -111.71 165.37 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -85.34 160.37 19.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 3.6 t -61.33 -45.21 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.6 0.714 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -58.12 -23.16 53.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.9 -52.01 11.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.009 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -68.11 -40.37 82.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.43 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.74 76.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.615 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.734 178.059 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.3 t80 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.76 19.31 44.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.388 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.4 t -66.92 -25.21 66.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.535 0.207 . . . . 0.0 111.312 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -99.17 -27.98 13.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.13 161.84 10.85 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.899 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -117.65 106.19 12.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.75 -0.725 . . . . 0.0 110.404 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.7 ttpp -90.56 119.32 30.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 -175.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 tt -60.08 113.13 2.17 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.09 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 95.4 mt -86.25 -52.14 5.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.452 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.2 t -148.57 158.98 44.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.783 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.495 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 4.1 t60 -135.71 136.24 40.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -127.3 139.52 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.571 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.495 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 28.5 mt-10 -108.95 106.4 16.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 110.063 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.637 -172.463 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.238 0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.82 152.95 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.992 0.901 . . . . 0.0 113.068 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.33 114.08 26.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.985 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.8 ttmt -107.09 116.12 31.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.433 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 34.1 mt -119.88 131.23 55.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.205 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.6 m -95.45 114.95 26.77 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.563 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.4 m-85 -100.99 164.93 11.58 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.337 0.589 . . . . 0.0 112.471 -171.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 6.6 t70 -133.19 129.12 20.75 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.019 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 287' ' ' VAL . 83.6 Cg_endo -81.44 9.12 4.01 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 122.155 1.903 . . . . 0.0 112.348 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 -47.97 0.99 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -124.53 98.19 5.63 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.547 ' HA ' ' HD2' ' A' ' 284' ' ' PRO . 5.2 p -67.52 -6.98 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.464 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.28 -12.6 61.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.538 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -66.2 -37.18 84.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.38 126.98 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.467 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 287' ' ' VAL . 1.8 mt -59.97 135.32 57.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.179 0.489 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.6 tm? -109.45 119.24 38.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 6.5 m -109.35 139.96 43.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 73.5 t -136.75 131.47 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -105.67 117.62 34.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.319 169.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 9.6 p -134.53 178.17 7.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.877 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -81.06 165.54 21.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.696 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -68.75 -22.91 64.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.839 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.76 19.62 15.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.241 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.23 120.04 79.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.351 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.5 136.46 13.93 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.482 2.122 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 79.9 m-85 -124.2 124.96 43.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 8.0 t80 -77.53 93.07 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 332' ' ' ASP . 65.8 t -80.47 130.34 36.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.581 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 56.6 tttp -56.39 133.9 53.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.824 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.8 m-20 78.95 -17.13 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.02 0.825 . . . . 0.0 112.283 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 327' ' ' GLU . 11.6 tttp -111.36 -41.86 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.073 0.463 . . . . 0.0 111.571 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 104.71 -155.13 17.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -61.66 113.61 2.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.96 0.41 . . . . 0.0 110.587 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.7 m -131.08 164.94 24.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.043 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 t -160.99 179.76 8.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.636 0.255 . . . . 0.0 110.771 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.433 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 67.3 m-85 -91.53 -34.32 14.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.07 70.31 40.77 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 42.4 Cg_exo -59.13 -30.49 93.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.792 2.328 . . . . 0.0 113.425 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 16.0 m -70.35 -25.31 63.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.9 tp -87.54 -42.36 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.296 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.2 m -53.87 -46.08 71.22 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.877 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.9 -27.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.14 -30.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 0.0 110.417 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -92.85 -38.58 11.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.613 -173.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -114.67 -4.02 12.81 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 122.118 -0.364 . . . . 0.0 111.859 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.01 78.87 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 48.1 mt -118.67 111.26 37.87 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 122.834 -0.216 . . . . 0.0 110.697 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.95 118.18 5.5 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.426 2.084 . . . . 0.0 110.82 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 85.0 m -117.76 153.94 32.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.3 0.571 . . . . 0.0 112.056 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 69.0 m -89.6 166.26 13.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.848 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 25.2 tt0 -77.02 125.16 28.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.315 0.246 . . . . 0.0 111.194 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -80.64 168.0 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.791 175.204 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -133.06 151.1 52.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.1 mm -59.41 111.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.269 0.557 . . . . 0.0 109.717 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.56 1.15 21.64 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.413 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 304' ' ' VAL . 16.8 m-20 -79.0 128.75 33.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.457 0.646 . . . . 0.0 111.047 176.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.8 137.91 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.796 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 55.6 m -103.44 133.76 47.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.302 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.0 144.9 29.52 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.258 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.2 Cg_endo -87.98 166.09 7.12 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.143 2.562 . . . . 0.0 112.624 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 119.07 6.02 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.623 2.215 . . . . 0.0 111.157 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 118.34 -19.35 10.79 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.611 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -69.32 127.44 92.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.98 -13.98 40.66 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.178 2.585 . . . . 0.0 113.115 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 32.9 t70 -90.31 -23.25 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.83 87.36 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.054 0.454 . . . . 0.0 109.786 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.84 -44.16 92.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.603 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -127.18 80.15 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.914 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.507 -178.29 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.614 -0.571 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.5 t -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.1 p -85.94 149.6 25.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.83 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.2 mm -79.23 -43.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -151.99 137.56 17.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.549 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 25.7 t-80 54.54 -136.53 1.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 47.8 t -100.25 37.6 1.64 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.145 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -111.12 137.14 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.347 0.594 . . . . 0.0 111.443 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.12 175.9 5.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.42 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -69.23 135.17 50.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.03 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.36 48.39 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.471 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.7 m -96.13 143.93 26.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.3 -0.45 . . . . 0.0 109.923 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -109.48 141.73 41.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.824 0.345 . . . . 0.0 110.548 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 46.5 mt -118.12 143.13 46.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.24 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.3 t -151.0 99.45 2.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.42 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.575 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 35.4 m-85 -91.97 132.41 36.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.7 m170 . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.76 -171.309 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 65.3 m95 . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 121.66 0.743 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 2.7 pt20 -128.66 161.21 30.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.685 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -82.06 158.1 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.423 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.6 t -58.25 -46.46 88.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.613 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 211' ' ' ILE . 25.6 mt-10 -57.55 -23.09 48.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.625 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.29 -45.94 14.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.0 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.75 -35.91 65.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.983 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.08 67.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.709 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 239' ' ' ARG . 34.0 ttm105 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.748 . . . . 0.0 109.691 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 121.018 0.437 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.15 27.52 12.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.022 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.0 p -68.84 -22.61 64.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -99.52 -27.15 13.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.26 0.552 . . . . 0.0 109.811 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 150.19 154.39 6.43 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.946 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 5.5 mp -113.25 98.66 7.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.952 -0.624 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 8.4 tptp -77.99 115.62 17.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.5 tt -59.84 111.74 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 283' ' ' ASP . 82.8 mt -83.13 -51.87 7.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.061 0.458 . . . . 0.0 111.061 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.8 t -148.54 161.81 40.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.161 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -141.59 150.38 41.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.027 -168.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.79 135.58 12.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.884 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -87.18 106.06 17.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.196 -168.147 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 m -134.6 157.07 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.695 0.76 . . . . 0.0 112.099 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 90.0 mt -94.18 109.66 21.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.467 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -96.35 112.36 24.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.665 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 279' ' ' LYS . 29.6 mt -121.42 142.75 49.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.527 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 32.3 m -108.26 117.04 33.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 96.2 m-85 -105.6 157.45 17.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.554 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.461 ' HB2' HD21 ' A' ' 265' ' ' LEU . 7.2 t70 -126.82 132.79 24.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.714 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.4 5.55 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.017 1.811 . . . . 0.0 112.174 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.7 -13.29 42.33 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.2 t -153.89 133.13 12.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.057 0.456 . . . . 0.0 110.156 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.0 -8.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.856 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.4 -23.2 63.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.314 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.87 -2.93 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.075 0.464 . . . . 0.0 110.248 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.07 169.95 29.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.949 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.71 152.16 19.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -126.4 120.47 29.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 292' ' ' LEU . 8.9 m -111.25 138.58 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 75.6 t -137.38 137.59 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.42 121.1 40.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.809 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -138.38 173.29 11.76 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -68.64 160.87 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.122 0.486 . . . . 0.0 111.23 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.711 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.62 -27.42 68.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.31 24.99 4.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.433 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -75.31 121.34 84.99 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.206 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.28 131.27 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.279 1.986 . . . . 0.0 111.805 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -121.82 116.62 24.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 29.1 t80 -73.25 108.69 6.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.896 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 74.1 t -99.12 137.96 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.427 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.718 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.0 tttp -56.78 124.46 18.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.792 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 87.3 m-20 77.95 -1.45 2.58 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.878 0.736 . . . . 0.0 112.177 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -117.16 -33.16 4.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 90.25 -157.13 25.64 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -60.87 113.02 2.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.294 0.547 . . . . 0.0 110.019 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.4 m -125.23 166.75 15.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.6 t -161.58 -178.58 6.68 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.413 ' CE1' HD11 ' A' ' 280' ' ' LEU . 33.3 m-85 -90.32 -41.48 11.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 110.292 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.35 77.31 68.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.948 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 60.4 Cg_exo -55.03 -38.7 93.27 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.042 2.495 . . . . 0.0 113.448 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 2.3 p -62.34 -24.96 67.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.253 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.74 -45.24 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.768 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.2 m -59.03 -39.78 83.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.094 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -70.31 -19.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.531 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.25 -40.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.295 0.569 . . . . 0.0 110.33 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.76 -58.28 3.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.771 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -95.51 -14.93 23.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.727 0.299 . . . . 0.0 111.284 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 84.33 10.31 80.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.876 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.8 mt -109.09 115.69 56.49 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.71 111.29 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.351 2.034 . . . . 0.0 110.184 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.8 m -108.48 157.18 18.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.987 -170.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 164.68 23.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.992 171.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.43 123.57 35.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.236 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.424 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.4 161.83 4.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.98 152.56 51.9 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 38.9 mm -54.87 114.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 0.0 110.742 -174.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.64 -3.59 19.69 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.714 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.418 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 4.2 m-20 -75.42 128.15 34.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.531 0.665 . . . . 0.0 111.161 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 305' ' ' LYS . 0.9 OUTLIER -87.48 131.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.586 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 42.3 t -95.14 134.7 37.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.975 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.62 145.34 30.84 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.154 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.9 Cg_endo -87.95 166.44 7.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.833 2.355 . . . . 0.0 112.188 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.88 126.3 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.588 2.192 . . . . 0.0 111.35 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.69 -12.99 35.49 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.773 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.11 131.44 81.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 -33.25 87.96 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.43 2.754 . . . . 0.0 113.504 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.26 -22.3 44.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.57 0.224 . . . . 0.0 111.051 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.8 84.36 4.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 98.8 mt -73.49 -46.2 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.245 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.54 52.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 110.284 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.83 -177.931 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 N-CA-C 110.688 -0.543 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.1 t -100.38 85.85 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.052 0.454 . . . . 0.0 110.18 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.2 p -85.78 142.02 29.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.7 mm -88.6 -45.34 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.203 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.504 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 78.8 t90 -151.64 130.12 12.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.529 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.4 t-80 55.68 -144.99 0.64 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 30.6 t -94.79 44.74 1.1 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.357 0.599 . . . . 0.0 109.898 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -115.38 136.66 52.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.298 0.57 . . . . 0.0 111.155 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.89 174.45 6.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.297 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -63.63 133.76 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.036 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.11 19.17 34.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.802 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.591 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.8 m -104.51 149.13 25.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 294' ' ' VAL . 8.9 mtt180 -113.6 138.67 49.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.93 0.395 . . . . 0.0 111.471 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 67.7 mt -117.6 145.93 43.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.973 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' CYS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 231' ' ' TRP . 9.1 t -156.46 95.57 1.58 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.871 0.367 . . . . 0.0 110.643 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -86.21 118.1 25.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 0.0 110.656 -178.01 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 222' ' ' CYS . 52.8 m95 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.066 0.46 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.5 pt20 -97.91 157.21 16.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.462 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.72 162.96 21.61 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.591 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -61.38 -51.34 74.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.145 0.497 . . . . 0.0 109.811 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 36.9 mt-10 -56.34 -22.88 33.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.585 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.33 -45.34 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 70.1 t80 -75.96 -41.04 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 0.0 110.474 176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.73 68.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 8.7 ttm180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.065 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.3 t80 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.49 67.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.978 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 53.0 m -70.15 -7.13 39.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.785 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -103.51 -31.58 9.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.275 0.56 . . . . 0.0 109.672 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.04 153.69 6.76 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.027 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.2 mp -119.17 103.33 9.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.604 0.361 . . . . 0.0 110.652 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 33.8 ttpt -86.7 123.73 32.18 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.004 0.431 . . . . 0.0 111.06 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.404 ' HG ' HD13 ' A' ' 280' ' ' LEU . 2.7 tt -65.36 97.75 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.654 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 283' ' ' ASP . 88.1 mt -71.63 -49.49 39.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.901 0.381 . . . . 0.0 110.461 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.1 t -151.46 165.95 32.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.274 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.758 ' HD2' ' HE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -131.44 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.618 -169.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -140.82 121.66 14.46 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.59 99.66 9.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.204 0.526 . . . . 0.0 109.841 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.6 t . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.92 -172.234 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.15 154.75 41.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.759 0.79 . . . . 0.0 112.421 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 84.6 mt -92.5 107.42 19.2 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.729 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.0 ttmt -106.69 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.469 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . 43.6 mt -118.19 135.45 54.24 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.3 m -91.47 110.28 21.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 90.3 m-85 -99.7 162.15 13.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.095 0.474 . . . . 0.0 111.48 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.421 ' HB2' HD21 ' A' ' 265' ' ' LEU . 22.1 t70 -130.65 135.25 27.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.316 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -81.28 11.12 3.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.162 1.908 . . . . 0.0 112.43 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.26 -8.87 62.87 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 t -153.33 106.02 2.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.481 -0.86 . . . . 0.0 109.537 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.94 -8.88 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.497 0.665 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.99 -26.31 68.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.104 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.34 -44.31 25.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.17 153.32 5.93 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.474 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -74.34 143.33 44.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.854 0.359 . . . . 0.0 110.592 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.06 118.75 28.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 140.84 41.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.9 t -134.14 131.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -104.19 118.6 37.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 12.3 p -136.13 165.33 25.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.668 0.271 . . . . 0.0 111.493 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -61.72 162.13 9.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.208 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.8 mm? -70.79 -21.31 62.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 -175.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.0 22.5 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.16 119.14 74.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.339 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.24 134.47 9.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.203 1.935 . . . . 0.0 111.713 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.513 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -120.71 119.4 32.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 35.8 t80 -75.13 93.55 2.8 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.23 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 71.5 t -79.87 138.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.728 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 333' ' ' VAL . 57.4 tttp -61.26 134.88 57.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.226 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 7.1 m-20 76.27 -33.36 0.21 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.562 0.745 . . . . 0.0 112.087 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -86.68 -43.86 12.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.787 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 98.18 -155.96 20.36 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.99 112.89 1.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.037 0.419 . . . . 0.0 110.459 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.428 ' CB ' HG22 ' A' ' 328' ' ' ILE . 17.7 m -129.84 165.66 21.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.697 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.3 t -161.57 -176.88 5.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.586 0.231 . . . . 0.0 110.389 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.758 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 36.6 m-85 -92.91 -40.93 10.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.88 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -120.99 76.38 30.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.298 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.1 Cg_exo -57.27 -35.51 98.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.908 2.405 . . . . 0.0 113.148 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 3.7 p -65.19 -26.06 67.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.8 -47.08 8.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.278 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.2 m -57.87 -38.6 76.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.103 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.569 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.6 p -68.79 -20.23 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 111.464 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.99 -49.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.269 0.557 . . . . 0.0 109.816 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -67.41 -55.59 13.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.158 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -100.68 -9.68 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.23 15.91 80.36 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.592 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.0 mt -110.87 114.49 54.22 Favored Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 122.846 -0.208 . . . . 0.0 110.798 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.49 104.64 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.57 2.18 . . . . 0.0 110.33 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.5 m -104.39 154.07 20.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.046 -169.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.7 165.1 23.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.946 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.36 123.91 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.219 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.2 160.92 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.086 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -134.16 154.68 51.07 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 49.3 mm -52.29 115.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.324 0.583 . . . . 0.0 111.426 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.28 -2.9 22.27 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.073 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.432 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 6.5 m-20 -75.29 124.58 27.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.305 0.553 . . . . 0.0 110.78 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -86.76 143.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 55.8 m -112.16 132.52 54.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.985 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.64 147.65 33.92 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.705 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 55.1 Cg_endo -91.89 170.33 2.87 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.495 2.797 . . . . 0.0 112.828 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.74 133.17 23.19 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.534 2.156 . . . . 0.0 111.38 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.74 55.85 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.629 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -77.73 125.2 86.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.95 -21.73 73.37 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.047 2.498 . . . . 0.0 112.823 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 34.0 t70 -80.0 -27.38 39.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.683 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.36 88.85 3.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.816 169.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 83.7 mt -71.74 -43.49 69.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.368 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -114.41 73.93 0.85 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.598 -178.65 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 N--CA 1.479 0.662 0 N-CA-C 110.118 -0.762 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -100.4 87.79 3.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -82.97 143.9 30.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.945 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.11 -42.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.34 0.591 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -148.08 135.21 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.167 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.52 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.9 t-80 55.15 -135.01 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.458 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 12.0 p -97.64 24.4 6.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -104.6 139.83 38.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 112.064 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 174.94 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.391 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.57 140.53 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.607 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.82 11.1 54.35 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.976 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.573 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 80.9 m -103.34 146.92 27.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -113.99 139.88 48.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.938 0.399 . . . . 0.0 110.779 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.532 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.6 mt -116.17 146.47 42.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.375 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.1 96.45 1.95 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.18 119.18 29.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.6 m170 . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.969 -178.201 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.409 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 89.3 m95 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 7.9 pt20 -108.96 161.55 15.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.541 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.13 162.91 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.43 -47.15 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.18 -22.22 50.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.75 -55.22 5.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.531 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.568 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 76.3 t80 -65.04 -41.0 95.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.83 -33.5 71.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.445 175.532 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 24.5 t80 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.116 0.484 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 106.48 6.94 35.28 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.549 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.9 m -67.1 -14.15 62.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 111.409 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.99 -30.82 11.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 0.0 109.294 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 149.3 161.15 9.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.526 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -122.6 99.1 6.22 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 122.483 0.313 . . . . 0.0 110.711 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 68.2 tttt -82.37 123.63 29.28 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.134 0.493 . . . . 0.0 111.525 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.97 95.35 0.26 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.584 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 283' ' ' ASP . 77.9 mt -71.47 -47.38 56.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 0.0 110.565 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.8 t -151.24 162.55 40.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.444 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.97 143.32 40.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.049 -168.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -149.57 137.49 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.366 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -98.99 97.17 8.35 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.445 -0.724 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.409 -171.287 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.8 m -132.17 156.85 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.661 0.744 . . . . 0.0 112.062 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.34 107.57 19.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.382 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.1 ttmm -98.94 106.25 18.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 312' ' ' PHE . 21.1 mt -112.95 138.04 50.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.529 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 4.1 m -103.09 110.19 22.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.465 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 92.1 m-85 -100.33 162.66 12.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.032 0.444 . . . . 0.0 111.849 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.441 ' HB2' HD21 ' A' ' 265' ' ' LEU . 14.6 t70 -128.89 134.44 26.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.14 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 76.8 Cg_endo -80.0 12.55 2.43 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.259 1.973 . . . . 0.0 112.291 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 -14.45 49.61 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 t -153.15 127.42 9.16 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.822 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.28 -8.45 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.215 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -50.74 -41.06 56.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.996 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -77.05 -43.51 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.89 167.51 11.52 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.67 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 83.2 mt -90.24 140.56 29.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 0.0 111.192 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -113.05 122.85 48.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.488 ' N ' HD22 ' A' ' 292' ' ' LEU . 20.8 m -111.67 135.18 52.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.0 t -133.06 136.27 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.066 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.409 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 52.8 mt-10 -115.57 121.94 44.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 109.772 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.5 p -138.56 175.34 9.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.748 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -70.03 158.21 36.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.998 0.427 . . . . 0.0 110.832 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.709 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.77 -17.07 63.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.282 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -97.49 13.58 29.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.88 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -72.26 120.98 83.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.574 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.85 141.52 13.46 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.239 1.959 . . . . 0.0 111.662 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.504 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.1 m-85 -127.84 127.27 43.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.551 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 31.2 t80 -80.09 96.32 6.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.34 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.6 t -82.31 130.88 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.907 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.462 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.1 tttp -55.86 134.21 51.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.35 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 83.1 m-20 77.64 -23.08 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.872 0.733 . . . . 0.0 112.202 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -96.08 -43.49 7.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.0 111.446 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.56 -126.27 8.43 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.24 118.47 29.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.804 0.802 . . . . 0.0 109.958 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 20.1 m -131.45 166.57 21.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.527 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.0 t -161.52 -175.57 4.84 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.454 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 48.2 m-85 -92.77 -41.45 10.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 0.0 110.403 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.53 76.64 45.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 77.6 Cg_exo -55.25 -31.48 76.58 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.246 2.631 . . . . 0.0 113.597 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 33.9 t -71.22 -23.21 61.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.257 0.551 . . . . 0.0 110.096 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 61.2 tp -87.89 -44.85 10.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.116 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.3 m -54.5 -41.03 69.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.028 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -73.41 -18.28 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 96.1 t -88.24 -35.64 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.317 0.58 . . . . 0.0 110.013 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.26 -53.23 5.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.128 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -103.84 -4.04 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 70.02 26.33 74.45 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.564 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.5 mt -116.63 110.97 41.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 122.753 -0.263 . . . . 0.0 110.59 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -71.79 115.83 4.46 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.493 2.129 . . . . 0.0 110.399 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 73.7 m -116.96 156.98 26.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.437 0.637 . . . . 0.0 111.977 -169.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 58.6 m -79.99 165.95 22.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.255 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.59 140.42 29.57 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.89 164.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.357 0.599 . . . . 0.0 110.62 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -118.78 142.35 47.78 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 30.8 mm -60.22 114.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 109.843 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.3 -4.24 20.07 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.956 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.537 ' HB3' HG13 ' A' ' 304' ' ' VAL . 70.7 m-20 -73.84 130.55 40.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.728 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.97 133.29 33.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.057 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 50.9 m -98.12 134.83 40.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.142 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 43.8 mt -108.94 142.06 24.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.041 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.2 Cg_endo -85.06 168.43 10.53 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.325 2.683 . . . . 0.0 112.362 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 56.6 Cg_endo -71.37 114.3 3.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.797 2.332 . . . . 0.0 111.687 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.01 -20.67 8.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.813 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -67.11 126.66 92.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.64 -27.25 50.28 Favored 'Trans proline' 0 N--CA 1.476 0.453 0 C-N-CA 123.721 2.947 . . . . 0.0 113.738 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.96 -22.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.326 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.14 85.99 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.254 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.63 -43.88 70.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.572 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -107.04 42.52 1.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 1.1 t80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.941 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.6 t -86.19 92.06 8.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.079 0.466 . . . . 0.0 110.161 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.7 p -79.15 147.07 32.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.5 mm -79.5 -45.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.62 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -149.4 132.73 16.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.0 t-80 57.19 -139.46 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 44.5 t -97.5 36.74 1.45 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.384 0.612 . . . . 0.0 110.202 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.56 140.73 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 111.701 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.99 170.83 8.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -67.57 133.68 49.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.957 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.17 44.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.49 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.575 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 87.7 m -86.65 142.07 28.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -110.62 136.78 49.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.172 0.511 . . . . 0.0 110.941 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.566 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 57.1 mt -112.41 147.48 36.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.967 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.0 t -150.87 93.01 1.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.97 0.414 . . . . 0.0 110.234 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CD2' ' HG ' ' A' ' 292' ' ' LEU . 78.3 m-85 -83.57 119.14 24.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.7 m170 . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.062 0.458 . . . . 0.0 110.559 -177.866 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 80.3 m95 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.176 0.512 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.706 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 10.0 pt20 -128.07 165.16 20.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.39 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.5 163.86 15.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.233 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.0 t -58.46 -51.5 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -58.01 -23.44 54.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.18 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 232' ' ' GLN . 31.9 t70 -73.58 -45.29 54.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.297 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.706 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.4 t80 -75.1 -45.41 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.49 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -55.72 -43.83 76.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.499 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 -179.446 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 23.0 t80 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.105 0.479 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.82 8.65 59.15 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.011 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.7 m -67.79 -15.86 63.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -102.88 -31.69 10.14 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 164.08 156.77 9.0 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.217 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.7 mp -119.97 103.75 9.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.709 -0.746 . . . . 0.0 110.163 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 21.8 ttpp -88.29 119.35 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.269 0.557 . . . . 0.0 111.339 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.401 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.7 tt -62.12 103.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.347 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 283' ' ' ASP . 86.7 mt -76.2 -49.17 17.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.898 0.38 . . . . 0.0 110.528 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 34.4 t -153.11 164.02 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.539 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -141.44 135.75 30.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 41.2 tt0 -130.14 137.54 50.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.245 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.39 124.43 34.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.628 -167.777 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.83 156.57 31.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.017 0.913 . . . . 0.0 112.861 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 79.1 mt -95.51 116.25 28.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.639 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 40.4 ttmt -100.65 112.25 24.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 19.3 mt -118.45 130.34 55.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 31.4 m -97.97 111.01 23.48 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.5 m-85 -96.94 162.48 13.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.332 0.587 . . . . 0.0 111.872 -172.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.451 ' HB2' HD21 ' A' ' 265' ' ' LEU . 4.1 t70 -127.85 127.45 23.94 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.49 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 80.0 Cg_endo -79.45 10.12 3.17 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.181 1.92 . . . . 0.0 112.067 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.7 -15.03 53.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.8 t -153.85 135.07 14.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.197 0.522 . . . . 0.0 110.667 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.32 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.131 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.87 -32.12 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.861 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -84.2 -47.13 11.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.524 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.43 159.49 7.96 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.794 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.1 151.17 25.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -119.68 123.4 43.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 26.0 m -110.27 130.92 55.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.51 131.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.384 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.52 118.38 34.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.453 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.6 p -134.58 164.0 28.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.732 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -66.17 157.85 30.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.364 0.602 . . . . 0.0 111.109 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.77 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.5 mm? -61.59 -23.83 66.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.212 -168.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.71 23.2 5.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.516 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.37 121.09 84.27 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.538 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.56 130.66 7.96 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.286 1.991 . . . . 0.0 111.609 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 90.8 m-85 -120.66 114.2 21.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 25.4 t80 -73.3 102.45 3.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.327 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 332' ' ' ASP . 55.2 t -88.7 136.04 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.255 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.656 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 54.4 tttp -57.93 124.46 19.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.905 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 76.81 -5.21 2.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.366 0.666 . . . . 0.0 112.392 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -110.85 -32.25 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.14 0.495 . . . . 0.0 111.403 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.92 -152.68 21.9 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -64.74 112.38 3.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 117.18 0.49 . . . . 0.0 110.382 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.4 m -125.33 165.26 18.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.0 t -161.48 -177.84 6.22 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 65.3 m-85 -93.0 -39.34 11.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.523 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -123.74 73.73 54.02 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.748 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.97 -37.05 93.75 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.176 2.584 . . . . 0.0 113.356 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.2 m -64.74 -25.75 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.232 0.539 . . . . 0.0 110.693 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.1 tp -87.25 -44.3 11.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.963 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.2 m -55.18 -41.86 72.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.993 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.8 p -70.77 -26.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.66 -35.16 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -84.32 -58.44 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.917 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.48 -10.98 24.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.04 25.65 61.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.615 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.6 mt -122.71 113.11 30.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 122.849 -0.206 . . . . 0.0 110.877 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.85 119.41 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.423 2.082 . . . . 0.0 110.365 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 68.2 m -117.37 156.11 28.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 112.141 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 57.5 m -79.71 164.45 23.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.104 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -93.76 115.79 28.23 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.491 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -66.46 165.23 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 111.229 -173.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -122.26 140.37 52.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.721 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.32 115.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.221 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.3 -2.27 22.27 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.908 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.442 ' HB3' HG13 ' A' ' 304' ' ' VAL . 44.0 m-20 -75.23 132.95 41.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.33 0.586 . . . . 0.0 111.34 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -93.68 135.16 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.964 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 51.1 m -100.81 132.69 46.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.463 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.424 HD11 ' OD2' ' A' ' 341' ' ' ASP . 76.0 mt -100.18 144.85 29.2 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.273 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 86.1 Cg_endo -87.63 165.04 7.78 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.099 2.532 . . . . 0.0 112.744 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.99 113.49 3.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.921 2.414 . . . . 0.0 111.572 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 124.83 -23.22 6.29 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.952 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -65.79 128.0 93.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.9 -20.24 64.31 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.127 2.551 . . . . 0.0 112.495 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.656 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 23.2 t0 -79.32 -26.03 42.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.967 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -72.16 98.89 2.22 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.53 -39.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.899 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.99 103.64 4.2 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.459 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.005 -178.756 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -107.99 109.41 20.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.0 p -96.28 147.4 23.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.384 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.73 -40.54 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.382 0.61 . . . . 0.0 109.817 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 71.4 t90 -156.7 134.52 10.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.924 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.473 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 27.3 t-80 57.5 -142.42 0.72 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 49.1 t -96.98 37.29 1.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.465 0.65 . . . . 0.0 110.157 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.89 133.32 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.59 171.55 8.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.546 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -61.57 131.15 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.933 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.13 12.55 31.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.286 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 52.2 m -103.5 149.94 24.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.6 mpt_? -119.67 144.73 47.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.937 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.4 mt -118.99 147.81 43.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.24 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 42.4 t -158.11 98.16 1.57 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.811 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.416 ' CD1' ' HG ' ' A' ' 292' ' ' LEU . 27.5 m-85 -81.86 126.26 31.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.8 m170 . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.835 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 70.2 m95 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.5 pt20 -97.32 155.42 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -82.53 161.8 22.21 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.0 t -63.59 -38.21 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -21.84 64.72 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.242 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -80.93 -50.33 9.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.443 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.477 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 63.8 t80 -65.84 -46.1 79.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.717 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.89 71.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 110.478 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.272 178.199 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 32.4 t80 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.14 55.88 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.494 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 50.7 m -65.56 -11.01 40.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -104.7 -34.16 8.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.285 0.564 . . . . 0.0 109.808 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 169.47 154.01 8.88 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.923 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.3 mp -122.63 99.82 6.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.778 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.703 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.5 ttpt -83.93 122.28 28.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.234 0.54 . . . . 0.0 110.942 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.437 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 2.3 tt -65.24 110.4 2.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.899 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 80.1 mt -85.12 -44.66 12.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.714 0.292 . . . . 0.0 111.161 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.6 t -153.12 157.19 40.01 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.96 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.3 OUTLIER -133.46 142.84 48.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.022 -170.229 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -149.23 125.95 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.73 120.8 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 -171.516 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.44 ' HB2' HD21 ' A' ' 298' ' ' LEU . 67.4 m . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.46 157.82 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.847 0.832 . . . . 0.0 112.566 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 95.8 mt -95.57 112.89 24.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.741 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.5 ttmm -99.39 105.5 17.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.542 HD11 ' HE1' ' A' ' 312' ' ' PHE . 22.1 mt -113.12 139.69 48.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.524 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.8 m -101.16 110.6 22.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.9 m-85 -100.85 158.53 15.91 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 0.0 111.685 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 9.7 t70 -124.94 135.96 27.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.362 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.576 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -83.44 9.81 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.948 1.765 . . . . 0.0 112.431 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.09 -6.15 53.59 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -153.26 125.19 7.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.343 0.592 . . . . 0.0 110.467 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -10.3 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.37 -35.45 80.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.919 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.17 -46.9 26.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.204 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.02 166.2 10.7 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.442 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.93 146.2 28.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.915 0.388 . . . . 0.0 110.686 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.451 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER -119.46 121.13 38.75 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.8 m -106.96 132.14 53.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 88.1 t -131.15 135.28 60.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.055 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -114.61 122.05 45.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.078 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.473 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.3 p -136.03 175.07 9.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 299' ' ' ASP . 10.5 mmmm -66.19 157.53 31.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.488 0.185 . . . . 0.0 111.056 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.834 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.1 mm? -60.8 -37.27 81.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.837 0.827 . . . . 0.0 109.677 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HB3' ' A' ' 297' ' ' LYS . 6.6 p-10 -80.79 24.52 0.48 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.08 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -82.92 119.65 74.73 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.347 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.06 132.8 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.078 1.852 . . . . 0.0 111.682 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.8 118.25 30.34 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 2.5 t80 -72.32 102.81 3.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.142 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.42 135.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.307 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.569 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.9 tttp -61.17 134.57 57.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 83.0 m-20 76.61 -6.45 2.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.531 0.732 . . . . 0.0 112.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.04 -47.75 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.64 -147.25 16.18 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' TRP . . . . . 0.461 ' HZ2' ' HA ' ' A' ' 345' ' ' PHE . 98.9 m95 -72.85 102.14 3.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.679 0.739 . . . . 0.0 110.974 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.499 ' CB ' HG22 ' A' ' 328' ' ' ILE . 5.6 m -106.47 172.51 6.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.737 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.1 t -163.04 179.2 7.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.532 0.206 . . . . 0.0 110.625 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.542 ' HE1' HD11 ' A' ' 280' ' ' LEU . 32.0 m-85 -92.84 -35.26 13.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 298' ' ' LEU . 93.0 m-85 -125.25 74.35 67.68 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 62.5 Cg_exo -55.09 -33.65 84.49 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.179 2.586 . . . . 0.0 113.534 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 35.9 t -74.85 -22.07 58.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.975 0.417 . . . . 0.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.6 tp -87.88 -45.75 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.502 . . . . 0.0 110.311 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -52.91 -37.17 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.974 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.69 -24.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.713 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.82 -33.81 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.0 110.456 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -101.99 -54.37 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.432 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -91.67 -8.05 48.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.161 -0.337 . . . . 0.0 110.736 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.58 16.94 76.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.378 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.8 mt -110.04 110.41 58.75 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.41 105.33 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.495 2.13 . . . . 0.0 110.445 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 84.4 m -101.47 159.18 15.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 112.369 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 1.4 p -85.83 159.68 19.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.416 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -79.93 125.61 29.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.499 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.82 168.36 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.386 -0.525 . . . . 0.0 109.816 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -133.37 146.67 51.48 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 41.3 mm -54.46 113.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.374 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.57 -4.37 19.52 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.419 -176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.52 121.42 17.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.155 0.502 . . . . 0.0 110.467 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -84.74 133.05 30.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.691 0.758 . . . . 0.0 112.115 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 47.3 t -95.39 134.79 37.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.376 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 69.1 mt -105.62 144.57 29.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.853 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -86.94 163.51 8.88 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.803 2.336 . . . . 0.0 112.142 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 121.42 8.73 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 112.047 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.01 31.98 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.491 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' HIS . . . . . 0.429 ' CD2' ' HD2' ' A' ' 340' ' ' PRO . 25.3 t-80 -75.18 134.08 74.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 339' ' ' HIS . 11.7 Cg_endo -54.73 -28.8 58.86 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.975 3.117 . . . . 0.0 114.0 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.27 -35.15 48.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -70.52 98.74 1.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.888 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.88 -45.66 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.256 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -131.18 94.51 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.461 ' HA ' ' HZ2' ' A' ' 309' ' ' TRP . 3.5 t80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.594 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.481 0.78 0 N-CA-C 110.769 -0.512 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 99.41 10.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.6 p -85.79 145.29 27.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.905 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.456 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.4 mm -80.41 -43.23 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.511 0.672 . . . . 0.0 109.5 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -151.51 136.04 16.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.244 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 25.4 t-80 55.53 -136.09 1.27 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 46.3 t -100.13 32.06 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.64 . . . . 0.0 110.011 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -103.0 139.81 38.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.256 0.55 . . . . 0.0 111.417 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 177.74 5.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.462 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -65.59 143.73 57.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.327 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.01 58.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.184 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 39.9 m -106.24 145.61 31.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.45 144.0 38.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.949 0.404 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 67.0 mt -119.45 149.05 42.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.057 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.2 t -158.07 103.96 1.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.042 0.448 . . . . 0.0 110.426 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.52 123.32 34.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.261 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -177.491 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.413 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 49.4 m95 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.372 0.606 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 8.7 pt20 -98.95 160.88 13.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.979 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 160.6 17.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -57.35 -48.83 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HA ' HG21 ' A' ' 211' ' ' ILE . 16.0 mt-10 -56.42 -24.82 47.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.35 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.53 -47.42 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.434 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.558 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.8 t80 -68.82 -42.15 77.61 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.605 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.34 70.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.332 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.835 176.428 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 21.8 t80 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.0 0.429 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.54 17.21 55.47 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.431 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -21.03 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.07 -27.56 13.19 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.459 0.647 . . . . 0.0 109.586 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 157.48 166.65 17.28 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.653 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.93 99.98 6.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.796 -0.702 . . . . 0.0 110.316 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 49.1 tttp -84.0 117.87 23.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.059 0.456 . . . . 0.0 110.589 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.435 ' HG ' HD13 ' A' ' 280' ' ' LEU . 3.1 tt -58.69 107.57 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.13 -42.02 16.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.659 0.266 . . . . 0.0 110.924 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.3 t -153.49 168.02 27.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.409 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.511 ' C ' ' CD2' ' A' ' 267' ' ' HIS . 0.2 OUTLIER -140.35 137.09 33.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.921 -167.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -143.77 135.63 26.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.414 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -106.76 127.59 53.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.913 -175.795 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.4 ' HB2' HD21 ' A' ' 298' ' ' LEU . 18.7 m . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.61 154.72 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.753 0.787 . . . . 0.0 112.905 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.57 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 95.5 mt -94.77 109.65 21.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.668 171.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -104.24 110.82 23.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.044 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 312' ' ' PHE . 45.7 mt -120.89 138.82 53.91 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.836 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.2 m -92.84 114.77 27.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.574 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 83.5 m-85 -102.72 161.56 13.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.055 0.455 . . . . 0.0 111.614 -174.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.0 t70 -131.15 135.81 27.8 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.138 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 95.9 Cg_endo -79.71 13.03 2.22 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.23 1.954 . . . . 0.0 112.714 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.17 -16.23 42.45 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.9 t -153.86 129.33 9.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.021 -0.589 . . . . 0.0 109.866 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.98 -8.16 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -61.32 -26.12 67.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.747 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.46 -46.67 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.1 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.33 166.46 10.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.905 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.35 148.69 25.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.76 121.98 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 14.8 m -105.99 133.11 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 59.1 t -132.72 134.1 58.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.413 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 90.4 mt-10 -107.84 112.72 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.931 172.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 10.2 p -122.95 172.5 8.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -76.77 160.81 28.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 0.0 110.317 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.757 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.76 -23.28 67.2 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -174.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -97.88 16.98 19.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.421 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.98 117.55 55.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.662 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.98 122.38 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.081 1.854 . . . . 0.0 111.432 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.506 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -112.04 105.73 14.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 26.4 t80 -70.67 108.9 4.61 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.979 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.48 138.2 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.557 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.704 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.0 tttp -63.14 128.59 36.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.456 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.9 m-20 72.13 17.33 5.08 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.635 0.584 . . . . 0.0 111.811 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -137.99 -43.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.431 . . . . 0.0 111.76 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 98.55 -160.09 20.42 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.14 115.66 3.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.537 0.668 . . . . 0.0 110.286 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 17.0 m -127.59 165.18 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.139 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.4 t -160.58 171.68 18.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.995 0.426 . . . . 0.0 110.397 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 280' ' ' LEU . 73.6 m-85 -85.88 -35.68 20.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.526 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -127.01 76.45 76.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.253 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.49 -34.44 97.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.686 2.257 . . . . 0.0 112.537 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.9 p -65.45 -23.04 66.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.167 0.508 . . . . 0.0 110.814 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.46 -46.35 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.777 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.0 m -56.43 -41.77 76.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.932 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.519 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.2 p -70.27 -21.36 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.752 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.0 -38.33 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.371 0.605 . . . . 0.0 110.242 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -80.87 -56.8 3.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.032 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.43 -8.76 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.843 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 75.38 21.07 78.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.462 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -115.23 116.2 42.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 122.773 -0.251 . . . . 0.0 110.432 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.48 117.71 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.514 2.142 . . . . 0.0 110.79 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.3 m -117.76 160.98 20.46 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 78.5 m -85.43 164.25 18.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.599 173.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.46 125.88 34.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.05 165.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.003 0.906 . . . . 0.0 111.542 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -121.09 144.16 48.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.833 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.78 110.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.684 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 263' ' ' LYS . . . 116.33 2.89 19.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.754 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -69.83 124.78 24.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.076 0.465 . . . . 0.0 110.641 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -91.25 125.2 44.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.826 0.822 . . . . 0.0 111.993 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.7 133.82 34.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.161 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 341' ' ' ASP . 63.6 mt -106.27 141.54 22.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.793 -174.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 81.5 Cg_endo -84.65 163.34 12.38 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.52 115.29 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.785 2.324 . . . . 0.0 111.45 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.9 -20.16 8.19 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.357 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -66.49 133.3 94.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.45 -24.09 67.29 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.665 2.91 . . . . 0.0 113.598 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.465 ' HB2' HD13 ' A' ' 335' ' ' LEU . 2.3 m-20 -78.53 -32.39 47.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.715 0.293 . . . . 0.0 110.594 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.655 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.74 87.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.084 0.469 . . . . 0.0 110.284 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.28 -47.68 88.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -130.86 99.65 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.92 -179.008 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.5 t -113.5 100.01 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.6 p -92.9 144.41 25.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.529 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 10.6 mm -83.48 -36.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.833 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -156.19 132.31 9.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.265 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 21.0 t-80 56.86 -139.15 0.92 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 49.4 t -98.96 40.05 1.23 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.634 . . . . 0.0 110.272 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -114.7 137.4 51.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.423 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.43 172.11 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.574 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -64.75 127.64 32.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.816 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.69 7.93 38.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.171 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.0 m -96.69 150.4 20.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.6 OUTLIER -117.02 140.35 49.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 110.988 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 79.0 mt -117.29 145.7 43.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.173 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.46 99.36 1.89 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.428 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.91 128.98 35.69 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.9 m170 . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.573 -174.709 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 39.6 m95 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.1 pt20 -102.78 156.2 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.052 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.9 159.34 22.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 2.4 t -59.75 -43.85 92.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 211' ' ' ILE . 35.0 mt-10 -57.86 -22.81 49.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.544 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.76 -50.51 8.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.467 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 68.0 t80 -65.23 -43.61 90.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.79 71.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.784 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 176.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.7 t80 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.85 13.35 50.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.009 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.8 t -67.01 -17.43 64.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.788 0.328 . . . . 0.0 111.084 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -108.62 -25.59 10.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.067 0.46 . . . . 0.0 110.395 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.14 158.53 9.14 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.312 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.617 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.7 mp -120.75 99.8 6.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.304 0.641 . . . . 0.0 110.587 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 29.2 ttpt -85.3 118.83 25.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.09 103.83 0.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.282 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.79 -52.75 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.352 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.9 t -147.65 167.32 24.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.442 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.402 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.0 t60 -145.9 135.61 23.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.145 0.498 . . . . 0.0 111.128 -173.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 32.6 tt0 -127.05 142.23 51.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.203 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -109.17 116.2 31.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 -170.959 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.9 m -129.06 154.24 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 122.172 0.987 . . . . 0.0 112.992 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.07 114.27 25.96 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.921 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 23.0 ttmm -103.32 110.81 22.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.515 HD11 ' HE1' ' A' ' 312' ' ' PHE . 20.5 mt -112.76 135.4 53.54 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.387 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.9 m -99.65 109.86 22.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.617 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 76.5 m-85 -100.08 163.98 12.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.443 . . . . 0.0 112.182 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 29.4 t70 -133.39 138.56 31.64 Favored Pre-proline 0 C--O 1.221 -0.437 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.296 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.536 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.3 Cg_endo -83.89 11.22 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.879 1.72 . . . . 0.0 112.532 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.68 -16.39 40.43 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -146.77 110.52 4.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.769 -0.715 . . . . 0.0 109.739 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.59 -14.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.279 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -67.1 -15.99 64.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.326 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.55 -43.57 22.79 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.65 170.71 11.92 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.223 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.48 147.45 23.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -122.92 121.23 35.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.452 ' N ' HD22 ' A' ' 292' ' ' LEU . 42.0 m -111.55 133.77 53.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 91.1 t -131.05 135.57 59.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.049 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -112.55 115.69 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.2 p -132.87 161.8 33.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.996 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -57.83 158.76 6.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.092 0.473 . . . . 0.0 111.829 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.742 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -63.97 -34.83 78.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.61 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -87.37 31.34 0.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.425 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -86.21 118.87 71.12 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.028 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.19 137.45 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.116 1.877 . . . . 0.0 111.821 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -119.92 142.81 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 18.2 t80 -96.73 98.62 10.3 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.961 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.589 HG23 ' OG ' ' A' ' 310' ' ' SER . 51.0 t -87.04 131.95 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 0.0 111.403 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.533 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.7 tttp -57.93 122.92 14.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.573 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 77.88 2.06 2.88 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.909 0.756 . . . . 0.0 111.833 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -116.68 -21.78 8.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.83 -121.33 5.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.41 140.51 29.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.398 0.599 . . . . 0.0 110.117 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.869 ' HB2' HG22 ' A' ' 328' ' ' ILE . 75.3 p -143.38 167.15 22.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.108 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.8 t -164.48 171.76 14.21 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.767 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.515 ' HE1' HD11 ' A' ' 280' ' ' LEU . 57.1 m-85 -89.22 -21.14 23.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.485 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.58 70.38 52.51 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.2 Cg_exo -51.32 -39.14 63.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.909 2.406 . . . . 0.0 112.898 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 19.4 m -66.63 -26.07 66.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 66.9 tp -87.56 -47.65 8.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.194 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.3 m -59.05 -39.02 80.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.372 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 10.9 p -68.77 -19.58 24.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 111.264 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.23 -41.97 13.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 110.372 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -77.14 -53.09 8.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.871 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -98.82 -15.92 19.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.786 0.326 . . . . 0.0 111.083 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.75 18.41 68.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.609 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.2 mt -113.18 113.36 49.06 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.907 -0.172 . . . . 0.0 110.748 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.76 110.42 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 110.487 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.442 ' HB3' ' C ' ' A' ' 310' ' ' SER . 58.2 m -111.29 157.66 19.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 0.0 111.971 -170.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.3 m -84.03 159.73 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.123 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.22 122.98 28.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.869 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.12 164.89 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.473 0.654 . . . . 0.0 110.671 -177.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -119.93 141.44 49.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.792 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 mm -57.18 110.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.074 0.464 . . . . 0.0 109.845 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.89 3.74 19.62 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.352 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -79.56 131.07 35.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.217 0.532 . . . . 0.0 110.793 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.6 p -93.83 126.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.24 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.5 m -93.28 136.63 33.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.342 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 55.6 mt -105.93 146.13 32.27 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.357 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 58.3 Cg_endo -88.53 165.36 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.933 2.422 . . . . 0.0 112.425 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.47 115.81 3.9 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.868 2.378 . . . . 0.0 111.824 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 122.17 -22.56 7.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.061 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.0 127.78 93.64 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.34 -22.85 60.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.411 2.741 . . . . 0.0 113.554 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.06 -27.25 43.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.54 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.575 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -75.29 85.93 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.305 0.574 . . . . 0.0 110.169 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.7 mt -72.88 -45.44 55.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.734 -173.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -109.65 43.74 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.435 0.636 . . . . 0.0 110.812 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.593 -0.579 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.2 t -97.19 87.58 4.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.051 0.453 . . . . 0.0 109.936 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.9 p -79.3 143.93 34.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.835 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.7 mm -79.35 -43.86 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.462 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 76.9 t90 -152.98 136.06 15.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.408 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 32.6 t-80 55.23 -135.75 1.34 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.485 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 15.0 p -96.05 23.91 6.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.798 0.332 . . . . 0.0 111.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -108.61 140.21 42.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.975 -173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.53 178.57 4.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.772 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.77 132.02 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.039 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.05 17.85 26.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.092 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.552 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 25.0 m -107.82 147.44 30.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 220' ' ' ARG . 3.7 mpt_? -110.6 144.23 39.81 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.211 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.0 mt -117.24 144.49 44.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.889 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 16.6 t -153.39 95.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.126 0.489 . . . . 0.0 110.358 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -86.16 118.21 25.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.0 m170 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.109 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 72.7 m95 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -106.63 164.52 12.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.39 172.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.64 160.5 16.6 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.97 -0.456 . . . . 0.0 110.299 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.9 t -60.03 -47.33 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 24.8 mt-10 -59.03 -22.36 60.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.63 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -81.7 -47.58 12.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.135 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 54.8 t80 -70.08 -48.67 56.78 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.45 69.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.211 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 19.4 ttm180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.597 0.713 . . . . 0.0 109.55 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.604 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 11.2 t80 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 103.09 12.21 32.21 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.391 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.8 m -68.74 -13.68 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.826 0.346 . . . . 0.0 111.758 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -108.27 -30.19 8.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.851 0.357 . . . . 0.0 110.282 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.77 157.89 8.86 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.07 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -122.53 105.8 10.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 110.476 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 22.0 ttpt -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.14 0.495 . . . . 0.0 110.976 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.52 107.48 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.868 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 61.1 mt -82.51 -41.1 20.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.466 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.7 t -158.39 162.35 37.62 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.791 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -140.94 140.25 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -133.43 139.69 46.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.246 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.61 106.14 18.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 109.776 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.0 t . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.69 -174.313 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.1 m -129.62 154.88 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.772 0.796 . . . . 0.0 111.838 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 295' ' ' GLU . 96.9 mt -95.57 110.61 22.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.558 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -98.24 110.66 23.2 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 17.2 mt -113.82 129.93 56.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.124 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 37.6 m -97.52 118.12 33.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.527 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 79.5 m-85 -106.55 164.65 11.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.288 0.566 . . . . 0.0 112.417 -171.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 19.0 t70 -131.29 135.06 26.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.146 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.604 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 72.8 Cg_endo -84.17 5.59 6.24 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.202 1.935 . . . . 0.0 112.346 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 -18.87 27.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.452 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -142.29 126.65 17.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.052 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.97 -8.15 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.39 -39.69 92.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.03 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.04 -46.76 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.036 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.99 11.48 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.39 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.0 143.26 29.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.72 0.295 . . . . 0.0 110.578 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.453 HD13 HG23 ' A' ' 294' ' ' VAL . 1.1 tm? -117.5 119.44 35.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.422 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.0 m -106.8 135.27 48.62 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.453 HG23 HD13 ' A' ' 292' ' ' LEU . 73.8 t -134.04 135.22 55.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.436 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 278' ' ' LEU . 41.8 mt-10 -126.95 127.73 45.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.716 173.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.454 ' HB2' HG23 ' A' ' 219' ' ' THR . 9.2 t -141.19 -174.61 4.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.773 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -76.0 172.84 12.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.574 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.9 mm? -74.67 -10.54 59.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.352 -168.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.96 17.45 24.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.721 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -75.89 117.93 67.36 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.527 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.5 135.16 17.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.158 1.905 . . . . 0.0 111.783 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -121.24 125.57 47.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 7.7 t80 -81.84 90.79 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.567 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.629 HG13 ' HB2' ' A' ' 332' ' ' ASP . 65.6 t -72.95 123.86 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.035 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.758 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.4 tttp -56.33 139.69 47.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.38 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.9 m-20 77.1 -8.68 1.65 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.819 0.699 . . . . 0.0 112.114 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -119.21 -54.0 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.17 -149.67 18.05 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -67.73 120.64 14.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.172 0.486 . . . . 0.0 110.259 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.414 ' HB2' HG22 ' A' ' 328' ' ' ILE . 18.0 m -134.94 169.66 17.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.351 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 43.2 t -160.63 172.13 17.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.914 0.387 . . . . 0.0 110.777 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -87.14 -28.88 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.974 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.46 76.39 77.63 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.687 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.555 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 65.8 Cg_exo -54.74 -41.96 73.08 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.103 2.535 . . . . 0.0 113.141 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 6.9 m -64.02 -24.35 67.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.8 tp -87.32 -49.14 7.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.951 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -55.75 -44.65 77.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.377 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.19 -31.67 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.745 0.307 . . . . 0.0 111.752 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.11 -40.35 22.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.229 0.538 . . . . 0.0 110.243 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.19 -49.97 13.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.589 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -102.75 -9.06 20.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.767 0.318 . . . . 0.0 111.737 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 75.67 29.6 59.27 Favored Glycine 0 CA--C 1.516 0.127 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.7 mt -128.34 112.79 19.67 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 122.772 -0.252 . . . . 0.0 110.433 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.8 116.79 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.448 2.099 . . . . 0.0 110.877 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 72.8 m -117.62 147.59 42.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.287 0.565 . . . . 0.0 111.698 -169.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.55 164.97 22.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.653 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.13 128.18 34.25 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -74.98 178.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.422 0.629 . . . . 0.0 111.07 -178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -141.71 132.88 26.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.93 115.13 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 O-C-N 123.67 0.606 . . . . 0.0 110.162 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.71 6.72 16.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.516 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.629 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -70.4 128.91 37.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 176.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.2 p -97.56 112.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.73 0.776 . . . . 0.0 111.13 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.9 m -79.96 132.29 36.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.425 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.85 145.91 31.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.908 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.1 Cg_endo -86.68 168.7 8.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.008 2.472 . . . . 0.0 112.357 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 42.0 Cg_endo -68.12 126.16 14.03 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.885 2.39 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.51 -21.33 30.74 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.35 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.4 122.0 77.81 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.79 -23.53 72.41 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 123.182 2.588 . . . . 0.0 113.108 -171.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.552 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 37.4 t70 -79.06 -27.18 43.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.55 86.57 4.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.178 0.513 . . . . 0.0 109.993 169.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 60.0 mt -66.86 -50.65 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.633 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -99.57 31.57 3.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.0 111.08 -169.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.358 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.481 0.752 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.4 t -94.78 94.3 8.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.287 0.565 . . . . 0.0 109.998 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -84.87 143.54 28.98 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.216 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 235' ' ' GLU . 11.4 mm -86.26 -41.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.58 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.483 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 80.9 t90 -154.33 127.63 8.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.499 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.4 t-80 59.06 -146.56 0.51 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 49.4 t -94.64 39.82 1.09 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.292 0.567 . . . . 0.0 110.37 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.13 138.04 45.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.361 0.601 . . . . 0.0 111.594 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.97 169.16 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.022 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.428 ' HG3' ' OE2' ' A' ' 235' ' ' GLU . 56.9 tttp -62.42 128.15 34.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.734 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.35 -16.85 34.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.027 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.523 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 60.6 m -73.73 148.17 42.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.489 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.4 OUTLIER -109.37 150.71 27.64 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.436 178.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.4 mt -123.54 143.88 49.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.9 t -151.96 92.03 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.449 . . . . 0.0 110.412 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.97 124.8 27.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.3 m170 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 110.91 -177.115 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.411 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 83.6 m95 . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 121.437 0.636 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.6 pt20 -99.99 158.44 15.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.513 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.43 161.44 16.28 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.913 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -58.5 -49.7 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.641 0.734 . . . . 0.0 109.355 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 35.3 mt-10 -58.08 -22.3 49.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.585 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.6 -45.77 24.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.331 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -74.96 -46.84 32.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -59.7 -25.07 64.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.568 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.672 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 35.9 ttm180 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.337 0.589 . . . . 0.0 109.835 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.7 t80 . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 97.25 18.55 28.44 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.376 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.6 m -75.8 -13.27 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.993 0.425 . . . . 0.0 110.459 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.07 -31.94 8.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 109.323 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.23 157.92 8.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.003 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.5 mp -123.12 98.7 6.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 123.234 0.614 . . . . 0.0 110.363 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 69.8 tttt -84.15 122.06 28.31 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.7 105.09 0.6 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.76 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 283' ' ' ASP . 87.0 mt -79.16 -48.13 14.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.7 t -150.28 163.37 38.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.849 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.602 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -134.08 148.49 51.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.888 -167.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.16 139.32 21.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.894 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -111.09 94.28 4.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.491 0.662 . . . . 0.0 109.468 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.444 -0.74 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.308 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.86 154.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.596 0.712 . . . . 0.0 112.03 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 312' ' ' PHE . 94.7 mt -92.54 109.4 20.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.259 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 4.9 ttpp -102.95 109.0 20.39 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 293' ' ' THR . 38.4 mt -118.71 140.9 49.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.247 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.0 m -99.05 122.56 42.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.556 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.2 m-85 -110.63 158.88 18.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.384 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.477 ' HB2' HD21 ' A' ' 265' ' ' LEU . 10.7 t70 -128.21 130.62 23.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.663 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.63 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 97.4 Cg_endo -86.82 12.55 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.607 2.204 . . . . 0.0 112.451 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.96 -16.61 46.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.883 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.5 t -154.4 139.92 17.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 111.031 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.99 -9.88 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.31 -38.76 77.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.183 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.82 -43.47 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.903 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 133.38 163.48 10.47 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.769 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.94 149.27 22.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.071 0.463 . . . . 0.0 110.143 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 294' ' ' VAL . 1.8 tm? -126.75 123.29 37.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.8 m -115.64 136.84 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 68.3 t -131.92 137.14 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.639 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' CG ' ' HD3' ' A' ' 279' ' ' LYS . 87.8 mt-10 -106.39 127.86 53.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.642 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.4 p -142.99 172.2 13.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -66.09 154.56 39.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.308 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.797 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.2 mm? -62.45 -21.13 65.21 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.47 0.652 . . . . 0.0 110.742 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.68 16.7 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.779 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -70.69 122.64 87.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -82.3 122.4 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.518 2.145 . . . . 0.0 111.906 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.66 120.62 42.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.7 t80 -72.84 104.4 4.01 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.23 137.15 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.267 0.556 . . . . 0.0 111.074 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.481 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.1 tttp -57.92 129.93 44.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.813 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 90.6 m-20 72.94 2.3 4.33 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.627 0.579 . . . . 0.0 112.099 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -121.6 -41.37 2.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.657 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 95.6 -152.78 20.47 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.67 113.84 3.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.238 0.519 . . . . 0.0 110.699 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.9 m -126.21 165.55 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.5 t -161.54 -177.83 6.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.656 0.265 . . . . 0.0 110.939 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 278' ' ' LEU . 30.1 m-85 -91.59 -43.6 9.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.244 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.67 74.22 17.67 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.705 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.7 Cg_exo -55.6 -36.26 94.28 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.748 2.298 . . . . 0.0 112.946 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 319' ' ' VAL . 23.2 t -63.1 -28.48 70.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.115 0.484 . . . . 0.0 110.559 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.3 tp -87.35 -41.97 13.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.886 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.9 m -53.33 -44.06 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.778 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.9 p -72.14 -20.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 315' ' ' SER . 97.2 t -85.31 -34.93 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.384 0.612 . . . . 0.0 110.117 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -84.67 -53.03 5.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.188 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.73 -11.52 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.103 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.98 24.85 65.66 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.254 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.1 mt -120.97 113.17 33.02 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.874 -0.192 . . . . 0.0 110.572 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.05 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.47 2.113 . . . . 0.0 110.7 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 79.5 m -117.57 155.88 29.04 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -169.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.55 165.77 18.8 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.618 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.57 126.71 33.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 162.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -130.03 153.75 48.12 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.5 mm -63.15 109.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.68 -0.61 20.1 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.825 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.88 129.43 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.532 0.666 . . . . 0.0 110.221 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.35 134.74 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.535 0.683 . . . . 0.0 112.654 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 50.5 t -95.85 138.95 32.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.971 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 76.0 mt -109.96 141.87 24.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.527 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.57 164.15 9.36 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.884 2.389 . . . . 0.0 112.033 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.49 122.78 9.8 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.292 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 114.45 -17.0 19.12 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.813 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -70.34 132.18 87.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.24 -26.35 76.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.389 2.726 . . . . 0.0 113.479 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.24 -26.67 42.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.668 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -80.02 85.83 5.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.68 -43.98 46.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.243 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -120.92 80.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.886 -178.946 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -105.64 92.01 4.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.3 p -82.23 141.52 32.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.033 0.444 . . . . 0.0 110.967 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -82.85 -37.76 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.709 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -156.88 135.65 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 23.1 t-80 55.83 -139.26 0.97 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.6 t -100.4 42.68 1.1 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.376 0.607 . . . . 0.0 109.92 176.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.09 139.48 50.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 111.89 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.1 174.83 5.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.825 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.491 ' HE2' ' OE2' ' A' ' 235' ' ' GLU . 64.4 tttm -63.77 127.89 33.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.421 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.85 -1.55 38.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.473 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.533 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 68.1 m -86.21 140.1 30.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -111.11 137.88 48.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.449 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 47.1 mt -112.78 145.49 40.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.717 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 21.3 t -149.48 97.46 2.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.185 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -85.74 108.28 17.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.0 m170 . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.105 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.0 m95 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 122.011 0.91 . . . . 0.0 113.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 12.2 pt20 -130.92 168.37 17.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.246 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -88.59 160.2 17.54 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.975 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.59 -46.93 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.491 ' OE2' ' HE2' ' A' ' 217' ' ' LYS . 27.3 mt-10 -57.73 -23.45 51.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.243 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.09 -44.75 21.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.341 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.581 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.9 t80 -74.26 -44.07 54.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.423 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.94 72.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.118 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 176.163 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 39.2 t80 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.024 0.44 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.19 26.61 23.27 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.591 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -81.41 -16.42 52.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.176 0.513 . . . . 0.0 110.417 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.88 -29.49 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 142.1 151.81 5.59 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.586 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.9 mp -107.57 97.59 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.73 0.412 . . . . 0.0 110.863 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.9 ttpp -85.68 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.182 0.515 . . . . 0.0 111.139 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.487 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 4.6 tt -54.77 122.48 10.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.465 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.2 mt -95.0 -47.71 6.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.561 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.7 t -151.0 164.98 35.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -142.12 133.04 25.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.207 0.527 . . . . 0.0 111.632 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -128.67 146.19 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.49 128.69 53.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.828 0.823 . . . . 0.0 110.359 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.864 -167.014 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 298' ' ' LEU . 49.6 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.1 m -132.72 153.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.147 0.975 . . . . 0.0 113.228 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 89.9 mt -92.92 119.96 32.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.249 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.7 ttmt -108.33 111.82 23.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 312' ' ' PHE . 36.9 mt -118.5 129.4 55.35 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.011 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.1 m -92.97 110.79 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.405 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.6 m-85 -96.51 155.27 16.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -172.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.491 ' HB2' HD21 ' A' ' 265' ' ' LEU . 15.7 t0 -118.84 123.43 29.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.448 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 60.5 Cg_endo -73.36 2.76 5.32 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.065 1.843 . . . . 0.0 111.755 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.79 9.85 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.5 t -145.9 130.94 18.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.11 -12.25 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.085 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.18 -34.7 78.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.557 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.52 -45.26 69.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 135.94 176.16 14.21 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.366 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 79.1 mt -103.32 150.33 23.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.915 0.388 . . . . 0.0 110.618 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -127.02 119.43 26.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.4 m -109.76 139.39 44.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.9 t -132.93 132.73 59.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -109.47 115.26 29.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 6.2 p -134.3 165.64 24.67 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.53 155.9 28.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.138 0.494 . . . . 0.0 111.01 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.823 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.1 mm? -64.4 -19.53 65.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.078 -173.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.21 17.67 16.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.194 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.51 117.27 60.74 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.773 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.65 116.38 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.238 1.959 . . . . 0.0 111.445 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.8 m-85 -103.59 116.06 31.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.355 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 11.4 t80 -73.48 105.08 4.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.406 175.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.75 130.79 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.349 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.84 ' HB3' HG13 ' A' ' 333' ' ' VAL . 58.9 tttp -59.97 126.44 27.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 93.7 m-20 77.64 0.05 2.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.995 0.81 . . . . 0.0 111.993 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -117.08 -33.8 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 111.495 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 94.47 -151.14 20.04 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' TRP . . . . . 0.454 ' CZ2' ' HA ' ' A' ' 345' ' ' PHE . 97.3 m95 -67.77 117.6 9.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.462 0.631 . . . . 0.0 109.457 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.427 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -128.28 166.66 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.772 0.32 . . . . 0.0 110.641 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 41.4 t -160.77 168.11 25.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.509 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.513 ' HE1' HD11 ' A' ' 280' ' ' LEU . 63.4 m-85 -84.92 -28.57 25.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.946 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.11 75.41 75.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.595 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.7 Cg_exo -55.42 -45.02 43.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.883 2.388 . . . . 0.0 112.677 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 18.3 m -62.5 -21.08 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.447 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.05 -45.3 10.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.909 0.385 . . . . 0.0 110.166 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.413 HG21 ' SG ' ' A' ' 325' ' ' CYS . 36.4 m -55.51 -40.74 72.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.742 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.554 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.9 p -71.72 -19.71 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.788 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.3 t -87.61 -36.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.327 0.584 . . . . 0.0 110.185 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -81.86 -54.88 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -101.79 -11.37 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.837 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.59 14.78 77.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.638 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.5 mt -110.53 114.18 55.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.634 0.217 . . . . 0.0 111.08 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.96 118.49 5.65 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.633 2.222 . . . . 0.0 110.601 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 317' ' ' THR . 62.6 m -117.77 157.78 25.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.248 0.547 . . . . 0.0 112.306 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.6 m -79.91 164.88 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.06 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -92.03 122.16 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.19 166.1 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.548 0.689 . . . . 0.0 111.412 -175.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -124.12 142.33 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.34 114.45 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.67 -0.65 21.72 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.525 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -73.15 132.09 42.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.88 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -92.92 134.8 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.273 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 49.5 t -96.5 134.32 39.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.369 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 82.2 mt -105.84 143.68 27.37 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.59 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 69.1 Cg_endo -86.91 167.66 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.637 2.225 . . . . 0.0 112.074 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.74 129.8 24.49 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.008 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.26 -14.32 54.94 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -69.3 128.3 92.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.36 -22.59 75.0 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.325 2.683 . . . . 0.0 113.866 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.87 -31.04 45.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -69.0 91.73 0.49 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.281 0.562 . . . . 0.0 109.954 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.0 mt -66.33 -41.53 89.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.671 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -129.13 101.7 6.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 309' ' ' TRP . 3.8 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.519 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -91.3 99.58 12.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.048 0.452 . . . . 0.0 110.098 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -87.63 141.77 28.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.452 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.4 mm -79.44 -40.31 21.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.334 0.588 . . . . 0.0 109.752 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -156.89 134.38 10.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.107 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 34.0 t-80 55.94 -139.22 0.97 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 40.3 t -99.8 40.09 1.27 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.418 0.628 . . . . 0.0 109.864 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -110.23 134.6 52.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.061 0.458 . . . . 0.0 111.237 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.51 176.17 6.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -67.37 137.82 56.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.66 31.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.022 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 38.2 m -112.11 147.63 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.3 OUTLIER -111.07 143.6 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.824 0.345 . . . . 0.0 111.058 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.8 mt -119.64 143.75 47.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.809 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 41.8 t -154.07 98.03 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.418 ' CD1' ' HG ' ' A' ' 292' ' ' LEU . 34.8 m-85 -83.34 122.18 28.12 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 31.4 m170 . . . . . 0 C--N 1.328 -0.366 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -174.44 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.487 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 85.4 m95 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.208 0.527 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 9.1 pt20 -120.45 154.37 35.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.688 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.37 162.57 23.33 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -60.68 -50.82 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.03 -24.2 57.38 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.289 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.17 -50.67 21.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.554 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 62.1 t80 -70.59 -43.65 68.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.698 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.53 68.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.245 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 239' ' ' ARG . 36.6 ttt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 14.9 t80 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.64 21.48 23.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.225 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.1 t -70.05 -23.56 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.02 -31.75 17.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.58 0.705 . . . . 0.0 109.828 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 141.0 144.28 4.41 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.762 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.2 mp -97.92 99.18 10.47 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.419 0.287 . . . . 0.0 111.0 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 19.2 ttpp -84.96 117.75 24.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.1 tt -61.22 102.83 0.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.829 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 67.1 mt -77.2 -47.65 19.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.445 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -152.58 163.15 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.097 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.571 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -133.68 146.2 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.668 -168.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.44 140.04 27.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.16 107.75 16.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 -170.6 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.67 154.87 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.997 0.904 . . . . 0.0 113.072 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 98.7 mt -94.15 110.31 22.04 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.807 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.8 ttmt -104.28 109.63 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.812 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 312' ' ' PHE . 40.9 mt -116.14 136.82 52.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.751 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 27.8 m -93.58 109.66 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 84.3 m-85 -101.09 150.05 23.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.324 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 12.8 t70 -116.6 133.44 23.02 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.7 Cg_endo -79.21 9.81 3.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.861 1.707 . . . . 0.0 112.04 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.38 63.16 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -146.73 100.01 3.27 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.603 0.716 . . . . 0.0 109.508 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.29 -18.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.415 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 288' ' ' GLU . 7.2 mp0 -56.25 -32.43 64.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.538 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.37 -1.18 49.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 111.472 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.08 172.96 25.31 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.791 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.4 mt -97.84 141.13 31.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.723 0.297 . . . . 0.0 110.22 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -112.43 121.29 44.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 28.2 m -110.06 133.97 52.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 89.2 t -131.69 134.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.518 -174.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 88.3 mt-10 -106.44 120.97 43.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.681 171.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 11.0 p -133.23 167.2 20.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.467 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -75.44 163.24 27.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.06 0.457 . . . . 0.0 110.494 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.64 HD22 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -66.89 -16.09 64.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.757 -168.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.97 26.0 10.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.159 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -79.24 117.53 67.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.726 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.48 133.35 11.72 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.242 1.961 . . . . 0.0 111.903 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.452 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 98.8 m-85 -118.07 125.04 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.423 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -76.51 89.34 3.27 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.524 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.79 134.12 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.6 ' HB3' HG13 ' A' ' 333' ' ' VAL . 69.2 tttt -59.35 125.53 24.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.901 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 92.2 m-20 81.45 -26.39 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.093 0.871 . . . . 0.0 112.171 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -89.83 -35.12 15.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.093 0.473 . . . . 0.0 111.203 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.89 -153.06 21.73 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -63.99 115.06 4.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.983 0.392 . . . . 0.0 110.209 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.465 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.0 m -127.74 169.19 14.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.222 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 45.9 t -160.7 169.37 22.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.461 ' HE1' HD11 ' A' ' 280' ' ' LEU . 53.4 m-85 -84.28 -32.27 24.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.929 174.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -126.95 77.38 75.1 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.421 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.0 Cg_exo -56.35 -36.81 97.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.814 2.343 . . . . 0.0 112.564 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.7 m -70.29 -20.75 63.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.43 -47.81 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 m -57.17 -40.95 78.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.048 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.504 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.2 p -68.5 -20.42 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.894 0.378 . . . . 0.0 111.642 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.5 t -91.01 -38.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.326 0.584 . . . . 0.0 110.393 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -78.81 -53.77 6.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.788 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -95.24 -22.22 17.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.096 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 88.15 12.97 64.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.306 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 45.0 mt -109.2 115.82 56.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 4.9 Cg_exo -72.0 109.48 2.7 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.532 2.155 . . . . 0.0 110.706 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 59.5 m -109.09 155.01 21.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.765 -170.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 79.2 m -84.8 166.38 16.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.015 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.29 123.51 31.63 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.291 -0.256 . . . . 0.0 110.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.34 164.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.229 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -134.33 150.82 50.97 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.0 mm -55.27 113.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 110.527 -176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.4 -2.09 20.46 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.865 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.51 128.35 35.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.257 0.551 . . . . 0.0 111.159 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.4 p -88.95 136.39 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.844 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 58.3 m -103.02 134.22 46.82 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.097 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 59.9 mt -104.39 143.14 26.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.503 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.578 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 63.5 Cg_endo -88.72 166.86 6.04 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.214 2.609 . . . . 0.0 112.871 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.5 128.69 17.61 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.352 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.88 -19.37 35.62 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.905 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -70.96 129.23 89.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 -32.0 80.11 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.807 3.005 . . . . 0.0 113.868 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.33 -23.06 43.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.9 86.51 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.917 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.25 -45.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.528 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -110.38 47.5 0.96 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.286 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.346 179.739 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 110.871 -0.473 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.6 t -91.69 93.65 9.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.0 p -84.11 143.79 29.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.476 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.8 mm -79.33 -44.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.44 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -151.37 137.19 18.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.416 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.523 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 24.1 t-80 56.43 -137.4 1.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 45.1 t -100.23 34.09 2.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.307 0.575 . . . . 0.0 110.112 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -108.63 138.57 44.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.29 175.65 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.882 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -68.32 130.3 42.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.419 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.82 36.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.113 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 23.9 m -101.82 145.55 29.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.17 143.7 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.735 0.302 . . . . 0.0 110.903 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 44.1 mt -121.65 144.13 48.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.654 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 10.1 m -148.99 91.93 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 12.3 m-85 -88.2 120.06 29.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.0 m170 . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 110.805 -173.444 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.543 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 68.1 m95 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.563 0.697 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 2.9 pt20 -101.0 167.27 10.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.567 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.13 159.11 17.67 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.3 t -58.17 -48.72 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 109.716 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.65 -21.51 40.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.762 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.2 -52.48 8.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -65.43 -41.38 93.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.839 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.04 73.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.768 174.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.579 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 12.6 t80 . . . . . 0 C--O 1.231 0.107 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 100.23 12.09 40.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.188 -1.005 . . . . 0.0 113.554 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.6 t -74.55 -15.48 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.038 0.447 . . . . 0.0 110.139 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -88.8 -26.47 21.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.591 0.71 . . . . 0.0 109.339 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.4 144.22 5.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.0 mp -105.46 98.2 7.93 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.434 0.294 . . . . 0.0 111.372 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.6 tttm -84.48 118.0 24.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.015 0.435 . . . . 0.0 110.648 -176.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.46 107.21 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 283' ' ' ASP . 85.9 mt -80.75 -51.62 8.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.714 0.292 . . . . 0.0 110.351 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.0 t -150.71 163.16 39.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.531 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.3 t60 -137.03 139.68 41.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 0.0 111.509 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -133.23 138.69 46.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.836 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.531 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 9.2 mt-10 -108.15 121.88 45.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 0.0 110.069 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.135 -173.444 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.69 154.11 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.853 0.835 . . . . 0.0 112.591 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.472 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 88.4 mt -94.38 114.36 26.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.734 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 20.3 ttpp -109.04 114.84 28.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.48 HD11 ' HE1' ' A' ' 312' ' ' PHE . 38.0 mt -115.72 130.83 57.0 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.251 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.0 m -93.91 111.79 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.531 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 77.3 m-85 -100.99 159.7 14.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.84 -172.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 35.9 t70 -122.94 137.45 28.13 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.652 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.579 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 86.9 Cg_endo -85.54 11.32 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.213 1.942 . . . . 0.0 112.083 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.71 39.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -154.14 115.56 4.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.339 0.59 . . . . 0.0 110.161 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.58 -7.77 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.654 0.74 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.13 -20.15 61.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.134 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.6 -38.63 39.49 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 145.31 168.21 12.82 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.243 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.11 143.06 26.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.9 OUTLIER -117.42 117.5 29.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.473 ' N ' HD22 ' A' ' 292' ' ' LEU . 5.5 m -108.94 138.21 45.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.0 t -132.13 132.98 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.543 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 70.6 mt-10 -104.16 116.34 32.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.588 170.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.56 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 11.1 p -128.06 167.24 17.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.992 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -81.65 161.14 23.55 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.721 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.8 mm? -61.54 -13.36 20.74 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.26 -169.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -108.18 13.11 26.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.591 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -71.69 119.35 73.62 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 0.0 110.888 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.44 136.39 17.51 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.21 1.94 . . . . 0.0 112.105 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.56 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.6 m-85 -122.77 118.15 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.694 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 17.0 t80 -74.5 101.65 4.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.368 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.4 t -90.6 135.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.205 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.604 ' HB3' HG13 ' A' ' 333' ' ' VAL . 59.1 tttm -62.0 128.4 35.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 16.3 m120 72.55 11.32 5.62 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.72 0.637 . . . . 0.0 111.721 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -128.3 -42.9 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.986 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 100.15 -153.3 19.39 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -63.97 116.84 6.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 117.24 0.52 . . . . 0.0 109.795 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.7 m -128.31 166.43 18.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.034 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -160.43 167.05 28.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 280' ' ' LEU . 71.0 m-85 -85.98 -19.57 30.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.113 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -137.21 72.78 52.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.656 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.533 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.4 Cg_exo -52.62 -37.62 74.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.924 2.416 . . . . 0.0 113.19 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.4 t -68.76 -22.48 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.511 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.2 tp -87.92 -47.01 8.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 0.0 110.218 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 m -55.02 -41.66 71.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.999 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.99 -17.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 111.58 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.56 -39.86 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.311 0.576 . . . . 0.0 110.458 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.47 -46.12 18.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.368 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -107.88 -12.32 15.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.61 0.243 . . . . 0.0 111.106 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.4 14.97 77.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.1 mt -109.26 114.55 57.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 122.628 -0.337 . . . . 0.0 110.86 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -72.07 116.27 4.64 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.527 2.151 . . . . 0.0 110.561 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 68.1 m -117.93 156.37 28.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.183 0.516 . . . . 0.0 112.101 -170.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.2 m -83.49 160.05 21.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.49 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.21 127.18 32.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.436 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.61 172.79 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.697 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 143.87 50.88 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.703 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.4 mm -63.03 111.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.813 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 116.12 -0.14 20.93 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.401 -173.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.49 ' HB3' HG13 ' A' ' 304' ' ' VAL . 66.0 m-20 -73.53 125.33 27.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.275 0.559 . . . . 0.0 110.755 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.0 OUTLIER -88.01 127.78 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.829 0.823 . . . . 0.0 112.041 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 42.0 t -89.51 131.08 35.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.73 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.8 mt -102.92 141.87 23.39 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.699 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.523 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 52.7 Cg_endo -89.13 170.26 4.94 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.844 2.362 . . . . 0.0 111.889 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 135.02 40.43 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.384 2.056 . . . . 0.0 111.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 98.76 -15.7 60.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.483 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -72.44 128.4 88.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.16 -31.27 54.29 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.123 3.216 . . . . 0.0 114.078 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.37 -24.0 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.249 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.44 85.07 3.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.95 -44.15 51.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.014 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -114.56 62.51 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 110.441 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.653 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 111.161 -0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.1 t -90.03 103.97 16.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.4 p -87.48 146.68 25.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.006 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -90.44 -38.3 10.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 109.607 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.413 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 82.8 t90 -157.1 128.73 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.25 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.535 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.7 t-80 57.83 -151.51 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 37.3 t -88.37 46.36 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.779 -0.576 . . . . 0.0 110.411 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -117.44 139.12 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.166 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.84 171.98 7.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.314 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.28 135.71 56.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.735 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.08 10.39 45.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.797 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 62.1 m -103.56 145.7 29.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.0 mpt_? -115.7 142.6 46.53 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.766 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 71.9 mt -118.91 148.6 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.697 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 7.7 m -156.96 96.53 1.61 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.444 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.413 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 3.8 m-85 -88.87 126.21 35.27 Favored 'General case' 0 C--O 1.228 -0.066 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 110.467 -177.795 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.2 pt20 -100.55 157.85 16.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.58 162.8 15.47 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -58.17 -47.54 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 28.8 mt-10 -55.49 -23.8 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.72 -46.02 14.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.68 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -75.16 -39.38 60.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -66.24 -26.06 67.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.29 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 41.8 ttm105 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.838 0.827 . . . . 0.0 109.474 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.593 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 13.9 t80 . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 98.7 14.17 38.28 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.174 -1.013 . . . . 0.0 112.695 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 8.1 t -69.05 -14.76 63.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.106 0.479 . . . . 0.0 110.879 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -100.95 -28.89 12.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.392 0.615 . . . . 0.0 110.316 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.4 153.65 6.85 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.628 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -121.64 102.45 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -0.616 . . . . 0.0 110.462 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.717 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.4 ttpt -87.79 125.09 34.25 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.37 102.93 0.93 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.181 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.06 -52.94 8.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.743 0.306 . . . . 0.0 110.46 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.4 t -146.34 157.97 43.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.128 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.448 ' ND1' HD23 ' A' ' 280' ' ' LEU . 9.3 t60 -141.85 145.32 34.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.288 0.566 . . . . 0.0 111.289 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . 34.1 tt0 -137.79 141.41 40.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.693 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -102.33 99.06 9.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.607 -169.655 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.8 m -135.54 155.82 37.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.97 105.31 17.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.901 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 268' ' ' GLU . 82.3 tttt -94.03 105.09 17.11 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.994 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 14.0 mt -115.64 132.22 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.966 0.413 . . . . 0.0 111.464 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 m -104.33 117.49 34.33 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.536 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 92.5 m-85 -105.41 168.65 8.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.096 0.475 . . . . 0.0 111.974 -171.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -137.43 136.77 20.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.511 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.593 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.4 Cg_endo -80.72 8.86 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.025 1.817 . . . . 0.0 112.451 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.65 -23.09 10.44 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 8.4 t -154.19 133.78 12.84 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.92 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.3 -7.21 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.296 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -56.95 -24.63 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.851 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.13 -46.96 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.561 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.72 148.84 4.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.99 152.54 45.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 110.617 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -133.11 117.04 17.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.454 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.4 m -105.97 135.98 46.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.536 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 69.5 t -135.39 122.96 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.151 0.501 . . . . 0.0 111.135 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -107.49 110.06 21.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.327 -178.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.545 ' HG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.0 p -125.37 175.63 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.566 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -75.77 166.13 23.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.521 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -71.75 -18.01 62.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.61 -168.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -100.43 19.63 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.28 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.26 121.62 85.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.665 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.46 133.03 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.371 2.047 . . . . 0.0 111.626 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.545 ' HZ ' ' HG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -119.4 121.7 40.11 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.943 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 28.0 t80 -76.23 102.15 5.7 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.752 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 78.6 t -92.62 134.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.3 0.571 . . . . 0.0 111.097 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.559 ' HB3' HG13 ' A' ' 333' ' ' VAL . 63.9 tttp -62.08 127.23 30.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.241 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 92.0 m-20 76.01 3.39 3.73 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.792 0.683 . . . . 0.0 111.947 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -123.95 -28.88 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 87.2 -153.74 25.69 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.06 115.04 4.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.03 0.443 . . . . 0.0 110.363 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.48 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.1 m -125.45 168.08 14.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.926 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -162.26 178.63 8.54 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.356 -0.215 . . . . 0.0 110.452 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 52.2 m-85 -95.94 -22.07 17.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.84 68.19 71.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 84.3 Cg_exo -48.92 -37.83 37.48 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 113.379 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 30.3 m -62.3 -31.28 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.084 0.469 . . . . 0.0 111.041 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.49 -44.15 11.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.437 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 m -56.42 -39.52 73.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.728 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.7 p -71.75 -23.51 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 -43.92 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 0.0 110.216 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.88 -54.29 7.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.245 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -99.34 -15.73 18.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.241 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 87.57 10.11 70.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.8 mt -109.72 117.73 51.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.583 0.191 . . . . 0.0 110.839 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 104.31 1.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.567 2.178 . . . . 0.0 110.405 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 64.3 m -102.45 156.5 17.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.196 -169.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 56.1 m -79.82 152.95 29.44 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.945 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -79.26 117.66 20.47 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.48 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -68.45 165.09 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 0.0 110.726 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -121.36 140.72 51.74 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.9 mm -55.48 112.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.147 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.48 3.58 20.58 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.139 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 50.8 m-20 -81.01 135.24 35.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.13 135.31 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.598 0.713 . . . . 0.0 112.129 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 60.2 m -100.82 135.53 42.12 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.742 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.74 142.0 23.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.353 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.78 165.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.214 2.609 . . . . 0.0 111.993 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.39 121.34 8.45 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.461 2.107 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 112.66 -11.2 25.6 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.446 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.3 127.22 86.74 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.7 -24.75 38.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.662 2.908 . . . . 0.0 113.935 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.23 -31.86 43.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.275 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.1 91.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 110.028 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 55.4 mt -74.58 -48.92 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.344 -176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.56 53.43 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.994 0.426 . . . . 0.0 110.673 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.023 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.1 t -95.45 94.82 8.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.325 0.583 . . . . 0.0 110.229 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.8 p -86.0 141.92 29.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.162 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.6 mm -88.36 -38.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.346 0.593 . . . . 0.0 109.72 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.417 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 67.8 t90 -156.15 135.93 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.386 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.405 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 18.8 t-80 53.53 -141.04 0.89 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 53.3 t -98.4 38.68 1.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.498 0.666 . . . . 0.0 109.931 176.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.55 139.35 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.241 0.544 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.4 173.17 7.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.383 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -62.57 137.57 58.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.113 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.76 60.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.096 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.1 m -82.54 145.64 29.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.41 139.3 49.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.382 0.61 . . . . 0.0 111.383 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 53.5 mt -113.45 148.01 36.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.193 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 11.7 t -153.9 98.09 2.14 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.2 0.524 . . . . 0.0 110.653 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.88 116.27 19.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.762 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.591 -178.407 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 73.1 m95 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.922 0.391 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 9.4 pt20 -124.98 162.15 25.12 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.39 162.99 17.88 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.067 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -59.76 -44.41 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.77 -23.57 30.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.975 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.19 -53.95 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.225 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 67.2 t80 -68.89 -42.81 76.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.29 -41.13 75.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.719 178.108 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 46.2 t80 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.72 24.14 50.75 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.0 t -78.01 -5.94 52.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.605 0.241 . . . . 0.0 111.59 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.04 -31.06 7.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.495 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 161.41 153.3 6.98 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.102 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.5 mp -121.2 103.69 9.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.904 0.482 . . . . 0.0 110.717 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 30.0 tttm -87.29 119.61 27.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.973 0.416 . . . . 0.0 110.558 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.78 113.31 2.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 283' ' ' ASP . 89.0 mt -87.43 -52.05 5.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.1 t -145.76 160.24 42.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.322 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' LYS . 6.3 t60 -143.36 141.58 30.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -175.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 41.5 tt0 -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.478 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -100.97 124.08 46.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.917 -170.092 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.981 0.896 . . . . 0.0 113.307 -172.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 92.8 mt -96.9 114.34 25.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.987 172.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 4.5 ttmp? -97.84 109.9 22.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.449 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 16.4 mt -116.55 127.01 54.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.467 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 90.3 m -98.02 120.02 37.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.492 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.0 m-85 -105.41 161.74 14.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.462 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD21 ' A' ' 265' ' ' LEU . 37.4 t70 -125.8 132.08 24.2 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.524 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -80.59 11.11 3.03 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.302 2.002 . . . . 0.0 111.706 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.4 11.08 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.334 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -153.67 138.01 16.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.045 0.45 . . . . 0.0 110.354 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.81 -9.27 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.895 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -34.68 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.93 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -78.71 -44.09 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.609 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.74 161.13 8.66 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.985 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.57 145.24 25.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.013 0.435 . . . . 0.0 110.645 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.66 122.52 27.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 99.6 m -115.79 136.39 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.6 t -129.76 136.42 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.192 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.47 120.99 39.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.43 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.8 p -136.89 169.88 17.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.046 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -64.82 161.86 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.403 0.62 . . . . 0.0 111.13 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.666 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -70.71 -18.09 62.81 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.503 -168.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.34 24.14 9.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.374 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.9 122.31 86.23 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.551 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.76 129.76 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.381 2.054 . . . . 0.0 111.999 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 93.7 m-85 -116.52 118.48 32.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 35.3 t80 -73.78 100.06 3.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.707 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 74.8 t -88.7 134.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.342 0.591 . . . . 0.0 110.743 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.523 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.8 tttp -57.96 127.44 32.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.682 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.3 m-20 76.85 -2.79 2.62 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.036 0.835 . . . . 0.0 111.945 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -119.46 -21.2 7.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.758 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 78.21 -152.01 37.52 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.846 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.38 115.68 4.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 164.51 21.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.019 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -161.53 176.88 10.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.844 0.354 . . . . 0.0 111.25 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 328' ' ' ILE . 63.0 m-85 -87.58 -34.38 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.01 71.82 53.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 80.9 Cg_exo -52.09 -36.94 67.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.839 2.359 . . . . 0.0 112.756 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 5.9 p -63.55 -29.35 70.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.2 0.524 . . . . 0.0 111.299 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.26 -47.42 8.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.8 m -56.5 -41.3 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.366 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.444 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.7 p -69.06 -21.33 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 111.68 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 73.1 t -91.28 -29.51 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.567 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.82 -52.15 5.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.966 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -99.92 -6.46 26.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 74.4 20.34 79.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.6 116.18 36.93 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.645 0.222 . . . . 0.0 110.798 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.98 106.31 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.729 2.286 . . . . 0.0 111.238 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.7 m -106.53 151.2 25.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.038 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 65.2 m -79.66 147.97 31.8 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.858 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.14 134.28 51.46 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.958 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -88.44 171.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.143 0.496 . . . . 0.0 110.101 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -132.57 156.71 46.37 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.72 110.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.443 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 115.47 4.05 20.21 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.845 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.74 127.57 32.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.444 0.622 . . . . 0.0 110.341 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.9 p -90.92 136.97 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.862 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.9 m -102.32 134.91 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.387 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 66.1 mt -101.93 145.91 31.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.12 165.25 8.46 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.988 2.459 . . . . 0.0 112.49 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.26 122.64 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.645 2.23 . . . . 0.0 111.755 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.68 -17.6 27.82 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.706 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -65.99 125.64 90.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.48 -21.67 72.52 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 123.01 2.473 . . . . 0.0 113.128 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.63 -23.16 29.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.586 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.19 99.12 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.46 -45.31 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.206 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -124.44 84.96 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.279 -0.263 . . . . 0.0 110.879 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.46 -178.863 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.718 -0.532 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -94.3 93.06 7.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.342 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -85.31 140.23 30.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.992 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.475 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.8 mm -91.78 -43.18 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 109.886 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -149.8 126.86 11.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 26.2 t-80 59.74 -149.59 0.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.483 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 43.8 t -90.68 36.15 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.367 0.604 . . . . 0.0 110.414 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 62.5 m-85 -106.39 141.48 37.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.213 0.53 . . . . 0.0 111.059 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.88 170.38 8.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.367 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -67.16 131.39 45.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.82 7.72 41.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.905 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.3 m -97.89 150.2 21.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 219' ' ' THR . 7.9 mpt_? -114.95 143.07 45.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.771 0.32 . . . . 0.0 110.6 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 73.8 mt -120.71 147.66 44.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.605 -171.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 38.2 t -155.29 102.7 2.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.526 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 292' ' ' LEU . 7.4 m-85 -90.08 128.06 36.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.8 m170 . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.166 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 96.5 m95 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 2.3 pt20 -107.78 160.81 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.951 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -83.56 159.38 21.66 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.471 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.8 t -57.95 -51.45 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.2 -23.46 22.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.837 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.84 -52.33 11.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.382 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.33 -39.95 62.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.201 0.525 . . . . 0.0 110.486 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -64.1 -26.3 68.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.877 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 109.714 175.958 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.521 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 52.6 t80 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 121.173 0.511 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 78.56 25.17 61.34 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.2 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 52.7 p -76.64 -8.98 58.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.573 0.687 . . . . 0.0 111.878 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -110.18 -30.23 7.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.541 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 165.26 158.01 10.24 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.821 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -126.3 101.48 6.75 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.082 0.553 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.9 ttpp -87.7 119.59 28.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.291 0.567 . . . . 0.0 110.686 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.78 107.39 0.96 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.237 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.2 -48.26 12.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.35 . . . . 0.0 110.765 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.1 t -152.69 164.88 36.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.149 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.538 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 9.9 t60 -146.4 138.74 25.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.375 0.607 . . . . 0.0 111.992 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 10.2 tt0 -133.04 140.65 47.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.413 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.538 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 10.1 mt-10 -108.56 108.64 19.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.381 0.61 . . . . 0.0 110.323 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.731 -174.959 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.62 154.06 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.791 0.805 . . . . 0.0 112.486 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.88 108.18 19.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.394 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.646 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 2.3 ttmp? -92.29 108.34 19.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.419 HD11 ' HE1' ' A' ' 312' ' ' PHE . 14.7 mt -116.0 120.02 37.78 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.655 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 8.8 m -90.97 116.48 28.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.495 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 69.6 m-85 -105.25 167.82 9.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.359 0.599 . . . . 0.0 112.433 -171.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.44 134.62 21.28 Favored Pre-proline 0 C--O 1.217 -0.606 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.458 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.521 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -77.64 9.6 2.87 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 121.557 1.505 . . . . 0.0 112.169 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.95 -5.43 56.38 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -154.64 135.42 13.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.352 0.596 . . . . 0.0 110.766 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.44 -8.04 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.32 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.27 -39.92 80.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.583 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -82.45 -46.75 13.07 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.392 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 136.24 176.67 14.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.77 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.74 150.88 24.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.884 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -136.45 121.04 18.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.004 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.434 ' N ' HD22 ' A' ' 292' ' ' LEU . 14.1 m -108.36 134.27 51.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 97.3 t -129.47 128.58 66.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.101 0.476 . . . . 0.0 110.881 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -113.97 107.88 16.28 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.455 -177.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.5 p -123.6 173.14 8.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.093 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -75.88 163.29 27.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.736 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -65.6 -14.32 60.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.066 -170.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.02 11.13 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.784 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.21 118.97 73.92 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.151 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.81 133.29 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.405 2.07 . . . . 0.0 111.814 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.49 119.58 34.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 25.7 t80 -74.51 107.19 6.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.518 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 332' ' ' ASP . 57.0 t -94.89 133.39 35.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.309 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.736 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.4 tttp -63.95 128.92 37.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.575 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 6.4 m-20 75.39 12.73 3.18 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.98 0.8 . . . . 0.0 112.027 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -133.51 -48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.015 0.436 . . . . 0.0 111.268 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 105.97 -156.45 16.43 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -171.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -61.3 114.58 3.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.312 0.556 . . . . 0.0 110.678 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.5 m -128.92 166.46 19.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.257 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -161.36 175.07 12.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.252 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 328' ' ' ILE . 76.6 m-85 -88.48 -37.42 15.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.743 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -122.53 77.17 46.05 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.895 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -58.18 -31.41 93.34 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.975 2.45 . . . . 0.0 113.114 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 40.4 t -75.8 -21.2 57.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.341 0.591 . . . . 0.0 110.073 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.88 -48.6 7.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.217 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -51.49 -40.3 59.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.054 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.2 p -74.79 -29.54 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.209 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.36 -37.45 79.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.63 0.729 . . . . 0.0 110.319 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -100.8 -38.94 8.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.047 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -107.18 -3.63 19.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.142 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 69.35 16.16 71.04 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.942 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.72 109.6 52.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.666 -0.314 . . . . 0.0 110.588 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.74 118.03 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.737 2.291 . . . . 0.0 110.211 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.0 m -116.76 160.52 20.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.302 0.572 . . . . 0.0 112.494 -168.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.2 m -81.09 166.66 20.52 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.976 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -93.26 129.35 39.36 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.449 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -73.6 168.3 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.258 0.551 . . . . 0.0 110.696 -177.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -125.23 142.18 51.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.56 114.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.079 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.27 -4.24 20.13 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.159 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.423 ' HB3' HG13 ' A' ' 304' ' ' VAL . 54.2 m-20 -73.63 132.87 43.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -95.3 134.36 33.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.171 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.9 t -96.14 133.06 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.401 -176.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 83.6 mt -102.04 140.58 21.3 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.39 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.59 163.68 9.37 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.933 2.422 . . . . 0.0 112.152 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.57 122.58 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.587 2.192 . . . . 0.0 112.023 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.97 -7.17 41.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.426 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -74.44 125.83 89.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.71 -22.13 51.13 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.451 2.767 . . . . 0.0 114.233 -171.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.76 -28.47 44.81 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.726 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.463 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.05 85.3 2.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 86.4 mt -70.71 -43.89 76.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.892 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -124.05 81.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.534 -178.795 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.2 t -110.44 99.02 8.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.035 0.445 . . . . 0.0 110.067 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.5 p -84.07 150.49 25.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.895 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.487 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.0 mm -90.35 -40.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.702 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.476 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 85.7 t90 -150.14 125.94 10.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.6 t-80 60.94 -138.54 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 43.8 t -95.4 32.38 1.78 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.252 0.548 . . . . 0.0 110.32 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 219' ' ' THR . 66.4 m-85 -107.48 137.73 44.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.399 0.619 . . . . 0.0 111.645 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.71 178.75 4.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.284 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -63.06 144.62 56.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.262 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.54 11.71 63.76 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.399 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 44.9 m -101.88 145.74 28.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 294' ' ' VAL . 1.0 OUTLIER -111.81 136.29 51.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.727 0.299 . . . . 0.0 110.594 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.404 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.6 mt -114.42 144.18 43.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.727 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 8.5 m -154.08 93.92 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.08 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.476 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 11.7 m-85 -80.67 126.6 31.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.7 m170 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 121.052 0.453 . . . . 0.0 110.066 178.7 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 51.7 m95 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 1.6 pt20 -96.38 153.21 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.67 158.35 20.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -55.68 -49.73 72.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.424 0.631 . . . . 0.0 109.84 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.25 -23.24 55.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.762 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.37 -58.03 3.53 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.995 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -62.65 -48.27 80.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.123 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.08 80.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.632 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.945 -175.704 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 121.246 0.546 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 91.11 14.92 56.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.447 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.6 t -68.5 -12.99 62.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.093 0.447 . . . . 0.0 111.795 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -102.96 -32.54 9.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 0.0 109.977 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.56 160.73 10.51 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.427 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 4.4 mp -123.67 100.53 6.83 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.455 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.9 ttpt -82.18 122.36 27.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.009 0.433 . . . . 0.0 110.173 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.492 ' CD1' HD22 ' A' ' 280' ' ' LEU . 46.1 tp -64.28 103.19 0.6 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.897 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.1 mt -81.94 -44.16 17.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.761 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 t -151.91 152.13 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.329 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.573 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.5 t60 -135.52 137.71 42.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.471 0.653 . . . . 0.0 111.466 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 34.1 tt0 -129.48 140.46 51.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.969 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.573 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 21.7 mt-10 -115.33 103.52 10.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.272 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.78 -174.584 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.44 155.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.852 0.834 . . . . 0.0 112.785 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.567 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 82.8 mt -93.13 108.0 19.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.838 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 49.5 tttm -103.64 106.89 17.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.499 HD12 ' HZ ' ' A' ' 282' ' ' PHE . 9.6 mt -111.91 140.85 46.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.24 -173.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 21.9 m -112.92 116.07 29.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.499 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 86.6 m-85 -108.96 161.76 14.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 265' ' ' LEU . 17.6 t70 -121.54 132.34 24.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.118 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.74 10.18 3.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 113.047 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.99 -17.72 51.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.894 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -145.46 128.32 16.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.291 0.567 . . . . 0.0 110.24 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 -11.01 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.244 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.44 -31.31 72.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.096 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.96 -46.48 15.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.712 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 131.06 -163.42 23.5 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.988 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 mt -108.85 165.07 11.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.728 0.299 . . . . 0.0 110.858 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -136.18 119.58 16.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.3 m -108.88 135.82 49.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 53.2 t -136.71 136.1 48.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -100.64 124.25 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.21 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.0 p -136.86 170.79 15.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.652 0.263 . . . . 0.0 110.482 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -81.5 165.85 20.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.246 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.641 HD22 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -67.85 -17.78 64.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.51 -172.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -105.3 22.05 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.299 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -78.76 119.04 75.82 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.45 137.23 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.0 111.94 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 88.4 m-85 -123.98 120.63 33.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 46.5 t80 -75.87 110.25 10.16 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.239 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 51.8 t -99.05 137.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.412 -175.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -57.53 126.43 27.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.236 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 28.5 m120 75.72 -6.84 1.91 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.377 0.671 . . . . 0.0 112.33 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -114.74 -20.76 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.813 0.34 . . . . 0.0 111.527 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.66 -152.63 41.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.765 0.317 . . . . 0.0 110.419 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 19.8 m -129.01 166.2 19.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.988 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 12.4 t -161.94 -178.58 6.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.493 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 69.8 m-85 -95.65 -35.91 11.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.63 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.71 70.92 48.73 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.29 -35.62 96.61 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.263 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.6 p -68.03 -20.82 65.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.246 0.546 . . . . 0.0 110.511 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.0 tp -88.15 -44.04 11.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.114 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.2 m -55.05 -39.79 69.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.562 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.23 -23.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.73 -39.2 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 110.098 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -80.12 -58.35 3.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.027 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -92.95 -25.46 18.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.916 0.389 . . . . 0.0 111.312 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 90.36 22.09 35.85 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.064 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 61.4 mt -115.41 114.55 42.73 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 5.4 Cg_exo -76.96 103.71 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.79 2.327 . . . . 0.0 110.768 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 48.1 m -103.85 156.99 17.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.376 -168.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.9 m -81.56 165.34 21.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.61 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -92.25 124.16 36.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.45 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -67.8 165.3 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 -175.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -122.79 138.9 54.5 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.82 112.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.057 0.456 . . . . 0.0 110.344 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.07 6.11 19.01 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.185 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 5.7 m-20 -81.05 134.53 35.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.0 111.594 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 2.4 t -79.63 125.58 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.419 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 72.5 m -94.49 119.58 33.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.4 mt -100.99 141.59 22.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.83 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.48 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 78.2 Cg_endo -86.67 166.1 8.92 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.253 2.635 . . . . 0.0 112.442 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.75 115.45 4.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.676 2.251 . . . . 0.0 111.805 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 119.49 -16.57 10.51 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.313 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -67.7 127.25 93.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.22 -24.63 51.55 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.569 2.846 . . . . 0.0 114.211 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.26 -35.16 48.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.618 0.247 . . . . 0.0 110.647 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.53 86.41 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 110.136 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.5 -53.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.17 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.97 74.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.367 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.048 178.314 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.652 -0.557 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -92.08 103.69 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 110.167 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 p -84.58 141.31 30.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 8.9 mm -85.85 -42.79 16.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.293 0.568 . . . . 0.0 109.657 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -154.65 128.69 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.908 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.7 t-80 57.63 -149.67 0.46 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.559 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 34.2 t -88.61 43.75 1.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.688 -0.632 . . . . 0.0 110.397 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 65.3 m-85 -114.31 138.53 50.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.201 0.524 . . . . 0.0 111.274 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.4 176.09 5.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.328 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.515 ' HG3' ' CD ' ' A' ' 235' ' ' GLU . 88.1 tttt -62.54 141.99 58.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.292 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.26 4.7 64.27 Favored Glycine 0 CA--C 1.517 0.178 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.401 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.1 m -94.69 149.15 21.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -113.44 143.32 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.96 0.409 . . . . 0.0 110.973 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 63.5 mt -118.18 148.94 41.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.076 -174.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 35.0 t -154.13 101.33 2.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.996 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -86.38 98.06 10.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 291' ' ' LEU . 22.6 m170 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 62.8 m95 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.368 0.604 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 11.7 pt20 -132.15 156.41 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.989 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.79 154.27 38.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -58.29 -47.61 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 168.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.515 ' CD ' ' HG3' ' A' ' 217' ' ' LYS . 4.6 mt-10 -59.05 -21.59 59.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.501 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.0 -52.35 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.204 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.513 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.7 t80 -62.86 -48.45 78.99 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.011 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.05 -34.92 68.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.006 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 11.2 ttm180 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.518 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.648 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 41.6 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.28 15.97 59.74 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.418 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.9 p -69.11 -15.09 63.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.93 -26.59 10.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.49 156.74 8.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.638 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -123.88 100.11 6.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.392 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 76.0 tttt -84.42 124.4 31.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -65.36 104.59 0.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 283' ' ' ASP . 69.5 mt -80.52 -45.83 16.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.6 t -152.01 164.61 36.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.804 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.431 ' C ' ' CD2' ' A' ' 267' ' ' HIS . 0.1 OUTLIER -137.87 139.66 40.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.493 -168.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -146.31 140.98 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.283 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.76 109.81 21.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.047 0.451 . . . . 0.0 109.792 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.221 -171.59 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.01 155.63 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.826 0.822 . . . . 0.0 112.551 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.21 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.17 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -97.82 106.77 19.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.507 HD11 ' CE1' ' A' ' 312' ' ' PHE . 20.5 mt -114.46 139.26 49.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.4 m -103.76 120.8 41.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.567 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.8 m-85 -109.39 163.75 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 31.9 t70 -132.75 137.56 30.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.846 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.648 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 93.5 Cg_endo -83.24 9.42 4.1 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.241 1.961 . . . . 0.0 112.674 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.42 -11.19 50.78 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -153.18 114.75 4.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.544 0.688 . . . . 0.0 109.718 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.21 -8.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.985 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.25 -23.18 66.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.905 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.76 -42.97 20.92 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.758 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.7 153.52 5.95 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.992 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 224' ' ' HIS . 1.9 mt -73.15 155.18 39.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.011 0.434 . . . . 0.0 110.931 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -136.09 119.49 16.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 19.0 m -110.38 137.05 48.62 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 215' ' ' PHE . 90.9 t -130.73 134.93 61.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.159 -176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 32.8 mt-10 -117.83 120.66 38.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 172.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.519 ' HB3' HG23 ' A' ' 219' ' ' THR . 3.9 p -137.44 172.32 13.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.636 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.21 162.04 23.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 110.777 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.697 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.4 mm? -69.72 -8.9 51.89 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.123 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -105.03 13.87 30.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.416 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -73.43 116.59 52.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.826 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.14 119.4 5.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.247 1.965 . . . . 0.0 111.584 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.65 119.38 38.85 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 12.1 t80 -74.27 106.35 5.87 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.507 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.0 t -94.45 134.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.349 0.595 . . . . 0.0 111.273 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' A' ' 333' ' ' VAL . 49.8 tttp -58.5 125.27 22.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.329 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 79.6 m-20 78.08 -1.95 2.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.407 0.683 . . . . 0.0 112.196 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -117.75 -28.72 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 111.35 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLY . . . . . 0.407 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 86.15 -152.4 25.62 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.71 116.79 5.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.067 0.433 . . . . 0.0 110.091 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.439 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.5 m -128.66 166.23 19.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.368 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.5 t -160.85 171.74 18.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.805 0.336 . . . . 0.0 110.649 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.507 ' CE1' HD11 ' A' ' 280' ' ' LEU . 56.6 m-85 -86.23 -36.42 19.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.64 174.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -126.25 77.3 72.21 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.454 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 48.8 Cg_exo -57.08 -38.51 95.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.94 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 20.0 m -66.06 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.0 110.796 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.24 -47.25 9.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.995 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.9 m -56.62 -41.83 77.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.064 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.545 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.5 p -69.33 -20.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.707 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.01 -43.79 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -72.13 -51.56 20.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.076 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -101.49 -20.34 15.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.033 0.444 . . . . 0.0 111.026 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 86.28 24.09 41.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.409 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.2 mt -118.86 113.52 35.95 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.888 -0.183 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -71.2 117.02 4.94 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 110.305 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 80.2 m -117.6 155.46 29.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.007 0.432 . . . . 0.0 112.1 -169.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.31 164.75 23.84 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.266 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -92.52 120.36 32.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.439 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.06 162.45 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.506 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -125.34 150.36 47.25 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.37 113.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.681 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.515 ' O ' ' HE3' ' A' ' 263' ' ' LYS . . . 115.87 1.36 21.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.018 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.27 127.33 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.178 0.513 . . . . 0.0 110.433 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.63 133.98 30.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.407 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 53.6 t -94.82 131.25 40.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.235 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.3 mt -103.14 140.78 21.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.216 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.431 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.4 Cg_endo -86.81 167.34 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.88 2.387 . . . . 0.0 111.916 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.09 127.21 17.93 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 111.356 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 111.05 -18.22 26.32 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.431 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -71.27 127.43 91.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.03 -22.28 73.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.255 2.636 . . . . 0.0 113.448 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.17 -25.81 47.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.159 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.48 86.68 2.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.09 -45.66 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.766 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -124.2 75.72 1.4 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.648 0.261 . . . . 0.0 110.459 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.574 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.656 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -103.86 89.45 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.233 0.539 . . . . 0.0 109.934 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -76.82 144.13 39.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.28 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.4 mm -81.33 -42.08 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 68.9 t90 -153.8 139.93 18.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.327 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 53.1 -137.54 1.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 52.1 t -100.35 35.03 2.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.488 0.661 . . . . 0.0 109.968 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.97 140.32 42.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.4 0.619 . . . . 0.0 111.656 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.03 175.73 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.023 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -66.66 139.97 57.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.885 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.66 12.1 51.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.959 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 61.6 m -105.82 146.88 29.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -115.65 140.66 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.02 0.438 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.447 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 80.0 mt -114.53 145.08 42.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.107 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.35 109.1 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.463 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 292' ' ' LEU . 28.7 m-85 -99.58 115.5 29.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.0 m170 . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.878 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.514 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 57.7 m95 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.7 pt20 -117.49 162.84 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.34 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -89.18 160.0 17.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.066 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -57.95 -47.9 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -55.26 -22.74 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.63 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.93 -56.99 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.641 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.588 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 80.6 t80 -66.55 -40.4 89.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -53.47 -50.98 64.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.754 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.475 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 t80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.077 0.465 . . . . 0.0 111.874 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.38 42.68 3.91 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.827 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.8 m -79.1 -17.95 54.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -104.85 -29.49 10.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.478 0.656 . . . . 0.0 109.684 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 156.38 160.55 10.11 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.75 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -118.2 100.31 7.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.519 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.7 ttpt -83.9 117.05 23.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.214 0.53 . . . . 0.0 110.426 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.406 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.2 tt -61.22 103.7 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.136 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.6 mt -78.4 -48.93 14.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.883 0.373 . . . . 0.0 110.444 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.9 t -151.94 167.18 29.2 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.408 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.553 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.6 t60 -141.1 139.81 34.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.294 0.569 . . . . 0.0 111.512 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 35.9 tt0 -133.66 144.37 49.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.808 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 25.6 mt-10 -115.85 133.19 56.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.814 0.34 . . . . 0.0 110.133 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.701 -170.506 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.56 155.6 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.972 0.891 . . . . 0.0 112.945 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.401 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 74.7 mt -96.71 116.69 29.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.313 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 22.4 ttmm -107.29 114.08 27.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 26.9 mt -114.63 135.59 53.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.868 0.366 . . . . 0.0 110.344 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 12.4 m -97.64 115.57 28.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.559 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 61.7 m-85 -106.06 163.54 12.69 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -170.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 265' ' ' LEU . 20.1 t70 -132.0 137.87 31.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.327 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.475 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 86.7 Cg_endo -87.03 11.13 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.341 2.027 . . . . 0.0 112.649 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.89 -12.73 56.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.27 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 t -153.49 134.87 14.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.974 0.416 . . . . 0.0 110.088 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.01 -8.52 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.525 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -55.07 -49.28 72.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.95 2.59 38.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 84.91 179.13 51.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.157 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mt -84.47 135.45 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.966 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -111.37 120.12 41.13 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 25.4 m -112.73 135.92 52.91 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 96.2 t -132.27 135.42 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.743 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 83.2 mt-10 -107.52 120.4 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 169.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.579 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.1 p -131.88 173.37 11.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -74.68 164.9 26.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.644 0.259 . . . . 0.0 110.941 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.66 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.9 mm? -66.2 -28.84 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.336 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.73 26.11 5.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.293 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -77.63 116.77 60.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.485 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.44 125.15 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.256 1.971 . . . . 0.0 111.646 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.579 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -111.45 116.3 30.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.525 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 17.9 t80 -74.67 104.66 5.42 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.487 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.1 t -92.38 134.73 29.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.663 ' HB3' HG13 ' A' ' 333' ' ' VAL . 45.9 tttt -59.47 120.7 9.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.225 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 74.45 6.9 4.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.004 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -117.02 -30.41 5.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.002 0.429 . . . . 0.0 110.582 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.91 -155.8 23.32 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.47 116.09 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.033 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.453 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -124.83 167.47 14.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.077 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 39.9 t -160.57 165.86 30.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.818 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.468 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 60.3 m-85 -86.83 -16.55 35.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.281 173.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -142.11 73.35 22.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.73 -41.03 77.52 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.812 2.341 . . . . 0.0 112.581 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 14.6 m -60.42 -29.04 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.27 -46.09 10.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.253 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.2 m -57.34 -41.24 79.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.158 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -68.82 -19.86 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 0.0 111.573 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.7 t -89.96 -45.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.075 0.464 . . . . 0.0 110.265 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -71.9 -58.7 3.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.314 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -95.75 -13.78 23.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 0.0 110.732 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 85.1 10.75 77.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.859 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.4 mt -108.82 117.56 53.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 122.741 -0.27 . . . . 0.0 111.008 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.89 116.76 4.83 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.513 2.142 . . . . 0.0 110.409 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.1 m -117.2 159.06 23.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.376 0.608 . . . . 0.0 112.462 -168.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 61.4 m -81.59 151.0 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.142 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 120.06 22.09 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.31 165.57 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.891 0.853 . . . . 0.0 111.413 -174.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -121.94 141.63 51.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.373 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.8 mm -58.09 113.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 109.673 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.41 -0.92 20.56 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.78 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -71.33 124.77 25.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.208 0.527 . . . . 0.0 111.181 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -89.57 126.08 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.859 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.1 t -88.96 135.09 33.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.061 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 81.4 mt -106.37 144.07 28.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.631 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.3 160.61 13.11 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.474 2.116 . . . . 0.0 111.757 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.77 114.84 3.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.965 2.444 . . . . 0.0 112.25 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 115.29 -13.68 18.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.519 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.46 132.42 94.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.71 -31.1 49.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.105 3.204 . . . . 0.0 114.349 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -79.18 -23.12 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.99 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.07 95.76 3.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.066 0.46 . . . . 0.0 110.333 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.36 -42.27 81.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.855 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -139.62 98.14 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.091 -176.291 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 110.834 -0.487 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.6 t -103.52 110.63 22.75 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.5 p -94.9 150.76 19.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.287 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.5 mm -79.28 -45.96 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.376 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TRP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 78.5 t90 -151.36 136.71 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.445 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.2 t-80 56.04 -133.54 1.49 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' CYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 14.9 p -99.17 26.61 5.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.012 0.434 . . . . 0.0 110.867 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -105.61 135.41 47.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.952 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.57 174.84 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.424 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -64.31 139.34 58.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.847 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.77 12.05 44.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.138 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 30.8 m -102.38 158.18 16.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.24 151.59 42.15 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.416 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 56.5 mt -122.31 145.72 47.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.13 92.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.658 175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -78.61 123.02 26.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 12.6 m170 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 0.0 111.632 -174.725 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 231' ' ' TRP . . . . . 0.447 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 88.3 m95 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -100.09 158.97 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.532 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.05 164.35 21.46 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.163 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.1 t -66.27 -39.06 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.23 -22.05 64.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.503 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.69 -53.32 12.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.33 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.496 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 88.1 t80 -74.68 -40.31 61.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.236 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 212' ' ' TRP . . . -61.06 -35.4 76.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.842 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.607 0.718 . . . . 0.0 109.909 178.492 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.661 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 38.3 t80 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.95 11.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.656 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.9 t -78.81 -24.82 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.704 0.288 . . . . 0.0 110.552 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -99.39 -25.37 14.49 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.39 168.0 17.83 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.646 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.04 102.79 7.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.771 -0.714 . . . . 0.0 110.138 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 75.5 tttt -87.49 119.12 27.45 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.0 110.796 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.51 107.87 0.74 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.163 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.7 mt -83.13 -45.83 13.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.0 0.429 . . . . 0.0 110.48 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 32.8 t -151.88 156.33 39.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.211 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.406 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.8 t60 -139.12 138.22 36.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -131.57 141.46 49.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.397 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.28 129.61 53.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.649 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.5 m -130.04 152.59 37.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 122.029 0.918 . . . . 0.0 112.897 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.64 112.87 24.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.591 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -102.87 110.0 21.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.418 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 23.0 mt -115.34 129.73 56.69 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 87.7 m -98.94 117.17 32.84 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.444 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.0 m-85 -104.51 167.02 10.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.137 -170.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.457 ' HB2' HD21 ' A' ' 265' ' ' LEU . 21.9 t70 -132.34 134.52 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.413 175.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.2 Cg_endo -83.72 12.11 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.143 1.895 . . . . 0.0 112.332 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.64 62.06 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -153.71 102.94 2.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.911 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 291' ' ' LEU . 12.1 p -61.52 -15.28 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.421 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.16 -28.24 69.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.671 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -72.27 -40.5 67.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 110.161 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.85 152.72 5.98 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.422 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 287' ' ' VAL . 85.1 mt -82.26 147.76 28.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.221 0.511 . . . . 0.0 110.638 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 294' ' ' VAL . 1.5 tm? -125.05 118.32 25.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 83.8 m -110.3 134.0 52.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.403 HG23 HD13 ' A' ' 292' ' ' LEU . 75.3 t -130.33 136.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.561 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.447 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 62.5 mt-10 -112.54 127.94 56.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.105 170.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.0 p -139.82 176.28 8.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.93 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.94 164.17 26.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.913 0.387 . . . . 0.0 110.329 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.716 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.7 mm? -64.85 -17.84 64.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.245 -173.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.35 17.89 20.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.979 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.92 118.47 72.07 Favored Pre-proline 0 C--N 1.323 -0.563 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.339 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.58 139.82 16.36 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.104 1.869 . . . . 0.0 111.677 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.471 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 80.9 m-85 -124.5 129.73 51.16 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.9 t80 -82.63 89.62 6.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.498 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 332' ' ' ASP . 74.8 t -75.83 125.91 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.068 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.658 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.9 tttp -56.09 141.4 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.641 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.4 m-20 78.21 -20.04 0.41 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.47 0.708 . . . . 0.0 111.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -105.2 -60.53 1.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 111.345 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 125.76 -124.34 5.19 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.25 117.39 28.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.765 0.782 . . . . 0.0 110.606 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.8 m -131.8 167.88 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.23 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.3 t -161.34 -177.34 5.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 328' ' ' ILE . 71.6 m-85 -91.81 -39.09 11.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.22 73.2 57.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.877 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -57.17 -34.21 97.34 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.121 2.547 . . . . 0.0 113.213 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.8 p -65.35 -30.02 70.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.8 tp -83.15 -44.11 15.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.157 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -55.36 -44.16 75.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.151 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.7 p -69.81 -27.04 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.541 -176.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.7 -38.52 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.285 0.565 . . . . 0.0 110.186 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.26 -58.19 3.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.051 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -98.97 -8.46 25.42 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.25 21.44 75.62 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.2 mt -116.58 111.22 41.78 Favored Pre-proline 0 C--N 1.327 -0.394 0 O-C-N 122.876 -0.191 . . . . 0.0 110.646 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.33 117.95 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.582 2.188 . . . . 0.0 110.534 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 58.0 m -117.38 157.65 25.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.711 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 72.6 m -87.38 165.2 15.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.232 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.76 127.04 33.06 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.085 -0.384 . . . . 0.0 109.97 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.424 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -72.27 177.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 0.0 110.598 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -139.19 141.07 37.97 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.6 mm -52.34 112.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 109.575 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.49 9.13 15.27 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.735 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.2 OUTLIER -72.29 127.99 34.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -96.61 111.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.946 0.879 . . . . 0.0 111.051 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.7 m -79.24 127.84 32.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.112 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 69.5 mt -98.75 138.95 20.77 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.066 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.6 Cg_endo -86.14 176.65 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.923 2.415 . . . . 0.0 111.734 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.96 155.1 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.255 1.97 . . . . 0.0 111.029 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.0 -23.14 5.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.564 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -65.32 126.26 91.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -24.49 79.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.096 2.531 . . . . 0.0 113.152 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.94 -25.15 40.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.21 84.87 3.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.392 0.615 . . . . 0.0 109.507 173.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.26 -44.54 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.639 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.74 44.24 1.94 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.93 0.395 . . . . 0.0 110.616 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.093 -178.345 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.0 t -96.9 93.39 6.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 110.222 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 23.7 p -87.72 144.2 26.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.808 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.504 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 13.8 mm -85.21 -37.95 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.32 0.581 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -151.91 131.38 12.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 18.4 t-80 58.62 -138.43 0.81 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 51.5 t -98.61 37.18 1.52 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 110.155 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -113.44 137.59 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.44 172.02 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.044 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.7 141.12 51.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.976 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.13 5.56 54.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.212 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 50.1 m -99.08 147.98 24.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.46 137.0 49.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.195 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 39.9 mt -113.12 144.06 43.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.257 -174.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 40.8 t -153.17 92.03 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.558 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.431 ' CD2' HD23 ' A' ' 292' ' ' LEU . 5.8 m-85 -86.43 123.1 31.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -75.1 -4.63 39.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.87 -26.32 68.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.603 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -109.05 -172.13 1.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 5.5 p -85.34 3.48 39.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -77.26 66.79 3.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.4 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -75.19 -11.39 60.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.906 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.21 172.39 6.89 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.57 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -82.17 120.12 24.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -170.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.9 pt20 -111.71 165.37 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -85.34 160.37 19.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 3.6 t -61.33 -45.21 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.6 0.714 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -58.12 -23.16 53.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.9 -52.01 11.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.009 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -68.11 -40.37 82.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.43 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.74 76.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.615 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -70.71 -44.32 67.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.734 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.94 97.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.416 0.627 . . . . 0.0 110.623 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -92.66 28.66 1.96 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.459 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.1 p -55.18 -36.11 65.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.046 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 35.2 t -90.8 134.19 34.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.96 8.27 33.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.377 0.608 . . . . 0.0 111.218 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -179.12 124.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.643 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 250' ' ' GLN . 45.2 mt-10 -114.86 49.56 1.03 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.53 -24.75 61.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.646 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.33 -23.25 32.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.043 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 76.5 mt -121.99 -62.51 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 246' ' ' GLU . 20.8 tt0 -141.23 92.83 2.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 44.5 ttm -69.04 149.11 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 123.15 -46.32 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.541 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.1 m -58.71 111.86 1.42 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -173.23 147.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -78.31 38.33 0.29 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -89.84 -39.49 6.17 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.784 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.3 t80 -64.17 115.39 4.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.418 0.609 . . . . 0.0 109.699 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.76 19.31 44.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.388 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.4 t -66.92 -25.21 66.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.535 0.207 . . . . 0.0 111.312 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -99.17 -27.98 13.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.13 161.84 10.85 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.899 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -117.65 106.19 12.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.75 -0.725 . . . . 0.0 110.404 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.7 ttpp -90.56 119.32 30.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 -175.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 tt -60.08 113.13 2.17 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.09 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 95.4 mt -86.25 -52.14 5.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.452 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.2 t -148.57 158.98 44.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.783 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.495 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 4.1 t60 -135.71 136.24 40.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -127.3 139.52 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.571 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.495 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 28.5 mt-10 -108.95 106.4 16.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 110.063 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.3 t -127.11 178.02 6.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.637 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.44 121.0 66.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.352 0.596 . . . . 0.0 109.921 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 8.5 t -111.89 115.36 28.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.571 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.1 p90 52.68 30.51 8.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.625 0.77 . . . . 0.0 112.177 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.24 61.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.256 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -106.45 125.57 51.16 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.682 -0.305 . . . . 0.0 111.021 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.4 m -65.21 134.33 53.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.82 152.95 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.992 0.901 . . . . 0.0 113.068 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.33 114.08 26.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.985 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.8 ttmt -107.09 116.12 31.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.433 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 34.1 mt -119.88 131.23 55.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.205 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.6 m -95.45 114.95 26.77 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.563 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.4 m-85 -100.99 164.93 11.58 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.337 0.589 . . . . 0.0 112.471 -171.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 6.6 t70 -133.19 129.12 20.75 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.019 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 287' ' ' VAL . 83.6 Cg_endo -81.44 9.12 4.01 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 122.155 1.903 . . . . 0.0 112.348 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 -47.97 0.99 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -124.53 98.19 5.63 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.547 ' HA ' ' HD2' ' A' ' 284' ' ' PRO . 5.2 p -67.52 -6.98 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.464 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.28 -12.6 61.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.538 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -66.2 -37.18 84.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.38 126.98 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.467 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 287' ' ' VAL . 1.8 mt -59.97 135.32 57.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.179 0.489 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.6 tm? -109.45 119.24 38.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 6.5 m -109.35 139.96 43.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 73.5 t -136.75 131.47 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -105.67 117.62 34.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.319 169.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 9.6 p -134.53 178.17 7.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.877 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -81.06 165.54 21.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.696 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -68.75 -22.91 64.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.839 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.76 19.62 15.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.241 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.23 120.04 79.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.351 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.5 136.46 13.93 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.482 2.122 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 79.9 m-85 -124.2 124.96 43.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 8.0 t80 -77.53 93.07 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 332' ' ' ASP . 65.8 t -80.47 130.34 36.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.581 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 56.6 tttp -56.39 133.9 53.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.824 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.8 m-20 78.95 -17.13 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.02 0.825 . . . . 0.0 112.283 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 327' ' ' GLU . 11.6 tttp -111.36 -41.86 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.073 0.463 . . . . 0.0 111.571 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 104.71 -155.13 17.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -61.66 113.61 2.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.96 0.41 . . . . 0.0 110.587 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.7 m -131.08 164.94 24.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.043 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 t -160.99 179.76 8.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.636 0.255 . . . . 0.0 110.771 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.433 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 67.3 m-85 -91.53 -34.32 14.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.07 70.31 40.77 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 42.4 Cg_exo -59.13 -30.49 93.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.792 2.328 . . . . 0.0 113.425 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 16.0 m -70.35 -25.31 63.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.9 tp -87.54 -42.36 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.296 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.2 m -53.87 -46.08 71.22 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.877 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.9 -27.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.14 -30.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 0.0 110.417 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -92.85 -38.58 11.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.613 -173.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -114.67 -4.02 12.81 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 122.118 -0.364 . . . . 0.0 111.859 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.01 78.87 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 48.1 mt -118.67 111.26 37.87 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 122.834 -0.216 . . . . 0.0 110.697 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.95 118.18 5.5 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.426 2.084 . . . . 0.0 110.82 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 85.0 m -117.76 153.94 32.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.3 0.571 . . . . 0.0 112.056 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 69.0 m -89.6 166.26 13.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.848 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 25.2 tt0 -77.02 125.16 28.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.315 0.246 . . . . 0.0 111.194 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -80.64 168.0 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.791 175.204 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -133.06 151.1 52.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.1 mm -59.41 111.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.269 0.557 . . . . 0.0 109.717 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.56 1.15 21.64 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.413 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 304' ' ' VAL . 16.8 m-20 -79.0 128.75 33.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.457 0.646 . . . . 0.0 111.047 176.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.8 137.91 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.796 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 55.6 m -103.44 133.76 47.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.302 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.0 144.9 29.52 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.258 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.2 Cg_endo -87.98 166.09 7.12 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.143 2.562 . . . . 0.0 112.624 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 119.07 6.02 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.623 2.215 . . . . 0.0 111.157 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 118.34 -19.35 10.79 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.611 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -69.32 127.44 92.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.98 -13.98 40.66 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.178 2.585 . . . . 0.0 113.115 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 32.9 t70 -90.31 -23.25 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.83 87.36 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.054 0.454 . . . . 0.0 109.786 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.84 -44.16 92.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.603 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -127.18 80.15 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.914 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.507 -178.29 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.614 -0.571 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.5 t -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.1 p -85.94 149.6 25.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.83 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.2 mm -79.23 -43.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -151.99 137.56 17.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.549 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 25.7 t-80 54.54 -136.53 1.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 47.8 t -100.25 37.6 1.64 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.145 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -111.12 137.14 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.347 0.594 . . . . 0.0 111.443 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.12 175.9 5.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.42 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -69.23 135.17 50.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.03 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.36 48.39 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.471 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.7 m -96.13 143.93 26.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.3 -0.45 . . . . 0.0 109.923 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -109.48 141.73 41.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.824 0.345 . . . . 0.0 110.548 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 46.5 mt -118.12 143.13 46.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.24 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.3 t -151.0 99.45 2.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.42 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.575 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 35.4 m-85 -91.97 132.41 36.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -78.94 -16.56 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.76 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 16.8 pttp -79.5 -18.79 51.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.411 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.44 173.61 7.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.2 m -80.91 7.6 10.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.271 0.558 . . . . 0.0 110.316 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -82.05 66.57 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.598 0.713 . . . . 0.0 110.011 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.584 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 12.0 pttp -62.11 -19.86 63.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.402 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 36.5 mt-10 -122.42 175.47 6.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.94 135.0 46.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.66 0.743 . . . . 0.0 112.75 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 18.4 pt20 -128.66 161.21 30.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.685 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -82.06 158.1 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.423 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.6 t -58.25 -46.46 88.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.613 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 211' ' ' ILE . 25.6 mt-10 -57.55 -23.09 48.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.625 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.29 -45.94 14.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.0 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.727 ' CZ ' ' HG3' ' A' ' 255' ' ' LYS . 85.3 t80 -73.75 -35.91 65.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.983 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.08 67.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.709 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 239' ' ' ARG . 34.0 ttm105 -62.58 -29.31 70.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.748 . . . . 0.0 109.691 173.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.67 -8.7 58.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.938 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.862 ' HA ' ' HD3' ' A' ' 255' ' ' LYS . . . -76.56 -7.52 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.318 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.0 m -71.91 -12.32 61.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.212 0.53 . . . . 0.0 110.118 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.8 m -90.3 152.55 20.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.67 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 245' ' ' ASN . 16.4 t70 -106.85 -169.18 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.456 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 20.0 m120 -68.12 72.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.99 51.51 1.53 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 245' ' ' ASN . 25.2 mm-40 -59.94 -24.9 64.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.044 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.49 -20.27 57.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.111 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.35 107.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.644 0.735 . . . . 0.0 109.708 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -66.54 81.41 0.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.661 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.88 46.79 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 107.27 100.92 2.68 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.962 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.1 p -104.73 -178.93 3.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -85.85 135.22 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.347 0.594 . . . . 0.0 110.113 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.862 ' HD3' ' HA ' ' A' ' 241' ' ' ALA . 10.1 mptt -87.81 42.42 1.05 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.101 -173.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -88.9 13.55 62.69 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -66.08 117.18 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.018 0.437 . . . . 0.0 109.872 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.15 27.52 12.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.022 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.0 p -68.84 -22.61 64.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -99.52 -27.15 13.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.26 0.552 . . . . 0.0 109.811 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 150.19 154.39 6.43 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.946 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 5.5 mp -113.25 98.66 7.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.952 -0.624 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 8.4 tptp -77.99 115.62 17.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.5 tt -59.84 111.74 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 283' ' ' ASP . 82.8 mt -83.13 -51.87 7.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.061 0.458 . . . . 0.0 111.061 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.8 t -148.54 161.81 40.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.161 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -141.59 150.38 41.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.027 -168.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.79 135.58 12.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.884 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -87.18 106.06 17.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 t -111.75 -178.45 3.44 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.196 -168.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.07 133.01 61.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.2 t -122.32 87.14 2.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.293 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 58.49 55.4 4.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.665 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.08 34.65 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.678 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.635 ' HG3' HG13 ' A' ' 277' ' ' VAL . 3.3 pt-20 -148.02 133.19 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.402 0.601 . . . . 0.0 111.07 177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -73.07 128.54 35.76 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.855 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.635 HG13 ' HG3' ' A' ' 275' ' ' GLU . 8.9 m -134.6 157.07 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.695 0.76 . . . . 0.0 112.099 -175.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 90.0 mt -94.18 109.66 21.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.467 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -96.35 112.36 24.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.665 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 279' ' ' LYS . 29.6 mt -121.42 142.75 49.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.527 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 32.3 m -108.26 117.04 33.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 96.2 m-85 -105.6 157.45 17.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.554 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.461 ' HB2' HD21 ' A' ' 265' ' ' LEU . 7.2 t70 -126.82 132.79 24.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.714 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.4 5.55 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.017 1.811 . . . . 0.0 112.174 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.7 -13.29 42.33 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.2 t -153.89 133.13 12.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.057 0.456 . . . . 0.0 110.156 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.0 -8.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.856 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.4 -23.2 63.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.314 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASP . . . . . 0.557 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 4.1 m-20 -90.87 -2.93 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.075 0.464 . . . . 0.0 110.248 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.07 169.95 29.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.949 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.71 152.16 19.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -126.4 120.47 29.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 292' ' ' LEU . 8.9 m -111.25 138.58 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 75.6 t -137.38 137.59 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.42 121.1 40.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.809 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -138.38 173.29 11.76 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -68.64 160.87 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.122 0.486 . . . . 0.0 111.23 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.711 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.62 -27.42 68.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.31 24.99 4.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.433 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -75.31 121.34 84.99 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.206 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.28 131.27 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.279 1.986 . . . . 0.0 111.805 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -121.82 116.62 24.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 29.1 t80 -73.25 108.69 6.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.896 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 74.1 t -99.12 137.96 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.427 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.718 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.0 tttp -56.78 124.46 18.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.792 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 87.3 m-20 77.95 -1.45 2.58 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.878 0.736 . . . . 0.0 112.177 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -117.16 -33.16 4.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 90.25 -157.13 25.64 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -60.87 113.02 2.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.294 0.547 . . . . 0.0 110.019 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.4 m -125.23 166.75 15.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.6 t -161.58 -178.58 6.68 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.413 ' CE1' HD11 ' A' ' 280' ' ' LEU . 33.3 m-85 -90.32 -41.48 11.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 110.292 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.35 77.31 68.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.948 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 60.4 Cg_exo -55.03 -38.7 93.27 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.042 2.495 . . . . 0.0 113.448 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 2.3 p -62.34 -24.96 67.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.253 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.74 -45.24 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.768 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.2 m -59.03 -39.78 83.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.094 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -70.31 -19.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.531 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.25 -40.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.295 0.569 . . . . 0.0 110.33 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.76 -58.28 3.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.771 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -95.51 -14.93 23.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.727 0.299 . . . . 0.0 111.284 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 84.33 10.31 80.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.876 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.8 mt -109.09 115.69 56.49 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.71 111.29 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.351 2.034 . . . . 0.0 110.184 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.8 m -108.48 157.18 18.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.987 -170.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 164.68 23.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.992 171.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.43 123.57 35.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.236 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.424 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.4 161.83 4.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.98 152.56 51.9 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 38.9 mm -54.87 114.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 0.0 110.742 -174.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.64 -3.59 19.69 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.714 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.418 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 4.2 m-20 -75.42 128.15 34.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.531 0.665 . . . . 0.0 111.161 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 305' ' ' LYS . 0.9 OUTLIER -87.48 131.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.586 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 42.3 t -95.14 134.7 37.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.975 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.62 145.34 30.84 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.154 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.9 Cg_endo -87.95 166.44 7.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.833 2.355 . . . . 0.0 112.188 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.88 126.3 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.588 2.192 . . . . 0.0 111.35 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.69 -12.99 35.49 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.773 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.11 131.44 81.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 -33.25 87.96 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.43 2.754 . . . . 0.0 113.504 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.26 -22.3 44.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.57 0.224 . . . . 0.0 111.051 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.8 84.36 4.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 98.8 mt -73.49 -46.2 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.245 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.54 52.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 110.284 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.83 -177.931 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 N-CA-C 110.688 -0.543 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.1 t -100.38 85.85 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.052 0.454 . . . . 0.0 110.18 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.2 p -85.78 142.02 29.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.7 mm -88.6 -45.34 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.203 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.504 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 78.8 t90 -151.64 130.12 12.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.529 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.4 t-80 55.68 -144.99 0.64 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 30.6 t -94.79 44.74 1.1 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.357 0.599 . . . . 0.0 109.898 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -115.38 136.66 52.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.298 0.57 . . . . 0.0 111.155 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.89 174.45 6.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.297 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -63.63 133.76 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.036 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.11 19.17 34.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.802 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.591 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.8 m -104.51 149.13 25.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 294' ' ' VAL . 8.9 mtt180 -113.6 138.67 49.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.93 0.395 . . . . 0.0 111.471 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 67.7 mt -117.6 145.93 43.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.973 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 228' ' ' ASN . 9.1 t -156.46 95.57 1.58 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.871 0.367 . . . . 0.0 110.643 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -86.21 118.1 25.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 228' ' ' ASN . 13.5 m170 -66.5 -16.99 64.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 0.0 110.656 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.38 -31.74 70.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.408 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 227' ' ' SER . 4.1 pt-20 -145.27 -95.05 0.1 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.563 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 22.9 t -77.22 61.17 2.06 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.667 ' HA ' ' SG ' ' A' ' 222' ' ' CYS . 7.2 p30 -102.57 26.13 8.29 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.626 -0.671 . . . . 0.0 112.318 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 19.9 pttp -92.01 -29.81 16.4 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.857 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 35.9 mt-10 -131.83 176.88 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.081 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 222' ' ' CYS . 52.8 m95 -99.09 109.63 22.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.857 170.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.5 pt20 -97.91 157.21 16.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.462 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.72 162.96 21.61 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.591 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -61.38 -51.34 74.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.145 0.497 . . . . 0.0 109.811 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 36.9 mt-10 -56.34 -22.88 33.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.585 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.33 -45.34 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 70.1 t80 -75.96 -41.04 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 0.0 110.474 176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.73 68.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 8.7 ttm180 -69.06 -34.06 74.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.065 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.08 60.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.932 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -88.87 15.56 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.882 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 2.0 p -63.76 -59.06 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.73 78.83 6.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.95 57.85 4.08 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.323 0.582 . . . . 0.0 111.554 -168.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.14 42.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.699 0.761 . . . . 0.0 110.724 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.665 ' H ' ' HB ' ' A' ' 253' ' ' THR . 12.5 mm-40 -86.68 45.49 1.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.003 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.97 -54.04 6.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.478 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -69.1 -32.16 71.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.87 -57.76 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.779 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -93.35 -64.91 1.04 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.622 -172.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -168.12 -70.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.053 0.454 . . . . 0.0 110.169 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.48 71.29 0.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.627 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 246' ' ' GLU . 22.0 m -93.02 110.29 21.76 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.944 -0.151 . . . . 0.0 110.639 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -159.85 139.52 11.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.515 0.674 . . . . 0.0 111.134 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 255' ' ' LYS . 33.6 ttmt -75.12 41.14 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.549 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -115.85 -9.05 12.8 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.963 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.3 t80 -73.25 117.65 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.721 0.76 . . . . 0.0 109.999 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.49 67.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.978 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 53.0 m -70.15 -7.13 39.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.785 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -103.51 -31.58 9.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.275 0.56 . . . . 0.0 109.672 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.04 153.69 6.76 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.027 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.2 mp -119.17 103.33 9.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.604 0.361 . . . . 0.0 110.652 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 33.8 ttpt -86.7 123.73 32.18 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.004 0.431 . . . . 0.0 111.06 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.404 ' HG ' HD13 ' A' ' 280' ' ' LEU . 2.7 tt -65.36 97.75 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.654 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 283' ' ' ASP . 88.1 mt -71.63 -49.49 39.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.901 0.381 . . . . 0.0 110.461 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.1 t -151.46 165.95 32.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.274 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.758 ' HD2' ' HE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -131.44 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.618 -169.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -140.82 121.66 14.46 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.59 99.66 9.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.204 0.526 . . . . 0.0 109.841 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.6 t -117.82 178.76 4.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.92 -172.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.4 t -118.13 116.78 27.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.777 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 52.29 19.34 1.09 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.824 1.25 . . . . 0.0 112.483 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.18 -21.23 12.17 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.809 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -97.56 129.12 44.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.644 0.259 . . . . 0.0 111.03 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.8 m -67.62 131.26 45.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.15 154.75 41.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.759 0.79 . . . . 0.0 112.421 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 84.6 mt -92.5 107.42 19.2 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.729 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.0 ttmt -106.69 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.469 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . 43.6 mt -118.19 135.45 54.24 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.3 m -91.47 110.28 21.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 90.3 m-85 -99.7 162.15 13.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.095 0.474 . . . . 0.0 111.48 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.421 ' HB2' HD21 ' A' ' 265' ' ' LEU . 22.1 t70 -130.65 135.25 27.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.316 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -81.28 11.12 3.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.162 1.908 . . . . 0.0 112.43 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.26 -8.87 62.87 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 t -153.33 106.02 2.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.481 -0.86 . . . . 0.0 109.537 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.94 -8.88 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.497 0.665 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.99 -26.31 68.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.104 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.34 -44.31 25.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.17 153.32 5.93 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.474 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -74.34 143.33 44.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.854 0.359 . . . . 0.0 110.592 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.06 118.75 28.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 140.84 41.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.9 t -134.14 131.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -104.19 118.6 37.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 12.3 p -136.13 165.33 25.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.668 0.271 . . . . 0.0 111.493 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -61.72 162.13 9.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.208 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.8 mm? -70.79 -21.31 62.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 -175.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.0 22.5 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.16 119.14 74.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.339 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.24 134.47 9.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.203 1.935 . . . . 0.0 111.713 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.513 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -120.71 119.4 32.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 35.8 t80 -75.13 93.55 2.8 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.23 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 71.5 t -79.87 138.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.728 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 333' ' ' VAL . 57.4 tttp -61.26 134.88 57.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.226 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 7.1 m-20 76.27 -33.36 0.21 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.562 0.745 . . . . 0.0 112.087 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -86.68 -43.86 12.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.787 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 98.18 -155.96 20.36 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.99 112.89 1.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.037 0.419 . . . . 0.0 110.459 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.428 ' CB ' HG22 ' A' ' 328' ' ' ILE . 17.7 m -129.84 165.66 21.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.697 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.3 t -161.57 -176.88 5.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.586 0.231 . . . . 0.0 110.389 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.758 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 36.6 m-85 -92.91 -40.93 10.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.88 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -120.99 76.38 30.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.298 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.1 Cg_exo -57.27 -35.51 98.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.908 2.405 . . . . 0.0 113.148 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 3.7 p -65.19 -26.06 67.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.8 -47.08 8.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.278 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.2 m -57.87 -38.6 76.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.103 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.569 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.6 p -68.79 -20.23 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 111.464 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.99 -49.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.269 0.557 . . . . 0.0 109.816 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -67.41 -55.59 13.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.158 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -100.68 -9.68 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.23 15.91 80.36 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.592 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.0 mt -110.87 114.49 54.22 Favored Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 122.846 -0.208 . . . . 0.0 110.798 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.49 104.64 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.57 2.18 . . . . 0.0 110.33 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.5 m -104.39 154.07 20.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.046 -169.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.7 165.1 23.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.946 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.36 123.91 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.219 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.2 160.92 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -134.16 154.68 51.07 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 49.3 mm -52.29 115.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.324 0.583 . . . . 0.0 111.426 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.28 -2.9 22.27 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.073 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.432 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 6.5 m-20 -75.29 124.58 27.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.305 0.553 . . . . 0.0 110.78 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -86.76 143.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 55.8 m -112.16 132.52 54.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.985 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.64 147.65 33.92 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.705 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 55.1 Cg_endo -91.89 170.33 2.87 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.495 2.797 . . . . 0.0 112.828 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.74 133.17 23.19 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.534 2.156 . . . . 0.0 111.38 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.74 55.85 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.629 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -77.73 125.2 86.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.95 -21.73 73.37 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.047 2.498 . . . . 0.0 112.823 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 34.0 t70 -80.0 -27.38 39.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.683 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.36 88.85 3.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.816 169.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 83.7 mt -71.74 -43.49 69.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.368 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -114.41 73.93 0.85 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.598 -178.65 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 N--CA 1.479 0.662 0 N-CA-C 110.118 -0.762 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -100.4 87.79 3.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -82.97 143.9 30.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.945 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.11 -42.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.34 0.591 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -148.08 135.21 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.167 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.52 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.9 t-80 55.15 -135.01 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.458 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 12.0 p -97.64 24.4 6.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -104.6 139.83 38.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 112.064 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 174.94 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.391 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.57 140.53 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.607 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.82 11.1 54.35 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.976 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.573 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 80.9 m -103.34 146.92 27.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -113.99 139.88 48.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.938 0.399 . . . . 0.0 110.779 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.532 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.6 mt -116.17 146.47 42.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.375 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.1 96.45 1.95 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.18 119.18 29.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -69.72 -9.53 54.79 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.969 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.91 -30.71 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.892 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -113.75 -175.8 2.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.258 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.2 t -88.68 7.65 32.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.866 0.365 . . . . 0.0 110.82 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -83.08 75.94 9.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -76.41 -21.03 56.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.751 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.73 150.81 20.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.83 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.409 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 89.3 m95 -70.15 123.52 21.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 7.9 pt20 -108.96 161.55 15.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.541 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.13 162.91 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.43 -47.15 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.18 -22.22 50.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.75 -55.22 5.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.531 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.568 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 76.3 t80 -65.04 -41.0 95.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.83 -33.5 71.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -69.78 -44.37 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.445 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.392 0.615 . . . . 0.0 110.716 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.48 21.14 4.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.103 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.8 t -66.4 -38.51 87.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 27.0 m -78.99 120.89 24.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -101.94 5.14 40.68 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.824 -170.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -152.65 120.3 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.311 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -134.45 25.22 3.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.845 0.831 . . . . 0.0 108.796 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.97 -15.79 61.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.899 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.43 -33.09 48.8 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.6 mt -74.4 -63.4 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.43 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 177.76 -51.42 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.21 0.528 . . . . 0.0 110.465 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 51.7 tpp -69.5 133.82 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.867 -173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -79.5 53.66 4.27 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.674 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 10.7 m -66.94 120.56 13.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.494 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -174.12 151.77 1.75 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -85.67 37.67 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -70.52 -29.49 69.79 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.62 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 24.5 t80 -68.44 100.58 1.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.512 0.656 . . . . 0.0 110.239 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 106.48 6.94 35.28 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.549 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.9 m -67.1 -14.15 62.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 111.409 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.99 -30.82 11.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 0.0 109.294 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 149.3 161.15 9.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.526 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -122.6 99.1 6.22 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 122.483 0.313 . . . . 0.0 110.711 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 68.2 tttt -82.37 123.63 29.28 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.134 0.493 . . . . 0.0 111.525 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.97 95.35 0.26 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.584 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 283' ' ' ASP . 77.9 mt -71.47 -47.38 56.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 0.0 110.565 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.8 t -151.24 162.55 40.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.444 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.97 143.32 40.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.049 -168.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -149.57 137.49 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.366 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -98.99 97.17 8.35 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 p -99.83 176.67 5.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.409 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.1 p -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.605 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 7.7 t -141.36 130.71 23.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 60.79 26.24 16.07 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.44 0.463 . . . . 0.0 111.718 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.06 86.56 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.782 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -121.27 153.75 37.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.3 m -77.7 134.75 38.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.683 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.8 m -132.17 156.85 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.661 0.744 . . . . 0.0 112.062 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.34 107.57 19.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.382 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.1 ttmm -98.94 106.25 18.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 312' ' ' PHE . 21.1 mt -112.95 138.04 50.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.529 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 4.1 m -103.09 110.19 22.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.465 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 92.1 m-85 -100.33 162.66 12.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.032 0.444 . . . . 0.0 111.849 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.441 ' HB2' HD21 ' A' ' 265' ' ' LEU . 14.6 t70 -128.89 134.44 26.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.14 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 76.8 Cg_endo -80.0 12.55 2.43 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.259 1.973 . . . . 0.0 112.291 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 -14.45 49.61 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 t -153.15 127.42 9.16 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.822 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.28 -8.45 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.215 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -50.74 -41.06 56.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.996 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -77.05 -43.51 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.89 167.51 11.52 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.67 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 83.2 mt -90.24 140.56 29.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 0.0 111.192 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -113.05 122.85 48.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.488 ' N ' HD22 ' A' ' 292' ' ' LEU . 20.8 m -111.67 135.18 52.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.0 t -133.06 136.27 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.066 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.409 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 52.8 mt-10 -115.57 121.94 44.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 109.772 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.5 p -138.56 175.34 9.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.748 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -70.03 158.21 36.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.998 0.427 . . . . 0.0 110.832 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.709 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.77 -17.07 63.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.282 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -97.49 13.58 29.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.88 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -72.26 120.98 83.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.574 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.85 141.52 13.46 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.239 1.959 . . . . 0.0 111.662 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.504 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.1 m-85 -127.84 127.27 43.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.551 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 31.2 t80 -80.09 96.32 6.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.34 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.6 t -82.31 130.88 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.907 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.462 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.1 tttp -55.86 134.21 51.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.35 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 83.1 m-20 77.64 -23.08 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.872 0.733 . . . . 0.0 112.202 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -96.08 -43.49 7.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.0 111.446 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.56 -126.27 8.43 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.24 118.47 29.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.804 0.802 . . . . 0.0 109.958 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 20.1 m -131.45 166.57 21.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.527 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.0 t -161.52 -175.57 4.84 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.454 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 48.2 m-85 -92.77 -41.45 10.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 0.0 110.403 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.53 76.64 45.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 77.6 Cg_exo -55.25 -31.48 76.58 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.246 2.631 . . . . 0.0 113.597 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 33.9 t -71.22 -23.21 61.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.257 0.551 . . . . 0.0 110.096 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 61.2 tp -87.89 -44.85 10.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.116 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.3 m -54.5 -41.03 69.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.028 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -73.41 -18.28 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 96.1 t -88.24 -35.64 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.317 0.58 . . . . 0.0 110.013 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.26 -53.23 5.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.128 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -103.84 -4.04 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 70.02 26.33 74.45 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.564 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.5 mt -116.63 110.97 41.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 122.753 -0.263 . . . . 0.0 110.59 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -71.79 115.83 4.46 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.493 2.129 . . . . 0.0 110.399 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 73.7 m -116.96 156.98 26.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.437 0.637 . . . . 0.0 111.977 -169.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 58.6 m -79.99 165.95 22.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.255 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.59 140.42 29.57 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.89 164.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.357 0.599 . . . . 0.0 110.62 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -118.78 142.35 47.78 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 30.8 mm -60.22 114.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 109.843 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.3 -4.24 20.07 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.956 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.537 ' HB3' HG13 ' A' ' 304' ' ' VAL . 70.7 m-20 -73.84 130.55 40.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.728 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.97 133.29 33.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.057 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 50.9 m -98.12 134.83 40.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.142 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 43.8 mt -108.94 142.06 24.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.041 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.2 Cg_endo -85.06 168.43 10.53 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.325 2.683 . . . . 0.0 112.362 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 56.6 Cg_endo -71.37 114.3 3.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.797 2.332 . . . . 0.0 111.687 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.01 -20.67 8.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.813 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -67.11 126.66 92.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.64 -27.25 50.28 Favored 'Trans proline' 0 N--CA 1.476 0.453 0 C-N-CA 123.721 2.947 . . . . 0.0 113.738 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.96 -22.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.326 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.14 85.99 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.254 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.63 -43.88 70.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.572 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -107.04 42.52 1.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 1.1 t80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.941 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.6 t -86.19 92.06 8.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.079 0.466 . . . . 0.0 110.161 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.7 p -79.15 147.07 32.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.5 mm -79.5 -45.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.62 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -149.4 132.73 16.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.0 t-80 57.19 -139.46 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 44.5 t -97.5 36.74 1.45 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.384 0.612 . . . . 0.0 110.202 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.56 140.73 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 111.701 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.99 170.83 8.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -67.57 133.68 49.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.957 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.17 44.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.49 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.575 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 87.7 m -86.65 142.07 28.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -110.62 136.78 49.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.172 0.511 . . . . 0.0 110.941 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.566 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 57.1 mt -112.41 147.48 36.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.967 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.0 t -150.87 93.01 1.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.97 0.414 . . . . 0.0 110.234 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CD2' ' HG ' ' A' ' 292' ' ' LEU . 78.3 m-85 -83.57 119.14 24.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -69.23 -16.22 63.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.062 0.458 . . . . 0.0 110.559 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -79.75 -7.55 58.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.239 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 68.6 mm-40 -104.92 174.92 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.126 0.488 . . . . 0.0 110.742 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.6 m -82.56 -3.98 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.554 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -94.74 90.44 6.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.488 . . . . 0.0 110.741 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -77.88 -36.53 49.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.18 0.99 . . . . 0.0 108.652 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 230' ' ' GLU . 5.1 mp0 -62.06 155.47 23.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.669 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -74.42 138.84 43.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 0.0 112.372 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.706 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 10.0 pt20 -128.07 165.16 20.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.39 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.5 163.86 15.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.233 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.0 t -58.46 -51.5 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -58.01 -23.44 54.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.18 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 232' ' ' GLN . 31.9 t70 -73.58 -45.29 54.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.297 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.706 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.4 t80 -75.1 -45.41 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.49 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -55.72 -43.83 76.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.499 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.68 -34.54 74.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.28 -16.66 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.72 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' A' ' 253' ' ' THR . . . -90.87 18.69 6.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.055 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 41.0 m -57.98 -36.59 72.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.276 0.56 . . . . 0.0 109.608 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.2 t -90.7 151.26 21.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -114.55 -8.06 12.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.064 0.935 . . . . 0.0 109.76 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -152.28 139.56 19.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.685 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.9 70.7 1.46 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.24 -22.52 38.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.321 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.08 -0.51 40.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 4.8 mt -139.09 150.44 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -71.41 69.45 0.58 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.171 0.51 . . . . 0.0 109.821 171.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.8 161.22 42.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.06 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -152.61 94.26 0.15 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.776 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.426 HG21 ' HA ' ' A' ' 241' ' ' ALA . 2.9 m -66.74 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.404 ' H ' ' HB ' ' A' ' 253' ' ' THR . 17.3 t60 64.1 93.05 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.952 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -69.53 -11.38 60.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.01 -13.86 50.26 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.779 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 23.0 t80 -65.28 105.84 1.21 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.376 0.588 . . . . 0.0 109.79 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.82 8.65 59.15 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.011 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.7 m -67.79 -15.86 63.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -102.88 -31.69 10.14 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 164.08 156.77 9.0 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.217 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.7 mp -119.97 103.75 9.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.709 -0.746 . . . . 0.0 110.163 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 21.8 ttpp -88.29 119.35 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.269 0.557 . . . . 0.0 111.339 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.401 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.7 tt -62.12 103.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.347 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 283' ' ' ASP . 86.7 mt -76.2 -49.17 17.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.898 0.38 . . . . 0.0 110.528 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 34.4 t -153.11 164.02 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.539 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -141.44 135.75 30.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 41.2 tt0 -130.14 137.54 50.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.245 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.39 124.43 34.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t -138.28 178.53 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.628 -167.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.44 69.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.1 t -134.34 122.61 22.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 59.47 35.45 22.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.375 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 77.02 3.69 81.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.938 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.606 ' HB3' ' HE2' ' A' ' 297' ' ' LYS . 46.2 mt-10 -112.12 136.37 51.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.5 m -71.04 134.61 47.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.071 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.83 156.57 31.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.017 0.913 . . . . 0.0 112.861 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 79.1 mt -95.51 116.25 28.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.639 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 40.4 ttmt -100.65 112.25 24.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 19.3 mt -118.45 130.34 55.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 31.4 m -97.97 111.01 23.48 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.5 m-85 -96.94 162.48 13.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.332 0.587 . . . . 0.0 111.872 -172.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.451 ' HB2' HD21 ' A' ' 265' ' ' LEU . 4.1 t70 -127.85 127.45 23.94 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.49 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 80.0 Cg_endo -79.45 10.12 3.17 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.181 1.92 . . . . 0.0 112.067 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.7 -15.03 53.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.8 t -153.85 135.07 14.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.197 0.522 . . . . 0.0 110.667 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.32 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.131 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.87 -32.12 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.861 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -84.2 -47.13 11.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.524 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.43 159.49 7.96 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.794 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.1 151.17 25.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -119.68 123.4 43.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 26.0 m -110.27 130.92 55.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.51 131.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.384 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.52 118.38 34.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.453 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.6 p -134.58 164.0 28.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.732 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.606 ' HE2' ' HB3' ' A' ' 275' ' ' GLU . 33.7 mmtp -66.17 157.85 30.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.364 0.602 . . . . 0.0 111.109 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.77 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.5 mm? -61.59 -23.83 66.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.212 -168.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.71 23.2 5.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.516 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.37 121.09 84.27 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.538 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.56 130.66 7.96 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.286 1.991 . . . . 0.0 111.609 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 90.8 m-85 -120.66 114.2 21.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 25.4 t80 -73.3 102.45 3.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.327 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 332' ' ' ASP . 55.2 t -88.7 136.04 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.255 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.656 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 54.4 tttp -57.93 124.46 19.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.905 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 76.81 -5.21 2.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.366 0.666 . . . . 0.0 112.392 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -110.85 -32.25 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.14 0.495 . . . . 0.0 111.403 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.92 -152.68 21.9 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -64.74 112.38 3.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 117.18 0.49 . . . . 0.0 110.382 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.4 m -125.33 165.26 18.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.0 t -161.48 -177.84 6.22 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 65.3 m-85 -93.0 -39.34 11.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.523 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -123.74 73.73 54.02 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.748 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.97 -37.05 93.75 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.176 2.584 . . . . 0.0 113.356 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.2 m -64.74 -25.75 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.232 0.539 . . . . 0.0 110.693 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.1 tp -87.25 -44.3 11.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.963 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.2 m -55.18 -41.86 72.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.993 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.8 p -70.77 -26.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.66 -35.16 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -84.32 -58.44 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.917 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.48 -10.98 24.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.04 25.65 61.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.615 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.6 mt -122.71 113.11 30.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 122.849 -0.206 . . . . 0.0 110.877 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.85 119.41 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.423 2.082 . . . . 0.0 110.365 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 68.2 m -117.37 156.11 28.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 112.141 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 57.5 m -79.71 164.45 23.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.104 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -93.76 115.79 28.23 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.491 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -66.46 165.23 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 111.229 -173.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -122.26 140.37 52.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.721 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.32 115.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.221 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.3 -2.27 22.27 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.908 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.442 ' HB3' HG13 ' A' ' 304' ' ' VAL . 44.0 m-20 -75.23 132.95 41.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.33 0.586 . . . . 0.0 111.34 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -93.68 135.16 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.964 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 51.1 m -100.81 132.69 46.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.463 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.424 HD11 ' OD2' ' A' ' 341' ' ' ASP . 76.0 mt -100.18 144.85 29.2 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.273 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 86.1 Cg_endo -87.63 165.04 7.78 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.099 2.532 . . . . 0.0 112.744 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.99 113.49 3.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.921 2.414 . . . . 0.0 111.572 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 124.83 -23.22 6.29 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.952 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -65.79 128.0 93.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.9 -20.24 64.31 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.127 2.551 . . . . 0.0 112.495 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.656 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 23.2 t0 -79.32 -26.03 42.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.967 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -72.16 98.89 2.22 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.53 -39.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.899 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.99 103.64 4.2 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.459 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.005 -178.756 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -107.99 109.41 20.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.0 p -96.28 147.4 23.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.384 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.73 -40.54 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.382 0.61 . . . . 0.0 109.817 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 71.4 t90 -156.7 134.52 10.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.924 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.473 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 27.3 t-80 57.5 -142.42 0.72 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 49.1 t -96.98 37.29 1.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.465 0.65 . . . . 0.0 110.157 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.89 133.32 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.59 171.55 8.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.546 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -61.57 131.15 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.933 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.13 12.55 31.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.286 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 52.2 m -103.5 149.94 24.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.6 mpt_? -119.67 144.73 47.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.937 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.4 mt -118.99 147.81 43.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.24 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 42.4 t -158.11 98.16 1.57 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.811 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.556 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 27.5 m-85 -81.86 126.26 31.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -66.66 -28.91 68.84 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 16.2 pttm -81.62 -5.19 57.82 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.083 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 65.4 mm-40 -97.73 160.67 14.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.852 0.358 . . . . 0.0 110.175 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 4.6 m -84.65 32.09 0.52 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.414 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.03 103.02 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.185 0.517 . . . . 0.0 110.871 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -88.15 -46.5 9.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.706 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.21 148.59 44.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.363 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -71.22 117.2 12.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.712 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.5 pt20 -97.32 155.42 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -82.53 161.8 22.21 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.0 t -63.59 -38.21 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -21.84 64.72 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.242 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -80.93 -50.33 9.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.443 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.477 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 63.8 t80 -65.84 -46.1 79.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.717 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.89 71.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 110.478 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -67.25 -44.9 78.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.272 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.98 71.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.409 0.623 . . . . 0.0 110.565 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 244' ' ' ASP . . . -90.59 21.58 3.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 8.3 t -76.94 -33.33 57.71 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 30.8 m -83.21 60.71 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.553 ' OD1' ' HA ' ' A' ' 254' ' ' HIS . 37.4 t70 -84.56 52.48 2.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.5 -168.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -176.37 47.84 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.589 ' HB2' HG21 ' A' ' 253' ' ' THR . 43.1 mt-10 -81.15 38.72 0.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.46 -23.4 66.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.102 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.42 -37.16 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.153 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.658 HG22 ' HG2' ' A' ' 250' ' ' GLN . 71.3 mt -93.38 -57.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.404 -175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 249' ' ' ILE . 18.4 mm-40 -120.68 141.46 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.915 0.388 . . . . 0.0 110.985 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 14.6 tpt -74.55 70.07 1.76 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.144 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 144.89 88.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.631 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 246' ' ' GLU . 11.3 m -146.15 81.18 1.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.553 ' HA ' ' OD1' ' A' ' 244' ' ' ASP . 42.4 t60 -161.23 135.9 7.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.761 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -67.34 39.52 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -91.87 4.65 78.81 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.164 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 32.4 t80 -69.41 108.09 3.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.14 55.88 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.494 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 50.7 m -65.56 -11.01 40.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -104.7 -34.16 8.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.285 0.564 . . . . 0.0 109.808 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 169.47 154.01 8.88 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.923 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.3 mp -122.63 99.82 6.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.778 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.703 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.5 ttpt -83.93 122.28 28.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.234 0.54 . . . . 0.0 110.942 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.437 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 2.3 tt -65.24 110.4 2.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.899 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 80.1 mt -85.12 -44.66 12.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.714 0.292 . . . . 0.0 111.161 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.6 t -153.12 157.19 40.01 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.96 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.3 OUTLIER -133.46 142.84 48.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.022 -170.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -149.23 125.95 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.73 120.8 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.8 t -139.23 179.66 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.09 138.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.3 t -140.82 113.38 8.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.756 0.312 . . . . 0.0 110.25 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 57.87 42.5 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.507 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 95.87 -26.47 20.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.443 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -103.51 138.35 40.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.084 0.442 . . . . 0.0 111.031 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.44 ' HB2' HD21 ' A' ' 298' ' ' LEU . 67.4 m -74.09 131.26 41.15 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.46 157.82 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.847 0.832 . . . . 0.0 112.566 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 95.8 mt -95.57 112.89 24.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.741 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.5 ttmm -99.39 105.5 17.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.542 HD11 ' HE1' ' A' ' 312' ' ' PHE . 22.1 mt -113.12 139.69 48.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.524 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.8 m -101.16 110.6 22.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.9 m-85 -100.85 158.53 15.91 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 0.0 111.685 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 9.7 t70 -124.94 135.96 27.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.362 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.576 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -83.44 9.81 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.948 1.765 . . . . 0.0 112.431 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.09 -6.15 53.59 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -153.26 125.19 7.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.343 0.592 . . . . 0.0 110.467 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -10.3 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.37 -35.45 80.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.919 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASP . . . . . 0.469 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 10.7 t70 -76.17 -46.9 26.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.204 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.02 166.2 10.7 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.442 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.93 146.2 28.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.915 0.388 . . . . 0.0 110.686 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.451 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER -119.46 121.13 38.75 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.8 m -106.96 132.14 53.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 88.1 t -131.15 135.28 60.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.055 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -114.61 122.05 45.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.078 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.473 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.3 p -136.03 175.07 9.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 299' ' ' ASP . 10.5 mmmm -66.19 157.53 31.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.488 0.185 . . . . 0.0 111.056 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.834 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.1 mm? -60.8 -37.27 81.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.837 0.827 . . . . 0.0 109.677 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HB3' ' A' ' 297' ' ' LYS . 6.6 p-10 -80.79 24.52 0.48 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.08 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -82.92 119.65 74.73 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.347 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.06 132.8 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.078 1.852 . . . . 0.0 111.682 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.8 118.25 30.34 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 2.5 t80 -72.32 102.81 3.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.142 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.42 135.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.307 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.569 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.9 tttp -61.17 134.57 57.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 83.0 m-20 76.61 -6.45 2.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.531 0.732 . . . . 0.0 112.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.04 -47.75 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.64 -147.25 16.18 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' TRP . . . . . 0.461 ' HZ2' ' HA ' ' A' ' 345' ' ' PHE . 98.9 m95 -72.85 102.14 3.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.679 0.739 . . . . 0.0 110.974 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.499 ' CB ' HG22 ' A' ' 328' ' ' ILE . 5.6 m -106.47 172.51 6.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.737 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.1 t -163.04 179.2 7.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.532 0.206 . . . . 0.0 110.625 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.542 ' HE1' HD11 ' A' ' 280' ' ' LEU . 32.0 m-85 -92.84 -35.26 13.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 298' ' ' LEU . 93.0 m-85 -125.25 74.35 67.68 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 62.5 Cg_exo -55.09 -33.65 84.49 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.179 2.586 . . . . 0.0 113.534 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 35.9 t -74.85 -22.07 58.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.975 0.417 . . . . 0.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.6 tp -87.88 -45.75 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.502 . . . . 0.0 110.311 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -52.91 -37.17 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.974 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.69 -24.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.713 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.82 -33.81 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.0 110.456 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -101.99 -54.37 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.432 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -91.67 -8.05 48.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.161 -0.337 . . . . 0.0 110.736 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.58 16.94 76.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.378 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.8 mt -110.04 110.41 58.75 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.41 105.33 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.495 2.13 . . . . 0.0 110.445 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 84.4 m -101.47 159.18 15.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 112.369 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 1.4 p -85.83 159.68 19.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.416 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -79.93 125.61 29.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.499 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.82 168.36 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.386 -0.525 . . . . 0.0 109.816 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -133.37 146.67 51.48 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 41.3 mm -54.46 113.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.374 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.57 -4.37 19.52 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.419 -176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.52 121.42 17.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.155 0.502 . . . . 0.0 110.467 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -84.74 133.05 30.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.691 0.758 . . . . 0.0 112.115 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 47.3 t -95.39 134.79 37.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.376 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 69.1 mt -105.62 144.57 29.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.853 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -86.94 163.51 8.88 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.803 2.336 . . . . 0.0 112.142 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 121.42 8.73 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 112.047 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.01 31.98 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.491 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.429 ' CD2' ' HD2' ' A' ' 340' ' ' PRO . 25.3 t-80 -75.18 134.08 74.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 339' ' ' HIS . 11.7 Cg_endo -54.73 -28.8 58.86 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.975 3.117 . . . . 0.0 114.0 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.27 -35.15 48.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -70.52 98.74 1.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.888 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.88 -45.66 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.256 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -131.18 94.51 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.461 ' HA ' ' HZ2' ' A' ' 309' ' ' TRP . 3.5 t80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.594 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.481 0.78 0 N-CA-C 110.769 -0.512 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 99.41 10.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.6 p -85.79 145.29 27.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.905 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.456 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.4 mm -80.41 -43.23 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.511 0.672 . . . . 0.0 109.5 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -151.51 136.04 16.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.244 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 25.4 t-80 55.53 -136.09 1.27 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 46.3 t -100.13 32.06 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.64 . . . . 0.0 110.011 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -103.0 139.81 38.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.256 0.55 . . . . 0.0 111.417 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 177.74 5.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.462 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -65.59 143.73 57.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.327 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.01 58.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.184 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 39.9 m -106.24 145.61 31.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.45 144.0 38.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.949 0.404 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 67.0 mt -119.45 149.05 42.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.057 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.2 t -158.07 103.96 1.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.042 0.448 . . . . 0.0 110.426 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.52 123.32 34.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.261 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -71.09 -20.78 62.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -85.15 3.49 38.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -128.84 175.63 8.48 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.8 t -93.21 6.18 48.92 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.239 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -77.87 86.69 4.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.87 0.843 . . . . 0.0 110.11 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -83.27 -41.37 18.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.366 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.25 156.52 31.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.413 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 49.4 m95 -71.91 112.26 7.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.372 0.606 . . . . 0.0 112.536 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 8.7 pt20 -98.95 160.88 13.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.979 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 160.6 17.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -57.35 -48.83 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HA ' HG21 ' A' ' 211' ' ' ILE . 16.0 mt-10 -56.42 -24.82 47.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.35 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.53 -47.42 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.434 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.558 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.8 t80 -68.82 -42.15 77.61 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.605 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.34 70.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.332 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -64.38 -44.34 91.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.835 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.98 83.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.17 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 253' ' ' THR . . . -90.74 21.97 3.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.048 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.0 m -79.75 -9.71 59.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.207 0.527 . . . . 0.0 110.004 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.597 ' HB3' HG21 ' A' ' 253' ' ' THR . 21.7 t -91.3 159.3 16.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 246' ' ' GLU . 20.9 t0 -67.04 154.21 41.76 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -62.42 105.82 0.67 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.75 0.785 . . . . 0.0 111.708 -176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 244' ' ' ASP . 34.6 mt-10 -115.22 37.42 3.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.978 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -20.88 59.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.676 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.69 -23.44 56.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.191 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.624 HG22 ' HG2' ' A' ' 250' ' ' GLN . 55.6 mt -101.21 -62.22 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.532 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.624 ' HG2' HG22 ' A' ' 249' ' ' ILE . 76.6 mm-40 -145.24 -68.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 24.7 ttt -92.26 154.35 18.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 111.467 -167.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.97 67.6 0.87 Allowed Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 243' ' ' CYS . 1.9 p -99.02 30.18 3.52 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.152 0.501 . . . . 0.0 111.641 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -90.01 75.54 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.399 0.618 . . . . 0.0 109.349 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -67.19 -3.12 6.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.167 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -73.85 -4.61 67.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.381 -0.437 . . . . 0.0 113.446 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 21.8 t80 -60.37 124.2 19.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.213 0.507 . . . . 0.0 109.92 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.54 17.21 55.47 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.431 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -21.03 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.07 -27.56 13.19 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.459 0.647 . . . . 0.0 109.586 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 157.48 166.65 17.28 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.653 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.93 99.98 6.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.796 -0.702 . . . . 0.0 110.316 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 49.1 tttp -84.0 117.87 23.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.059 0.456 . . . . 0.0 110.589 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.435 ' HG ' HD13 ' A' ' 280' ' ' LEU . 3.1 tt -58.69 107.57 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.13 -42.02 16.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.659 0.266 . . . . 0.0 110.924 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.3 t -153.49 168.02 27.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.409 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.511 ' C ' ' CD2' ' A' ' 267' ' ' HIS . 0.2 OUTLIER -140.35 137.09 33.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.921 -167.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -143.77 135.63 26.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.414 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -106.76 127.59 53.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t -149.35 178.04 9.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.913 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.7 p -117.44 116.46 51.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 23.7 t -122.49 125.13 45.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.253 -172.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 59.74 29.4 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.667 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 86.87 -1.29 86.83 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.84 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.28 130.27 55.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.803 0.335 . . . . 0.0 110.375 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 18.7 m -68.95 131.13 44.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.61 154.72 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.753 0.787 . . . . 0.0 112.905 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.57 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 95.5 mt -94.77 109.65 21.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.668 171.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -104.24 110.82 23.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.044 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 312' ' ' PHE . 45.7 mt -120.89 138.82 53.91 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.836 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.2 m -92.84 114.77 27.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.574 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 83.5 m-85 -102.72 161.56 13.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.055 0.455 . . . . 0.0 111.614 -174.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.0 t70 -131.15 135.81 27.8 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.138 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 95.9 Cg_endo -79.71 13.03 2.22 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.23 1.954 . . . . 0.0 112.714 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.17 -16.23 42.45 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.9 t -153.86 129.33 9.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.021 -0.589 . . . . 0.0 109.866 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.98 -8.16 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -61.32 -26.12 67.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.747 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.46 -46.67 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.1 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.33 166.46 10.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.905 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.35 148.69 25.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.76 121.98 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 14.8 m -105.99 133.11 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 59.1 t -132.72 134.1 58.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.413 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 90.4 mt-10 -107.84 112.72 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.931 172.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 10.2 p -122.95 172.5 8.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -76.77 160.81 28.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 0.0 110.317 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.757 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -64.76 -23.28 67.2 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -174.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -97.88 16.98 19.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.421 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.98 117.55 55.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.662 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.98 122.38 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.081 1.854 . . . . 0.0 111.432 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.506 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -112.04 105.73 14.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 26.4 t80 -70.67 108.9 4.61 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.979 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.48 138.2 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.557 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.704 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.0 tttp -63.14 128.59 36.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.456 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.9 m-20 72.13 17.33 5.08 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.635 0.584 . . . . 0.0 111.811 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -137.99 -43.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.431 . . . . 0.0 111.76 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 98.55 -160.09 20.42 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.14 115.66 3.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.537 0.668 . . . . 0.0 110.286 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 17.0 m -127.59 165.18 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.139 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.4 t -160.58 171.68 18.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.995 0.426 . . . . 0.0 110.397 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 280' ' ' LEU . 73.6 m-85 -85.88 -35.68 20.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.526 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -127.01 76.45 76.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.253 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.49 -34.44 97.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.686 2.257 . . . . 0.0 112.537 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.9 p -65.45 -23.04 66.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.167 0.508 . . . . 0.0 110.814 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.46 -46.35 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.777 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.0 m -56.43 -41.77 76.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.932 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.519 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.2 p -70.27 -21.36 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.752 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.0 -38.33 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.371 0.605 . . . . 0.0 110.242 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -80.87 -56.8 3.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.032 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.43 -8.76 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.843 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 75.38 21.07 78.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.462 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -115.23 116.2 42.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 122.773 -0.251 . . . . 0.0 110.432 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.48 117.71 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.514 2.142 . . . . 0.0 110.79 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.3 m -117.76 160.98 20.46 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 78.5 m -85.43 164.25 18.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.599 173.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.46 125.88 34.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.05 165.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.003 0.906 . . . . 0.0 111.542 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -121.09 144.16 48.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.833 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.78 110.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.684 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 263' ' ' LYS . . . 116.33 2.89 19.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.754 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -69.83 124.78 24.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.076 0.465 . . . . 0.0 110.641 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -91.25 125.2 44.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.826 0.822 . . . . 0.0 111.993 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.7 133.82 34.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.161 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 341' ' ' ASP . 63.6 mt -106.27 141.54 22.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.793 -174.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 81.5 Cg_endo -84.65 163.34 12.38 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.52 115.29 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.785 2.324 . . . . 0.0 111.45 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.9 -20.16 8.19 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.357 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -66.49 133.3 94.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.45 -24.09 67.29 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.665 2.91 . . . . 0.0 113.598 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.465 ' HB2' HD13 ' A' ' 335' ' ' LEU . 2.3 m-20 -78.53 -32.39 47.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.715 0.293 . . . . 0.0 110.594 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.655 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.74 87.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.084 0.469 . . . . 0.0 110.284 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.28 -47.68 88.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -130.86 99.65 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.92 -179.008 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.5 t -113.5 100.01 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.6 p -92.9 144.41 25.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.529 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 10.6 mm -83.48 -36.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.833 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.586 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 78.6 t90 -156.19 132.31 9.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.265 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 21.0 t-80 56.86 -139.15 0.92 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 49.4 t -98.96 40.05 1.23 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.634 . . . . 0.0 110.272 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -114.7 137.4 51.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.423 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.43 172.11 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.574 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -64.75 127.64 32.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.816 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.69 7.93 38.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.171 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.0 m -96.69 150.4 20.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.6 OUTLIER -117.02 140.35 49.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 110.988 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 79.0 mt -117.29 145.7 43.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.173 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.46 99.36 1.89 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.428 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.91 128.98 35.69 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -76.99 -19.63 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.573 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -77.36 -21.38 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.264 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.47 173.8 7.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -88.75 30.07 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.283 0.563 . . . . 0.0 110.157 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.02 67.99 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.826 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -5.79 46.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.929 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.47 152.4 20.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -77.35 110.58 12.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.1 pt20 -102.78 156.2 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.052 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.9 159.34 22.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 2.4 t -59.75 -43.85 92.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 211' ' ' ILE . 35.0 mt-10 -57.86 -22.81 49.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.544 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.76 -50.51 8.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.467 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 68.0 t80 -65.23 -43.61 90.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.79 71.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.784 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -65.66 -36.89 84.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.13 64.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.624 0.726 . . . . 0.0 110.391 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -93.89 21.52 6.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.741 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.418 ' HB2' ' HG3' ' A' ' 246' ' ' GLU . 58.1 m -38.54 -70.81 0.09 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.971 0.795 . . . . 0.0 112.159 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 244' ' ' ASP . 25.9 p -74.47 -62.53 1.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 171.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.455 ' N ' ' SG ' ' A' ' 243' ' ' CYS . 32.2 t70 178.57 -31.25 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.965 168.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.979 ' HB3' ' HB2' ' A' ' 248' ' ' GLU . 80.5 m-20 -132.31 58.54 1.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.73 -173.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' A' ' 242' ' ' SER . 6.4 mm-40 -75.56 -4.42 39.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.158 0.504 . . . . 0.0 110.872 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -116.36 13.78 15.59 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.527 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.979 ' HB2' ' HB3' ' A' ' 245' ' ' ASN . 41.8 tt0 -59.53 -15.89 21.16 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.935 0.874 . . . . 0.0 110.672 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 64.8 mt -69.1 -24.34 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.594 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -139.08 -47.95 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.768 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.42 172.45 6.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -101.03 42.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.235 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.5 m -64.83 113.71 4.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 122.457 0.303 . . . . 0.0 110.501 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 256' ' ' GLY . 20.7 t60 -154.49 128.88 9.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.428 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.586 ' HB2' ' HE1' ' A' ' 212' ' ' TRP . 6.5 ptpp? -75.13 29.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.291 0.567 . . . . 0.0 112.202 -173.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -85.72 -19.86 57.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.532 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.7 t80 -67.27 110.66 3.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.85 13.35 50.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.009 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.8 t -67.01 -17.43 64.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.788 0.328 . . . . 0.0 111.084 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -108.62 -25.59 10.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.067 0.46 . . . . 0.0 110.395 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.14 158.53 9.14 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.312 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.617 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.7 mp -120.75 99.8 6.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.304 0.641 . . . . 0.0 110.587 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 29.2 ttpt -85.3 118.83 25.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.09 103.83 0.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.282 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.79 -52.75 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.352 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.9 t -147.65 167.32 24.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.442 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.402 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.0 t60 -145.9 135.61 23.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.145 0.498 . . . . 0.0 111.128 -173.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 32.6 tt0 -127.05 142.23 51.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.203 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -109.17 116.2 31.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.3 t -141.79 178.43 7.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.98 129.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 8.3 t -132.07 121.32 23.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 58.93 31.92 21.77 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.52 0.512 . . . . 0.0 111.658 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 90.58 -13.12 66.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.87 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -102.74 133.89 47.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.675 -0.309 . . . . 0.0 110.336 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 46.7 m -71.46 130.07 40.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.9 m -129.06 154.24 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 122.172 0.987 . . . . 0.0 112.992 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.07 114.27 25.96 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.921 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 23.0 ttmm -103.32 110.81 22.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.515 HD11 ' HE1' ' A' ' 312' ' ' PHE . 20.5 mt -112.76 135.4 53.54 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.387 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.9 m -99.65 109.86 22.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.617 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 76.5 m-85 -100.08 163.98 12.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.443 . . . . 0.0 112.182 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 29.4 t70 -133.39 138.56 31.64 Favored Pre-proline 0 C--O 1.221 -0.437 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.296 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.536 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.3 Cg_endo -83.89 11.22 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.879 1.72 . . . . 0.0 112.532 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.68 -16.39 40.43 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -146.77 110.52 4.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.769 -0.715 . . . . 0.0 109.739 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.59 -14.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.279 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -67.1 -15.99 64.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.326 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.55 -43.57 22.79 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.65 170.71 11.92 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.223 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.48 147.45 23.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -122.92 121.23 35.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.452 ' N ' HD22 ' A' ' 292' ' ' LEU . 42.0 m -111.55 133.77 53.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 91.1 t -131.05 135.57 59.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.049 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -112.55 115.69 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.2 p -132.87 161.8 33.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.996 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -57.83 158.76 6.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.092 0.473 . . . . 0.0 111.829 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.742 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -63.97 -34.83 78.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.61 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -87.37 31.34 0.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.425 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -86.21 118.87 71.12 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.028 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.19 137.45 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.116 1.877 . . . . 0.0 111.821 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -119.92 142.81 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 18.2 t80 -96.73 98.62 10.3 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.961 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.589 HG23 ' OG ' ' A' ' 310' ' ' SER . 51.0 t -87.04 131.95 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 0.0 111.403 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.533 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.7 tttp -57.93 122.92 14.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.573 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 77.88 2.06 2.88 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.909 0.756 . . . . 0.0 111.833 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -116.68 -21.78 8.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.83 -121.33 5.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.41 140.51 29.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.398 0.599 . . . . 0.0 110.117 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.869 ' HB2' HG22 ' A' ' 328' ' ' ILE . 75.3 p -143.38 167.15 22.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.108 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.8 t -164.48 171.76 14.21 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.767 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.515 ' HE1' HD11 ' A' ' 280' ' ' LEU . 57.1 m-85 -89.22 -21.14 23.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.485 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.58 70.38 52.51 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.2 Cg_exo -51.32 -39.14 63.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.909 2.406 . . . . 0.0 112.898 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 19.4 m -66.63 -26.07 66.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 66.9 tp -87.56 -47.65 8.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.194 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.3 m -59.05 -39.02 80.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.372 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 10.9 p -68.77 -19.58 24.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 111.264 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.23 -41.97 13.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 110.372 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -77.14 -53.09 8.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.871 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -98.82 -15.92 19.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.786 0.326 . . . . 0.0 111.083 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.75 18.41 68.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.609 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.2 mt -113.18 113.36 49.06 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.907 -0.172 . . . . 0.0 110.748 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.76 110.42 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 110.487 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.442 ' HB3' ' C ' ' A' ' 310' ' ' SER . 58.2 m -111.29 157.66 19.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 0.0 111.971 -170.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.3 m -84.03 159.73 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.123 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.22 122.98 28.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.869 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.12 164.89 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.473 0.654 . . . . 0.0 110.671 -177.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -119.93 141.44 49.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.792 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 mm -57.18 110.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.074 0.464 . . . . 0.0 109.845 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.89 3.74 19.62 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.352 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -79.56 131.07 35.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.217 0.532 . . . . 0.0 110.793 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.6 p -93.83 126.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.24 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.5 m -93.28 136.63 33.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.342 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 55.6 mt -105.93 146.13 32.27 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.357 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 58.3 Cg_endo -88.53 165.36 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.933 2.422 . . . . 0.0 112.425 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.47 115.81 3.9 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.868 2.378 . . . . 0.0 111.824 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 122.17 -22.56 7.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.061 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.0 127.78 93.64 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.34 -22.85 60.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.411 2.741 . . . . 0.0 113.554 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.06 -27.25 43.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.54 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.575 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -75.29 85.93 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.305 0.574 . . . . 0.0 110.169 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.7 mt -72.88 -45.44 55.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.734 -173.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -109.65 43.74 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.435 0.636 . . . . 0.0 110.812 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.593 -0.579 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.2 t -97.19 87.58 4.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.051 0.453 . . . . 0.0 109.936 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.9 p -79.3 143.93 34.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.835 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.7 mm -79.35 -43.86 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.791 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 76.9 t90 -152.98 136.06 15.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.408 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 32.6 t-80 55.23 -135.75 1.34 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.485 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 15.0 p -96.05 23.91 6.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.798 0.332 . . . . 0.0 111.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -108.61 140.21 42.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.975 -173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.53 178.57 4.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.772 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.77 132.02 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.039 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.05 17.85 26.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.092 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.552 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 25.0 m -107.82 147.44 30.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 220' ' ' ARG . 3.7 mpt_? -110.6 144.23 39.81 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.211 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.0 mt -117.24 144.49 44.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.889 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 16.6 t -153.39 95.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.126 0.489 . . . . 0.0 110.358 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -86.16 118.21 25.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -72.6 -9.29 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -66.81 -34.22 77.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.145 176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -104.22 -177.27 3.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.992 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 p -79.75 -0.16 33.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -80.71 105.84 12.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -90.46 -41.55 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.733 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -92.9 -178.99 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.563 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -82.68 117.62 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -106.63 164.52 12.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.39 172.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.64 160.5 16.6 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.97 -0.456 . . . . 0.0 110.299 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.9 t -60.03 -47.33 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 24.8 mt-10 -59.03 -22.36 60.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.63 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -81.7 -47.58 12.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.135 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 54.8 t80 -70.08 -48.67 56.78 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.45 69.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.211 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 19.4 ttm180 -68.91 -37.35 78.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.597 0.713 . . . . 0.0 109.55 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.56 -8.93 59.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.699 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.746 ' HB1' ' HE3' ' A' ' 255' ' ' LYS . . . -86.71 28.48 0.87 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.729 0.776 . . . . 0.0 110.36 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.6 m -96.55 -56.25 2.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.021 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.4 m -93.84 24.95 3.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.7 ' HB3' ' HA ' ' A' ' 241' ' ' ALA . 9.5 p-10 -82.87 36.21 0.49 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.052 0.453 . . . . 0.0 111.399 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -139.66 -36.26 0.51 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.978 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -68.49 -17.81 64.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.443 0.639 . . . . 0.0 109.799 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.45 -5.45 46.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.397 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 251' ' ' MET . 66.1 tt0 -67.98 -10.37 52.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.837 0.827 . . . . 0.0 110.536 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.3 -33.15 53.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -108.72 -42.72 4.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.469 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -118.95 -178.81 3.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -90.41 38.28 3.24 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.061 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 254' ' ' HIS . 1.0 OUTLIER -69.95 108.82 4.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.365 0.266 . . . . 0.0 110.661 -177.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 253' ' ' THR . 3.2 t60 176.27 130.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.791 ' HB2' ' HE1' ' A' ' 212' ' ' TRP . 0.0 OUTLIER -73.68 25.36 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.515 177.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -79.27 -13.63 82.58 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.994 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.604 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 11.2 t80 -66.85 107.1 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 103.09 12.21 32.21 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.391 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.8 m -68.74 -13.68 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.826 0.346 . . . . 0.0 111.758 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -108.27 -30.19 8.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.851 0.357 . . . . 0.0 110.282 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.77 157.89 8.86 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.07 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -122.53 105.8 10.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 110.476 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 22.0 ttpt -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.14 0.495 . . . . 0.0 110.976 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.52 107.48 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.868 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 61.1 mt -82.51 -41.1 20.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.466 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.7 t -158.39 162.35 37.62 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.791 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -140.94 140.25 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -133.43 139.69 46.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.246 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.61 106.14 18.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 109.776 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.0 t -109.6 179.73 4.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.69 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.72 128.92 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.023 0.44 . . . . 0.0 110.119 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.6 t -131.63 124.44 29.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.333 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 56.06 32.6 20.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.629 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.1 -2.71 88.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -111.23 133.3 53.67 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.733 -0.275 . . . . 0.0 110.297 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.2 m -67.15 137.92 56.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.1 m -129.62 154.88 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.772 0.796 . . . . 0.0 111.838 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 295' ' ' GLU . 96.9 mt -95.57 110.61 22.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.558 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -98.24 110.66 23.2 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 17.2 mt -113.82 129.93 56.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.124 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 37.6 m -97.52 118.12 33.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.527 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 79.5 m-85 -106.55 164.65 11.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.288 0.566 . . . . 0.0 112.417 -171.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 19.0 t70 -131.29 135.06 26.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.146 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.604 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 72.8 Cg_endo -84.17 5.59 6.24 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.202 1.935 . . . . 0.0 112.346 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 -18.87 27.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.452 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -142.29 126.65 17.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.052 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.97 -8.15 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.39 -39.69 92.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.03 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.04 -46.76 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.036 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.99 11.48 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.39 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.0 143.26 29.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.72 0.295 . . . . 0.0 110.578 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.453 HD13 HG23 ' A' ' 294' ' ' VAL . 1.1 tm? -117.5 119.44 35.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.422 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.0 m -106.8 135.27 48.62 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.453 HG23 HD13 ' A' ' 292' ' ' LEU . 73.8 t -134.04 135.22 55.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.436 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 278' ' ' LEU . 41.8 mt-10 -126.95 127.73 45.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.716 173.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.454 ' HB2' HG23 ' A' ' 219' ' ' THR . 9.2 t -141.19 -174.61 4.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.773 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -76.0 172.84 12.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.574 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.9 mm? -74.67 -10.54 59.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.352 -168.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.96 17.45 24.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.721 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -75.89 117.93 67.36 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.527 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.5 135.16 17.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.158 1.905 . . . . 0.0 111.783 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -121.24 125.57 47.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 7.7 t80 -81.84 90.79 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.567 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.629 HG13 ' HB2' ' A' ' 332' ' ' ASP . 65.6 t -72.95 123.86 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.035 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.758 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.4 tttp -56.33 139.69 47.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.38 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.9 m-20 77.1 -8.68 1.65 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.819 0.699 . . . . 0.0 112.114 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -119.21 -54.0 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.17 -149.67 18.05 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -67.73 120.64 14.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.172 0.486 . . . . 0.0 110.259 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.414 ' HB2' HG22 ' A' ' 328' ' ' ILE . 18.0 m -134.94 169.66 17.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.351 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 43.2 t -160.63 172.13 17.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.914 0.387 . . . . 0.0 110.777 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -87.14 -28.88 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.974 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.46 76.39 77.63 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.687 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.555 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 65.8 Cg_exo -54.74 -41.96 73.08 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.103 2.535 . . . . 0.0 113.141 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 6.9 m -64.02 -24.35 67.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.8 tp -87.32 -49.14 7.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.951 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -55.75 -44.65 77.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.377 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.19 -31.67 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.745 0.307 . . . . 0.0 111.752 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.11 -40.35 22.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.229 0.538 . . . . 0.0 110.243 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.19 -49.97 13.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.589 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -102.75 -9.06 20.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.767 0.318 . . . . 0.0 111.737 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 75.67 29.6 59.27 Favored Glycine 0 CA--C 1.516 0.127 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.7 mt -128.34 112.79 19.67 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 122.772 -0.252 . . . . 0.0 110.433 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.8 116.79 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.448 2.099 . . . . 0.0 110.877 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 72.8 m -117.62 147.59 42.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.287 0.565 . . . . 0.0 111.698 -169.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.55 164.97 22.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.653 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.13 128.18 34.25 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -74.98 178.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.422 0.629 . . . . 0.0 111.07 -178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -141.71 132.88 26.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.93 115.13 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 O-C-N 123.67 0.606 . . . . 0.0 110.162 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.71 6.72 16.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.516 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.629 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -70.4 128.91 37.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 176.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.2 p -97.56 112.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.73 0.776 . . . . 0.0 111.13 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.9 m -79.96 132.29 36.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.425 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.85 145.91 31.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.908 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.1 Cg_endo -86.68 168.7 8.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.008 2.472 . . . . 0.0 112.357 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 42.0 Cg_endo -68.12 126.16 14.03 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.885 2.39 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.51 -21.33 30.74 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.35 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.4 122.0 77.81 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.79 -23.53 72.41 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 123.182 2.588 . . . . 0.0 113.108 -171.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.552 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 37.4 t70 -79.06 -27.18 43.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.55 86.57 4.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.178 0.513 . . . . 0.0 109.993 169.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 60.0 mt -66.86 -50.65 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.633 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -99.57 31.57 3.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.0 111.08 -169.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.358 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.481 0.752 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.4 t -94.78 94.3 8.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.287 0.565 . . . . 0.0 109.998 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -84.87 143.54 28.98 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.216 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 235' ' ' GLU . 11.4 mm -86.26 -41.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.58 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.483 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 80.9 t90 -154.33 127.63 8.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.499 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.4 t-80 59.06 -146.56 0.51 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 49.4 t -94.64 39.82 1.09 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.292 0.567 . . . . 0.0 110.37 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.13 138.04 45.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.361 0.601 . . . . 0.0 111.594 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.97 169.16 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.022 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.428 ' HG3' ' OE2' ' A' ' 235' ' ' GLU . 56.9 tttp -62.42 128.15 34.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.734 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.35 -16.85 34.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.027 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.523 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 60.6 m -73.73 148.17 42.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.489 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.4 OUTLIER -109.37 150.71 27.64 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.436 178.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.4 mt -123.54 143.88 49.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.9 t -151.96 92.03 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.449 . . . . 0.0 110.412 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.521 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 47.3 m-85 -75.97 124.8 27.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -65.4 -22.1 66.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 110.91 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -78.05 -6.89 56.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.521 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 60.8 mm-40 -100.43 172.3 7.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.016 0.436 . . . . 0.0 110.881 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.9 m -96.87 26.44 4.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.168 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -114.87 97.44 6.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 111.505 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -78.66 -35.73 44.84 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.04 139.07 56.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.098 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.411 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 83.6 m95 -73.47 122.73 22.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -172.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.6 pt20 -99.99 158.44 15.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.513 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.43 161.44 16.28 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.913 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -58.5 -49.7 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.641 0.734 . . . . 0.0 109.355 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 35.3 mt-10 -58.08 -22.3 49.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.585 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.6 -45.77 24.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.331 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -74.96 -46.84 32.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -59.7 -25.07 64.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.568 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.672 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 35.9 ttm180 -63.13 -36.81 84.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.337 0.589 . . . . 0.0 109.835 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.39 -23.22 62.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.594 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.671 ' HB1' ' HE3' ' A' ' 255' ' ' LYS . . . -91.38 13.85 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.705 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.0 m -81.42 -9.73 59.67 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 247' ' ' GLU . 1.7 p -75.59 -68.94 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 t70 178.52 -160.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -77.65 52.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.393 1.451 . . . . 0.0 110.501 171.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -140.5 30.06 1.93 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.776 ' OE1' ' HB ' ' A' ' 253' ' ' THR . 6.1 mp0 -57.46 -52.51 65.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.205 -172.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -101.64 -23.9 14.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.028 0.442 . . . . 0.0 111.368 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 253' ' ' THR . 0.2 OUTLIER -134.82 120.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.207 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.03 68.96 0.47 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.572 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 41.2 ttm -169.91 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.642 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 173.48 91.41 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.776 ' HB ' ' OE1' ' A' ' 247' ' ' GLU . 7.2 m -95.52 -79.83 0.43 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.907 -0.172 . . . . 0.0 111.145 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 253' ' ' THR . 22.0 t-80 74.22 141.64 0.07 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.796 0.685 . . . . 0.0 109.575 -173.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.671 ' HE3' ' HB1' ' A' ' 241' ' ' ALA . 9.3 mptt -49.86 -50.6 45.08 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.311 0.382 . . . . 0.0 110.667 -171.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 74.1 -65.92 1.89 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.358 165.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.7 t80 -66.45 105.75 1.56 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 110.868 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 97.25 18.55 28.44 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.376 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.6 m -75.8 -13.27 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.993 0.425 . . . . 0.0 110.459 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.07 -31.94 8.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 109.323 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.23 157.92 8.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.003 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.5 mp -123.12 98.7 6.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 123.234 0.614 . . . . 0.0 110.363 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 69.8 tttt -84.15 122.06 28.31 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.7 105.09 0.6 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.76 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 283' ' ' ASP . 87.0 mt -79.16 -48.13 14.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.7 t -150.28 163.37 38.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.849 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.602 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -134.08 148.49 51.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.888 -167.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.16 139.32 21.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.894 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -111.09 94.28 4.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.491 0.662 . . . . 0.0 109.468 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.42 177.91 4.9 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.308 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.6 p -127.3 116.82 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.394 0.616 . . . . 0.0 110.053 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 69.7 p -112.19 113.43 25.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.612 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 54.38 35.37 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.461 0.475 . . . . 0.0 111.814 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.29 -21.69 36.7 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.496 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -110.85 134.72 52.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.13 0.465 . . . . 0.0 111.227 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 19.4 m -71.84 137.92 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.025 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.86 154.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.596 0.712 . . . . 0.0 112.03 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 312' ' ' PHE . 94.7 mt -92.54 109.4 20.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.259 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 4.9 ttpp -102.95 109.0 20.39 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 293' ' ' THR . 38.4 mt -118.71 140.9 49.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.247 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.0 m -99.05 122.56 42.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.556 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.2 m-85 -110.63 158.88 18.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.384 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.477 ' HB2' HD21 ' A' ' 265' ' ' LEU . 10.7 t70 -128.21 130.62 23.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.663 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.63 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 97.4 Cg_endo -86.82 12.55 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.607 2.204 . . . . 0.0 112.451 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.96 -16.61 46.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.883 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.5 t -154.4 139.92 17.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 111.031 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.99 -9.88 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.31 -38.76 77.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.183 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.82 -43.47 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.903 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 133.38 163.48 10.47 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.769 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.94 149.27 22.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.071 0.463 . . . . 0.0 110.143 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 294' ' ' VAL . 1.8 tm? -126.75 123.29 37.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.8 m -115.64 136.84 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 68.3 t -131.92 137.14 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.639 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' CG ' ' HD3' ' A' ' 279' ' ' LYS . 87.8 mt-10 -106.39 127.86 53.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.642 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.4 p -142.99 172.2 13.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -66.09 154.56 39.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.308 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.797 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.2 mm? -62.45 -21.13 65.21 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.47 0.652 . . . . 0.0 110.742 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.68 16.7 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.779 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -70.69 122.64 87.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -82.3 122.4 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.518 2.145 . . . . 0.0 111.906 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.66 120.62 42.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.7 t80 -72.84 104.4 4.01 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.23 137.15 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.267 0.556 . . . . 0.0 111.074 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.481 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.1 tttp -57.92 129.93 44.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.813 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 90.6 m-20 72.94 2.3 4.33 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.627 0.579 . . . . 0.0 112.099 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -121.6 -41.37 2.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.657 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 95.6 -152.78 20.47 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.67 113.84 3.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.238 0.519 . . . . 0.0 110.699 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.9 m -126.21 165.55 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.5 t -161.54 -177.83 6.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.656 0.265 . . . . 0.0 110.939 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 278' ' ' LEU . 30.1 m-85 -91.59 -43.6 9.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.244 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.67 74.22 17.67 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.705 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.7 Cg_exo -55.6 -36.26 94.28 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.748 2.298 . . . . 0.0 112.946 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 319' ' ' VAL . 23.2 t -63.1 -28.48 70.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.115 0.484 . . . . 0.0 110.559 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.3 tp -87.35 -41.97 13.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.886 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.9 m -53.33 -44.06 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.778 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.9 p -72.14 -20.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 315' ' ' SER . 97.2 t -85.31 -34.93 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.384 0.612 . . . . 0.0 110.117 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -84.67 -53.03 5.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.188 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.73 -11.52 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.103 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.98 24.85 65.66 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.254 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.1 mt -120.97 113.17 33.02 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.874 -0.192 . . . . 0.0 110.572 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.05 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.47 2.113 . . . . 0.0 110.7 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 79.5 m -117.57 155.88 29.04 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -169.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.55 165.77 18.8 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.618 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.57 126.71 33.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 162.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -130.03 153.75 48.12 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.5 mm -63.15 109.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.68 -0.61 20.1 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.825 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.88 129.43 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.532 0.666 . . . . 0.0 110.221 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.35 134.74 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.535 0.683 . . . . 0.0 112.654 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 50.5 t -95.85 138.95 32.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.971 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 76.0 mt -109.96 141.87 24.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.527 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.57 164.15 9.36 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.884 2.389 . . . . 0.0 112.033 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.49 122.78 9.8 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.292 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 114.45 -17.0 19.12 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.813 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -70.34 132.18 87.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.24 -26.35 76.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.389 2.726 . . . . 0.0 113.479 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.24 -26.67 42.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.668 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -80.02 85.83 5.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.68 -43.98 46.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.243 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -120.92 80.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.886 -178.946 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -105.64 92.01 4.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.3 p -82.23 141.52 32.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.033 0.444 . . . . 0.0 110.967 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -82.85 -37.76 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.709 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -156.88 135.65 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 23.1 t-80 55.83 -139.26 0.97 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.6 t -100.4 42.68 1.1 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.376 0.607 . . . . 0.0 109.92 176.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.09 139.48 50.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 111.89 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.1 174.83 5.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.825 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.491 ' HE2' ' OE2' ' A' ' 235' ' ' GLU . 64.4 tttm -63.77 127.89 33.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.421 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.85 -1.55 38.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.473 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.533 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 68.1 m -86.21 140.1 30.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -111.11 137.88 48.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.449 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 47.1 mt -112.78 145.49 40.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.717 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' CYS . . . . . 0.415 ' HA ' ' OD1' ' A' ' 228' ' ' ASN . 21.3 t -149.48 97.46 2.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.185 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -85.74 108.28 17.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -71.04 -19.38 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -58.86 -36.46 74.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.498 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.78 -156.5 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.642 -173.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -85.27 -17.28 37.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 222' ' ' CYS . 2.2 p30 -93.02 108.06 19.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.591 -171.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.794 ' HD2' ' HG3' ' A' ' 230' ' ' GLU . 0.9 OUTLIER -102.38 7.42 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.456 174.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.794 ' HG3' ' HD2' ' A' ' 229' ' ' LYS . 27.2 mt-10 -114.35 172.22 7.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.329 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -87.52 132.85 33.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.011 0.91 . . . . 0.0 113.211 -168.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 12.2 pt20 -130.92 168.37 17.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.246 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -88.59 160.2 17.54 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.975 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.59 -46.93 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.491 ' OE2' ' HE2' ' A' ' 217' ' ' LYS . 27.3 mt-10 -57.73 -23.45 51.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.243 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.09 -44.75 21.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.341 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.581 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.9 t80 -74.26 -44.07 54.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.423 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.94 72.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.118 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -58.77 -41.77 87.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.56 72.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.06 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.428 ' O ' ' HE3' ' A' ' 255' ' ' LYS . . . -90.31 20.08 4.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.728 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 29.7 t -63.02 -28.96 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.04 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 244' ' ' ASP . 22.8 p -76.43 -80.65 0.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' A' ' 254' ' ' HIS . 16.4 t70 177.05 -33.71 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.907 0.861 . . . . 0.0 109.127 173.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.418 ' CG ' ' HB2' ' A' ' 254' ' ' HIS . 55.2 t30 177.54 128.59 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.411 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 249' ' ' ILE . 40.2 mt-10 -95.12 50.09 1.25 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 110.228 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -41.97 81.1 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.326 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.51 -24.87 25.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.155 0.503 . . . . 0.0 110.216 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 246' ' ' GLU . 34.9 mt -79.58 -47.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.746 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -150.01 -62.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.34 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 58.2 ttp -152.06 -76.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.28 -0.263 . . . . 0.0 111.411 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.46 142.78 7.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.457 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.47 38.36 0.17 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.715 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 67.8 t60 -83.25 144.02 30.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.426 -171.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 241' ' ' ALA . 94.4 mttt -89.27 34.95 0.8 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.102 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -99.03 -15.4 33.45 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.951 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 39.2 t80 -74.59 120.64 20.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 110.034 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.19 26.61 23.27 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.591 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -81.41 -16.42 52.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.176 0.513 . . . . 0.0 110.417 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.88 -29.49 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 142.1 151.81 5.59 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.586 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.9 mp -107.57 97.59 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.73 0.412 . . . . 0.0 110.863 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.9 ttpp -85.68 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.182 0.515 . . . . 0.0 111.139 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.487 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 4.6 tt -54.77 122.48 10.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.465 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.2 mt -95.0 -47.71 6.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.561 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.7 t -151.0 164.98 35.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -142.12 133.04 25.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.207 0.527 . . . . 0.0 111.632 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -128.67 146.19 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.49 128.69 53.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.828 0.823 . . . . 0.0 110.359 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 30.8 t -133.07 179.98 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.864 -167.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.19 128.7 56.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.03 0.443 . . . . 0.0 109.874 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 32.2 t -126.47 111.31 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.119 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 54.91 42.25 31.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.16 -11.72 59.92 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.905 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -97.14 115.25 27.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 110.481 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 298' ' ' LEU . 49.6 m -62.34 133.95 55.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.1 m -132.72 153.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.147 0.975 . . . . 0.0 113.228 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 89.9 mt -92.92 119.96 32.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.249 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.7 ttmt -108.33 111.82 23.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 312' ' ' PHE . 36.9 mt -118.5 129.4 55.35 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.011 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.1 m -92.97 110.79 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.405 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.6 m-85 -96.51 155.27 16.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -172.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.491 ' HB2' HD21 ' A' ' 265' ' ' LEU . 15.7 t0 -118.84 123.43 29.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.448 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 60.5 Cg_endo -73.36 2.76 5.32 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.065 1.843 . . . . 0.0 111.755 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.79 9.85 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.5 t -145.9 130.94 18.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.11 -12.25 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.085 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.18 -34.7 78.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.557 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.52 -45.26 69.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 135.94 176.16 14.21 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.366 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 79.1 mt -103.32 150.33 23.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.915 0.388 . . . . 0.0 110.618 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -127.02 119.43 26.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.4 m -109.76 139.39 44.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.9 t -132.93 132.73 59.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -109.47 115.26 29.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 6.2 p -134.3 165.64 24.67 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.53 155.9 28.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.138 0.494 . . . . 0.0 111.01 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.823 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.1 mm? -64.4 -19.53 65.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.078 -173.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.21 17.67 16.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.194 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.51 117.27 60.74 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.773 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.65 116.38 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.238 1.959 . . . . 0.0 111.445 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.8 m-85 -103.59 116.06 31.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.355 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 11.4 t80 -73.48 105.08 4.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.406 175.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.75 130.79 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.349 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.84 ' HB3' HG13 ' A' ' 333' ' ' VAL . 58.9 tttp -59.97 126.44 27.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 93.7 m-20 77.64 0.05 2.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.995 0.81 . . . . 0.0 111.993 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -117.08 -33.8 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 111.495 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 94.47 -151.14 20.04 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' TRP . . . . . 0.454 ' CZ2' ' HA ' ' A' ' 345' ' ' PHE . 97.3 m95 -67.77 117.6 9.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.462 0.631 . . . . 0.0 109.457 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.427 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -128.28 166.66 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.772 0.32 . . . . 0.0 110.641 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 41.4 t -160.77 168.11 25.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.509 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.513 ' HE1' HD11 ' A' ' 280' ' ' LEU . 63.4 m-85 -84.92 -28.57 25.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.946 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.11 75.41 75.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.595 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.7 Cg_exo -55.42 -45.02 43.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.883 2.388 . . . . 0.0 112.677 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 18.3 m -62.5 -21.08 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.447 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.05 -45.3 10.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.909 0.385 . . . . 0.0 110.166 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.413 HG21 ' SG ' ' A' ' 325' ' ' CYS . 36.4 m -55.51 -40.74 72.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.742 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.554 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.9 p -71.72 -19.71 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.788 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.3 t -87.61 -36.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.327 0.584 . . . . 0.0 110.185 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -81.86 -54.88 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -101.79 -11.37 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.837 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.59 14.78 77.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.638 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.5 mt -110.53 114.18 55.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.634 0.217 . . . . 0.0 111.08 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.96 118.49 5.65 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.633 2.222 . . . . 0.0 110.601 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 317' ' ' THR . 62.6 m -117.77 157.78 25.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.248 0.547 . . . . 0.0 112.306 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.6 m -79.91 164.88 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.06 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -92.03 122.16 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.19 166.1 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.548 0.689 . . . . 0.0 111.412 -175.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -124.12 142.33 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.34 114.45 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.67 -0.65 21.72 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.525 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -73.15 132.09 42.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.88 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -92.92 134.8 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.273 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 49.5 t -96.5 134.32 39.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.369 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 82.2 mt -105.84 143.68 27.37 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.59 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 69.1 Cg_endo -86.91 167.66 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.637 2.225 . . . . 0.0 112.074 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.74 129.8 24.49 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.008 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.26 -14.32 54.94 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -69.3 128.3 92.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.36 -22.59 75.0 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.325 2.683 . . . . 0.0 113.866 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.87 -31.04 45.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -69.0 91.73 0.49 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.281 0.562 . . . . 0.0 109.954 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.0 mt -66.33 -41.53 89.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.671 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -129.13 101.7 6.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 309' ' ' TRP . 3.8 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.519 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -91.3 99.58 12.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.048 0.452 . . . . 0.0 110.098 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -87.63 141.77 28.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.452 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.4 mm -79.44 -40.31 21.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.334 0.588 . . . . 0.0 109.752 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -156.89 134.38 10.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.107 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 34.0 t-80 55.94 -139.22 0.97 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 40.3 t -99.8 40.09 1.27 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.418 0.628 . . . . 0.0 109.864 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -110.23 134.6 52.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.061 0.458 . . . . 0.0 111.237 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.51 176.17 6.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -67.37 137.82 56.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.66 31.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.022 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 38.2 m -112.11 147.63 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.586 HH12 ' HB3' ' A' ' 272' ' ' SER . 0.3 OUTLIER -111.07 143.6 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.824 0.345 . . . . 0.0 111.058 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.8 mt -119.64 143.75 47.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.809 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 41.8 t -154.07 98.03 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.55 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 34.8 m-85 -83.34 122.18 28.12 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -66.98 -24.32 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 19.0 pttp -75.1 -12.67 60.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.996 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.55 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 9.0 mm-40 -94.38 172.39 8.23 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.187 0.518 . . . . 0.0 110.843 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 6.3 m -88.16 18.1 4.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.382 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -115.48 102.6 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.184 0.993 . . . . 0.0 111.41 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -83.69 -31.8 25.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.646 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -70.57 154.93 41.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.026 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.487 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 85.4 m95 -79.96 138.67 37.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.235 -175.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 9.1 pt20 -120.45 154.37 35.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.688 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.37 162.57 23.33 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -60.68 -50.82 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.03 -24.2 57.38 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.289 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.17 -50.67 21.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.554 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 62.1 t80 -70.59 -43.65 68.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.698 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.53 68.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.245 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 239' ' ' ARG . 36.6 ttt180 -68.15 -34.81 77.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.38 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.09 -20.03 49.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.991 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -83.99 15.78 3.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.762 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.9 p -72.65 -27.74 62.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.992 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 21.2 m -80.06 149.18 30.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.71 -177.76 5.62 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.822 ' HB2' ' HG2' ' A' ' 247' ' ' GLU . 0.3 OUTLIER -73.89 103.13 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.757 0.789 . . . . 0.0 112.889 -170.08 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.502 ' HB3' HD12 ' A' ' 249' ' ' ILE . 4.1 mm-40 -89.13 44.9 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.514 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.822 ' HG2' ' HB2' ' A' ' 245' ' ' ASN . 18.0 mm-40 -62.07 -41.81 98.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.309 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.84 -24.62 62.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 246' ' ' GLU . 62.4 mt -75.49 -60.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.76 -56.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.298 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 14.0 tpt -81.29 149.29 29.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.596 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.54 82.81 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.287 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 m -97.72 18.36 15.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.511 0.672 . . . . 0.0 110.601 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 245' ' ' ASN . 84.8 t60 -71.21 94.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.45 4.26 0.1 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -95.83 30.49 8.38 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.236 -176.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 14.9 t80 -74.28 119.66 18.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.64 21.48 23.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.225 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.1 t -70.05 -23.56 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.02 -31.75 17.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.58 0.705 . . . . 0.0 109.828 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 141.0 144.28 4.41 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.762 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.2 mp -97.92 99.18 10.47 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.419 0.287 . . . . 0.0 111.0 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 19.2 ttpp -84.96 117.75 24.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.1 tt -61.22 102.83 0.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.829 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 67.1 mt -77.2 -47.65 19.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.445 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -152.58 163.15 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.097 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.571 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -133.68 146.2 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.668 -168.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.44 140.04 27.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.16 107.75 16.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.3 t -127.43 178.46 6.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.8 p -128.5 127.15 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.586 ' HB3' HH12 ' A' ' 220' ' ' ARG . 13.7 t -116.1 106.55 13.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.777 -173.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.2 p90 54.94 17.08 1.69 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.82 1.248 . . . . 0.0 113.022 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 123.05 -16.29 8.2 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.464 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.95 115.03 29.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.876 0.369 . . . . 0.0 110.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 22.9 m -68.02 133.62 49.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.67 154.87 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.997 0.904 . . . . 0.0 113.072 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 98.7 mt -94.15 110.31 22.04 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.807 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.8 ttmt -104.28 109.63 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.812 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 312' ' ' PHE . 40.9 mt -116.14 136.82 52.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.751 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 27.8 m -93.58 109.66 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 84.3 m-85 -101.09 150.05 23.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.324 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 12.8 t70 -116.6 133.44 23.02 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.7 Cg_endo -79.21 9.81 3.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.861 1.707 . . . . 0.0 112.04 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.38 63.16 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -146.73 100.01 3.27 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.603 0.716 . . . . 0.0 109.508 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.29 -18.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.415 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 288' ' ' GLU . 7.2 mp0 -56.25 -32.43 64.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.538 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 1.5 m-20 -82.37 -1.18 49.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 111.472 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.08 172.96 25.31 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.791 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.4 mt -97.84 141.13 31.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.723 0.297 . . . . 0.0 110.22 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -112.43 121.29 44.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 28.2 m -110.06 133.97 52.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 89.2 t -131.69 134.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.518 -174.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 88.3 mt-10 -106.44 120.97 43.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.681 171.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 11.0 p -133.23 167.2 20.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.467 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -75.44 163.24 27.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.06 0.457 . . . . 0.0 110.494 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.64 HD22 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -66.89 -16.09 64.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.757 -168.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.97 26.0 10.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.159 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -79.24 117.53 67.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.726 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.48 133.35 11.72 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.242 1.961 . . . . 0.0 111.903 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.452 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 98.8 m-85 -118.07 125.04 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.423 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -76.51 89.34 3.27 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.524 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.79 134.12 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.6 ' HB3' HG13 ' A' ' 333' ' ' VAL . 69.2 tttt -59.35 125.53 24.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.901 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 92.2 m-20 81.45 -26.39 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.093 0.871 . . . . 0.0 112.171 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -89.83 -35.12 15.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.093 0.473 . . . . 0.0 111.203 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.89 -153.06 21.73 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -63.99 115.06 4.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.983 0.392 . . . . 0.0 110.209 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.465 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.0 m -127.74 169.19 14.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.222 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 45.9 t -160.7 169.37 22.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.461 ' HE1' HD11 ' A' ' 280' ' ' LEU . 53.4 m-85 -84.28 -32.27 24.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.929 174.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -126.95 77.38 75.1 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.421 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.0 Cg_exo -56.35 -36.81 97.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.814 2.343 . . . . 0.0 112.564 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.7 m -70.29 -20.75 63.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.43 -47.81 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 m -57.17 -40.95 78.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.048 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.504 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.2 p -68.5 -20.42 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.894 0.378 . . . . 0.0 111.642 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.5 t -91.01 -38.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.326 0.584 . . . . 0.0 110.393 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -78.81 -53.77 6.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.788 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -95.24 -22.22 17.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.096 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 88.15 12.97 64.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.306 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 45.0 mt -109.2 115.82 56.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 4.9 Cg_exo -72.0 109.48 2.7 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.532 2.155 . . . . 0.0 110.706 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 59.5 m -109.09 155.01 21.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.765 -170.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 79.2 m -84.8 166.38 16.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.015 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.29 123.51 31.63 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.291 -0.256 . . . . 0.0 110.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.34 164.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.229 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -134.33 150.82 50.97 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.0 mm -55.27 113.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 110.527 -176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.4 -2.09 20.46 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.865 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.51 128.35 35.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.257 0.551 . . . . 0.0 111.159 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.4 p -88.95 136.39 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.844 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 58.3 m -103.02 134.22 46.82 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.097 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 59.9 mt -104.39 143.14 26.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.503 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.578 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 63.5 Cg_endo -88.72 166.86 6.04 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.214 2.609 . . . . 0.0 112.871 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.5 128.69 17.61 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.352 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.88 -19.37 35.62 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.905 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -70.96 129.23 89.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 -32.0 80.11 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.807 3.005 . . . . 0.0 113.868 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.33 -23.06 43.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.9 86.51 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.917 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.25 -45.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.528 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -110.38 47.5 0.96 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.286 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.346 179.739 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 110.871 -0.473 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.6 t -91.69 93.65 9.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.0 p -84.11 143.79 29.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.476 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.8 mm -79.33 -44.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.44 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -151.37 137.19 18.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.416 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.523 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 24.1 t-80 56.43 -137.4 1.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 45.1 t -100.23 34.09 2.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.307 0.575 . . . . 0.0 110.112 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -108.63 138.57 44.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.29 175.65 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.882 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -68.32 130.3 42.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.419 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.82 36.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.113 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 23.9 m -101.82 145.55 29.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.17 143.7 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.735 0.302 . . . . 0.0 110.903 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 44.1 mt -121.65 144.13 48.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.654 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 10.1 m -148.99 91.93 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 12.3 m-85 -88.2 120.06 29.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -70.78 -9.88 58.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 110.805 -173.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -73.77 -25.52 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.325 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.62 -165.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.215 0.531 . . . . 0.0 110.276 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.5 t -89.82 3.73 51.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -82.03 43.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -12.77 60.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.047 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.0 154.28 18.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.931 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.543 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 68.1 m95 -71.36 108.96 5.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.563 0.697 . . . . 0.0 112.516 -169.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 23.4 pt20 -101.0 167.27 10.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.567 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.13 159.11 17.67 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.3 t -58.17 -48.72 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 109.716 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.65 -21.51 40.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.762 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.2 -52.48 8.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.461 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 66.1 t80 -65.43 -41.38 93.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.839 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.04 73.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -60.96 -51.1 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.768 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.77 91.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.117 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -87.32 5.64 37.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.059 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.0 m -103.93 27.89 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.531 0.682 . . . . 0.0 110.617 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.73 ' HB3' HG21 ' A' ' 253' ' ' THR . 36.5 t -90.63 -179.21 5.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.526 ' O ' ' HB ' ' A' ' 253' ' ' THR . 32.9 t70 -59.85 156.98 13.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 253' ' ' THR . 0.2 OUTLIER -76.31 68.17 2.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.772 ' HB3' HD12 ' A' ' 249' ' ' ILE . 28.5 mt-10 -83.22 47.32 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.232 -175.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 1.028 ' HA ' ' HA2' ' A' ' 252' ' ' GLY . 11.2 pt-20 -71.75 -26.06 62.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.171 -173.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -94.89 -3.25 49.09 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.122 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.772 HD12 ' HB3' ' A' ' 246' ' ' GLU . 44.5 mt -77.24 -59.3 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.08 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -166.42 -56.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.233 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 23.1 ttt -79.23 -54.58 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.978 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 1.028 ' HA2' ' HA ' ' A' ' 247' ' ' GLU . . . 98.35 84.99 1.8 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.915 -175.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.73 HG21 ' HB3' ' A' ' 243' ' ' CYS . 4.0 m -90.43 85.38 6.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.044 0.45 . . . . 0.0 110.39 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' A' ' 256' ' ' GLY . 31.9 t60 -143.3 105.55 4.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.459 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -69.5 32.17 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.598 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -91.3 -2.84 70.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.464 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.579 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 12.6 t80 -62.89 112.29 2.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 100.23 12.09 40.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.188 -1.005 . . . . 0.0 113.554 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.6 t -74.55 -15.48 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.038 0.447 . . . . 0.0 110.139 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -88.8 -26.47 21.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.591 0.71 . . . . 0.0 109.339 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.4 144.22 5.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.0 mp -105.46 98.2 7.93 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.434 0.294 . . . . 0.0 111.372 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.6 tttm -84.48 118.0 24.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.015 0.435 . . . . 0.0 110.648 -176.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.46 107.21 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 283' ' ' ASP . 85.9 mt -80.75 -51.62 8.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.714 0.292 . . . . 0.0 110.351 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.0 t -150.71 163.16 39.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.531 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.3 t60 -137.03 139.68 41.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 0.0 111.509 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -133.23 138.69 46.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.836 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.531 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 9.2 mt-10 -108.15 121.88 45.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 0.0 110.069 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -139.97 174.08 10.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.135 -173.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.65 113.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 17.8 t -120.38 121.64 39.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.416 -171.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 58.65 30.17 19.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.523 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.98 82.95 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.027 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -110.22 127.32 54.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 0.189 . . . . 0.0 110.503 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.6 m -65.25 132.12 48.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.69 154.11 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.853 0.835 . . . . 0.0 112.591 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.472 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 88.4 mt -94.38 114.36 26.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.734 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 20.3 ttpp -109.04 114.84 28.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.48 HD11 ' HE1' ' A' ' 312' ' ' PHE . 38.0 mt -115.72 130.83 57.0 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.251 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.0 m -93.91 111.79 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.531 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 77.3 m-85 -100.99 159.7 14.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.84 -172.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 35.9 t70 -122.94 137.45 28.13 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.652 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.579 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 86.9 Cg_endo -85.54 11.32 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.213 1.942 . . . . 0.0 112.083 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.71 39.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -154.14 115.56 4.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.339 0.59 . . . . 0.0 110.161 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.58 -7.77 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.654 0.74 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.13 -20.15 61.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.134 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.6 -38.63 39.49 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 145.31 168.21 12.82 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.243 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.11 143.06 26.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.9 OUTLIER -117.42 117.5 29.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.473 ' N ' HD22 ' A' ' 292' ' ' LEU . 5.5 m -108.94 138.21 45.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.0 t -132.13 132.98 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.543 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 70.6 mt-10 -104.16 116.34 32.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.588 170.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.56 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 11.1 p -128.06 167.24 17.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.992 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -81.65 161.14 23.55 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.721 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.8 mm? -61.54 -13.36 20.74 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.26 -169.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -108.18 13.11 26.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.591 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -71.69 119.35 73.62 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 0.0 110.888 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.44 136.39 17.51 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.21 1.94 . . . . 0.0 112.105 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.56 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.6 m-85 -122.77 118.15 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.694 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 17.0 t80 -74.5 101.65 4.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.368 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.4 t -90.6 135.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.205 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.604 ' HB3' HG13 ' A' ' 333' ' ' VAL . 59.1 tttm -62.0 128.4 35.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 16.3 m120 72.55 11.32 5.62 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.72 0.637 . . . . 0.0 111.721 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -128.3 -42.9 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.986 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 100.15 -153.3 19.39 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -63.97 116.84 6.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 117.24 0.52 . . . . 0.0 109.795 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.7 m -128.31 166.43 18.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.034 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -160.43 167.05 28.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 280' ' ' LEU . 71.0 m-85 -85.98 -19.57 30.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.113 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -137.21 72.78 52.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.656 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.533 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.4 Cg_exo -52.62 -37.62 74.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.924 2.416 . . . . 0.0 113.19 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.4 t -68.76 -22.48 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.511 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.2 tp -87.92 -47.01 8.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 0.0 110.218 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 m -55.02 -41.66 71.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.999 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.99 -17.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 111.58 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.56 -39.86 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.311 0.576 . . . . 0.0 110.458 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.47 -46.12 18.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.368 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -107.88 -12.32 15.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.61 0.243 . . . . 0.0 111.106 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.4 14.97 77.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.1 mt -109.26 114.55 57.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 122.628 -0.337 . . . . 0.0 110.86 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -72.07 116.27 4.64 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.527 2.151 . . . . 0.0 110.561 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 68.1 m -117.93 156.37 28.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.183 0.516 . . . . 0.0 112.101 -170.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.2 m -83.49 160.05 21.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.49 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.21 127.18 32.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.436 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.61 172.79 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.697 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 143.87 50.88 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.703 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.4 mm -63.03 111.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.813 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 116.12 -0.14 20.93 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.401 -173.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.49 ' HB3' HG13 ' A' ' 304' ' ' VAL . 66.0 m-20 -73.53 125.33 27.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.275 0.559 . . . . 0.0 110.755 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.0 OUTLIER -88.01 127.78 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.829 0.823 . . . . 0.0 112.041 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 42.0 t -89.51 131.08 35.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.73 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.8 mt -102.92 141.87 23.39 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.699 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.523 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 52.7 Cg_endo -89.13 170.26 4.94 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.844 2.362 . . . . 0.0 111.889 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 135.02 40.43 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.384 2.056 . . . . 0.0 111.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 98.76 -15.7 60.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.483 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -72.44 128.4 88.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.16 -31.27 54.29 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.123 3.216 . . . . 0.0 114.078 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.37 -24.0 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.249 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.44 85.07 3.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.95 -44.15 51.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.014 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -114.56 62.51 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 110.441 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.653 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 111.161 -0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.1 t -90.03 103.97 16.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.4 p -87.48 146.68 25.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.006 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -90.44 -38.3 10.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 109.607 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.413 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 82.8 t90 -157.1 128.73 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.25 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.535 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.7 t-80 57.83 -151.51 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 37.3 t -88.37 46.36 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.779 -0.576 . . . . 0.0 110.411 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -117.44 139.12 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.166 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.84 171.98 7.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.314 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.28 135.71 56.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.735 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.08 10.39 45.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.797 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 62.1 m -103.56 145.7 29.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.0 mpt_? -115.7 142.6 46.53 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.766 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 71.9 mt -118.91 148.6 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.697 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 7.7 m -156.96 96.53 1.61 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.444 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.413 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 3.8 m-85 -88.87 126.21 35.27 Favored 'General case' 0 C--O 1.228 -0.066 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -78.24 -9.7 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 110.467 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -18.95 62.26 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.675 174.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.52 -166.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 6.6 t -93.74 49.51 1.36 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.931 -0.48 . . . . 0.0 111.098 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -77.14 75.57 3.7 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -86.04 -49.89 7.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.72 157.21 19.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.63 122.96 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -163.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.2 pt20 -100.55 157.85 16.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.58 162.8 15.47 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -58.17 -47.54 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 28.8 mt-10 -55.49 -23.8 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.72 -46.02 14.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.68 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.532 ' CZ ' ' HG3' ' A' ' 255' ' ' LYS . 88.0 t80 -75.16 -39.38 60.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -66.24 -26.06 67.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.29 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 41.8 ttm105 -67.57 -33.67 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.838 0.827 . . . . 0.0 109.474 174.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.39 -8.72 59.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.029 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 255' ' ' LYS . . . -70.15 -7.22 39.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.9 m -58.72 -45.83 88.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.72 82.98 5.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.902 ' HA ' ' HD3' ' A' ' 255' ' ' LYS . 6.5 p-10 -76.89 -8.95 58.3 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 111.58 -170.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -136.09 102.29 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.506 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.686 ' HG2' HD12 ' A' ' 249' ' ' ILE . 41.0 mt-10 -107.56 39.3 1.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 0.0 109.666 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.92 -33.69 74.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.699 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.43 -27.41 24.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.839 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.686 HD12 ' HG2' ' A' ' 246' ' ' GLU . 31.7 mt -69.92 -49.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.65 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -133.72 -61.73 0.79 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.587 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 50.3 tpp -160.79 -68.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.971 0.415 . . . . 0.0 110.81 -175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.32 101.32 0.16 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.892 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 246' ' ' GLU . 15.6 m -98.98 -66.56 0.89 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 80.6 t60 53.64 91.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.393 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.902 ' HD3' ' HA ' ' A' ' 244' ' ' ASP . 13.1 mptt -63.23 -7.91 7.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.014 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.61 9.75 61.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.978 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.593 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 13.9 t80 -60.56 115.75 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.37 0.585 . . . . 0.0 109.612 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 98.7 14.17 38.28 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.174 -1.013 . . . . 0.0 112.695 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 8.1 t -69.05 -14.76 63.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.106 0.479 . . . . 0.0 110.879 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -100.95 -28.89 12.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.392 0.615 . . . . 0.0 110.316 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.4 153.65 6.85 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.628 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -121.64 102.45 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -0.616 . . . . 0.0 110.462 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.717 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.4 ttpt -87.79 125.09 34.25 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.37 102.93 0.93 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.181 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.06 -52.94 8.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.743 0.306 . . . . 0.0 110.46 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.4 t -146.34 157.97 43.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.128 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.448 ' ND1' HD23 ' A' ' 280' ' ' LEU . 9.3 t60 -141.85 145.32 34.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.288 0.566 . . . . 0.0 111.289 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . 34.1 tt0 -137.79 141.41 40.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.693 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -102.33 99.06 9.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.8 t -113.66 178.14 4.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.607 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 6.5 p -133.8 119.69 33.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.323 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 t -117.45 115.86 26.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 55.76 33.95 22.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.29 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 98.6 -21.3 46.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.844 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.45 119.61 34.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.472 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 41.5 m -70.89 134.88 47.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.8 m -135.54 155.82 37.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.97 105.31 17.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.901 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 268' ' ' GLU . 82.3 tttt -94.03 105.09 17.11 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.994 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 14.0 mt -115.64 132.22 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.966 0.413 . . . . 0.0 111.464 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 m -104.33 117.49 34.33 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.536 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 92.5 m-85 -105.41 168.65 8.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.096 0.475 . . . . 0.0 111.974 -171.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -137.43 136.77 20.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.511 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.593 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.4 Cg_endo -80.72 8.86 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.025 1.817 . . . . 0.0 112.451 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.65 -23.09 10.44 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 8.4 t -154.19 133.78 12.84 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.92 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.3 -7.21 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.296 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -56.95 -24.63 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.851 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.13 -46.96 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.561 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.72 148.84 4.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.99 152.54 45.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 110.617 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -133.11 117.04 17.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.454 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.4 m -105.97 135.98 46.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.536 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 69.5 t -135.39 122.96 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.151 0.501 . . . . 0.0 111.135 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -107.49 110.06 21.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.327 -178.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.545 ' HG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.0 p -125.37 175.63 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.566 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -75.77 166.13 23.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.521 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -71.75 -18.01 62.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.61 -168.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -100.43 19.63 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.28 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.26 121.62 85.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.665 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.46 133.03 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.371 2.047 . . . . 0.0 111.626 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.545 ' HZ ' ' HG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -119.4 121.7 40.11 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.943 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 28.0 t80 -76.23 102.15 5.7 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.752 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 78.6 t -92.62 134.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.3 0.571 . . . . 0.0 111.097 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.559 ' HB3' HG13 ' A' ' 333' ' ' VAL . 63.9 tttp -62.08 127.23 30.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.241 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 92.0 m-20 76.01 3.39 3.73 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.792 0.683 . . . . 0.0 111.947 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -123.95 -28.88 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 87.2 -153.74 25.69 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.06 115.04 4.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.03 0.443 . . . . 0.0 110.363 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.48 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.1 m -125.45 168.08 14.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.926 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -162.26 178.63 8.54 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.356 -0.215 . . . . 0.0 110.452 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 52.2 m-85 -95.94 -22.07 17.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.84 68.19 71.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 84.3 Cg_exo -48.92 -37.83 37.48 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 113.379 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 30.3 m -62.3 -31.28 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.084 0.469 . . . . 0.0 111.041 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.49 -44.15 11.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.437 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 m -56.42 -39.52 73.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.728 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.7 p -71.75 -23.51 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 -43.92 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 0.0 110.216 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.88 -54.29 7.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.245 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -99.34 -15.73 18.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.241 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 87.57 10.11 70.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.8 mt -109.72 117.73 51.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.583 0.191 . . . . 0.0 110.839 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 104.31 1.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.567 2.178 . . . . 0.0 110.405 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 64.3 m -102.45 156.5 17.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.196 -169.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 56.1 m -79.82 152.95 29.44 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.945 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -79.26 117.66 20.47 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.48 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -68.45 165.09 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 0.0 110.726 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -121.36 140.72 51.74 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.9 mm -55.48 112.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.147 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.48 3.58 20.58 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.139 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 50.8 m-20 -81.01 135.24 35.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.13 135.31 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.598 0.713 . . . . 0.0 112.129 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 60.2 m -100.82 135.53 42.12 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.742 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.74 142.0 23.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.353 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.78 165.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.214 2.609 . . . . 0.0 111.993 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.39 121.34 8.45 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.461 2.107 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 112.66 -11.2 25.6 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.446 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.3 127.22 86.74 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.7 -24.75 38.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.662 2.908 . . . . 0.0 113.935 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.23 -31.86 43.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.275 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.1 91.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 110.028 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 55.4 mt -74.58 -48.92 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.344 -176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.56 53.43 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.994 0.426 . . . . 0.0 110.673 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.023 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.1 t -95.45 94.82 8.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.325 0.583 . . . . 0.0 110.229 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.8 p -86.0 141.92 29.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.162 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.6 mm -88.36 -38.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.346 0.593 . . . . 0.0 109.72 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.417 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 67.8 t90 -156.15 135.93 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.386 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.405 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 18.8 t-80 53.53 -141.04 0.89 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 53.3 t -98.4 38.68 1.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.498 0.666 . . . . 0.0 109.931 176.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.55 139.35 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.241 0.544 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.4 173.17 7.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.383 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -62.57 137.57 58.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.113 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.76 60.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.096 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.1 m -82.54 145.64 29.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.41 139.3 49.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.382 0.61 . . . . 0.0 111.383 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 53.5 mt -113.45 148.01 36.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.193 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 228' ' ' ASN . 11.7 t -153.9 98.09 2.14 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.2 0.524 . . . . 0.0 110.653 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.88 116.27 19.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.762 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.86 ' HA ' ' HB2' ' A' ' 228' ' ' ASN . 11.2 m170 -64.17 -24.66 67.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.591 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' A' ' 289' ' ' ASP . 39.2 tttp -70.46 -17.87 62.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.05 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.447 ' HB2' ' H ' ' A' ' 227' ' ' SER . 7.9 mt-10 -126.85 -101.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.115 0.483 . . . . 0.0 111.319 -176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.447 ' H ' ' HB2' ' A' ' 226' ' ' GLU . 15.5 t -93.27 65.4 3.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.665 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.86 ' HB2' ' HA ' ' A' ' 224' ' ' HIS . 3.2 t-20 -80.8 38.76 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.903 0.859 . . . . 0.0 109.733 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.581 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 18.7 pttp -112.82 -30.4 7.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.563 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.581 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 42.0 mt-10 -135.36 173.03 12.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.745 0.307 . . . . 0.0 110.283 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -107.67 137.3 45.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 9.4 pt20 -124.98 162.15 25.12 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.39 162.99 17.88 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.067 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -59.76 -44.41 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.77 -23.57 30.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.975 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.19 -53.95 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.225 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 67.2 t80 -68.89 -42.81 76.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.29 -41.13 75.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -65.0 -33.35 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.719 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -78.48 -39.15 39.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.379 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -90.72 17.2 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.738 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 33.0 p -76.1 -25.45 55.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.597 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 20.5 m -72.92 156.36 38.94 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.623 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.29 147.73 46.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 166.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 254' ' ' HIS . 2.2 p-10 -79.82 57.14 2.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -167.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -80.03 -17.51 52.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -79.72 -34.04 40.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.715 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 253' ' ' THR . 34.7 tt0 -141.89 67.5 1.33 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.265 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.75 -31.3 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 113.034 -1.893 . . . . 0.0 111.984 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -71.89 -54.19 10.84 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.219 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 47.2 ttp -91.74 -67.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.184 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 131.91 93.6 0.59 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.919 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.453 ' H ' ' HB3' ' A' ' 248' ' ' GLU . 14.5 m -76.15 77.47 2.97 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 245' ' ' ASN . 47.4 t60 -160.01 178.5 9.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -170.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -88.53 41.95 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.68 0.276 . . . . 0.0 111.013 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -91.36 -34.2 7.63 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.745 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 46.2 t80 -64.73 121.44 14.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.707 0.753 . . . . 0.0 110.491 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.72 24.14 50.75 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.0 t -78.01 -5.94 52.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.605 0.241 . . . . 0.0 111.59 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.04 -31.06 7.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.495 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 161.41 153.3 6.98 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.102 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.5 mp -121.2 103.69 9.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.904 0.482 . . . . 0.0 110.717 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 30.0 tttm -87.29 119.61 27.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.973 0.416 . . . . 0.0 110.558 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.78 113.31 2.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 283' ' ' ASP . 89.0 mt -87.43 -52.05 5.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.1 t -145.76 160.24 42.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.322 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' LYS . 6.3 t60 -143.36 141.58 30.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -175.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 41.5 tt0 -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.478 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -100.97 124.08 46.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.4 m -146.22 167.71 22.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.917 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.31 129.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 12.3 t -131.99 119.82 21.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 56.48 39.35 30.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 111.298 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 81.12 -6.11 64.4 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.884 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -102.46 120.45 40.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.613 0.245 . . . . 0.0 111.147 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 34.1 m -66.74 127.66 33.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.981 0.896 . . . . 0.0 113.307 -172.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 92.8 mt -96.9 114.34 25.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.987 172.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 4.5 ttmp? -97.84 109.9 22.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.449 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 16.4 mt -116.55 127.01 54.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.467 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 90.3 m -98.02 120.02 37.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.492 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.0 m-85 -105.41 161.74 14.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.462 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD21 ' A' ' 265' ' ' LEU . 37.4 t70 -125.8 132.08 24.2 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.524 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -80.59 11.11 3.03 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.302 2.002 . . . . 0.0 111.706 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.4 11.08 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.334 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -153.67 138.01 16.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.045 0.45 . . . . 0.0 110.354 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.81 -9.27 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.895 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -34.68 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.93 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 57.5 m-20 -78.71 -44.09 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.609 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.74 161.13 8.66 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.985 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.57 145.24 25.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.013 0.435 . . . . 0.0 110.645 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.66 122.52 27.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 99.6 m -115.79 136.39 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.6 t -129.76 136.42 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.192 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.47 120.99 39.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.43 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.8 p -136.89 169.88 17.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.046 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -64.82 161.86 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.403 0.62 . . . . 0.0 111.13 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.666 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -70.71 -18.09 62.81 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.503 -168.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.34 24.14 9.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.374 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.9 122.31 86.23 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.551 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.76 129.76 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.381 2.054 . . . . 0.0 111.999 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 93.7 m-85 -116.52 118.48 32.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 35.3 t80 -73.78 100.06 3.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.707 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 74.8 t -88.7 134.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.342 0.591 . . . . 0.0 110.743 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.523 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.8 tttp -57.96 127.44 32.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.682 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.3 m-20 76.85 -2.79 2.62 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.036 0.835 . . . . 0.0 111.945 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -119.46 -21.2 7.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.758 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 78.21 -152.01 37.52 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.846 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.38 115.68 4.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 164.51 21.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.019 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -161.53 176.88 10.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.844 0.354 . . . . 0.0 111.25 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 328' ' ' ILE . 63.0 m-85 -87.58 -34.38 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.01 71.82 53.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 80.9 Cg_exo -52.09 -36.94 67.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.839 2.359 . . . . 0.0 112.756 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 5.9 p -63.55 -29.35 70.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.2 0.524 . . . . 0.0 111.299 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.26 -47.42 8.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.8 m -56.5 -41.3 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.366 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.444 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.7 p -69.06 -21.33 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 111.68 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 73.1 t -91.28 -29.51 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.567 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.82 -52.15 5.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.966 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -99.92 -6.46 26.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 74.4 20.34 79.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.6 116.18 36.93 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.645 0.222 . . . . 0.0 110.798 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.98 106.31 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.729 2.286 . . . . 0.0 111.238 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.7 m -106.53 151.2 25.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.038 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 65.2 m -79.66 147.97 31.8 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.858 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.14 134.28 51.46 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.958 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -88.44 171.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.143 0.496 . . . . 0.0 110.101 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -132.57 156.71 46.37 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.72 110.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.443 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 115.47 4.05 20.21 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.845 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.74 127.57 32.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.444 0.622 . . . . 0.0 110.341 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.9 p -90.92 136.97 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.862 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.9 m -102.32 134.91 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.387 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 66.1 mt -101.93 145.91 31.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.12 165.25 8.46 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.988 2.459 . . . . 0.0 112.49 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.26 122.64 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.645 2.23 . . . . 0.0 111.755 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.68 -17.6 27.82 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.706 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -65.99 125.64 90.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.48 -21.67 72.52 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 123.01 2.473 . . . . 0.0 113.128 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.63 -23.16 29.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.586 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.19 99.12 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.46 -45.31 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.206 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -124.44 84.96 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.279 -0.263 . . . . 0.0 110.879 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.46 -178.863 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.718 -0.532 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -94.3 93.06 7.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.342 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -85.31 140.23 30.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.992 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.475 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.8 mm -91.78 -43.18 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 109.886 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -149.8 126.86 11.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 26.2 t-80 59.74 -149.59 0.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.483 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 43.8 t -90.68 36.15 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.367 0.604 . . . . 0.0 110.414 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 62.5 m-85 -106.39 141.48 37.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.213 0.53 . . . . 0.0 111.059 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.88 170.38 8.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.367 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -67.16 131.39 45.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.82 7.72 41.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.905 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.3 m -97.89 150.2 21.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 219' ' ' THR . 7.9 mpt_? -114.95 143.07 45.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.771 0.32 . . . . 0.0 110.6 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 73.8 mt -120.71 147.66 44.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.605 -171.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 38.2 t -155.29 102.7 2.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.526 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 292' ' ' LEU . 7.4 m-85 -90.08 128.06 36.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -75.13 -15.79 60.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.5 -32.61 74.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.889 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -111.57 172.56 6.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.734 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.7 m -88.47 41.03 0.99 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.411 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -119.61 87.57 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 110.06 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.14 -42.8 30.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.126 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.15 146.61 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.604 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -75.18 126.96 32.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.898 -170.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 2.3 pt20 -107.78 160.81 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.951 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -83.56 159.38 21.66 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.471 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.8 t -57.95 -51.45 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.2 -23.46 22.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.837 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.84 -52.33 11.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.382 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.33 -39.95 62.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.201 0.525 . . . . 0.0 110.486 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -64.1 -26.3 68.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.877 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 242' ' ' SER . 31.5 ttt180 -73.07 -34.82 66.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 109.714 175.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -43.01 84.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.538 0.685 . . . . 0.0 109.929 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -93.41 29.55 1.93 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.096 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 239' ' ' ARG . 26.5 t -49.96 -60.97 2.42 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.174 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.447 ' HB2' ' OG1' ' A' ' 253' ' ' THR . 7.5 m -62.5 151.89 36.17 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 254' ' ' HIS . 48.2 m-20 -77.11 -39.58 48.97 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.464 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.5 p30 176.03 133.72 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.086 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.8 43.41 1.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.549 0.69 . . . . 0.0 109.341 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.53 1.09 51.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.854 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.1 -29.69 60.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.7 mt -77.26 -51.85 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.089 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -174.8 -58.09 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.918 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 41.5 ttm -170.61 146.09 2.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -158.73 -104.06 0.2 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.857 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 243' ' ' CYS . 0.8 OUTLIER -80.56 -92.25 0.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 64.5 t60 69.12 109.17 0.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.031 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.402 ' NZ ' ' HA ' ' A' ' 244' ' ' ASP . 14.6 mptt -52.88 -40.5 63.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.941 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 77.37 -79.78 1.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.791 -0.641 . . . . 0.0 114.157 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.521 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 52.6 t80 -80.46 131.42 35.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.391 0.596 . . . . 0.0 111.739 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 78.56 25.17 61.34 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.2 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 52.7 p -76.64 -8.98 58.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.573 0.687 . . . . 0.0 111.878 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -110.18 -30.23 7.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.541 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 165.26 158.01 10.24 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.821 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -126.3 101.48 6.75 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.082 0.553 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.9 ttpp -87.7 119.59 28.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.291 0.567 . . . . 0.0 110.686 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.78 107.39 0.96 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.237 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.2 -48.26 12.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.35 . . . . 0.0 110.765 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.1 t -152.69 164.88 36.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.149 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.538 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 9.9 t60 -146.4 138.74 25.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.375 0.607 . . . . 0.0 111.992 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 10.2 tt0 -133.04 140.65 47.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.413 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.538 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 10.1 mt-10 -108.56 108.64 19.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.381 0.61 . . . . 0.0 110.323 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.2 t -126.8 179.17 5.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.731 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.59 131.23 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.2 t -133.13 121.01 21.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 58.52 36.44 25.23 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.3 -15.01 47.54 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.068 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.8 122.02 41.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 111.2 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.8 m -67.62 133.72 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.597 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.62 154.06 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.791 0.805 . . . . 0.0 112.486 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.88 108.18 19.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.394 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.646 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 2.3 ttmp? -92.29 108.34 19.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.419 HD11 ' HE1' ' A' ' 312' ' ' PHE . 14.7 mt -116.0 120.02 37.78 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.655 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 8.8 m -90.97 116.48 28.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.495 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 69.6 m-85 -105.25 167.82 9.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.359 0.599 . . . . 0.0 112.433 -171.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.44 134.62 21.28 Favored Pre-proline 0 C--O 1.217 -0.606 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.458 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.521 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -77.64 9.6 2.87 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 121.557 1.505 . . . . 0.0 112.169 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.95 -5.43 56.38 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -154.64 135.42 13.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.352 0.596 . . . . 0.0 110.766 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.44 -8.04 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.32 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.27 -39.92 80.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.583 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -82.45 -46.75 13.07 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.392 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 136.24 176.67 14.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.77 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.74 150.88 24.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.884 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -136.45 121.04 18.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.004 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.434 ' N ' HD22 ' A' ' 292' ' ' LEU . 14.1 m -108.36 134.27 51.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 97.3 t -129.47 128.58 66.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.101 0.476 . . . . 0.0 110.881 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -113.97 107.88 16.28 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.455 -177.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.5 p -123.6 173.14 8.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.093 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -75.88 163.29 27.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.736 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.6 mm? -65.6 -14.32 60.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.066 -170.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.02 11.13 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.784 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.21 118.97 73.92 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.151 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.81 133.29 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.405 2.07 . . . . 0.0 111.814 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.49 119.58 34.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 25.7 t80 -74.51 107.19 6.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.518 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 332' ' ' ASP . 57.0 t -94.89 133.39 35.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.309 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.736 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.4 tttp -63.95 128.92 37.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.575 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 6.4 m-20 75.39 12.73 3.18 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.98 0.8 . . . . 0.0 112.027 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -133.51 -48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.015 0.436 . . . . 0.0 111.268 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 105.97 -156.45 16.43 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -171.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -61.3 114.58 3.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.312 0.556 . . . . 0.0 110.678 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.5 m -128.92 166.46 19.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.257 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -161.36 175.07 12.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.252 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 328' ' ' ILE . 76.6 m-85 -88.48 -37.42 15.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.743 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -122.53 77.17 46.05 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.895 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -58.18 -31.41 93.34 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.975 2.45 . . . . 0.0 113.114 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 40.4 t -75.8 -21.2 57.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.341 0.591 . . . . 0.0 110.073 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.88 -48.6 7.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.217 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -51.49 -40.3 59.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.054 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.2 p -74.79 -29.54 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.209 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.36 -37.45 79.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.63 0.729 . . . . 0.0 110.319 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -100.8 -38.94 8.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.047 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -107.18 -3.63 19.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.142 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 69.35 16.16 71.04 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.942 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.72 109.6 52.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.666 -0.314 . . . . 0.0 110.588 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.74 118.03 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.737 2.291 . . . . 0.0 110.211 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.0 m -116.76 160.52 20.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.302 0.572 . . . . 0.0 112.494 -168.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.2 m -81.09 166.66 20.52 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.976 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -93.26 129.35 39.36 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.449 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -73.6 168.3 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.258 0.551 . . . . 0.0 110.696 -177.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -125.23 142.18 51.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.56 114.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.079 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.27 -4.24 20.13 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.159 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.423 ' HB3' HG13 ' A' ' 304' ' ' VAL . 54.2 m-20 -73.63 132.87 43.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -95.3 134.36 33.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.171 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.9 t -96.14 133.06 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.401 -176.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 83.6 mt -102.04 140.58 21.3 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.39 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.59 163.68 9.37 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.933 2.422 . . . . 0.0 112.152 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.57 122.58 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.587 2.192 . . . . 0.0 112.023 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.97 -7.17 41.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.426 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -74.44 125.83 89.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.71 -22.13 51.13 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.451 2.767 . . . . 0.0 114.233 -171.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.76 -28.47 44.81 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.726 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.463 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.05 85.3 2.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 86.4 mt -70.71 -43.89 76.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.892 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -124.05 81.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.534 -178.795 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.2 t -110.44 99.02 8.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.035 0.445 . . . . 0.0 110.067 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.5 p -84.07 150.49 25.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.895 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.487 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.0 mm -90.35 -40.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.702 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.476 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 85.7 t90 -150.14 125.94 10.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.6 t-80 60.94 -138.54 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 43.8 t -95.4 32.38 1.78 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.252 0.548 . . . . 0.0 110.32 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 219' ' ' THR . 66.4 m-85 -107.48 137.73 44.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.399 0.619 . . . . 0.0 111.645 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.71 178.75 4.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.284 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -63.06 144.62 56.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.262 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.54 11.71 63.76 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.399 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 44.9 m -101.88 145.74 28.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 294' ' ' VAL . 1.0 OUTLIER -111.81 136.29 51.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.727 0.299 . . . . 0.0 110.594 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.404 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.6 mt -114.42 144.18 43.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.727 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' CYS . . . . . 0.567 ' HB3' HD22 ' A' ' 228' ' ' ASN . 8.5 m -154.08 93.92 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.08 174.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.476 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 11.7 m-85 -80.67 126.6 31.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -75.42 -12.44 60.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.052 0.453 . . . . 0.0 110.066 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -60.06 -30.17 69.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.633 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -114.95 169.93 8.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.935 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.3 m -74.45 69.19 1.64 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.989 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.567 HD22 ' HB3' ' A' ' 222' ' ' CYS . 20.3 p-10 -65.7 101.12 0.59 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 121.772 0.796 . . . . 0.0 111.458 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -91.67 -45.71 8.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.532 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -118.93 161.35 20.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.234 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -80.74 113.0 18.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.416 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 1.6 pt20 -96.38 153.21 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.67 158.35 20.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -55.68 -49.73 72.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.424 0.631 . . . . 0.0 109.84 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.25 -23.24 55.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.762 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.37 -58.03 3.53 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.995 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -62.65 -48.27 80.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.123 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.08 80.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.632 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -83.68 -22.95 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.945 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.63 -29.85 20.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.56 90.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.774 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.942 ' HB3' HG22 ' A' ' 253' ' ' THR . 34.6 p 178.77 -177.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.463 0.477 . . . . 0.0 110.395 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 41.8 m -90.12 -33.24 16.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.518 ' HA ' ' HZ2' ' A' ' 255' ' ' LYS . 25.9 t70 179.52 -28.9 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.522 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -165.98 91.48 0.48 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.66 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.652 ' HB2' HG21 ' A' ' 253' ' ' THR . 6.6 mm-40 -107.67 38.86 2.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.64 -26.93 67.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.905 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -70.44 -24.75 62.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.037 0.446 . . . . 0.0 110.365 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.629 HG22 ' HG2' ' A' ' 250' ' ' GLN . 61.9 mt -68.08 -45.17 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.726 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.629 ' HG2' HG22 ' A' ' 249' ' ' ILE . 22.5 mm-40 -131.99 -85.05 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -176.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -170.05 -69.09 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -101.92 102.84 2.4 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 242' ' ' SER . 2.4 m -137.91 73.99 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.5 0.667 . . . . 0.0 109.426 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -152.1 158.9 43.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.989 -169.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' HZ2' ' HA ' ' A' ' 244' ' ' ASP . 12.2 mptt -69.78 44.14 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.591 0.357 . . . . 0.0 111.124 174.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.03 91.34 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.56 115.34 4.6 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 117.8 0.8 . . . . 0.0 110.544 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 91.11 14.92 56.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.447 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.6 t -68.5 -12.99 62.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.093 0.447 . . . . 0.0 111.795 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -102.96 -32.54 9.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 0.0 109.977 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.56 160.73 10.51 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.427 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 4.4 mp -123.67 100.53 6.83 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.455 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.9 ttpt -82.18 122.36 27.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.009 0.433 . . . . 0.0 110.173 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.492 ' CD1' HD22 ' A' ' 280' ' ' LEU . 46.1 tp -64.28 103.19 0.6 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.897 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.1 mt -81.94 -44.16 17.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.761 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 t -151.91 152.13 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.329 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.573 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.5 t60 -135.52 137.71 42.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.471 0.653 . . . . 0.0 111.466 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 34.1 tt0 -129.48 140.46 51.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.969 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.573 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 21.7 mt-10 -115.33 103.52 10.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.272 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -120.38 174.28 6.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.78 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.3 104.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.809 0.814 . . . . 0.0 109.047 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.4 t -93.72 104.68 16.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 57.94 17.79 4.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.476 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 123.85 -15.34 7.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.929 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.98 122.73 47.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.198 0.499 . . . . 0.0 111.472 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.0 m -62.52 128.06 34.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.44 155.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.852 0.834 . . . . 0.0 112.785 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.567 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 82.8 mt -93.13 108.0 19.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.838 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 49.5 tttm -103.64 106.89 17.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.499 HD12 ' HZ ' ' A' ' 282' ' ' PHE . 9.6 mt -111.91 140.85 46.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.24 -173.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 21.9 m -112.92 116.07 29.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.499 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 86.6 m-85 -108.96 161.76 14.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 265' ' ' LEU . 17.6 t70 -121.54 132.34 24.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.118 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.74 10.18 3.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 113.047 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.99 -17.72 51.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.894 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -145.46 128.32 16.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.291 0.567 . . . . 0.0 110.24 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 -11.01 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.244 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.44 -31.31 72.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.096 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.96 -46.48 15.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.712 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 131.06 -163.42 23.5 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.988 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 mt -108.85 165.07 11.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.728 0.299 . . . . 0.0 110.858 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -136.18 119.58 16.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.3 m -108.88 135.82 49.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 53.2 t -136.71 136.1 48.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -100.64 124.25 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.21 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.0 p -136.86 170.79 15.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.652 0.263 . . . . 0.0 110.482 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -81.5 165.85 20.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.246 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.641 HD22 ' H ' ' A' ' 298' ' ' LEU . 2.0 mm? -67.85 -17.78 64.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.51 -172.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -105.3 22.05 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.299 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -78.76 119.04 75.82 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.45 137.23 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.0 111.94 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 88.4 m-85 -123.98 120.63 33.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 46.5 t80 -75.87 110.25 10.16 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.239 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 51.8 t -99.05 137.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.412 -175.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -57.53 126.43 27.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.236 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 28.5 m120 75.72 -6.84 1.91 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.377 0.671 . . . . 0.0 112.33 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -114.74 -20.76 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.813 0.34 . . . . 0.0 111.527 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.66 -152.63 41.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.765 0.317 . . . . 0.0 110.419 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 19.8 m -129.01 166.2 19.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.988 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 12.4 t -161.94 -178.58 6.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.493 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 69.8 m-85 -95.65 -35.91 11.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.63 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.71 70.92 48.73 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.29 -35.62 96.61 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.263 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.6 p -68.03 -20.82 65.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.246 0.546 . . . . 0.0 110.511 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.0 tp -88.15 -44.04 11.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.114 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.2 m -55.05 -39.79 69.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.562 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.23 -23.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.73 -39.2 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 110.098 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -80.12 -58.35 3.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.027 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -92.95 -25.46 18.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.916 0.389 . . . . 0.0 111.312 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 90.36 22.09 35.85 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.064 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 61.4 mt -115.41 114.55 42.73 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 5.4 Cg_exo -76.96 103.71 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.79 2.327 . . . . 0.0 110.768 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 48.1 m -103.85 156.99 17.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.376 -168.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.9 m -81.56 165.34 21.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.61 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -92.25 124.16 36.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.45 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -67.8 165.3 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 -175.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -122.79 138.9 54.5 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.82 112.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.057 0.456 . . . . 0.0 110.344 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.07 6.11 19.01 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.185 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 5.7 m-20 -81.05 134.53 35.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.0 111.594 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 2.4 t -79.63 125.58 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.419 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 72.5 m -94.49 119.58 33.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.4 mt -100.99 141.59 22.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.83 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.48 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 78.2 Cg_endo -86.67 166.1 8.92 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.253 2.635 . . . . 0.0 112.442 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.75 115.45 4.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.676 2.251 . . . . 0.0 111.805 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 119.49 -16.57 10.51 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.313 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -67.7 127.25 93.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.22 -24.63 51.55 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.569 2.846 . . . . 0.0 114.211 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.26 -35.16 48.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.618 0.247 . . . . 0.0 110.647 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.53 86.41 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 110.136 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.5 -53.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.17 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.97 74.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.367 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.048 178.314 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.652 -0.557 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -92.08 103.69 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 110.167 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 p -84.58 141.31 30.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 8.9 mm -85.85 -42.79 16.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.293 0.568 . . . . 0.0 109.657 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -154.65 128.69 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.908 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.7 t-80 57.63 -149.67 0.46 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.559 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 34.2 t -88.61 43.75 1.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.688 -0.632 . . . . 0.0 110.397 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 65.3 m-85 -114.31 138.53 50.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.201 0.524 . . . . 0.0 111.274 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.4 176.09 5.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.328 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.515 ' HG3' ' CD ' ' A' ' 235' ' ' GLU . 88.1 tttt -62.54 141.99 58.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.292 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.26 4.7 64.27 Favored Glycine 0 CA--C 1.517 0.178 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.401 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.1 m -94.69 149.15 21.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -113.44 143.32 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.96 0.409 . . . . 0.0 110.973 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 63.5 mt -118.18 148.94 41.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.076 -174.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 229' ' ' LYS . 35.0 t -154.13 101.33 2.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.996 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -86.38 98.06 10.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 291' ' ' LEU . 22.6 m170 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.788 ' HA ' ' HA3' ' A' ' 290' ' ' GLY . 40.2 tttp -48.34 -40.66 26.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.986 173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.69 -168.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.6 p -82.67 42.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.936 0.398 . . . . 0.0 110.684 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 222' ' ' CYS . 22.3 t-20 -122.38 96.79 5.18 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.602 0.715 . . . . 0.0 111.07 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.683 ' HA ' ' SG ' ' A' ' 222' ' ' CYS . 0.0 OUTLIER -115.41 19.58 15.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.841 0.829 . . . . 0.0 110.544 174.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -107.14 139.69 41.16 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.335 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 62.8 m95 -74.29 130.27 39.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.368 0.604 . . . . 0.0 111.912 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 11.7 pt20 -132.15 156.41 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.989 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.79 154.27 38.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -58.29 -47.61 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 168.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.515 ' CD ' ' HG3' ' A' ' 217' ' ' LYS . 4.6 mt-10 -59.05 -21.59 59.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.501 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.0 -52.35 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.204 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.513 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.7 t80 -62.86 -48.45 78.99 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.011 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.05 -34.92 68.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.006 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 11.2 ttm180 -71.53 -45.11 63.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.518 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.6 63.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.494 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 255' ' ' LYS . . . -90.75 28.0 1.64 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.135 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.9 m -56.58 -29.84 62.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 168.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 1.098 ' HA ' ' HG2' ' A' ' 247' ' ' GLU . 7.9 p -73.49 116.37 13.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.415 166.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.6 -18.58 63.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 122.139 0.971 . . . . 0.0 108.642 175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.74 ' O ' ' HB ' ' A' ' 253' ' ' THR . 1.5 m-20 -136.11 -68.67 0.5 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.222 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.661 ' HG3' ' C ' ' A' ' 245' ' ' ASN . 8.5 mt-10 -154.68 18.61 0.46 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -161.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 1.098 ' HG2' ' HA ' ' A' ' 243' ' ' CYS . 0.1 OUTLIER -59.23 -48.19 82.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.118 0.417 . . . . 0.0 111.238 -171.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -105.8 -40.9 5.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.41 -69.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -168.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 246' ' ' GLU . 0.0 OUTLIER 179.49 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.026 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 56.0 ttp -75.63 68.21 2.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.188 0.518 . . . . 0.0 109.911 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.54 89.03 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.202 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 245' ' ' ASN . 27.6 m -153.03 -77.51 0.12 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 245' ' ' ASN . 64.1 t60 65.12 114.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.808 0.692 . . . . 0.0 112.056 175.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.613 ' HD2' ' HB1' ' A' ' 241' ' ' ALA . 47.6 mtpt -80.55 40.3 0.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -118.7 3.76 14.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.915 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.648 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 41.6 t80 -72.72 121.18 19.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.282 0.541 . . . . 0.0 109.594 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.28 15.97 59.74 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.418 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.9 p -69.11 -15.09 63.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.93 -26.59 10.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.49 156.74 8.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.638 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -123.88 100.11 6.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.392 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 76.0 tttt -84.42 124.4 31.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -65.36 104.59 0.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 283' ' ' ASP . 69.5 mt -80.52 -45.83 16.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.6 t -152.01 164.61 36.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.804 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.431 ' C ' ' CD2' ' A' ' 267' ' ' HIS . 0.1 OUTLIER -137.87 139.66 40.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.493 -168.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -146.31 140.98 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.283 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.76 109.81 21.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.047 0.451 . . . . 0.0 109.792 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -124.3 179.89 4.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.221 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.15 119.76 62.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 109.784 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 13.1 t -130.24 140.98 50.66 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 47.33 28.7 1.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.803 0.841 . . . . 0.0 111.922 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 95.82 -16.55 60.96 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.325 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -108.04 148.22 30.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.05 0.452 . . . . 0.0 111.509 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.6 m -67.54 128.97 38.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 172.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.01 155.63 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.826 0.822 . . . . 0.0 112.551 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.21 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.17 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -97.82 106.77 19.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.507 HD11 ' CE1' ' A' ' 312' ' ' PHE . 20.5 mt -114.46 139.26 49.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.4 m -103.76 120.8 41.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.567 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.8 m-85 -109.39 163.75 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 31.9 t70 -132.75 137.56 30.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.846 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.648 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 93.5 Cg_endo -83.24 9.42 4.1 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.241 1.961 . . . . 0.0 112.674 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.42 -11.19 50.78 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -153.18 114.75 4.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.544 0.688 . . . . 0.0 109.718 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.21 -8.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.985 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.25 -23.18 66.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.905 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.76 -42.97 20.92 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.758 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.788 ' HA3' ' HA ' ' A' ' 225' ' ' LYS . . . 141.7 153.52 5.95 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.992 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 224' ' ' HIS . 1.9 mt -73.15 155.18 39.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.011 0.434 . . . . 0.0 110.931 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -136.09 119.49 16.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 19.0 m -110.38 137.05 48.62 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 215' ' ' PHE . 90.9 t -130.73 134.93 61.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.159 -176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 32.8 mt-10 -117.83 120.66 38.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 172.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.519 ' HB3' HG23 ' A' ' 219' ' ' THR . 3.9 p -137.44 172.32 13.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.636 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.21 162.04 23.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 110.777 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.697 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.4 mm? -69.72 -8.9 51.89 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.123 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -105.03 13.87 30.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.416 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -73.43 116.59 52.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.826 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.14 119.4 5.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.247 1.965 . . . . 0.0 111.584 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.65 119.38 38.85 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 12.1 t80 -74.27 106.35 5.87 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.507 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.0 t -94.45 134.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.349 0.595 . . . . 0.0 111.273 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' A' ' 333' ' ' VAL . 49.8 tttp -58.5 125.27 22.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.329 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 79.6 m-20 78.08 -1.95 2.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.407 0.683 . . . . 0.0 112.196 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -117.75 -28.72 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 111.35 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.407 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 86.15 -152.4 25.62 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.71 116.79 5.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.067 0.433 . . . . 0.0 110.091 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.439 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.5 m -128.66 166.23 19.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.368 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.5 t -160.85 171.74 18.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.805 0.336 . . . . 0.0 110.649 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.507 ' CE1' HD11 ' A' ' 280' ' ' LEU . 56.6 m-85 -86.23 -36.42 19.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.64 174.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -126.25 77.3 72.21 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.454 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 48.8 Cg_exo -57.08 -38.51 95.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.94 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 20.0 m -66.06 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.0 110.796 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.24 -47.25 9.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.995 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.9 m -56.62 -41.83 77.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.064 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.545 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.5 p -69.33 -20.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.707 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.01 -43.79 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -72.13 -51.56 20.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.076 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -101.49 -20.34 15.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.033 0.444 . . . . 0.0 111.026 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 86.28 24.09 41.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.409 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.2 mt -118.86 113.52 35.95 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.888 -0.183 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -71.2 117.02 4.94 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 110.305 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 80.2 m -117.6 155.46 29.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.007 0.432 . . . . 0.0 112.1 -169.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.31 164.75 23.84 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.266 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -92.52 120.36 32.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.439 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.06 162.45 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.506 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -125.34 150.36 47.25 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.37 113.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.681 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.515 ' O ' ' HE3' ' A' ' 263' ' ' LYS . . . 115.87 1.36 21.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.018 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.27 127.33 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.178 0.513 . . . . 0.0 110.433 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.63 133.98 30.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.407 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 53.6 t -94.82 131.25 40.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.235 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.3 mt -103.14 140.78 21.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.216 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.431 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.4 Cg_endo -86.81 167.34 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.88 2.387 . . . . 0.0 111.916 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.09 127.21 17.93 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 111.356 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 111.05 -18.22 26.32 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.431 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -71.27 127.43 91.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.03 -22.28 73.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.255 2.636 . . . . 0.0 113.448 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.17 -25.81 47.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.159 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.48 86.68 2.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.09 -45.66 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.766 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -124.2 75.72 1.4 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.648 0.261 . . . . 0.0 110.459 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.574 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.656 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -103.86 89.45 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.233 0.539 . . . . 0.0 109.934 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -76.82 144.13 39.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.28 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.4 mm -81.33 -42.08 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 68.9 t90 -153.8 139.93 18.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.327 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 53.1 -137.54 1.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 52.1 t -100.35 35.03 2.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.488 0.661 . . . . 0.0 109.968 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.97 140.32 42.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.4 0.619 . . . . 0.0 111.656 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.03 175.73 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.023 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -66.66 139.97 57.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.885 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.66 12.1 51.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.959 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 61.6 m -105.82 146.88 29.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -115.65 140.66 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.02 0.438 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.447 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 80.0 mt -114.53 145.08 42.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.107 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.35 109.1 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.463 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 292' ' ' LEU . 28.7 m-85 -99.58 115.5 29.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -65.04 -37.56 87.98 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -65.03 -27.55 68.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.887 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -89.64 167.93 12.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 27.1 t -82.18 31.08 0.39 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.978 0.418 . . . . 0.0 110.389 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.94 70.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -3.7 58.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.507 0.67 . . . . 0.0 110.528 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -93.46 161.96 14.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.497 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.514 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 57.7 m95 -80.2 124.86 29.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.435 0.636 . . . . 0.0 111.822 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.7 pt20 -117.49 162.84 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.34 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -89.18 160.0 17.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.066 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -57.95 -47.9 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -55.26 -22.74 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.63 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.93 -56.99 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.641 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.588 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 80.6 t80 -66.55 -40.4 89.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -53.47 -50.98 64.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.754 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -56.08 -29.78 61.05 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.35 18.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.098 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.29 -40.8 11.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -170.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.2 p -90.02 63.26 5.86 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.37 -40.36 51.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.008 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 253' ' ' THR . 5.9 t0 178.52 -177.73 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.44 70.46 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.408 ' HB3' HD12 ' A' ' 249' ' ' ILE . 31.4 mt-10 -79.03 52.07 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.396 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.2 -12.61 52.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.379 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.1 11.43 16.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.115 0.96 . . . . 0.0 109.274 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 246' ' ' GLU . 7.3 mt -138.77 135.57 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -64.22 74.58 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.295 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 25.6 ttt -156.4 -48.2 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.578 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 64.39 70.17 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.919 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 244' ' ' ASP . 0.2 OUTLIER -65.59 -68.89 0.33 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.512 ' CG ' ' H ' ' A' ' 255' ' ' LYS . 73.2 t60 59.85 -164.25 0.22 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.742 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 254' ' ' HIS . 6.0 tptm -97.96 26.35 5.29 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.521 -0.737 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 77.93 -174.64 54.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 114.929 0.731 . . . . 0.0 114.929 168.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.475 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 t80 -48.3 131.87 16.48 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.233 1.013 . . . . 0.0 111.874 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.38 42.68 3.91 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.827 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.8 m -79.1 -17.95 54.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -104.85 -29.49 10.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.478 0.656 . . . . 0.0 109.684 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 156.38 160.55 10.11 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.75 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -118.2 100.31 7.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.519 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.7 ttpt -83.9 117.05 23.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.214 0.53 . . . . 0.0 110.426 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.406 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.2 tt -61.22 103.7 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.136 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.6 mt -78.4 -48.93 14.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.883 0.373 . . . . 0.0 110.444 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.9 t -151.94 167.18 29.2 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.408 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.553 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.6 t60 -141.1 139.81 34.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.294 0.569 . . . . 0.0 111.512 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 35.9 tt0 -133.66 144.37 49.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.808 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 25.6 mt-10 -115.85 133.19 56.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.814 0.34 . . . . 0.0 110.133 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 t -155.56 -179.62 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.701 -170.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.44 131.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 0.0 110.316 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 14.2 t -126.79 107.52 10.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.151 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 57.2 48.74 14.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.166 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 83.94 -12.58 52.9 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.175 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.04 125.35 51.45 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.652 -0.322 . . . . 0.0 111.02 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 67.7 m -64.45 134.73 55.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.56 155.6 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.972 0.891 . . . . 0.0 112.945 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.401 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 74.7 mt -96.71 116.69 29.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.313 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 22.4 ttmm -107.29 114.08 27.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 26.9 mt -114.63 135.59 53.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.868 0.366 . . . . 0.0 110.344 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 12.4 m -97.64 115.57 28.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.559 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 61.7 m-85 -106.06 163.54 12.69 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -170.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 265' ' ' LEU . 20.1 t70 -132.0 137.87 31.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.327 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.475 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 86.7 Cg_endo -87.03 11.13 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.341 2.027 . . . . 0.0 112.649 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.89 -12.73 56.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.27 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 t -153.49 134.87 14.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.974 0.416 . . . . 0.0 110.088 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.01 -8.52 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.525 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -55.07 -49.28 72.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.95 2.59 38.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 84.91 179.13 51.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.157 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mt -84.47 135.45 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.966 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -111.37 120.12 41.13 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 25.4 m -112.73 135.92 52.91 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 96.2 t -132.27 135.42 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.743 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 83.2 mt-10 -107.52 120.4 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 169.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.579 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.1 p -131.88 173.37 11.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -74.68 164.9 26.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.644 0.259 . . . . 0.0 110.941 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.66 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.9 mm? -66.2 -28.84 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.336 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.73 26.11 5.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.293 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -77.63 116.77 60.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.485 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.44 125.15 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.256 1.971 . . . . 0.0 111.646 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.579 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -111.45 116.3 30.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.525 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 17.9 t80 -74.67 104.66 5.42 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.487 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.1 t -92.38 134.73 29.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.663 ' HB3' HG13 ' A' ' 333' ' ' VAL . 45.9 tttt -59.47 120.7 9.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.225 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 74.45 6.9 4.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.004 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -117.02 -30.41 5.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.002 0.429 . . . . 0.0 110.582 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.91 -155.8 23.32 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.47 116.09 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.033 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.453 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -124.83 167.47 14.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.077 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 39.9 t -160.57 165.86 30.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.818 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.468 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 60.3 m-85 -86.83 -16.55 35.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.281 173.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -142.11 73.35 22.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.73 -41.03 77.52 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.812 2.341 . . . . 0.0 112.581 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 14.6 m -60.42 -29.04 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.27 -46.09 10.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.253 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.2 m -57.34 -41.24 79.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.158 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -68.82 -19.86 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 0.0 111.573 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.7 t -89.96 -45.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.075 0.464 . . . . 0.0 110.265 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -71.9 -58.7 3.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.314 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -95.75 -13.78 23.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 0.0 110.732 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 85.1 10.75 77.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.859 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.4 mt -108.82 117.56 53.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 122.741 -0.27 . . . . 0.0 111.008 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.89 116.76 4.83 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.513 2.142 . . . . 0.0 110.409 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.1 m -117.2 159.06 23.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.376 0.608 . . . . 0.0 112.462 -168.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 61.4 m -81.59 151.0 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.142 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 120.06 22.09 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.31 165.57 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.891 0.853 . . . . 0.0 111.413 -174.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -121.94 141.63 51.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.373 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.8 mm -58.09 113.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 109.673 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.41 -0.92 20.56 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.78 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -71.33 124.77 25.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.208 0.527 . . . . 0.0 111.181 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -89.57 126.08 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.859 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.1 t -88.96 135.09 33.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.061 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 81.4 mt -106.37 144.07 28.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.631 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.3 160.61 13.11 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.474 2.116 . . . . 0.0 111.757 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.77 114.84 3.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.965 2.444 . . . . 0.0 112.25 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 115.29 -13.68 18.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.519 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.46 132.42 94.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.71 -31.1 49.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.105 3.204 . . . . 0.0 114.349 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -79.18 -23.12 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.99 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.07 95.76 3.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.066 0.46 . . . . 0.0 110.333 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.36 -42.27 81.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.855 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -139.62 98.14 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.091 -176.291 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 110.834 -0.487 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.6 t -103.52 110.63 22.75 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.5 p -94.9 150.76 19.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.287 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 253' ' ' THR . 32.5 mm -79.28 -45.96 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.376 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TRP . . . . . 0.679 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 78.5 t90 -151.36 136.71 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.445 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.2 t-80 56.04 -133.54 1.49 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 14.9 p -99.17 26.61 5.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.012 0.434 . . . . 0.0 110.867 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -105.61 135.41 47.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.952 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.57 174.84 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.424 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -64.31 139.34 58.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.847 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.77 12.05 44.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.138 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 30.8 m -102.38 158.18 16.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.24 151.59 42.15 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.416 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 56.5 mt -122.31 145.72 47.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.13 92.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.658 175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -78.61 123.02 26.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -67.95 -20.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 0.0 111.632 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -76.94 -7.56 55.78 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.834 0.349 . . . . 0.0 110.92 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -97.12 170.78 8.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.026 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.2 m -96.42 7.72 45.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.459 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -91.58 84.89 5.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -9.07 59.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.708 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -94.81 153.14 17.88 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' TRP . . . . . 0.447 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 88.3 m95 -74.08 120.04 19.12 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -100.09 158.97 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.532 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.05 164.35 21.46 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.163 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.1 t -66.27 -39.06 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.23 -22.05 64.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.503 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.69 -53.32 12.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.33 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.496 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 88.1 t80 -74.68 -40.31 61.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.236 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 212' ' ' TRP . . . -61.06 -35.4 76.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.842 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -67.76 -24.54 65.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.607 0.718 . . . . 0.0 109.909 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -80.6 -9.6 59.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.715 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.51 ' HA ' ' NZ ' ' A' ' 255' ' ' LYS . . . -80.69 -48.91 11.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.155 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 96.4 p 178.18 -145.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.58 -33.98 15.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.956 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -168.31 175.17 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -171.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -74.86 72.11 2.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.702 0.763 . . . . 0.0 109.622 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -76.05 40.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.628 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.93 -16.32 60.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.059 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -82.85 -30.45 28.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.2 -56.41 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.529 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -168.17 -61.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.327 . . . . 0.0 110.413 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 53.7 ttm -161.29 148.16 14.76 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -165.45 -128.88 1.0 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.681 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 211' ' ' ILE . 9.2 m -61.8 -15.18 39.4 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.79 76.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 166.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.679 ' HB2' ' HE1' ' A' ' 212' ' ' TRP . 22.0 tptt -62.66 -56.31 18.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.73 -162.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 150.98 -59.26 0.43 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.256 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.661 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 38.3 t80 -61.27 114.93 3.44 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.95 11.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.656 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.9 t -78.81 -24.82 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.704 0.288 . . . . 0.0 110.552 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -99.39 -25.37 14.49 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.39 168.0 17.83 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.646 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.04 102.79 7.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.771 -0.714 . . . . 0.0 110.138 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 75.5 tttt -87.49 119.12 27.45 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.0 110.796 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.51 107.87 0.74 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.163 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.7 mt -83.13 -45.83 13.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.0 0.429 . . . . 0.0 110.48 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 32.8 t -151.88 156.33 39.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.211 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.406 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.8 t60 -139.12 138.22 36.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -131.57 141.46 49.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.397 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.28 129.61 53.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.1 t -148.47 178.52 8.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -118.3 122.94 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 109.763 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.8 m -115.29 94.27 4.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.31 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 57.9 65.73 1.25 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.347 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.85 22.14 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.589 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.94 122.93 49.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.992 0.396 . . . . 0.0 110.733 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.5 m -71.63 129.66 39.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.5 m -130.04 152.59 37.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 122.029 0.918 . . . . 0.0 112.897 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.64 112.87 24.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.591 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -102.87 110.0 21.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.418 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 23.0 mt -115.34 129.73 56.69 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 87.7 m -98.94 117.17 32.84 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.444 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.0 m-85 -104.51 167.02 10.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.137 -170.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.457 ' HB2' HD21 ' A' ' 265' ' ' LEU . 21.9 t70 -132.34 134.52 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.413 175.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.2 Cg_endo -83.72 12.11 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.143 1.895 . . . . 0.0 112.332 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.64 62.06 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -153.71 102.94 2.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.911 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 291' ' ' LEU . 12.1 p -61.52 -15.28 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.421 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.16 -28.24 69.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.671 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -72.27 -40.5 67.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 110.161 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.85 152.72 5.98 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.422 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 287' ' ' VAL . 85.1 mt -82.26 147.76 28.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.221 0.511 . . . . 0.0 110.638 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 294' ' ' VAL . 1.5 tm? -125.05 118.32 25.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 83.8 m -110.3 134.0 52.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.403 HG23 HD13 ' A' ' 292' ' ' LEU . 75.3 t -130.33 136.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.561 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.447 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 62.5 mt-10 -112.54 127.94 56.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.105 170.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.0 p -139.82 176.28 8.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.93 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.94 164.17 26.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.913 0.387 . . . . 0.0 110.329 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.716 HD22 ' H ' ' A' ' 298' ' ' LEU . 1.7 mm? -64.85 -17.84 64.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.245 -173.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.35 17.89 20.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.979 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.92 118.47 72.07 Favored Pre-proline 0 C--N 1.323 -0.563 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.339 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.58 139.82 16.36 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.104 1.869 . . . . 0.0 111.677 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.471 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 80.9 m-85 -124.5 129.73 51.16 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.9 t80 -82.63 89.62 6.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.498 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 332' ' ' ASP . 74.8 t -75.83 125.91 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.068 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.658 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.9 tttp -56.09 141.4 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.641 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.4 m-20 78.21 -20.04 0.41 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.47 0.708 . . . . 0.0 111.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -105.2 -60.53 1.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 111.345 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 125.76 -124.34 5.19 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.25 117.39 28.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.765 0.782 . . . . 0.0 110.606 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.8 m -131.8 167.88 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.23 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.3 t -161.34 -177.34 5.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 328' ' ' ILE . 71.6 m-85 -91.81 -39.09 11.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.22 73.2 57.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.877 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -57.17 -34.21 97.34 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.121 2.547 . . . . 0.0 113.213 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.8 p -65.35 -30.02 70.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.8 tp -83.15 -44.11 15.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.157 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -55.36 -44.16 75.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.151 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.7 p -69.81 -27.04 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.541 -176.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.7 -38.52 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.285 0.565 . . . . 0.0 110.186 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.26 -58.19 3.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.051 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -98.97 -8.46 25.42 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.25 21.44 75.62 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.2 mt -116.58 111.22 41.78 Favored Pre-proline 0 C--N 1.327 -0.394 0 O-C-N 122.876 -0.191 . . . . 0.0 110.646 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.33 117.95 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.582 2.188 . . . . 0.0 110.534 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 58.0 m -117.38 157.65 25.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.711 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 72.6 m -87.38 165.2 15.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.232 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.76 127.04 33.06 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.085 -0.384 . . . . 0.0 109.97 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.424 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -72.27 177.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 0.0 110.598 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -139.19 141.07 37.97 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.6 mm -52.34 112.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 109.575 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.49 9.13 15.27 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.735 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.2 OUTLIER -72.29 127.99 34.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -96.61 111.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.946 0.879 . . . . 0.0 111.051 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.7 m -79.24 127.84 32.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.112 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 69.5 mt -98.75 138.95 20.77 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.066 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.6 Cg_endo -86.14 176.65 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.923 2.415 . . . . 0.0 111.734 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.96 155.1 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.255 1.97 . . . . 0.0 111.029 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.0 -23.14 5.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.564 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -65.32 126.26 91.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -24.49 79.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.096 2.531 . . . . 0.0 113.152 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.94 -25.15 40.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.21 84.87 3.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.392 0.615 . . . . 0.0 109.507 173.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.26 -44.54 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.639 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.74 44.24 1.94 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.93 0.395 . . . . 0.0 110.616 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.093 -178.345 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.0 t -96.9 93.39 6.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 110.222 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 23.7 p -87.72 144.2 26.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.808 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.504 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 13.8 mm -85.21 -37.95 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.32 0.581 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -151.91 131.38 12.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 18.4 t-80 58.62 -138.43 0.81 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 51.5 t -98.61 37.18 1.52 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 110.155 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -113.44 137.59 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.44 172.02 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.044 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.7 141.12 51.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.976 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.13 5.56 54.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.212 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 50.1 m -99.08 147.98 24.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.46 137.0 49.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.195 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 39.9 mt -113.12 144.06 43.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.257 -174.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 40.8 t -153.17 92.03 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.558 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.431 ' CD2' HD23 ' A' ' 292' ' ' LEU . 5.8 m-85 -86.43 123.1 31.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.1 m170 . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.849 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 75.2 m95 . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.9 pt20 -111.71 165.37 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -85.34 160.37 19.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 3.6 t -61.33 -45.21 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.6 0.714 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -58.12 -23.16 53.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.9 -52.01 11.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.009 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -68.11 -40.37 82.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.43 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.74 76.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.615 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.734 178.059 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.3 t80 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.76 19.31 44.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.388 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.4 t -66.92 -25.21 66.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.535 0.207 . . . . 0.0 111.312 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -99.17 -27.98 13.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.13 161.84 10.85 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.899 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -117.65 106.19 12.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.75 -0.725 . . . . 0.0 110.404 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.7 ttpp -90.56 119.32 30.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 -175.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 tt -60.08 113.13 2.17 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.09 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 95.4 mt -86.25 -52.14 5.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.452 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.2 t -148.57 158.98 44.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.783 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.495 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 4.1 t60 -135.71 136.24 40.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -127.3 139.52 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.571 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.495 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 28.5 mt-10 -108.95 106.4 16.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 110.063 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.637 -172.463 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.238 0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.82 152.95 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.992 0.901 . . . . 0.0 113.068 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.33 114.08 26.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.985 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.8 ttmt -107.09 116.12 31.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.433 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 34.1 mt -119.88 131.23 55.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.205 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.6 m -95.45 114.95 26.77 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.563 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.4 m-85 -100.99 164.93 11.58 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.337 0.589 . . . . 0.0 112.471 -171.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 6.6 t70 -133.19 129.12 20.75 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.019 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 287' ' ' VAL . 83.6 Cg_endo -81.44 9.12 4.01 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 122.155 1.903 . . . . 0.0 112.348 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 -47.97 0.99 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -124.53 98.19 5.63 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.547 ' HA ' ' HD2' ' A' ' 284' ' ' PRO . 5.2 p -67.52 -6.98 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.464 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.28 -12.6 61.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.538 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -66.2 -37.18 84.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.38 126.98 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.467 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 287' ' ' VAL . 1.8 mt -59.97 135.32 57.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.179 0.489 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.6 tm? -109.45 119.24 38.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 6.5 m -109.35 139.96 43.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 73.5 t -136.75 131.47 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -105.67 117.62 34.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.319 169.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 9.6 p -134.53 178.17 7.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.877 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -81.06 165.54 21.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.696 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -68.75 -22.91 64.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.839 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.76 19.62 15.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.241 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.23 120.04 79.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.351 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.5 136.46 13.93 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.482 2.122 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 79.9 m-85 -124.2 124.96 43.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 8.0 t80 -77.53 93.07 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 332' ' ' ASP . 65.8 t -80.47 130.34 36.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.581 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 56.6 tttp -56.39 133.9 53.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.824 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.8 m-20 78.95 -17.13 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.02 0.825 . . . . 0.0 112.283 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 327' ' ' GLU . 11.6 tttp -111.36 -41.86 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.073 0.463 . . . . 0.0 111.571 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 104.71 -155.13 17.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -61.66 113.61 2.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.96 0.41 . . . . 0.0 110.587 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.7 m -131.08 164.94 24.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.043 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 t -160.99 179.76 8.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.636 0.255 . . . . 0.0 110.771 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.433 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 67.3 m-85 -91.53 -34.32 14.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.07 70.31 40.77 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 42.4 Cg_exo -59.13 -30.49 93.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.792 2.328 . . . . 0.0 113.425 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 16.0 m -70.35 -25.31 63.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.9 tp -87.54 -42.36 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.296 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.2 m -53.87 -46.08 71.22 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.877 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.9 -27.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.14 -30.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 0.0 110.417 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -92.85 -38.58 11.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.613 -173.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -114.67 -4.02 12.81 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 122.118 -0.364 . . . . 0.0 111.859 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.01 78.87 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 48.1 mt -118.67 111.26 37.87 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 122.834 -0.216 . . . . 0.0 110.697 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.95 118.18 5.5 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.426 2.084 . . . . 0.0 110.82 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 85.0 m -117.76 153.94 32.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.3 0.571 . . . . 0.0 112.056 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 69.0 m -89.6 166.26 13.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.848 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 25.2 tt0 -77.02 125.16 28.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.315 0.246 . . . . 0.0 111.194 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -80.64 168.0 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.791 175.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -133.06 151.1 52.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.1 mm -59.41 111.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.269 0.557 . . . . 0.0 109.717 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.56 1.15 21.64 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.413 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 304' ' ' VAL . 16.8 m-20 -79.0 128.75 33.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.457 0.646 . . . . 0.0 111.047 176.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.8 137.91 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.796 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 55.6 m -103.44 133.76 47.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.302 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.0 144.9 29.52 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.258 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.2 Cg_endo -87.98 166.09 7.12 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.143 2.562 . . . . 0.0 112.624 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 119.07 6.02 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.623 2.215 . . . . 0.0 111.157 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 118.34 -19.35 10.79 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.611 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -69.32 127.44 92.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.98 -13.98 40.66 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.178 2.585 . . . . 0.0 113.115 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 32.9 t70 -90.31 -23.25 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.83 87.36 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.054 0.454 . . . . 0.0 109.786 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.84 -44.16 92.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.603 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.18 80.15 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.914 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.507 -178.29 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.614 -0.571 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.5 t -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.1 p -85.94 149.6 25.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.83 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.2 mm -79.23 -43.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -151.99 137.56 17.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.549 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 25.7 t-80 54.54 -136.53 1.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 47.8 t -100.25 37.6 1.64 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.145 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -111.12 137.14 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.347 0.594 . . . . 0.0 111.443 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.12 175.9 5.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.42 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -69.23 135.17 50.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.03 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.36 48.39 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.471 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.7 m -96.13 143.93 26.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.3 -0.45 . . . . 0.0 109.923 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -109.48 141.73 41.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.824 0.345 . . . . 0.0 110.548 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 46.5 mt -118.12 143.13 46.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.24 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.3 t -151.0 99.45 2.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.42 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.575 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 35.4 m-85 -91.97 132.41 36.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.7 m170 . . . . . 0 C--N 1.318 -0.777 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.76 -171.309 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 65.3 m95 . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 121.66 0.743 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 18.4 pt20 -128.66 161.21 30.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.685 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -82.06 158.1 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.423 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.6 t -58.25 -46.46 88.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.613 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 211' ' ' ILE . 25.6 mt-10 -57.55 -23.09 48.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.625 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.29 -45.94 14.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.0 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -73.75 -35.91 65.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.983 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.08 67.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.709 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 239' ' ' ARG . 34.0 ttm105 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.748 . . . . 0.0 109.691 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 121.018 0.437 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.15 27.52 12.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.022 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.0 p -68.84 -22.61 64.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -99.52 -27.15 13.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.26 0.552 . . . . 0.0 109.811 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 150.19 154.39 6.43 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.946 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 5.5 mp -113.25 98.66 7.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.952 -0.624 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 8.4 tptp -77.99 115.62 17.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.5 tt -59.84 111.74 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 283' ' ' ASP . 82.8 mt -83.13 -51.87 7.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.061 0.458 . . . . 0.0 111.061 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.8 t -148.54 161.81 40.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.161 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -141.59 150.38 41.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.027 -168.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.79 135.58 12.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.884 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -87.18 106.06 17.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.317 -0.81 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.196 -168.147 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 m -134.6 157.07 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.695 0.76 . . . . 0.0 112.099 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 90.0 mt -94.18 109.66 21.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.467 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -96.35 112.36 24.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.665 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 279' ' ' LYS . 29.6 mt -121.42 142.75 49.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.527 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 32.3 m -108.26 117.04 33.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 96.2 m-85 -105.6 157.45 17.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.554 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.461 ' HB2' HD21 ' A' ' 265' ' ' LEU . 7.2 t70 -126.82 132.79 24.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.714 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.4 5.55 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.017 1.811 . . . . 0.0 112.174 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.7 -13.29 42.33 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.2 t -153.89 133.13 12.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.057 0.456 . . . . 0.0 110.156 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.0 -8.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.856 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.4 -23.2 63.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.314 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.87 -2.93 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.075 0.464 . . . . 0.0 110.248 176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.07 169.95 29.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.949 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.71 152.16 19.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -126.4 120.47 29.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 292' ' ' LEU . 8.9 m -111.25 138.58 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 75.6 t -137.38 137.59 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.42 121.1 40.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.809 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -138.38 173.29 11.76 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -68.64 160.87 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.122 0.486 . . . . 0.0 111.23 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.711 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -64.62 -27.42 68.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.31 24.99 4.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.433 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -75.31 121.34 84.99 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.206 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.28 131.27 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.279 1.986 . . . . 0.0 111.805 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -121.82 116.62 24.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 29.1 t80 -73.25 108.69 6.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.896 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 74.1 t -99.12 137.96 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.427 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.718 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.0 tttp -56.78 124.46 18.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.792 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 77.95 -1.45 2.58 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.878 0.736 . . . . 0.0 112.177 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -117.16 -33.16 4.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 90.25 -157.13 25.64 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -60.87 113.02 2.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.294 0.547 . . . . 0.0 110.019 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.4 m -125.23 166.75 15.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.6 t -161.58 -178.58 6.68 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.437 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 33.3 m-85 -90.32 -41.48 11.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 110.292 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.35 77.31 68.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.948 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 60.4 Cg_exo -55.03 -38.7 93.27 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.042 2.495 . . . . 0.0 113.448 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 2.3 p -62.34 -24.96 67.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.253 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.74 -45.24 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.768 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.2 m -59.03 -39.78 83.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.094 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -70.31 -19.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.531 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.25 -40.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.295 0.569 . . . . 0.0 110.33 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.76 -58.28 3.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.771 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -95.51 -14.93 23.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.727 0.299 . . . . 0.0 111.284 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 84.33 10.31 80.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.876 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.8 mt -109.09 115.69 56.49 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.71 111.29 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.351 2.034 . . . . 0.0 110.184 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.8 m -108.48 157.18 18.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.987 -170.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 164.68 23.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.992 171.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.43 123.57 35.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.236 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.424 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.4 161.83 4.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.98 152.56 51.9 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 38.9 mm -54.87 114.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 0.0 110.742 -174.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.64 -3.59 19.69 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.714 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.418 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 4.2 m-20 -75.42 128.15 34.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.531 0.665 . . . . 0.0 111.161 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 305' ' ' LYS . 0.9 OUTLIER -87.48 131.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.586 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 42.3 t -95.14 134.7 37.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.975 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.62 145.34 30.84 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.154 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.9 Cg_endo -87.95 166.44 7.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.833 2.355 . . . . 0.0 112.188 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.88 126.3 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.588 2.192 . . . . 0.0 111.35 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.69 -12.99 35.49 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.773 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.11 131.44 81.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 -33.25 87.96 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.43 2.754 . . . . 0.0 113.504 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.26 -22.3 44.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.57 0.224 . . . . 0.0 111.051 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.8 84.36 4.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 98.8 mt -73.49 -46.2 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.245 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.54 52.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 110.284 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.83 -177.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 N-CA-C 110.688 -0.543 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.1 t -100.38 85.85 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.052 0.454 . . . . 0.0 110.18 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.2 p -85.78 142.02 29.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.7 mm -88.6 -45.34 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.203 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.504 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 78.8 t90 -151.64 130.12 12.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.529 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.4 t-80 55.68 -144.99 0.64 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 30.6 t -94.79 44.74 1.1 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.357 0.599 . . . . 0.0 109.898 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -115.38 136.66 52.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.298 0.57 . . . . 0.0 111.155 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.89 174.45 6.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.297 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -63.63 133.76 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.036 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.11 19.17 34.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.802 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.591 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.8 m -104.51 149.13 25.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 294' ' ' VAL . 8.9 mtt180 -113.6 138.67 49.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.93 0.395 . . . . 0.0 111.471 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 67.7 mt -117.6 145.93 43.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.973 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 231' ' ' TRP . 9.1 t -156.46 95.57 1.58 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.871 0.367 . . . . 0.0 110.643 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -86.21 118.1 25.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 0.0 110.656 -178.01 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 222' ' ' CYS . 52.8 m95 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.066 0.46 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.5 pt20 -97.91 157.21 16.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.462 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.72 162.96 21.61 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.591 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -61.38 -51.34 74.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.145 0.497 . . . . 0.0 109.811 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 36.9 mt-10 -56.34 -22.88 33.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.585 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.33 -45.34 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 70.1 t80 -75.96 -41.04 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 0.0 110.474 176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.73 68.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 8.7 ttm180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.065 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.3 t80 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.49 67.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.978 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 53.0 m -70.15 -7.13 39.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.785 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -103.51 -31.58 9.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.275 0.56 . . . . 0.0 109.672 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.04 153.69 6.76 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.027 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.2 mp -119.17 103.33 9.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.604 0.361 . . . . 0.0 110.652 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 33.8 ttpt -86.7 123.73 32.18 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.004 0.431 . . . . 0.0 111.06 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.404 ' HG ' HD13 ' A' ' 280' ' ' LEU . 2.7 tt -65.36 97.75 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.654 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 283' ' ' ASP . 88.1 mt -71.63 -49.49 39.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.901 0.381 . . . . 0.0 110.461 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.1 t -151.46 165.95 32.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.274 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.758 ' HD2' ' HE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -131.44 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.618 -169.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -140.82 121.66 14.46 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.59 99.66 9.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.204 0.526 . . . . 0.0 109.841 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.6 t . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.92 -172.234 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.15 154.75 41.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.759 0.79 . . . . 0.0 112.421 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 84.6 mt -92.5 107.42 19.2 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.729 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.0 ttmt -106.69 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.469 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . 43.6 mt -118.19 135.45 54.24 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.3 m -91.47 110.28 21.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 90.3 m-85 -99.7 162.15 13.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.095 0.474 . . . . 0.0 111.48 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.421 ' HB2' HD21 ' A' ' 265' ' ' LEU . 22.1 t70 -130.65 135.25 27.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.316 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -81.28 11.12 3.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.162 1.908 . . . . 0.0 112.43 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.26 -8.87 62.87 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 t -153.33 106.02 2.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.481 -0.86 . . . . 0.0 109.537 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.94 -8.88 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.497 0.665 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.99 -26.31 68.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.104 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.34 -44.31 25.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.17 153.32 5.93 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.474 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -74.34 143.33 44.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.854 0.359 . . . . 0.0 110.592 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.06 118.75 28.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 140.84 41.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.9 t -134.14 131.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -104.19 118.6 37.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 12.3 p -136.13 165.33 25.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.668 0.271 . . . . 0.0 111.493 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -61.72 162.13 9.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.208 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.62 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.8 mm? -70.79 -21.31 62.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 -175.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.0 22.5 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.16 119.14 74.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.339 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.24 134.47 9.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.203 1.935 . . . . 0.0 111.713 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.513 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -120.71 119.4 32.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 35.8 t80 -75.13 93.55 2.8 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.23 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 71.5 t -79.87 138.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.728 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 333' ' ' VAL . 57.4 tttp -61.26 134.88 57.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.226 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 7.1 m-20 76.27 -33.36 0.21 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.562 0.745 . . . . 0.0 112.087 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -86.68 -43.86 12.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.787 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 98.18 -155.96 20.36 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.99 112.89 1.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.037 0.419 . . . . 0.0 110.459 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.428 ' CB ' HG22 ' A' ' 328' ' ' ILE . 17.7 m -129.84 165.66 21.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.697 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.3 t -161.57 -176.88 5.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.586 0.231 . . . . 0.0 110.389 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.758 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 36.6 m-85 -92.91 -40.93 10.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.88 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -120.99 76.38 30.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.298 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.1 Cg_exo -57.27 -35.51 98.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.908 2.405 . . . . 0.0 113.148 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 3.7 p -65.19 -26.06 67.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.8 -47.08 8.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.278 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.2 m -57.87 -38.6 76.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.103 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.569 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.6 p -68.79 -20.23 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 111.464 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.99 -49.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.269 0.557 . . . . 0.0 109.816 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -67.41 -55.59 13.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.158 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -100.68 -9.68 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.23 15.91 80.36 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.592 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.0 mt -110.87 114.49 54.22 Favored Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 122.846 -0.208 . . . . 0.0 110.798 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.49 104.64 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.57 2.18 . . . . 0.0 110.33 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.5 m -104.39 154.07 20.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.046 -169.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.7 165.1 23.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.946 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.36 123.91 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.219 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.2 160.92 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -134.16 154.68 51.07 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 49.3 mm -52.29 115.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.324 0.583 . . . . 0.0 111.426 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.28 -2.9 22.27 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.073 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.432 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 6.5 m-20 -75.29 124.58 27.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.305 0.553 . . . . 0.0 110.78 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -86.76 143.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 55.8 m -112.16 132.52 54.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.985 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.64 147.65 33.92 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.705 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 55.1 Cg_endo -91.89 170.33 2.87 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.495 2.797 . . . . 0.0 112.828 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.74 133.17 23.19 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.534 2.156 . . . . 0.0 111.38 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.74 55.85 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.629 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -77.73 125.2 86.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.95 -21.73 73.37 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.047 2.498 . . . . 0.0 112.823 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 34.0 t70 -80.0 -27.38 39.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.683 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.36 88.85 3.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.816 169.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 83.7 mt -71.74 -43.49 69.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.368 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -114.41 73.93 0.85 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.598 -178.65 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 N--CA 1.479 0.662 0 N-CA-C 110.118 -0.762 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -100.4 87.79 3.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -82.97 143.9 30.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.945 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.11 -42.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.34 0.591 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -148.08 135.21 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.167 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.52 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.9 t-80 55.15 -135.01 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.458 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 12.0 p -97.64 24.4 6.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -104.6 139.83 38.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 112.064 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 174.94 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.391 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.57 140.53 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.607 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.82 11.1 54.35 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.976 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.573 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 80.9 m -103.34 146.92 27.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -113.99 139.88 48.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.938 0.399 . . . . 0.0 110.779 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.532 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.6 mt -116.17 146.47 42.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.375 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.1 96.45 1.95 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.18 119.18 29.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.6 m170 . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.969 -178.201 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.409 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 89.3 m95 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 7.9 pt20 -108.96 161.55 15.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.541 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.13 162.91 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.43 -47.15 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.18 -22.22 50.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.75 -55.22 5.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.531 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.568 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 76.3 t80 -65.04 -41.0 95.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.83 -33.5 71.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.445 175.532 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 24.5 t80 . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.116 0.484 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 106.48 6.94 35.28 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.549 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.9 m -67.1 -14.15 62.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 111.409 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.99 -30.82 11.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 0.0 109.294 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 149.3 161.15 9.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.526 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -122.6 99.1 6.22 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 122.483 0.313 . . . . 0.0 110.711 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 68.2 tttt -82.37 123.63 29.28 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.134 0.493 . . . . 0.0 111.525 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.97 95.35 0.26 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.584 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 283' ' ' ASP . 77.9 mt -71.47 -47.38 56.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 0.0 110.565 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.8 t -151.24 162.55 40.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.444 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.97 143.32 40.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.049 -168.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -149.57 137.49 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.366 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -98.99 97.17 8.35 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.445 -0.724 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.409 -171.287 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.8 m -132.17 156.85 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.661 0.744 . . . . 0.0 112.062 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.34 107.57 19.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.382 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.1 ttmm -98.94 106.25 18.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 312' ' ' PHE . 21.1 mt -112.95 138.04 50.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.529 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 4.1 m -103.09 110.19 22.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.465 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 92.1 m-85 -100.33 162.66 12.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.032 0.444 . . . . 0.0 111.849 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.441 ' HB2' HD21 ' A' ' 265' ' ' LEU . 14.6 t70 -128.89 134.44 26.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.14 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 76.8 Cg_endo -80.0 12.55 2.43 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.259 1.973 . . . . 0.0 112.291 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 -14.45 49.61 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 t -153.15 127.42 9.16 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.822 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.28 -8.45 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.215 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -50.74 -41.06 56.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.996 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -77.05 -43.51 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.89 167.51 11.52 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.67 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 83.2 mt -90.24 140.56 29.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 0.0 111.192 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -113.05 122.85 48.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.488 ' N ' HD22 ' A' ' 292' ' ' LEU . 20.8 m -111.67 135.18 52.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.0 t -133.06 136.27 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.066 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.409 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 52.8 mt-10 -115.57 121.94 44.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 109.772 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.5 p -138.56 175.34 9.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.748 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -70.03 158.21 36.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.998 0.427 . . . . 0.0 110.832 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.709 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -64.77 -17.07 63.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.282 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -97.49 13.58 29.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.88 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -72.26 120.98 83.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.574 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.85 141.52 13.46 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.239 1.959 . . . . 0.0 111.662 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.504 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.1 m-85 -127.84 127.27 43.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.551 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 31.2 t80 -80.09 96.32 6.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.34 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.6 t -82.31 130.88 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.907 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.462 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.1 tttp -55.86 134.21 51.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.35 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.2 m120 77.64 -23.08 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.872 0.733 . . . . 0.0 112.202 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -96.08 -43.49 7.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.0 111.446 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.56 -126.27 8.43 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.24 118.47 29.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.804 0.802 . . . . 0.0 109.958 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 20.1 m -131.45 166.57 21.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.527 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.0 t -161.52 -175.57 4.84 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.454 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 48.2 m-85 -92.77 -41.45 10.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 0.0 110.403 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.53 76.64 45.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 77.6 Cg_exo -55.25 -31.48 76.58 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.246 2.631 . . . . 0.0 113.597 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 33.9 t -71.22 -23.21 61.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.257 0.551 . . . . 0.0 110.096 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 61.2 tp -87.89 -44.85 10.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.116 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.3 m -54.5 -41.03 69.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.028 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -73.41 -18.28 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 96.1 t -88.24 -35.64 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.317 0.58 . . . . 0.0 110.013 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.26 -53.23 5.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.128 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -103.84 -4.04 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 70.02 26.33 74.45 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.564 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.5 mt -116.63 110.97 41.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 122.753 -0.263 . . . . 0.0 110.59 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -71.79 115.83 4.46 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.493 2.129 . . . . 0.0 110.399 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 73.7 m -116.96 156.98 26.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.437 0.637 . . . . 0.0 111.977 -169.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 58.6 m -79.99 165.95 22.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.255 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.59 140.42 29.57 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.89 164.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.357 0.599 . . . . 0.0 110.62 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -118.78 142.35 47.78 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 30.8 mm -60.22 114.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 109.843 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.3 -4.24 20.07 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.956 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.537 ' HB3' HG13 ' A' ' 304' ' ' VAL . 70.7 m-20 -73.84 130.55 40.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.728 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.97 133.29 33.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.057 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 50.9 m -98.12 134.83 40.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.142 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 43.8 mt -108.94 142.06 24.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.041 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.2 Cg_endo -85.06 168.43 10.53 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.325 2.683 . . . . 0.0 112.362 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 56.6 Cg_endo -71.37 114.3 3.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.797 2.332 . . . . 0.0 111.687 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.01 -20.67 8.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.813 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -67.11 126.66 92.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.64 -27.25 50.28 Favored 'Trans proline' 0 N--CA 1.476 0.453 0 C-N-CA 123.721 2.947 . . . . 0.0 113.738 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.96 -22.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.326 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.14 85.99 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.254 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.63 -43.88 70.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.572 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -107.04 42.52 1.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 1.1 t80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.941 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.6 t -86.19 92.06 8.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.079 0.466 . . . . 0.0 110.161 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.7 p -79.15 147.07 32.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.5 mm -79.5 -45.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.62 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -149.4 132.73 16.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.0 t-80 57.19 -139.46 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 44.5 t -97.5 36.74 1.45 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.384 0.612 . . . . 0.0 110.202 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.56 140.73 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 111.701 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.99 170.83 8.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -67.57 133.68 49.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.957 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.17 44.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.49 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.575 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 87.7 m -86.65 142.07 28.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -110.62 136.78 49.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.172 0.511 . . . . 0.0 110.941 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.566 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 57.1 mt -112.41 147.48 36.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.967 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.0 t -150.87 93.01 1.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.97 0.414 . . . . 0.0 110.234 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CD2' ' HG ' ' A' ' 292' ' ' LEU . 78.3 m-85 -83.57 119.14 24.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.7 m170 . . . . . 0 C--N 1.324 -0.506 0 CA-C-O 121.062 0.458 . . . . 0.0 110.559 -177.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 80.3 m95 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.176 0.512 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.706 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 10.0 pt20 -128.07 165.16 20.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.39 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.5 163.86 15.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.233 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.0 t -58.46 -51.5 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -58.01 -23.44 54.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.18 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 232' ' ' GLN . 31.9 t70 -73.58 -45.29 54.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.297 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.706 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.4 t80 -75.1 -45.41 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.49 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -55.72 -43.83 76.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.499 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 -179.446 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 23.0 t80 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.105 0.479 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.82 8.65 59.15 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.011 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.7 m -67.79 -15.86 63.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -102.88 -31.69 10.14 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 164.08 156.77 9.0 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.217 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.7 mp -119.97 103.75 9.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.709 -0.746 . . . . 0.0 110.163 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 21.8 ttpp -88.29 119.35 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.269 0.557 . . . . 0.0 111.339 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.401 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.7 tt -62.12 103.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.347 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 283' ' ' ASP . 86.7 mt -76.2 -49.17 17.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.898 0.38 . . . . 0.0 110.528 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 34.4 t -153.11 164.02 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.539 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -141.44 135.75 30.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 41.2 tt0 -130.14 137.54 50.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.245 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.39 124.43 34.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.628 -167.777 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.83 156.57 31.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.017 0.913 . . . . 0.0 112.861 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 79.1 mt -95.51 116.25 28.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.639 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 40.4 ttmt -100.65 112.25 24.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 19.3 mt -118.45 130.34 55.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 31.4 m -97.97 111.01 23.48 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.5 m-85 -96.94 162.48 13.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.332 0.587 . . . . 0.0 111.872 -172.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.451 ' HB2' HD21 ' A' ' 265' ' ' LEU . 4.1 t70 -127.85 127.45 23.94 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.49 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 80.0 Cg_endo -79.45 10.12 3.17 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.181 1.92 . . . . 0.0 112.067 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.7 -15.03 53.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.8 t -153.85 135.07 14.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.197 0.522 . . . . 0.0 110.667 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.32 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.131 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.87 -32.12 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.861 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -84.2 -47.13 11.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.524 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.43 159.49 7.96 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.794 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.1 151.17 25.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -119.68 123.4 43.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 26.0 m -110.27 130.92 55.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.51 131.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.384 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.52 118.38 34.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.453 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.6 p -134.58 164.0 28.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.732 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -66.17 157.85 30.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.364 0.602 . . . . 0.0 111.109 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.77 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.5 mm? -61.59 -23.83 66.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.212 -168.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.71 23.2 5.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.516 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.37 121.09 84.27 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.538 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.56 130.66 7.96 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.286 1.991 . . . . 0.0 111.609 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 90.8 m-85 -120.66 114.2 21.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 25.4 t80 -73.3 102.45 3.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.327 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 332' ' ' ASP . 55.2 t -88.7 136.04 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.255 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.656 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 54.4 tttp -57.93 124.46 19.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.905 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 14.9 m120 76.81 -5.21 2.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.366 0.666 . . . . 0.0 112.392 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -110.85 -32.25 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.14 0.495 . . . . 0.0 111.403 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.92 -152.68 21.9 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -64.74 112.38 3.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 117.18 0.49 . . . . 0.0 110.382 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.4 m -125.33 165.26 18.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.0 t -161.48 -177.84 6.22 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 65.3 m-85 -93.0 -39.34 11.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.523 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -123.74 73.73 54.02 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.748 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.97 -37.05 93.75 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.176 2.584 . . . . 0.0 113.356 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.2 m -64.74 -25.75 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.232 0.539 . . . . 0.0 110.693 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.1 tp -87.25 -44.3 11.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.963 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.2 m -55.18 -41.86 72.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.993 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.8 p -70.77 -26.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.66 -35.16 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -84.32 -58.44 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.917 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.48 -10.98 24.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.04 25.65 61.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.615 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.6 mt -122.71 113.11 30.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 122.849 -0.206 . . . . 0.0 110.877 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.85 119.41 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.423 2.082 . . . . 0.0 110.365 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 68.2 m -117.37 156.11 28.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 112.141 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 57.5 m -79.71 164.45 23.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.104 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -93.76 115.79 28.23 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.491 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -66.46 165.23 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 111.229 -173.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -122.26 140.37 52.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.721 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.32 115.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.221 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.3 -2.27 22.27 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.908 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.442 ' HB3' HG13 ' A' ' 304' ' ' VAL . 44.0 m-20 -75.23 132.95 41.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.33 0.586 . . . . 0.0 111.34 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -93.68 135.16 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.964 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 51.1 m -100.81 132.69 46.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.463 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.424 HD11 ' OD2' ' A' ' 341' ' ' ASP . 76.0 mt -100.18 144.85 29.2 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.273 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 86.1 Cg_endo -87.63 165.04 7.78 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.099 2.532 . . . . 0.0 112.744 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.99 113.49 3.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.921 2.414 . . . . 0.0 111.572 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 124.83 -23.22 6.29 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.952 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -65.79 128.0 93.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.9 -20.24 64.31 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.127 2.551 . . . . 0.0 112.495 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.656 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 23.2 t0 -79.32 -26.03 42.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.967 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -72.16 98.89 2.22 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.53 -39.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.899 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.99 103.64 4.2 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.459 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.005 -178.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -107.99 109.41 20.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.0 p -96.28 147.4 23.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.384 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.73 -40.54 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.382 0.61 . . . . 0.0 109.817 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 71.4 t90 -156.7 134.52 10.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.924 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.473 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 27.3 t-80 57.5 -142.42 0.72 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 49.1 t -96.98 37.29 1.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.465 0.65 . . . . 0.0 110.157 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.89 133.32 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.59 171.55 8.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.546 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -61.57 131.15 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.933 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.13 12.55 31.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.286 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 52.2 m -103.5 149.94 24.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.6 mpt_? -119.67 144.73 47.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.937 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.4 mt -118.99 147.81 43.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.24 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 42.4 t -158.11 98.16 1.57 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.811 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.416 ' CD1' ' HG ' ' A' ' 292' ' ' LEU . 27.5 m-85 -81.86 126.26 31.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.8 m170 . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.835 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 70.2 m95 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.5 pt20 -97.32 155.42 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -82.53 161.8 22.21 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.0 t -63.59 -38.21 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -21.84 64.72 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.242 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -80.93 -50.33 9.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.443 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.477 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 63.8 t80 -65.84 -46.1 79.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.717 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.89 71.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 110.478 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.272 178.199 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 32.4 t80 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.14 55.88 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.494 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 50.7 m -65.56 -11.01 40.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -104.7 -34.16 8.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.285 0.564 . . . . 0.0 109.808 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 169.47 154.01 8.88 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.923 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.3 mp -122.63 99.82 6.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.778 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.703 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.5 ttpt -83.93 122.28 28.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.234 0.54 . . . . 0.0 110.942 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.437 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 2.3 tt -65.24 110.4 2.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.899 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 80.1 mt -85.12 -44.66 12.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.714 0.292 . . . . 0.0 111.161 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.6 t -153.12 157.19 40.01 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.96 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.3 OUTLIER -133.46 142.84 48.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.022 -170.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -149.23 125.95 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.73 120.8 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 -171.516 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.44 ' HB2' HD21 ' A' ' 298' ' ' LEU . 67.4 m . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.46 157.82 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.847 0.832 . . . . 0.0 112.566 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 95.8 mt -95.57 112.89 24.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.741 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.5 ttmm -99.39 105.5 17.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.542 HD11 ' HE1' ' A' ' 312' ' ' PHE . 22.1 mt -113.12 139.69 48.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.524 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.8 m -101.16 110.6 22.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.9 m-85 -100.85 158.53 15.91 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 0.0 111.685 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 9.7 t70 -124.94 135.96 27.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.362 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.576 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -83.44 9.81 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.948 1.765 . . . . 0.0 112.431 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.09 -6.15 53.59 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -153.26 125.19 7.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.343 0.592 . . . . 0.0 110.467 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -10.3 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.37 -35.45 80.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.919 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.17 -46.9 26.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.204 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.02 166.2 10.7 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.442 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.93 146.2 28.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.915 0.388 . . . . 0.0 110.686 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.451 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER -119.46 121.13 38.75 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.8 m -106.96 132.14 53.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 88.1 t -131.15 135.28 60.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.055 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -114.61 122.05 45.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.078 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.473 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.3 p -136.03 175.07 9.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 299' ' ' ASP . 10.5 mmmm -66.19 157.53 31.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.488 0.185 . . . . 0.0 111.056 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.834 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.1 mm? -60.8 -37.27 81.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.837 0.827 . . . . 0.0 109.677 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HB3' ' A' ' 297' ' ' LYS . 6.6 p-10 -80.79 24.52 0.48 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.08 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -82.92 119.65 74.73 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.347 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.06 132.8 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.078 1.852 . . . . 0.0 111.682 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.8 118.25 30.34 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 342' ' ' ALA . 2.5 t80 -72.32 102.81 3.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.142 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.42 135.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.307 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.569 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.9 tttp -61.17 134.57 57.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 76.61 -6.45 2.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.531 0.732 . . . . 0.0 112.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.04 -47.75 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.64 -147.25 16.18 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . 0.461 ' HZ2' ' HA ' ' A' ' 345' ' ' PHE . 98.9 m95 -72.85 102.14 3.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.679 0.739 . . . . 0.0 110.974 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.499 ' CB ' HG22 ' A' ' 328' ' ' ILE . 5.6 m -106.47 172.51 6.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.737 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.1 t -163.04 179.2 7.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.532 0.206 . . . . 0.0 110.625 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.542 ' HE1' HD11 ' A' ' 280' ' ' LEU . 32.0 m-85 -92.84 -35.26 13.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 298' ' ' LEU . 93.0 m-85 -125.25 74.35 67.68 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 62.5 Cg_exo -55.09 -33.65 84.49 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.179 2.586 . . . . 0.0 113.534 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 35.9 t -74.85 -22.07 58.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.975 0.417 . . . . 0.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.6 tp -87.88 -45.75 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.502 . . . . 0.0 110.311 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -52.91 -37.17 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.974 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.69 -24.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.713 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.82 -33.81 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.0 110.456 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -101.99 -54.37 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.432 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -91.67 -8.05 48.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.161 -0.337 . . . . 0.0 110.736 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.58 16.94 76.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.378 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.8 mt -110.04 110.41 58.75 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.41 105.33 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.495 2.13 . . . . 0.0 110.445 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 84.4 m -101.47 159.18 15.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 112.369 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 1.4 p -85.83 159.68 19.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.416 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -79.93 125.61 29.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.499 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.82 168.36 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.386 -0.525 . . . . 0.0 109.816 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -133.37 146.67 51.48 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 41.3 mm -54.46 113.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.374 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.57 -4.37 19.52 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.419 -176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.52 121.42 17.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.155 0.502 . . . . 0.0 110.467 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -84.74 133.05 30.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.691 0.758 . . . . 0.0 112.115 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 47.3 t -95.39 134.79 37.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.376 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 69.1 mt -105.62 144.57 29.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.853 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -86.94 163.51 8.88 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.803 2.336 . . . . 0.0 112.142 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 121.42 8.73 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 112.047 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.01 31.98 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.491 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . 0.429 ' CD2' ' HD2' ' A' ' 340' ' ' PRO . 25.3 t-80 -75.18 134.08 74.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 339' ' ' HIS . 11.7 Cg_endo -54.73 -28.8 58.86 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.975 3.117 . . . . 0.0 114.0 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.27 -35.15 48.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 303' ' ' TYR . . . -70.52 98.74 1.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.888 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.88 -45.66 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.256 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -131.18 94.51 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.461 ' HA ' ' HZ2' ' A' ' 309' ' ' TRP . 3.5 t80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.594 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.481 0.78 0 N-CA-C 110.769 -0.512 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 99.41 10.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.6 p -85.79 145.29 27.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.905 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.456 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.4 mm -80.41 -43.23 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.511 0.672 . . . . 0.0 109.5 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -151.51 136.04 16.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.244 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 25.4 t-80 55.53 -136.09 1.27 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 46.3 t -100.13 32.06 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.64 . . . . 0.0 110.011 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -103.0 139.81 38.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.256 0.55 . . . . 0.0 111.417 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 177.74 5.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.462 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -65.59 143.73 57.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.327 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.01 58.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.184 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 39.9 m -106.24 145.61 31.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.45 144.0 38.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.949 0.404 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 67.0 mt -119.45 149.05 42.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.057 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.2 t -158.07 103.96 1.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.042 0.448 . . . . 0.0 110.426 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.52 123.32 34.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.261 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -177.491 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.413 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 49.4 m95 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.372 0.606 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 8.7 pt20 -98.95 160.88 13.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.979 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 160.6 17.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -57.35 -48.83 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HA ' HG21 ' A' ' 211' ' ' ILE . 16.0 mt-10 -56.42 -24.82 47.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.35 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.53 -47.42 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.434 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.558 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.8 t80 -68.82 -42.15 77.61 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.605 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.34 70.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.332 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.835 176.428 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 21.8 t80 . . . . . 0 C--O 1.233 0.217 0 CA-C-O 121.0 0.429 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.54 17.21 55.47 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.431 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -21.03 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.07 -27.56 13.19 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.459 0.647 . . . . 0.0 109.586 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 157.48 166.65 17.28 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.653 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.93 99.98 6.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.796 -0.702 . . . . 0.0 110.316 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 49.1 tttp -84.0 117.87 23.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.059 0.456 . . . . 0.0 110.589 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.435 ' HG ' HD13 ' A' ' 280' ' ' LEU . 3.1 tt -58.69 107.57 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.13 -42.02 16.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.659 0.266 . . . . 0.0 110.924 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.3 t -153.49 168.02 27.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.409 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.671 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -140.35 137.09 33.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.921 -167.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -143.77 135.63 26.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.414 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -106.76 127.59 53.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.913 -175.795 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.4 ' HB2' HD21 ' A' ' 298' ' ' LEU . 18.7 m . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.61 154.72 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.753 0.787 . . . . 0.0 112.905 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.57 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 95.5 mt -94.77 109.65 21.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.668 171.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -104.24 110.82 23.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.044 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 312' ' ' PHE . 45.7 mt -120.89 138.82 53.91 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.836 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.2 m -92.84 114.77 27.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.574 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 83.5 m-85 -102.72 161.56 13.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.055 0.455 . . . . 0.0 111.614 -174.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.0 t70 -131.15 135.81 27.8 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.138 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 95.9 Cg_endo -79.71 13.03 2.22 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.23 1.954 . . . . 0.0 112.714 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.17 -16.23 42.45 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.9 t -153.86 129.33 9.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.021 -0.589 . . . . 0.0 109.866 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.98 -8.16 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -61.32 -26.12 67.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.747 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.46 -46.67 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.1 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.33 166.46 10.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.905 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.35 148.69 25.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.76 121.98 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 14.8 m -105.99 133.11 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 59.1 t -132.72 134.1 58.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.413 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 90.4 mt-10 -107.84 112.72 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.931 172.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 10.2 p -122.95 172.5 8.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -76.77 160.81 28.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 0.0 110.317 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.757 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -64.76 -23.28 67.2 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -174.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -97.88 16.98 19.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.421 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.98 117.55 55.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.662 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.98 122.38 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.081 1.854 . . . . 0.0 111.432 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.506 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -112.04 105.73 14.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 26.4 t80 -70.67 108.9 4.61 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.979 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.48 138.2 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.557 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.704 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.0 tttp -63.14 128.59 36.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.456 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.0 OUTLIER 72.13 17.33 5.08 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.635 0.584 . . . . 0.0 111.811 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -137.99 -43.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.431 . . . . 0.0 111.76 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 98.55 -160.09 20.42 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.14 115.66 3.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.537 0.668 . . . . 0.0 110.286 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 17.0 m -127.59 165.18 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.139 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.4 t -160.58 171.68 18.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.995 0.426 . . . . 0.0 110.397 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.671 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 73.6 m-85 -85.88 -35.68 20.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.526 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -127.01 76.45 76.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.253 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.49 -34.44 97.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.686 2.257 . . . . 0.0 112.537 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.9 p -65.45 -23.04 66.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.167 0.508 . . . . 0.0 110.814 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.46 -46.35 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.777 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.0 m -56.43 -41.77 76.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.932 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.519 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.2 p -70.27 -21.36 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.752 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.0 -38.33 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.371 0.605 . . . . 0.0 110.242 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -80.87 -56.8 3.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.032 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.43 -8.76 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.843 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 75.38 21.07 78.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.462 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -115.23 116.2 42.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 122.773 -0.251 . . . . 0.0 110.432 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.48 117.71 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.514 2.142 . . . . 0.0 110.79 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.3 m -117.76 160.98 20.46 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 78.5 m -85.43 164.25 18.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.599 173.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.46 125.88 34.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.05 165.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.003 0.906 . . . . 0.0 111.542 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -121.09 144.16 48.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.833 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.78 110.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.684 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 263' ' ' LYS . . . 116.33 2.89 19.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.754 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -69.83 124.78 24.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.076 0.465 . . . . 0.0 110.641 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -91.25 125.2 44.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.826 0.822 . . . . 0.0 111.993 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.7 133.82 34.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.161 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 341' ' ' ASP . 63.6 mt -106.27 141.54 22.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.793 -174.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 81.5 Cg_endo -84.65 163.34 12.38 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.52 115.29 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.785 2.324 . . . . 0.0 111.45 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.9 -20.16 8.19 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.357 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -66.49 133.3 94.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.45 -24.09 67.29 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.665 2.91 . . . . 0.0 113.598 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.465 ' HB2' HD13 ' A' ' 335' ' ' LEU . 2.3 m-20 -78.53 -32.39 47.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.715 0.293 . . . . 0.0 110.594 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.655 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.74 87.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.084 0.469 . . . . 0.0 110.284 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.28 -47.68 88.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -130.86 99.65 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.92 -179.008 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.5 t -113.5 100.01 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.6 p -92.9 144.41 25.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.529 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 10.6 mm -83.48 -36.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.833 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -156.19 132.31 9.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.265 176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 21.0 t-80 56.86 -139.15 0.92 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 49.4 t -98.96 40.05 1.23 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.634 . . . . 0.0 110.272 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -114.7 137.4 51.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.423 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.43 172.11 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.574 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -64.75 127.64 32.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.816 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.69 7.93 38.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.171 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.0 m -96.69 150.4 20.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.6 OUTLIER -117.02 140.35 49.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 110.988 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 79.0 mt -117.29 145.7 43.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.173 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.46 99.36 1.89 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.428 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.91 128.98 35.69 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.9 m170 . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.573 -174.709 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 39.6 m95 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.1 pt20 -102.78 156.2 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.052 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.9 159.34 22.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 2.4 t -59.75 -43.85 92.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 211' ' ' ILE . 35.0 mt-10 -57.86 -22.81 49.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.544 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.76 -50.51 8.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.467 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 68.0 t80 -65.23 -43.61 90.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.79 71.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.784 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 176.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.7 t80 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.85 13.35 50.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.009 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.8 t -67.01 -17.43 64.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.788 0.328 . . . . 0.0 111.084 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -108.62 -25.59 10.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.067 0.46 . . . . 0.0 110.395 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.14 158.53 9.14 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.312 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.617 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.7 mp -120.75 99.8 6.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.304 0.641 . . . . 0.0 110.587 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 29.2 ttpt -85.3 118.83 25.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.09 103.83 0.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.282 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.79 -52.75 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.352 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.9 t -147.65 167.32 24.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.442 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.402 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.0 t60 -145.9 135.61 23.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.145 0.498 . . . . 0.0 111.128 -173.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 32.6 tt0 -127.05 142.23 51.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.203 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -109.17 116.2 31.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 -170.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.9 m -129.06 154.24 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 122.172 0.987 . . . . 0.0 112.992 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.07 114.27 25.96 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.921 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 23.0 ttmm -103.32 110.81 22.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.515 HD11 ' HE1' ' A' ' 312' ' ' PHE . 20.5 mt -112.76 135.4 53.54 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.387 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.9 m -99.65 109.86 22.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.617 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 76.5 m-85 -100.08 163.98 12.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.443 . . . . 0.0 112.182 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 29.4 t70 -133.39 138.56 31.64 Favored Pre-proline 0 C--O 1.221 -0.437 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.296 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.536 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.3 Cg_endo -83.89 11.22 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.879 1.72 . . . . 0.0 112.532 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.68 -16.39 40.43 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -146.77 110.52 4.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.769 -0.715 . . . . 0.0 109.739 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.59 -14.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.279 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -67.1 -15.99 64.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.326 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.55 -43.57 22.79 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.65 170.71 11.92 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.223 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.48 147.45 23.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -122.92 121.23 35.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.452 ' N ' HD22 ' A' ' 292' ' ' LEU . 42.0 m -111.55 133.77 53.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 91.1 t -131.05 135.57 59.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.049 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -112.55 115.69 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.2 p -132.87 161.8 33.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.996 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -57.83 158.76 6.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.092 0.473 . . . . 0.0 111.829 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -63.97 -34.83 78.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.61 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -87.37 31.34 0.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.425 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -86.21 118.87 71.12 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.028 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.19 137.45 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.116 1.877 . . . . 0.0 111.821 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -119.92 142.81 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 18.2 t80 -96.73 98.62 10.3 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.961 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.589 HG23 ' OG ' ' A' ' 310' ' ' SER . 51.0 t -87.04 131.95 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 0.0 111.403 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.533 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.7 tttp -57.93 122.92 14.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.573 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 15.2 m120 77.88 2.06 2.88 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.909 0.756 . . . . 0.0 111.833 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -116.68 -21.78 8.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.83 -121.33 5.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.41 140.51 29.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.398 0.599 . . . . 0.0 110.117 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.869 ' HB2' HG22 ' A' ' 328' ' ' ILE . 75.3 p -143.38 167.15 22.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.108 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.8 t -164.48 171.76 14.21 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.767 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.515 ' HE1' HD11 ' A' ' 280' ' ' LEU . 57.1 m-85 -89.22 -21.14 23.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.485 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.58 70.38 52.51 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.2 Cg_exo -51.32 -39.14 63.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.909 2.406 . . . . 0.0 112.898 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 19.4 m -66.63 -26.07 66.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 66.9 tp -87.56 -47.65 8.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.194 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.3 m -59.05 -39.02 80.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.372 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 10.9 p -68.77 -19.58 24.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 111.264 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.23 -41.97 13.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 110.372 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -77.14 -53.09 8.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.871 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -98.82 -15.92 19.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.786 0.326 . . . . 0.0 111.083 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.75 18.41 68.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.609 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.2 mt -113.18 113.36 49.06 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.907 -0.172 . . . . 0.0 110.748 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.76 110.42 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 110.487 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.442 ' HB3' ' C ' ' A' ' 310' ' ' SER . 58.2 m -111.29 157.66 19.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 0.0 111.971 -170.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.3 m -84.03 159.73 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.123 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.22 122.98 28.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.869 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.12 164.89 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.473 0.654 . . . . 0.0 110.671 -177.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -119.93 141.44 49.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.792 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 mm -57.18 110.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.074 0.464 . . . . 0.0 109.845 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.89 3.74 19.62 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.352 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -79.56 131.07 35.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.217 0.532 . . . . 0.0 110.793 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.6 p -93.83 126.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.24 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.5 m -93.28 136.63 33.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.342 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 55.6 mt -105.93 146.13 32.27 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.357 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 58.3 Cg_endo -88.53 165.36 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.933 2.422 . . . . 0.0 112.425 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.47 115.81 3.9 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.868 2.378 . . . . 0.0 111.824 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 122.17 -22.56 7.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.061 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.0 127.78 93.64 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.34 -22.85 60.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.411 2.741 . . . . 0.0 113.554 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.06 -27.25 43.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.54 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.575 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -75.29 85.93 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.305 0.574 . . . . 0.0 110.169 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.7 mt -72.88 -45.44 55.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.734 -173.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 344' ' ' ASN . 3.0 t-20 -109.65 43.74 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.435 0.636 . . . . 0.0 110.812 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.593 -0.579 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.2 t -97.19 87.58 4.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.051 0.453 . . . . 0.0 109.936 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.9 p -79.3 143.93 34.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.835 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.7 mm -79.35 -43.86 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.462 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 76.9 t90 -152.98 136.06 15.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.408 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 32.6 t-80 55.23 -135.75 1.34 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.485 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 15.0 p -96.05 23.91 6.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.798 0.332 . . . . 0.0 111.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -108.61 140.21 42.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.975 -173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.53 178.57 4.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.772 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.77 132.02 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.039 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.05 17.85 26.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.092 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.552 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 25.0 m -107.82 147.44 30.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 220' ' ' ARG . 3.7 mpt_? -110.6 144.23 39.81 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.211 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.0 mt -117.24 144.49 44.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.889 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 16.6 t -153.39 95.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.126 0.489 . . . . 0.0 110.358 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -86.16 118.21 25.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.0 m170 . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.109 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 72.7 m95 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -106.63 164.52 12.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.39 172.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.64 160.5 16.6 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.97 -0.456 . . . . 0.0 110.299 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.9 t -60.03 -47.33 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 24.8 mt-10 -59.03 -22.36 60.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.63 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -81.7 -47.58 12.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.135 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 54.8 t80 -70.08 -48.67 56.78 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.45 69.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.211 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 19.4 ttm180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.597 0.713 . . . . 0.0 109.55 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.604 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 11.2 t80 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 103.09 12.21 32.21 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.391 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.8 m -68.74 -13.68 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.826 0.346 . . . . 0.0 111.758 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -108.27 -30.19 8.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.851 0.357 . . . . 0.0 110.282 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.77 157.89 8.86 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.07 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -122.53 105.8 10.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 110.476 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 22.0 ttpt -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.14 0.495 . . . . 0.0 110.976 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.52 107.48 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.868 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 61.1 mt -82.51 -41.1 20.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.466 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.7 t -158.39 162.35 37.62 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.791 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -140.94 140.25 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -133.43 139.69 46.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.246 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.61 106.14 18.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 109.776 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.0 t . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.69 -174.313 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.1 m -129.62 154.88 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.772 0.796 . . . . 0.0 111.838 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 295' ' ' GLU . 96.9 mt -95.57 110.61 22.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.558 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -98.24 110.66 23.2 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 17.2 mt -113.82 129.93 56.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.124 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 37.6 m -97.52 118.12 33.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.527 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 79.5 m-85 -106.55 164.65 11.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.288 0.566 . . . . 0.0 112.417 -171.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 19.0 t70 -131.29 135.06 26.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.146 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.604 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 72.8 Cg_endo -84.17 5.59 6.24 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.202 1.935 . . . . 0.0 112.346 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 -18.87 27.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.452 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -142.29 126.65 17.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.052 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.97 -8.15 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.39 -39.69 92.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.03 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.04 -46.76 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.036 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.99 11.48 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.39 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.0 143.26 29.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.72 0.295 . . . . 0.0 110.578 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.453 HD13 HG23 ' A' ' 294' ' ' VAL . 1.1 tm? -117.5 119.44 35.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.422 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.0 m -106.8 135.27 48.62 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.453 HG23 HD13 ' A' ' 292' ' ' LEU . 73.8 t -134.04 135.22 55.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.436 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 278' ' ' LEU . 41.8 mt-10 -126.95 127.73 45.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.716 173.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 300' ' ' HIS . 9.2 t -141.19 -174.61 4.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.773 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -76.0 172.84 12.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.574 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.9 mm? -74.67 -10.54 59.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.352 -168.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.96 17.45 24.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.721 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . 0.548 ' HD2' ' SG ' ' A' ' 296' ' ' CYS . 48.4 t-80 -75.89 117.93 67.36 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.527 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.5 135.16 17.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.158 1.905 . . . . 0.0 111.783 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -121.24 125.57 47.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 7.7 t80 -81.84 90.79 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.567 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.629 HG13 ' HB2' ' A' ' 332' ' ' ASP . 65.6 t -72.95 123.86 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.035 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.758 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.4 tttp -56.33 139.69 47.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.38 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.9 m-20 77.1 -8.68 1.65 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.819 0.699 . . . . 0.0 112.114 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -119.21 -54.0 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.17 -149.67 18.05 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -67.73 120.64 14.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.172 0.486 . . . . 0.0 110.259 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.414 ' HB2' HG22 ' A' ' 328' ' ' ILE . 18.0 m -134.94 169.66 17.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.351 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 43.2 t -160.63 172.13 17.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.914 0.387 . . . . 0.0 110.777 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -87.14 -28.88 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.974 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.46 76.39 77.63 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.687 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.555 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 65.8 Cg_exo -54.74 -41.96 73.08 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.103 2.535 . . . . 0.0 113.141 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 6.9 m -64.02 -24.35 67.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.8 tp -87.32 -49.14 7.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.951 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -55.75 -44.65 77.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.377 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.19 -31.67 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.745 0.307 . . . . 0.0 111.752 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.11 -40.35 22.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.229 0.538 . . . . 0.0 110.243 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.19 -49.97 13.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.589 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -102.75 -9.06 20.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.767 0.318 . . . . 0.0 111.737 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 75.67 29.6 59.27 Favored Glycine 0 CA--C 1.516 0.127 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.7 mt -128.34 112.79 19.67 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 122.772 -0.252 . . . . 0.0 110.433 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.8 116.79 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.448 2.099 . . . . 0.0 110.877 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 72.8 m -117.62 147.59 42.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.287 0.565 . . . . 0.0 111.698 -169.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.55 164.97 22.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.653 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.13 128.18 34.25 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -74.98 178.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.422 0.629 . . . . 0.0 111.07 -178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -141.71 132.88 26.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.93 115.13 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 O-C-N 123.67 0.606 . . . . 0.0 110.162 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.71 6.72 16.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.516 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.629 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -70.4 128.91 37.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 176.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.2 p -97.56 112.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.73 0.776 . . . . 0.0 111.13 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.9 m -79.96 132.29 36.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.425 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.85 145.91 31.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.908 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.1 Cg_endo -86.68 168.7 8.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.008 2.472 . . . . 0.0 112.357 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 42.0 Cg_endo -68.12 126.16 14.03 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.885 2.39 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.51 -21.33 30.74 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.35 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.4 122.0 77.81 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.79 -23.53 72.41 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 123.182 2.588 . . . . 0.0 113.108 -171.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.552 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 37.4 t70 -79.06 -27.18 43.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.55 86.57 4.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.178 0.513 . . . . 0.0 109.993 169.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 60.0 mt -66.86 -50.65 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.633 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -99.57 31.57 3.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.0 111.08 -169.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.358 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.481 0.752 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.4 t -94.78 94.3 8.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.287 0.565 . . . . 0.0 109.998 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -84.87 143.54 28.98 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.216 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 235' ' ' GLU . 11.4 mm -86.26 -41.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.58 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.483 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 80.9 t90 -154.33 127.63 8.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.499 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.4 t-80 59.06 -146.56 0.51 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 49.4 t -94.64 39.82 1.09 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.292 0.567 . . . . 0.0 110.37 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.13 138.04 45.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.361 0.601 . . . . 0.0 111.594 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.97 169.16 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.022 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.428 ' HG3' ' OE2' ' A' ' 235' ' ' GLU . 56.9 tttp -62.42 128.15 34.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.734 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.35 -16.85 34.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.027 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.523 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 60.6 m -73.73 148.17 42.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.489 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.4 OUTLIER -109.37 150.71 27.64 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.436 178.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.4 mt -123.54 143.88 49.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.9 t -151.96 92.03 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.449 . . . . 0.0 110.412 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.97 124.8 27.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.3 m170 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 110.91 -177.115 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.411 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 83.6 m95 . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 121.437 0.636 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.6 pt20 -99.99 158.44 15.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.513 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.43 161.44 16.28 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.913 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -58.5 -49.7 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.641 0.734 . . . . 0.0 109.355 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 35.3 mt-10 -58.08 -22.3 49.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.585 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.6 -45.77 24.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.331 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -74.96 -46.84 32.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -59.7 -25.07 64.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.568 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.672 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 35.9 ttm180 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.337 0.589 . . . . 0.0 109.835 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.7 t80 . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 97.25 18.55 28.44 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.376 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.6 m -75.8 -13.27 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.993 0.425 . . . . 0.0 110.459 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.07 -31.94 8.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 109.323 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.23 157.92 8.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.003 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.5 mp -123.12 98.7 6.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 123.234 0.614 . . . . 0.0 110.363 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 69.8 tttt -84.15 122.06 28.31 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.7 105.09 0.6 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.76 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 283' ' ' ASP . 87.0 mt -79.16 -48.13 14.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.7 t -150.28 163.37 38.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.849 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.602 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -134.08 148.49 51.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.888 -167.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.16 139.32 21.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.894 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -111.09 94.28 4.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.491 0.662 . . . . 0.0 109.468 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.444 -0.74 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.308 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.86 154.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.596 0.712 . . . . 0.0 112.03 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 312' ' ' PHE . 94.7 mt -92.54 109.4 20.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.259 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 4.9 ttpp -102.95 109.0 20.39 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 293' ' ' THR . 38.4 mt -118.71 140.9 49.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.247 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.0 m -99.05 122.56 42.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.556 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.2 m-85 -110.63 158.88 18.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.384 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.477 ' HB2' HD21 ' A' ' 265' ' ' LEU . 10.7 t70 -128.21 130.62 23.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.663 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.63 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 97.4 Cg_endo -86.82 12.55 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.607 2.204 . . . . 0.0 112.451 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.96 -16.61 46.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.883 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.5 t -154.4 139.92 17.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 111.031 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.99 -9.88 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.31 -38.76 77.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.183 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.82 -43.47 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.903 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 133.38 163.48 10.47 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.769 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.94 149.27 22.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.071 0.463 . . . . 0.0 110.143 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 294' ' ' VAL . 1.8 tm? -126.75 123.29 37.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.8 m -115.64 136.84 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 68.3 t -131.92 137.14 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.639 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' CG ' ' HD3' ' A' ' 279' ' ' LYS . 87.8 mt-10 -106.39 127.86 53.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.642 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.4 p -142.99 172.2 13.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -66.09 154.56 39.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.308 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.2 mm? -62.45 -21.13 65.21 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.47 0.652 . . . . 0.0 110.742 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.68 16.7 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.779 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -70.69 122.64 87.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -82.3 122.4 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.518 2.145 . . . . 0.0 111.906 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.66 120.62 42.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.7 t80 -72.84 104.4 4.01 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.23 137.15 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.267 0.556 . . . . 0.0 111.074 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.481 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.1 tttp -57.92 129.93 44.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.813 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.7 m120 72.94 2.3 4.33 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.627 0.579 . . . . 0.0 112.099 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -121.6 -41.37 2.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.657 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 95.6 -152.78 20.47 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.67 113.84 3.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.238 0.519 . . . . 0.0 110.699 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.9 m -126.21 165.55 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.5 t -161.54 -177.83 6.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.656 0.265 . . . . 0.0 110.939 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 278' ' ' LEU . 30.1 m-85 -91.59 -43.6 9.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.244 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.67 74.22 17.67 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.705 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.7 Cg_exo -55.6 -36.26 94.28 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.748 2.298 . . . . 0.0 112.946 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 319' ' ' VAL . 23.2 t -63.1 -28.48 70.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.115 0.484 . . . . 0.0 110.559 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.3 tp -87.35 -41.97 13.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.886 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.9 m -53.33 -44.06 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.778 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.9 p -72.14 -20.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 315' ' ' SER . 97.2 t -85.31 -34.93 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.384 0.612 . . . . 0.0 110.117 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -84.67 -53.03 5.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.188 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.73 -11.52 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.103 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.98 24.85 65.66 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.254 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.1 mt -120.97 113.17 33.02 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.874 -0.192 . . . . 0.0 110.572 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.05 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.47 2.113 . . . . 0.0 110.7 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 79.5 m -117.57 155.88 29.04 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -169.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.55 165.77 18.8 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.618 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.57 126.71 33.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 162.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -130.03 153.75 48.12 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.5 mm -63.15 109.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.68 -0.61 20.1 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.825 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.88 129.43 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.532 0.666 . . . . 0.0 110.221 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.35 134.74 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.535 0.683 . . . . 0.0 112.654 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 50.5 t -95.85 138.95 32.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.971 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 76.0 mt -109.96 141.87 24.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.527 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.57 164.15 9.36 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.884 2.389 . . . . 0.0 112.033 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.49 122.78 9.8 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.292 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 114.45 -17.0 19.12 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.813 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -70.34 132.18 87.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.24 -26.35 76.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.389 2.726 . . . . 0.0 113.479 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.24 -26.67 42.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.668 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -80.02 85.83 5.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.68 -43.98 46.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.243 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -120.92 80.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.886 -178.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -105.64 92.01 4.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.3 p -82.23 141.52 32.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.033 0.444 . . . . 0.0 110.967 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -82.85 -37.76 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.709 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -156.88 135.65 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 23.1 t-80 55.83 -139.26 0.97 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.6 t -100.4 42.68 1.1 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.376 0.607 . . . . 0.0 109.92 176.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.09 139.48 50.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 111.89 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.1 174.83 5.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.825 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.491 ' HE2' ' OE2' ' A' ' 235' ' ' GLU . 64.4 tttm -63.77 127.89 33.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.421 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.85 -1.55 38.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.473 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.533 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 68.1 m -86.21 140.1 30.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -111.11 137.88 48.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.449 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 47.1 mt -112.78 145.49 40.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.717 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 21.3 t -149.48 97.46 2.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.185 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -85.74 108.28 17.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.0 m170 . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.105 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.0 m95 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 122.011 0.91 . . . . 0.0 113.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 12.2 pt20 -130.92 168.37 17.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.246 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -88.59 160.2 17.54 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.975 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.59 -46.93 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.491 ' OE2' ' HE2' ' A' ' 217' ' ' LYS . 27.3 mt-10 -57.73 -23.45 51.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.243 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.09 -44.75 21.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.341 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.581 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.9 t80 -74.26 -44.07 54.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.423 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.94 72.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.118 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 176.163 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 39.2 t80 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.024 0.44 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.19 26.61 23.27 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.591 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -81.41 -16.42 52.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.176 0.513 . . . . 0.0 110.417 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.88 -29.49 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 142.1 151.81 5.59 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.586 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.9 mp -107.57 97.59 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.73 0.412 . . . . 0.0 110.863 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.9 ttpp -85.68 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.182 0.515 . . . . 0.0 111.139 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.487 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 4.6 tt -54.77 122.48 10.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.465 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.2 mt -95.0 -47.71 6.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.561 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.7 t -151.0 164.98 35.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -142.12 133.04 25.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.207 0.527 . . . . 0.0 111.632 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -128.67 146.19 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.49 128.69 53.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.828 0.823 . . . . 0.0 110.359 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.864 -167.014 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 298' ' ' LEU . 49.6 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.1 m -132.72 153.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.147 0.975 . . . . 0.0 113.228 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 89.9 mt -92.92 119.96 32.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.249 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.7 ttmt -108.33 111.82 23.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 312' ' ' PHE . 36.9 mt -118.5 129.4 55.35 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.011 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.1 m -92.97 110.79 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.405 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.6 m-85 -96.51 155.27 16.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -172.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.491 ' HB2' HD21 ' A' ' 265' ' ' LEU . 15.7 t0 -118.84 123.43 29.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.448 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 60.5 Cg_endo -73.36 2.76 5.32 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.065 1.843 . . . . 0.0 111.755 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.79 9.85 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.5 t -145.9 130.94 18.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.11 -12.25 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.085 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.18 -34.7 78.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.557 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.52 -45.26 69.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 135.94 176.16 14.21 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.366 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 79.1 mt -103.32 150.33 23.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.915 0.388 . . . . 0.0 110.618 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -127.02 119.43 26.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.4 m -109.76 139.39 44.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.9 t -132.93 132.73 59.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -109.47 115.26 29.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 6.2 p -134.3 165.64 24.67 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.53 155.9 28.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.138 0.494 . . . . 0.0 111.01 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.823 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.1 mm? -64.4 -19.53 65.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.078 -173.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.21 17.67 16.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.194 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.51 117.27 60.74 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.773 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.65 116.38 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.238 1.959 . . . . 0.0 111.445 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.8 m-85 -103.59 116.06 31.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.355 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 11.4 t80 -73.48 105.08 4.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.406 175.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.75 130.79 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.349 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.84 ' HB3' HG13 ' A' ' 333' ' ' VAL . 58.9 tttp -59.97 126.44 27.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 13.2 m120 77.64 0.05 2.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.995 0.81 . . . . 0.0 111.993 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -117.08 -33.8 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 111.495 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 94.47 -151.14 20.04 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . 0.454 ' CZ2' ' HA ' ' A' ' 345' ' ' PHE . 97.3 m95 -67.77 117.6 9.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.462 0.631 . . . . 0.0 109.457 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.427 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -128.28 166.66 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.772 0.32 . . . . 0.0 110.641 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 41.4 t -160.77 168.11 25.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.509 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.513 ' HE1' HD11 ' A' ' 280' ' ' LEU . 63.4 m-85 -84.92 -28.57 25.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.946 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.11 75.41 75.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.595 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.7 Cg_exo -55.42 -45.02 43.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.883 2.388 . . . . 0.0 112.677 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 18.3 m -62.5 -21.08 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.447 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.05 -45.3 10.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.909 0.385 . . . . 0.0 110.166 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.413 HG21 ' SG ' ' A' ' 325' ' ' CYS . 36.4 m -55.51 -40.74 72.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.742 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.554 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.9 p -71.72 -19.71 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.788 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.3 t -87.61 -36.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.327 0.584 . . . . 0.0 110.185 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -81.86 -54.88 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -101.79 -11.37 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.837 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.59 14.78 77.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.638 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.5 mt -110.53 114.18 55.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.634 0.217 . . . . 0.0 111.08 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.96 118.49 5.65 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.633 2.222 . . . . 0.0 110.601 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 317' ' ' THR . 62.6 m -117.77 157.78 25.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.248 0.547 . . . . 0.0 112.306 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.6 m -79.91 164.88 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.06 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -92.03 122.16 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.19 166.1 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.548 0.689 . . . . 0.0 111.412 -175.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -124.12 142.33 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.34 114.45 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.67 -0.65 21.72 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.525 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -73.15 132.09 42.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.88 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -92.92 134.8 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.273 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 49.5 t -96.5 134.32 39.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.369 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 82.2 mt -105.84 143.68 27.37 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.59 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 69.1 Cg_endo -86.91 167.66 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.637 2.225 . . . . 0.0 112.074 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.74 129.8 24.49 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.008 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.26 -14.32 54.94 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -69.3 128.3 92.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.36 -22.59 75.0 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.325 2.683 . . . . 0.0 113.866 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.87 -31.04 45.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -69.0 91.73 0.49 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.281 0.562 . . . . 0.0 109.954 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.0 mt -66.33 -41.53 89.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.671 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -129.13 101.7 6.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 309' ' ' TRP . 3.8 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.519 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -91.3 99.58 12.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.048 0.452 . . . . 0.0 110.098 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -87.63 141.77 28.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.452 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.4 mm -79.44 -40.31 21.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.334 0.588 . . . . 0.0 109.752 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -156.89 134.38 10.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.107 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 34.0 t-80 55.94 -139.22 0.97 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 40.3 t -99.8 40.09 1.27 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.418 0.628 . . . . 0.0 109.864 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -110.23 134.6 52.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.061 0.458 . . . . 0.0 111.237 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.51 176.17 6.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -67.37 137.82 56.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.66 31.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.022 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 38.2 m -112.11 147.63 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.3 OUTLIER -111.07 143.6 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.824 0.345 . . . . 0.0 111.058 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.8 mt -119.64 143.75 47.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.809 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 41.8 t -154.07 98.03 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.418 ' CD1' ' HG ' ' A' ' 292' ' ' LEU . 34.8 m-85 -83.34 122.18 28.12 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 31.4 m170 . . . . . 0 C--N 1.328 -0.366 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -174.44 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.487 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 85.4 m95 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.208 0.527 . . . . 0.0 112.235 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 9.1 pt20 -120.45 154.37 35.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.688 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.37 162.57 23.33 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -60.68 -50.82 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.03 -24.2 57.38 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.289 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.17 -50.67 21.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.554 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 62.1 t80 -70.59 -43.65 68.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.698 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.53 68.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.245 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 239' ' ' ARG . 36.6 ttt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 14.9 t80 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.64 21.48 23.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.225 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.1 t -70.05 -23.56 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.02 -31.75 17.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.58 0.705 . . . . 0.0 109.828 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 141.0 144.28 4.41 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.762 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.2 mp -97.92 99.18 10.47 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.419 0.287 . . . . 0.0 111.0 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 19.2 ttpp -84.96 117.75 24.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.1 tt -61.22 102.83 0.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.829 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 67.1 mt -77.2 -47.65 19.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.445 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -152.58 163.15 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.097 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.571 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -133.68 146.2 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.668 -168.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.44 140.04 27.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.16 107.75 16.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 -170.6 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.67 154.87 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.997 0.904 . . . . 0.0 113.072 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 98.7 mt -94.15 110.31 22.04 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.807 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.8 ttmt -104.28 109.63 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.812 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 312' ' ' PHE . 40.9 mt -116.14 136.82 52.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.751 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 27.8 m -93.58 109.66 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 84.3 m-85 -101.09 150.05 23.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.324 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 12.8 t70 -116.6 133.44 23.02 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.7 Cg_endo -79.21 9.81 3.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.861 1.707 . . . . 0.0 112.04 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.38 63.16 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -146.73 100.01 3.27 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.603 0.716 . . . . 0.0 109.508 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.29 -18.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.415 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 288' ' ' GLU . 7.2 mp0 -56.25 -32.43 64.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.538 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.37 -1.18 49.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 111.472 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.08 172.96 25.31 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.791 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.4 mt -97.84 141.13 31.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.723 0.297 . . . . 0.0 110.22 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -112.43 121.29 44.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 28.2 m -110.06 133.97 52.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 89.2 t -131.69 134.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.518 -174.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 88.3 mt-10 -106.44 120.97 43.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.681 171.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 11.0 p -133.23 167.2 20.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.467 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -75.44 163.24 27.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.06 0.457 . . . . 0.0 110.494 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.64 ' H ' HD22 ' A' ' 298' ' ' LEU . 2.0 mm? -66.89 -16.09 64.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.757 -168.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.97 26.0 10.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.159 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -79.24 117.53 67.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.726 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.48 133.35 11.72 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.242 1.961 . . . . 0.0 111.903 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.452 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 98.8 m-85 -118.07 125.04 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.423 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -76.51 89.34 3.27 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.524 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.79 134.12 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.6 ' HB3' HG13 ' A' ' 333' ' ' VAL . 69.2 tttt -59.35 125.53 24.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.901 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.3 m120 81.45 -26.39 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.093 0.871 . . . . 0.0 112.171 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -89.83 -35.12 15.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.093 0.473 . . . . 0.0 111.203 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.89 -153.06 21.73 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -63.99 115.06 4.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.983 0.392 . . . . 0.0 110.209 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.465 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.0 m -127.74 169.19 14.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.222 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 45.9 t -160.7 169.37 22.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.461 ' HE1' HD11 ' A' ' 280' ' ' LEU . 53.4 m-85 -84.28 -32.27 24.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.929 174.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -126.95 77.38 75.1 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.421 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.0 Cg_exo -56.35 -36.81 97.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.814 2.343 . . . . 0.0 112.564 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.7 m -70.29 -20.75 63.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.43 -47.81 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 m -57.17 -40.95 78.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.048 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.504 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.2 p -68.5 -20.42 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.894 0.378 . . . . 0.0 111.642 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.5 t -91.01 -38.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.326 0.584 . . . . 0.0 110.393 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -78.81 -53.77 6.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.788 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -95.24 -22.22 17.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.096 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 88.15 12.97 64.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.306 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 45.0 mt -109.2 115.82 56.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 4.9 Cg_exo -72.0 109.48 2.7 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.532 2.155 . . . . 0.0 110.706 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 59.5 m -109.09 155.01 21.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.765 -170.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 79.2 m -84.8 166.38 16.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.015 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.29 123.51 31.63 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.291 -0.256 . . . . 0.0 110.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.34 164.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.229 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -134.33 150.82 50.97 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.0 mm -55.27 113.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 110.527 -176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.4 -2.09 20.46 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.865 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.51 128.35 35.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.257 0.551 . . . . 0.0 111.159 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.4 p -88.95 136.39 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.844 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 58.3 m -103.02 134.22 46.82 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.097 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 59.9 mt -104.39 143.14 26.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.503 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.578 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 63.5 Cg_endo -88.72 166.86 6.04 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.214 2.609 . . . . 0.0 112.871 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.5 128.69 17.61 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.352 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.88 -19.37 35.62 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.905 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -70.96 129.23 89.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 -32.0 80.11 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.807 3.005 . . . . 0.0 113.868 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.33 -23.06 43.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.9 86.51 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.917 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.25 -45.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.528 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -110.38 47.5 0.96 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.286 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.346 179.739 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 110.871 -0.473 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.6 t -91.69 93.65 9.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.0 p -84.11 143.79 29.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.476 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.8 mm -79.33 -44.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.44 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -151.37 137.19 18.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.416 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.523 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 24.1 t-80 56.43 -137.4 1.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 45.1 t -100.23 34.09 2.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.307 0.575 . . . . 0.0 110.112 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -108.63 138.57 44.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.29 175.65 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.882 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -68.32 130.3 42.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.419 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.82 36.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.113 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 23.9 m -101.82 145.55 29.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.17 143.7 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.735 0.302 . . . . 0.0 110.903 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 44.1 mt -121.65 144.13 48.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.654 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 10.1 m -148.99 91.93 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 12.3 m-85 -88.2 120.06 29.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.0 m170 . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 110.805 -173.444 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.543 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 68.1 m95 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.563 0.697 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 23.4 pt20 -101.0 167.27 10.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.567 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.13 159.11 17.67 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.3 t -58.17 -48.72 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 109.716 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.65 -21.51 40.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.762 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.2 -52.48 8.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.461 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 66.1 t80 -65.43 -41.38 93.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.839 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.04 73.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.768 174.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.579 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 12.6 t80 . . . . . 0 C--O 1.231 0.107 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 100.23 12.09 40.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.188 -1.005 . . . . 0.0 113.554 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.6 t -74.55 -15.48 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.038 0.447 . . . . 0.0 110.139 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -88.8 -26.47 21.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.591 0.71 . . . . 0.0 109.339 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.4 144.22 5.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.0 mp -105.46 98.2 7.93 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.434 0.294 . . . . 0.0 111.372 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.6 tttm -84.48 118.0 24.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.015 0.435 . . . . 0.0 110.648 -176.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.46 107.21 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 283' ' ' ASP . 85.9 mt -80.75 -51.62 8.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.714 0.292 . . . . 0.0 110.351 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.0 t -150.71 163.16 39.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.531 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.3 t60 -137.03 139.68 41.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 0.0 111.509 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -133.23 138.69 46.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.836 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.531 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 9.2 mt-10 -108.15 121.88 45.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 0.0 110.069 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.32 -0.709 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.135 -173.444 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.69 154.11 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.853 0.835 . . . . 0.0 112.591 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.472 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 88.4 mt -94.38 114.36 26.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.734 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 20.3 ttpp -109.04 114.84 28.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.48 HD11 ' HE1' ' A' ' 312' ' ' PHE . 38.0 mt -115.72 130.83 57.0 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.251 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.0 m -93.91 111.79 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.531 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 77.3 m-85 -100.99 159.7 14.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.84 -172.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 35.9 t70 -122.94 137.45 28.13 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.652 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.579 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 86.9 Cg_endo -85.54 11.32 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.213 1.942 . . . . 0.0 112.083 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.71 39.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -154.14 115.56 4.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.339 0.59 . . . . 0.0 110.161 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.58 -7.77 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.654 0.74 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.13 -20.15 61.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.134 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.6 -38.63 39.49 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 145.31 168.21 12.82 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.243 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.11 143.06 26.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.9 OUTLIER -117.42 117.5 29.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.473 ' N ' HD22 ' A' ' 292' ' ' LEU . 5.5 m -108.94 138.21 45.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.0 t -132.13 132.98 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.543 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 70.6 mt-10 -104.16 116.34 32.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.588 170.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.56 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 11.1 p -128.06 167.24 17.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.992 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -81.65 161.14 23.55 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.721 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.8 mm? -61.54 -13.36 20.74 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.26 -169.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -108.18 13.11 26.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.591 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -71.69 119.35 73.62 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 0.0 110.888 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.44 136.39 17.51 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.21 1.94 . . . . 0.0 112.105 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.56 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.6 m-85 -122.77 118.15 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.694 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 17.0 t80 -74.5 101.65 4.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.368 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.4 t -90.6 135.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.205 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.604 ' HB3' HG13 ' A' ' 333' ' ' VAL . 59.1 tttm -62.0 128.4 35.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 16.3 m120 72.55 11.32 5.62 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.72 0.637 . . . . 0.0 111.721 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -128.3 -42.9 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.986 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 100.15 -153.3 19.39 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -63.97 116.84 6.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 117.24 0.52 . . . . 0.0 109.795 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.7 m -128.31 166.43 18.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.034 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -160.43 167.05 28.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 280' ' ' LEU . 71.0 m-85 -85.98 -19.57 30.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.113 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -137.21 72.78 52.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.656 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.533 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.4 Cg_exo -52.62 -37.62 74.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.924 2.416 . . . . 0.0 113.19 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.4 t -68.76 -22.48 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.511 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.2 tp -87.92 -47.01 8.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 0.0 110.218 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 m -55.02 -41.66 71.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.999 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.99 -17.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 111.58 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.56 -39.86 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.311 0.576 . . . . 0.0 110.458 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.47 -46.12 18.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.368 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -107.88 -12.32 15.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.61 0.243 . . . . 0.0 111.106 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.4 14.97 77.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.1 mt -109.26 114.55 57.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 122.628 -0.337 . . . . 0.0 110.86 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -72.07 116.27 4.64 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.527 2.151 . . . . 0.0 110.561 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 68.1 m -117.93 156.37 28.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.183 0.516 . . . . 0.0 112.101 -170.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.2 m -83.49 160.05 21.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.49 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.21 127.18 32.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.436 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.61 172.79 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.697 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 143.87 50.88 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.703 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.4 mm -63.03 111.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.813 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 116.12 -0.14 20.93 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.401 -173.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.49 ' HB3' HG13 ' A' ' 304' ' ' VAL . 66.0 m-20 -73.53 125.33 27.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.275 0.559 . . . . 0.0 110.755 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.0 OUTLIER -88.01 127.78 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.829 0.823 . . . . 0.0 112.041 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 42.0 t -89.51 131.08 35.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.73 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.8 mt -102.92 141.87 23.39 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.699 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.523 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 52.7 Cg_endo -89.13 170.26 4.94 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.844 2.362 . . . . 0.0 111.889 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 135.02 40.43 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.384 2.056 . . . . 0.0 111.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 98.76 -15.7 60.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.483 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -72.44 128.4 88.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.16 -31.27 54.29 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.123 3.216 . . . . 0.0 114.078 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.37 -24.0 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.249 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.44 85.07 3.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.95 -44.15 51.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.014 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -114.56 62.51 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 110.441 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.653 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 111.161 -0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.1 t -90.03 103.97 16.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.4 p -87.48 146.68 25.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.006 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -90.44 -38.3 10.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 109.607 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.413 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 82.8 t90 -157.1 128.73 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.25 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.535 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.7 t-80 57.83 -151.51 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 37.3 t -88.37 46.36 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.779 -0.576 . . . . 0.0 110.411 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -117.44 139.12 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.166 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.84 171.98 7.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.314 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.28 135.71 56.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.735 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.08 10.39 45.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.797 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 62.1 m -103.56 145.7 29.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.0 mpt_? -115.7 142.6 46.53 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.766 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 71.9 mt -118.91 148.6 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.697 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 7.7 m -156.96 96.53 1.61 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.444 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.413 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 3.8 m-85 -88.87 126.21 35.27 Favored 'General case' 0 C--O 1.228 -0.066 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 110.467 -177.795 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.2 pt20 -100.55 157.85 16.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.58 162.8 15.47 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -58.17 -47.54 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 28.8 mt-10 -55.49 -23.8 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.72 -46.02 14.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.68 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -75.16 -39.38 60.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -66.24 -26.06 67.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.29 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 41.8 ttm105 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.838 0.827 . . . . 0.0 109.474 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.593 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 13.9 t80 . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 98.7 14.17 38.28 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.174 -1.013 . . . . 0.0 112.695 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 8.1 t -69.05 -14.76 63.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.106 0.479 . . . . 0.0 110.879 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -100.95 -28.89 12.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.392 0.615 . . . . 0.0 110.316 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.4 153.65 6.85 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.628 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -121.64 102.45 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -0.616 . . . . 0.0 110.462 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.717 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.4 ttpt -87.79 125.09 34.25 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.37 102.93 0.93 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.181 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.06 -52.94 8.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.743 0.306 . . . . 0.0 110.46 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.4 t -146.34 157.97 43.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.128 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.448 ' ND1' HD23 ' A' ' 280' ' ' LEU . 9.3 t60 -141.85 145.32 34.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.288 0.566 . . . . 0.0 111.289 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . 34.1 tt0 -137.79 141.41 40.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.693 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -102.33 99.06 9.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.607 -169.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.8 m -135.54 155.82 37.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.97 105.31 17.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.901 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 268' ' ' GLU . 82.3 tttt -94.03 105.09 17.11 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.994 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 14.0 mt -115.64 132.22 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.966 0.413 . . . . 0.0 111.464 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 m -104.33 117.49 34.33 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.536 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 92.5 m-85 -105.41 168.65 8.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.096 0.475 . . . . 0.0 111.974 -171.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -137.43 136.77 20.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.511 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.593 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.4 Cg_endo -80.72 8.86 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.025 1.817 . . . . 0.0 112.451 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.65 -23.09 10.44 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 8.4 t -154.19 133.78 12.84 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.92 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.3 -7.21 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.296 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -56.95 -24.63 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.851 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.13 -46.96 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.561 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.72 148.84 4.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.99 152.54 45.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 110.617 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -133.11 117.04 17.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.454 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.4 m -105.97 135.98 46.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.536 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 69.5 t -135.39 122.96 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.151 0.501 . . . . 0.0 111.135 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -107.49 110.06 21.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.327 -178.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.545 ' HG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.0 p -125.37 175.63 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.566 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -75.77 166.13 23.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.521 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 298' ' ' LEU . 2.0 mm? -71.75 -18.01 62.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.61 -168.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -100.43 19.63 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.28 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.26 121.62 85.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.665 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.46 133.03 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.371 2.047 . . . . 0.0 111.626 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.545 ' HZ ' ' HG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -119.4 121.7 40.11 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.943 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 28.0 t80 -76.23 102.15 5.7 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.752 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 78.6 t -92.62 134.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.3 0.571 . . . . 0.0 111.097 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.559 ' HB3' HG13 ' A' ' 333' ' ' VAL . 63.9 tttp -62.08 127.23 30.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.241 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.0 m120 76.01 3.39 3.73 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.792 0.683 . . . . 0.0 111.947 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -123.95 -28.88 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 87.2 -153.74 25.69 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.06 115.04 4.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.03 0.443 . . . . 0.0 110.363 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.48 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.1 m -125.45 168.08 14.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.926 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -162.26 178.63 8.54 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.356 -0.215 . . . . 0.0 110.452 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 52.2 m-85 -95.94 -22.07 17.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.84 68.19 71.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 84.3 Cg_exo -48.92 -37.83 37.48 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 113.379 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 30.3 m -62.3 -31.28 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.084 0.469 . . . . 0.0 111.041 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.49 -44.15 11.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.437 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 m -56.42 -39.52 73.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.728 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.7 p -71.75 -23.51 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 -43.92 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 0.0 110.216 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.88 -54.29 7.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.245 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -99.34 -15.73 18.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.241 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 87.57 10.11 70.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.8 mt -109.72 117.73 51.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.583 0.191 . . . . 0.0 110.839 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 104.31 1.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.567 2.178 . . . . 0.0 110.405 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 64.3 m -102.45 156.5 17.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.196 -169.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 56.1 m -79.82 152.95 29.44 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.945 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -79.26 117.66 20.47 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.48 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -68.45 165.09 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 0.0 110.726 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -121.36 140.72 51.74 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.9 mm -55.48 112.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.147 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.48 3.58 20.58 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.139 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 50.8 m-20 -81.01 135.24 35.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.13 135.31 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.598 0.713 . . . . 0.0 112.129 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 60.2 m -100.82 135.53 42.12 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.742 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.74 142.0 23.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.353 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.78 165.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.214 2.609 . . . . 0.0 111.993 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.39 121.34 8.45 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.461 2.107 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 112.66 -11.2 25.6 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.446 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.3 127.22 86.74 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.7 -24.75 38.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.662 2.908 . . . . 0.0 113.935 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.23 -31.86 43.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.275 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.1 91.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 110.028 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 55.4 mt -74.58 -48.92 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.344 -176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.56 53.43 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.994 0.426 . . . . 0.0 110.673 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.023 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.1 t -95.45 94.82 8.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.325 0.583 . . . . 0.0 110.229 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.8 p -86.0 141.92 29.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.162 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.6 mm -88.36 -38.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.346 0.593 . . . . 0.0 109.72 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.417 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 67.8 t90 -156.15 135.93 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.386 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.405 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 18.8 t-80 53.53 -141.04 0.89 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 53.3 t -98.4 38.68 1.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.498 0.666 . . . . 0.0 109.931 176.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.55 139.35 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.241 0.544 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.4 173.17 7.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.383 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -62.57 137.57 58.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.113 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.76 60.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.096 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.1 m -82.54 145.64 29.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.41 139.3 49.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.382 0.61 . . . . 0.0 111.383 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 53.5 mt -113.45 148.01 36.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.193 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 11.7 t -153.9 98.09 2.14 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.2 0.524 . . . . 0.0 110.653 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.88 116.27 19.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.762 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.591 -178.407 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 73.1 m95 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.922 0.391 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 9.4 pt20 -124.98 162.15 25.12 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.39 162.99 17.88 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.067 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -59.76 -44.41 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.77 -23.57 30.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.975 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.19 -53.95 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.225 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 67.2 t80 -68.89 -42.81 76.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.29 -41.13 75.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.719 178.108 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 46.2 t80 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.72 24.14 50.75 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.0 t -78.01 -5.94 52.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.605 0.241 . . . . 0.0 111.59 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.04 -31.06 7.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.495 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 161.41 153.3 6.98 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.102 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.5 mp -121.2 103.69 9.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.904 0.482 . . . . 0.0 110.717 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 30.0 tttm -87.29 119.61 27.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.973 0.416 . . . . 0.0 110.558 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.78 113.31 2.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 283' ' ' ASP . 89.0 mt -87.43 -52.05 5.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.1 t -145.76 160.24 42.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.322 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' LYS . 6.3 t60 -143.36 141.58 30.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -175.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 41.5 tt0 -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.478 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -100.97 124.08 46.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.917 -170.092 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.981 0.896 . . . . 0.0 113.307 -172.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 92.8 mt -96.9 114.34 25.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.987 172.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 4.5 ttmp? -97.84 109.9 22.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.449 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 16.4 mt -116.55 127.01 54.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.467 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 90.3 m -98.02 120.02 37.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.492 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.0 m-85 -105.41 161.74 14.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.462 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD21 ' A' ' 265' ' ' LEU . 37.4 t70 -125.8 132.08 24.2 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.524 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -80.59 11.11 3.03 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.302 2.002 . . . . 0.0 111.706 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.4 11.08 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.334 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -153.67 138.01 16.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.045 0.45 . . . . 0.0 110.354 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.81 -9.27 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.895 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -34.68 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.93 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -78.71 -44.09 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.609 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.74 161.13 8.66 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.985 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.57 145.24 25.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.013 0.435 . . . . 0.0 110.645 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.66 122.52 27.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 99.6 m -115.79 136.39 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.6 t -129.76 136.42 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.192 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.47 120.99 39.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.43 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.8 p -136.89 169.88 17.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.046 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -64.82 161.86 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.403 0.62 . . . . 0.0 111.13 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -70.71 -18.09 62.81 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.503 -168.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.34 24.14 9.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.374 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.9 122.31 86.23 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.551 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.76 129.76 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.381 2.054 . . . . 0.0 111.999 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 93.7 m-85 -116.52 118.48 32.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 35.3 t80 -73.78 100.06 3.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.707 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 74.8 t -88.7 134.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.342 0.591 . . . . 0.0 110.743 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.523 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.8 tttp -57.96 127.44 32.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.682 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.3 m-20 76.85 -2.79 2.62 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.036 0.835 . . . . 0.0 111.945 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -119.46 -21.2 7.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.758 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 78.21 -152.01 37.52 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.846 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.38 115.68 4.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 164.51 21.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.019 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -161.53 176.88 10.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.844 0.354 . . . . 0.0 111.25 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 328' ' ' ILE . 63.0 m-85 -87.58 -34.38 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.01 71.82 53.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 80.9 Cg_exo -52.09 -36.94 67.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.839 2.359 . . . . 0.0 112.756 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 5.9 p -63.55 -29.35 70.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.2 0.524 . . . . 0.0 111.299 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.26 -47.42 8.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.8 m -56.5 -41.3 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.366 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.444 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.7 p -69.06 -21.33 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 111.68 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 73.1 t -91.28 -29.51 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.567 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.82 -52.15 5.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.966 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -99.92 -6.46 26.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 74.4 20.34 79.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.6 116.18 36.93 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.645 0.222 . . . . 0.0 110.798 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.98 106.31 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.729 2.286 . . . . 0.0 111.238 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.7 m -106.53 151.2 25.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.038 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 65.2 m -79.66 147.97 31.8 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.858 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.14 134.28 51.46 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.958 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -88.44 171.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.143 0.496 . . . . 0.0 110.101 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -132.57 156.71 46.37 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.72 110.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.443 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 115.47 4.05 20.21 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.845 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.74 127.57 32.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.444 0.622 . . . . 0.0 110.341 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.9 p -90.92 136.97 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.862 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.9 m -102.32 134.91 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.387 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 66.1 mt -101.93 145.91 31.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.12 165.25 8.46 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.988 2.459 . . . . 0.0 112.49 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.26 122.64 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.645 2.23 . . . . 0.0 111.755 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.68 -17.6 27.82 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.706 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -65.99 125.64 90.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.48 -21.67 72.52 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 123.01 2.473 . . . . 0.0 113.128 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.63 -23.16 29.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.586 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.19 99.12 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.46 -45.31 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.206 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -124.44 84.96 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.279 -0.263 . . . . 0.0 110.879 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.46 -178.863 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.718 -0.532 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -94.3 93.06 7.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.342 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -85.31 140.23 30.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.992 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.475 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.8 mm -91.78 -43.18 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 109.886 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -149.8 126.86 11.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 26.2 t-80 59.74 -149.59 0.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.483 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 43.8 t -90.68 36.15 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.367 0.604 . . . . 0.0 110.414 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 62.5 m-85 -106.39 141.48 37.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.213 0.53 . . . . 0.0 111.059 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.88 170.38 8.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.367 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -67.16 131.39 45.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.82 7.72 41.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.905 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.3 m -97.89 150.2 21.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 219' ' ' THR . 7.9 mpt_? -114.95 143.07 45.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.771 0.32 . . . . 0.0 110.6 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 73.8 mt -120.71 147.66 44.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.605 -171.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 38.2 t -155.29 102.7 2.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.526 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 292' ' ' LEU . 7.4 m-85 -90.08 128.06 36.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.8 m170 . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.166 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 96.5 m95 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.3 pt20 -107.78 160.81 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.951 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -83.56 159.38 21.66 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.471 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.8 t -57.95 -51.45 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.2 -23.46 22.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.837 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.84 -52.33 11.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.382 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.33 -39.95 62.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.201 0.525 . . . . 0.0 110.486 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -64.1 -26.3 68.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.877 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 109.714 175.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.521 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 52.6 t80 . . . . . 0 C--O 1.234 0.248 0 CA-C-O 121.173 0.511 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 78.56 25.17 61.34 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.2 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 52.7 p -76.64 -8.98 58.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.573 0.687 . . . . 0.0 111.878 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -110.18 -30.23 7.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.541 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 165.26 158.01 10.24 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.821 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -126.3 101.48 6.75 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.082 0.553 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.9 ttpp -87.7 119.59 28.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.291 0.567 . . . . 0.0 110.686 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.78 107.39 0.96 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.237 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.2 -48.26 12.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.35 . . . . 0.0 110.765 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.1 t -152.69 164.88 36.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.149 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.538 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 9.9 t60 -146.4 138.74 25.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.375 0.607 . . . . 0.0 111.992 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 10.2 tt0 -133.04 140.65 47.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.413 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.538 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 10.1 mt-10 -108.56 108.64 19.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.381 0.61 . . . . 0.0 110.323 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.731 -174.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.62 154.06 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.791 0.805 . . . . 0.0 112.486 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.88 108.18 19.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.394 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.646 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 2.3 ttmp? -92.29 108.34 19.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.419 HD11 ' HE1' ' A' ' 312' ' ' PHE . 14.7 mt -116.0 120.02 37.78 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.655 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 8.8 m -90.97 116.48 28.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.495 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 69.6 m-85 -105.25 167.82 9.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.359 0.599 . . . . 0.0 112.433 -171.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.44 134.62 21.28 Favored Pre-proline 0 C--O 1.217 -0.606 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.458 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.521 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -77.64 9.6 2.87 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 121.557 1.505 . . . . 0.0 112.169 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.95 -5.43 56.38 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -154.64 135.42 13.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.352 0.596 . . . . 0.0 110.766 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.44 -8.04 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.32 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.27 -39.92 80.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.583 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -82.45 -46.75 13.07 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.392 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 136.24 176.67 14.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.77 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.74 150.88 24.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.884 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -136.45 121.04 18.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.434 ' N ' HD22 ' A' ' 292' ' ' LEU . 14.1 m -108.36 134.27 51.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 97.3 t -129.47 128.58 66.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.101 0.476 . . . . 0.0 110.881 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -113.97 107.88 16.28 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.455 -177.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.5 p -123.6 173.14 8.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.093 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -75.88 163.29 27.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.736 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -65.6 -14.32 60.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.066 -170.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.02 11.13 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.784 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.21 118.97 73.92 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.151 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.81 133.29 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.405 2.07 . . . . 0.0 111.814 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.49 119.58 34.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 25.7 t80 -74.51 107.19 6.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.518 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 332' ' ' ASP . 57.0 t -94.89 133.39 35.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.309 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.736 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.4 tttp -63.95 128.92 37.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.575 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 6.4 m-20 75.39 12.73 3.18 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.98 0.8 . . . . 0.0 112.027 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -133.51 -48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.015 0.436 . . . . 0.0 111.268 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 105.97 -156.45 16.43 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -171.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -61.3 114.58 3.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.312 0.556 . . . . 0.0 110.678 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.5 m -128.92 166.46 19.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.257 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -161.36 175.07 12.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.252 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 328' ' ' ILE . 76.6 m-85 -88.48 -37.42 15.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.743 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -122.53 77.17 46.05 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.895 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -58.18 -31.41 93.34 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.975 2.45 . . . . 0.0 113.114 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 40.4 t -75.8 -21.2 57.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.341 0.591 . . . . 0.0 110.073 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.88 -48.6 7.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.217 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -51.49 -40.3 59.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.054 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.2 p -74.79 -29.54 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.209 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.36 -37.45 79.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.63 0.729 . . . . 0.0 110.319 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -100.8 -38.94 8.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.047 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -107.18 -3.63 19.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.142 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 69.35 16.16 71.04 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.942 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.72 109.6 52.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.666 -0.314 . . . . 0.0 110.588 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.74 118.03 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.737 2.291 . . . . 0.0 110.211 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.0 m -116.76 160.52 20.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.302 0.572 . . . . 0.0 112.494 -168.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.2 m -81.09 166.66 20.52 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.976 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -93.26 129.35 39.36 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.449 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -73.6 168.3 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.258 0.551 . . . . 0.0 110.696 -177.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -125.23 142.18 51.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.56 114.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.079 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.27 -4.24 20.13 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.159 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.423 ' HB3' HG13 ' A' ' 304' ' ' VAL . 54.2 m-20 -73.63 132.87 43.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -95.3 134.36 33.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.171 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.9 t -96.14 133.06 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.401 -176.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 83.6 mt -102.04 140.58 21.3 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.39 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.59 163.68 9.37 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.933 2.422 . . . . 0.0 112.152 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.57 122.58 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.587 2.192 . . . . 0.0 112.023 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.97 -7.17 41.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.426 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -74.44 125.83 89.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.71 -22.13 51.13 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.451 2.767 . . . . 0.0 114.233 -171.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.76 -28.47 44.81 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.726 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.463 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.05 85.3 2.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 86.4 mt -70.71 -43.89 76.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.892 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -124.05 81.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.534 -178.795 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.2 t -110.44 99.02 8.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.035 0.445 . . . . 0.0 110.067 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.5 p -84.07 150.49 25.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.895 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.487 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.0 mm -90.35 -40.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.702 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.476 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 85.7 t90 -150.14 125.94 10.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.6 t-80 60.94 -138.54 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 43.8 t -95.4 32.38 1.78 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.252 0.548 . . . . 0.0 110.32 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 219' ' ' THR . 66.4 m-85 -107.48 137.73 44.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.399 0.619 . . . . 0.0 111.645 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.71 178.75 4.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.284 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -63.06 144.62 56.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.262 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.54 11.71 63.76 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.399 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 44.9 m -101.88 145.74 28.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 294' ' ' VAL . 1.0 OUTLIER -111.81 136.29 51.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.727 0.299 . . . . 0.0 110.594 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.417 ' HB2' HE21 ' A' ' 232' ' ' GLN . 69.6 mt -114.42 144.18 43.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.727 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 8.5 m -154.08 93.92 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.08 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.476 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 11.7 m-85 -80.67 126.6 31.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.7 m170 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 121.052 0.453 . . . . 0.0 110.066 178.7 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 51.7 m95 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 121.035 0.445 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 221' ' ' LEU . 16.7 pt20 -96.38 153.21 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.67 158.35 20.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -55.68 -49.73 72.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.424 0.631 . . . . 0.0 109.84 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.25 -23.24 55.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.762 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.37 -58.03 3.53 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.995 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -62.65 -48.27 80.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.123 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.08 80.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.632 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.945 -175.704 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 121.246 0.546 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 91.11 14.92 56.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.447 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.6 t -68.5 -12.99 62.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.093 0.447 . . . . 0.0 111.795 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -102.96 -32.54 9.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 0.0 109.977 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.56 160.73 10.51 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.427 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 4.4 mp -123.67 100.53 6.83 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.455 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.9 ttpt -82.18 122.36 27.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.009 0.433 . . . . 0.0 110.173 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.492 ' CD1' HD22 ' A' ' 280' ' ' LEU . 46.1 tp -64.28 103.19 0.6 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.897 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.1 mt -81.94 -44.16 17.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.761 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 t -151.91 152.13 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.329 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.573 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.5 t60 -135.52 137.71 42.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.471 0.653 . . . . 0.0 111.466 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 34.1 tt0 -129.48 140.46 51.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.969 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.573 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 21.7 mt-10 -115.33 103.52 10.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.272 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.78 -174.584 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.44 155.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.852 0.834 . . . . 0.0 112.785 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.567 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 82.8 mt -93.13 108.0 19.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.838 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 49.5 tttm -103.64 106.89 17.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.499 HD12 ' HZ ' ' A' ' 282' ' ' PHE . 9.6 mt -111.91 140.85 46.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.24 -173.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 21.9 m -112.92 116.07 29.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.499 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 86.6 m-85 -108.96 161.76 14.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 265' ' ' LEU . 17.6 t70 -121.54 132.34 24.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.118 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.74 10.18 3.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 113.047 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.99 -17.72 51.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.894 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -145.46 128.32 16.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.291 0.567 . . . . 0.0 110.24 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 -11.01 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.244 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.44 -31.31 72.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.096 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.96 -46.48 15.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.712 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 131.06 -163.42 23.5 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.988 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 mt -108.85 165.07 11.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.728 0.299 . . . . 0.0 110.858 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -136.18 119.58 16.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.3 m -108.88 135.82 49.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 53.2 t -136.71 136.1 48.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -100.64 124.25 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.21 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.0 p -136.86 170.79 15.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.652 0.263 . . . . 0.0 110.482 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -81.5 165.85 20.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.246 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.641 ' H ' HD22 ' A' ' 298' ' ' LEU . 2.0 mm? -67.85 -17.78 64.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.51 -172.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -105.3 22.05 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.299 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -78.76 119.04 75.82 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.45 137.23 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.0 111.94 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 88.4 m-85 -123.98 120.63 33.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 46.5 t80 -75.87 110.25 10.16 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.239 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 51.8 t -99.05 137.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.412 -175.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -57.53 126.43 27.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.236 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 28.5 m120 75.72 -6.84 1.91 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.377 0.671 . . . . 0.0 112.33 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -114.74 -20.76 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.813 0.34 . . . . 0.0 111.527 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.66 -152.63 41.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.765 0.317 . . . . 0.0 110.419 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 19.8 m -129.01 166.2 19.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.988 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 12.4 t -161.94 -178.58 6.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.493 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 69.8 m-85 -95.65 -35.91 11.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.63 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.71 70.92 48.73 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.29 -35.62 96.61 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.263 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.6 p -68.03 -20.82 65.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.246 0.546 . . . . 0.0 110.511 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.0 tp -88.15 -44.04 11.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.114 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.2 m -55.05 -39.79 69.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.562 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.23 -23.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.73 -39.2 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 110.098 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -80.12 -58.35 3.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.027 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -92.95 -25.46 18.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.916 0.389 . . . . 0.0 111.312 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 90.36 22.09 35.85 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.064 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 61.4 mt -115.41 114.55 42.73 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 5.4 Cg_exo -76.96 103.71 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.79 2.327 . . . . 0.0 110.768 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 48.1 m -103.85 156.99 17.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.376 -168.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.9 m -81.56 165.34 21.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.61 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -92.25 124.16 36.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.45 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -67.8 165.3 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 -175.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -122.79 138.9 54.5 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.82 112.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.057 0.456 . . . . 0.0 110.344 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.07 6.11 19.01 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.185 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 5.7 m-20 -81.05 134.53 35.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.0 111.594 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 2.4 t -79.63 125.58 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.419 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 72.5 m -94.49 119.58 33.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.4 mt -100.99 141.59 22.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.83 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.48 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 78.2 Cg_endo -86.67 166.1 8.92 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.253 2.635 . . . . 0.0 112.442 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.75 115.45 4.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.676 2.251 . . . . 0.0 111.805 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 119.49 -16.57 10.51 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.313 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -67.7 127.25 93.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.22 -24.63 51.55 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.569 2.846 . . . . 0.0 114.211 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.26 -35.16 48.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.618 0.247 . . . . 0.0 110.647 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.53 86.41 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 110.136 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.5 -53.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.17 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.97 74.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.367 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.048 178.314 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.652 -0.557 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -92.08 103.69 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 110.167 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 p -84.58 141.31 30.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 8.9 mm -85.85 -42.79 16.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.293 0.568 . . . . 0.0 109.657 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -154.65 128.69 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.908 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.7 t-80 57.63 -149.67 0.46 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.559 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 34.2 t -88.61 43.75 1.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.688 -0.632 . . . . 0.0 110.397 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 65.3 m-85 -114.31 138.53 50.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.201 0.524 . . . . 0.0 111.274 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.4 176.09 5.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.328 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.515 ' HG3' ' CD ' ' A' ' 235' ' ' GLU . 88.1 tttt -62.54 141.99 58.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.292 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.26 4.7 64.27 Favored Glycine 0 CA--C 1.517 0.178 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.401 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.1 m -94.69 149.15 21.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -113.44 143.32 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.96 0.409 . . . . 0.0 110.973 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 63.5 mt -118.18 148.94 41.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.076 -174.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 35.0 t -154.13 101.33 2.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.996 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -86.38 98.06 10.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 291' ' ' LEU . 22.6 m170 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 62.8 m95 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.368 0.604 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 11.7 pt20 -132.15 156.41 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.989 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.79 154.27 38.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -58.29 -47.61 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 168.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.515 ' CD ' ' HG3' ' A' ' 217' ' ' LYS . 4.6 mt-10 -59.05 -21.59 59.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.501 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.0 -52.35 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.204 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.513 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.7 t80 -62.86 -48.45 78.99 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.011 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.05 -34.92 68.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.006 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 11.2 ttm180 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.518 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.648 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 41.6 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.28 15.97 59.74 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.418 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.9 p -69.11 -15.09 63.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.93 -26.59 10.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.49 156.74 8.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.638 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -123.88 100.11 6.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.392 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 76.0 tttt -84.42 124.4 31.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -65.36 104.59 0.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 283' ' ' ASP . 69.5 mt -80.52 -45.83 16.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.6 t -152.01 164.61 36.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.804 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.87 139.66 40.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.493 -168.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -146.31 140.98 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.283 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.76 109.81 21.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.047 0.451 . . . . 0.0 109.792 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.221 -171.59 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.01 155.63 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.826 0.822 . . . . 0.0 112.551 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.21 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.17 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -97.82 106.77 19.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.507 HD11 ' CE1' ' A' ' 312' ' ' PHE . 20.5 mt -114.46 139.26 49.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.4 m -103.76 120.8 41.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.567 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.8 m-85 -109.39 163.75 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 31.9 t70 -132.75 137.56 30.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.846 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.648 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 93.5 Cg_endo -83.24 9.42 4.1 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.241 1.961 . . . . 0.0 112.674 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.42 -11.19 50.78 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -153.18 114.75 4.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.544 0.688 . . . . 0.0 109.718 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.21 -8.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.985 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.25 -23.18 66.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.905 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.76 -42.97 20.92 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.758 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.7 153.52 5.95 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.992 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 224' ' ' HIS . 1.9 mt -73.15 155.18 39.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.011 0.434 . . . . 0.0 110.931 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -136.09 119.49 16.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 19.0 m -110.38 137.05 48.62 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 215' ' ' PHE . 90.9 t -130.73 134.93 61.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.159 -176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 32.8 mt-10 -117.83 120.66 38.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 172.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.519 ' HB3' HG23 ' A' ' 219' ' ' THR . 3.9 p -137.44 172.32 13.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.636 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.21 162.04 23.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 110.777 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.4 mm? -69.72 -8.9 51.89 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.123 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -105.03 13.87 30.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.416 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -73.43 116.59 52.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.826 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.14 119.4 5.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.247 1.965 . . . . 0.0 111.584 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.65 119.38 38.85 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 12.1 t80 -74.27 106.35 5.87 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.507 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.0 t -94.45 134.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.349 0.595 . . . . 0.0 111.273 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' A' ' 333' ' ' VAL . 49.8 tttp -58.5 125.27 22.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.329 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.4 m120 78.08 -1.95 2.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.407 0.683 . . . . 0.0 112.196 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -117.75 -28.72 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 111.35 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . 0.407 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 86.15 -152.4 25.62 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.71 116.79 5.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.067 0.433 . . . . 0.0 110.091 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.439 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.5 m -128.66 166.23 19.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.368 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.5 t -160.85 171.74 18.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.805 0.336 . . . . 0.0 110.649 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.53 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 56.6 m-85 -86.23 -36.42 19.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.64 174.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -126.25 77.3 72.21 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.454 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 48.8 Cg_exo -57.08 -38.51 95.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.94 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 20.0 m -66.06 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.0 110.796 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.24 -47.25 9.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.995 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.9 m -56.62 -41.83 77.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.064 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.545 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.5 p -69.33 -20.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.707 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.01 -43.79 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -72.13 -51.56 20.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.076 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -101.49 -20.34 15.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.033 0.444 . . . . 0.0 111.026 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 86.28 24.09 41.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.409 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.2 mt -118.86 113.52 35.95 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.888 -0.183 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -71.2 117.02 4.94 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 110.305 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 80.2 m -117.6 155.46 29.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.007 0.432 . . . . 0.0 112.1 -169.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.31 164.75 23.84 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.266 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -92.52 120.36 32.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.439 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.06 162.45 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.506 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -125.34 150.36 47.25 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.37 113.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.681 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.515 ' O ' ' HE3' ' A' ' 263' ' ' LYS . . . 115.87 1.36 21.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.018 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.27 127.33 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.178 0.513 . . . . 0.0 110.433 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.63 133.98 30.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.407 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 53.6 t -94.82 131.25 40.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.235 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.3 mt -103.14 140.78 21.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.216 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.431 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.4 Cg_endo -86.81 167.34 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.88 2.387 . . . . 0.0 111.916 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.09 127.21 17.93 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 111.356 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 111.05 -18.22 26.32 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.431 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -71.27 127.43 91.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.03 -22.28 73.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.255 2.636 . . . . 0.0 113.448 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.17 -25.81 47.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.159 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.48 86.68 2.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.09 -45.66 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.766 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -124.2 75.72 1.4 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.648 0.261 . . . . 0.0 110.459 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.574 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.656 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -103.86 89.45 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.233 0.539 . . . . 0.0 109.934 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -76.82 144.13 39.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.28 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.4 mm -81.33 -42.08 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 68.9 t90 -153.8 139.93 18.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.327 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 53.1 -137.54 1.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 52.1 t -100.35 35.03 2.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.488 0.661 . . . . 0.0 109.968 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.97 140.32 42.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.4 0.619 . . . . 0.0 111.656 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.03 175.73 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.023 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -66.66 139.97 57.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.885 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.66 12.1 51.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.959 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 61.6 m -105.82 146.88 29.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -115.65 140.66 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.02 0.438 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.447 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 80.0 mt -114.53 145.08 42.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.107 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.35 109.1 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.463 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 292' ' ' LEU . 28.7 m-85 -99.58 115.5 29.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.0 m170 . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.878 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.514 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 57.7 m95 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.7 pt20 -117.49 162.84 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.34 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -89.18 160.0 17.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.066 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -57.95 -47.9 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -55.26 -22.74 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.63 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.93 -56.99 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.641 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.588 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 80.6 t80 -66.55 -40.4 89.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -53.47 -50.98 64.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.754 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.475 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 t80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.077 0.465 . . . . 0.0 111.874 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.38 42.68 3.91 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.827 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.8 m -79.1 -17.95 54.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -104.85 -29.49 10.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.478 0.656 . . . . 0.0 109.684 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 156.38 160.55 10.11 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.75 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -118.2 100.31 7.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.519 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.7 ttpt -83.9 117.05 23.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.214 0.53 . . . . 0.0 110.426 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.406 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.2 tt -61.22 103.7 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.136 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.6 mt -78.4 -48.93 14.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.883 0.373 . . . . 0.0 110.444 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.9 t -151.94 167.18 29.2 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.408 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.553 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.6 t60 -141.1 139.81 34.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.294 0.569 . . . . 0.0 111.512 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 35.9 tt0 -133.66 144.37 49.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.808 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 25.6 mt-10 -115.85 133.19 56.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.814 0.34 . . . . 0.0 110.133 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.701 -170.506 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.56 155.6 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.972 0.891 . . . . 0.0 112.945 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.401 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 74.7 mt -96.71 116.69 29.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.313 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 22.4 ttmm -107.29 114.08 27.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 26.9 mt -114.63 135.59 53.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.868 0.366 . . . . 0.0 110.344 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 12.4 m -97.64 115.57 28.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.559 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 61.7 m-85 -106.06 163.54 12.69 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -170.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 265' ' ' LEU . 20.1 t70 -132.0 137.87 31.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.327 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.475 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 86.7 Cg_endo -87.03 11.13 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.341 2.027 . . . . 0.0 112.649 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.89 -12.73 56.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.27 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 t -153.49 134.87 14.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.974 0.416 . . . . 0.0 110.088 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.01 -8.52 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.525 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -55.07 -49.28 72.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.95 2.59 38.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 84.91 179.13 51.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.157 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mt -84.47 135.45 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.966 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -111.37 120.12 41.13 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 25.4 m -112.73 135.92 52.91 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 96.2 t -132.27 135.42 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.743 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 83.2 mt-10 -107.52 120.4 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 169.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.579 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.1 p -131.88 173.37 11.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -74.68 164.9 26.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.644 0.259 . . . . 0.0 110.941 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.66 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.9 mm? -66.2 -28.84 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.336 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.73 26.11 5.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.293 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -77.63 116.77 60.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.485 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.44 125.15 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.256 1.971 . . . . 0.0 111.646 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.579 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -111.45 116.3 30.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.525 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 17.9 t80 -74.67 104.66 5.42 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.487 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.1 t -92.38 134.73 29.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.663 ' HB3' HG13 ' A' ' 333' ' ' VAL . 45.9 tttt -59.47 120.7 9.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.225 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 15.6 m120 74.45 6.9 4.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.004 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -117.02 -30.41 5.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.002 0.429 . . . . 0.0 110.582 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.91 -155.8 23.32 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.47 116.09 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.033 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.453 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -124.83 167.47 14.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.077 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 39.9 t -160.57 165.86 30.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.818 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.468 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 60.3 m-85 -86.83 -16.55 35.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.281 173.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -142.11 73.35 22.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.73 -41.03 77.52 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.812 2.341 . . . . 0.0 112.581 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 14.6 m -60.42 -29.04 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.27 -46.09 10.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.253 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.2 m -57.34 -41.24 79.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.158 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -68.82 -19.86 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 0.0 111.573 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.7 t -89.96 -45.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.075 0.464 . . . . 0.0 110.265 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -71.9 -58.7 3.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.314 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -95.75 -13.78 23.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 0.0 110.732 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 85.1 10.75 77.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.859 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.4 mt -108.82 117.56 53.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 122.741 -0.27 . . . . 0.0 111.008 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.89 116.76 4.83 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.513 2.142 . . . . 0.0 110.409 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.1 m -117.2 159.06 23.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.376 0.608 . . . . 0.0 112.462 -168.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 61.4 m -81.59 151.0 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.142 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 120.06 22.09 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.31 165.57 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.891 0.853 . . . . 0.0 111.413 -174.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -121.94 141.63 51.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.373 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.8 mm -58.09 113.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 109.673 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.41 -0.92 20.56 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.78 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -71.33 124.77 25.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.208 0.527 . . . . 0.0 111.181 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -89.57 126.08 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.859 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.1 t -88.96 135.09 33.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.061 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 81.4 mt -106.37 144.07 28.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.631 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.3 160.61 13.11 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.474 2.116 . . . . 0.0 111.757 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.77 114.84 3.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.965 2.444 . . . . 0.0 112.25 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 115.29 -13.68 18.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.519 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.46 132.42 94.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.71 -31.1 49.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.105 3.204 . . . . 0.0 114.349 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -79.18 -23.12 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.99 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.07 95.76 3.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.066 0.46 . . . . 0.0 110.333 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.36 -42.27 81.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.855 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -139.62 98.14 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.091 -176.291 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 110.834 -0.487 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.6 t -103.52 110.63 22.75 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.5 p -94.9 150.76 19.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.287 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.5 mm -79.28 -45.96 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.376 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TRP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 78.5 t90 -151.36 136.71 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.445 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.2 t-80 56.04 -133.54 1.49 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' CYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 14.9 p -99.17 26.61 5.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.012 0.434 . . . . 0.0 110.867 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -105.61 135.41 47.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.952 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.57 174.84 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.424 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -64.31 139.34 58.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.847 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.77 12.05 44.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.138 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 30.8 m -102.38 158.18 16.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.24 151.59 42.15 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.416 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 56.5 mt -122.31 145.72 47.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.13 92.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.658 175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -78.61 123.02 26.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 12.6 m170 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 0.0 111.632 -174.725 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' TRP . . . . . 0.447 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 88.3 m95 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -100.09 158.97 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.532 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.05 164.35 21.46 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.163 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.1 t -66.27 -39.06 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.23 -22.05 64.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.503 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.69 -53.32 12.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.33 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.496 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 88.1 t80 -74.68 -40.31 61.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.236 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 212' ' ' TRP . . . -61.06 -35.4 76.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.842 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.607 0.718 . . . . 0.0 109.909 178.492 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.661 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 38.3 t80 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.95 11.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.656 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.9 t -78.81 -24.82 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.704 0.288 . . . . 0.0 110.552 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -99.39 -25.37 14.49 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.39 168.0 17.83 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.646 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.04 102.79 7.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.771 -0.714 . . . . 0.0 110.138 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 75.5 tttt -87.49 119.12 27.45 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.0 110.796 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.51 107.87 0.74 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.163 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.7 mt -83.13 -45.83 13.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.0 0.429 . . . . 0.0 110.48 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 32.8 t -151.88 156.33 39.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.211 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.406 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.8 t60 -139.12 138.22 36.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -131.57 141.46 49.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.397 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.28 129.61 53.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.317 -0.837 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.649 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.5 m -130.04 152.59 37.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 122.029 0.918 . . . . 0.0 112.897 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.64 112.87 24.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.591 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -102.87 110.0 21.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.418 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 23.0 mt -115.34 129.73 56.69 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 87.7 m -98.94 117.17 32.84 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.444 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.0 m-85 -104.51 167.02 10.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.137 -170.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.457 ' HB2' HD21 ' A' ' 265' ' ' LEU . 21.9 t70 -132.34 134.52 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.413 175.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.2 Cg_endo -83.72 12.11 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.143 1.895 . . . . 0.0 112.332 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.64 62.06 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -153.71 102.94 2.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.911 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 291' ' ' LEU . 12.1 p -61.52 -15.28 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.421 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.16 -28.24 69.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.671 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -72.27 -40.5 67.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 110.161 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.85 152.72 5.98 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.422 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 287' ' ' VAL . 85.1 mt -82.26 147.76 28.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.221 0.511 . . . . 0.0 110.638 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 294' ' ' VAL . 1.5 tm? -125.05 118.32 25.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 83.8 m -110.3 134.0 52.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.403 HG23 HD13 ' A' ' 292' ' ' LEU . 75.3 t -130.33 136.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.561 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.447 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 62.5 mt-10 -112.54 127.94 56.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.105 170.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.0 p -139.82 176.28 8.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.93 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.94 164.17 26.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.913 0.387 . . . . 0.0 110.329 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.716 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.7 mm? -64.85 -17.84 64.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.245 -173.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.35 17.89 20.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.979 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.92 118.47 72.07 Favored Pre-proline 0 C--N 1.323 -0.563 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.339 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.58 139.82 16.36 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.104 1.869 . . . . 0.0 111.677 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.471 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 80.9 m-85 -124.5 129.73 51.16 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.9 t80 -82.63 89.62 6.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.498 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 332' ' ' ASP . 74.8 t -75.83 125.91 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.068 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.658 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.9 tttp -56.09 141.4 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.641 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.4 m-20 78.21 -20.04 0.41 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.47 0.708 . . . . 0.0 111.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -105.2 -60.53 1.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 111.345 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 125.76 -124.34 5.19 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.25 117.39 28.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.765 0.782 . . . . 0.0 110.606 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.8 m -131.8 167.88 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.23 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.3 t -161.34 -177.34 5.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 328' ' ' ILE . 71.6 m-85 -91.81 -39.09 11.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.22 73.2 57.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.877 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -57.17 -34.21 97.34 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.121 2.547 . . . . 0.0 113.213 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.8 p -65.35 -30.02 70.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.8 tp -83.15 -44.11 15.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.157 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -55.36 -44.16 75.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.151 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.7 p -69.81 -27.04 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.541 -176.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.7 -38.52 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.285 0.565 . . . . 0.0 110.186 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.26 -58.19 3.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.051 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -98.97 -8.46 25.42 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.25 21.44 75.62 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.2 mt -116.58 111.22 41.78 Favored Pre-proline 0 C--N 1.327 -0.394 0 O-C-N 122.876 -0.191 . . . . 0.0 110.646 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.33 117.95 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.582 2.188 . . . . 0.0 110.534 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 58.0 m -117.38 157.65 25.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.711 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 72.6 m -87.38 165.2 15.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.232 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.76 127.04 33.06 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.085 -0.384 . . . . 0.0 109.97 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.424 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -72.27 177.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 0.0 110.598 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -139.19 141.07 37.97 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.6 mm -52.34 112.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 109.575 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.49 9.13 15.27 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.735 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.2 OUTLIER -72.29 127.99 34.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -96.61 111.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.946 0.879 . . . . 0.0 111.051 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.7 m -79.24 127.84 32.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.112 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 69.5 mt -98.75 138.95 20.77 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.066 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.6 Cg_endo -86.14 176.65 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.923 2.415 . . . . 0.0 111.734 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.96 155.1 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.255 1.97 . . . . 0.0 111.029 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.0 -23.14 5.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.564 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -65.32 126.26 91.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -24.49 79.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.096 2.531 . . . . 0.0 113.152 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.94 -25.15 40.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.21 84.87 3.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.392 0.615 . . . . 0.0 109.507 173.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.26 -44.54 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.639 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.74 44.24 1.94 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.93 0.395 . . . . 0.0 110.616 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.093 -178.345 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.0 t -96.9 93.39 6.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.038 0.447 . . . . 0.0 110.222 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 23.7 p -87.72 144.2 26.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.808 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.504 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 13.8 mm -85.21 -37.95 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.32 0.581 . . . . 0.0 109.894 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -151.91 131.38 12.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.507 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 18.4 t-80 58.62 -138.43 0.81 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 51.5 t -98.61 37.18 1.52 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 110.155 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -113.44 137.59 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.364 0.602 . . . . 0.0 111.724 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.44 172.02 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.044 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.7 141.12 51.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.976 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.13 5.56 54.56 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.212 -172.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 50.1 m -99.08 147.98 24.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.46 137.0 49.83 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.195 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 39.9 mt -113.12 144.06 43.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.257 -174.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 40.8 t -153.17 92.03 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.558 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.431 ' CD2' HD23 ' A' ' 292' ' ' LEU . 5.8 m-85 -86.43 123.1 31.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -75.1 -4.63 39.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -63.87 -26.32 68.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.603 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -109.05 -172.13 1.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 5.5 p -85.34 3.48 39.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -77.26 66.79 3.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.4 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.7 pttm -75.19 -11.39 60.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.906 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.21 172.39 6.89 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.57 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -82.17 120.12 24.93 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -170.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 19.9 pt20 -111.71 165.37 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.691 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -85.34 160.37 19.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.504 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 3.6 t -61.33 -45.21 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.6 0.714 . . . . 0.0 109.471 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -58.12 -23.16 53.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -75.9 -52.01 11.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.009 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -68.11 -40.37 82.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.43 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.88 -38.74 76.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.615 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -70.71 -44.32 67.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.734 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.94 97.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.416 0.627 . . . . 0.0 110.623 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -92.66 28.66 1.96 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.459 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.1 p -55.18 -36.11 65.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.046 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 35.2 t -90.8 134.19 34.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.96 8.27 33.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.377 0.608 . . . . 0.0 111.218 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -179.12 124.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.643 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 250' ' ' GLN . 45.2 mt-10 -114.86 49.56 1.03 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.53 -24.75 61.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.646 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -83.33 -23.25 32.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.043 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 76.5 mt -121.99 -62.51 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 246' ' ' GLU . 20.8 tt0 -141.23 92.83 2.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 44.5 ttm -69.04 149.11 49.12 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 123.15 -46.32 1.11 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.541 -172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.1 m -58.71 111.86 1.42 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -173.23 147.56 1.56 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -172.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -78.31 38.33 0.29 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -89.84 -39.49 6.17 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.784 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.3 t80 -64.17 115.39 4.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.418 0.609 . . . . 0.0 109.699 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.76 19.31 44.45 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.388 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.4 t -66.92 -25.21 66.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.535 0.207 . . . . 0.0 111.312 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -99.17 -27.98 13.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.13 161.84 10.85 Favored Glycine 0 N--CA 1.434 -1.437 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.899 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -117.65 106.19 12.82 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.75 -0.725 . . . . 0.0 110.404 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.7 ttpp -90.56 119.32 30.72 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.1 0.476 . . . . 0.0 110.531 -175.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.9 tt -60.08 113.13 2.17 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.09 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 95.4 mt -86.25 -52.14 5.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.452 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.2 t -148.57 158.98 44.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.783 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.495 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 4.1 t60 -135.71 136.24 40.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -127.3 139.52 52.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.571 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.495 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 28.5 mt-10 -108.95 106.4 16.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.398 0.618 . . . . 0.0 110.063 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.3 t -127.11 178.02 6.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.637 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.44 121.0 66.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.352 0.596 . . . . 0.0 109.921 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 8.5 t -111.89 115.36 28.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.571 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.1 p90 52.68 30.51 8.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.625 0.77 . . . . 0.0 112.177 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 99.25 -10.24 61.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.256 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -106.45 125.57 51.16 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.682 -0.305 . . . . 0.0 111.021 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.4 m -65.21 134.33 53.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.4 m -133.82 152.95 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.992 0.901 . . . . 0.0 113.068 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 83.5 mt -93.33 114.08 26.42 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.985 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.8 ttmt -107.09 116.12 31.38 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.433 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 34.1 mt -119.88 131.23 55.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.205 -178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.6 m -95.45 114.95 26.77 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 171.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.563 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.4 m-85 -100.99 164.93 11.58 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.337 0.589 . . . . 0.0 112.471 -171.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 6.6 t70 -133.19 129.12 20.75 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.019 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 287' ' ' VAL . 83.6 Cg_endo -81.44 9.12 4.01 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 122.155 1.903 . . . . 0.0 112.348 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 -47.97 0.99 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -124.53 98.19 5.63 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.547 ' HA ' ' HD2' ' A' ' 284' ' ' PRO . 5.2 p -67.52 -6.98 5.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.464 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.28 -12.6 61.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.538 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -66.2 -37.18 84.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.38 126.98 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.467 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 287' ' ' VAL . 1.8 mt -59.97 135.32 57.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.179 0.489 . . . . 0.0 110.269 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.431 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.6 tm? -109.45 119.24 38.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 6.5 m -109.35 139.96 43.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 73.5 t -136.75 131.47 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -105.67 117.62 34.49 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.319 169.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 9.6 p -134.53 178.17 7.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.877 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -81.06 165.54 21.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.696 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -68.75 -22.91 64.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.839 -173.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -99.76 19.62 15.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.241 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.23 120.04 79.79 Favored Pre-proline 0 C--N 1.325 -0.492 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.351 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.5 136.46 13.93 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.482 2.122 . . . . 0.0 111.717 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 79.9 m-85 -124.2 124.96 43.61 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 8.0 t80 -77.53 93.07 4.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 332' ' ' ASP . 65.8 t -80.47 130.34 36.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.898 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.581 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 56.6 tttp -56.39 133.9 53.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.824 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.8 m-20 78.95 -17.13 0.61 Allowed 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.02 0.825 . . . . 0.0 112.283 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 327' ' ' GLU . 11.6 tttp -111.36 -41.86 4.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.073 0.463 . . . . 0.0 111.571 -175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 104.71 -155.13 17.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -61.66 113.61 2.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.96 0.41 . . . . 0.0 110.587 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.7 m -131.08 164.94 24.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.043 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 t -160.99 179.76 8.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.636 0.255 . . . . 0.0 110.771 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.433 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 67.3 m-85 -91.53 -34.32 14.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.035 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.07 70.31 40.77 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 42.4 Cg_exo -59.13 -30.49 93.3 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.792 2.328 . . . . 0.0 113.425 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 16.0 m -70.35 -25.31 63.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.28 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.9 tp -87.54 -42.36 12.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.296 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.2 m -53.87 -46.08 71.22 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.877 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.9 -27.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.14 -30.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.446 0.641 . . . . 0.0 110.417 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -92.85 -38.58 11.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.613 -173.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -114.67 -4.02 12.81 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 122.118 -0.364 . . . . 0.0 111.859 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.01 78.87 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 48.1 mt -118.67 111.26 37.87 Favored Pre-proline 0 C--N 1.327 -0.381 0 O-C-N 122.834 -0.216 . . . . 0.0 110.697 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.95 118.18 5.5 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.426 2.084 . . . . 0.0 110.82 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 85.0 m -117.76 153.94 32.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.3 0.571 . . . . 0.0 112.056 -171.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 69.0 m -89.6 166.26 13.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.848 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 25.2 tt0 -77.02 125.16 28.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.315 0.246 . . . . 0.0 111.194 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -80.64 168.0 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.791 175.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -133.06 151.1 52.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 37.1 mm -59.41 111.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.269 0.557 . . . . 0.0 109.717 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.56 1.15 21.64 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.413 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 304' ' ' VAL . 16.8 m-20 -79.0 128.75 33.66 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.457 0.646 . . . . 0.0 111.047 176.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.8 137.91 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.796 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 55.6 m -103.44 133.76 47.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.302 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.0 144.9 29.52 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.258 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.507 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.2 Cg_endo -87.98 166.09 7.12 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 123.143 2.562 . . . . 0.0 112.624 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 119.07 6.02 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.623 2.215 . . . . 0.0 111.157 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 118.34 -19.35 10.79 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.611 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -69.32 127.44 92.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.98 -13.98 40.66 Favored 'Trans proline' 0 N--CA 1.474 0.369 0 C-N-CA 123.178 2.585 . . . . 0.0 113.115 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.581 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 32.9 t70 -90.31 -23.25 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.302 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.83 87.36 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.054 0.454 . . . . 0.0 109.786 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.84 -44.16 92.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.603 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.18 80.15 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.914 -172.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.507 -178.29 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.483 0.859 0 N-CA-C 110.614 -0.571 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.5 t -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.1 p -85.94 149.6 25.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.83 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.2 mm -79.23 -43.31 23.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -151.99 137.56 17.78 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.549 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.506 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 25.7 t-80 54.54 -136.53 1.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 47.8 t -100.25 37.6 1.64 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.246 0.546 . . . . 0.0 110.145 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -111.12 137.14 49.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.347 0.594 . . . . 0.0 111.443 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.12 175.9 5.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.42 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -69.23 135.17 50.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.03 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.1 3.36 48.39 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.471 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.7 m -96.13 143.93 26.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.3 -0.45 . . . . 0.0 109.923 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -109.48 141.73 41.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.824 0.345 . . . . 0.0 110.548 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 46.5 mt -118.12 143.13 46.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.24 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.3 t -151.0 99.45 2.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.42 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.575 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 35.4 m-85 -91.97 132.41 36.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -78.94 -16.56 56.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.76 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 16.8 pttp -79.5 -18.79 51.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.411 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -93.44 173.61 7.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.2 m -80.91 7.6 10.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.271 0.558 . . . . 0.0 110.316 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -82.05 66.57 7.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.598 0.713 . . . . 0.0 110.011 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.584 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 12.0 pttp -62.11 -19.86 63.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.506 -1.224 . . . . 0.0 112.402 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.584 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 36.5 mt-10 -122.42 175.47 6.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -71.94 135.0 46.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.66 0.743 . . . . 0.0 112.75 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 18.4 pt20 -128.66 161.21 30.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.685 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -82.06 158.1 23.88 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.423 172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.6 t -58.25 -46.46 88.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.613 173.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 211' ' ' ILE . 25.6 mt-10 -57.55 -23.09 48.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.625 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.29 -45.94 14.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.0 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.727 ' CZ ' ' HG3' ' A' ' 255' ' ' LYS . 85.3 t80 -73.75 -35.91 65.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.983 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -66.29 -27.08 67.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.709 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 239' ' ' ARG . 34.0 ttm105 -62.58 -29.31 70.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.748 . . . . 0.0 109.691 173.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -85.67 -8.7 58.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.938 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.862 ' HA ' ' HD3' ' A' ' 255' ' ' LYS . . . -76.56 -7.52 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.318 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 32.0 m -71.91 -12.32 61.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.212 0.53 . . . . 0.0 110.118 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.8 m -90.3 152.55 20.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.67 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 245' ' ' ASN . 16.4 t70 -106.85 -169.18 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.456 ' H ' ' CG ' ' A' ' 244' ' ' ASP . 20.0 m120 -68.12 72.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -174.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.99 51.51 1.53 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 245' ' ' ASN . 25.2 mm-40 -59.94 -24.9 64.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.044 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.49 -20.27 57.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.111 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.35 107.03 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 121.644 0.735 . . . . 0.0 109.708 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -66.54 81.41 0.1 Allowed 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.661 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -157.88 46.79 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 107.27 100.92 2.68 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.962 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.1 p -104.73 -178.93 3.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -85.85 135.22 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.347 0.594 . . . . 0.0 110.113 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.862 ' HD3' ' HA ' ' A' ' 241' ' ' ALA . 10.1 mptt -87.81 42.42 1.05 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.101 -173.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -88.9 13.55 62.69 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -66.08 117.18 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.018 0.437 . . . . 0.0 109.872 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.15 27.52 12.08 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.022 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.0 p -68.84 -22.61 64.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -99.52 -27.15 13.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.26 0.552 . . . . 0.0 109.811 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 150.19 154.39 6.43 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.946 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 5.5 mp -113.25 98.66 7.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.952 -0.624 . . . . 0.0 111.02 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 8.4 tptp -77.99 115.62 17.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.476 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.5 tt -59.84 111.74 1.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 283' ' ' ASP . 82.8 mt -83.13 -51.87 7.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.061 0.458 . . . . 0.0 111.061 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.8 t -148.54 161.81 40.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.161 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -141.59 150.38 41.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.027 -168.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.79 135.58 12.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.884 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -87.18 106.06 17.63 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 47.2 t -111.75 -178.45 3.44 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.196 -168.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.07 133.01 61.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.2 t -122.32 87.14 2.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.293 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 58.49 55.4 4.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.665 175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.08 34.65 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.678 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.635 ' HG3' HG13 ' A' ' 277' ' ' VAL . 3.3 pt-20 -148.02 133.19 18.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.402 0.601 . . . . 0.0 111.07 177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -73.07 128.54 35.76 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.855 175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.635 HG13 ' HG3' ' A' ' 275' ' ' GLU . 8.9 m -134.6 157.07 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.695 0.76 . . . . 0.0 112.099 -175.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 90.0 mt -94.18 109.66 21.44 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.467 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -96.35 112.36 24.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.665 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 279' ' ' LYS . 29.6 mt -121.42 142.75 49.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.527 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 32.3 m -108.26 117.04 33.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 96.2 m-85 -105.6 157.45 17.39 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.554 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.461 ' HB2' HD21 ' A' ' 265' ' ' LEU . 7.2 t70 -126.82 132.79 24.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.714 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.4 5.55 5.74 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.017 1.811 . . . . 0.0 112.174 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.7 -13.29 42.33 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.2 t -153.89 133.13 12.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.057 0.456 . . . . 0.0 110.156 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.0 -8.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.098 0.475 . . . . 0.0 110.856 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -69.4 -23.2 63.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.314 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . 0.557 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 4.1 m-20 -90.87 -2.93 57.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.075 0.464 . . . . 0.0 110.248 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.07 169.95 29.62 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.949 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.5 mt -98.71 152.16 19.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.5 OUTLIER -126.4 120.47 29.88 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 292' ' ' LEU . 8.9 m -111.25 138.58 47.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 75.6 t -137.38 137.59 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.42 121.1 40.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.809 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 5.8 p -138.38 173.29 11.76 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -68.64 160.87 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.122 0.486 . . . . 0.0 111.23 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.711 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -64.62 -27.42 68.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.31 24.99 4.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.433 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -75.31 121.34 84.99 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.206 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.28 131.27 7.56 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.279 1.986 . . . . 0.0 111.805 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -121.82 116.62 24.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 29.1 t80 -73.25 108.69 6.27 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.896 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 74.1 t -99.12 137.96 25.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.427 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.718 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.0 tttp -56.78 124.46 18.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.792 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 77.95 -1.45 2.58 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.878 0.736 . . . . 0.0 112.177 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -117.16 -33.16 4.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 90.25 -157.13 25.64 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -60.87 113.02 2.28 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.294 0.547 . . . . 0.0 110.019 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.4 m -125.23 166.75 15.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.069 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.6 t -161.58 -178.58 6.68 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.437 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 33.3 m-85 -90.32 -41.48 11.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 110.292 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.35 77.31 68.37 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.948 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.416 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 60.4 Cg_exo -55.03 -38.7 93.27 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.042 2.495 . . . . 0.0 113.448 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 2.3 p -62.34 -24.96 67.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.253 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.74 -45.24 11.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.768 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.2 m -59.03 -39.78 83.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.094 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -70.31 -19.64 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.531 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.25 -40.21 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.295 0.569 . . . . 0.0 110.33 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.76 -58.28 3.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.771 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -95.51 -14.93 23.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.727 0.299 . . . . 0.0 111.284 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 84.33 10.31 80.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.876 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.8 mt -109.09 115.69 56.49 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.71 111.29 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.351 2.034 . . . . 0.0 110.184 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.8 m -108.48 157.18 18.67 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.987 -170.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 164.68 23.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.992 171.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.43 123.57 35.84 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.236 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.424 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.4 161.83 4.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.98 152.56 51.9 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 38.9 mm -54.87 114.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.075 0.464 . . . . 0.0 110.742 -174.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.64 -3.59 19.69 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.714 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.418 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 4.2 m-20 -75.42 128.15 34.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.531 0.665 . . . . 0.0 111.161 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 305' ' ' LYS . 0.9 OUTLIER -87.48 131.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.586 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 42.3 t -95.14 134.7 37.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.975 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.62 145.34 30.84 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.154 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.9 Cg_endo -87.95 166.44 7.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.833 2.355 . . . . 0.0 112.188 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.88 126.3 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.588 2.192 . . . . 0.0 111.35 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.69 -12.99 35.49 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.773 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.11 131.44 81.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.86 -33.25 87.96 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.43 2.754 . . . . 0.0 113.504 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -79.26 -22.3 44.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.57 0.224 . . . . 0.0 111.051 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.8 84.36 4.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 98.8 mt -73.49 -46.2 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.245 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.54 52.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.683 0.278 . . . . 0.0 110.284 -169.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.83 -177.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.484 0.925 0 N-CA-C 110.688 -0.543 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 25.1 t -100.38 85.85 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.052 0.454 . . . . 0.0 110.18 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.2 p -85.78 142.02 29.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.7 mm -88.6 -45.34 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.203 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.504 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 78.8 t90 -151.64 130.12 12.17 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.529 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.4 t-80 55.68 -144.99 0.64 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 30.6 t -94.79 44.74 1.1 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.357 0.599 . . . . 0.0 109.898 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -115.38 136.66 52.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.298 0.57 . . . . 0.0 111.155 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.89 174.45 6.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.297 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -63.63 133.76 54.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.036 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.11 19.17 34.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.802 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.591 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.8 m -104.51 149.13 25.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 294' ' ' VAL . 8.9 mtt180 -113.6 138.67 49.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.93 0.395 . . . . 0.0 111.471 -177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 67.7 mt -117.6 145.93 43.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.973 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 228' ' ' ASN . 9.1 t -156.46 95.57 1.58 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.871 0.367 . . . . 0.0 110.643 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -86.21 118.1 25.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 228' ' ' ASN . 13.5 m170 -66.5 -16.99 64.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.179 0.514 . . . . 0.0 110.656 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.38 -31.74 70.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.408 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 227' ' ' SER . 4.1 pt-20 -145.27 -95.05 0.1 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.563 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 22.9 t -77.22 61.17 2.06 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.667 ' HA ' ' SG ' ' A' ' 222' ' ' CYS . 7.2 p30 -102.57 26.13 8.29 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.626 -0.671 . . . . 0.0 112.318 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 19.9 pttp -92.01 -29.81 16.4 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.857 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 35.9 mt-10 -131.83 176.88 7.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.081 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 222' ' ' CYS . 52.8 m95 -99.09 109.63 22.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.857 170.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.5 pt20 -97.91 157.21 16.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.462 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.72 162.96 21.61 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.591 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -61.38 -51.34 74.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.145 0.497 . . . . 0.0 109.811 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 36.9 mt-10 -56.34 -22.88 33.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.585 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.33 -45.34 32.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.286 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 70.1 t80 -75.96 -41.04 52.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.12 0.486 . . . . 0.0 110.474 176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.73 68.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 8.7 ttm180 -69.06 -34.06 74.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.065 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -74.4 -13.08 60.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.932 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -88.87 15.56 8.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.882 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 2.0 p -63.76 -59.06 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 32.0 t -90.73 78.83 6.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.95 57.85 4.08 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.323 0.582 . . . . 0.0 111.554 -168.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -170.14 42.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.699 0.761 . . . . 0.0 110.724 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.665 ' H ' ' HB ' ' A' ' 253' ' ' THR . 12.5 mm-40 -86.68 45.49 1.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.003 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.97 -54.04 6.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.478 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -69.1 -32.16 71.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.87 -57.76 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.779 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -93.35 -64.91 1.04 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.622 -172.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -168.12 -70.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.053 0.454 . . . . 0.0 110.169 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.48 71.29 0.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.627 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 246' ' ' GLU . 22.0 m -93.02 110.29 21.76 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.944 -0.151 . . . . 0.0 110.639 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -159.85 139.52 11.36 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.515 0.674 . . . . 0.0 111.134 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 255' ' ' LYS . 33.6 ttmt -75.12 41.14 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.549 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -115.85 -9.05 12.8 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.963 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.3 t80 -73.25 117.65 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.721 0.76 . . . . 0.0 109.999 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.49 67.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.978 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 53.0 m -70.15 -7.13 39.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.785 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -103.51 -31.58 9.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.275 0.56 . . . . 0.0 109.672 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 157.04 153.69 6.76 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.027 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.57 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.2 mp -119.17 103.33 9.43 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.604 0.361 . . . . 0.0 110.652 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 33.8 ttpt -86.7 123.73 32.18 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.004 0.431 . . . . 0.0 111.06 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.404 ' HG ' HD13 ' A' ' 280' ' ' LEU . 2.7 tt -65.36 97.75 0.3 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.654 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 283' ' ' ASP . 88.1 mt -71.63 -49.49 39.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.901 0.381 . . . . 0.0 110.461 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.1 t -151.46 165.95 32.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.274 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.758 ' HD2' ' HE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -131.44 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.618 -169.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -140.82 121.66 14.46 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.59 99.66 9.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.204 0.526 . . . . 0.0 109.841 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.6 t -117.82 178.76 4.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.92 -172.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.4 t -118.13 116.78 27.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.777 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 29.2 p90 52.29 19.34 1.09 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.824 1.25 . . . . 0.0 112.483 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 116.18 -21.23 12.17 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.809 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -97.56 129.12 44.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.644 0.259 . . . . 0.0 111.03 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.8 m -67.62 131.26 45.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.15 154.75 41.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.759 0.79 . . . . 0.0 112.421 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 84.6 mt -92.5 107.42 19.2 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.729 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 39.0 ttmt -106.69 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.469 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . 43.6 mt -118.19 135.45 54.24 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.3 m -91.47 110.28 21.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 90.3 m-85 -99.7 162.15 13.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.095 0.474 . . . . 0.0 111.48 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.421 ' HB2' HD21 ' A' ' 265' ' ' LEU . 22.1 t70 -130.65 135.25 27.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.316 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -81.28 11.12 3.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.162 1.908 . . . . 0.0 112.43 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.26 -8.87 62.87 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.7 t -153.33 106.02 2.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.481 -0.86 . . . . 0.0 109.537 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.94 -8.88 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.497 0.665 . . . . 0.0 110.914 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.99 -26.31 68.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.104 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.34 -44.31 25.5 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 141.17 153.32 5.93 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.474 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -74.34 143.33 44.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.854 0.359 . . . . 0.0 110.592 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -123.06 118.75 28.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 140.84 41.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.9 t -134.14 131.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -104.19 118.6 37.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 12.3 p -136.13 165.33 25.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.668 0.271 . . . . 0.0 111.493 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -61.72 162.13 9.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.208 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.62 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.8 mm? -70.79 -21.31 62.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 -175.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.0 22.5 10.19 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.136 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -74.16 119.14 74.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.339 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.24 134.47 9.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.203 1.935 . . . . 0.0 111.713 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.513 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -120.71 119.4 32.68 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 35.8 t80 -75.13 93.55 2.8 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.23 176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 332' ' ' ASP . 71.5 t -79.87 138.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.728 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 333' ' ' VAL . 57.4 tttp -61.26 134.88 57.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.226 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 7.1 m-20 76.27 -33.36 0.21 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.562 0.745 . . . . 0.0 112.087 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -86.68 -43.86 12.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.787 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 98.18 -155.96 20.36 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -171.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.99 112.89 1.65 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.037 0.419 . . . . 0.0 110.459 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.428 ' CB ' HG22 ' A' ' 328' ' ' ILE . 17.7 m -129.84 165.66 21.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.697 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.3 t -161.57 -176.88 5.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.586 0.231 . . . . 0.0 110.389 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.758 ' HE2' ' HD2' ' A' ' 267' ' ' HIS . 36.6 m-85 -92.91 -40.93 10.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.88 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -120.99 76.38 30.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.298 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.1 Cg_exo -57.27 -35.51 98.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.908 2.405 . . . . 0.0 113.148 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 3.7 p -65.19 -26.06 67.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.9 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 62.7 tp -87.8 -47.08 8.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.278 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.2 m -57.87 -38.6 76.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.103 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.569 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.6 p -68.79 -20.23 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.017 0.437 . . . . 0.0 111.464 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 93.3 t -86.99 -49.85 14.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.269 0.557 . . . . 0.0 109.816 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -67.41 -55.59 13.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.158 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -100.68 -9.68 21.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.765 0.317 . . . . 0.0 111.12 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.23 15.91 80.36 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.592 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.0 mt -110.87 114.49 54.22 Favored Pre-proline 0 C--N 1.324 -0.537 0 O-C-N 122.846 -0.208 . . . . 0.0 110.798 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.49 104.64 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.57 2.18 . . . . 0.0 110.33 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.5 m -104.39 154.07 20.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.046 -169.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.7 165.1 23.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.946 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -89.36 123.91 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.219 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.2 160.92 4.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -134.16 154.68 51.07 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 49.3 mm -52.29 115.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.324 0.583 . . . . 0.0 111.426 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.28 -2.9 22.27 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 113.073 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.432 ' HB3' ' CG1' ' A' ' 304' ' ' VAL . 6.5 m-20 -75.29 124.58 27.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.305 0.553 . . . . 0.0 110.78 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -86.76 143.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 55.8 m -112.16 132.52 54.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.985 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 82.1 mt -100.64 147.65 33.92 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.705 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.529 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 55.1 Cg_endo -91.89 170.33 2.87 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.495 2.797 . . . . 0.0 112.828 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.74 133.17 23.19 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.534 2.156 . . . . 0.0 111.38 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.74 55.85 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.629 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -77.73 125.2 86.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.95 -21.73 73.37 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.047 2.498 . . . . 0.0 112.823 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 34.0 t70 -80.0 -27.38 39.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.683 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.36 88.85 3.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.816 169.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 83.7 mt -71.74 -43.49 69.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.368 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -114.41 73.93 0.85 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.598 -178.65 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 N--CA 1.479 0.662 0 N-CA-C 110.118 -0.762 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -100.4 87.79 3.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -82.97 143.9 30.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.945 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.11 -42.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.34 0.591 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -148.08 135.21 20.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.167 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.52 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 30.9 t-80 55.15 -135.01 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.458 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 12.0 p -97.64 24.4 6.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -104.6 139.83 38.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 112.064 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 174.94 6.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.391 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -67.57 140.53 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.607 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.82 11.1 54.35 Favored Glycine 0 N--CA 1.454 -0.109 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.976 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.573 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 80.9 m -103.34 146.92 27.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -113.99 139.88 48.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.938 0.399 . . . . 0.0 110.779 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.532 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.6 mt -116.17 146.47 42.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.375 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.1 96.45 1.95 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.18 119.18 29.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -69.72 -9.53 54.79 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.969 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -60.91 -30.71 70.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.892 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -113.75 -175.8 2.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.258 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.2 t -88.68 7.65 32.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.866 0.365 . . . . 0.0 110.82 -176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -83.08 75.94 9.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -76.41 -21.03 56.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.751 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -97.73 150.81 20.81 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.83 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.409 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 89.3 m95 -70.15 123.52 21.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -166.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 7.9 pt20 -108.96 161.55 15.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.541 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.13 162.91 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.43 -47.15 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.18 -22.22 50.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.75 -55.22 5.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.531 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.568 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 76.3 t80 -65.04 -41.0 95.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.593 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.83 -33.5 71.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.602 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -69.78 -44.37 70.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.445 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.392 0.615 . . . . 0.0 110.716 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.48 21.14 4.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.103 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.8 t -66.4 -38.51 87.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 27.0 m -78.99 120.89 24.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -101.94 5.14 40.68 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.824 -170.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -152.65 120.3 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.311 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -134.45 25.22 3.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.845 0.831 . . . . 0.0 108.796 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.97 -15.79 61.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.899 -173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.43 -33.09 48.8 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.6 mt -74.4 -63.4 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.43 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 177.76 -51.42 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.21 0.528 . . . . 0.0 110.465 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 51.7 tpp -69.5 133.82 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.867 -173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -79.5 53.66 4.27 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.674 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 10.7 m -66.94 120.56 13.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.494 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -174.12 151.77 1.75 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -85.67 37.67 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -70.52 -29.49 69.79 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.62 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 24.5 t80 -68.44 100.58 1.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.512 0.656 . . . . 0.0 110.239 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 106.48 6.94 35.28 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.549 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.9 m -67.1 -14.15 62.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 111.409 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.99 -30.82 11.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 0.0 109.294 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 149.3 161.15 9.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.526 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -122.6 99.1 6.22 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 122.483 0.313 . . . . 0.0 110.711 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 68.2 tttt -82.37 123.63 29.28 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.134 0.493 . . . . 0.0 111.525 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.97 95.35 0.26 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.584 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 283' ' ' ASP . 77.9 mt -71.47 -47.38 56.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 0.0 110.565 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.8 t -151.24 162.55 40.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.444 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.97 143.32 40.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.049 -168.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -149.57 137.49 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.366 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -98.99 97.17 8.35 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 p -99.83 176.67 5.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.409 -171.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.1 p -114.59 127.42 72.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.605 171.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 7.7 t -141.36 130.71 23.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 60.79 26.24 16.07 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.44 0.463 . . . . 0.0 111.718 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.91 2.06 86.56 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.782 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -121.27 153.75 37.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.902 0.382 . . . . 0.0 110.612 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.3 m -77.7 134.75 38.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.683 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.8 m -132.17 156.85 42.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.661 0.744 . . . . 0.0 112.062 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.34 107.57 19.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.382 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.1 ttmm -98.94 106.25 18.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 312' ' ' PHE . 21.1 mt -112.95 138.04 50.41 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.529 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 4.1 m -103.09 110.19 22.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.465 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 92.1 m-85 -100.33 162.66 12.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.032 0.444 . . . . 0.0 111.849 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.441 ' HB2' HD21 ' A' ' 265' ' ' LEU . 14.6 t70 -128.89 134.44 26.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.14 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 76.8 Cg_endo -80.0 12.55 2.43 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.259 1.973 . . . . 0.0 112.291 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.76 -14.45 49.61 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.3 t -153.15 127.42 9.16 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.822 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.28 -8.45 11.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.215 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -50.74 -41.06 56.04 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.996 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -77.05 -43.51 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.209 -173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.89 167.51 11.52 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.67 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 83.2 mt -90.24 140.56 29.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 0.0 111.192 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -113.05 122.85 48.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.488 ' N ' HD22 ' A' ' 292' ' ' LEU . 20.8 m -111.67 135.18 52.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 85.0 t -133.06 136.27 55.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.066 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.409 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 52.8 mt-10 -115.57 121.94 44.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 109.772 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.5 p -138.56 175.34 9.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.748 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -70.03 158.21 36.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.998 0.427 . . . . 0.0 110.832 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.709 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -64.77 -17.07 63.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.282 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -97.49 13.58 29.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.88 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -72.26 120.98 83.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.574 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.85 141.52 13.46 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.239 1.959 . . . . 0.0 111.662 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.504 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.1 m-85 -127.84 127.27 43.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.551 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 31.2 t80 -80.09 96.32 6.46 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.994 -0.683 . . . . 0.0 109.34 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.6 t -82.31 130.88 35.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.907 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.462 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.1 tttp -55.86 134.21 51.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.35 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.2 m120 77.64 -23.08 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.872 0.733 . . . . 0.0 112.202 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -96.08 -43.49 7.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.434 . . . . 0.0 111.446 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.56 -126.27 8.43 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.24 118.47 29.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.804 0.802 . . . . 0.0 109.958 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 20.1 m -131.45 166.57 21.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.527 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.0 t -161.52 -175.57 4.84 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.454 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 48.2 m-85 -92.77 -41.45 10.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 0.0 110.403 177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -122.53 76.64 45.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.076 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 77.6 Cg_exo -55.25 -31.48 76.58 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.246 2.631 . . . . 0.0 113.597 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 33.9 t -71.22 -23.21 61.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.257 0.551 . . . . 0.0 110.096 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 61.2 tp -87.89 -44.85 10.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.116 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.3 m -54.5 -41.03 69.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.028 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.542 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -73.41 -18.28 17.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.625 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 96.1 t -88.24 -35.64 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.317 0.58 . . . . 0.0 110.013 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -85.26 -53.23 5.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.128 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -103.84 -4.04 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 110.805 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 70.02 26.33 74.45 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.564 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.5 mt -116.63 110.97 41.84 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 122.753 -0.263 . . . . 0.0 110.59 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -71.79 115.83 4.46 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.493 2.129 . . . . 0.0 110.399 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 73.7 m -116.96 156.98 26.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.437 0.637 . . . . 0.0 111.977 -169.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 58.6 m -79.99 165.95 22.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.255 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.59 140.42 29.57 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.89 164.69 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.357 0.599 . . . . 0.0 110.62 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -118.78 142.35 47.78 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 30.8 mm -60.22 114.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 109.843 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.3 -4.24 20.07 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.956 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.537 ' HB3' HG13 ' A' ' 304' ' ' VAL . 70.7 m-20 -73.84 130.55 40.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.171 0.51 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.728 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.97 133.29 33.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.057 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 50.9 m -98.12 134.83 40.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.142 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 43.8 mt -108.94 142.06 24.71 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.041 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.52 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.2 Cg_endo -85.06 168.43 10.53 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.325 2.683 . . . . 0.0 112.362 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 56.6 Cg_endo -71.37 114.3 3.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.797 2.332 . . . . 0.0 111.687 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.01 -20.67 8.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.813 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -67.11 126.66 92.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.64 -27.25 50.28 Favored 'Trans proline' 0 N--CA 1.476 0.453 0 C-N-CA 123.721 2.947 . . . . 0.0 113.738 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.96 -22.96 41.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.326 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.14 85.99 3.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.165 0.507 . . . . 0.0 110.254 174.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.63 -43.88 70.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.572 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -107.04 42.52 1.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.763 0.316 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 1.1 t80 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.941 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.48 0.725 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.6 t -86.19 92.06 8.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.079 0.466 . . . . 0.0 110.161 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.7 p -79.15 147.07 32.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 27.5 mm -79.5 -45.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.62 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -149.4 132.73 16.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.0 t-80 57.19 -139.46 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 44.5 t -97.5 36.74 1.45 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.384 0.612 . . . . 0.0 110.202 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.56 140.73 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 111.701 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.99 170.83 8.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -67.57 133.68 49.87 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.957 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.07 -4.17 44.99 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.49 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.575 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 87.7 m -86.65 142.07 28.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -110.62 136.78 49.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.172 0.511 . . . . 0.0 110.941 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.566 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 57.1 mt -112.41 147.48 36.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.967 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.0 t -150.87 93.01 1.89 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.97 0.414 . . . . 0.0 110.234 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CD2' ' HG ' ' A' ' 292' ' ' LEU . 78.3 m-85 -83.57 119.14 24.36 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -69.23 -16.22 63.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.062 0.458 . . . . 0.0 110.559 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -79.75 -7.55 58.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.239 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 68.6 mm-40 -104.92 174.92 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.126 0.488 . . . . 0.0 110.742 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.6 m -82.56 -3.98 56.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.554 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -94.74 90.44 6.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.126 0.488 . . . . 0.0 110.741 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -77.88 -36.53 49.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.18 0.99 . . . . 0.0 108.652 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 230' ' ' GLU . 5.1 mp0 -62.06 155.47 23.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.669 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -74.42 138.84 43.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.176 0.512 . . . . 0.0 112.372 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.706 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 10.0 pt20 -128.07 165.16 20.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.39 176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.5 163.86 15.05 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.233 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.0 t -58.46 -51.5 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -58.01 -23.44 54.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.18 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 232' ' ' GLN . 31.9 t70 -73.58 -45.29 54.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.297 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.706 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.4 t80 -75.1 -45.41 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.49 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -55.72 -43.83 76.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.499 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.68 -34.54 74.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.524 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.28 -16.66 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.72 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' A' ' 253' ' ' THR . . . -90.87 18.69 6.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.055 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 41.0 m -57.98 -36.59 72.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.276 0.56 . . . . 0.0 109.608 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.2 t -90.7 151.26 21.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -114.55 -8.06 12.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.064 0.935 . . . . 0.0 109.76 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -152.28 139.56 19.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.685 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.9 70.7 1.46 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.24 -22.52 38.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.321 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -81.08 -0.51 40.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.623 0.725 . . . . 0.0 110.23 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 4.8 mt -139.09 150.44 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -71.41 69.45 0.58 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.171 0.51 . . . . 0.0 109.821 171.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 17.1 tpt -153.8 161.22 42.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.06 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -152.61 94.26 0.15 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.776 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.426 HG21 ' HA ' ' A' ' 241' ' ' ALA . 2.9 m -66.74 -80.14 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.404 ' H ' ' HB ' ' A' ' 253' ' ' THR . 17.3 t60 64.1 93.05 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.952 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -69.53 -11.38 60.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.895 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -63.01 -13.86 50.26 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.779 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 23.0 t80 -65.28 105.84 1.21 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.376 0.588 . . . . 0.0 109.79 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.82 8.65 59.15 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.011 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.7 m -67.79 -15.86 63.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -102.88 -31.69 10.14 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 164.08 156.77 9.0 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.217 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.7 mp -119.97 103.75 9.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.709 -0.746 . . . . 0.0 110.163 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 21.8 ttpp -88.29 119.35 28.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.269 0.557 . . . . 0.0 111.339 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.401 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.7 tt -62.12 103.67 0.4 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.347 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 283' ' ' ASP . 86.7 mt -76.2 -49.17 17.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.898 0.38 . . . . 0.0 110.528 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 34.4 t -153.11 164.02 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.539 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -141.44 135.75 30.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.224 -176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 41.2 tt0 -130.14 137.54 50.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.245 172.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.39 124.43 34.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t -138.28 178.53 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.628 -167.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.14 130.44 69.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.1 t -134.34 122.61 22.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 59.47 35.45 22.87 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.375 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 77.02 3.69 81.71 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.938 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.606 ' HB3' ' HE2' ' A' ' 297' ' ' LYS . 46.2 mt-10 -112.12 136.37 51.59 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.5 m -71.04 134.61 47.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.071 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.83 156.57 31.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.017 0.913 . . . . 0.0 112.861 -174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 79.1 mt -95.51 116.25 28.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.974 -1.467 . . . . 0.0 108.639 172.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 268' ' ' GLU . 40.4 ttmt -100.65 112.25 24.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 19.3 mt -118.45 130.34 55.9 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.025 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 31.4 m -97.97 111.01 23.48 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.5 m-85 -96.94 162.48 13.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.332 0.587 . . . . 0.0 111.872 -172.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.451 ' HB2' HD21 ' A' ' 265' ' ' LEU . 4.1 t70 -127.85 127.45 23.94 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.49 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 80.0 Cg_endo -79.45 10.12 3.17 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.181 1.92 . . . . 0.0 112.067 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.7 -15.03 53.16 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.8 t -153.85 135.07 14.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.197 0.522 . . . . 0.0 110.667 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.32 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.131 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -58.87 -32.12 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.861 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -84.2 -47.13 11.14 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.524 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.43 159.49 7.96 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.794 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.1 151.17 25.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 0.0 110.917 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CD2' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -119.68 123.4 43.72 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 26.0 m -110.27 130.92 55.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.51 131.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.384 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.52 118.38 34.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.453 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.6 p -134.58 164.0 28.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.732 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.606 ' HE2' ' HB3' ' A' ' 275' ' ' GLU . 33.7 mmtp -66.17 157.85 30.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.364 0.602 . . . . 0.0 111.109 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.77 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.5 mm? -61.59 -23.83 66.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.212 -168.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.71 23.2 5.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.516 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.37 121.09 84.27 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.538 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.56 130.66 7.96 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.286 1.991 . . . . 0.0 111.609 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 90.8 m-85 -120.66 114.2 21.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 25.4 t80 -73.3 102.45 3.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.327 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 332' ' ' ASP . 55.2 t -88.7 136.04 24.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.255 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.656 ' HG3' ' OD2' ' A' ' 341' ' ' ASP . 54.4 tttp -57.93 124.46 19.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.905 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 14.9 m120 76.81 -5.21 2.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.366 0.666 . . . . 0.0 112.392 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -110.85 -32.25 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.14 0.495 . . . . 0.0 111.403 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 90.92 -152.68 21.9 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -64.74 112.38 3.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 117.18 0.49 . . . . 0.0 110.382 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.491 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.4 m -125.33 165.26 18.69 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.0 t -161.48 -177.84 6.22 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 65.3 m-85 -93.0 -39.34 11.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.523 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -123.74 73.73 54.02 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.748 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -54.97 -37.05 93.75 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.176 2.584 . . . . 0.0 113.356 -175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.2 m -64.74 -25.75 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.232 0.539 . . . . 0.0 110.693 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.1 tp -87.25 -44.3 11.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.963 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 8.2 m -55.18 -41.86 72.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.993 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.8 p -70.77 -26.65 28.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.66 -35.16 18.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 110.358 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -84.32 -58.44 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.917 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.48 -10.98 24.36 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 78.04 25.65 61.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.615 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.6 mt -122.71 113.11 30.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 122.849 -0.206 . . . . 0.0 110.877 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.85 119.41 6.3 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.423 2.082 . . . . 0.0 110.365 173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 68.2 m -117.37 156.11 28.43 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.15 0.5 . . . . 0.0 112.141 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 57.5 m -79.71 164.45 23.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.104 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -93.76 115.79 28.23 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.491 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -66.46 165.23 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 111.229 -173.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -122.26 140.37 52.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.721 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.32 115.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.221 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.3 -2.27 22.27 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.908 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.442 ' HB3' HG13 ' A' ' 304' ' ' VAL . 44.0 m-20 -75.23 132.95 41.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.33 0.586 . . . . 0.0 111.34 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -93.68 135.16 29.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.964 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 51.1 m -100.81 132.69 46.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.463 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.424 HD11 ' OD2' ' A' ' 341' ' ' ASP . 76.0 mt -100.18 144.85 29.2 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.273 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 86.1 Cg_endo -87.63 165.04 7.78 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.099 2.532 . . . . 0.0 112.744 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.99 113.49 3.05 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.921 2.414 . . . . 0.0 111.572 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 124.83 -23.22 6.29 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.952 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -65.79 128.0 93.5 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.9 -20.24 64.31 Favored 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 123.127 2.551 . . . . 0.0 112.495 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.656 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 23.2 t0 -79.32 -26.03 42.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.967 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -72.16 98.89 2.22 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 70.0 mt -66.53 -39.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.899 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.99 103.64 4.2 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.459 -176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.005 -178.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.479 0.675 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -107.99 109.41 20.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.0 p -96.28 147.4 23.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.384 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mm -79.73 -40.54 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.382 0.61 . . . . 0.0 109.817 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 71.4 t90 -156.7 134.52 10.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.924 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.473 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 27.3 t-80 57.5 -142.42 0.72 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 49.1 t -96.98 37.29 1.32 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.465 0.65 . . . . 0.0 110.157 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.89 133.32 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.59 171.55 8.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.546 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -61.57 131.15 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.933 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.13 12.55 31.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.286 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 52.2 m -103.5 149.94 24.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.6 mpt_? -119.67 144.73 47.03 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 110.937 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.4 mt -118.99 147.81 43.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.24 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 42.4 t -158.11 98.16 1.57 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.153 0.502 . . . . 0.0 110.811 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.556 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 27.5 m-85 -81.86 126.26 31.67 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -66.66 -28.91 68.84 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 16.2 pttm -81.62 -5.19 57.82 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.083 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 65.4 mm-40 -97.73 160.67 14.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.852 0.358 . . . . 0.0 110.175 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 4.6 m -84.65 32.09 0.52 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.414 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.03 103.02 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.185 0.517 . . . . 0.0 110.871 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -88.15 -46.5 9.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.706 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.21 148.59 44.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.363 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -71.22 117.2 12.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.712 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.5 pt20 -97.32 155.42 16.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -82.53 161.8 22.21 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.0 t -63.59 -38.21 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 170.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -21.84 64.72 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.242 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -80.93 -50.33 9.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.443 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.477 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 63.8 t80 -65.84 -46.1 79.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.717 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.89 71.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 110.478 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -67.25 -44.9 78.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.272 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.98 71.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.409 0.623 . . . . 0.0 110.565 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 244' ' ' ASP . . . -90.59 21.58 3.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 8.3 t -76.94 -33.33 57.71 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 30.8 m -83.21 60.71 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.553 ' OD1' ' HA ' ' A' ' 254' ' ' HIS . 37.4 t70 -84.56 52.48 2.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.5 -168.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -176.37 47.84 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.589 ' HB2' HG21 ' A' ' 253' ' ' THR . 43.1 mt-10 -81.15 38.72 0.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.684 -0.635 . . . . 0.0 110.372 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.46 -23.4 66.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.102 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.42 -37.16 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.153 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.658 HG22 ' HG2' ' A' ' 250' ' ' GLN . 71.3 mt -93.38 -57.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.404 -175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' A' ' 249' ' ' ILE . 18.4 mm-40 -120.68 141.46 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.915 0.388 . . . . 0.0 110.985 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 14.6 tpt -74.55 70.07 1.76 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.144 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 144.89 88.33 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.631 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 246' ' ' GLU . 11.3 m -146.15 81.18 1.58 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.553 ' HA ' ' OD1' ' A' ' 244' ' ' ASP . 42.4 t60 -161.23 135.9 7.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.761 -178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -67.34 39.52 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -91.87 4.65 78.81 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.164 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 32.4 t80 -69.41 108.09 3.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.67 11.14 55.88 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.494 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 50.7 m -65.56 -11.01 40.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -104.7 -34.16 8.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.285 0.564 . . . . 0.0 109.808 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 169.47 154.01 8.88 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.923 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.3 mp -122.63 99.82 6.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.778 176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.703 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.5 ttpt -83.93 122.28 28.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.234 0.54 . . . . 0.0 110.942 -175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.437 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 2.3 tt -65.24 110.4 2.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.899 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 80.1 mt -85.12 -44.66 12.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.714 0.292 . . . . 0.0 111.161 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.6 t -153.12 157.19 40.01 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.96 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.3 OUTLIER -133.46 142.84 48.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.022 -170.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -149.23 125.95 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.646 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.73 120.8 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.8 t -139.23 179.66 6.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.319 -171.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.09 138.42 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.3 t -140.82 113.38 8.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.756 0.312 . . . . 0.0 110.25 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 57.87 42.5 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.507 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 95.87 -26.47 20.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.443 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -103.51 138.35 40.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.084 0.442 . . . . 0.0 111.031 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.44 ' HB2' HD21 ' A' ' 298' ' ' LEU . 67.4 m -74.09 131.26 41.15 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.8 m -131.46 157.82 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.847 0.832 . . . . 0.0 112.566 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 95.8 mt -95.57 112.89 24.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.741 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 19.5 ttmm -99.39 105.5 17.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.542 HD11 ' HE1' ' A' ' 312' ' ' PHE . 22.1 mt -113.12 139.69 48.52 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.524 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 24.8 m -101.16 110.6 22.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.9 m-85 -100.85 158.53 15.91 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 0.0 111.685 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 9.7 t70 -124.94 135.96 27.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.362 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.576 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -83.44 9.81 3.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.948 1.765 . . . . 0.0 112.431 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.09 -6.15 53.59 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -153.26 125.19 7.86 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.343 0.592 . . . . 0.0 110.467 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -10.3 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.37 -35.45 80.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.919 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . 0.469 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 10.7 t70 -76.17 -46.9 26.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.204 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.02 166.2 10.7 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.442 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.93 146.2 28.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.915 0.388 . . . . 0.0 110.686 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.451 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER -119.46 121.13 38.75 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.8 m -106.96 132.14 53.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 88.1 t -131.15 135.28 60.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.055 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -114.61 122.05 45.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.078 172.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.473 ' HB3' HG23 ' A' ' 219' ' ' THR . 6.3 p -136.03 175.07 9.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.461 ' HB3' ' OD1' ' A' ' 299' ' ' ASP . 10.5 mmmm -66.19 157.53 31.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.488 0.185 . . . . 0.0 111.056 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.834 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.1 mm? -60.8 -37.27 81.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.837 0.827 . . . . 0.0 109.677 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HB3' ' A' ' 297' ' ' LYS . 6.6 p-10 -80.79 24.52 0.48 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.08 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -82.92 119.65 74.73 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.347 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -79.06 132.8 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.078 1.852 . . . . 0.0 111.682 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -119.8 118.25 30.34 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 342' ' ' ALA . 2.5 t80 -72.32 102.81 3.22 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.142 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.42 135.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.307 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.569 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.9 tttp -61.17 134.57 57.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.083 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.1 m120 76.61 -6.45 2.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.531 0.732 . . . . 0.0 112.246 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -119.04 -47.75 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 106.64 -147.25 16.18 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . 0.461 ' HZ2' ' HA ' ' A' ' 345' ' ' PHE . 98.9 m95 -72.85 102.14 3.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.679 0.739 . . . . 0.0 110.974 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.499 ' CB ' HG22 ' A' ' 328' ' ' ILE . 5.6 m -106.47 172.51 6.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.737 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.1 t -163.04 179.2 7.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.532 0.206 . . . . 0.0 110.625 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.542 ' HE1' HD11 ' A' ' 280' ' ' LEU . 32.0 m-85 -92.84 -35.26 13.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 298' ' ' LEU . 93.0 m-85 -125.25 74.35 67.68 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.454 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 62.5 Cg_exo -55.09 -33.65 84.49 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.179 2.586 . . . . 0.0 113.534 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 35.9 t -74.85 -22.07 58.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.975 0.417 . . . . 0.0 110.257 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 47.6 tp -87.88 -45.75 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.155 0.502 . . . . 0.0 110.311 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -52.91 -37.17 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.974 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.69 -24.83 13.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.713 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.82 -33.81 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.425 0.631 . . . . 0.0 110.456 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -101.99 -54.37 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.432 -172.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -91.67 -8.05 48.19 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.161 -0.337 . . . . 0.0 110.736 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 71.58 16.94 76.1 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.378 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.8 mt -110.04 110.41 58.75 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.41 105.33 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.495 2.13 . . . . 0.0 110.445 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 84.4 m -101.47 159.18 15.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 112.369 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 1.4 p -85.83 159.68 19.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.416 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -79.93 125.61 29.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.499 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.82 168.36 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.386 -0.525 . . . . 0.0 109.816 177.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -133.37 146.67 51.48 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.537 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 41.3 mm -54.46 113.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.374 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.57 -4.37 19.52 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.419 -176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.52 121.42 17.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.155 0.502 . . . . 0.0 110.467 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -84.74 133.05 30.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.691 0.758 . . . . 0.0 112.115 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 47.3 t -95.39 134.79 37.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.376 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 69.1 mt -105.62 144.57 29.11 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.853 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -86.94 163.51 8.88 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.803 2.336 . . . . 0.0 112.142 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.17 121.42 8.73 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 112.047 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.01 31.98 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.491 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.429 ' CD2' ' HD2' ' A' ' 340' ' ' PRO . 25.3 t-80 -75.18 134.08 74.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . 0.429 ' HD2' ' CD2' ' A' ' 339' ' ' HIS . 11.7 Cg_endo -54.73 -28.8 58.86 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.975 3.117 . . . . 0.0 114.0 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.27 -35.15 48.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 303' ' ' TYR . . . -70.52 98.74 1.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.888 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 62.4 mt -73.88 -45.66 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.256 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -131.18 94.51 3.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.461 ' HA ' ' HZ2' ' A' ' 309' ' ' TRP . 3.5 t80 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.594 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 N--CA 1.481 0.78 0 N-CA-C 110.769 -0.512 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 99.41 10.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.6 p -85.79 145.29 27.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.905 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.456 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.4 mm -80.41 -43.23 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.511 0.672 . . . . 0.0 109.5 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 59.9 t90 -151.51 136.04 16.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.244 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 25.4 t-80 55.53 -136.09 1.27 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 46.3 t -100.13 32.06 3.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.64 . . . . 0.0 110.011 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -103.0 139.81 38.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.256 0.55 . . . . 0.0 111.417 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 177.74 5.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.462 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -65.59 143.73 57.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.327 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 91.66 13.01 58.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.184 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 39.9 m -106.24 145.61 31.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.45 144.0 38.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.949 0.404 . . . . 0.0 110.871 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 67.0 mt -119.45 149.05 42.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.057 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.2 t -158.07 103.96 1.87 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.042 0.448 . . . . 0.0 110.426 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.52 123.32 34.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.261 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -71.09 -20.78 62.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.057 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -85.15 3.49 38.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.853 0.359 . . . . 0.0 110.919 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -128.84 175.63 8.48 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.8 t -93.21 6.18 48.92 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.239 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -77.87 86.69 4.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.87 0.843 . . . . 0.0 110.11 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -83.27 -41.37 18.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.366 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.25 156.52 31.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.494 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.413 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 49.4 m95 -71.91 112.26 7.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.372 0.606 . . . . 0.0 112.536 -175.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 8.7 pt20 -98.95 160.88 13.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.979 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 160.6 17.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -57.35 -48.83 81.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 173.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HA ' HG21 ' A' ' 211' ' ' ILE . 16.0 mt-10 -56.42 -24.82 47.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.35 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.53 -47.42 12.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.434 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.558 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.8 t80 -68.82 -42.15 77.61 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.605 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.35 -42.34 70.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.332 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -64.38 -44.34 91.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.835 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.98 83.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.17 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 253' ' ' THR . . . -90.74 21.97 3.8 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.048 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.0 m -79.75 -9.71 59.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.207 0.527 . . . . 0.0 110.004 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.597 ' HB3' HG21 ' A' ' 253' ' ' THR . 21.7 t -91.3 159.3 16.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' A' ' 246' ' ' GLU . 20.9 t0 -67.04 154.21 41.76 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.453 ' N ' HD22 ' A' ' 245' ' ' ASN . 0.1 OUTLIER -62.42 105.82 0.67 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.75 0.785 . . . . 0.0 111.708 -176.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 244' ' ' ASP . 34.6 mt-10 -115.22 37.42 3.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.978 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -20.88 59.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.676 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.69 -23.44 56.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.191 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.624 HG22 ' HG2' ' A' ' 250' ' ' GLN . 55.6 mt -101.21 -62.22 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.532 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.624 ' HG2' HG22 ' A' ' 249' ' ' ILE . 76.6 mm-40 -145.24 -68.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -173.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 24.7 ttt -92.26 154.35 18.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 0.0 111.467 -167.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.97 67.6 0.87 Allowed Glycine 0 CA--C 1.504 -0.594 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 243' ' ' CYS . 1.9 p -99.02 30.18 3.52 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.152 0.501 . . . . 0.0 111.641 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -90.01 75.54 7.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.399 0.618 . . . . 0.0 109.349 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -67.19 -3.12 6.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.167 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -73.85 -4.61 67.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.381 -0.437 . . . . 0.0 113.446 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 21.8 t80 -60.37 124.2 19.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.213 0.507 . . . . 0.0 109.92 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.54 17.21 55.47 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.431 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -21.03 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -101.07 -27.56 13.19 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.459 0.647 . . . . 0.0 109.586 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 157.48 166.65 17.28 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.653 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.93 99.98 6.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.796 -0.702 . . . . 0.0 110.316 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 49.1 tttp -84.0 117.87 23.67 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.059 0.456 . . . . 0.0 110.589 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.435 ' HG ' HD13 ' A' ' 280' ' ' LEU . 3.1 tt -58.69 107.57 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.965 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 74.0 mt -84.13 -42.02 16.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.659 0.266 . . . . 0.0 110.924 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.3 t -153.49 168.02 27.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.409 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.671 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -140.35 137.09 33.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.921 -167.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -143.77 135.63 26.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.414 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -106.76 127.59 53.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.4 t -149.35 178.04 9.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.913 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.7 p -117.44 116.46 51.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 23.7 t -122.49 125.13 45.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.253 -172.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 59.74 29.4 18.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.667 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 86.87 -1.29 86.83 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.84 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.28 130.27 55.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.803 0.335 . . . . 0.0 110.375 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 18.7 m -68.95 131.13 44.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.61 154.72 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.753 0.787 . . . . 0.0 112.905 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.57 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 95.5 mt -94.77 109.65 21.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.668 171.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 37.9 ttmt -104.24 110.82 23.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.044 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 312' ' ' PHE . 45.7 mt -120.89 138.82 53.91 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.836 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.2 m -92.84 114.77 27.42 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.574 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 83.5 m-85 -102.72 161.56 13.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.055 0.455 . . . . 0.0 111.614 -174.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 22.0 t70 -131.15 135.81 27.8 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.138 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 261' ' ' GLY . 95.9 Cg_endo -79.71 13.03 2.22 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.23 1.954 . . . . 0.0 112.714 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.17 -16.23 42.45 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.9 t -153.86 129.33 9.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.021 -0.589 . . . . 0.0 109.866 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.98 -8.16 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -61.32 -26.12 67.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.747 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.46 -46.67 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.1 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 140.33 166.46 10.68 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.905 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 9.0 mt -85.35 148.69 25.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.76 121.98 33.51 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 14.8 m -105.99 133.11 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 59.1 t -132.72 134.1 58.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.413 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 90.4 mt-10 -107.84 112.72 25.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.931 172.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 10.2 p -122.95 172.5 8.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -76.77 160.81 28.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.791 0.329 . . . . 0.0 110.317 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.757 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -64.76 -23.28 67.2 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.327 -174.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -97.88 16.98 19.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.421 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.98 117.55 55.0 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.662 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.98 122.38 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.081 1.854 . . . . 0.0 111.432 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.506 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -112.04 105.73 14.2 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 26.4 t80 -70.67 108.9 4.61 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.979 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.48 138.2 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.557 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.704 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.0 tttp -63.14 128.59 36.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.456 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 1.0 OUTLIER 72.13 17.33 5.08 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.635 0.584 . . . . 0.0 111.811 -179.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -137.99 -43.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.431 . . . . 0.0 111.76 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 98.55 -160.09 20.42 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.14 115.66 3.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 117.537 0.668 . . . . 0.0 110.286 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 17.0 m -127.59 165.18 20.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.139 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.4 t -160.58 171.68 18.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.995 0.426 . . . . 0.0 110.397 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.671 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 73.6 m-85 -85.88 -35.68 20.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.526 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -127.01 76.45 76.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.253 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.49 -34.44 97.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.686 2.257 . . . . 0.0 112.537 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.9 p -65.45 -23.04 66.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.167 0.508 . . . . 0.0 110.814 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 58.5 tp -86.46 -46.35 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.777 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.0 m -56.43 -41.77 76.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.932 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.519 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.2 p -70.27 -21.36 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.752 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.0 -38.33 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.371 0.605 . . . . 0.0 110.242 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -80.87 -56.8 3.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.032 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.43 -8.76 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.041 0.448 . . . . 0.0 110.843 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 75.38 21.07 78.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.462 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.3 mt -115.23 116.2 42.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 122.773 -0.251 . . . . 0.0 110.432 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.48 117.71 5.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.514 2.142 . . . . 0.0 110.79 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.3 m -117.76 160.98 20.46 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -168.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 78.5 m -85.43 164.25 18.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.599 173.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -88.46 125.88 34.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.05 165.59 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.003 0.906 . . . . 0.0 111.542 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -121.09 144.16 48.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.833 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.78 110.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.684 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 263' ' ' LYS . . . 116.33 2.89 19.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.754 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -69.83 124.78 24.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.076 0.465 . . . . 0.0 110.641 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -91.25 125.2 44.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.826 0.822 . . . . 0.0 111.993 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 50.9 t -88.7 133.82 34.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.161 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.465 HD13 ' HB2' ' A' ' 341' ' ' ASP . 63.6 mt -106.27 141.54 22.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.793 -174.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.402 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 81.5 Cg_endo -84.65 163.34 12.38 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.807 2.338 . . . . 0.0 111.847 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.52 115.29 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.785 2.324 . . . . 0.0 111.45 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 121.9 -20.16 8.19 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.357 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -66.49 133.3 94.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.45 -24.09 67.29 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.665 2.91 . . . . 0.0 113.598 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.465 ' HB2' HD13 ' A' ' 335' ' ' LEU . 2.3 m-20 -78.53 -32.39 47.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.715 0.293 . . . . 0.0 110.594 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.655 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.74 87.54 0.97 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.084 0.469 . . . . 0.0 110.284 176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 35.5 mt -64.28 -47.68 88.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.016 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -130.86 99.65 4.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 9.1 t80 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.92 -179.008 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.481 0.754 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.5 t -113.5 100.01 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.6 p -92.9 144.41 25.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.956 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.529 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 10.6 mm -83.48 -36.4 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.833 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.586 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 78.6 t90 -156.19 132.31 9.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.265 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.492 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 21.0 t-80 56.86 -139.15 0.92 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 49.4 t -98.96 40.05 1.23 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.634 . . . . 0.0 110.272 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -114.7 137.4 51.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.423 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.43 172.11 8.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.574 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -64.75 127.64 32.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.816 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 104.69 7.93 38.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.171 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.0 m -96.69 150.4 20.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.6 OUTLIER -117.02 140.35 49.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 110.988 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 79.0 mt -117.29 145.7 43.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.173 -172.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.46 99.36 1.89 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.428 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -88.91 128.98 35.69 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -76.99 -19.63 57.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.573 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -77.36 -21.38 53.37 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.264 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.47 173.8 7.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -88.75 30.07 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.283 0.563 . . . . 0.0 110.157 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.02 67.99 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.826 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -5.79 46.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.929 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.47 152.4 20.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -77.35 110.58 12.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.232 0.539 . . . . 0.0 111.112 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.1 pt20 -102.78 156.2 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.052 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -82.9 159.34 22.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 211' ' ' ILE . 2.4 t -59.75 -43.85 92.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HA ' HG21 ' A' ' 211' ' ' ILE . 35.0 mt-10 -57.86 -22.81 49.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.544 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -83.76 -50.51 8.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.467 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 68.0 t80 -65.23 -43.61 90.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.79 71.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.784 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -65.66 -36.89 84.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -71.86 -29.13 64.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.624 0.726 . . . . 0.0 110.391 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -93.89 21.52 6.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.741 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.418 ' HB2' ' HG3' ' A' ' 246' ' ' GLU . 58.1 m -38.54 -70.81 0.09 Allowed 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.971 0.795 . . . . 0.0 112.159 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 244' ' ' ASP . 25.9 p -74.47 -62.53 1.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 171.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.455 ' N ' ' SG ' ' A' ' 243' ' ' CYS . 32.2 t70 178.57 -31.25 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.965 168.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.979 ' HB3' ' HB2' ' A' ' 248' ' ' GLU . 15.7 m120 -132.31 58.54 1.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.73 -173.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' A' ' 242' ' ' SER . 6.4 mm-40 -75.56 -4.42 39.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.158 0.504 . . . . 0.0 110.872 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -116.36 13.78 15.59 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.527 175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.979 ' HB2' ' HB3' ' A' ' 245' ' ' ASN . 41.8 tt0 -59.53 -15.89 21.16 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.935 0.874 . . . . 0.0 110.672 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 64.8 mt -69.1 -24.34 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.594 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -139.08 -47.95 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.768 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.42 172.45 6.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.047 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -101.03 42.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.235 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.5 m -64.83 113.71 4.0 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 122.457 0.303 . . . . 0.0 110.501 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.568 ' HB2' HD21 ' A' ' 245' ' ' ASN . 20.7 t60 -154.49 128.88 9.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.428 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.586 ' HB2' ' HE1' ' A' ' 212' ' ' TRP . 6.5 ptpp? -75.13 29.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.291 0.567 . . . . 0.0 112.202 -173.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -85.72 -19.86 57.22 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.532 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 31.7 t80 -67.27 110.66 3.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.85 13.35 50.41 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.009 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.8 t -67.01 -17.43 64.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.788 0.328 . . . . 0.0 111.084 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -108.62 -25.59 10.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.067 0.46 . . . . 0.0 110.395 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.14 158.53 9.14 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.312 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.617 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.7 mp -120.75 99.8 6.73 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.304 0.641 . . . . 0.0 110.587 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 29.2 ttpt -85.3 118.83 25.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.09 103.83 0.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.282 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.79 -52.75 8.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.352 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 12.9 t -147.65 167.32 24.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.442 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.402 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.0 t60 -145.9 135.61 23.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.145 0.498 . . . . 0.0 111.128 -173.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 32.6 tt0 -127.05 142.23 51.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.203 174.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -109.17 116.2 31.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.3 t -141.79 178.43 7.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.046 -170.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.98 129.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 8.3 t -132.07 121.32 23.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 58.93 31.92 21.77 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.52 0.512 . . . . 0.0 111.658 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 90.58 -13.12 66.42 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.87 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -102.74 133.89 47.03 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.675 -0.309 . . . . 0.0 110.336 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 46.7 m -71.46 130.07 40.37 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.9 m -129.06 154.24 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 122.172 0.987 . . . . 0.0 112.992 -173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.5 mt -96.07 114.27 25.96 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 113.69 -1.596 . . . . 0.0 108.921 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 23.0 ttmm -103.32 110.81 22.94 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.515 HD11 ' HE1' ' A' ' 312' ' ' PHE . 20.5 mt -112.76 135.4 53.54 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.387 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.9 m -99.65 109.86 22.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.617 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 76.5 m-85 -100.08 163.98 12.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.029 0.443 . . . . 0.0 112.182 -171.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 29.4 t70 -133.39 138.56 31.64 Favored Pre-proline 0 C--O 1.221 -0.437 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.296 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.536 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.3 Cg_endo -83.89 11.22 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.879 1.72 . . . . 0.0 112.532 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.68 -16.39 40.43 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -146.77 110.52 4.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.769 -0.715 . . . . 0.0 109.739 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.59 -14.76 16.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.279 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -67.1 -15.99 64.06 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.326 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.55 -43.57 22.79 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.65 170.71 11.92 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.223 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.48 147.45 23.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -122.92 121.23 35.67 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.452 ' N ' HD22 ' A' ' 292' ' ' LEU . 42.0 m -111.55 133.77 53.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 91.1 t -131.05 135.57 59.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.049 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -112.55 115.69 29.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 7.2 p -132.87 161.8 33.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.996 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -57.83 158.76 6.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.092 0.473 . . . . 0.0 111.829 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -63.97 -34.83 78.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.61 -176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -87.37 31.34 0.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.425 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -86.21 118.87 71.12 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.028 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.19 137.45 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.116 1.877 . . . . 0.0 111.821 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -119.92 142.81 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 18.2 t80 -96.73 98.62 10.3 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.961 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.589 HG23 ' OG ' ' A' ' 310' ' ' SER . 51.0 t -87.04 131.95 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.356 0.598 . . . . 0.0 111.403 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.533 ' HB3' HG13 ' A' ' 333' ' ' VAL . 56.7 tttp -57.93 122.92 14.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.573 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 15.2 m120 77.88 2.06 2.88 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.909 0.756 . . . . 0.0 111.833 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -116.68 -21.78 8.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.83 -121.33 5.48 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.41 140.51 29.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.398 0.599 . . . . 0.0 110.117 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.869 ' HB2' HG22 ' A' ' 328' ' ' ILE . 75.3 p -143.38 167.15 22.84 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.108 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.8 t -164.48 171.76 14.21 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.767 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.515 ' HE1' HD11 ' A' ' 280' ' ' LEU . 57.1 m-85 -89.22 -21.14 23.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.022 0.439 . . . . 0.0 110.485 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -137.58 70.38 52.51 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.062 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.2 Cg_exo -51.32 -39.14 63.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.909 2.406 . . . . 0.0 112.898 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 19.4 m -66.63 -26.07 66.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 110.812 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 66.9 tp -87.56 -47.65 8.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.194 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.3 m -59.05 -39.02 80.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.372 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 10.9 p -68.77 -19.58 24.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.157 0.503 . . . . 0.0 111.264 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.23 -41.97 13.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 110.372 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -77.14 -53.09 8.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.871 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -98.82 -15.92 19.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.786 0.326 . . . . 0.0 111.083 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.75 18.41 68.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.609 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 56.2 mt -113.18 113.36 49.06 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.907 -0.172 . . . . 0.0 110.748 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.76 110.42 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.574 2.183 . . . . 0.0 110.487 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.442 ' HB3' ' C ' ' A' ' 310' ' ' SER . 58.2 m -111.29 157.66 19.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.122 0.487 . . . . 0.0 111.971 -170.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.3 m -84.03 159.73 21.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.123 173.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -82.22 122.98 28.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.869 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.12 164.89 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.473 0.654 . . . . 0.0 110.671 -177.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -119.93 141.44 49.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.792 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.4 mm -57.18 110.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.074 0.464 . . . . 0.0 109.845 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.89 3.74 19.62 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.352 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -79.56 131.07 35.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.217 0.532 . . . . 0.0 110.793 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.6 p -93.83 126.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.24 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.5 m -93.28 136.63 33.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.342 -177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 55.6 mt -105.93 146.13 32.27 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.357 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 58.3 Cg_endo -88.53 165.36 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.933 2.422 . . . . 0.0 112.425 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.47 115.81 3.9 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.868 2.378 . . . . 0.0 111.824 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 122.17 -22.56 7.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.061 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -67.0 127.78 93.64 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.34 -22.85 60.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.411 2.741 . . . . 0.0 113.554 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.06 -27.25 43.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.54 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.575 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -75.29 85.93 2.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.305 0.574 . . . . 0.0 110.169 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.7 mt -72.88 -45.44 55.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.734 -173.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 344' ' ' ASN . 3.0 t-20 -109.65 43.74 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.435 0.636 . . . . 0.0 110.812 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.593 -0.579 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.2 t -97.19 87.58 4.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.051 0.453 . . . . 0.0 109.936 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.9 p -79.3 143.93 34.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.835 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.7 mm -79.35 -43.86 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.791 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 76.9 t90 -152.98 136.06 15.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.408 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 32.6 t-80 55.23 -135.75 1.34 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.485 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 15.0 p -96.05 23.91 6.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.798 0.332 . . . . 0.0 111.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -108.61 140.21 42.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.975 -173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.53 178.57 4.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.772 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.77 132.02 47.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.039 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 99.05 17.85 26.3 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.35 -0.928 . . . . 0.0 112.092 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.552 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 25.0 m -107.82 147.44 30.88 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 220' ' ' ARG . 3.7 mpt_? -110.6 144.23 39.81 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.211 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 69.0 mt -117.24 144.49 44.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.889 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 16.6 t -153.39 95.53 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.126 0.489 . . . . 0.0 110.358 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -86.16 118.21 25.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -72.6 -9.29 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -66.81 -34.22 77.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.145 176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -104.22 -177.27 3.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.992 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 p -79.75 -0.16 33.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.913 0.387 . . . . 0.0 111.314 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -80.71 105.84 12.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -90.46 -41.55 11.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.733 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -92.9 -178.99 4.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.563 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -82.68 117.62 22.75 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -106.63 164.52 12.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.39 172.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.64 160.5 16.6 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.97 -0.456 . . . . 0.0 110.299 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.552 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.9 t -60.03 -47.33 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 24.8 mt-10 -59.03 -22.36 60.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.63 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -81.7 -47.58 12.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.135 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 54.8 t80 -70.08 -48.67 56.78 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.985 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -59.57 -31.45 69.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.211 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 19.4 ttm180 -68.91 -37.35 78.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.597 0.713 . . . . 0.0 109.55 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.56 -8.93 59.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.699 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.746 ' HB1' ' HE3' ' A' ' 255' ' ' LYS . . . -86.71 28.48 0.87 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.729 0.776 . . . . 0.0 110.36 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.6 m -96.55 -56.25 2.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.021 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.4 m -93.84 24.95 3.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.037 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.7 ' HB3' ' HA ' ' A' ' 241' ' ' ALA . 9.5 p-10 -82.87 36.21 0.49 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.052 0.453 . . . . 0.0 111.399 -172.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -139.66 -36.26 0.51 Allowed 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.978 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -68.49 -17.81 64.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.443 0.639 . . . . 0.0 109.799 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.45 -5.45 46.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.397 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 251' ' ' MET . 66.1 tt0 -67.98 -10.37 52.98 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.837 0.827 . . . . 0.0 110.536 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 64.8 mt -70.3 -33.15 53.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.72 -42.72 4.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.469 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -118.95 -178.81 3.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -90.41 38.28 3.24 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.061 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 254' ' ' HIS . 1.0 OUTLIER -69.95 108.82 4.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.365 0.266 . . . . 0.0 110.661 -177.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 253' ' ' THR . 3.2 t60 176.27 130.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.791 ' HB2' ' HE1' ' A' ' 212' ' ' TRP . 0.0 OUTLIER -73.68 25.36 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.917 0.389 . . . . 0.0 111.515 177.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -79.27 -13.63 82.58 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.994 -176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.604 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 11.2 t80 -66.85 107.1 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 103.09 12.21 32.21 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.391 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.8 m -68.74 -13.68 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.826 0.346 . . . . 0.0 111.758 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -108.27 -30.19 8.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.851 0.357 . . . . 0.0 110.282 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 159.77 157.89 8.86 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.07 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.8 mp -122.53 105.8 10.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 110.476 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 22.0 ttpt -90.42 121.25 32.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.14 0.495 . . . . 0.0 110.976 -175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.52 107.48 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.868 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 283' ' ' ASP . 61.1 mt -82.51 -41.1 20.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.466 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 14.7 t -158.39 162.35 37.62 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.791 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -140.94 140.25 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 111.482 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -133.43 139.69 46.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.246 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.61 106.14 18.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.182 0.515 . . . . 0.0 109.776 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.0 t -109.6 179.73 4.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.69 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.72 128.92 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.023 0.44 . . . . 0.0 110.119 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.6 t -131.63 124.44 29.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.333 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 56.06 32.6 20.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.629 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.1 -2.71 88.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.869 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -111.23 133.3 53.67 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.733 -0.275 . . . . 0.0 110.297 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.2 m -67.15 137.92 56.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.1 m -129.62 154.88 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.772 0.796 . . . . 0.0 111.838 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 295' ' ' GLU . 96.9 mt -95.57 110.61 22.67 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.558 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -98.24 110.66 23.2 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 17.2 mt -113.82 129.93 56.53 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.124 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 37.6 m -97.52 118.12 33.3 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.527 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 79.5 m-85 -106.55 164.65 11.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.288 0.566 . . . . 0.0 112.417 -171.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.446 ' HB2' HD21 ' A' ' 265' ' ' LEU . 19.0 t70 -131.29 135.06 26.51 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.146 176.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.604 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 72.8 Cg_endo -84.17 5.59 6.24 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.202 1.935 . . . . 0.0 112.346 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.4 -18.87 27.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.452 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -142.29 126.65 17.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.052 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.97 -8.15 11.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.396 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.39 -39.69 92.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.03 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.04 -46.76 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.036 -178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.99 11.48 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.39 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.0 mt -85.0 143.26 29.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.72 0.295 . . . . 0.0 110.578 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.453 HD13 HG23 ' A' ' 294' ' ' VAL . 1.1 tm? -117.5 119.44 35.05 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.422 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.0 m -106.8 135.27 48.62 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.453 HG23 HD13 ' A' ' 292' ' ' LEU . 73.8 t -134.04 135.22 55.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.436 -177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 278' ' ' LEU . 41.8 mt-10 -126.95 127.73 45.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.716 173.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 300' ' ' HIS . 9.2 t -141.19 -174.61 4.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.773 175.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -76.0 172.84 12.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.28 0.562 . . . . 0.0 110.52 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.574 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.9 mm? -74.67 -10.54 59.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.352 -168.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -103.96 17.45 24.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.721 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . 0.548 ' HD2' ' SG ' ' A' ' 296' ' ' CYS . 48.4 t-80 -75.89 117.93 67.36 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.527 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.5 135.16 17.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.158 1.905 . . . . 0.0 111.783 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 94.7 m-85 -121.24 125.57 47.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 7.7 t80 -81.84 90.79 6.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.567 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.629 HG13 ' HB2' ' A' ' 332' ' ' ASP . 65.6 t -72.95 123.86 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.035 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.758 ' HB3' HG13 ' A' ' 333' ' ' VAL . 60.4 tttp -56.33 139.69 47.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.38 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 10.9 m-20 77.1 -8.68 1.65 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.819 0.699 . . . . 0.0 112.114 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -119.21 -54.0 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.908 0.385 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.17 -149.67 18.05 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -67.73 120.64 14.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.172 0.486 . . . . 0.0 110.259 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.414 ' HB2' HG22 ' A' ' 328' ' ' ILE . 18.0 m -134.94 169.66 17.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.351 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 43.2 t -160.63 172.13 17.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.914 0.387 . . . . 0.0 110.777 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -87.14 -28.88 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.974 172.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.46 76.39 77.63 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.687 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.555 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 65.8 Cg_exo -54.74 -41.96 73.08 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.103 2.535 . . . . 0.0 113.141 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 6.9 m -64.02 -24.35 67.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.994 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.8 tp -87.32 -49.14 7.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.951 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -55.75 -44.65 77.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.377 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.19 -31.67 54.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.745 0.307 . . . . 0.0 111.752 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -79.11 -40.35 22.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.229 0.538 . . . . 0.0 110.243 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.19 -49.97 13.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.589 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -102.75 -9.06 20.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.767 0.318 . . . . 0.0 111.737 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 75.67 29.6 59.27 Favored Glycine 0 CA--C 1.516 0.127 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.7 mt -128.34 112.79 19.67 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 122.772 -0.252 . . . . 0.0 110.433 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.8 116.79 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.448 2.099 . . . . 0.0 110.877 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 72.8 m -117.62 147.59 42.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.287 0.565 . . . . 0.0 111.698 -169.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 85.5 m -80.55 164.97 22.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.653 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.13 128.18 34.25 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -74.98 178.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 121.422 0.629 . . . . 0.0 111.07 -178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -141.71 132.88 26.32 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.93 115.13 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 O-C-N 123.67 0.606 . . . . 0.0 110.162 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.71 6.72 16.71 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.516 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.629 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.0 OUTLIER -70.4 128.91 37.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 176.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.758 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.2 p -97.56 112.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.73 0.776 . . . . 0.0 111.13 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.9 m -79.96 132.29 36.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.425 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.85 145.91 31.44 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.908 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 68.1 Cg_endo -86.68 168.7 8.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.008 2.472 . . . . 0.0 112.357 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.413 ' HB3' ' CE1' ' A' ' 345' ' ' PHE . 42.0 Cg_endo -68.12 126.16 14.03 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.885 2.39 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.51 -21.33 30.74 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.35 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.4 122.0 77.81 Favored Pre-proline 0 C--O 1.224 -0.25 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.79 -23.53 72.41 Favored 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 123.182 2.588 . . . . 0.0 113.108 -171.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.552 ' OD2' ' HG3' ' A' ' 305' ' ' LYS . 37.4 t70 -79.06 -27.18 43.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -78.55 86.57 4.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.178 0.513 . . . . 0.0 109.993 169.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 60.0 mt -66.86 -50.65 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.633 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -99.57 31.57 3.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.0 111.08 -169.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 337' ' ' PRO . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.358 -178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.481 0.752 0 N-CA-C 110.551 -0.596 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.4 t -94.78 94.3 8.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.287 0.565 . . . . 0.0 109.998 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.7 p -84.87 143.54 28.98 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.216 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 235' ' ' GLU . 11.4 mm -86.26 -41.51 15.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.58 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.483 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 80.9 t90 -154.33 127.63 8.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.499 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.4 t-80 59.06 -146.56 0.51 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 49.4 t -94.64 39.82 1.09 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.292 0.567 . . . . 0.0 110.37 175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -108.13 138.04 45.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.361 0.601 . . . . 0.0 111.594 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.97 169.16 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.022 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.428 ' HG3' ' OE2' ' A' ' 235' ' ' GLU . 56.9 tttp -62.42 128.15 34.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.734 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 108.35 -16.85 34.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.027 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.523 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 60.6 m -73.73 148.17 42.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.489 ' O ' HG13 ' A' ' 294' ' ' VAL . 0.4 OUTLIER -109.37 150.71 27.64 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.436 178.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 62.4 mt -123.54 143.88 49.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 51.9 t -151.96 92.03 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.044 0.449 . . . . 0.0 110.412 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.521 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 47.3 m-85 -75.97 124.8 27.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -65.4 -22.1 66.74 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 110.91 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -78.05 -6.89 56.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.317 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.521 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 60.8 mm-40 -100.43 172.3 7.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.016 0.436 . . . . 0.0 110.881 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.9 m -96.87 26.44 4.6 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.168 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -114.87 97.44 6.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.977 0.417 . . . . 0.0 111.505 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -78.66 -35.73 44.84 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -68.04 139.07 56.27 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.352 -1.294 . . . . 0.0 110.098 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.411 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 83.6 m95 -73.47 122.73 22.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -172.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 7.6 pt20 -99.99 158.44 15.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.513 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.43 161.44 16.28 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.913 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -58.5 -49.7 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-O 121.641 0.734 . . . . 0.0 109.355 174.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 35.3 mt-10 -58.08 -22.3 49.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.585 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -77.6 -45.77 24.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.331 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -74.96 -46.84 32.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -59.7 -25.07 64.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.568 177.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.672 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 35.9 ttm180 -63.13 -36.81 84.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.337 0.589 . . . . 0.0 109.835 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -70.39 -23.22 62.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.594 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.671 ' HB1' ' HE3' ' A' ' 255' ' ' LYS . . . -91.38 13.85 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.705 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.0 m -81.42 -9.73 59.67 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 247' ' ' GLU . 1.7 p -75.59 -68.94 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 t70 178.52 -160.92 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -77.65 52.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 120.393 1.451 . . . . 0.0 110.501 171.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -140.5 30.06 1.93 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.776 ' OE1' ' HB ' ' A' ' 253' ' ' THR . 6.1 mp0 -57.46 -52.51 65.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.205 -172.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -101.64 -23.9 14.19 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.028 0.442 . . . . 0.0 111.368 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 253' ' ' THR . 0.2 OUTLIER -134.82 120.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -173.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.03 68.96 0.47 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.572 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 41.2 ttm -169.91 -54.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.642 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 173.48 91.41 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.776 ' HB ' ' OE1' ' A' ' 247' ' ' GLU . 7.2 m -95.52 -79.83 0.43 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.907 -0.172 . . . . 0.0 111.145 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 253' ' ' THR . 22.0 t-80 74.22 141.64 0.07 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.796 0.685 . . . . 0.0 109.575 -173.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.671 ' HE3' ' HB1' ' A' ' 241' ' ' ALA . 9.3 mptt -49.86 -50.6 45.08 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.311 0.382 . . . . 0.0 110.667 -171.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 74.1 -65.92 1.89 Allowed Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.92 -0.582 . . . . 0.0 114.358 165.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 42.7 t80 -66.45 105.75 1.56 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.25 0.548 . . . . 0.0 110.868 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 97.25 18.55 28.44 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.376 174.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 12.6 m -75.8 -13.27 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.993 0.425 . . . . 0.0 110.459 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -105.07 -31.94 8.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.539 0.685 . . . . 0.0 109.323 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.23 157.92 8.73 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.003 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.5 mp -123.12 98.7 6.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 123.234 0.614 . . . . 0.0 110.363 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 69.8 tttt -84.15 122.06 28.31 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.078 0.466 . . . . 0.0 111.111 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.7 105.09 0.6 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.76 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 283' ' ' ASP . 87.0 mt -79.16 -48.13 14.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.7 t -150.28 163.37 38.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.849 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.602 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -134.08 148.49 51.03 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.888 -167.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.16 139.32 21.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.894 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -111.09 94.28 4.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.491 0.662 . . . . 0.0 109.468 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.42 177.91 4.9 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.308 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.6 p -127.3 116.82 45.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.394 0.616 . . . . 0.0 110.053 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 69.7 p -112.19 113.43 25.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.612 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 54.38 35.37 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.461 0.475 . . . . 0.0 111.814 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.29 -21.69 36.7 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.496 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -110.85 134.72 52.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.13 0.465 . . . . 0.0 111.227 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 19.4 m -71.84 137.92 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.025 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.86 154.72 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.596 0.712 . . . . 0.0 112.03 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 312' ' ' PHE . 94.7 mt -92.54 109.4 20.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.259 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 4.9 ttpp -102.95 109.0 20.39 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 293' ' ' THR . 38.4 mt -118.71 140.9 49.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.247 -175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.0 m -99.05 122.56 42.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.556 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.2 m-85 -110.63 158.88 18.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.384 -174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.477 ' HB2' HD21 ' A' ' 265' ' ' LEU . 10.7 t70 -128.21 130.62 23.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.663 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.63 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 97.4 Cg_endo -86.82 12.55 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.607 2.204 . . . . 0.0 112.451 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.96 -16.61 46.35 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.883 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.5 t -154.4 139.92 17.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 111.031 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.99 -9.88 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.31 -38.76 77.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.183 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.82 -43.47 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.903 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 133.38 163.48 10.47 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.769 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 12.9 mt -89.94 149.27 22.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.071 0.463 . . . . 0.0 110.143 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 294' ' ' VAL . 1.8 tm? -126.75 123.29 37.1 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 280' ' ' LEU . 57.8 m -115.64 136.84 52.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 68.3 t -131.92 137.14 55.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.639 -174.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' CG ' ' HD3' ' A' ' 279' ' ' LYS . 87.8 mt-10 -106.39 127.86 53.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.642 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.4 p -142.99 172.2 13.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -66.09 154.56 39.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.308 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.2 mm? -62.45 -21.13 65.21 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.47 0.652 . . . . 0.0 110.742 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -95.68 16.7 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.779 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -70.69 122.64 87.29 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -82.3 122.4 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.518 2.145 . . . . 0.0 111.906 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.66 120.62 42.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.7 t80 -72.84 104.4 4.01 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.23 137.15 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.267 0.556 . . . . 0.0 111.074 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.481 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.1 tttp -57.92 129.93 44.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.813 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 15.7 m120 72.94 2.3 4.33 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.627 0.579 . . . . 0.0 112.099 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -121.6 -41.37 2.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.657 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 95.6 -152.78 20.47 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.67 113.84 3.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 117.238 0.519 . . . . 0.0 110.699 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 18.9 m -126.21 165.55 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.5 t -161.54 -177.83 6.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.656 0.265 . . . . 0.0 110.939 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 278' ' ' LEU . 30.1 m-85 -91.59 -43.6 9.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.244 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.67 74.22 17.67 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.705 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.7 Cg_exo -55.6 -36.26 94.28 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.748 2.298 . . . . 0.0 112.946 -174.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 319' ' ' VAL . 23.2 t -63.1 -28.48 70.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.115 0.484 . . . . 0.0 110.559 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.3 tp -87.35 -41.97 13.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.886 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.9 m -53.33 -44.06 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.778 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.9 p -72.14 -20.74 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 315' ' ' SER . 97.2 t -85.31 -34.93 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.384 0.612 . . . . 0.0 110.117 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -84.67 -53.03 5.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.188 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -100.73 -11.52 19.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.827 0.346 . . . . 0.0 111.103 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.98 24.85 65.66 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.254 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 44.1 mt -120.97 113.17 33.02 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.874 -0.192 . . . . 0.0 110.572 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.05 116.91 4.89 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.47 2.113 . . . . 0.0 110.7 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 79.5 m -117.57 155.88 29.04 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -169.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.2 m -83.55 165.77 18.8 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.618 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.57 126.71 33.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 162.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -130.03 153.75 48.12 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.5 mm -63.15 109.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.68 -0.61 20.1 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.825 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.88 129.43 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.532 0.666 . . . . 0.0 110.221 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -91.35 134.74 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.535 0.683 . . . . 0.0 112.654 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 50.5 t -95.85 138.95 32.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.971 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 76.0 mt -109.96 141.87 24.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.527 -175.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -86.57 164.15 9.36 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.884 2.389 . . . . 0.0 112.033 175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.49 122.78 9.8 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.461 2.107 . . . . 0.0 111.292 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 114.45 -17.0 19.12 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.813 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -70.34 132.18 87.98 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.24 -26.35 76.18 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.389 2.726 . . . . 0.0 113.479 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.24 -26.67 42.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.668 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -80.02 85.83 5.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.153 174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.68 -43.98 46.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.243 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -120.92 80.86 1.69 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 -172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.886 -178.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.663 -0.553 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -105.64 92.01 4.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.3 p -82.23 141.52 32.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.033 0.444 . . . . 0.0 110.967 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.472 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -82.85 -37.76 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.709 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -156.88 135.65 11.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.994 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 23.1 t-80 55.83 -139.26 0.97 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 335' ' ' LEU . 43.6 t -100.4 42.68 1.1 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.376 0.607 . . . . 0.0 109.92 176.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -116.09 139.48 50.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 111.89 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.1 174.83 5.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.825 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.491 ' HE2' ' OE2' ' A' ' 235' ' ' GLU . 64.4 tttm -63.77 127.89 33.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.421 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 105.85 -1.55 38.75 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.473 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.533 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 68.1 m -86.21 140.1 30.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -111.11 137.88 48.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.449 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 47.1 mt -112.78 145.49 40.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.717 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . 0.736 ' HA ' HD21 ' A' ' 228' ' ' ASN . 21.3 t -149.48 97.46 2.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.185 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -85.74 108.28 17.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.464 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -71.04 -19.38 62.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -58.86 -36.46 74.64 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.498 173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.78 -156.5 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.642 -173.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -85.27 -17.28 37.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.736 HD21 ' HA ' ' A' ' 222' ' ' CYS . 1.4 p-10 -93.02 108.06 19.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.179 0.99 . . . . 0.0 111.591 -171.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.794 ' HD2' ' HG3' ' A' ' 230' ' ' GLU . 0.9 OUTLIER -102.38 7.42 40.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.456 174.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.794 ' HG3' ' HD2' ' A' ' 229' ' ' LYS . 27.2 mt-10 -114.35 172.22 7.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.329 177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -87.52 132.85 33.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.011 0.91 . . . . 0.0 113.211 -168.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 12.2 pt20 -130.92 168.37 17.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.246 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -88.59 160.2 17.54 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.975 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.7 t -59.59 -46.93 92.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.491 ' OE2' ' HE2' ' A' ' 217' ' ' LYS . 27.3 mt-10 -57.73 -23.45 51.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.243 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -79.09 -44.75 21.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.341 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.581 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 58.9 t80 -74.26 -44.07 54.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.423 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.94 72.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.118 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -58.77 -41.77 87.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.56 72.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.06 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.428 ' O ' ' HE3' ' A' ' 255' ' ' LYS . . . -90.31 20.08 4.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.728 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 29.7 t -63.02 -28.96 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.04 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 244' ' ' ASP . 22.8 p -76.43 -80.65 0.09 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' A' ' 254' ' ' HIS . 16.4 t70 177.05 -33.71 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.907 0.861 . . . . 0.0 109.127 173.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.418 ' CG ' ' HB2' ' A' ' 254' ' ' HIS . 55.2 t30 177.54 128.59 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.411 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 249' ' ' ILE . 40.2 mt-10 -95.12 50.09 1.25 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 110.228 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -41.97 81.1 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.326 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.51 -24.87 25.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.155 0.503 . . . . 0.0 110.216 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 246' ' ' GLU . 34.9 mt -79.58 -47.03 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.746 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -150.01 -62.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.34 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 58.2 ttp -152.06 -76.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.28 -0.263 . . . . 0.0 111.411 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.46 142.78 7.0 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.457 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.47 38.36 0.17 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.404 0.621 . . . . 0.0 109.334 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.715 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 67.8 t60 -83.25 144.02 30.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.426 -171.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 241' ' ' ALA . 94.4 mttt -89.27 34.95 0.8 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.102 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -99.03 -15.4 33.45 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.951 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 39.2 t80 -74.59 120.64 20.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 110.034 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 90.19 26.61 23.27 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.591 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 32.3 t -81.41 -16.42 52.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.176 0.513 . . . . 0.0 110.417 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.88 -29.49 11.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.462 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 142.1 151.81 5.59 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.586 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.9 mp -107.57 97.59 7.3 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.73 0.412 . . . . 0.0 110.863 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.721 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.9 ttpp -85.68 114.22 22.49 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.182 0.515 . . . . 0.0 111.139 -175.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.487 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 4.6 tt -54.77 122.48 10.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.465 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.2 mt -95.0 -47.71 6.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.561 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 40.7 t -151.0 164.98 35.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.118 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -142.12 133.04 25.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.207 0.527 . . . . 0.0 111.632 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -128.67 146.19 50.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -105.49 128.69 53.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.828 0.823 . . . . 0.0 110.359 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 30.8 t -133.07 179.98 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.864 -167.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.19 128.7 56.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.03 0.443 . . . . 0.0 109.874 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 32.2 t -126.47 111.31 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.119 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 54.91 42.25 31.25 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.301 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.16 -11.72 59.92 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.905 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -97.14 115.25 27.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.772 0.32 . . . . 0.0 110.481 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 298' ' ' LEU . 49.6 m -62.34 133.95 55.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.1 m -132.72 153.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 122.147 0.975 . . . . 0.0 113.228 -173.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 89.9 mt -92.92 119.96 32.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 113.501 -1.681 . . . . 0.0 109.249 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.7 ttmt -108.33 111.82 23.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.513 HD11 ' HE1' ' A' ' 312' ' ' PHE . 36.9 mt -118.5 129.4 55.35 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.011 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.1 m -92.97 110.79 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.405 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 82.6 m-85 -96.51 155.27 16.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.059 0.457 . . . . 0.0 111.969 -172.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.491 ' HB2' HD21 ' A' ' 265' ' ' LEU . 15.7 t0 -118.84 123.43 29.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.448 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 60.5 Cg_endo -73.36 2.76 5.32 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 122.065 1.843 . . . . 0.0 111.755 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.79 9.85 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.5 t -145.9 130.94 18.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.11 -12.25 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.085 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.18 -34.7 78.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.557 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.52 -45.26 69.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 135.94 176.16 14.21 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.366 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 79.1 mt -103.32 150.33 23.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.915 0.388 . . . . 0.0 110.618 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -127.02 119.43 26.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 7.4 m -109.76 139.39 44.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.9 t -132.93 132.73 59.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -109.47 115.26 29.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 6.2 p -134.3 165.64 24.67 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.929 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.53 155.9 28.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.138 0.494 . . . . 0.0 111.01 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.823 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.1 mm? -64.4 -19.53 65.56 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.078 -173.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.21 17.67 16.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.194 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -74.51 117.27 60.74 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.773 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.65 116.38 4.66 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.238 1.959 . . . . 0.0 111.445 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.8 m-85 -103.59 116.06 31.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.355 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 11.4 t80 -73.48 105.08 4.69 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.406 175.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.75 130.79 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.349 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.84 ' HB3' HG13 ' A' ' 333' ' ' VAL . 58.9 tttp -59.97 126.44 27.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 13.2 m120 77.64 0.05 2.82 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.995 0.81 . . . . 0.0 111.993 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -117.08 -33.8 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.929 0.395 . . . . 0.0 111.495 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.431 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 94.47 -151.14 20.04 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . 0.454 ' CZ2' ' HA ' ' A' ' 345' ' ' PHE . 97.3 m95 -67.77 117.6 9.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.462 0.631 . . . . 0.0 109.457 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.427 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -128.28 166.66 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.772 0.32 . . . . 0.0 110.641 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 41.4 t -160.77 168.11 25.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.509 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.513 ' HE1' HD11 ' A' ' 280' ' ' LEU . 63.4 m-85 -84.92 -28.57 25.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.946 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.11 75.41 75.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.595 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.7 Cg_exo -55.42 -45.02 43.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.883 2.388 . . . . 0.0 112.677 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 18.3 m -62.5 -21.08 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.447 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 63.1 tp -88.05 -45.3 10.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.909 0.385 . . . . 0.0 110.166 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.413 HG21 ' SG ' ' A' ' 325' ' ' CYS . 36.4 m -55.51 -40.74 72.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.742 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.554 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.9 p -71.72 -19.71 20.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.788 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.3 t -87.61 -36.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.327 0.584 . . . . 0.0 110.185 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -81.86 -54.88 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.844 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -101.79 -11.37 19.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.837 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.59 14.78 77.46 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.638 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 51.5 mt -110.53 114.18 55.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.634 0.217 . . . . 0.0 111.08 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.96 118.49 5.65 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.633 2.222 . . . . 0.0 110.601 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 317' ' ' THR . 62.6 m -117.77 157.78 25.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.248 0.547 . . . . 0.0 112.306 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 68.6 m -79.91 164.88 23.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.06 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -92.03 122.16 34.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.427 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -75.19 166.1 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.548 0.689 . . . . 0.0 111.412 -175.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -124.12 142.33 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 24.4 mm -59.34 114.45 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 115.67 -0.65 21.72 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.525 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -73.15 132.09 42.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.88 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -92.92 134.8 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.273 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 49.5 t -96.5 134.32 39.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.369 -177.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 82.2 mt -105.84 143.68 27.37 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.59 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 69.1 Cg_endo -86.91 167.66 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.637 2.225 . . . . 0.0 112.074 174.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.74 129.8 24.49 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.008 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 103.26 -14.32 54.94 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.65 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -69.3 128.3 92.5 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.36 -22.59 75.0 Favored 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 123.325 2.683 . . . . 0.0 113.866 -172.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.87 -31.04 45.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -69.0 91.73 0.49 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.281 0.562 . . . . 0.0 109.954 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 84.0 mt -66.33 -41.53 89.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.671 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -129.13 101.7 6.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 309' ' ' TRP . 3.8 t80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.519 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.728 -0.528 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -91.3 99.58 12.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.048 0.452 . . . . 0.0 110.098 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.5 p -87.63 141.77 28.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.44 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.452 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.4 mm -79.44 -40.31 21.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.334 0.588 . . . . 0.0 109.752 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -156.89 134.38 10.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.107 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 34.0 t-80 55.94 -139.22 0.97 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 40.3 t -99.8 40.09 1.27 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.418 0.628 . . . . 0.0 109.864 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -110.23 134.6 52.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.061 0.458 . . . . 0.0 111.237 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -93.51 176.17 6.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -67.37 137.82 56.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.788 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.66 31.15 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.022 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 38.2 m -112.11 147.63 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.586 HH12 ' HB3' ' A' ' 272' ' ' SER . 0.3 OUTLIER -111.07 143.6 41.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.824 0.345 . . . . 0.0 111.058 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 84.8 mt -119.64 143.75 47.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.809 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . 0.538 ' HA ' HD21 ' A' ' 228' ' ' ASN . 41.8 t -154.07 98.03 2.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 174.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.55 ' HB2' ' HG2' ' A' ' 226' ' ' GLU . 34.8 m-85 -83.34 122.18 28.12 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -66.98 -24.32 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.573 ' HD3' ' O ' ' A' ' 289' ' ' ASP . 19.0 pttp -75.1 -12.67 60.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.996 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.55 ' HG2' ' HB2' ' A' ' 223' ' ' PHE . 9.0 mm-40 -94.38 172.39 8.23 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.187 0.518 . . . . 0.0 110.843 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 6.3 m -88.16 18.1 4.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.382 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.538 HD21 ' HA ' ' A' ' 222' ' ' CYS . 3.8 p-10 -115.48 102.6 9.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.184 0.993 . . . . 0.0 111.41 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -83.69 -31.8 25.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.646 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -70.57 154.93 41.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.026 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.487 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 85.4 m95 -79.96 138.67 37.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.235 -175.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 9.1 pt20 -120.45 154.37 35.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.688 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.37 162.57 23.33 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -60.68 -50.82 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.03 -24.2 57.38 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.289 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -73.17 -50.67 21.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.829 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.554 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 62.1 t80 -70.59 -43.65 68.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.698 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.08 -36.53 68.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.245 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 239' ' ' ARG . 36.6 ttt180 -68.15 -34.81 77.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.38 177.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -79.09 -20.03 49.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.991 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -83.99 15.78 3.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.762 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.9 p -72.65 -27.74 62.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.992 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 21.2 m -80.06 149.18 30.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.71 -177.76 5.62 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.822 ' HB2' ' HG2' ' A' ' 247' ' ' GLU . 0.3 OUTLIER -73.89 103.13 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.757 0.789 . . . . 0.0 112.889 -170.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.502 ' HB3' HD12 ' A' ' 249' ' ' ILE . 4.1 mm-40 -89.13 44.9 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.514 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.822 ' HG2' ' HB2' ' A' ' 245' ' ' ASN . 18.0 mm-40 -62.07 -41.81 98.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.309 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.84 -24.62 62.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.458 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 246' ' ' GLU . 62.4 mt -75.49 -60.11 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.813 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -178.76 -56.31 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.843 0.354 . . . . 0.0 111.298 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 14.0 tpt -81.29 149.29 29.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.596 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.54 82.81 0.78 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.287 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 m -97.72 18.36 15.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.511 0.672 . . . . 0.0 110.601 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 245' ' ' ASN . 84.8 t60 -71.21 94.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.45 4.26 0.1 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -95.83 30.49 8.38 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.236 -176.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 14.9 t80 -74.28 119.66 18.79 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 95.64 21.48 23.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.225 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.1 t -70.05 -23.56 63.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.628 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -90.02 -31.75 17.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.58 0.705 . . . . 0.0 109.828 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 141.0 144.28 4.41 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.762 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 4.2 mp -97.92 99.18 10.47 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.419 0.287 . . . . 0.0 111.0 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 19.2 ttpp -84.96 117.75 24.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.1 tt -61.22 102.83 0.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.829 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 283' ' ' ASP . 67.1 mt -77.2 -47.65 19.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.074 0.464 . . . . 0.0 110.445 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -152.58 163.15 40.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.097 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.571 ' HB3' ' CD1' ' A' ' 330' ' ' ILE . 0.0 OUTLIER -133.68 146.2 50.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.668 -168.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.44 140.04 27.31 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.16 107.75 16.76 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.3 t -127.43 178.46 6.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.525 -170.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 7.8 p -128.5 127.15 66.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.586 ' HB3' HH12 ' A' ' 220' ' ' ARG . 13.7 t -116.1 106.55 13.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.777 -173.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.2 p90 54.94 17.08 1.69 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.82 1.248 . . . . 0.0 113.022 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 123.05 -16.29 8.2 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.464 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.95 115.03 29.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.876 0.369 . . . . 0.0 110.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 271' ' ' VAL . 22.9 m -68.02 133.62 49.33 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.67 154.87 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.997 0.904 . . . . 0.0 113.072 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 98.7 mt -94.15 110.31 22.04 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 113.846 -1.524 . . . . 0.0 108.807 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 38.8 ttmt -104.28 109.63 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.812 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' HE1' ' A' ' 312' ' ' PHE . 40.9 mt -116.14 136.82 52.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.751 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 27.8 m -93.58 109.66 21.28 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 84.3 m-85 -101.09 150.05 23.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.324 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.43 ' HB2' HD21 ' A' ' 265' ' ' LEU . 12.8 t70 -116.6 133.44 23.02 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.47 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.7 Cg_endo -79.21 9.81 3.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.861 1.707 . . . . 0.0 112.04 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.38 63.16 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -146.73 100.01 3.27 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.603 0.716 . . . . 0.0 109.508 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 3.3 p -56.29 -18.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.415 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 288' ' ' GLU . 7.2 mp0 -56.25 -32.43 64.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.538 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . 0.573 ' O ' ' HD3' ' A' ' 225' ' ' LYS . 1.5 m-20 -82.37 -1.18 49.07 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.831 0.348 . . . . 0.0 111.472 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.08 172.96 25.31 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.791 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 10.4 mt -97.84 141.13 31.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.723 0.297 . . . . 0.0 110.22 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 223' ' ' PHE . 0.0 OUTLIER -112.43 121.29 44.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 28.2 m -110.06 133.97 52.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 89.2 t -131.69 134.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.518 -174.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 88.3 mt-10 -106.44 120.97 43.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.681 171.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 11.0 p -133.23 167.2 20.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.467 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -75.44 163.24 27.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.06 0.457 . . . . 0.0 110.494 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.64 ' H ' HD22 ' A' ' 298' ' ' LEU . 2.0 mm? -66.89 -16.09 64.08 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.757 -168.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -106.97 26.0 10.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.159 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -79.24 117.53 67.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.726 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.48 133.35 11.72 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.242 1.961 . . . . 0.0 111.903 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.452 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 98.8 m-85 -118.07 125.04 49.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.423 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -76.51 89.34 3.27 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.524 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.79 134.12 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.464 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.6 ' HB3' HG13 ' A' ' 333' ' ' VAL . 69.2 tttt -59.35 125.53 24.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.901 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.3 m120 81.45 -26.39 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.093 0.871 . . . . 0.0 112.171 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -89.83 -35.12 15.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.093 0.473 . . . . 0.0 111.203 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.89 -153.06 21.73 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -63.99 115.06 4.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.983 0.392 . . . . 0.0 110.209 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.465 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.0 m -127.74 169.19 14.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.222 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 45.9 t -160.7 169.37 22.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.766 0.317 . . . . 0.0 110.966 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.461 ' HE1' HD11 ' A' ' 280' ' ' LEU . 53.4 m-85 -84.28 -32.27 24.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.929 174.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -126.95 77.38 75.1 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.421 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 51.0 Cg_exo -56.35 -36.81 97.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.814 2.343 . . . . 0.0 112.564 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 28.7 m -70.29 -20.75 63.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.43 -47.81 8.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 m -57.17 -40.95 78.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.048 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.504 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.2 p -68.5 -20.42 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 120.894 0.378 . . . . 0.0 111.642 -177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 85.5 t -91.01 -38.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.326 0.584 . . . . 0.0 110.393 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -78.81 -53.77 6.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.788 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -95.24 -22.22 17.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.096 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 88.15 12.97 64.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.306 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 45.0 mt -109.2 115.82 56.08 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.515 -0.179 . . . . 0.0 110.515 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 4.9 Cg_exo -72.0 109.48 2.7 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.532 2.155 . . . . 0.0 110.706 175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 59.5 m -109.09 155.01 21.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.765 -170.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 79.2 m -84.8 166.38 16.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.015 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -86.29 123.51 31.63 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.291 -0.256 . . . . 0.0 110.498 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 310' ' ' SER . 0.1 OUTLIER -77.34 164.0 3.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.229 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -134.33 150.82 50.97 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 267' ' ' HIS . 35.0 mm -55.27 113.72 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 110.527 -176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.4 -2.09 20.46 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.865 -176.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.51 128.35 35.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.257 0.551 . . . . 0.0 111.159 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.4 p -88.95 136.39 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.844 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 58.3 m -103.02 134.22 46.82 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.097 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 59.9 mt -104.39 143.14 26.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.503 -174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.578 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 63.5 Cg_endo -88.72 166.86 6.04 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.214 2.609 . . . . 0.0 112.871 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.5 128.69 17.61 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.352 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 106.88 -19.37 35.62 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.905 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -70.96 129.23 89.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.42 -32.0 80.11 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.807 3.005 . . . . 0.0 113.868 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -79.33 -23.06 43.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.9 86.51 1.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.186 0.517 . . . . 0.0 109.917 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.25 -45.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.528 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -110.38 47.5 0.96 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.286 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.346 179.739 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.481 0.766 0 N-CA-C 110.871 -0.473 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 22.6 t -91.69 93.65 9.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.0 p -84.11 143.79 29.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.476 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 19.8 mm -79.33 -44.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.44 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 75.8 t90 -151.37 137.19 18.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.416 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.523 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 24.1 t-80 56.43 -137.4 1.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . . . . . . . . . 45.1 t -100.23 34.09 2.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.307 0.575 . . . . 0.0 110.112 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -108.63 138.57 44.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.226 0.536 . . . . 0.0 111.602 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.29 175.65 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.882 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -68.32 130.3 42.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.419 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.82 36.46 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.113 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 23.9 m -101.82 145.55 29.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.17 143.7 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.735 0.302 . . . . 0.0 110.903 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 44.1 mt -121.65 144.13 48.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.654 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 10.1 m -148.99 91.93 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 292' ' ' LEU . 12.3 m-85 -88.2 120.06 29.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -70.78 -9.88 58.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.923 0.392 . . . . 0.0 110.805 -173.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -73.77 -25.52 60.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.325 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -101.62 -165.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.215 0.531 . . . . 0.0 110.276 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.5 t -89.82 3.73 51.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -82.03 43.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.936 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -12.77 60.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.047 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.0 154.28 18.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.931 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.543 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 68.1 m95 -71.36 108.96 5.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.563 0.697 . . . . 0.0 112.516 -169.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 23.4 pt20 -101.0 167.27 10.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.567 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.13 159.11 17.67 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.497 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 3.3 t -58.17 -48.72 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.288 0.566 . . . . 0.0 109.716 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.65 -21.51 40.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.762 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.2 -52.48 8.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.461 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 66.1 t80 -65.43 -41.38 93.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.839 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -54.88 -44.04 73.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -60.96 -51.1 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.768 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.77 91.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.117 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -87.32 5.64 37.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.059 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 68.0 m -103.93 27.89 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.531 0.682 . . . . 0.0 110.617 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.73 ' HB3' HG21 ' A' ' 253' ' ' THR . 36.5 t -90.63 -179.21 5.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.526 ' O ' ' HB ' ' A' ' 253' ' ' THR . 32.9 t70 -59.85 156.98 13.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 253' ' ' THR . 0.2 OUTLIER -76.31 68.17 2.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.772 ' HB3' HD12 ' A' ' 249' ' ' ILE . 28.5 mt-10 -83.22 47.32 1.23 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.232 -175.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 1.028 ' HA ' ' HA2' ' A' ' 252' ' ' GLY . 11.2 pt-20 -71.75 -26.06 62.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.171 -173.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -94.89 -3.25 49.09 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.122 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.772 HD12 ' HB3' ' A' ' 246' ' ' GLU . 44.5 mt -77.24 -59.3 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.08 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -166.42 -56.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 111.233 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 23.1 ttt -79.23 -54.58 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.978 -174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 1.028 ' HA2' ' HA ' ' A' ' 247' ' ' GLU . . . 98.35 84.99 1.8 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.915 -175.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.73 HG21 ' HB3' ' A' ' 243' ' ' CYS . 4.0 m -90.43 85.38 6.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.044 0.45 . . . . 0.0 110.39 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' A' ' 256' ' ' GLY . 31.9 t60 -143.3 105.55 4.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.459 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -69.5 32.17 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.598 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 254' ' ' HIS . . . -91.3 -2.84 70.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.464 -173.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.579 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 12.6 t80 -62.89 112.29 2.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 100.23 12.09 40.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.188 -1.005 . . . . 0.0 113.554 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.6 t -74.55 -15.48 60.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.038 0.447 . . . . 0.0 110.139 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -88.8 -26.47 21.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.591 0.71 . . . . 0.0 109.339 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.4 144.22 5.01 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.311 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.0 mp -105.46 98.2 7.93 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.434 0.294 . . . . 0.0 111.372 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 37.6 tttm -84.48 118.0 24.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.015 0.435 . . . . 0.0 110.648 -176.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.46 107.21 0.54 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 283' ' ' ASP . 85.9 mt -80.75 -51.62 8.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.714 0.292 . . . . 0.0 110.351 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.0 t -150.71 163.16 39.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.531 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.3 t60 -137.03 139.68 41.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 0.0 111.509 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -133.23 138.69 46.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.836 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.531 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 9.2 mt-10 -108.15 121.88 45.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.072 0.463 . . . . 0.0 110.069 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -139.97 174.08 10.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.135 -173.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.65 113.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 17.8 t -120.38 121.64 39.02 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.416 -171.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 58.65 30.17 19.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.523 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.98 82.95 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.027 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -110.22 127.32 54.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 0.189 . . . . 0.0 110.503 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 50.6 m -65.25 132.12 48.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.69 154.11 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.853 0.835 . . . . 0.0 112.591 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.472 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 88.4 mt -94.38 114.36 26.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.734 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 20.3 ttpp -109.04 114.84 28.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.48 HD11 ' HE1' ' A' ' 312' ' ' PHE . 38.0 mt -115.72 130.83 57.0 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.251 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 23.0 m -93.91 111.79 23.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.531 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 77.3 m-85 -100.99 159.7 14.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.84 -172.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 35.9 t70 -122.94 137.45 28.13 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.652 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.579 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 86.9 Cg_endo -85.54 11.32 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.213 1.942 . . . . 0.0 112.083 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.05 -15.71 39.72 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -154.14 115.56 4.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.339 0.59 . . . . 0.0 110.161 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.58 -7.77 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.654 0.74 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.13 -20.15 61.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.134 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.6 -38.63 39.49 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 145.31 168.21 12.82 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.243 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.11 143.06 26.61 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 223' ' ' PHE . 0.9 OUTLIER -117.42 117.5 29.64 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.473 ' N ' HD22 ' A' ' 292' ' ' LEU . 5.5 m -108.94 138.21 45.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 92.0 t -132.13 132.98 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.543 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 70.6 mt-10 -104.16 116.34 32.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.588 170.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.56 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 11.1 p -128.06 167.24 17.02 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.992 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -81.65 161.14 23.55 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.721 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.8 mm? -61.54 -13.36 20.74 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.26 -169.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -108.18 13.11 26.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.591 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -71.69 119.35 73.62 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.673 0.273 . . . . 0.0 110.888 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.44 136.39 17.51 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.21 1.94 . . . . 0.0 112.105 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.56 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 87.6 m-85 -122.77 118.15 27.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.694 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 17.0 t80 -74.5 101.65 4.23 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.368 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.49 HG13 ' HB3' ' A' ' 332' ' ' ASP . 53.4 t -90.6 135.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.205 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.604 ' HB3' HG13 ' A' ' 333' ' ' VAL . 59.1 tttm -62.0 128.4 35.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.75 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 16.3 m120 72.55 11.32 5.62 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.72 0.637 . . . . 0.0 111.721 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -128.3 -42.9 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.986 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 100.15 -153.3 19.39 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -63.97 116.84 6.24 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 117.24 0.52 . . . . 0.0 109.795 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.7 m -128.31 166.43 18.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.034 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -160.43 167.05 28.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.749 0.309 . . . . 0.0 110.656 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.48 ' HE1' HD11 ' A' ' 280' ' ' LEU . 71.0 m-85 -85.98 -19.57 30.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.113 173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -137.21 72.78 52.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.656 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.533 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 76.4 Cg_exo -52.62 -37.62 74.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.924 2.416 . . . . 0.0 113.19 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.4 t -68.76 -22.48 64.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 0.0 110.511 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 44.2 tp -87.92 -47.01 8.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.379 . . . . 0.0 110.218 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 m -55.02 -41.66 71.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.999 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.99 -17.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 111.58 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.56 -39.86 11.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.311 0.576 . . . . 0.0 110.458 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -79.47 -46.12 18.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.368 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -107.88 -12.32 15.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.61 0.243 . . . . 0.0 111.106 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 81.4 14.97 77.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 45.1 mt -109.26 114.55 57.61 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 122.628 -0.337 . . . . 0.0 110.86 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -72.07 116.27 4.64 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.527 2.151 . . . . 0.0 110.561 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 68.1 m -117.93 156.37 28.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.183 0.516 . . . . 0.0 112.101 -170.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.2 m -83.49 160.05 21.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.49 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.21 127.18 32.17 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.436 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -76.61 172.79 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.697 -178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.25 143.87 50.88 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.703 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 32.4 mm -63.03 111.97 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.813 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.502 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 116.12 -0.14 20.93 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.401 -173.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.49 ' HB3' HG13 ' A' ' 304' ' ' VAL . 66.0 m-20 -73.53 125.33 27.71 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.275 0.559 . . . . 0.0 110.755 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.0 OUTLIER -88.01 127.78 40.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.829 0.823 . . . . 0.0 112.041 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 42.0 t -89.51 131.08 35.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.73 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 63.8 mt -102.92 141.87 23.39 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.699 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.523 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 52.7 Cg_endo -89.13 170.26 4.94 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.844 2.362 . . . . 0.0 111.889 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.59 135.02 40.43 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.384 2.056 . . . . 0.0 111.243 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 98.76 -15.7 60.53 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.483 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -72.44 128.4 88.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.16 -31.27 54.29 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.123 3.216 . . . . 0.0 114.078 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.37 -24.0 42.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.249 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.44 85.07 3.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 172.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 79.1 mt -73.95 -44.15 51.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.014 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -114.56 62.51 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 110.441 -175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 4.9 t80 . . . . . 0 C--O 1.247 0.951 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.653 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 N-CA-C 111.161 -0.361 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 8.1 t -90.03 103.97 16.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.4 p -87.48 146.68 25.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.006 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.477 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.2 mm -90.44 -38.3 10.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.245 0.545 . . . . 0.0 109.607 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.413 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 82.8 t90 -157.1 128.73 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.25 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.535 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 38.7 t-80 57.83 -151.51 0.42 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 37.3 t -88.37 46.36 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.779 -0.576 . . . . 0.0 110.411 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -117.44 139.12 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.166 176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.84 171.98 7.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.314 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.28 135.71 56.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.735 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 100.08 10.39 45.78 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.797 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 62.1 m -103.56 145.7 29.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 220' ' ' ARG . 2.0 mpt_? -115.7 142.6 46.53 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.766 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 71.9 mt -118.91 148.6 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.697 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 7.7 m -156.96 96.53 1.61 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.444 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.413 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 3.8 m-85 -88.87 126.21 35.27 Favored 'General case' 0 C--O 1.228 -0.066 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -78.24 -9.7 59.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.872 0.368 . . . . 0.0 110.467 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -18.95 62.26 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.675 174.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.52 -166.5 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 6.6 t -93.74 49.51 1.36 Allowed 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.931 -0.48 . . . . 0.0 111.098 -173.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -77.14 75.57 3.7 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -86.04 -49.89 7.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.72 157.21 19.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -87.63 122.96 31.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -163.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 6.2 pt20 -100.55 157.85 16.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.58 162.8 15.47 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.5 t -58.17 -47.54 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' ARG . 28.8 mt-10 -55.49 -23.8 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.381 -1.282 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.72 -46.02 14.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.68 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.532 ' CZ ' ' HG3' ' A' ' 255' ' ' LYS . 88.0 t80 -75.16 -39.38 60.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.754 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -66.24 -26.06 67.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.29 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 41.8 ttm105 -67.57 -33.67 75.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.838 0.827 . . . . 0.0 109.474 174.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -81.39 -8.72 59.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.029 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 255' ' ' LYS . . . -70.15 -7.22 39.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.9 m -58.72 -45.83 88.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.72 82.98 5.71 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.902 ' HA ' ' HD3' ' A' ' 255' ' ' LYS . 6.5 p-10 -76.89 -8.95 58.3 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.198 0.523 . . . . 0.0 111.58 -170.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -136.09 102.29 4.97 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.506 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.686 ' HG2' HD12 ' A' ' 249' ' ' ILE . 41.0 mt-10 -107.56 39.3 1.94 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 0.0 109.666 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.92 -33.69 74.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.699 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.43 -27.41 24.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.839 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.686 HD12 ' HG2' ' A' ' 246' ' ' GLU . 31.7 mt -69.92 -49.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.65 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -133.72 -61.73 0.79 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.587 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 50.3 tpp -160.79 -68.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.971 0.415 . . . . 0.0 110.81 -175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -174.32 101.32 0.16 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.892 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 246' ' ' GLU . 15.6 m -98.98 -66.56 0.89 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 80.6 t60 53.64 91.07 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.393 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.902 ' HD3' ' HA ' ' A' ' 244' ' ' ASP . 13.1 mptt -63.23 -7.91 7.12 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.014 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.61 9.75 61.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.315 -0.469 . . . . 0.0 112.978 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.593 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 13.9 t80 -60.56 115.75 3.83 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.37 0.585 . . . . 0.0 109.612 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 98.7 14.17 38.28 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.174 -1.013 . . . . 0.0 112.695 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 8.1 t -69.05 -14.76 63.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.106 0.479 . . . . 0.0 110.879 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -100.95 -28.89 12.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.392 0.615 . . . . 0.0 110.316 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.4 153.65 6.85 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.628 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.467 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -121.64 102.45 8.23 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -0.616 . . . . 0.0 110.462 176.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.717 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.4 ttpt -87.79 125.09 34.25 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.203 0.525 . . . . 0.0 111.051 -176.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.8 tt -66.37 102.93 0.93 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.181 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.06 -52.94 8.46 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.743 0.306 . . . . 0.0 110.46 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 21.4 t -146.34 157.97 43.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.128 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.448 ' ND1' HD23 ' A' ' 280' ' ' LEU . 9.3 t60 -141.85 145.32 34.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.288 0.566 . . . . 0.0 111.289 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 279' ' ' LYS . 34.1 tt0 -137.79 141.41 40.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.693 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -102.33 99.06 9.11 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.8 t -113.66 178.14 4.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.607 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 6.5 p -133.8 119.69 33.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.323 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 t -117.45 115.86 26.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 55.76 33.95 22.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.29 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 98.6 -21.3 46.63 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.844 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -95.45 119.61 34.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.472 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 41.5 m -70.89 134.88 47.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.8 m -135.54 155.82 37.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.97 105.31 17.74 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.901 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 268' ' ' GLU . 82.3 tttt -94.03 105.09 17.11 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.994 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 14.0 mt -115.64 132.22 56.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.966 0.413 . . . . 0.0 111.464 -175.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 m -104.33 117.49 34.33 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 171.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.536 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 92.5 m-85 -105.41 168.65 8.94 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.096 0.475 . . . . 0.0 111.974 -171.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -137.43 136.77 20.88 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.511 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.593 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 66.4 Cg_endo -80.72 8.86 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.025 1.817 . . . . 0.0 112.451 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.65 -23.09 10.44 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 8.4 t -154.19 133.78 12.84 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.92 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.3 -7.21 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.296 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -56.95 -24.63 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.851 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -88.13 -46.96 8.84 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.561 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.72 148.84 4.83 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.99 152.54 45.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.724 0.297 . . . . 0.0 110.617 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 293' ' ' THR . 0.9 OUTLIER -133.11 117.04 17.03 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.454 ' N ' HD22 ' A' ' 292' ' ' LEU . 7.4 m -105.97 135.98 46.46 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.536 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 69.5 t -135.39 122.96 36.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.151 0.501 . . . . 0.0 111.135 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -107.49 110.06 21.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.327 -178.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.545 ' HG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.0 p -125.37 175.63 7.34 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.566 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -75.77 166.13 23.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.521 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 298' ' ' LEU . 2.0 mm? -71.75 -18.01 62.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.61 -168.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -100.43 19.63 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.28 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -76.26 121.62 85.28 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.665 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.46 133.03 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.371 2.047 . . . . 0.0 111.626 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.545 ' HZ ' ' HG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -119.4 121.7 40.11 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.943 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 28.0 t80 -76.23 102.15 5.7 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.752 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 78.6 t -92.62 134.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.3 0.571 . . . . 0.0 111.097 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.559 ' HB3' HG13 ' A' ' 333' ' ' VAL . 63.9 tttp -62.08 127.23 30.39 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.241 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 17.0 m120 76.01 3.39 3.73 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.792 0.683 . . . . 0.0 111.947 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -123.95 -28.88 3.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 87.2 -153.74 25.69 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.06 115.04 4.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.03 0.443 . . . . 0.0 110.363 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.48 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.1 m -125.45 168.08 14.09 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.926 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -162.26 178.63 8.54 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.356 -0.215 . . . . 0.0 110.452 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 52.2 m-85 -95.94 -22.07 17.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -134.84 68.19 71.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 84.3 Cg_exo -48.92 -37.83 37.48 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 113.379 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 30.3 m -62.3 -31.28 71.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.084 0.469 . . . . 0.0 111.041 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 59.9 tp -87.49 -44.15 11.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.437 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 m -56.42 -39.52 73.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.728 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.7 p -71.75 -23.51 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 -43.92 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.243 0.544 . . . . 0.0 110.216 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -75.88 -54.29 7.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.245 -175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -99.34 -15.73 18.69 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.241 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 87.57 10.11 70.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.8 mt -109.72 117.73 51.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.583 0.191 . . . . 0.0 110.839 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 104.31 1.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.567 2.178 . . . . 0.0 110.405 175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 64.3 m -102.45 156.5 17.56 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.196 -169.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 56.1 m -79.82 152.95 29.44 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.945 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -79.26 117.66 20.47 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.48 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -68.45 165.09 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 0.0 110.726 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -121.36 140.72 51.74 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.9 mm -55.48 112.13 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.147 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.48 3.58 20.58 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.139 -176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 50.8 m-20 -81.01 135.24 35.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 111.117 177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.5 p -96.13 135.31 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.598 0.713 . . . . 0.0 112.129 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 60.2 m -100.82 135.53 42.12 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.742 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 81.0 mt -104.74 142.0 23.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.353 -175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.78 165.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.214 2.609 . . . . 0.0 111.993 175.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.39 121.34 8.45 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.461 2.107 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 112.66 -11.2 25.6 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.446 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.3 127.22 86.74 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.7 -24.75 38.89 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.662 2.908 . . . . 0.0 113.935 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.23 -31.86 43.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.275 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -71.1 91.79 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.113 0.482 . . . . 0.0 110.028 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 55.4 mt -74.58 -48.92 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.344 -176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.56 53.43 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.994 0.426 . . . . 0.0 110.673 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.023 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 110.553 -0.595 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.1 t -95.45 94.82 8.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.325 0.583 . . . . 0.0 110.229 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 13.8 p -86.0 141.92 29.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.162 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 11.6 mm -88.36 -38.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.346 0.593 . . . . 0.0 109.72 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.417 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 67.8 t90 -156.15 135.93 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.386 176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.405 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 18.8 t-80 53.53 -141.04 0.89 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 53.3 t -98.4 38.68 1.31 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.498 0.666 . . . . 0.0 109.931 176.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.55 139.35 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.241 0.544 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -98.4 173.17 7.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.383 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -62.57 137.57 58.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.113 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.37 -5.76 60.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.096 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.561 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 90.1 m -82.54 145.64 29.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -113.41 139.3 49.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.382 0.61 . . . . 0.0 111.383 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 53.5 mt -113.45 148.01 36.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.193 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 228' ' ' ASN . 11.7 t -153.9 98.09 2.14 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.2 0.524 . . . . 0.0 110.653 174.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -79.88 116.27 19.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.762 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.86 ' HA ' ' HB2' ' A' ' 228' ' ' ASN . 11.2 m170 -64.17 -24.66 67.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.091 0.472 . . . . 0.0 110.591 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' A' ' 289' ' ' ASP . 39.2 tttp -70.46 -17.87 62.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.05 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.447 ' HB2' ' H ' ' A' ' 227' ' ' SER . 7.9 mt-10 -126.85 -101.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.115 0.483 . . . . 0.0 111.319 -176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.447 ' H ' ' HB2' ' A' ' 226' ' ' GLU . 15.5 t -93.27 65.4 3.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.665 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.86 ' HB2' ' HA ' ' A' ' 224' ' ' HIS . 3.2 t-20 -80.8 38.76 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.903 0.859 . . . . 0.0 109.733 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.581 ' HG3' ' HG3' ' A' ' 230' ' ' GLU . 18.7 pttp -112.82 -30.4 7.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.563 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.581 ' HG3' ' HG3' ' A' ' 229' ' ' LYS . 42.0 mt-10 -135.36 173.03 12.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.745 0.307 . . . . 0.0 110.283 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -107.67 137.3 45.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 9.4 pt20 -124.98 162.15 25.12 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.39 162.99 17.88 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.067 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.561 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.3 t -59.76 -44.41 93.79 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -55.77 -23.57 30.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.975 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.19 -53.95 6.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.225 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.57 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 67.2 t80 -68.89 -42.81 76.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -56.29 -41.13 75.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -65.0 -33.35 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.719 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -78.48 -39.15 39.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.379 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -90.72 17.2 7.91 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.738 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 33.0 p -76.1 -25.45 55.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.597 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 20.5 m -72.92 156.36 38.94 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.623 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.29 147.73 46.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 166.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 254' ' ' HIS . 2.2 p-10 -79.82 57.14 2.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -167.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -80.03 -17.51 52.57 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -79.72 -34.04 40.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.715 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 253' ' ' THR . 34.7 tt0 -141.89 67.5 1.33 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.265 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.4 mt -59.75 -31.3 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 113.034 -1.893 . . . . 0.0 111.984 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -71.89 -54.19 10.84 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.219 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 47.2 ttp -91.74 -67.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.184 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 131.91 93.6 0.59 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.919 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.453 ' H ' ' HB3' ' A' ' 248' ' ' GLU . 14.5 m -76.15 77.47 2.97 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 245' ' ' ASN . 47.4 t60 -160.01 178.5 9.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -170.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -88.53 41.95 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.68 0.276 . . . . 0.0 111.013 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -91.36 -34.2 7.63 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.955 -0.641 . . . . 0.0 113.745 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 46.2 t80 -64.73 121.44 14.53 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.707 0.753 . . . . 0.0 110.491 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 83.72 24.14 50.75 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.453 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 36.0 t -78.01 -5.94 52.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.605 0.241 . . . . 0.0 111.59 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.04 -31.06 7.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.495 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 161.41 153.3 6.98 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.102 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.5 mp -121.2 103.69 9.18 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.904 0.482 . . . . 0.0 110.717 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 30.0 tttm -87.29 119.61 27.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.973 0.416 . . . . 0.0 110.558 -178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.78 113.31 2.2 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 283' ' ' ASP . 89.0 mt -87.43 -52.05 5.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 31.1 t -145.76 160.24 42.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.322 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' LYS . 6.3 t60 -143.36 141.58 30.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.976 0.417 . . . . 0.0 111.217 -175.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 41.5 tt0 -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.478 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -100.97 124.08 46.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.4 m -146.22 167.71 22.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.917 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.31 129.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 12.3 t -131.99 119.82 21.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 56.48 39.35 30.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 111.298 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 81.12 -6.11 64.4 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.884 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -102.46 120.45 40.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.613 0.245 . . . . 0.0 111.147 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 34.1 m -66.74 127.66 33.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.36 156.83 39.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.981 0.896 . . . . 0.0 113.307 -172.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 298' ' ' LEU . 92.8 mt -96.9 114.34 25.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.818 -1.537 . . . . 0.0 108.987 172.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 4.5 ttmp? -97.84 109.9 22.57 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.449 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 16.4 mt -116.55 127.01 54.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.467 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 90.3 m -98.02 120.02 37.67 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.492 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 91.0 m-85 -105.41 161.74 14.06 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.462 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.437 ' HB2' HD21 ' A' ' 265' ' ' LEU . 37.4 t70 -125.8 132.08 24.2 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.524 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 73.3 Cg_endo -80.59 11.11 3.03 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.302 2.002 . . . . 0.0 111.706 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.4 11.08 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.334 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.6 t -153.67 138.01 16.66 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.045 0.45 . . . . 0.0 110.354 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.81 -9.27 12.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.895 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -34.68 74.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.93 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 57.5 m-20 -78.71 -44.09 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.609 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 142.74 161.13 8.66 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.985 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.57 145.24 25.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.013 0.435 . . . . 0.0 110.645 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.66 122.52 27.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 99.6 m -115.79 136.39 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.6 t -129.76 136.42 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.192 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -117.47 120.99 39.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.43 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.8 p -136.89 169.88 17.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.046 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -64.82 161.86 17.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.403 0.62 . . . . 0.0 111.13 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -70.71 -18.09 62.81 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.503 -168.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -101.34 24.14 9.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.374 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.9 122.31 86.23 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.551 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -80.76 129.76 7.34 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.381 2.054 . . . . 0.0 111.999 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.477 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 93.7 m-85 -116.52 118.48 32.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 35.3 t80 -73.78 100.06 3.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.707 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 74.8 t -88.7 134.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.342 0.591 . . . . 0.0 110.743 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.523 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.8 tttp -57.96 127.44 32.07 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.682 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.3 m-20 76.85 -2.79 2.62 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.036 0.835 . . . . 0.0 111.945 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -119.46 -21.2 7.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.758 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 78.21 -152.01 37.52 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.846 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -63.38 115.68 4.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 164.51 21.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.019 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 9.4 t -161.53 176.88 10.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.844 0.354 . . . . 0.0 111.25 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 328' ' ' ILE . 63.0 m-85 -87.58 -34.38 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.347 177.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.01 71.82 53.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.24 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 80.9 Cg_exo -52.09 -36.94 67.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.839 2.359 . . . . 0.0 112.756 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 5.9 p -63.55 -29.35 70.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.2 0.524 . . . . 0.0 111.299 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.26 -47.42 8.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.8 m -56.5 -41.3 76.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.366 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.444 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 14.7 p -69.06 -21.33 25.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 111.68 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 73.1 t -91.28 -29.51 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.567 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -89.82 -52.15 5.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.966 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -99.92 -6.46 26.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 74.4 20.34 79.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.759 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.6 116.18 36.93 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.645 0.222 . . . . 0.0 110.798 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.98 106.31 1.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.729 2.286 . . . . 0.0 111.238 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 67.7 m -106.53 151.2 25.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.038 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 65.2 m -79.66 147.97 31.8 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.858 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.14 134.28 51.46 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.958 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -88.44 171.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.143 0.496 . . . . 0.0 110.101 178.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -132.57 156.71 46.37 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.72 110.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.443 ' O ' ' HE2' ' A' ' 263' ' ' LYS . . . 115.47 4.05 20.21 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.845 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.74 127.57 32.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.444 0.622 . . . . 0.0 110.341 174.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.9 p -90.92 136.97 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.862 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 56.9 m -102.32 134.91 44.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.387 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 66.1 mt -101.93 145.91 31.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.12 165.25 8.46 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.988 2.459 . . . . 0.0 112.49 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.26 122.64 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.645 2.23 . . . . 0.0 111.755 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.68 -17.6 27.82 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.706 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -65.99 125.64 90.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.48 -21.67 72.52 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 123.01 2.473 . . . . 0.0 113.128 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.63 -23.16 29.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.586 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -70.19 99.12 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 69.9 mt -70.46 -45.31 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.206 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -124.44 84.96 2.34 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.279 -0.263 . . . . 0.0 110.879 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.408 -0.806 . . . . 0.0 110.46 -178.863 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 N-CA-C 110.718 -0.532 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 38.3 t -94.3 93.06 7.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.342 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -85.31 140.23 30.98 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.992 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.475 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.8 mm -91.78 -43.18 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.209 0.528 . . . . 0.0 109.886 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -149.8 126.86 11.23 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 26.2 t-80 59.74 -149.59 0.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.483 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 43.8 t -90.68 36.15 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.367 0.604 . . . . 0.0 110.414 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 62.5 m-85 -106.39 141.48 37.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.213 0.53 . . . . 0.0 111.059 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.88 170.38 8.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.367 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -67.16 131.39 45.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 103.82 7.72 41.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.905 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 57.3 m -97.89 150.2 21.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 219' ' ' THR . 7.9 mpt_? -114.95 143.07 45.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.771 0.32 . . . . 0.0 110.6 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 73.8 mt -120.71 147.66 44.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.605 -171.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 38.2 t -155.29 102.7 2.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.526 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 292' ' ' LEU . 7.4 m-85 -90.08 128.06 36.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -75.13 -15.79 60.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.5 -32.61 74.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.889 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -111.57 172.56 6.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.734 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 45.7 m -88.47 41.03 0.99 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.411 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 232' ' ' GLN . 66.2 t30 -119.61 87.57 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 110.06 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -78.14 -42.8 30.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.126 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -65.15 146.61 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.604 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -75.18 126.96 32.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.898 -170.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.482 ' HB3' HD21 ' A' ' 228' ' ' ASN . 19.3 pt20 -107.78 160.81 15.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.951 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -83.56 159.38 21.66 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.471 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.8 t -57.95 -51.45 70.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -55.2 -23.46 22.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.837 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.84 -52.33 11.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.382 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.33 -39.95 62.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.201 0.525 . . . . 0.0 110.486 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 211' ' ' ILE . . . -64.1 -26.3 68.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.877 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 242' ' ' SER . 31.5 ttt180 -73.07 -34.82 66.48 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.249 0.547 . . . . 0.0 109.714 175.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -66.84 -43.01 84.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.538 0.685 . . . . 0.0 109.929 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -93.41 29.55 1.93 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.096 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 239' ' ' ARG . 26.5 t -49.96 -60.97 2.42 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.174 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.447 ' HB2' ' OG1' ' A' ' 253' ' ' THR . 7.5 m -62.5 151.89 36.17 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 175.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 254' ' ' HIS . 48.2 m-20 -77.11 -39.58 48.97 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.464 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.5 p30 176.03 133.72 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.086 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -105.8 43.41 1.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.549 0.69 . . . . 0.0 109.341 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -96.53 1.09 51.07 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.854 -174.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.1 -29.69 60.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 62.7 mt -77.26 -51.85 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.089 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -174.8 -58.09 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.918 177.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 41.5 ttm -170.61 146.09 2.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -158.73 -104.06 0.2 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.857 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 243' ' ' CYS . 0.8 OUTLIER -80.56 -92.25 0.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 244' ' ' ASP . 16.1 t-80 69.12 109.17 0.05 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.031 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.402 ' NZ ' ' HA ' ' A' ' 244' ' ' ASP . 14.6 mptt -52.88 -40.5 63.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.941 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 77.37 -79.78 1.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.791 -0.641 . . . . 0.0 114.157 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.521 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 52.6 t80 -80.46 131.42 35.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.391 0.596 . . . . 0.0 111.739 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 78.56 25.17 61.34 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.556 -0.747 . . . . 0.0 114.2 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 52.7 p -76.64 -8.98 58.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.573 0.687 . . . . 0.0 111.878 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -110.18 -30.23 7.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.541 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 165.26 158.01 10.24 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.821 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -126.3 101.48 6.75 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.082 0.553 . . . . 0.0 110.528 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 23.9 ttpp -87.7 119.59 28.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.291 0.567 . . . . 0.0 110.686 -175.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.78 107.39 0.96 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.237 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 81.3 mt -81.2 -48.26 12.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.836 0.35 . . . . 0.0 110.765 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.1 t -152.69 164.88 36.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.149 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.538 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 9.9 t60 -146.4 138.74 25.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.375 0.607 . . . . 0.0 111.992 -174.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 10.2 tt0 -133.04 140.65 47.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.413 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.538 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 10.1 mt-10 -108.56 108.64 19.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.381 0.61 . . . . 0.0 110.323 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 31.2 t -126.8 179.17 5.5 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.731 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.59 131.23 73.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.2 t -133.13 121.01 21.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 58.52 36.44 25.23 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 85.3 -15.01 47.54 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.068 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.8 122.02 41.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 111.2 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.8 m -67.62 133.72 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.597 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.62 154.06 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.791 0.805 . . . . 0.0 112.486 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.88 108.18 19.8 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.394 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.646 ' HD2' ' HB3' ' A' ' 268' ' ' GLU . 2.3 ttmp? -92.29 108.34 19.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.419 HD11 ' HE1' ' A' ' 312' ' ' PHE . 14.7 mt -116.0 120.02 37.78 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.655 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 8.8 m -90.97 116.48 28.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.495 ' HE2' ' HB ' ' A' ' 294' ' ' VAL . 69.6 m-85 -105.25 167.82 9.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.359 0.599 . . . . 0.0 112.433 -171.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -135.44 134.62 21.28 Favored Pre-proline 0 C--O 1.217 -0.606 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.458 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.521 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 73.9 Cg_endo -77.64 9.6 2.87 Favored 'Trans proline' 0 C--N 1.327 -0.558 0 C-N-CA 121.557 1.505 . . . . 0.0 112.169 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.95 -5.43 56.38 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -154.64 135.42 13.63 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.352 0.596 . . . . 0.0 110.766 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.44 -8.04 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.32 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.27 -39.92 80.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.583 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -82.45 -46.75 13.07 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.392 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 136.24 176.67 14.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.77 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 8.2 mt -84.74 150.88 24.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.884 -177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 293' ' ' THR . 1.0 OUTLIER -136.45 121.04 18.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.434 ' N ' HD22 ' A' ' 292' ' ' LEU . 14.1 m -108.36 134.27 51.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' A' ' 282' ' ' PHE . 97.3 t -129.47 128.58 66.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.101 0.476 . . . . 0.0 110.881 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -113.97 107.88 16.28 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.455 -177.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' HB3' HG23 ' A' ' 219' ' ' THR . 5.5 p -123.6 173.14 8.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.093 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -75.88 163.29 27.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.736 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.6 mm? -65.6 -14.32 60.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.066 -170.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -99.02 11.13 39.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.784 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.21 118.97 73.92 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.151 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -77.81 133.29 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.405 2.07 . . . . 0.0 111.814 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -119.49 119.58 34.28 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 25.7 t80 -74.51 107.19 6.49 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.518 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' A' ' 332' ' ' ASP . 57.0 t -94.89 133.39 35.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.309 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.736 ' HB3' HG13 ' A' ' 333' ' ' VAL . 55.4 tttp -63.95 128.92 37.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.575 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 6.4 m-20 75.39 12.73 3.18 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.98 0.8 . . . . 0.0 112.027 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -133.51 -48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.015 0.436 . . . . 0.0 111.268 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 105.97 -156.45 16.43 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -171.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -61.3 114.58 3.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 117.312 0.556 . . . . 0.0 110.678 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 328' ' ' ILE . 19.5 m -128.92 166.46 19.09 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.257 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.7 t -161.36 175.07 12.63 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.252 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.449 ' CE2' HD11 ' A' ' 328' ' ' ILE . 76.6 m-85 -88.48 -37.42 15.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.743 173.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -122.53 77.17 46.05 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.895 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -58.18 -31.41 93.34 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.975 2.45 . . . . 0.0 113.114 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 40.4 t -75.8 -21.2 57.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.341 0.591 . . . . 0.0 110.073 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.88 -48.6 7.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.217 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 51.6 m -51.49 -40.3 59.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.054 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.2 p -74.79 -29.54 23.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.209 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.36 -37.45 79.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.63 0.729 . . . . 0.0 110.319 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -100.8 -38.94 8.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.047 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -107.18 -3.63 19.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.142 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 69.35 16.16 71.04 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.942 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.3 mt -112.72 109.6 52.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.666 -0.314 . . . . 0.0 110.588 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.74 118.03 5.15 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.737 2.291 . . . . 0.0 110.211 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 61.0 m -116.76 160.52 20.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.302 0.572 . . . . 0.0 112.494 -168.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 76.2 m -81.09 166.66 20.52 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.976 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -93.26 129.35 39.36 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.449 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -73.6 168.3 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.258 0.551 . . . . 0.0 110.696 -177.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -125.23 142.18 51.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 30.2 mm -55.56 114.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.878 0.37 . . . . 0.0 110.079 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 116.27 -4.24 20.13 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.159 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.423 ' HB3' HG13 ' A' ' 304' ' ' VAL . 54.2 m-20 -73.63 132.87 43.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.301 0.572 . . . . 0.0 111.104 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -95.3 134.36 33.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.171 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.9 t -96.14 133.06 40.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.401 -176.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 83.6 mt -102.04 140.58 21.3 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.39 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.59 163.68 9.37 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.933 2.422 . . . . 0.0 112.152 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.57 122.58 10.51 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.587 2.192 . . . . 0.0 112.023 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.97 -7.17 41.05 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.426 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -74.44 125.83 89.43 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.71 -22.13 51.13 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.451 2.767 . . . . 0.0 114.233 -171.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.76 -28.47 44.81 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.726 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.463 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -76.05 85.3 2.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 86.4 mt -70.71 -43.89 76.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.892 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -124.05 81.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.534 -178.795 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.481 0.751 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 19.2 t -110.44 99.02 8.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.035 0.445 . . . . 0.0 110.067 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.5 p -84.07 150.49 25.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.895 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.487 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 12.0 mm -90.35 -40.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.702 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.476 ' CH2' ' HE2' ' A' ' 223' ' ' PHE . 85.7 t90 -150.14 125.94 10.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.132 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 336' ' ' PRO . 28.6 t-80 60.94 -138.54 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 43.8 t -95.4 32.38 1.78 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.252 0.548 . . . . 0.0 110.32 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 219' ' ' THR . 66.4 m-85 -107.48 137.73 44.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.399 0.619 . . . . 0.0 111.645 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.71 178.75 4.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.284 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -63.06 144.62 56.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.262 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.54 11.71 63.76 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.399 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 44.9 m -101.88 145.74 28.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 294' ' ' VAL . 1.0 OUTLIER -111.81 136.29 51.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.727 0.299 . . . . 0.0 110.594 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.417 ' HB2' HE21 ' A' ' 232' ' ' GLN . 69.6 mt -114.42 144.18 43.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.727 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . 0.567 ' HB3' HD22 ' A' ' 228' ' ' ASN . 8.5 m -154.08 93.92 1.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.08 174.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.476 ' HE2' ' CH2' ' A' ' 212' ' ' TRP . 11.7 m-85 -80.67 126.6 31.48 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -75.42 -12.44 60.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.052 0.453 . . . . 0.0 110.066 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -60.06 -30.17 69.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.633 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -114.95 169.93 8.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.935 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.3 m -74.45 69.19 1.64 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.989 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.567 HD22 ' HB3' ' A' ' 222' ' ' CYS . 20.3 p-10 -65.7 101.12 0.59 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 121.772 0.796 . . . . 0.0 111.458 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -91.67 -45.71 8.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.532 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -118.93 161.35 20.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.234 -171.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -80.74 113.0 18.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 110.416 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 221' ' ' LEU . 16.7 pt20 -96.38 153.21 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.67 158.35 20.84 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -55.68 -49.73 72.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.424 0.631 . . . . 0.0 109.84 176.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.25 -23.24 55.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.762 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.37 -58.03 3.53 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.995 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -62.65 -48.27 80.08 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.123 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.61 -41.08 80.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.632 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -83.68 -22.95 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.945 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.63 -29.85 20.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.56 90.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.774 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.942 ' HB3' HG22 ' A' ' 253' ' ' THR . 34.6 p 178.77 -177.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.463 0.477 . . . . 0.0 110.395 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 41.8 m -90.12 -33.24 16.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.518 ' HA ' ' HZ2' ' A' ' 255' ' ' LYS . 25.9 t70 179.52 -28.9 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.522 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -165.98 91.48 0.48 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.66 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.652 ' HB2' HG21 ' A' ' 253' ' ' THR . 6.6 mm-40 -107.67 38.86 2.05 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -60.64 -26.93 67.41 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.905 -170.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -70.44 -24.75 62.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.037 0.446 . . . . 0.0 110.365 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.629 HG22 ' HG2' ' A' ' 250' ' ' GLN . 61.9 mt -68.08 -45.17 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.726 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.629 ' HG2' HG22 ' A' ' 249' ' ' ILE . 22.5 mm-40 -131.99 -85.05 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.415 -176.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -170.05 -69.09 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -101.92 102.84 2.4 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 242' ' ' SER . 2.4 m -137.91 73.99 1.46 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.5 0.667 . . . . 0.0 109.426 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -152.1 158.9 43.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.989 -169.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' HZ2' ' HA ' ' A' ' 244' ' ' ASP . 12.2 mptt -69.78 44.14 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.591 0.357 . . . . 0.0 111.124 174.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.03 91.34 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -63.56 115.34 4.6 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-N 117.8 0.8 . . . . 0.0 110.544 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 91.11 14.92 56.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.447 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 29.6 t -68.5 -12.99 62.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 117.093 0.447 . . . . 0.0 111.795 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -102.96 -32.54 9.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 0.0 109.977 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.56 160.73 10.51 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.427 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 283' ' ' ASP . 4.4 mp -123.67 100.53 6.83 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.455 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 39.9 ttpt -82.18 122.36 27.79 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.009 0.433 . . . . 0.0 110.173 -177.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.492 ' CD1' HD22 ' A' ' 280' ' ' LEU . 46.1 tp -64.28 103.19 0.6 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.897 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 283' ' ' ASP . 59.1 mt -81.94 -44.16 17.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.761 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 45.2 t -151.91 152.13 32.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.329 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.573 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.5 t60 -135.52 137.71 42.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.471 0.653 . . . . 0.0 111.466 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 34.1 tt0 -129.48 140.46 51.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.969 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.573 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 21.7 mt-10 -115.33 103.52 10.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.272 174.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -120.38 174.28 6.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.78 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.3 104.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.809 0.814 . . . . 0.0 109.047 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.4 t -93.72 104.68 16.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.578 -170.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 57.94 17.79 4.58 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.476 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 123.85 -15.34 7.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.929 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.98 122.73 47.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.198 0.499 . . . . 0.0 111.472 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.0 m -62.52 128.06 34.25 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.44 155.15 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.852 0.834 . . . . 0.0 112.785 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.567 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 82.8 mt -93.13 108.0 19.69 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.838 172.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 49.5 tttm -103.64 106.89 17.53 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.499 HD12 ' HZ ' ' A' ' 282' ' ' PHE . 9.6 mt -111.91 140.85 46.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.24 -173.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 21.9 m -112.92 116.07 29.43 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.499 ' HZ ' HD12 ' A' ' 280' ' ' LEU . 86.6 m-85 -108.96 161.76 14.85 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -170.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.513 ' HB2' HD21 ' A' ' 265' ' ' LEU . 17.6 t70 -121.54 132.34 24.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.118 172.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.74 10.18 3.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.589 2.192 . . . . 0.0 113.047 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.99 -17.72 51.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.894 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.1 t -145.46 128.32 16.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.291 0.567 . . . . 0.0 110.24 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.49 -11.01 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.244 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.44 -31.31 72.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.096 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.96 -46.48 15.06 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.712 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 131.06 -163.42 23.5 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.988 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 mt -108.85 165.07 11.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.728 0.299 . . . . 0.0 110.858 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -136.18 119.58 16.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 17.3 m -108.88 135.82 49.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 53.2 t -136.71 136.1 48.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -100.64 124.25 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.21 167.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 278' ' ' LEU . 7.0 p -136.86 170.79 15.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.652 0.263 . . . . 0.0 110.482 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -81.5 165.85 20.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.246 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.641 ' H ' HD22 ' A' ' 298' ' ' LEU . 2.0 mm? -67.85 -17.78 64.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.51 -172.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -105.3 22.05 16.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.299 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -78.76 119.04 75.82 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.45 137.23 10.27 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.222 1.948 . . . . 0.0 111.94 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.44 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 88.4 m-85 -123.98 120.63 33.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.5 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 46.5 t80 -75.87 110.25 10.16 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.239 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 332' ' ' ASP . 51.8 t -99.05 137.38 26.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.412 -175.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -57.53 126.43 27.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.236 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 28.5 m120 75.72 -6.84 1.91 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.377 0.671 . . . . 0.0 112.33 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -114.74 -20.76 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.813 0.34 . . . . 0.0 111.527 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 76.66 -152.63 41.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -59.2 115.34 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.765 0.317 . . . . 0.0 110.419 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.424 ' CB ' HG22 ' A' ' 328' ' ' ILE . 19.8 m -129.01 166.2 19.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.988 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 12.4 t -161.94 -178.58 6.54 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.493 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 69.8 m-85 -95.65 -35.91 11.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.63 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -123.71 70.92 48.73 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.29 -35.62 96.61 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.263 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.6 p -68.03 -20.82 65.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.246 0.546 . . . . 0.0 110.511 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 68.0 tp -88.15 -44.04 11.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.114 175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.2 m -55.05 -39.79 69.59 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.562 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 11.3 p -71.23 -23.38 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.73 -39.2 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.158 0.504 . . . . 0.0 110.098 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -80.12 -58.35 3.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.027 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -92.95 -25.46 18.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.916 0.389 . . . . 0.0 111.312 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 90.36 22.09 35.85 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.064 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.445 ' HA ' ' HD3' ' A' ' 324' ' ' PRO . 61.4 mt -115.41 114.55 42.73 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 323' ' ' ILE . 5.4 Cg_exo -76.96 103.71 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.79 2.327 . . . . 0.0 110.768 177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 48.1 m -103.85 156.99 17.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.376 -168.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 59.9 m -81.56 165.34 21.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.61 170.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -92.25 124.16 36.12 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.45 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -67.8 165.3 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.183 0.516 . . . . 0.0 110.933 -175.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -122.79 138.9 54.5 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.82 112.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.057 0.456 . . . . 0.0 110.344 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 115.07 6.11 19.01 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.185 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 304' ' ' VAL . 5.7 m-20 -81.05 134.53 35.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.106 0.479 . . . . 0.0 111.594 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 2.4 t -79.63 125.58 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.419 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 72.5 m -94.49 119.58 33.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.4 mt -100.99 141.59 22.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.83 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.48 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 78.2 Cg_endo -86.67 166.1 8.92 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.253 2.635 . . . . 0.0 112.442 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.75 115.45 4.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.676 2.251 . . . . 0.0 111.805 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 119.49 -16.57 10.51 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.313 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -67.7 127.25 93.36 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.22 -24.63 51.55 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.569 2.846 . . . . 0.0 114.211 -172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.26 -35.16 48.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.618 0.247 . . . . 0.0 110.647 175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -71.53 86.41 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 110.136 174.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 37.9 mt -74.5 -53.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.17 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.97 74.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.367 -174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.048 178.314 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.786 0 N-CA-C 110.652 -0.557 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -92.08 103.69 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 110.167 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.6 p -84.58 141.31 30.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.767 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 8.9 mm -85.85 -42.79 16.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.293 0.568 . . . . 0.0 109.657 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -154.65 128.69 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.908 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.7 t-80 57.63 -149.67 0.46 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -177.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.559 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 34.2 t -88.61 43.75 1.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.688 -0.632 . . . . 0.0 110.397 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 294' ' ' VAL . 65.3 m-85 -114.31 138.53 50.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.201 0.524 . . . . 0.0 111.274 176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.4 176.09 5.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.328 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.515 ' HG3' ' CD ' ' A' ' 235' ' ' GLU . 88.1 tttt -62.54 141.99 58.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.292 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.26 4.7 64.27 Favored Glycine 0 CA--C 1.517 0.178 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.401 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 89.1 m -94.69 149.15 21.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -113.44 143.32 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.96 0.409 . . . . 0.0 110.973 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 63.5 mt -118.18 148.94 41.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.076 -174.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . 0.683 ' SG ' ' HA ' ' A' ' 229' ' ' LYS . 35.0 t -154.13 101.33 2.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.996 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -86.38 98.06 10.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 291' ' ' LEU . 22.6 m170 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.788 ' HA ' ' HA3' ' A' ' 290' ' ' GLY . 40.2 tttp -48.34 -40.66 26.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.986 173.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -110.69 -168.21 1.28 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.6 p -82.67 42.45 0.77 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.936 0.398 . . . . 0.0 110.684 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 222' ' ' CYS . 22.3 t-20 -122.38 96.79 5.18 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.602 0.715 . . . . 0.0 111.07 -176.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.683 ' HA ' ' SG ' ' A' ' 222' ' ' CYS . 0.0 OUTLIER -115.41 19.58 15.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.841 0.829 . . . . 0.0 110.544 174.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -107.14 139.69 41.16 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.335 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 62.8 m95 -74.29 130.27 39.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.368 0.604 . . . . 0.0 111.912 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 11.7 pt20 -132.15 156.41 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.989 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.79 154.27 38.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -58.29 -47.61 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 168.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.515 ' CD ' ' HG3' ' A' ' 217' ' ' LYS . 4.6 mt-10 -59.05 -21.59 59.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.501 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.0 -52.35 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.204 177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.513 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 50.7 t80 -62.86 -48.45 78.99 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.011 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -57.05 -34.92 68.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.006 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 235' ' ' GLU . 11.2 ttm180 -71.53 -45.11 63.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.518 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.6 63.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.494 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 255' ' ' LYS . . . -90.75 28.0 1.64 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.135 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.9 m -56.58 -29.84 62.52 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 168.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 1.098 ' HA ' ' HG2' ' A' ' 247' ' ' GLU . 7.9 p -73.49 116.37 13.98 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.415 166.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.6 -18.58 63.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 122.139 0.971 . . . . 0.0 108.642 175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.74 ' O ' ' HB ' ' A' ' 253' ' ' THR . 1.5 m-20 -136.11 -68.67 0.5 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.222 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.661 ' HG3' ' C ' ' A' ' 245' ' ' ASN . 8.5 mt-10 -154.68 18.61 0.46 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -161.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 1.098 ' HG2' ' HA ' ' A' ' 243' ' ' CYS . 0.1 OUTLIER -59.23 -48.19 82.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.118 0.417 . . . . 0.0 111.238 -171.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -105.8 -40.9 5.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.41 -69.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -168.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 246' ' ' GLU . 0.0 OUTLIER 179.49 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -171.026 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 56.0 ttp -75.63 68.21 2.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.188 0.518 . . . . 0.0 109.911 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.54 89.03 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.202 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.74 ' HB ' ' O ' ' A' ' 245' ' ' ASN . 27.6 m -153.03 -77.51 0.12 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 245' ' ' ASN . 64.1 t60 65.12 114.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.808 0.692 . . . . 0.0 112.056 175.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.613 ' HD2' ' HB1' ' A' ' 241' ' ' ALA . 47.6 mtpt -80.55 40.3 0.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -118.7 3.76 14.97 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.915 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.648 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 41.6 t80 -72.72 121.18 19.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.282 0.541 . . . . 0.0 109.594 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 88.28 15.97 59.74 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.418 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.9 p -69.11 -15.09 63.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -107.93 -26.59 10.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 284' ' ' PRO . . . 159.49 156.74 8.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.638 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 1.9 mp -123.88 100.11 6.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.392 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 76.0 tttt -84.42 124.4 31.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -175.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.0 tt -65.36 104.59 0.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.846 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 283' ' ' ASP . 69.5 mt -80.52 -45.83 16.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.6 t -152.01 164.61 36.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.804 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.53 ' HD2' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -137.87 139.66 40.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.493 -168.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -146.31 140.98 26.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.283 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -107.76 109.81 21.47 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.047 0.451 . . . . 0.0 109.792 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -124.3 179.89 4.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.221 -171.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.15 119.76 62.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 109.784 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 13.1 t -130.24 140.98 50.66 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.9 p90 47.33 28.7 1.11 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.803 0.841 . . . . 0.0 111.922 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 95.82 -16.55 60.96 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.325 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -108.04 148.22 30.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.05 0.452 . . . . 0.0 111.509 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 22.6 m -67.54 128.97 38.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 172.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.01 155.63 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.826 0.822 . . . . 0.0 112.551 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.21 110.41 21.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.17 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -97.82 106.77 19.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.507 HD11 ' CE1' ' A' ' 312' ' ' PHE . 20.5 mt -114.46 139.26 49.67 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.4 m -103.76 120.8 41.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.567 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 81.8 m-85 -109.39 163.75 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 262' ' ' LEU . 31.9 t70 -132.75 137.56 30.01 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.846 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.648 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 93.5 Cg_endo -83.24 9.42 4.1 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.241 1.961 . . . . 0.0 112.674 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.42 -11.19 50.78 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.9 t -153.18 114.75 4.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.544 0.688 . . . . 0.0 109.718 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.21 -8.71 11.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.985 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.25 -23.18 66.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.905 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.76 -42.97 20.92 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.758 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.788 ' HA3' ' HA ' ' A' ' 225' ' ' LYS . . . 141.7 153.52 5.95 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.992 177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 224' ' ' HIS . 1.9 mt -73.15 155.18 39.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.011 0.434 . . . . 0.0 110.931 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -136.09 119.49 16.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 19.0 m -110.38 137.05 48.62 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 215' ' ' PHE . 90.9 t -130.73 134.93 61.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.159 -176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 32.8 mt-10 -117.83 120.66 38.6 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 172.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.519 ' HB3' HG23 ' A' ' 219' ' ' THR . 3.9 p -137.44 172.32 13.15 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.636 -178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.21 162.04 23.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.103 0.478 . . . . 0.0 110.777 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.697 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.4 mm? -69.72 -8.9 51.89 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.123 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -105.03 13.87 30.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.416 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -73.43 116.59 52.82 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.826 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.14 119.4 5.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.247 1.965 . . . . 0.0 111.584 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.65 119.38 38.85 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 12.1 t80 -74.27 106.35 5.87 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.507 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.0 t -94.45 134.92 30.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.349 0.595 . . . . 0.0 111.273 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.555 ' HB3' HG13 ' A' ' 333' ' ' VAL . 49.8 tttp -58.5 125.27 22.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.329 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 14.4 m120 78.08 -1.95 2.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.407 0.683 . . . . 0.0 112.196 177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -117.75 -28.72 5.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.838 0.352 . . . . 0.0 111.35 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.407 ' HA2' ' CZ ' ' A' ' 303' ' ' TYR . . . 86.15 -152.4 25.62 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.71 116.79 5.08 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.067 0.433 . . . . 0.0 110.091 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.439 ' CB ' HG22 ' A' ' 328' ' ' ILE . 16.5 m -128.66 166.23 19.31 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.368 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 40.5 t -160.85 171.74 18.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.805 0.336 . . . . 0.0 110.649 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.53 ' CE2' ' HD2' ' A' ' 267' ' ' HIS . 56.6 m-85 -86.23 -36.42 19.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.64 174.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -126.25 77.3 72.21 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.454 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 48.8 Cg_exo -57.08 -38.51 95.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.94 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 20.0 m -66.06 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.0 110.796 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 55.9 tp -87.24 -47.25 9.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.995 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.9 m -56.62 -41.83 77.74 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.064 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.545 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.5 p -69.33 -20.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.707 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.01 -43.79 14.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -72.13 -51.56 20.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.076 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -101.49 -20.34 15.15 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.033 0.444 . . . . 0.0 111.026 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 86.28 24.09 41.61 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.409 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 50.2 mt -118.86 113.52 35.95 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 122.888 -0.183 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -71.2 117.02 4.94 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.533 2.155 . . . . 0.0 110.305 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 80.2 m -117.6 155.46 29.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.007 0.432 . . . . 0.0 112.1 -169.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 84.2 m -79.31 164.75 23.84 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.266 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -92.52 120.36 32.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.439 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.06 162.45 3.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.506 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -125.34 150.36 47.25 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 31.1 mm -59.37 113.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.252 0.548 . . . . 0.0 110.681 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.515 ' O ' ' HE3' ' A' ' 263' ' ' LYS . . . 115.87 1.36 21.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.018 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.27 127.33 32.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.178 0.513 . . . . 0.0 110.433 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 263' ' ' LYS . 1.3 p -90.63 133.98 30.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.407 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 303' ' ' TYR . 53.6 t -94.82 131.25 40.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.235 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 72.3 mt -103.14 140.78 21.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.216 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.431 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 65.4 Cg_endo -86.81 167.34 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.88 2.387 . . . . 0.0 111.916 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.09 127.21 17.93 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.459 2.106 . . . . 0.0 111.356 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 111.05 -18.22 26.32 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.431 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -71.27 127.43 91.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.03 -22.28 73.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.255 2.636 . . . . 0.0 113.448 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.17 -25.81 47.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.159 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.48 86.68 2.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.09 -45.66 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.766 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -124.2 75.72 1.4 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.648 0.261 . . . . 0.0 110.459 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.574 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.656 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.1 t -103.86 89.45 3.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.233 0.539 . . . . 0.0 109.934 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 20.6 p -76.82 144.13 39.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.28 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 234' ' ' VAL . 16.4 mm -81.33 -42.08 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 234' ' ' VAL . 68.9 t90 -153.8 139.93 18.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.327 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 53.1 -137.54 1.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 52.1 t -100.35 35.03 2.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.488 0.661 . . . . 0.0 109.968 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -108.97 140.32 42.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.4 0.619 . . . . 0.0 111.656 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.03 175.73 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.023 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -66.66 139.97 57.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.885 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 96.66 12.1 51.61 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.959 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 61.6 m -105.82 146.88 29.32 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -115.65 140.66 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.02 0.438 . . . . 0.0 111.418 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.447 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 80.0 mt -114.53 145.08 42.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.107 -173.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.35 109.1 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.463 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.432 ' CD2' HD23 ' A' ' 292' ' ' LEU . 28.7 m-85 -99.58 115.5 29.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -65.04 -37.56 87.98 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -65.03 -27.55 68.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.887 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -89.64 167.93 12.53 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.318 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 27.1 t -82.18 31.08 0.39 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.978 0.418 . . . . 0.0 110.389 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -120.94 70.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 -176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -3.7 58.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.507 0.67 . . . . 0.0 110.528 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -93.46 161.96 14.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.497 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.514 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 57.7 m95 -80.2 124.86 29.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.435 0.636 . . . . 0.0 111.822 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.588 ' NE2' ' HB2' ' A' ' 237' ' ' PHE . 6.7 pt20 -117.49 162.84 17.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.34 175.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -89.18 160.0 17.19 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.066 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 2.2 t -57.95 -47.9 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -55.26 -22.74 19.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.63 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.93 -56.99 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.641 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.588 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 80.6 t80 -66.55 -40.4 89.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -53.47 -50.98 64.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.754 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -56.08 -29.78 61.05 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -87.46 -35.35 18.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.098 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -91.29 -40.8 11.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -170.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.2 p -90.02 63.26 5.86 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -170.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 37.4 m -76.37 -40.36 51.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.008 172.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 253' ' ' THR . 5.9 t0 178.52 -177.73 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -174.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -106.44 70.46 0.83 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.408 ' HB3' HD12 ' A' ' 249' ' ' ILE . 31.4 mt-10 -79.03 52.07 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.396 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.2 -12.61 52.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.379 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -88.1 11.43 16.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.115 0.96 . . . . 0.0 109.274 173.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 246' ' ' GLU . 7.3 mt -138.77 135.57 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -64.22 74.58 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.295 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 25.6 ttt -156.4 -48.2 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.578 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 64.39 70.17 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.919 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 244' ' ' ASP . 0.2 OUTLIER -65.59 -68.89 0.33 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.512 ' CG ' ' H ' ' A' ' 255' ' ' LYS . 73.2 t60 59.85 -164.25 0.22 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.742 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 254' ' ' HIS . 6.0 tptm -97.96 26.35 5.29 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.521 -0.737 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 77.93 -174.64 54.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 114.929 0.731 . . . . 0.0 114.929 168.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.475 ' OH ' ' HD3' ' A' ' 284' ' ' PRO . 3.2 t80 -48.3 131.87 16.48 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.233 1.013 . . . . 0.0 111.874 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 94.38 42.68 3.91 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.827 174.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.8 m -79.1 -17.95 54.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -104.85 -29.49 10.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.478 0.656 . . . . 0.0 109.684 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 156.38 160.55 10.11 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.75 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 2.5 mp -118.2 100.31 7.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.519 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 25.7 ttpt -83.9 117.05 23.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.214 0.53 . . . . 0.0 110.426 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.406 ' O ' ' HA2' ' A' ' 331' ' ' GLY . 3.2 tt -61.22 103.7 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.136 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.6 mt -78.4 -48.93 14.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.883 0.373 . . . . 0.0 110.444 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.9 t -151.94 167.18 29.2 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.408 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.553 ' CE1' ' HG3' ' A' ' 269' ' ' GLU . 5.6 t60 -141.1 139.81 34.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.294 0.569 . . . . 0.0 111.512 -174.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . 0.448 ' HB3' ' HD2' ' A' ' 279' ' ' LYS . 35.9 tt0 -133.66 144.37 49.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.808 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.553 ' HG3' ' CE1' ' A' ' 267' ' ' HIS . 25.6 mt-10 -115.85 133.19 56.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.814 0.34 . . . . 0.0 110.133 176.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 t -155.56 -179.62 8.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.701 -170.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.44 131.61 68.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.146 0.498 . . . . 0.0 110.316 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 14.2 t -126.79 107.52 10.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.151 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 57.2 48.74 14.65 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.166 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 83.94 -12.58 52.9 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.175 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.04 125.35 51.45 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.652 -0.322 . . . . 0.0 111.02 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 67.7 m -64.45 134.73 55.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.56 155.6 41.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.972 0.891 . . . . 0.0 112.945 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.401 ' HB2' ' SG ' ' A' ' 296' ' ' CYS . 74.7 mt -96.71 116.69 29.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.313 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 294' ' ' VAL . 22.4 ttmm -107.29 114.08 27.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.468 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 26.9 mt -114.63 135.59 53.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.868 0.366 . . . . 0.0 110.344 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 12.4 m -97.64 115.57 28.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.559 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 61.7 m-85 -106.06 163.54 12.69 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -170.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 265' ' ' LEU . 20.1 t70 -132.0 137.87 31.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.327 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.475 ' HD3' ' OH ' ' A' ' 257' ' ' TYR . 86.7 Cg_endo -87.03 11.13 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.341 2.027 . . . . 0.0 112.649 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.89 -12.73 56.23 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.27 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 t -153.49 134.87 14.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.974 0.416 . . . . 0.0 110.088 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.01 -8.52 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.525 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -55.07 -49.28 72.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.95 2.59 38.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.863 0.363 . . . . 0.0 110.905 -175.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 84.91 179.13 51.11 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.157 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mt -84.47 135.45 34.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.966 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' A' ' 223' ' ' PHE . 1.3 tm? -111.37 120.12 41.13 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.413 ' N ' HD22 ' A' ' 292' ' ' LEU . 25.4 m -112.73 135.92 52.91 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 279' ' ' LYS . 96.2 t -132.27 135.42 58.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.743 -174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 83.2 mt-10 -107.52 120.4 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 169.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.579 ' SG ' ' HZ ' ' A' ' 302' ' ' PHE . 7.1 p -131.88 173.37 11.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 -177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -74.68 164.9 26.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.644 0.259 . . . . 0.0 110.941 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.66 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.9 mm? -66.2 -28.84 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.336 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.73 26.11 5.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.293 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -77.63 116.77 60.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.485 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.44 125.15 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.256 1.971 . . . . 0.0 111.646 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.579 ' HZ ' ' SG ' ' A' ' 296' ' ' CYS . 94.4 m-85 -111.45 116.3 30.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.525 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 334' ' ' CYS . 17.9 t80 -74.67 104.66 5.42 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.487 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 53.1 t -92.38 134.73 29.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.832 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.663 ' HB3' HG13 ' A' ' 333' ' ' VAL . 45.9 tttt -59.47 120.7 9.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.225 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 15.6 m120 74.45 6.9 4.59 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.004 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -117.02 -30.41 5.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.002 0.429 . . . . 0.0 110.582 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 91.91 -155.8 23.32 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -64.47 116.09 5.78 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.944 0.402 . . . . 0.0 110.033 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.453 ' CB ' HG22 ' A' ' 328' ' ' ILE . 15.6 m -124.83 167.47 14.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.077 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 39.9 t -160.57 165.86 30.04 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.818 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.468 ' CZ ' HD21 ' A' ' 280' ' ' LEU . 60.3 m-85 -86.83 -16.55 35.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.281 173.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -142.11 73.35 22.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.73 -41.03 77.52 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.812 2.341 . . . . 0.0 112.581 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 14.6 m -60.42 -29.04 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.27 -46.09 10.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.253 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.2 m -57.34 -41.24 79.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.158 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 12.5 p -68.82 -19.86 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.039 0.447 . . . . 0.0 111.573 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 97.7 t -89.96 -45.07 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.075 0.464 . . . . 0.0 110.265 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -71.9 -58.7 3.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.314 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -95.75 -13.78 23.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.832 0.348 . . . . 0.0 110.732 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 85.1 10.75 77.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.859 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.4 mt -108.82 117.56 53.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 122.741 -0.27 . . . . 0.0 111.008 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.89 116.76 4.83 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.513 2.142 . . . . 0.0 110.409 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . . . . . . . . . 63.1 m -117.2 159.06 23.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.376 0.608 . . . . 0.0 112.462 -168.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 61.4 m -81.59 151.0 27.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.142 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.69 120.06 22.09 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.453 HG22 ' CB ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -70.31 165.57 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.891 0.853 . . . . 0.0 111.413 -174.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -121.94 141.63 51.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.373 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 28.8 mm -58.09 113.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.366 0.603 . . . . 0.0 109.673 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 264' ' ' LEU . . . 116.41 -0.92 20.56 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.78 -174.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -71.33 124.77 25.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.208 0.527 . . . . 0.0 111.181 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.4 p -89.57 126.08 42.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.859 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 214' ' ' CYS . 53.1 t -88.96 135.09 33.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.061 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 214' ' ' CYS . 81.4 mt -106.37 144.07 28.26 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.631 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.3 160.61 13.11 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.474 2.116 . . . . 0.0 111.757 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.77 114.84 3.1 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.965 2.444 . . . . 0.0 112.25 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 115.29 -13.68 18.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.519 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.46 132.42 94.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.71 -31.1 49.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.105 3.204 . . . . 0.0 114.349 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -79.18 -23.12 44.08 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.99 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.07 95.76 3.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.066 0.46 . . . . 0.0 110.333 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.36 -42.27 81.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.855 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -139.62 98.14 3.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.091 -176.291 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 110.834 -0.487 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 10.6 t -103.52 110.63 22.75 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.5 p -94.9 150.76 19.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.287 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 253' ' ' THR . 32.5 mm -79.28 -45.96 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.376 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TRP . . . . . 0.679 ' HE1' ' HB2' ' A' ' 255' ' ' LYS . 78.5 t90 -151.36 136.71 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.445 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 214' ' ' CYS . 44.2 t-80 56.04 -133.54 1.49 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 213' ' ' HIS . 14.9 p -99.17 26.61 5.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.012 0.434 . . . . 0.0 110.867 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -105.61 135.41 47.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.448 . . . . 0.0 111.952 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.57 174.84 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.424 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -64.31 139.34 58.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.847 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 98.77 12.05 44.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.138 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 234' ' ' VAL . 30.8 m -102.38 158.18 16.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.24 151.59 42.15 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.416 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 56.5 mt -122.31 145.72 47.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.082 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' CYS . . . . . . . . . . . . . 43.5 t -153.13 92.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.658 175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -78.61 123.02 26.67 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -67.95 -20.43 65.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 0.0 111.632 -174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -76.94 -7.56 55.78 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.834 0.349 . . . . 0.0 110.92 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -97.12 170.78 8.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.026 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.2 m -96.42 7.72 45.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.459 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -91.58 84.89 5.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -9.07 59.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.708 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -94.81 153.14 17.88 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' TRP . . . . . 0.447 ' CZ2' ' HG3' ' A' ' 295' ' ' GLU . 88.3 m95 -74.08 120.04 19.12 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 221' ' ' LEU . 10.2 pt20 -100.09 158.97 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.532 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.05 164.35 21.46 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.163 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.468 ' CG2' ' HB ' ' A' ' 219' ' ' THR . 1.1 t -66.27 -39.06 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -68.23 -22.05 64.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.503 -174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.69 -53.32 12.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.33 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.496 ' HB2' ' NE2' ' A' ' 232' ' ' GLN . 88.1 t80 -74.68 -40.31 61.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.236 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 212' ' ' TRP . . . -61.06 -35.4 76.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.842 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -67.76 -24.54 65.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.607 0.718 . . . . 0.0 109.909 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -80.6 -9.6 59.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.715 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.51 ' HA ' ' NZ ' ' A' ' 255' ' ' LYS . . . -80.69 -48.91 11.89 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.155 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 96.4 p 178.18 -145.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.58 -33.98 15.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.956 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -168.31 175.17 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -171.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -74.86 72.11 2.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.702 0.763 . . . . 0.0 109.622 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -76.05 40.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.628 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.93 -16.32 60.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.059 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -82.85 -30.45 28.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.2 -56.41 7.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.529 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -168.17 -61.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.327 . . . . 0.0 110.413 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 53.7 ttm -161.29 148.16 14.76 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -165.45 -128.88 1.0 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.681 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 211' ' ' ILE . 9.2 m -61.8 -15.18 39.4 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.606 0.717 . . . . 0.0 110.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.79 76.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 166.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.679 ' HB2' ' HE1' ' A' ' 212' ' ' TRP . 22.0 tptt -62.66 -56.31 18.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.73 -162.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 150.98 -59.26 0.43 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.256 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.661 ' CE2' ' HG3' ' A' ' 284' ' ' PRO . 38.3 t80 -61.27 114.93 3.44 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.95 11.15 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.656 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 22.9 t -78.81 -24.82 44.29 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.704 0.288 . . . . 0.0 110.552 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -99.39 -25.37 14.49 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 155.39 168.0 17.83 Favored Glycine 0 N--CA 1.433 -1.518 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.646 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 282' ' ' PHE . 3.2 mp -124.04 102.79 7.93 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.771 -0.714 . . . . 0.0 110.138 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 333' ' ' VAL . 75.5 tttt -87.49 119.12 27.45 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.0 110.796 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.51 107.87 0.74 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.163 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 283' ' ' ASP . 71.7 mt -83.13 -45.83 13.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.0 0.429 . . . . 0.0 110.48 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 32.8 t -151.88 156.33 39.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.211 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.406 ' ND1' HD23 ' A' ' 280' ' ' LEU . 5.8 t60 -139.12 138.22 36.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -131.57 141.46 49.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.397 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -105.28 129.61 53.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.1 t -148.47 178.52 8.54 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -118.3 122.94 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 109.763 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 67.8 m -115.29 94.27 4.65 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.31 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 57.9 65.73 1.25 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.347 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 78.99 -12.85 22.14 Favored Glycine 0 CA--C 1.518 0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 113.589 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.94 122.93 49.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.992 0.396 . . . . 0.0 110.733 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.5 m -71.63 129.66 39.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 9.5 m -130.04 152.59 37.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 122.029 0.918 . . . . 0.0 112.897 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.64 112.87 24.98 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.591 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -102.87 110.0 21.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.418 HD21 ' CZ ' ' A' ' 312' ' ' PHE . 23.0 mt -115.34 129.73 56.69 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.176 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 87.7 m -98.94 117.17 32.84 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.444 ' HB3' ' HG ' ' A' ' 262' ' ' LEU . 86.0 m-85 -104.51 167.02 10.01 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.137 -170.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.457 ' HB2' HD21 ' A' ' 265' ' ' LEU . 21.9 t70 -132.34 134.52 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.413 175.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.661 ' HG3' ' CE2' ' A' ' 257' ' ' TYR . 87.2 Cg_endo -83.72 12.11 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.143 1.895 . . . . 0.0 112.332 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.78 -5.64 62.06 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 5.0 t -153.71 102.94 2.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.911 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 291' ' ' LEU . 12.1 p -61.52 -15.28 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.421 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.16 -28.24 69.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.671 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -72.27 -40.5 67.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 110.161 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 138.85 152.72 5.98 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.422 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 287' ' ' VAL . 85.1 mt -82.26 147.76 28.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.221 0.511 . . . . 0.0 110.638 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 294' ' ' VAL . 1.5 tm? -125.05 118.32 25.92 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 83.8 m -110.3 134.0 52.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.403 HG23 HD13 ' A' ' 292' ' ' LEU . 75.3 t -130.33 136.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.561 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.447 ' HG3' ' CZ2' ' A' ' 231' ' ' TRP . 62.5 mt-10 -112.54 127.94 56.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.105 170.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 6.0 p -139.82 176.28 8.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.93 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.94 164.17 26.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.913 0.387 . . . . 0.0 110.329 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.716 ' H ' HD22 ' A' ' 298' ' ' LEU . 1.7 mm? -64.85 -17.84 64.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.245 -173.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.35 17.89 20.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.979 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -76.92 118.47 72.07 Favored Pre-proline 0 C--N 1.323 -0.563 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.339 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -78.58 139.82 16.36 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.104 1.869 . . . . 0.0 111.677 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.471 ' HB3' ' SG ' ' A' ' 334' ' ' CYS . 80.9 m-85 -124.5 129.73 51.16 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.509 ' CE1' ' HA ' ' A' ' 342' ' ' ALA . 16.9 t80 -82.63 89.62 6.74 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.498 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.562 HG13 ' HB2' ' A' ' 332' ' ' ASP . 74.8 t -75.83 125.91 35.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.068 -177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.658 ' HB3' HG13 ' A' ' 333' ' ' VAL . 62.9 tttp -56.09 141.4 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.641 176.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 305' ' ' LYS . 8.4 m-20 78.21 -20.04 0.41 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.47 0.708 . . . . 0.0 111.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -105.2 -60.53 1.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 111.345 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 125.76 -124.34 5.19 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.25 117.39 28.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.765 0.782 . . . . 0.0 110.606 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 37.8 m -131.8 167.88 18.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.23 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.3 t -161.34 -177.34 5.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 328' ' ' ILE . 71.6 m-85 -91.81 -39.09 11.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.22 73.2 57.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.877 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 325' ' ' CYS . 50.6 Cg_exo -57.17 -34.21 97.34 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.121 2.547 . . . . 0.0 113.213 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 11.8 p -65.35 -30.02 70.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 60.8 tp -83.15 -44.11 15.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.157 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.1 m -55.36 -44.16 75.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.151 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 322' ' ' GLY . 13.7 p -69.81 -27.04 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.689 0.28 . . . . 0.0 111.541 -176.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.7 -38.52 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.285 0.565 . . . . 0.0 110.186 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.26 -58.19 3.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.051 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -98.97 -8.46 25.42 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 318' ' ' VAL . . . 76.25 21.44 75.62 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 52.2 mt -116.58 111.22 41.78 Favored Pre-proline 0 C--N 1.327 -0.394 0 O-C-N 122.876 -0.191 . . . . 0.0 110.646 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -72.33 117.95 5.37 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.582 2.188 . . . . 0.0 110.534 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' CYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 314' ' ' PRO . 58.0 m -117.38 157.65 25.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.711 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' CYS . . . . . . . . . . . . . 72.6 m -87.38 165.2 15.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.232 171.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.76 127.04 33.06 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.085 -0.384 . . . . 0.0 109.97 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.424 HD11 ' CE2' ' A' ' 312' ' ' PHE . 0.1 OUTLIER -72.27 177.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 0.0 110.598 -179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -139.19 141.07 37.97 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ILE . . . . . . . . . . . . . 33.6 mm -52.34 112.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.234 0.54 . . . . 0.0 109.575 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.49 9.13 15.27 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.735 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.562 ' HB2' HG13 ' A' ' 304' ' ' VAL . 0.2 OUTLIER -72.29 127.99 34.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 305' ' ' LYS . 1.5 p -96.61 111.95 27.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.946 0.879 . . . . 0.0 111.051 175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 302' ' ' PHE . 60.7 m -79.24 127.84 32.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.145 -1.389 . . . . 0.0 111.112 -177.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' LEU . . . . . . . . . . . . . 69.5 mt -98.75 138.95 20.77 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.066 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 213' ' ' HIS . 54.6 Cg_endo -86.14 176.65 4.99 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.923 2.415 . . . . 0.0 111.734 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.96 155.1 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.255 1.97 . . . . 0.0 111.029 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.0 -23.14 5.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.564 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -65.32 126.26 91.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -24.49 79.22 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.096 2.531 . . . . 0.0 113.152 -173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.94 -25.15 40.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 303' ' ' TYR . . . -77.21 84.87 3.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.392 0.615 . . . . 0.0 109.507 173.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.26 -44.54 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.639 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.74 44.24 1.94 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.93 0.395 . . . . 0.0 110.616 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.093 -178.345 . . . . . . . . 0 0 . 1 stop_ save_